1	Articles	NNPS	O	Articles	_	0	SENT_1	[p1l101t169r251b205],

1	Effect	NN	O	effect	_	0	SENT_2	[p1l358t359r527b414],
2	of	IN	O	of	_	0	SENT_2	[p1l543t359r607b414],
3	ADRB2	NN	O	adrb2	nn	4	SENT_2	[p1l618t364r818b414],
4	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_2	[p1l837t360r1310b431],
5	on	IN	O	on	dep	1	SENT_2	[p1l1327t378r1401b414],
6	response	NN	O	response	pobj	5	SENT_2	[p1l1423t378r1686b430],
7	to	TO	O	to	_	0	SENT_2	[p1l1700t369r1765b414],
8	Iongacting	VBG	O	iongact	prepc_to	6	SENT_2	[p1l1785t360r2105b431],
9	[	CD	NUMBER	[	num	11	SENT_2	[p1l358t450r666b522],
10	3,-agonist	JJ	O	3,-agonist	amod	11	SENT_2	[p1l358t450r666b522],
11	therapy	NN	O	therapy	dobj	8	SENT_2	[p1l679t450r930b521],
12	:	:	O	:	_	0	SENT_2	[p1l679t450r930b521],
13	a	DT	O	a	det	15	SENT_2	[p1l950t468r981b505],
14	pharmacogenetic	JJ	O	pharmacogenetic	amod	15	SENT_2	[p1l998t450r1524b522],
15	analysis	NN	O	analysis	dep	11	SENT_2	[p1l1541t450r1777b521],
16	of	IN	O	of	_	0	SENT_2	[p1l1794t450r1858b505],
17	two	CD	NUMBER	two	num	19	SENT_2	[p1l1868t459r1989b505],
18	randomised	JJ	O	randomised	amod	19	SENT_2	[p1l358t542r714b597],
19	studies	NNS	O	study	prep_of	15	SENT_2	[p1l731t542r945b597],

1	Eugene	NNP	PERSON	Eugene	nn	2	SENT_3	[p1l355t665r445b696],
2	R	NNP	PERSON	R	dep	8	SENT_3	[p1l453t665r468b688],
3	Bleecker	NNP	PERSON	Bleecker	nn	5	SENT_3	[p1l476t662r582b693],
4	,	,	O	,	_	0	SENT_3	[p1l476t662r582b693],
5	Dirl	NNP	O	Dirl	dep	2	SENT_3	[p1l591t662r683b696],
6	<	JJR	O	<	amod	7	SENT_3	[p1l591t662r683b696],
7	jeS	NN	O	je	dep	8	SENT_3	[p1l591t662r683b696],
8	Postma	NNP	PERSON	Postma	_	0	SENT_3	[p1l691t665r793b693],
9	,	,	O	,	_	0	SENT_3	[p1l691t665r793b693],
10	Rachael	NNP	PERSON	Rachael	nn	12	SENT_3	[p1l802t662r900b688],
11	M	NNP	PERSON	M	nn	12	SENT_3	[p1l907t664r930b688],
12	Lawrance	NNP	PERSON	Lawrance	appos	8	SENT_3	[p1l940t664r1066b693],
13	,	,	O	,	_	0	SENT_3	[p1l940t664r1066b693],
14	Deborah	NNP	PERSON	Deborah	nn	16	SENT_3	[p1l1075t662r1180b688],
15	A	NNP	PERSON	A	nn	16	SENT_3	[p1l1187t664r1205b688],
16	Meyers	NNP	PERSON	Meyers	appos	8	SENT_3	[p1l1214t664r1309b696],
17	,	,	O	,	_	0	SENT_3	[p1l1214t664r1309b696],
18	Helen	NNP	PERSON	Helen	nn	20	SENT_3	[p1l1318t662r1387b688],
19	}	NNP	O	}	nn	20	SENT_3	[p1l1391t664r1402b694],
20	Ambrose	NNP	O	Ambrose	appos	8	SENT_3	[p1l1409t662r1528b693],
21	,	,	O	,	_	0	SENT_3	[p1l1409t662r1528b693],
22	Mitch	NNP	PERSON	Mitch	nn	23	SENT_3	[p1l1537t662r1610b688],
23	Goldman	NNP	PERSON	Goldman	appos	8	SENT_3	[p1l1618t662r1733b688],

1	Summary	NN	O	summary	nn	2	SENT_4	[p1l6t749r184b790],
2	Lancet2007	NN	O	lancet2007	_	0	SENT_4	[p1l47t806r183b828],
3	;	:	O	;	_	0	SENT_4	[p1l47t806r183b828],
4	370	CD	NUMBER	370	num	6	SENT_4	[p1l200t807r246b827],
5	:	:	O	:	_	0	SENT_4	[p1l200t807r246b827],
6	2118-25	CD	NUMBER	2118-25	dep	2	SENT_4	[p1l263t804r353b827],
7	Background	NNP	O	Background	nn	9	SENT_4	[p1l403t797r584b834],
8	New	NNP	O	New	nn	9	SENT_4	[p1l606t799r675b825],
9	evidence	NN	O	evidence	nsubj	11	SENT_4	[p1l695t796r831b825],
10	has	VBZ	O	have	aux	11	SENT_4	[p1l852t796r905b825],
11	suggested	VBN	O	suggest	rcmod	6	SENT_4	[p1l927t796r1082b834],
12	that	IN	O	that	_	0	SENT_4	[p1l1102t796r1163b825],
13	people	NNS	O	people	prep_that	11	SENT_4	[p1l1184t796r1287b834],
14	with	IN	O	with	_	0	SENT_4	[p1l1307t796r1376b825],
15	asthma	NN	O	asthma	prep_with	13	SENT_4	[p1l1396t796r1511b825],
16	who	WP	O	who	nsubj	18	SENT_4	[p1l1532t796r1598b825],
17	are	VBP	O	be	cop	18	SENT_4	[p1l1619t807r1666b825],
18	homozygous	JJ	O	homozygous	rcmod	13	SENT_4	[p1l1687t796r1887b834],
19	for	IN	O	for	_	0	SENT_4	[p1l1909t796r1954b825],
20	arginine	NN	O	arginine	prep_for	18	SENT_4	[p1l1974t797r2105b834],
21	at	IN	O	at	_	0	SENT_4	[p1l2126t802r2154b825],
22	aminoacid	JJ	O	aminoacid	amod	23	SENT_4	[p1l6t842r170b870],
23	16	CD	NUMBER	16	prep_at	18	SENT_4	[p1l181t844r214b870],

1	See	VB	O	see	csubj	13	SENT_5	[p1l71t899r106b917],
2	Commentpage	NNP	O	Commentpage	dobj	1	SENT_5	[p1l124t899r287b924],
3	2075	CD	DATE	2075	num	2	SENT_5	[p1l306t900r356b920],
4	of	IN	O	of	_	0	SENT_5	[p1l405t887r441b916],
5	the	DT	O	the	det	11	SENT_5	[p1l442t887r491b916],
6	[	CD	NUMBER	[	num	11	SENT_5	[p1l512t887r718b925],
7	3,-adrenergic	JJ	O	3,-adrenergic	amod	11	SENT_5	[p1l512t887r718b925],
8	receptor	NN	O	receptor	nn	11	SENT_5	[p1l736t893r865b925],
9	(	NN	O	(	nn	11	SENT_5	[p1l885t889r1024b925],
10	ADRB2	NN	O	adrb2	nn	11	SENT_5	[p1l885t889r1024b925],
11	)	NN	O	)	prep_of	2	SENT_5	[p1l885t889r1024b925],
12	might	MD	O	might	aux	13	SENT_5	[p1l1044t887r1139b925],
13	notbeneﬁt	VB	O	notbeneﬁt	_	0	SENT_5	[p1l1157t887r1324b916],
14	from	IN	O	from	_	0	SENT_5	[p1l1342t887r1419b916],
15	Iongacting	VBG	O	iongact	prepc_from	13	SENT_5	[p1l1438t887r1603b925],
16	[	NN	O	[	nn	17	SENT_5	[p1l1623t887r1905b925],
17	3,-agonisttherapy	NN	O	3,-agonisttherapy	dobj	15	SENT_5	[p1l1623t887r1905b925],
18	.	.	O	.	_	0	SENT_5	[p1l1623t887r1905b925],

1	We	PRP	O	we	nsubj	5	SENT_6	[p1l1924t890r1983b920],
2	,	,	O	,	_	0	SENT_6	[p1l1924t890r1983b920],
3	therefore	RB	O	therefore	advmod	1	SENT_6	[p1l2003t887r2154b920],
4	,	,	O	,	_	0	SENT_6	[p1l2003t887r2154b920],
5	investigated	VBD	O	investigate	_	0	SENT_6	[p1l6t933r194b971],
6	(	CD	NUMBER	(	num	8	SENT_6	[p1l205t946r399b966],
7	jenterfm-Human	NN	MISC	jenterfm-human	nn	8	SENT_6	[p1l205t946r399b966],
8	genomics	NNS	O	genomic	dobj	5	SENT_6	[p1l407t947r519b969],
9	,	,	O	,	_	0	SENT_6	[p1l407t947r519b969],
10	whether	IN	O	whether	complm	13	SENT_6	[p1l557t933r686b962],
11	ADRB2	NN	O	adrb2	nn	12	SENT_6	[p1l716t935r837b961],
12	polymorphisms	NNS	O	polymorphism	nsubj	13	SENT_6	[p1l867t933r1114b971],
13	affect	VBP	O	affect	ccomp	5	SENT_6	[p1l1146t933r1231b962],
14	response	NN	O	response	dobj	13	SENT_6	[p1l1262t943r1402b970],
15	to	TO	O	to	_	0	SENT_6	[p1l1433t939r1462b962],
16	Iongacting	VBG	O	iongact	prepc_to	13	SENT_6	[p1l1493t933r1659b971],
17	B,-agonists	NNS	O	b,-agonist	dobj	16	SENT_6	[p1l1692t933r1860b971],
18	in	IN	O	in	_	0	SENT_6	[p1l1892t935r1923b961],
19	combination	NN	O	combination	prep_in	17	SENT_6	[p1l1955t933r2154b962],
20	With	IN	O	with	_	0	SENT_6	[p1l6t978r75b1007],
21	inhaled	VBN	O	inhale	prepc_with	16	SENT_6	[p1l105t978r223b1007],
22	Wake	NNP	ORGANIZATION	Wake	nn	26	SENT_6	[p1l230t986r290b1006],
23	Forest	NNP	ORGANIZATION	Forest	nn	26	SENT_6	[p1l297t988r363b1006],
24	University	NNP	ORGANIZATION	University	nn	26	SENT_6	[p1l369t987r481b1012],
25	School	NNP	ORGANIZATION	School	nn	26	SENT_6	[p1l487t986r557b1006],
26	(	NNP	O	(	nsubj	36	SENT_6	[p1l595t983r831b1012],
27	;	:	O	;	_	0	SENT_6	[p1l595t983r831b1012],
28	o1	NN	O	o1	dep	26	SENT_6	[p1l595t983r831b1012],
29	'	''	O	'	_	0	SENT_6	[p1l595t983r831b1012],
30	ﬁ	JJ	O	ﬁ	amod	31	SENT_6	[p1l595t983r831b1012],
31	(	NN	O	(	dep	26	SENT_6	[p1l595t983r831b1012],
32	;	:	O	;	_	0	SENT_6	[p1l595t983r831b1012],
33	oste1	NN	O	oste1	dep	31	SENT_6	[p1l595t983r831b1012],
34	'	''	O	'	_	0	SENT_6	[p1l595t983r831b1012],
35	oids	NNS	O	oid	nn	36	SENT_6	[p1l595t983r831b1012],
36	_	NN	O	_	xcomp	21	SENT_6	[p1l595t983r831b1012],
37	of	IN	O	of	_	0	SENT_6	[p1l6t1022r29b1042],
38	Medicine	NNP	MISC	Medicine	nn	46	SENT_6	[p1l35t1022r139b1046],
39	,	,	O	,	_	0	SENT_6	[p1l35t1022r139b1046],
40	Winston-Salem	NNP	LOCATION	Winston-Salem	appos	46	SENT_6	[p1l144t1022r318b1046],
41	,	,	O	,	_	0	SENT_6	[p1l144t1022r318b1046],
42	NC	NNP	O	NC	appos	46	SENT_6	[p1l6t1061r42b1083],
43	,	,	O	,	_	0	SENT_6	[p1l6t1061r42b1083],
44	USA	NNP	LOCATION	USA	appos	46	SENT_6	[p1l49t1061r93b1079],
45	(	CD	NUMBER	(	num	46	SENT_6	[p1l100t1059r152b1084],
46	Prof	NNP	O	Prof	prep_of	36	SENT_6	[p1l100t1059r152b1084],
47	E	NNP	O	E	nn	50	SENT_6	[p1l158t1061r168b1079],
48	R	NNP	O	R	nn	50	SENT_6	[p1l175t1061r187b1079],
49	Bleecker	NNP	O	Bleecker	nn	50	SENT_6	[p1l194t1059r278b1079],
50	MD	NNP	O	MD	dep	46	SENT_6	[p1l285t1061r325b1083],
51	,	,	O	,	_	0	SENT_6	[p1l285t1061r325b1083],
52	Prof	NNP	O	Prof	nn	56	SENT_6	[p1l100t1095r143b1115],
53	D	NNP	O	D	nn	56	SENT_6	[p1l149t1098r162b1115],
54	A	NNP	O	A	nn	56	SENT_6	[p1l168t1097r183b1115],
55	Meyers	NNP	O	Meyers	nn	56	SENT_6	[p1l190t1097r262b1121],
56	PhD	NNP	O	PhD	appos	46	SENT_6	[p1l270t1096r325b1120],
57	)	NN	O	)	dep	56	SENT_6	[p1l270t1096r325b1120],
58	;	:	O	;	_	0	SENT_6	[p1l270t1096r325b1120],
59	Department	NNP	O	Department	dep	56	SENT_6	[p1l7t1134r139b1158],
60	of	IN	O	of	_	0	SENT_6	[p1l145t1132r169b1152],
61	Pulmonology	NNP	O	Pulmonology	prep_of	59	SENT_6	[p1l174t1132r325b1158],
62	,	,	O	,	_	0	SENT_6	[p1l174t1132r325b1158],

1	Methods	NNS	O	method	nn	2	SENT_7	[p1l7t1216r141b1243],
2	Asthmatics	NNS	O	asthmatic	nsubjpass	4	SENT_7	[p1l151t1215r328b1243],
3	were	VBD	O	be	auxpass	4	SENT_7	[p1l338t1225r413b1243],
4	stratiﬁed	VBN	O	stratiﬁed	_	0	SENT_7	[p1l423t1215r561b1243],
5	by	IN	O	by	_	0	SENT_7	[p1l570t1215r607b1252],
6	ADRB2	NN	O	adrb2	nn	7	SENT_7	[p1l616t1217r737b1243],
7	genotype	NN	O	genotype	agent	4	SENT_7	[p1l745t1220r887b1252],
8	in	IN	O	in	_	0	SENT_7	[p1l897t1216r928b1243],
9	two	CD	NUMBER	two	num	10	SENT_7	[p1l938t1220r994b1243],
10	studies	NNS	O	study	prep_in	7	SENT_7	[p1l1005t1215r1114b1243],
11	to	TO	O	to	aux	12	SENT_7	[p1l1125t1221r1154b1243],
12	assess	VB	O	assess	xcomp	4	SENT_7	[p1l1164t1225r1260b1243],
13	the	DT	O	the	det	14	SENT_7	[p1l1271t1215r1320b1243],
14	eﬂects	NNS	O	eﬂects	dobj	12	SENT_7	[p1l1330t1215r1429b1243],
15	of	IN	O	of	_	0	SENT_7	[p1l1440t1215r1476b1243],
16	inhaled	VBN	O	inhale	prepc_of	14	SENT_7	[p1l1480t1215r1598b1243],
17	corticosteroids	NNS	O	corticosteroid	dobj	16	SENT_7	[p1l1608t1215r1835b1243],
18	plus	CC	O	plus	prep	16	SENT_7	[p1l6t1261r72b1298],
19	Iongacting	JJ	O	iongacting	amod	21	SENT_7	[p1l89t1261r255b1298],
20	[	NN	O	[	nn	21	SENT_7	[p1l272t1260r440b1298],
21	3,-agonists	NNS	O	3,-agonist	dep	18	SENT_7	[p1l272t1260r440b1298],
22	on	IN	O	on	_	0	SENT_7	[p1l458t1271r498b1289],
23	asthma	NN	O	asthma	nn	24	SENT_7	[p1l515t1261r630b1289],
24	exacerbations	NNS	O	exacerbation	prep_on	16	SENT_7	[p1l647t1261r867b1289],
25	.	.	O	.	_	0	SENT_7	[p1l647t1261r867b1289],

1	In	IN	O	in	_	0	SENT_8	[p1l886t1264r920b1289],
2	study	NN	O	study	prep_in	10	SENT_8	[p1l938t1261r1022b1298],
3	1	CD	NUMBER	1	num	2	SENT_8	[p1l1039t1263r1053b1289],
4	(	CD	NUMBER	(	num	6	SENT_8	[p1l1072t1261r1300b1298],
5	double-blind	JJ	O	double-blind	amod	6	SENT_8	[p1l1072t1261r1300b1298],
6	)	NN	O	)	dep	2	SENT_8	[p1l1072t1261r1300b1298],
7	,	,	O	,	_	0	SENT_8	[p1l1072t1261r1300b1298],
8	2250	CD	NUMBER	2250	num	9	SENT_8	[p1l1319t1262r1392b1289],
9	asthmatics	NNS	O	asthmatic	nsubj	10	SENT_8	[p1l1409t1261r1577b1289],
10	were	VBD	O	be	_	0	SENT_8	[p1l1594t1271r1669b1289],
11	randomly	RB	O	randomly	advmod	10	SENT_8	[p1l1686t1261r1837b1298],

1	University	NNP	ORGANIZATION	University	nn	4	SENT_9	[p1l56t1307r168b1332],
2	Medical	NNP	ORGANIZATION	Medical	nn	4	SENT_9	[p1l175t1306r257b1326],
3	Centre	NNP	ORGANIZATION	Centre	nn	4	SENT_9	[p1l264t1308r334b1326],
4	Groningen	NNP	ORGANIZATION	Groningen	nsubj	13	SENT_9	[p1l67t1343r188b1369],
5	,	,	O	,	_	0	SENT_9	[p1l67t1343r188b1369],
6	University	NNP	ORGANIZATION	University	dep	12	SENT_9	[p1l195t1343r307b1368],
7	of	IN	ORGANIZATION	of	_	0	SENT_9	[p1l313t1342r336b1362],
8	Groningen	NNP	ORGANIZATION	Groningen	nn	10	SENT_9	[p1l85t1380r206b1405],
9	,	,	O	,	_	0	SENT_9	[p1l85t1380r206b1405],
10	Groningen	NNP	ORGANIZATION	Groningen	prep_of	6	SENT_9	[p1l213t1380r334b1405],
11	,	,	O	,	_	0	SENT_9	[p1l213t1380r334b1405],
12	Netherlands	NNP	LOCATION	Netherlands	nsubj	13	SENT_9	[p1l202t1415r335b1435],
13	assigned	VBN	O	assign	_	0	SENT_9	[p1l6t1509r143b1547],
14	to	TO	O	to	_	0	SENT_9	[p1l152t1515r182b1537],
15	budesonide	NN	O	budesonide	prep_to	13	SENT_9	[p1l191t1509r374b1537],
16	plus	CC	O	plus	_	0	SENT_9	[p1l384t1509r449b1546],
17	formoterol	NN	O	formoterol	nn	18	SENT_9	[p1l460t1509r629b1537],
18	maintenance	NN	O	maintenance	conj_plus	15	SENT_9	[p1l639t1510r843b1537],
19	and	CC	O	and	_	0	SENT_9	[p1l853t1509r911b1537],
20	reliever	NN	O	reliever	nn	21	SENT_9	[p1l921t1509r1038b1537],
21	therapy	NN	O	therapy	conj_and	18	SENT_9	[p1l1047t1509r1170b1546],
22	,	,	O	,	_	0	SENT_9	[p1l1047t1509r1170b1546],
23	ﬁxed-dose	JJ	O	ﬁxed-dose	amod	24	SENT_9	[p1l1181t1509r1338b1537],
24	budesonide	NN	O	budesonide	conj_plus	15	SENT_9	[p1l1347t1509r1530b1537],
25	plus	CC	O	plus	prep	24	SENT_9	[p1l1540t1509r1605b1546],
26	formoterol	NN	O	formoterol	dep	25	SENT_9	[p1l1616t1509r1793b1542],
27	,	,	O	,	_	0	SENT_9	[p1l1616t1509r1793b1542],
28	or	CC	O	or	_	0	SENT_9	[p1l1804t1519r1837b1537],
29	ﬁxed-dose	JJ	O	ﬁxed-dose	amod	30	SENT_9	[p1l6t1555r163b1583],
30	ﬂuticasone	NN	O	ﬂuticasone	conj_or	15	SENT_9	[p1l174t1555r345b1583],
31	plus	CC	O	plus	prep	30	SENT_9	[p1l357t1555r422b1592],
32	salmeterol	NN	O	salmeterol	dep	31	SENT_9	[p1l435t1555r599b1583],
33	for	IN	O	for	_	0	SENT_9	[p1l610t1555r655b1583],
34	6	CD	DURATION	6	num	35	SENT_9	[p1l667t1557r683b1583],
35	months	NNS	NUMBER	month	prep_for	32	SENT_9	[p1l696t1555r824b1583],
36	.	.	O	.	_	0	SENT_9	[p1l696t1555r824b1583],

1	Study	NN	O	study	_	0	SENT_10	[p1l840t1555r928b1592],
2	2	CD	NUMBER	2	num	1	SENT_10	[p1l939t1558r956b1583],
3	(	CD	NUMBER	(	num	5	SENT_10	[p1l970t1555r1151b1592],
4	open-label	JJ	O	open-label	amod	5	SENT_10	[p1l970t1555r1151b1592],
5	)	NN	O	)	nsubj	6	SENT_10	[p1l970t1555r1151b1592],
6	consisted	VBD	O	consist	rcmod	1	SENT_10	[p1l1164t1555r1311b1583],
7	of	IN	O	of	_	0	SENT_10	[p1l1322t1555r1358b1583],
8	405	CD	NUMBER	405	num	9	SENT_10	[p1l1364t1556r1418b1583],
9	asthmatics	NNS	O	asthmatic	prep_of	6	SENT_10	[p1l1431t1555r1599b1583],
10	and	CC	O	and	_	0	SENT_10	[p1l1611t1555r1669b1583],
11	compared	VBN	O	compare	rcmod	1	SENT_10	[p1l1680t1555r1837b1592],
12	an	DT	O	a	det	14	SENT_10	[p1l6t1611r44b1629],
13	adjustable	JJ	O	adjustable	amod	14	SENT_10	[p1l59t1601r218b1638],
14	regimen	NN	O	regimen	dobj	11	SENT_10	[p1l234t1602r366b1638],
15	of	IN	O	of	_	0	SENT_10	[p1l381t1601r417b1629],
16	budesonide	NN	O	budesonide	prep_of	14	SENT_10	[p1l426t1601r608b1629],
17	plus	CC	O	plus	_	0	SENT_10	[p1l624t1601r689b1638],
18	formoterol	NN	O	formoterol	conj_plus	14	SENT_10	[p1l705t1601r873b1629],
19	with	IN	O	with	_	0	SENT_10	[p1l888t1601r957b1629],
20	ﬁxed-dose	JJ	O	ﬁxed-dose	amod	21	SENT_10	[p1l973t1601r1129b1629],
21	budesonide	NN	O	budesonide	prep_with	18	SENT_10	[p1l1144t1601r1326b1629],
22	plus	CC	O	plus	prep	21	SENT_10	[p1l1342t1601r1407b1638],
23	formoterol	NN	O	formoterol	dep	22	SENT_10	[p1l1423t1601r1591b1629],
24	and	CC	O	and	_	0	SENT_10	[p1l1606t1601r1665b1629],
25	ﬁxed-dose	NN	O	ﬁxed-dose	dep	22	SENT_10	[p1l1680t1601r1836b1629],

1	(	NN	O	(	nn	2	SENT_11	[p1l105t1654r175b1680],
2	ProfD	NN	O	profd	nsubj	6	SENT_11	[p1l105t1654r175b1680],
3	s	VBZ	O	s	cop	6	SENT_11	[p1l194t1656r204b1675],
4	Postma	NNP	PERSON	Postma	nn	6	SENT_11	[p1l223t1656r300b1675],
5	MD	NNP	O	MD	nn	6	SENT_11	[p1l318t1656r368b1680],
6	)	NN	O	)	_	0	SENT_11	[p1l318t1656r368b1680],
7	;	:	O	;	_	0	SENT_11	[p1l318t1656r368b1680],
8	ﬂuticasone	NN	O	ﬂuticasone	dep	6	SENT_11	[p1l417t1644r588b1673],
9	plus	CC	O	plus	prep	8	SENT_11	[p1l610t1644r675b1682],
10	salmeterol	NN	O	salmeterol	dep	9	SENT_11	[p1l698t1644r862b1673],
11	for	IN	O	for	_	0	SENT_11	[p1l883t1644r928b1673],
12	7	CD	DURATION	7	num	13	SENT_11	[p1l951t1646r967b1673],
13	months	NNS	NUMBER	month	prep_for	10	SENT_11	[p1l989t1644r1118b1673],
14	.	.	O	.	_	0	SENT_11	[p1l989t1644r1118b1673],

1	The	DT	O	the	det	2	SENT_12	[p1l1141t1644r1201b1673],
2	relation	NN	O	relation	nsubjpass	20	SENT_12	[p1l1223t1644r1343b1673],
3	between	IN	O	between	_	0	SENT_12	[p1l1364t1644r1495b1673],
4	ADRB2	NN	O	adrb2	nn	5	SENT_12	[p1l1516t1646r1637b1672],
5	polymorphism	NN	O	polymorphism	prep_between	2	SENT_12	[p1l1657t1644r1897b1682],
6	,	,	O	,	_	0	SENT_12	[p1l1657t1644r1897b1682],
7	severe	JJ	O	severe	amod	9	SENT_12	[p1l1921t1654r2017b1673],
8	asthma	NN	O	asthma	nn	9	SENT_12	[p1l2039t1644r2154b1673],
9	exacerbations	NNS	O	exacerbation	appos	5	SENT_12	[p1l6t1690r226b1723],
10	,	,	O	,	_	0	SENT_12	[p1l6t1690r226b1723],
11	Astrazenecar	NNP	O	Astrazenecar	nn	12	SENT_12	[p1l240t1693r380b1715],
12	Macclesﬁeld	NNP	O	Macclesﬁeld	appos	5	SENT_12	[p1l391t1691r528b1715],
13	:	:	O	:	_	0	SENT_12	[p1l391t1691r528b1715],
14	UK	NNP	LOCATION	UK	conj_and	9	SENT_12	[p1l539t1693r570b1712],
15	and	CC	O	and	_	0	SENT_12	[p1l609t1690r667b1719],
16	other	JJ	O	other	amod	18	SENT_12	[p1l684t1690r767b1719],
17	asthma	NN	O	asthma	nn	18	SENT_12	[p1l782t1690r897b1719],
18	outcomes	NNS	O	outcome	conj_and	9	SENT_12	[p1l914t1696r1065b1719],
19	was	VBD	O	be	auxpass	20	SENT_12	[p1l1082t1700r1140b1719],
20	analysed	VBN	O	analyse	_	0	SENT_12	[p1l1158t1690r1301b1728],
21	.	.	O	.	_	0	SENT_12	[p1l1158t1690r1301b1728],

1	Primary	JJ	O	primary	amod	2	SENT_13	[p1l1320t1692r1447b1728],
2	endpoints	NNS	O	endpoint	nsubj	11	SENT_13	[p1l1463t1690r1618b1728],
3	for	IN	O	for	_	0	SENT_13	[p1l1636t1690r1681b1719],
4	studies	NNS	O	study	prep_for	2	SENT_13	[p1l1698t1690r1807b1719],
5	1	CD	NUMBER	1	num	4	SENT_13	[p1l1826t1693r1840b1719],
6	and	CC	O	and	_	0	SENT_13	[p1l1856t1690r1915b1719],
7	2	CD	NUMBER	2	prep_for	2	SENT_13	[p1l1932t1693r1949b1719],
8	were	VBD	O	be	cop	11	SENT_13	[p1l1965t1701r2040b1719],
9	severe	JJ	O	severe	amod	11	SENT_13	[p1l2058t1700r2154b1719],
10	asthma	NN	O	asthma	nn	11	SENT_13	[p1l6t1745r120b1773],
11	exacerbation	NN	O	exacerbation	_	0	SENT_13	[p1l134t1745r330b1773],
12	(	CD	NUMBER	(	num	13	SENT_13	[p1l434t1737r567b1778],
13	HlAmb	NN	O	hlamb	dep	11	SENT_13	[p1l434t1737r567b1778],
14	,	,	O	,	_	0	SENT_13	[p1l434t1737r567b1778],
15	'	''	O	'	_	0	SENT_13	[p1l434t1737r567b1778],
16	°	CD	NUMBER	°	number	17	SENT_13	[p1l434t1737r567b1778],
17	‘	CD	NUMBER	‘	num	18	SENT_13	[p1l434t1737r567b1778],
18	_	NN	O	_	dep	11	SENT_13	[p1l434t1737r567b1778],
19	e	SYM	O	e	dep	20	SENT_13	[p1l434t1737r567b1778],
20	PhD	NN	O	phd	dep	22	SENT_13	[p1l574t1737r630b1761],
21	)	CD	NUMBER	)	num	20	SENT_13	[p1l574t1737r630b1761],
22	’	CD	NUMBER	’	dep	11	SENT_13	[p1l574t1737r630b1761],
23	a	DT	O	a	det	25	SENT_13	[p1l636t1737r677b1756],
24	"	``	O	"	punct	25	SENT_13	[p1l636t1737r677b1756],
25	d	NN	O	d	dep	22	SENT_13	[p1l636t1737r677b1756],
26	Astrazeneca	NNP	ORGANIZATION	Astrazeneca	nn	28	SENT_13	[p1l351t1775r491b1796],
27	,	,	O	,	_	0	SENT_13	[p1l351t1775r491b1796],
28	Wilmington	NNP	LOCATION	Wilmington	dep	25	SENT_13	[p1l496t1773r635b1799],
29	,	,	O	,	_	0	SENT_13	[p1l496t1773r635b1799],
30	DE	NN	O	de	appos	28	SENT_13	[p1l642t1775r676b1796],
31	,	,	O	,	_	0	SENT_13	[p1l642t1775r676b1796],

1	USA	NNP	LOCATION	USA	tmod	19	SENT_14	[p1l107t1803r152b1822],
2	(	CD	NUMBER	(	num	12	SENT_14	[p1l159t1803r185b1827],
3	M	NN	O	m	nn	12	SENT_14	[p1l159t1803r185b1827],
4	Goldman	NNP	ORGANIZATION	Goldman	nn	12	SENT_14	[p1l192t1802r285b1822],
5	MD	NNP	ORGANIZATION	MD	nn	12	SENT_14	[p1l294t1804r333b1825],
6	,	,	O	,	_	0	SENT_14	[p1l294t1804r333b1825],
7	R	NNP	O	R	appos	12	SENT_14	[p1l143t1840r154b1858],
8	M	NNP	O	M	nn	12	SENT_14	[p1l171t1840r189b1858],
9	Lawrence	NNP	ORGANIZATION	Lawrence	nn	12	SENT_14	[p1l207t1840r302b1858],
10	BSc	NNP	ORGANIZATION	BSc	nn	12	SENT_14	[p1l320t1839r362b1864],
11	)	NNP	O	)	nn	12	SENT_14	[p1l320t1839r362b1864],
12	Findings	NNS	O	finding	dep	1	SENT_14	[p1l410t1830r539b1866],
13	In	IN	O	in	_	0	SENT_14	[p1l565t1832r598b1857],
14	study	NN	O	study	prep_in	19	SENT_14	[p1l623t1829r707b1866],
15	1	CD	NUMBER	1	num	14	SENT_14	[p1l731t1831r753b1862],
16	,	,	O	,	_	0	SENT_14	[p1l731t1831r753b1862],
17	Gly16Arg	NN	O	gly16arg	nn	18	SENT_14	[p1l780t1829r926b1867],
18	genotype	NN	O	genotype	nsubj	19	SENT_14	[p1l950t1835r1091b1867],
19	had	VBD	O	have	_	0	SENT_14	[p1l1115t1829r1173b1858],
20	no	DT	O	no	det	21	SENT_14	[p1l1197t1839r1236b1858],
21	eifect	NN	O	eifect	dobj	19	SENT_14	[p1l1261t1829r1345b1858],
22	on	IN	O	on	_	0	SENT_14	[p1l1369t1839r1408b1858],
23	the	DT	O	the	det	24	SENT_14	[p1l1432t1829r1481b1858],
24	percentage	NN	O	percentage	prep_on	21	SENT_14	[p1l1505t1835r1676b1867],
25	of	IN	O	of	_	0	SENT_14	[p1l1700t1829r1736b1858],
26	participants	NNS	O	participant	prep_of	24	SENT_14	[p1l1754t1830r1939b1866],
27	with	IN	O	with	_	0	SENT_14	[p1l1963t1829r2032b1858],
28	severe	JJ	O	severe	amod	29	SENT_14	[p1l2057t1839r2154b1858],
29	exacerbations	NNS	O	exacerbation	prep_with	19	SENT_14	[p1l6t1869r218b1897],

1	Correspondencetoj	NNP	O	Correspondencetoj	nsubj	6	SENT_15	[p1l135t1926r333b1952],
2	across	IN	O	across	_	0	SENT_15	[p1l375t1924r472b1943],
3	all	DT	O	all	det	5	SENT_15	[p1l496t1914r532b1943],
4	treatment	NN	O	treatment	nn	5	SENT_15	[p1l555t1920r709b1943],
5	groups	NNS	O	group	prep_across	1	SENT_15	[p1l732t1924r840b1952],
6	(	VBP	O	(	_	0	SENT_15	[p1l866t1917r912b1952],
7	99	CD	PERCENT	99	number	8	SENT_15	[p1l866t1917r912b1952],
8	[	CD	PERCENT	[	dobj	6	SENT_15	[p1l937t1916r1019b1952],
9	12	CD	PERCENT	12	num	10	SENT_15	[p1l937t1916r1019b1952],
10	%	NN	PERCENT	%	dep	8	SENT_15	[p1l937t1916r1019b1952],
11	]	CD	NUMBER	]	dep	20	SENT_15	[p1l937t1916r1019b1952],
12	of	IN	O	of	_	0	SENT_15	[p1l1043t1914r1079b1943],
13	833	CD	NUMBER	833	num	14	SENT_15	[p1l1098t1917r1150b1943],
14	Gly/Gly	NN	O	gly/gly	prep_of	11	SENT_15	[p1l1176t1914r1304b1952],
15	,	,	O	,	_	0	SENT_15	[p1l1176t1914r1304b1952],
16	110	CD	NUMBER	110	num	17	SENT_15	[p1l1330t1917r1378b1943],
17	[	NN	O	[	appos	14	SENT_15	[p1l1403t1916r1482b1952],
18	11	CD	PERCENT	11	num	19	SENT_15	[p1l1403t1916r1482b1952],
19	%	NN	PERCENT	%	dep	20	SENT_15	[p1l1403t1916r1482b1952],
20	]	CD	NUMBER	]	dep	30	SENT_15	[p1l1403t1916r1482b1952],
21	of	IN	O	of	_	0	SENT_15	[p1l1507t1914r1543b1943],
22	1028	CD	DATE	1028	num	23	SENT_15	[p1l1561t1917r1630b1943],
23	Gly/Arg	NN	O	gly/arg	prep_of	20	SENT_15	[p1l1656t1914r1790b1952],
24	,	,	O	,	_	0	SENT_15	[p1l1656t1914r1790b1952],
25	and	CC	O	and	_	0	SENT_15	[p1l1815t1914r1873b1943],
26	32	CD	PERCENT	32	number	27	SENT_15	[p1l1897t1917r1933b1943],
27	[	CD	PERCENT	[	conj_and	23	SENT_15	[p1l1958t1916r2023b1952],
28	9	CD	PERCENT	9	num	29	SENT_15	[p1l1958t1916r2023b1952],
29	%	NN	PERCENT	%	dep	27	SENT_15	[p1l1958t1916r2023b1952],
30	]	CD	NUMBER	]	dep	8	SENT_15	[p1l1958t1916r2023b1952],
31	of	IN	O	of	_	0	SENT_15	[p1l2048t1914r2084b1943],
32	361	CD	NUMBER	361	prep_of	30	SENT_15	[p1l2103t1917r2154b1943],

1	Arg/Arg	NN	O	arg/arg	_	0	SENT_16	[p1l6t1962r139b1997],

1	Prof	NNP	O	Prof	nn	4	SENT_17	[p1l95t2005r137b2025],
2	Eugene	NNP	PERSON	Eugene	nn	4	SENT_17	[p1l143t2007r218b2031],
3	R	NNP	PERSON	R	nn	4	SENT_17	[p1l225t2007r236b2025],
4	Bleecker	NNP	PERSON	Bleecker	_	0	SENT_17	[p1l244t2005r334b2028],
5	,	,	O	,	_	0	SENT_17	[p1l244t2005r334b2028],
6	Thomas	NNP	PERSON	Thomas	nn	9	SENT_17	[p1l40t2042r123b2061],
7	H	NNP	PERSON	H	nn	9	SENT_17	[p1l131t2043r144b2061],
8	Davis	NNP	PERSON	Davis	nn	9	SENT_17	[p1l153t2043r206b2061],
9	Professor	NNP	O	Professor	appos	4	SENT_17	[p1l214t2041r308b2061],
10	of	IN	O	of	_	0	SENT_17	[p1l314t2041r336b2061],
11	Pulmonan	NNP	LOCATION	Pulmonan	prep_of	9	SENT_17	[p1l57t2078r168b2104],
12	;	:	O	;	_	0	SENT_17	[p1l57t2078r168b2104],
13	Medicine	NNP	O	Medicine	dep	4	SENT_17	[p1l175t2078r273b2102],
14	,	,	O	,	_	0	SENT_17	[p1l175t2078r273b2102],
15	Wake	NNP	ORGANIZATION	Wake	nn	18	SENT_17	[p1l278t2078r334b2098],
16	Forest	NNP	ORGANIZATION	Forest	nn	18	SENT_17	[p1l89t2117r151b2135],
17	University	NNP	ORGANIZATION	University	nn	18	SENT_17	[p1l158t2116r261b2140],
18	Health	NNP	ORGANIZATION	Health	dep	4	SENT_17	[p1l268t2115r333b2135],
19	and	CC	O	and	_	0	SENT_17	[p1l713t1745r771b1773],
20	asthma	NN	O	asthma	nn	21	SENT_17	[p1l781t1745r896b1773],
21	control	NN	O	control	dep	4	SENT_17	[p1l906t1745r1017b1773],
22	as	IN	O	as	mark	23	SENT_17	[p1l1027t1755r1058b1773],
23	assessed	VBN	O	assess	dep	21	SENT_17	[p1l1069t1745r1203b1773],
24	by	IN	O	by	_	0	SENT_17	[p1l1213t1745r1249b1782],
25	measures	NNS	O	measure	prep_by	23	SENT_17	[p1l1259t1755r1409b1773],
26	of	IN	O	of	_	0	SENT_17	[p1l1420t1745r1456b1773],
27	exacerbations	NNS	O	exacerbation	prep_of	25	SENT_17	[p1l1461t1745r1681b1778],
28	,	,	O	,	_	0	SENT_17	[p1l1461t1745r1681b1778],
29	respectively	RB	O	respectively	advmod	23	SENT_17	[p1l1693t1745r1880b1782],
30	.	.	O	.	_	0	SENT_17	[p1l1693t1745r1880b1782],

1	participants	NNS	O	participant	_	0	SENT_18	[p1l6t2209r211b2246],
2	)	CD	NUMBER	)	num	1	SENT_18	[p1l6t2209r211b2246],
3	.	.	O	.	_	0	SENT_18	[p1l6t2209r211b2246],

1	Secondary	JJ	O	secondary	amod	2	SENT_19	[p1l226t2208r386b2245],
2	endpoints	NNS	O	endpoint	nsubj	28	SENT_19	[p1l396t2208r561b2245],
3	,	,	O	,	_	0	SENT_19	[p1l396t2208r561b2245],
4	including	VBG	O	include	_	0	SENT_19	[p1l573t2208r724b2246],
5	forced	VBN	O	force	amod	7	SENT_19	[p1l734t2208r832b2236],
6	expiratory	JJ	O	expiratory	amod	7	SENT_19	[p1l843t2209r999b2245],
7	volume	NN	O	volume	prep_including	28	SENT_19	[p1l1009t2208r1126b2237],
8	in	IN	O	in	_	0	SENT_19	[p1l1137t2209r1169b2236],
9	1	CD	NUMBER	1	num	10	SENT_19	[p1l1181t2211r1195b2236],
10	s	NNS	O	s	prep_in	7	SENT_19	[p1l1207t2218r1228b2241],
11	,	,	O	,	_	0	SENT_19	[p1l1207t2218r1228b2241],
12	peak	JJ	O	peak	amod	14	SENT_19	[p1l1241t2208r1314b2245],
13	expiratory	JJ	O	expiratory	amod	14	SENT_19	[p1l1325t2209r1481b2245],
14	ﬂow	NN	O	ﬂow	nsubj	28	SENT_19	[p1l1491t2208r1563b2241],
15	,	,	O	,	_	0	SENT_19	[p1l1491t2208r1563b2241],
16	use	NN	O	use	appos	14	SENT_19	[p1l1575t2218r1629b2236],
17	of	IN	O	of	_	0	SENT_19	[p1l1640t2208r1675b2236],
18	as-needed	JJ	O	as-needed	amod	19	SENT_19	[p1l1681t2208r1837b2236],
19	medication	NN	O	medication	prep_of	16	SENT_19	[p1l7t2254r190b2287],
20	,	,	O	,	_	0	SENT_19	[p1l7t2254r190b2287],
21	and	CC	O	and	_	0	SENT_19	[p1l201t2254r259b2282],
22	number	NN	O	number	appos	14	SENT_19	[p1l269t2254r396b2282],
23	of	IN	O	of	_	0	SENT_19	[p1l405t2254r441b2282],
24	nights	NNS	TIME	night	prep_of	22	SENT_19	[p1l445t2254r542b2291],
25	with	IN	O	with	_	0	SENT_19	[p1l552t2254r622b2282],
26	awakenings	NNS	O	awakening	prep_with	24	SENT_19	[p1l631t2254r815b2291],
27	were	VBD	O	be	cop	28	SENT_19	[p1l825t2264r900b2282],
28	similar	JJ	O	similar	_	0	SENT_19	[p1l911t2254r1021b2282],
29	between	IN	O	between	_	0	SENT_19	[p1l1029t2254r1160b2282],
30	genotype	NN	O	genotype	nn	31	SENT_19	[p1l1169t2259r1311b2291],
31	groups	NNS	O	group	prep_between	28	SENT_19	[p1l1320t2264r1437b2291],
32	.	.	O	.	_	0	SENT_19	[p1l1320t2264r1437b2291],

1	No	DT	O	no	det	2	SENT_20	[p1l1448t2257r1492b2282],
2	relation	NN	O	relation	nsubjpass	4	SENT_20	[p1l1502t2254r1622b2282],
3	was	VBD	O	be	auxpass	4	SENT_20	[p1l1631t2264r1690b2282],
4	recorded	VBN	O	record	_	0	SENT_20	[p1l1700t2254r1837b2282],
5	between	IN	O	between	_	0	SENT_20	[p1l6t2300r137b2328],
6	ADRB2	NN	O	adrb2	nn	7	SENT_20	[p1l147t2302r268b2328],
7	haplotype	NN	O	haplotype	prep_between	4	SENT_20	[p1l276t2300r429b2337],
8	and	CC	O	and	_	0	SENT_20	[p1l439t2300r498b2328],
9	primary	JJ	O	primary	amod	12	SENT_20	[p1l508t2301r633b2337],
10	and	CC	O	and	_	0	SENT_20	[p1l643t2300r701b2328],
11	secondary	JJ	O	secondary	amod	12	SENT_20	[p1l712t2300r869b2337],
12	endpoints	NNS	O	endpoint	prep_between	4	SENT_20	[p1l879t2300r1043b2337],
13	.	.	O	.	_	0	SENT_20	[p1l879t2300r1043b2337],

1	In	IN	O	in	_	0	SENT_21	[p1l1056t2302r1090b2328],
2	study	NN	O	study	prep_in	48	SENT_21	[p1l1102t2300r1186b2337],
3	2	CD	NUMBER	2	num	2	SENT_21	[p1l1196t2302r1221b2332],
4	,	,	O	,	_	0	SENT_21	[p1l1196t2302r1221b2332],
5	the	DT	O	the	det	6	SENT_21	[p1l1233t2300r1282b2328],
6	frequency	NN	O	frequency	dep	27	SENT_21	[p1l1293t2300r1449b2337],
7	of	IN	O	of	_	0	SENT_21	[p1l1459t2300r1494b2328],
8	asthma	NN	O	asthma	nn	9	SENT_21	[p1l1499t2300r1614b2328],
9	exacerbations	NNS	O	exacerbation	nn	10	SENT_21	[p1l1625t2300r1836b2328],
10	Sciences	NNPS	O	Sciences	prep_of	6	SENT_21	[p1l53t2350r143b2372],
11	,	,	O	,	_	0	SENT_21	[p1l53t2350r143b2372],
12	Centerfor	NNP	O	Centerfor	nn	13	SENT_21	[p1l151t2348r254b2368],
13	Human	NNP	O	Human	dep	19	SENT_21	[p1l263t2350r337b2368],
14	(	CD	PERCENT	(	number	15	SENT_21	[p1l378t2339r420b2375],
15	15	CD	PERCENT	15	dep	13	SENT_21	[p1l378t2339r420b2375],
16	[	CD	PERCENT	[	dep	15	SENT_21	[p1l434t2339r500b2375],
17	9	CD	PERCENT	9	num	18	SENT_21	[p1l434t2339r500b2375],
18	%	NN	PERCENT	%	dep	19	SENT_21	[p1l434t2339r500b2375],
19	]	CD	NUMBER	]	dep	10	SENT_21	[p1l434t2339r500b2375],
20	of	IN	O	of	_	0	SENT_21	[p1l512t2337r547b2366],
21	168	CD	NUMBER	168	num	22	SENT_21	[p1l552t2340r602b2366],
22	Gly/Gly	NN	O	gly/gly	prep_of	19	SENT_21	[p1l615t2337r742b2375],
23	,	,	O	,	_	0	SENT_21	[p1l615t2337r742b2375],
24	13	CD	PERCENT	13	dep	27	SENT_21	[p1l756t2340r787b2366],
25	[	CD	PERCENT	[	num	27	SENT_21	[p1l801t2339r867b2375],
26	8	CD	PERCENT	8	num	27	SENT_21	[p1l801t2339r867b2375],
27	%	NN	PERCENT	%	dep	38	SENT_21	[p1l801t2339r867b2375],
28	]	CD	NUMBER	]	number	30	SENT_21	[p1l801t2339r867b2375],
29	of	IN	O	of	quantmod	30	SENT_21	[p1l879t2337r915b2366],
30	169	CD	NUMBER	169	num	31	SENT_21	[p1l919t2340r970b2366],
31	Gly/Arg	NN	O	gly/arg	dep	27	SENT_21	[p1l983t2337r1117b2375],
32	,	,	O	,	_	0	SENT_21	[p1l983t2337r1117b2375],
33	and	CC	O	and	_	0	SENT_21	[p1l1129t2337r1187b2366],
34	6	CD	PERCENT	6	number	35	SENT_21	[p1l1199t2340r1215b2366],
35	[	CD	PERCENT	[	conj_and	31	SENT_21	[p1l1228t2339r1294b2375],
36	9	CD	PERCENT	9	num	37	SENT_21	[p1l1228t2339r1294b2375],
37	%	NN	PERCENT	%	dep	35	SENT_21	[p1l1228t2339r1294b2375],
38	]	CD	NUMBER	]	dep	48	SENT_21	[p1l1228t2339r1294b2375],
39	of	IN	O	of	_	0	SENT_21	[p1l1306t2337r1341b2366],
40	67	CD	NUMBER	67	num	42	SENT_21	[p1l1346t2339r1382b2366],
41	Arg/Arg	NN	O	arg/arg	nn	42	SENT_21	[p1l1392t2340r1524b2375],
42	participants	NNS	O	participant	prep_of	38	SENT_21	[p1l1534t2339r1729b2375],
43	)	CD	NUMBER	)	nn	47	SENT_21	[p1l1534t2339r1729b2375],
44	and	CC	O	and	_	0	SENT_21	[p1l1742t2337r1800b2366],
45	other	JJ	O	other	conj_and	43	SENT_21	[p1l1811t2337r1893b2366],
46	study	NN	O	study	nn	47	SENT_21	[p1l1904t2337r1988b2375],
47	endpoints	NNS	O	endpoint	nsubj	48	SENT_21	[p1l1999t2337r2154b2375],
48	WCITC	VBP	O	wcitc	_	0	SENT_21	[p1l6t2393r81b2411],

1	Ge	SYM	O	ge	dep	3	SENT_22	[p1l68t2422r175b2444],
2	-	:	O	-	_	0	SENT_22	[p1l68t2422r175b2444],
3	“	NN	O	“	_	0	SENT_22	[p1l68t2422r175b2444],
4	omits	VBZ	O	omit	rcmod	3	SENT_22	[p1l68t2422r175b2444],
5	,	,	O	,	_	0	SENT_22	[p1l68t2422r175b2444],
6	Medical	NNP	ORGANIZATION	Medical	nn	7	SENT_22	[p1l183t2420r260b2440],
7	Center	NNP	ORGANIZATION	Center	nsubj	9	SENT_22	[p1l267t2422r334b2440],
8	dosely	RB	O	dosely	advmod	9	SENT_22	[p1l371t2419r475b2456],
9	similar	JJ	O	similar	xcomp	4	SENT_22	[p1l485t2419r596b2447],
10	for	IN	O	for	_	0	SENT_22	[p1l605t2419r650b2447],
11	all	DT	O	all	det	13	SENT_22	[p1l660t2419r696b2447],
12	ADRB2	NN	O	adrb2	nn	13	SENT_22	[p1l706t2421r827b2447],
13	genotypes	NNS	O	genotype	prep_for	9	SENT_22	[p1l836t2425r1001b2456],
14	.	.	O	.	_	0	SENT_22	[p1l836t2425r1001b2456],

1	Boulevard	NNP	O	Boulevard	_	0	SENT_23	[p1l56t2457r163b2480],
2	,	,	O	,	_	0	SENT_23	[p1l56t2457r163b2480],
3	Winston	NNP	LOCATION	Winston	appos	1	SENT_23	[p1l169t2457r333b2480],
4	.	.	O	.	_	0	SENT_23	[p1l169t2457r333b2480],

1	—	NN	O	—	_	0	SENT_24	[p1l169t2457r333b2480],
2	.	.	O	.	_	0	SENT_24	[p1l169t2457r333b2480],

1	Salem	NNP	LOCATION	Salem	_	0	SENT_25	[p1l169t2457r333b2480],
2	,	,	O	,	_	0	SENT_25	[p1l169t2457r333b2480],

1	NC	NN	O	nc	_	0	SENT_26	[p1l184t2494r213b2512],
2	27157	CD	NUMBER	27157	num	1	SENT_26	[p1l220t2495r284b2516],
3	,	,	O	,	_	0	SENT_26	[p1l220t2495r284b2516],
4	USA	NNP	LOCATION	USA	nn	5	SENT_26	[p1l292t2494r334b2512],
5	. . . . .	NNP	O	. . . . .	appos	1	SENT_26	[p1l1638t2511r1643b2517],[p1l548t2512r553b2517],
6	.	.	O	.	_	0	SENT_26	[p1l1919t2511r1925b2517],

1	.	.	O	.	_	0	SENT_27	[p1l2125t2511r2130b2517],

1	eb,eeck@wfUbmc_edu	NNP	O	eb,eeck@wfUbmc_edu	nn	2	SENT_28	[p1l93t2529r333b2552],
2	Interpretation	NNP	O	Interpretation	_	0	SENT_28	[p1l380t2514r593b2547],
3	Since	IN	O	since	mark	5	SENT_28	[p1l617t2512r699b2538],
4	we	PRP	O	we	nsubj	5	SENT_28	[p1l719t2520r762b2538],
5	showed	VBD	O	show	dep	2	SENT_28	[p1l783t2510r901b2538],
6	no	DT	O	no	det	8	SENT_28	[p1l921t2520r961b2538],
7	pharmacogenetic	JJ	O	pharmacogenetic	amod	8	SENT_28	[p1l980t2510r1251b2548],
8	eﬂect	NN	O	eﬂect	dobj	5	SENT_28	[p1l1271t2510r1355b2538],
9	of	IN	O	of	_	0	SENT_28	[p1l1375t2510r1411b2538],
10	ADRB2	NN	O	adrb2	nn	11	SENT_28	[p1l1417t2512r1538b2538],
11	variation	NN	O	variation	prep_of	8	SENT_28	[p1l1548t2516r1686b2538],
12	on	IN	O	on	_	0	SENT_28	[p1l1706t2520r1746b2538],
13	therapeutic	JJ	O	therapeutic	amod	14	SENT_28	[p1l1765t2510r1943b2547],
14	response	NN	O	response	prep_on	5	SENT_28	[p1l1963t2520r2103b2547],
15	in	IN	O	in	_	0	SENT_28	[p1l2123t2520r2154b2538],
16	asthma	NN	O	asthma	prep_in	14	SENT_28	[p1l6t2569r129b2602],
17	,	,	O	,	_	0	SENT_28	[p1l6t2569r129b2602],

1	patients	NNS	O	patient	nsubj	9	SENT_29	[p1l366t2606r498b2642],
2	,	,	O	,	_	0	SENT_29	[p1l366t2606r498b2642],
3	irrespective	RB	O	irrespective	_	0	SENT_29	[p1l510t2606r690b2642],
4	of	IN	O	of	_	0	SENT_29	[p1l701t2605r736b2634],
5	their	PRP$	O	they	poss	6	SENT_29	[p1l741t2605r815b2634],
6	genotype	NN	O	genotype	prep_irrespective_of	1	SENT_29	[p1l825t2611r974b2643],
7	,	,	O	,	_	0	SENT_29	[p1l825t2611r974b2643],
8	can	MD	O	can	aux	9	SENT_29	[p1l986t2615r1040b2634],
9	continue	VB	O	continue	_	0	SENT_29	[p1l1051t2606r1189b2634],
10	to	TO	O	to	aux	11	SENT_29	[p1l1199t2611r1228b2634],
11	receive	VB	O	receive	xcomp	9	SENT_29	[p1l1239t2607r1347b2634],
12	inhaled	VBN	O	inhale	dep	11	SENT_29	[p1l1357t2605r1475b2634],
13	corticosteroids	NNS	O	corticosteroid	dobj	12	SENT_29	[p1l1485t2605r1713b2634],
14	plus	CC	O	plus	prep	13	SENT_29	[p1l1724t2605r1789b2642],
15	Iongacting	JJ	O	iongacting	amod	17	SENT_29	[p1l1800t2605r1966b2643],
16	[	NN	O	[	nn	17	SENT_29	[p1l1977t2605r2154b2643],
17	3,-agonists	NNS	O	3,-agonist	dep	14	SENT_29	[p1l1977t2605r2154b2643],
18	.	.	O	.	_	0	SENT_29	[p1l1977t2605r2154b2643],

1	Introduction	NN	O	introduction	_	0	SENT_30	[p1l649t2726r1040b2782],

1	The	DT	O	the	det	2	SENT_31	[p1l644t2811r746b2858],
2	combination	NN	O	combination	nsubj	14	SENT_31	[p1l771t2811r1105b2858],
3	of	IN	O	of	_	0	SENT_31	[p1l1130t2810r1188b2858],
4	Iongacting	VBG	O	iongact	prepc_of	2	SENT_31	[p1l1202t2811r1480b2874],
5	B,-agonists	NNS	O	b,-agonist	dobj	4	SENT_31	[p1l1508t2810r1788b2874],
6	with	IN	O	with	_	0	SENT_31	[p1l1812t2811r1929b2858],
7	inhaled	VBN	O	inhale	prepc_with	4	SENT_31	[p1l1952t2811r2150b2858],
8	corticosteroids	NNS	O	corticosteroid	dobj	7	SENT_31	[p1l646t2886r1029b2934],
9	is	VBZ	O	be	cop	11	SENT_31	[p1l1092t2889r1132b2934],
10	an	DT	O	a	det	11	SENT_31	[p1l1195t2903r1258b2934],
11	eﬁective	JJ	O	eﬁective	_	0	SENT_31	[p1l1319t2887r1535b2934],
12	and	CC	O	and	_	0	SENT_31	[p1l1597t2886r1694b2934],
13	well	RB	O	well	advmod	14	SENT_31	[p1l1753t2886r1860b2934],
14	tolerated	VBD	O	tolerate	conj_and	11	SENT_31	[p1l1919t2886r2150b2934],
15	maintenance	NN	O	maintenance	nn	16	SENT_31	[p1l645t2965r989b3010],
16	therapy	NN	O	therapy	dobj	14	SENT_31	[p1l1006t2962r1205b3025],
17	for	IN	O	for	_	0	SENT_31	[p1l1220t2962r1295b3010],
18	adults	NNS	O	adult	prep_for	14	SENT_31	[p1l1312t2962r1468b3010],
19	with	IN	O	with	_	0	SENT_31	[p1l1486t2962r1602b3010],
20	persistent	JJ	O	persistent	amod	21	SENT_31	[p1l1619t2965r1880b3024],
21	asthma	NN	O	asthma	prep_with	14	SENT_31	[p1l1897t2962r2149b3017],
22	,	,	O	,	_	0	SENT_31	[p1l1897t2962r2149b3017],
23	”	NN	O	”	appos	21	SENT_31	[p1l1897t2962r2149b3017],
24	and	CC	O	and	_	0	SENT_31	[p1l646t3039r743b3087],
25	has	VBZ	O	have	conj_and	14	SENT_31	[p1l776t3039r864b3087],
26	an	DT	O	a	det	28	SENT_31	[p1l901t3056r964b3087],
27	established	JJ	O	established	amod	28	SENT_31	[p1l999t3039r1295b3087],
28	position	NN	O	position	dobj	25	SENT_31	[p1l1328t3042r1542b3102],
29	in	IN	O	in	_	0	SENT_31	[p1l1577t3042r1629b3086],
30	asthma	NN	O	asthma	nn	32	SENT_31	[p1l1664t3039r1857b3087],
31	treatment	NN	O	treatment	nn	32	SENT_31	[p1l1890t3048r2151b3087],
32	guidelines	NNS	O	guideline	prep_in	28	SENT_31	[p1l646t3115r980b3178],
33	.	.	O	.	_	0	SENT_31	[p1l646t3115r980b3178],

1	”	NN	O	”	nn	2	SENT_32	[p1l646t3115r980b3178],
2	Response	NN	O	response	nsubj	8	SENT_32	[p1l1010t3120r1258b3178],
3	to	TO	O	to	_	0	SENT_32	[p1l1286t3125r1335b3163],
4	treatment	NN	O	treatment	prep_to	2	SENT_32	[p1l1363t3125r1623b3163],
5	with	IN	O	with	_	0	SENT_32	[p1l1649t3115r1766b3163],
6	B,-agonists	NNS	O	b,-agonist	prep_with	4	SENT_32	[p1l1797t3115r2078b3178],
7	is	VBZ	O	be	cop	8	SENT_32	[p1l2107t3119r2148b3163],
8	heterogeneous	JJ	O	heterogeneous	_	0	SENT_32	[p1l644t3191r1033b3254],
9	in	IN	O	in	_	0	SENT_32	[p1l1080t3194r1132b3238],
10	individuals	NNS	O	individual	prep_in	8	SENT_32	[p1l1177t3191r1468b3239],
11	with	IN	O	with	_	0	SENT_32	[p1l1513t3191r1630b3239],
12	asthma	NN	O	asthma	prep_with	10	SENT_32	[p1l1676t3191r1945b3246],
13	,	,	O	,	_	0	SENT_32	[p1l1676t3191r1945b3246],
14	”	NN	O	”	appos	12	SENT_32	[p1l1676t3191r1945b3246],
15	which	WDT	O	which	nsubjpass	19	SENT_32	[p1l1989t3191r2150b3239],
16	might	MD	O	might	aux	19	SENT_32	[p1l645t3268r805b3331],
17	be	VB	O	be	auxpass	19	SENT_32	[p1l846t3268r906b3315],
18	partly	RB	O	partly	advmod	19	SENT_32	[p1l950t3268r1100b3330],
19	caused	VBN	O	cause	rcmod	14	SENT_32	[p1l1142t3268r1322b3315],
20	by	IN	O	by	_	0	SENT_32	[p1l1363t3268r1425b3330],
21	genetic	JJ	O	genetic	amod	22	SENT_32	[p1l1467t3271r1655b3331],
22	Variation	NN	O	variation	agent	19	SENT_32	[p1l1697t3271r1929b3315],
23	in	IN	O	in	_	0	SENT_32	[p1l1972t3271r2025b3315],
24	the	DT	O	the	det	27	SENT_32	[p1l2067t3268r2149b3315],
25	B,-adrenergic	JJ	O	b,-adrenergic	amod	27	SENT_32	[p1l649t3343r994b3406],
26	receptor	NN	O	receptor	nn	27	SENT_32	[p1l1026t3353r1242b3406],
27	gene	NN	O	gene	prep_in	22	SENT_32	[p1l1274t3361r1398b3406],
28	(	CD	NUMBER	(	num	30	SENT_32	[p1l1434t3347r1682b3406],
29	ADRB2	NN	O	adrb2	nn	30	SENT_32	[p1l1434t3347r1682b3406],
30	)	NN	O	)	dep	27	SENT_32	[p1l1434t3347r1682b3406],
31	.	.	O	.	_	0	SENT_32	[p1l1434t3347r1682b3406],

1	Various	JJ	O	various	amod	3	SENT_33	[p1l1716t3347r1916b3391],
2	ADRB2	NN	O	adrb2	nn	3	SENT_33	[p1l1948t3347r2152b3390],
3	polymorphisms	NNS	O	polymorphism	nsubjpass	6	SENT_33	[p1l645t3419r1061b3482],
4	have	VBP	O	have	aux	6	SENT_33	[p1l1080t3419r1200b3467],
5	been	VBN	O	be	auxpass	6	SENT_33	[p1l1217t3419r1345b3467],
6	described	VBN	O	describe	_	0	SENT_33	[p1l1363t3419r1693b3474],
7	,	,	O	,	_	0	SENT_33	[p1l1363t3419r1693b3474],
8	“	NN	O	“	dobj	6	SENT_33	[p1l1363t3419r1693b3474],
9	with	IN	O	with	_	0	SENT_33	[p1l1710t3419r1827b3467],
10	the	DT	O	the	det	12	SENT_33	[p1l1843t3419r1925b3467],
11	greatest	JJS	O	greatest	amod	12	SENT_33	[p1l1945t3429r2150b3482],
12	attention	NN	O	attention	prep_with	8	SENT_33	[p1l646t3499r882b3543],
13	devoted	VBN	O	devote	partmod	12	SENT_33	[p1l895t3496r1098b3543],
14	to	TO	O	to	_	0	SENT_33	[p1l1109t3505r1158b3543],
15	the	DT	O	the	det	17	SENT_33	[p1l1170t3496r1253b3543],
16	single-nucleotide	JJ	O	single-nucleotide	amod	17	SENT_33	[p1l1268t3496r1718b3559],
17	polymorphisms	NNS	O	polymorphism	prep_to	13	SENT_33	[p1l1731t3496r2148b3558],
18	causing	VBG	O	cause	xcomp	13	SENT_33	[p1l646t3574r849b3634],
19	aminoacid	JJ	O	aminoacid	amod	20	SENT_33	[p1l867t3571r1144b3619],
20	substitutions	NNS	O	substitution	dobj	18	SENT_33	[p1l1162t3571r1503b3619],
21	at	IN	O	at	_	0	SENT_33	[p1l1523t3581r1569b3619],
22	positions	NNS	O	position	prep_at	18	SENT_33	[p1l1585t3574r1824b3633],
23	16	CD	NUMBER	16	num	22	SENT_33	[p1l1845t3576r1897b3619],
24	and	CC	O	and	_	0	SENT_33	[p1l1916t3571r2013b3619],
25	27	CD	NUMBER	27	prep_at	18	SENT_33	[p1l2032t3574r2151b3621],
26	—	CD	NUMBER	—	tmod	18	SENT_33	[p1l2032t3574r2151b3621],
27	namely	RB	O	namely	advmod	26	SENT_33	[p1l645t3647r847b3710],
28	,	,	O	,	_	0	SENT_33	[p1l645t3647r847b3710],
29	the	DT	O	the	det	33	SENT_33	[p1l866t3647r948b3695],
30	Gly16Arg	NN	O	gly16arg	nn	33	SENT_33	[p1l968t3647r1212b3710],
31	and	CC	O	and	_	0	SENT_33	[p1l1230t3647r1327b3695],
32	Gln27Glu	NN	O	gln27glu	conj_and	30	SENT_33	[p1l1345t3647r1602b3696],
33	polymorphisms	NNS	O	polymorphism	appos	26	SENT_33	[p1l1618t3647r2152b3710],
34	.	.	O	.	_	0	SENT_33	[p1l1618t3647r2152b3710],

1	“‘	NN	O	“‘	dep	7	SENT_34	[p1l1618t3647r2152b3710],
2	3	CD	NUMBER	3	dep	1	SENT_34	[p1l1618t3647r2152b3710],
3	'	''	O	'	_	0	SENT_34	[p1l1618t3647r2152b3710],
4	“	CD	NUMBER	“	num	5	SENT_34	[p1l1618t3647r2152b3710],
5	Studies	NNS	O	study	nsubj	7	SENT_34	[p1l699t3724r889b3771],
6	have	VBP	O	have	aux	7	SENT_34	[p1l920t3724r1040b3771],
7	shown	VBN	O	show	_	0	SENT_34	[p1l1072t3724r1245b3771],
8	a	DT	O	a	det	10	SENT_34	[p1l1275t3741r1301b3771],
9	reduced	JJ	O	reduced	amod	10	SENT_34	[p1l1331t3724r1542b3771],
10	response	NN	O	response	dobj	7	SENT_34	[p1l1571t3741r1807b3786],
11	to	TO	O	to	aux	13	SENT_34	[p1l1837t3733r1885b3771],
12	regularly	RB	O	regularly	advmod	13	SENT_34	[p1l1916t3724r2151b3787],
13	scheduled	VBN	O	schedule	xcomp	7	SENT_34	[p2l647t13r912b61],
14	shortacting	VBG	O	shortact	xcomp	13	SENT_34	[p2l934t13r1230b76],
15	[	CD	NUMBER	[	num	17	SENT_34	[p2l1254t13r1510b76],
16	3,-agonist	JJ	O	3,-agonist	amod	17	SENT_34	[p2l1254t13r1510b76],
17	albuterol	NN	O	albuterol	dobj	14	SENT_34	[p2l1531t13r1764b61],
18	in	IN	O	in	_	0	SENT_34	[p2l1784t17r1837b60],
19	individuals	NNS	O	individual	prep_in	17	SENT_34	[p2l1858t13r2148b61],
20	with	IN	O	with	_	0	SENT_34	[p2l644t89r761b137],
21	the	DT	O	the	det	23	SENT_34	[p2l793t89r876b137],
22	Arg/Arg	NN	O	arg/arg	nn	23	SENT_34	[p2l909t92r1131b152],
23	genotype	NN	O	genotype	prep_with	19	SENT_34	[p2l1166t99r1402b152],
24	relative	JJ	O	relative	advmod	19	SENT_34	[p2l1437t89r1627b137],
25	to	TO	O	to	_	0	SENT_34	[p2l1661t99r1709b137],
26	those	DT	O	those	dobj	36	SENT_34	[p2l1743t89r1884b137],
27	with	IN	O	with	_	0	SENT_34	[p2l1917t89r2034b137],
28	the	DT	O	the	det	30	SENT_34	[p2l2067t89r2149b137],
29	Gly/Gly	NNP	O	Gly/Gly	nn	30	SENT_34	[p2l647t166r855b228],
30	genotype	NN	O	genotype	prep_with	26	SENT_34	[p2l881t168r1206b229],
31	.15	CD	NUMBER	.15	number	32	SENT_34	[p2l881t168r1206b229],
32	'17	CD	NUMBER	'17	num	34	SENT_34	[p2l881t168r1206b229],
33	Similar	JJ	O	similar	amod	34	SENT_34	[p2l1235t166r1426b213],
34	ﬁndings	NNS	O	ﬁndings	nsubjpass	36	SENT_34	[p2l1451t166r1668b229],
35	were	VBD	O	be	auxpass	36	SENT_34	[p2l1695t183r1821b213],
36	reported	VBN	O	report	prepc_to	24	SENT_34	[p2l1848t166r2071b228],
37	in	IN	O	in	_	0	SENT_34	[p2l2097t169r2150b213],
38	some	DT	O	some	prep_in	36	SENT_34	[p2l647t245r832b297],
39	,	,	O	,	_	0	SENT_34	[p2l647t245r832b297],
40	”	NN	O	”	appos	38	SENT_34	[p2l647t245r832b297],
41	but	CC	O	but	_	0	SENT_34	[p2l880t242r968b290],
42	not	RB	O	not	_	0	SENT_34	[p2l1016t251r1103b290],
43	all	DT	O	all	conj_negcc	38	SENT_34	[p2l1152t242r1225b297],
44	,	,	O	,	_	0	SENT_34	[p2l1152t242r1225b297],
45	studiesm	NN	O	studiesm	appos	43	SENT_34	[p2l1279t242r1527b290],
46	with	IN	O	with	_	0	SENT_34	[p2l1575t242r1692b290],
47	the	DT	O	the	det	50	SENT_34	[p2l1740t242r1822b290],
48	longacting	VBG	O	longact	amod	50	SENT_34	[p2l1871t242r2150b305],
49	B,-agonist	NN	O	b,-agonist	nn	50	SENT_34	[p2l649t318r905b381],
50	salmeterol	NN	O	salmeterol	prep_with	45	SENT_34	[p2l960t318r1248b366],
51	.	.	O	.	_	0	SENT_34	[p2l960t318r1248b366],

1	Additionally	RB	O	additionally	advmod	6	SENT_35	[p2l1304t318r1634b381],
2	,	,	O	,	_	0	SENT_35	[p2l1304t318r1634b381],
3	there	EX	O	there	expl	6	SENT_35	[p2l1690t318r1825b366],
4	has	VBZ	O	have	aux	6	SENT_35	[p2l1879t318r1967b366],
5	been	VBN	O	be	cop	6	SENT_35	[p2l2022t318r2150b366],
6	interest	NN	O	interest	_	0	SENT_35	[p2l645t398r845b443],
7	in	IN	O	in	_	0	SENT_35	[p2l866t398r918b442],
8	whether	IN	O	whether	dep	13	SENT_35	[p2l938t395r1156b443],
9	some	DT	O	some	det	10	SENT_35	[p2l1178t412r1317b443],
10	people	NNS	O	people	nsubj	13	SENT_35	[p2l1338t395r1511b458],
11	with	IN	O	with	_	0	SENT_35	[p2l1532t395r1648b443],
12	asthma	NN	O	asthma	prep_with	10	SENT_35	[p2l1670t395r1863b443],
13	are	VBP	O	be	prepc_in	6	SENT_35	[p2l1884t412r1963b443],
14	at	IN	O	at	_	0	SENT_35	[p2l1985t404r2031b443],
15	risk	NN	O	risk	prep_at	13	SENT_35	[p2l2051t395r2151b443],
16	of	IN	O	of	_	0	SENT_35	[p2l646t471r704b519],
17	adverse	JJ	O	adverse	amod	18	SENT_35	[p2l746t471r942b519],
18	outcomes	NNS	O	outcome	prep_of	15	SENT_35	[p2l994t481r1247b519],
19	with	IN	O	with	_	0	SENT_35	[p2l1298t471r1415b519],
20	B2-agonist	JJ	O	b2-agonist	amod	22	SENT_35	[p2l1468t471r1725b534],
21	therapy	NN	O	therapy	nn	22	SENT_35	[p2l1773t471r2003b534],
22	”	NN	O	”	prep_with	18	SENT_35	[p2l1773t471r2003b534],
23	and	CC	O	and	_	0	SENT_35	[p2l2053t471r2150b519],
24	whether	IN	O	whether	dep	30	SENT_35	[p2l644t547r862b595],
25	speciﬁc	NN	O	speciﬁc	nsubj	30	SENT_35	[p2l895t547r1090b609],
26	:	:	O	:	_	0	SENT_35	[p2l895t547r1090b609],
27	ADRB2	NN	O	adrb2	nn	28	SENT_35	[p2l1121t551r1325b594],
28	genotypes	NNS	O	genotype	dep	25	SENT_35	[p2l1355t557r1617b610],
29	might	MD	O	might	aux	30	SENT_35	[p2l1651t547r1810b610],
30	represent	VB	O	represent	conj_and	13	SENT_35	[p2l1841t557r2092b609],
31	a	DT	O	a	det	33	SENT_35	[p2l2124t564r2150b595],
32	risk	NN	O	risk	nn	33	SENT_35	[p2l645t624r745b672],
33	factor	NN	O	factor	dobj	30	SENT_35	[p2l774t624r1002b672],
34	?	.	O	?	_	0	SENT_35	[p2l774t624r1002b672],

1	”	NN	O	”	ccomp	15	SENT_36	[p2l774t624r1002b672],
2	Thus	RB	O	thus	advmod	1	SENT_36	[p2l1032t624r1181b679],
3	,	,	O	,	_	0	SENT_36	[p2l1032t624r1181b679],
4	further	JJ	O	further	amod	5	SENT_36	[p2l1214t624r1401b672],
5	analysis	NN	O	analysis	nsubj	15	SENT_36	[p2l1431t624r1638b687],
6	of	IN	O	of	_	0	SENT_36	[p2l1671t624r1729b672],
7	the	DT	O	the	det	8	SENT_36	[p2l1750t624r1832b672],
8	interaction	NN	O	interaction	prep_of	5	SENT_36	[p2l1863t627r2150b672],
9	between	IN	O	between	_	0	SENT_36	[p2l7t1029r319b1097],
10	ADRB2	NN	O	adrb2	nn	11	SENT_36	[p2l339t1034r628b1096],
11	polymorphisms	NNS	O	polymorphism	prep_between	8	SENT_36	[p2l645t1029r1235b1119],
12	and	CC	O	and	_	0	SENT_36	[p2l1260t1029r1397b1097],
13	B2-agonist	JJ	O	b2-agonist	amod	14	SENT_36	[p2l1423t1029r1786b1119],
14	response	NN	O	response	prep_between	8	SENT_36	[p2l1805t1053r2139b1118],
15	is	VBZ	O	be	_	0	SENT_36	[p2l9t1144r66b1207],
16	of	IN	O	of	_	0	SENT_36	[p2l98t1139r181b1207],
17	great	JJ	O	great	amod	18	SENT_36	[p2l198t1152r384b1229],
18	importance	NN	O	importance	prep_of	15	SENT_36	[p2l411t1144r839b1228],
19	because	IN	O	because	mark	21	SENT_36	[p2l867t1139r1163b1207],
20	B,-agonists	NNS	O	b,-agonist	nsubj	21	SENT_36	[p2l1198t1139r1595b1229],
21	constitute	VBP	O	constitute	advcl	15	SENT_36	[p2l1627t1144r1994b1207],
22	the	DT	O	the	det	25	SENT_36	[p2l2023t1139r2139b1206],
23	most	RBS	O	most	advmod	24	SENT_36	[p2l8t1261r196b1315],
24	common	JJ	O	common	amod	25	SENT_36	[p2l249t1272r584b1315],
25	form	NN	O	form	dobj	21	SENT_36	[p2l637t1247r821b1315],
26	of	IN	O	of	_	0	SENT_36	[p2l875t1247r959b1315],
27	pharmacotherapy	NN	O	pharmacotherapy	prep_of	25	SENT_36	[p2l998t1247r1658b1337],
28	for	IN	O	for	_	0	SENT_36	[p2l1709t1247r1815b1315],
29	asthma	NN	O	asthma	prep_for	27	SENT_36	[p2l1868t1247r2140b1315],
30	worldwide	RB	O	worldwide	advmod	21	SENT_36	[p2l7t1356r416b1434],
31	,	,	O	,	_	0	SENT_36	[p2l7t1356r416b1434],
32	and	CC	O	and	_	0	SENT_36	[p2l440t1356r577b1424],
33	potential	JJ	O	potential	amod	35	SENT_36	[p2l594t1356r923b1445],
34	negative	JJ	O	negative	amod	35	SENT_36	[p2l941t1361r1251b1446],
35	effects	NNS	O	effect	nsubj	43	SENT_36	[p2l1271t1357r1507b1424],
36	of	IN	O	of	_	0	SENT_36	[p2l1529t1356r1612b1424],
37	this	DT	O	this	det	38	SENT_36	[p2l1616t1356r1752b1424],
38	treatment	NN	O	treatment	prep_of	35	SENT_36	[p2l1772t1370r2141b1424],
39	in	IN	O	in	_	0	SENT_36	[p2l8t1470r83b1532],
40	some	DT	O	some	det	41	SENT_36	[p2l103t1490r299b1533],
41	asthmatics	NNS	O	asthmatic	prep_in	38	SENT_36	[p2l319t1466r718b1533],
42	will	MD	O	will	aux	43	SENT_36	[p2l736t1466r870b1534],
43	have	VB	O	have	conj_and	15	SENT_36	[p2l887t1466r1057b1534],
44	a	DT	O	a	det	52	SENT_36	[p2l1076t1490r1113b1533],
45	large	JJ	O	large	amod	46	SENT_36	[p2l1128t1466r1312b1556],
46	personal	JJ	O	personal	amod	52	SENT_36	[p2l1329t1466r1669b1555],
47	,	,	O	,	_	0	SENT_36	[p2l1329t1466r1669b1555],
48	economical	JJ	O	economical	amod	52	SENT_36	[p2l1691t1466r2136b1544],
49	,	,	O	,	_	0	SENT_36	[p2l1691t1466r2136b1544],
50	and	CC	O	and	_	0	SENT_36	[p2l10t1575r147b1644],
51	societal	JJ	O	societal	amod	52	SENT_36	[p2l175t1575r450b1644],
52	effect	NN	O	effect	dobj	43	SENT_36	[p2l476t1576r695b1644],
53	.	.	O	.	_	0	SENT_36	[p2l476t1576r695b1644],

1	In	IN	O	in	_	0	SENT_37	[p2l730t1582r808b1642],
2	this	DT	O	this	det	3	SENT_37	[p2l833t1575r969b1644],
3	report	NN	O	report	prep_in	7	SENT_37	[p2l998t1589r1243b1664],
4	,	,	O	,	_	0	SENT_37	[p2l998t1589r1243b1664],
5	we	PRP	O	we	nsubj	7	SENT_37	[p2l1271t1600r1374b1644],
6	have	VBP	O	have	aux	7	SENT_37	[p2l1399t1575r1569b1644],
7	examined	VBN	O	examine	_	0	SENT_37	[p2l1597t1575r1962b1644],
8	data	NNS	O	datum	dobj	7	SENT_37	[p2l1988t1575r2140b1644],
9	from	IN	O	from	_	0	SENT_37	[p2l9t1685r193b1753],
10	two	CD	NUMBER	two	num	12	SENT_37	[p2l231t1699r363b1753],
11	clinical	JJ	O	clinical	amod	12	SENT_37	[p2l404t1685r669b1754],
12	studies	NNS	O	study	prep_from	7	SENT_37	[p2l710t1685r970b1753],
13	in	IN	O	in	_	0	SENT_37	[p2l1011t1690r1086b1752],
14	which	WDT	O	which	rel	18	SENT_37	[p2l1122t1685r1350b1754],
15	DNA	NN	O	dna	nn	16	SENT_37	[p2l1393t1690r1580b1753],
16	samples	NNS	O	sample	nsubjpass	18	SENT_37	[p2l1620t1685r1922b1774],
17	were	VBD	O	be	auxpass	18	SENT_37	[p2l1961t1710r2139b1754],
18	obtained	VBN	O	obtain	rcmod	12	SENT_37	[p2l10t1795r334b1862],
19	for	IN	O	for	_	0	SENT_37	[p2l370t1795r476b1862],
20	pharmacogenetic	JJ	O	pharmacogenetic	amod	21	SENT_37	[p2l512t1795r1159b1885],
21	analyseszm	NN	O	analyseszm	prep_for	18	SENT_37	[p2l1197t1795r1609b1884],
22	with	IN	O	with	_	0	SENT_37	[p2l1642t1795r1807b1863],
23	the	DT	O	the	det	24	SENT_37	[p2l1843t1795r1959b1862],
24	aim	NN	O	aim	prep_with	18	SENT_37	[p2l1999t1799r2140b1862],
25	of	IN	O	of	_	0	SENT_37	[p2l10t1903r92b1971],
26	seeing	VBG	O	see	prepc_of	24	SENT_37	[p2l136t1908r374b1993],
27	whether	IN	O	whether	complm	30	SENT_37	[p2l425t1903r734b1972],
28	ADRB2	NN	O	adrb2	nn	29	SENT_37	[p2l785t1909r1074b1970],
29	polymorphisms	NNS	O	polymorphism	nsubj	30	SENT_37	[p2l1123t1903r1713b1993],
30	affect	VBP	O	affect	ccomp	26	SENT_37	[p2l1770t1904r1972b1971],
31	the	DT	O	the	det	32	SENT_37	[p2l2023t1903r2139b1971],
32	effectiveness	NN	O	effectiveness	dobj	30	SENT_37	[p2l9t2013r483b2080],
33	and	CC	O	and	_	0	SENT_37	[p2l547t2012r685b2080],
34	safety	NN	O	safety	conj_and	32	SENT_37	[p2l746t2012r958b2102],
35	of	IN	O	of	_	0	SENT_37	[p2l1017t2012r1100b2080],
36	longacting	VBG	O	longact	prepc_of	32	SENT_37	[p2l1146t2012r1540b2102],
37	B,-agonists	NNS	O	b,-agonist	dobj	36	SENT_37	[p2l1606t2012r2003b2102],
38	in	IN	O	in	_	0	SENT_37	[p2l2066t2017r2140b2079],
39	combination	NN	O	combination	prep_in	37	SENT_37	[p2l9t2122r484b2189],
40	with	IN	O	with	_	0	SENT_37	[p2l508t2122r673b2189],
41	inhaled	VBN	O	inhale	prepc_with	36	SENT_37	[p2l699t2122r979b2189],
42	corticosteroids	NNS	O	corticosteroid	dobj	41	SENT_37	[p2l1004t2122r1569b2189],
43	.	.	O	.	_	0	SENT_37	[p2l1004t2122r1569b2189],

1	Methods	NNS	O	method	nsubj	45	SENT_38	[p2l13t2330r401b2409],
2	Study	NNP	O	Study	nn	4	SENT_38	[p2l10t2450r232b2540],
3	design	NN	O	design	nn	4	SENT_38	[p2l252t2450r499b2540],
4	Study	NN	O	study	nsubj	11	SENT_38	[p2l14t2561r225b2650],
5	123	CD	NUMBER	123	dep	4	SENT_38	[p2l257t2565r332b2627],
6	was	VBD	O	be	cop	11	SENT_38	[p2l348t2585r487b2629],
7	a	DT	O	a	det	11	SENT_38	[p2l523t2585r559b2629],
8	6-month	JJ	DURATION	6-month	amod	11	SENT_38	[p2l592t2561r914b2629],
9	double-blind	JJ	O	double-blind	amod	11	SENT_38	[p2l946t2561r1424b2629],
10	randomised	JJ	O	randomised	amod	11	SENT_38	[p2l1455t2561r1908b2629],
11	study	NN	O	study	rcmod	1	SENT_38	[p2l1941t2561r2141b2650],
12	in	IN	O	in	_	0	SENT_38	[p2l9t2674r84b2736],
13	individuals	NNS	O	individual	prep_in	11	SENT_38	[p2l112t2669r527b2737],
14	aged	JJ	O	aged	amod	13	SENT_38	[p2l560t2669r733b2759],
15	12	CD	DURATION	12	num	16	SENT_38	[p2l764t2675r837b2736],
16	years	NNS	NUMBER	year	tmod	14	SENT_38	[p2l867t2693r1058b2759],
17	or	CC	O	or	_	0	SENT_38	[p2l1091t2694r1168b2737],
18	more	JJR	O	more	dep	11	SENT_38	[p2l1195t2694r1392b2737],
19	with	IN	O	with	_	0	SENT_38	[p2l1419t2669r1586b2737],
20	a	DT	O	a	det	21	SENT_38	[p2l1616t2694r1653b2737],
21	diagnosis	NN	O	diagnosis	prep_with	11	SENT_38	[p2l1683t2669r2037b2759],
22	of	IN	O	of	_	0	SENT_38	[p2l2069t2669r2153b2737],
23	asthma	NN	O	asthma	nn	24	SENT_38	[p2l10t2779r284b2846],
24	(	NN	O	(	prep_of	21	SENT_38	[p2l323t2785r419b2869],
25	as	IN	O	as	mark	26	SENT_38	[p2l323t2785r419b2869],
26	deﬁned	VBN	O	deﬁned	rcmod	21	SENT_38	[p2l456t2779r737b2846],
27	by	IN	O	by	_	0	SENT_38	[p2l768t2779r856b2868],
28	the	DT	O	the	det	33	SENT_38	[p2l886t2779r1003b2846],
29	American	JJ	O	american	amod	33	SENT_38	[p2l1036t2783r1409b2846],
30	Thoracic	NNP	ORGANIZATION	Thoracic	nn	33	SENT_38	[p2l1441t2779r1769b2846],
31	Society	NNP	ORGANIZATION	Society	nn	33	SENT_38	[p2l1808t2782r2139b2869],
32	)	CD	NUMBER	)	num	33	SENT_38	[p2l1808t2782r2139b2869],
33	”	NN	O	”	prep_by	26	SENT_38	[p2l1808t2782r2139b2869],
34	for	IN	O	for	_	0	SENT_38	[p2l8t2887r116b2955],
35	at	IN	DURATION	at	quantmod	37	SENT_38	[p2l167t2901r233b2955],
36	least	JJS	DURATION	least	mwe	35	SENT_38	[p2l282t2887r454b2955],
37	6	CD	DURATION	6	num	38	SENT_38	[p2l506t2893r545b2955],
38	months	NNS	NUMBER	month	prep_for	33	SENT_38	[p2l598t2887r887b2955],
39	and	CC	O	and	_	0	SENT_38	[p2l943t2887r1081b2955],
40	who	WP	O	who	nsubj	42	SENT_38	[p2l1130t2887r1288b2956],
41	were	VBD	O	be	aux	42	SENT_38	[p2l1339t2912r1518b2955],
42	taking	VBG	O	take	rcmod	21	SENT_38	[p2l1570t2887r1806b2977],
43	inhaled	VBN	O	inhale	dep	42	SENT_38	[p2l1858t2887r2141b2955],
44	corticosteroids	NNS	O	corticosteroid	dobj	43	SENT_38	[p2l9t2996r558b3064],
45	(	VBP	O	(	_	0	SENT_38	[p2l602t3001r805b3086],
46	2500	CD	DATE	2500	num	47	SENT_38	[p2l602t3001r805b3086],
47	pg	NN	O	pg	dobj	45	SENT_38	[p2l841t3021r936b3086],
48	per	IN	O	per	_	0	SENT_38	[p2l972t3021r1095b3085],
49	day	NN	DURATION	day	prep_per	47	SENT_38	[p2l1131t2996r1277b3086],
50	)	CD	NUMBER	)	num	49	SENT_38	[p2l1131t2996r1277b3086],
51	for	IN	O	for	_	0	SENT_38	[p2l1320t2996r1427b3064],
52	the	DT	DATE	the	det	53	SENT_38	[p2l1460t2996r1577b3064],
53	month	NN	DATE	month	prep_for	49	SENT_38	[p2l1614t2996r1867b3064],
54	before	IN	DATE	before	_	0	SENT_38	[p2l1901t2996r2139b3064],
55	enrolment	NN	O	enrolment	prep_before	45	SENT_38	[p2l9t3106r406b3173],
56	(	CD	NUMBER	(	number	57	SENT_38	[p2l518t3110r714b3196],
57	3335	CD	DATE	3335	num	58	SENT_38	[p2l518t3110r714b3196],
58	individuals	NNS	O	individual	nsubjpass	60	SENT_38	[p2l826t3106r1241b3174],
59	were	VBD	O	be	auxpass	60	SENT_38	[p2l1350t3130r1528b3174],
60	randomised	VBN	O	randomise	rcmod	55	SENT_38	[p2l1637t3106r2135b3196],
61	)	NN	O	)	dobj	60	SENT_38	[p2l1637t3106r2135b3196],
62	.	.	O	.	_	0	SENT_38	[p2l1637t3106r2135b3196],

1	Participants	NNS	O	participant	nsubj	2	SENT_39	[p2l13t3219r455b3303],
2	had	VBD	O	have	_	0	SENT_39	[p2l480t3214r620b3282],
3	to	TO	O	to	aux	4	SENT_39	[p2l640t3228r710b3282],
4	have	VB	O	have	xcomp	2	SENT_39	[p2l733t3214r905b3283],
5	a	DT	O	a	det	8	SENT_39	[p2l931t3239r967b3282],
6	forced	JJ	O	forced	amod	8	SENT_39	[p2l991t3214r1226b3282],
7	expiratory	JJ	O	expiratory	amod	8	SENT_39	[p2l1250t3219r1625b3304],
8	volume	NN	O	volume	dobj	4	SENT_39	[p2l1645t3214r1926b3283],
9	in	IN	O	in	_	0	SENT_39	[p2l1950t3219r2025b3281],
10	1	CD	NUMBER	1	num	11	SENT_39	[p2l2051t3221r2082b3281],
11	s	NNS	O	s	prep_in	8	SENT_39	[p2l2107t3239r2137b3282],
12	(	VBP	O	(	rcmod	11	SENT_39	[p2l14t3328r238b3413],
13	FEV1	NN	O	fev1	nn	14	SENT_39	[p2l14t3328r238b3413],
14	)	NN	O	)	nsubj	20	SENT_39	[p2l14t3328r238b3413],
15	of	IN	O	of	_	0	SENT_39	[p2l269t3323r353b3391],
16	at	IN	O	at	quantmod	18	SENT_39	[p2l366t3337r431b3391],
17	least	JJS	O	least	mwe	16	SENT_39	[p2l453t3323r625b3391],
18	50	CD	PERCENT	50	num	19	SENT_39	[p2l652t3328r811b3394],
19	%	NN	PERCENT	%	prep_of	14	SENT_39	[p2l652t3328r811b3394],
20	predicted	VBD	O	predict	ccomp	12	SENT_39	[p2l836t3323r1188b3412],
21	normal	JJ	O	normal	amod	27	SENT_39	[p2l1212t3323r1487b3391],
22	with	IN	O	with	_	0	SENT_39	[p2l1509t3323r1676b3391],
23	at	IN	O	at	quantmod	25	SENT_39	[p2l1702t3337r1767b3391],
24	least	JJS	O	least	mwe	23	SENT_39	[p2l1789t3323r1961b3391],
25	12	CD	PERCENT	12	num	26	SENT_39	[p2l1987t3328r2139b3394],
26	%	NN	PERCENT	%	prep_with	21	SENT_39	[p2l1987t3328r2139b3394],
27	reversibility	NN	O	reversibility	dobj	20	SENT_39	[p2l9t3433r453b3522],
28	after	IN	O	after	_	0	SENT_39	[p2l478t3433r647b3500],
29	1	CD	NUMBER	1	num	30	SENT_39	[p2l675t3439r706b3499],
30	mg	NN	O	mg	prep_after	20	SENT_39	[p2l731t3457r853b3523],
31	terbutaline	NN	O	terbutaline	nn	33	SENT_39	[p2l878t3433r1290b3500],
32	(	CD	NUMBER	(	num	33	SENT_39	[p2l1322t3433r1675b3523],
33	Bricanyl	NNP	O	Bricanyl	dep	30	SENT_39	[p2l1322t3433r1675b3523],
34	,	,	O	,	_	0	SENT_39	[p2l1322t3433r1675b3523],
35	Turbuhaler	NNP	O	Turbuhaler	appos	30	SENT_39	[p2l1703t3433r2136b3511],
36	,	,	O	,	_	0	SENT_39	[p2l1703t3433r2136b3511],

1	www	NN	O	www	_	0	SENT_40	[p2l641t3703r1174b3754],
2	.	.	O	.	_	0	SENT_40	[p2l641t3703r1174b3754],

1	the	DT	O	the	det	4	SENT_41	[p2l641t3703r1174b3754],
2	|	NN	O	|	nn	4	SENT_41	[p2l641t3703r1174b3754],
3	ancet.com	NN	O	ancet.com	nn	4	SENT_41	[p2l641t3703r1174b3754],
4	Vol	NN	O	vol	_	0	SENT_41	[p2l1217t3703r1304b3753],
5	370	CD	NUMBER	370	dep	4	SENT_41	[p2l1324t3709r1427b3761],
6	December	NNP	DATE	December	tmod	5	SENT_41	[p2l1476t3703r1754b3754],
7	22/29	CD	DATE	22/29	num	6	SENT_41	[p2l1771t3704r1951b3762],
8	,	,	DATE	,	_	0	SENT_41	[p2l1771t3704r1951b3762],
9	2007	CD	DATE	2007	num	6	SENT_41	[p2l1970t3709r2112b3760],

1	Articles	NNPS	O	Articles	_	0	SENT_42	[p3l6t209r156b245],
2	I	PRP	O	I	dep	1	SENT_42	[p3l204t46r252b244],

1	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	_	0	SENT_43	[p3l7t509r503b583],
2	,	,	O	,	_	0	SENT_43	[p3l7t509r503b583],
3	Lund	NNP	PERSON	Lund	conj_or	1	SENT_43	[p3l550t505r761b583],
4	,	,	O	,	_	0	SENT_43	[p3l550t505r761b583],
5	Sweden	NNP	LOCATION	Sweden	conj_or	1	SENT_43	[p3l809t505r1122b594],
6	)	CD	NUMBER	)	num	5	SENT_43	[p3l809t505r1122b594],
7	and	CC	O	and	_	0	SENT_43	[p3l1168t505r1307b573],
8	one	CD	NUMBER	one	conj_and	5	SENT_43	[p3l1346t529r1481b573],
9	or	CC	O	or	_	0	SENT_43	[p3l1522t529r1600b572],
10	more	JJR	O	more	amod	12	SENT_43	[p3l1637t529r1835b573],
11	asthma	NN	O	asthma	nn	12	SENT_43	[p3l1876t505r2152b573],
12	exacerbations	NNS	O	exacerbation	conj_or	1	SENT_43	[p3l10t613r521b681],
13	in	IN	O	in	_	0	SENT_43	[p3l558t618r633b680],
14	the	DT	O	the	det	17	SENT_43	[p3l667t613r785b681],
15	previous	JJ	O	previous	amod	17	SENT_43	[p3l819t618r1141b702],
16	1-12	CD	NUMBER	1-12	num	17	SENT_43	[p3l1182t619r1337b680],
17	months	NNS	NUMBER	month	prep_in	12	SENT_43	[p3l1375t613r1686b681],
18	.	.	O	.	_	0	SENT_43	[p3l1375t613r1686b681],

1	During	IN	O	during	_	0	SENT_44	[p3l1729t618r2000b703],
2	the	DT	O	the	det	5	SENT_44	[p3l2033t613r2151b681],
3	2-week	JJ	DURATION	2-week	amod	5	SENT_44	[p3l11t723r272b790],
4	run-in	NN	O	run-in	nn	5	SENT_44	[p3l321t727r560b790],
5	period	NN	O	period	prep_during	8	SENT_44	[p3l610t723r871b812],
6	,	,	O	,	_	0	SENT_44	[p3l610t723r871b812],
7	participants	NNS	O	participant	nsubj	8	SENT_44	[p3l925t727r1372b812],
8	used	VBD	O	use	_	0	SENT_44	[p3l1423t723r1603b790],
9	their	PRP$	O	they	poss	10	SENT_44	[p3l1651t723r1831b790],
10	regular	JJ	O	regular	dobj	8	SENT_44	[p3l1881t723r2153b813],
11	inhaled	VBN	O	inhale	partmod	10	SENT_44	[p3l9t831r293b900],
12	corticosteroid	NN	O	corticosteroid	dobj	11	SENT_44	[p3l331t831r847b900],
13	for	IN	O	for	_	0	SENT_44	[p3l884t831r992b900],
14	maintenance	NN	O	maintenance	prep_for	12	SENT_44	[p3l1029t836r1521b900],
15	and	CC	O	and	_	0	SENT_44	[p3l1562t831r1701b900],
16	terbutaline	NN	O	terbutaline	prep_for	12	SENT_44	[p3l1737t831r2151b900],
17	for	IN	O	for	_	0	SENT_44	[p3l9t941r117b1009],
18	symptom	NN	O	symptom	nn	19	SENT_44	[p3l216t955r571b1031],
19	relief	NN	O	relief	prep_for	11	SENT_44	[p3l670t941r883b1009],
20	.	.	O	.	_	0	SENT_44	[p3l670t941r883b1009],

1	Inhaled	VBN	O	inhale	csubjpass	9	SENT_45	[p3l990t941r1278b1009],
2	corticosteroid	NN	O	corticosteroid	dobj	1	SENT_45	[p3l1378t941r1894b1009],
3	plus	CC	O	plus	prep	2	SENT_45	[p3l1991t941r2149b1030],
4	longacting	VBG	O	longact	dep	3	SENT_45	[p3l7t1051r407b1141],
5	B,-agonist	JJ	O	b,-agonist	amod	7	SENT_45	[p3l434t1051r803b1141],
6	combination	NN	O	combination	nn	7	SENT_45	[p3l824t1051r1305b1119],
7	inhalers	NNS	O	inhaler	dobj	4	SENT_45	[p3l1326t1051r1631b1119],
8	were	VBD	O	be	auxpass	9	SENT_45	[p3l1653t1075r1833b1119],
9	stopped	VBN	O	stop	_	0	SENT_45	[p3l1858t1051r2153b1140],
10	72	CD	NUMBER	72	num	11	SENT_45	[p3l8t1164r87b1230],
11	h	NN	O	h	dobj	9	SENT_45	[p3l125t1159r174b1226],
12	before	IN	O	before	_	0	SENT_45	[p3l208t1159r447b1227],
13	study	NN	O	study	nn	14	SENT_45	[p3l486t1159r688b1249],
14	entry	NN	O	entry	prep_before	9	SENT_45	[p3l724t1173r918b1249],
15	and	CC	O	and	_	0	SENT_45	[p3l953t1159r1093b1227],
16	the	DT	O	the	det	17	SENT_45	[p3l1126t1159r1244b1227],
17	corresponding	JJ	O	corresponding	prep_before	9	SENT_45	[p3l1282t1159r1832b1249],
18	inhaled	VBN	O	inhale	partmod	17	SENT_45	[p3l1869t1159r2153b1227],
19	corticosteroid	NN	O	corticosteroid	nn	20	SENT_45	[p3l9t1268r526b1336],
20	dose	NN	O	dose	nsubjpass	22	SENT_45	[p3l558t1268r728b1336],
21	was	VBD	O	be	auxpass	22	SENT_45	[p3l759t1292r899b1336],
22	used	VBN	O	use	ccomp	18	SENT_45	[p3l932t1268r1129b1336],
23	.	.	O	.	_	0	SENT_45	[p3l932t1268r1129b1336],

1	Individuals	NNS	O	individual	nsubjpass	19	SENT_46	[p3l1170t1268r1591b1336],
2	using	VBG	O	use	partmod	1	SENT_46	[p3l1625t1273r1838b1358],
3	reliever	NN	O	reliever	nn	4	SENT_46	[p3l1870t1268r2153b1336],
4	medication	NN	O	medication	dobj	2	SENT_46	[p3l9t1379r434b1447],
5	on	IN	O	on	_	0	SENT_46	[p3l463t1403r557b1447],
6	5	CD	NUMBER	5	prep_on	2	SENT_46	[p3l589t1383r623b1447],
7	or	CC	O	or	_	0	SENT_46	[p3l656t1403r733b1447],
8	more	JJR	O	more	prep_on	2	SENT_46	[p3l760t1403r958b1447],
9	of	IN	O	of	_	0	SENT_46	[p3l988t1379r1071b1447],
10	the	DT	DURATION	the	det	13	SENT_46	[p3l1085t1379r1203b1447],
11	last	JJ	DURATION	last	amod	13	SENT_46	[p3l1231t1379r1361b1447],
12	7	CD	DURATION	7	num	13	SENT_46	[p3l1387t1383r1425b1450],
13	days	NNS	NUMBER	day	prep_of	6	SENT_46	[p3l1453t1379r1614b1468],
14	of	IN	O	of	_	0	SENT_46	[p3l1646t1379r1730b1447],
15	the	DT	O	the	det	17	SENT_46	[p3l1744t1379r1862b1447],
16	2-week	JJ	DURATION	2-week	amod	17	SENT_46	[p3l1893t1379r2153b1447],
17	run-in	NN	O	run-in	prep_of	13	SENT_46	[p3l8t1492r248b1555],
18	were	VBD	O	be	auxpass	19	SENT_46	[p3l302t1512r482b1555],
19	randomised	VBN	O	randomise	_	0	SENT_46	[p3l539t1487r1012b1566],
20	;	:	O	;	_	0	SENT_46	[p3l539t1487r1012b1566],
21	those	DT	O	those	nsubjpass	44	SENT_46	[p3l1071t1487r1273b1555],
22	with	IN	O	with	_	0	SENT_46	[p3l1328t1487r1496b1555],
23	more	JJR	O	more	mwe	24	SENT_46	[p3l1552t1512r1750b1555],
24	than	IN	O	than	quantmod	25	SENT_46	[p3l1806t1487r1977b1555],
25	ten	CD	NUMBER	ten	num	27	SENT_46	[p3l2032t1501r2152b1555],
26	as-needed	JJ	O	as-needed	amod	27	SENT_46	[p3l10t1596r386b1664],
27	inhalations	NNS	O	inhalation	prep_with	21	SENT_46	[p3l409t1596r831b1664],
28	in	IN	O	in	_	0	SENT_46	[p3l857t1601r932b1663],
29	any	DT	O	any	det	30	SENT_46	[p3l956t1621r1088b1686],
30	day	NN	DURATION	day	prep_in	27	SENT_46	[p3l1111t1596r1238b1686],
31	of	IN	O	of	_	0	SENT_46	[p3l1261t1596r1345b1664],
32	run-in	NN	O	run-in	prep_of	30	SENT_46	[p3l1355t1601r1595b1664],
33	or	CC	O	or	_	0	SENT_46	[p3l1619t1621r1696b1664],
34	who	WP	O	who	nsubj	35	SENT_46	[p3l1716t1596r1875b1664],
35	had	VBD	O	have	prep_with	21	SENT_46	[p3l1898t1596r2039b1664],
36	an	DT	O	a	det	38	SENT_46	[p3l2062t1621r2152b1664],
37	asthma	NN	O	asthma	nn	38	SENT_46	[p3l10t1706r286b1773],
38	exacerbation	NN	O	exacerbation	dobj	35	SENT_46	[p3l373t1706r848b1773],
39	during	IN	O	during	_	0	SENT_46	[p3l936t1706r1190b1796],
40	that	DT	O	that	det	41	SENT_46	[p3l1275t1706r1422b1773],
41	time	NN	O	time	prep_during	38	SENT_46	[p3l1505t1710r1677b1773],
42	were	VBD	O	be	auxpass	44	SENT_46	[p3l1762t1730r1942b1773],
43	not	RB	O	not	neg	44	SENT_46	[p3l2029t1719r2153b1773],
44	randomised	VBN	O	randomise	parataxis	19	SENT_46	[p3l9t1814r481b1882],
45	.	.	O	.	_	0	SENT_46	[p3l9t1814r481b1882],

1	After	IN	O	after	dep	110	SENT_47	[p3l552t1814r745b1882],
2	run-in	NN	O	run-in	dep	110	SENT_47	[p3l811t1819r1070b1893],
3	,	,	O	,	_	0	SENT_47	[p3l811t1819r1070b1893],
4	eligible	JJ	O	eligible	dep	110	SENT_47	[p3l1143t1814r1415b1904],
5	individuals	NNS	O	individual	dep	110	SENT_47	[p3l1485t1814r1902b1883],
6	were	VBD	O	be	dep	110	SENT_47	[p3l1971t1839r2151b1883],
7	randomised	VBN	O	randomise	dep	110	SENT_47	[p3l9t1923r463b1991],
8	to	TO	O	to	dep	110	SENT_47	[p3l525t1937r614b1991],
9	:	:	O	:	_	0	SENT_47	[p3l525t1937r614b1991],
10	(	CD	NUMBER	(	dep	110	SENT_47	[p3l688t1929r766b2013],
11	1	CD	NUMBER	1	dep	110	SENT_47	[p3l688t1929r766b2013],
12	)	NN	O	)	dep	110	SENT_47	[p3l688t1929r766b2013],
13	budesonide	NN	O	budesonide	dep	110	SENT_47	[p3l834t1923r1275b1991],
14	plus	CC	O	plus	dep	110	SENT_47	[p3l1338t1923r1496b2012],
15	formoterol	NN	O	formoterol	dep	110	SENT_47	[p3l1562t1923r1969b1991],
16	dry	JJ	O	dry	dep	110	SENT_47	[p3l2033t1923r2153b2013],
17	powder	NN	O	powder	dep	110	SENT_47	[p3l8t2033r290b2122],
18	inhaler	NN	O	inhaler	dep	110	SENT_47	[p3l332t2033r602b2100],
19	160	CD	NUMBER	160	dep	110	SENT_47	[p3l646t2039r767b2100],
20	ug	NN	O	ug	dep	110	SENT_47	[p3l809t2057r905b2123],
21	and	CC	O	and	dep	110	SENT_47	[p3l948t2033r1087b2100],
22	4-5	CD	NUMBER	4-5	dep	110	SENT_47	[p3l1127t2037r1251b2100],
23	ug	NN	O	ug	dep	110	SENT_47	[p3l1296t2057r1411b2123],
24	,	,	O	,	_	0	SENT_47	[p3l1296t2057r1411b2123],
25	respectively	RB	O	respectively	dep	110	SENT_47	[p3l1457t2033r1911b2122],
26	,	,	O	,	_	0	SENT_47	[p3l1457t2033r1911b2122],
27	twice	RB	O	twice	dep	110	SENT_47	[p3l1955t2037r2151b2101],
28	daily	RB	SET	daily	dep	110	SENT_47	[p3l9t2141r188b2231],
29	(	CD	NUMBER	(	dep	110	SENT_47	[p3l255t2141r685b2231],
30	Symbicort	NNP	ORGANIZATION	Symbicort	dep	110	SENT_47	[p3l255t2141r685b2231],
31	,	,	O	,	_	0	SENT_47	[p3l255t2141r685b2231],
32	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	dep	110	SENT_47	[p3l752t2146r1248b2220],
33	,	,	O	,	_	0	SENT_47	[p3l752t2146r1248b2220],
34	Lund	NNP	PERSON	Lund	dep	110	SENT_47	[p3l1319t2141r1530b2219],
35	,	,	O	,	_	0	SENT_47	[p3l1319t2141r1530b2219],
36	Sweden	NNP	LOCATION	Sweden	dep	110	SENT_47	[p3l1603t2141r1916b2231],
37	)	CD	NUMBER	)	dep	110	SENT_47	[p3l1603t2141r1916b2231],
38	with	IN	O	with	dep	110	SENT_47	[p3l1984t2141r2152b2210],
39	additional	JJ	O	additional	dep	110	SENT_47	[p3l10t2250r387b2318],
40	budesonide	NN	O	budesonide	dep	110	SENT_47	[p3l424t2250r865b2318],
41	plus	CC	O	plus	dep	110	SENT_47	[p3l904t2250r1062b2339],
42	formoterol	NN	O	formoterol	dep	110	SENT_47	[p3l1103t2250r1509b2318],
43	reliever	NN	O	reliever	dep	110	SENT_47	[p3l1549t2250r1832b2318],
44	therapy	NN	O	therapy	dep	110	SENT_47	[p3l1868t2250r2153b2340],
45	as	IN	O	as	dep	110	SENT_47	[p3l10t2384r82b2427],
46	needed	VBN	O	need	dep	110	SENT_47	[p3l123t2360r414b2438],
47	;	:	O	;	_	0	SENT_47	[p3l123t2360r414b2438],
48	(	NN	O	(	dep	110	SENT_47	[p3l462t2366r549b2450],
49	2	CD	NUMBER	2	dep	110	SENT_47	[p3l462t2366r549b2450],
50	)	CD	NUMBER	)	dep	110	SENT_47	[p3l462t2366r549b2450],
51	budesonide	NN	O	budesonide	dep	110	SENT_47	[p3l592t2360r1032b2427],
52	plus	CC	O	plus	dep	110	SENT_47	[p3l1071t2360r1228b2449],
53	formoterol	NN	O	formoterol	dep	110	SENT_47	[p3l1269t2360r1675b2427],
54	dry	JJ	O	dry	dep	110	SENT_47	[p3l1715t2360r1835b2449],
55	powder	NN	O	powder	dep	110	SENT_47	[p3l1871t2360r2153b2449],
56	inhaler	NN	O	inhaler	dep	110	SENT_47	[p3l9t2468r279b2536],
57	320	CD	NUMBER	320	dep	110	SENT_47	[p3l321t2474r449b2536],
58	ug	NN	O	ug	dep	110	SENT_47	[p3l488t2493r584b2558],
59	and	CC	O	and	dep	110	SENT_47	[p3l624t2468r763b2536],
60	9	CD	NUMBER	9	dep	110	SENT_47	[p3l803t2475r841b2537],
61	ug	NN	O	ug	dep	110	SENT_47	[p3l882t2493r996b2558],
62	,	,	O	,	_	0	SENT_47	[p3l882t2493r996b2558],
63	respectively	RB	O	respectively	dep	110	SENT_47	[p3l1039t2468r1493b2558],
64	,	,	O	,	_	0	SENT_47	[p3l1039t2468r1493b2558],
65	twice	RB	O	twice	dep	110	SENT_47	[p3l1534t2473r1730b2536],
66	daily	RB	SET	daily	dep	110	SENT_47	[p3l1771t2468r1949b2558],
67	with	IN	O	with	dep	110	SENT_47	[p3l1984t2468r2152b2537],
68	terbutaline	NN	O	terbutaline	dep	110	SENT_47	[p3l7t2577r421b2645],
69	as	IN	O	as	dep	110	SENT_47	[p3l527t2601r600b2645],
70	needed	VBN	O	need	dep	110	SENT_47	[p3l706t2577r979b2645],
71	for	IN	O	for	dep	110	SENT_47	[p3l1082t2577r1190b2645],
72	symptom	NN	O	symptom	dep	110	SENT_47	[p3l1295t2591r1650b2667],
73	relief	NN	O	relief	dep	110	SENT_47	[p3l1753t2577r1967b2655],
74	;	:	O	;	_	0	SENT_47	[p3l1753t2577r1967b2655],
75	or	CC	O	or	dep	110	SENT_47	[p3l2076t2602r2153b2645],
76	(	CD	NUMBER	(	dep	110	SENT_47	[p3l14t2693r101b2777],
77	3	CD	NUMBER	3	dep	110	SENT_47	[p3l14t2693r101b2777],
78	)	NN	O	)	dep	110	SENT_47	[p3l14t2693r101b2777],
79	ﬂuticasone	NN	O	ﬂuticasone	dep	110	SENT_47	[p3l129t2687r543b2754],
80	plus	CC	O	plus	dep	110	SENT_47	[p3l565t2687r723b2776],
81	salmeterol	NN	O	salmeterol	dep	110	SENT_47	[p3l750t2687r1145b2754],
82	dry	JJ	O	dry	dep	110	SENT_47	[p3l1168t2687r1288b2776],
83	powder	NN	O	powder	dep	110	SENT_47	[p3l1308t2687r1590b2776],
84	inhaler	NN	O	inhaler	dep	110	SENT_47	[p3l1611t2687r1881b2754],
85	250	CD	NUMBER	250	dep	110	SENT_47	[p3l1905t2691r2034b2754],
86	pg	NN	O	pg	dep	110	SENT_47	[p3l2056t2711r2152b2777],
87	and	CC	O	and	dep	110	SENT_47	[p3l10t2795r149b2863],
88	50	CD	NUMBER	50	dep	110	SENT_47	[p3l207t2800r290b2863],
89	ug	NN	O	ug	dep	110	SENT_47	[p3l345t2820r460b2885],
90	,	,	O	,	_	0	SENT_47	[p3l345t2820r460b2885],
91	respectively	RB	O	respectively	dep	110	SENT_47	[p3l518t2795r972b2885],
92	,	,	O	,	_	0	SENT_47	[p3l518t2795r972b2885],
93	twice	RB	O	twice	dep	110	SENT_47	[p3l1030t2800r1225b2864],
94	daily	JJ	SET	daily	dep	110	SENT_47	[p3l1282t2795r1460b2885],
95	(	NN	O	(	dep	110	SENT_47	[p3l1520t2795r2148b2885],
96	Seretide/Advair	NN	O	seretide/advair	dep	110	SENT_47	[p3l1520t2795r2148b2885],
97	,	,	O	,	_	0	SENT_47	[p3l1520t2795r2148b2885],
98	GlaxoSmithKline	NNP	ORGANIZATION	GlaxoSmithKline	dep	110	SENT_47	[p3l11t2904r684b2982],
99	,	,	O	,	_	0	SENT_47	[p3l11t2904r684b2982],
100	Uxbridge	NNP	LOCATION	Uxbridge	dep	110	SENT_47	[p3l747t2904r1114b2994],
101	,	,	O	,	_	0	SENT_47	[p3l747t2904r1114b2994],
102	UK	NNP	LOCATION	UK	dep	110	SENT_47	[p3l1178t2911r1323b2994],
103	)	CD	NUMBER	)	dep	110	SENT_47	[p3l1178t2911r1323b2994],
104	with	IN	O	with	dep	110	SENT_47	[p3l1383t2904r1550b2972],
105	terbutaline	NN	O	terbutaline	dep	110	SENT_47	[p3l1604t2904r2018b2972],
106	as	IN	O	as	dep	110	SENT_47	[p3l2076t2928r2149b2972],
107	needed	VBN	O	need	dep	110	SENT_47	[p3l9t3015r282b3083],
108	for	IN	O	for	dep	110	SENT_47	[p3l307t3015r415b3083],
109	symptom	NN	O	symptom	dep	110	SENT_47	[p3l443t3028r798b3104],
110	relief	NN	O	relief	_	0	SENT_47	[p3l824t3015r1037b3083],
111	.	.	O	.	_	0	SENT_47	[p3l824t3015r1037b3083],

1	Pharmacogenetic	JJ	O	pharmacogenetic	amod	2	SENT_48	[p3l84t3123r740b3213],
2	analysis	NN	O	analysis	nsubj	8	SENT_48	[p3l765t3123r1062b3213],
3	of	IN	O	of	_	0	SENT_48	[p3l1089t3123r1173b3191],
4	data	NNS	O	datum	prep_of	2	SENT_48	[p3l1185t3123r1340b3191],
5	from	IN	O	from	_	0	SENT_48	[p3l1364t3123r1550b3191],
6	study	NN	O	study	prep_from	4	SENT_48	[p3l1577t3123r1779b3213],
7	224	CD	NUMBER	224	num	6	SENT_48	[p3l1804t3129r1889b3190],
8	served	VBD	O	serve	_	0	SENT_48	[p3l1912t3123r2153b3191],
9	as	IN	O	as	_	0	SENT_48	[p3l10t3256r83b3300],
10	a	DT	O	a	det	11	SENT_48	[p3l136t3257r172b3300],
11	conﬁrmation	NN	O	conﬁrmation	prep_as	8	SENT_48	[p3l222t3232r717b3300],
12	of	IN	O	of	_	0	SENT_48	[p3l767t3232r851b3300],
13	the	DT	O	the	det	15	SENT_48	[p3l886t3232r1004b3300],
14	primary	JJ	O	primary	amod	15	SENT_48	[p3l1054t3237r1358b3322],
15	study	NN	O	study	prep_of	11	SENT_48	[p3l1408t3232r1619b3322],
16	.	.	O	.	_	0	SENT_48	[p3l1408t3232r1619b3322],

1	This	DT	DATE	this	det	3	SENT_49	[p3l1671t3232r1837b3300],
2	second	JJ	DATE	second	amod	3	SENT_49	[p3l1891t3232r2153b3300],
3	study	NN	O	study	nsubj	8	SENT_49	[p3l11t3343r213b3432],
4	was	VBD	O	be	cop	8	SENT_49	[p3l256t3367r396b3411],
5	a	DT	O	a	det	8	SENT_49	[p3l447t3367r484b3411],
6	7-month	JJ	DURATION	7-month	amod	8	SENT_49	[p3l530t3343r849b3413],
7	open-label	JJ	O	open-label	amod	8	SENT_49	[p3l897t3343r1288b3432],
8	study	NN	O	study	_	0	SENT_49	[p3l1337t3343r1539b3432],
9	of	IN	O	of	_	0	SENT_49	[p3l1585t3343r1669b3411],
10	participants	NNS	O	participant	prep_of	8	SENT_49	[p3l1703t3347r2149b3432],
11	aged	VBN	O	age	partmod	10	SENT_49	[p3l10t3451r184b3541],
12	at	IN	DURATION	at	quantmod	14	SENT_49	[p3l228t3465r294b3519],
13	least	JJS	DURATION	least	mwe	12	SENT_49	[p3l336t3451r509b3519],
14	12	CD	DURATION	12	num	15	SENT_49	[p3l555t3458r628b3518],
15	years	NNS	NUMBER	year	dobj	11	SENT_49	[p3l674t3476r865b3541],
16	with	IN	O	with	_	0	SENT_49	[p3l911t3451r1078b3519],
17	a	DT	O	a	det	18	SENT_49	[p3l1124t3476r1161b3519],
18	diagnosis	NN	O	diagnosis	prep_with	15	SENT_49	[p3l1207t3451r1562b3541],
19	of	IN	O	of	_	0	SENT_49	[p3l1610t3451r1694b3519],
20	asthma	NN	O	asthma	nn	21	SENT_49	[p3l1727t3451r2003b3519],
21	(	NN	O	(	prep_of	18	SENT_49	[p3l2053t3458r2149b3541],
22	as	IN	O	as	mark	67	SENT_49	[p3l2053t3458r2149b3541],
23	deﬁned	VBN	O	deﬁned	csubjpass	67	SENT_49	[p3l10t3560r292b3628],
24	by	IN	O	by	_	0	SENT_49	[p3l339t3560r427b3650],
25	the	DT	O	the	det	28	SENT_49	[p3l473t3560r591b3628],
26	American	JJ	O	american	amod	28	SENT_49	[p3l639t3565r1014b3628],
27	Thoracic	NNP	ORGANIZATION	Thoracic	nn	28	SENT_49	[p3l1061t3560r1391b3628],
28	Society	NNP	ORGANIZATION	Society	prep_by	23	SENT_49	[p3l1446t3564r1779b3650],
29	)	CD	NUMBER	)	num	30	SENT_49	[p3l1446t3564r1779b3650],
30	“	NN	O	“	dobj	23	SENT_49	[p3l1446t3564r1779b3650],
31	for	IN	O	for	_	0	SENT_49	[p3l1829t3560r1937b3628],
32	6	CD	NUMBER	6	num	35	SENT_49	[p3l1986t3566r2024b3628],
33	or	CC	O	or	_	0	SENT_49	[p3l2076t3585r2153b3628],
34	more	JJR	O	more	conj_or	32	SENT_49	[p3l9t3694r207b3737],
35	months	NNS	DURATION	month	prep_for	30	SENT_49	[p3l238t3670r528b3737],
36	who	WP	O	who	nsubjpass	39	SENT_49	[p3l560t3670r719b3737],
37	had	VBD	O	have	aux	39	SENT_49	[p3l750t3670r891b3737],
38	been	VBN	O	be	auxpass	39	SENT_49	[p3l919t3670r1101b3737],
39	maintained	VBN	O	maintain	rcmod	30	SENT_49	[p3l1132t3670r1568b3737],
40	on	IN	O	on	_	0	SENT_49	[p3l1599t3694r1693b3737],
41	a	DT	O	a	det	44	SENT_49	[p3l1726t3694r1763b3737],
42	moderate	JJ	O	moderate	amod	44	SENT_49	[p3l1793t3670r2151b3737],
43	daily	JJ	SET	daily	amod	44	SENT_49	[p4l9t27r188b117],
44	dose	NN	O	dose	prep_on	39	SENT_49	[p4l254t27r423b95],
45	of	IN	O	of	_	0	SENT_49	[p4l493t27r577b95],
46	inhaled	VBN	O	inhale	prepc_of	44	SENT_49	[p4l631t27r915b95],
47	corticosteroid	NN	O	corticosteroid	dobj	46	SENT_49	[p4l983t27r1499b95],
48	or	CC	O	or	_	0	SENT_49	[p4l1567t52r1644b95],
49	an	DT	O	a	dobj	46	SENT_49	[p4l1711t52r1801b95],
50	inhaled	VBN	O	inhale	partmod	47	SENT_49	[p4l1869t27r2153b95],
51	corticosteroid	NN	O	corticosteroid	dobj	50	SENT_49	[p4l9t136r526b204],
52	plus	CC	O	plus	prep	51	SENT_49	[p4l578t136r736b225],
53	longacting	VBG	O	longact	dep	52	SENT_49	[p4l791t136r1191b226],
54	B,-agonist	JJ	O	b,-agonist	amod	55	SENT_49	[p4l1250t136r1618b226],
55	combination	NN	O	combination	dobj	53	SENT_49	[p4l1671t136r2152b204],
56	for	IN	O	for	_	0	SENT_49	[p4l8t246r116b313],
57	at	IN	DURATION	at	quantmod	59	SENT_49	[p4l146t259r212b313],
58	least	JJS	DURATION	least	mwe	57	SENT_49	[p4l239t246r412b313],
59	12	CD	DURATION	12	num	60	SENT_49	[p4l443t252r516b312],
60	weeks	NNS	NUMBER	week	prep_for	55	SENT_49	[p4l546t246r775b314],
61	before	IN	O	before	_	0	SENT_49	[p4l806t246r1045b313],
62	screening	VBG	O	screen	prepc_before	53	SENT_49	[p4l1078t250r1445b336],
63	(	CD	NUMBER	(	number	64	SENT_49	[p4l1481t250r1669b336],
64	1225	CD	DATE	1225	num	65	SENT_49	[p4l1481t250r1669b336],
65	participants	NNS	O	participant	dobj	62	SENT_49	[p4l1702t250r2148b335],
66	were	VBD	O	be	auxpass	67	SENT_49	[p4l7t379r186b422],
67	randomised	VBN	O	randomise	advcl	11	SENT_49	[p4l223t354r724b444],
68	)	NN	O	)	dobj	67	SENT_49	[p4l223t354r724b444],
69	.	.	O	.	_	0	SENT_49	[p4l223t354r724b444],

1	Bronchodilator	NN	MISC	bronchodilator	nn	2	SENT_50	[p4l768t354r1337b422],
2	reversibility	NN	O	reversibility	nsubj	7	SENT_50	[p4l1372t354r1819b444],
3	was	VBD	O	be	cop	7	SENT_50	[p4l1851t379r1990b422],
4	not	RB	O	not	neg	7	SENT_50	[p4l2029t368r2153b422],
5	an	DT	O	a	det	7	SENT_50	[p4l10t488r100b531],
6	entry	NN	O	entry	nn	7	SENT_50	[p4l127t477r321b553],
7	requirement	NN	O	requirement	_	0	SENT_50	[p4l345t468r822b552],
8	in	IN	O	in	_	0	SENT_50	[p4l847t468r922b530],
9	study	NN	O	study	prep_in	7	SENT_50	[p4l951t463r1153b552],
10	2	CD	NUMBER	2	num	9	SENT_50	[p4l1179t470r1237b531],
11	.	.	O	.	_	0	SENT_50	[p4l1179t470r1237b531],

1	Individuals	NNS	O	individual	nsubj	60	SENT_51	[p4l1272t463r1693b531],
2	who	WP	O	who	nsubj	3	SENT_51	[p4l1720t463r1879b531],
3	used	VBD	O	use	rcmod	1	SENT_51	[p4l1905t463r2084b531],
4	8	CD	NUMBER	8	num	7	SENT_51	[p4l2110t469r2150b531],
5	or	CC	O	or	_	0	SENT_51	[p4l10t597r87b640],
6	more	JJR	O	more	num	7	SENT_51	[p4l110t597r308b640],
7	inhalations	NNS	O	inhalation	dobj	3	SENT_51	[p4l333t573r755b640],
8	of	IN	O	of	_	0	SENT_51	[p4l783t573r867b640],
9	albuterol	NN	O	albuterol	nn	12	SENT_51	[p4l879t573r1214b640],
10	(	CD	NUMBER	(	num	12	SENT_51	[p4l1245t578r1475b663],
11	IVAX	NNP	ORGANIZATION	IVAX	nn	12	SENT_51	[p4l1245t578r1475b663],
12	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	prep_of	7	SENT_51	[p4l1503t573r2147b651],
13	,	,	O	,	_	0	SENT_51	[p4l1503t573r2147b651],
14	Miami	NNP	LOCATION	Miami	appos	12	SENT_51	[p4l12t686r277b759],
15	,	,	O	,	_	0	SENT_51	[p4l12t686r277b759],
16	FL	NN	LOCATION	fl	appos	12	SENT_51	[p4l320t686r432b760],
17	,	,	O	,	_	0	SENT_51	[p4l320t686r432b760],
18	USA	NNP	LOCATION	USA	appos	12	SENT_51	[p4l474t687r671b771],
19	)	CD	NUMBER	)	num	18	SENT_51	[p4l474t687r671b771],
20	during	IN	O	during	_	0	SENT_51	[p4l713t681r968b771],
21	the	DT	DURATION	the	det	24	SENT_51	[p4l1001t681r1119b749],
22	last	JJ	DURATION	last	amod	24	SENT_51	[p4l1154t681r1284b749],
23	10	CD	DURATION	10	num	24	SENT_51	[p4l1320t687r1396b749],
24	days	NNS	NUMBER	day	prep_during	18	SENT_51	[p4l1432t681r1594b771],
25	of	IN	O	of	_	0	SENT_51	[p4l1632t681r1716b749],
26	the	DT	O	the	det	28	SENT_51	[p4l1736t681r1854b749],
27	2-week	JJ	DURATION	2-week	amod	28	SENT_51	[p4l1893t681r2153b749],
28	run-in	NN	O	run-in	prep_of	12	SENT_51	[p4l9t796r248b859],
29	and	CC	O	and	_	0	SENT_51	[p4l273t791r413b860],
30	who	WP	O	who	nsubj	31	SENT_51	[p4l434t791r592b860],
31	had	VBD	O	have	conj_and	12	SENT_51	[p4l617t791r757b859],
32	an	DT	O	a	det	33	SENT_51	[p4l782t816r871b860],
33	FEV1	NN	O	fev1	dobj	31	SENT_51	[p4l900t796r1076b876],
34	of	IN	O	of	_	0	SENT_51	[p4l1101t791r1184b859],
35	at	IN	O	at	quantmod	37	SENT_51	[p4l1197t805r1262b859],
36	least	JJS	O	least	mwe	35	SENT_51	[p4l1284t791r1457b859],
37	50	CD	PERCENT	50	num	38	SENT_51	[p4l1484t796r1643b862],
38	%	NN	PERCENT	%	prep_of	33	SENT_51	[p4l1484t796r1643b862],
39	predicted	VBN	O	predict	conj_and	39	SENT_51	[p4l1668t791r2022b880],
40	for	IN	O	for	_	0	SENT_51	[p4l2046t791r2153b859],
41	6	CD	NUMBER	6	num	42	SENT_51	[p4l10t907r49b968],
42	h	NN	O	h	prep_for	39	SENT_51	[p4l81t901r130b967],
43	or	CC	O	or	_	0	SENT_51	[p4l162t925r240b968],
44	longer	JJR	O	longer	prep_for	39	SENT_51	[p4l268t901r514b991],
45	after	IN	O	after	_	0	SENT_51	[p4l545t901r715b969],
46	taking	VBG	O	take	prepc_after	39	SENT_51	[p4l743t901r981b991],
47	shortacting	JJ	O	shortacting	amod	48	SENT_51	[p4l1015t901r1440b991],
48	B,-agonist	NN	O	b,-agonist	dobj	46	SENT_51	[p4l1477t901r1845b991],
49	and	CC	O	and	_	0	SENT_51	[p4l1876t901r2015b969],
50	for	IN	O	for	_	0	SENT_51	[p4l2046t901r2153b969],
51	at	IN	O	at	quantmod	53	SENT_51	[p4l10t1023r76b1077],
52	least	JJS	O	least	mwe	51	SENT_51	[p4l125t1009r298b1077],
53	24	CD	NUMBER	24	num	54	SENT_51	[p4l352t1016r436b1076],
54	h	NN	O	h	prep_for	39	SENT_51	[p4l483t1009r533b1076],
55	after	IN	O	after	_	0	SENT_51	[p4l587t1009r757b1077],
56	taking	VBG	O	take	prepc_after	54	SENT_51	[p4l806t1009r1045b1099],
57	longacting	JJ	O	longacting	amod	58	SENT_51	[p4l1096t1009r1496b1099],
58	B,-agonist	NN	O	b,-agonist	dobj	56	SENT_51	[p4l1554t1009r1922b1099],
59	were	VBD	O	be	cop	60	SENT_51	[p4l1971t1034r2151b1078],
60	eligible	JJ	O	eligible	_	0	SENT_51	[p4l10t1118r283b1208],
61	for	IN	O	for	_	0	SENT_51	[p4l333t1118r440b1186],
62	randomisation	NN	O	randomisation	prep_for	60	SENT_51	[p4l488t1118r1064b1186],
63	.	.	O	.	_	0	SENT_51	[p4l488t1118r1064b1186],

1	Additionally	RB	O	additionally	advmod	6	SENT_52	[p4l1117t1118r1591b1208],
2	,	,	O	,	_	0	SENT_52	[p4l1117t1118r1591b1208],
3	eligibility	NN	O	eligibility	nsubj	6	SENT_52	[p4l1645t1118r1998b1208],
4	for	IN	O	for	_	0	SENT_52	[p4l2046t1118r2153b1186],
5	randomisation	NN	O	randomisation	prep_for	3	SENT_52	[p4l9t1228r566b1295],
6	included	VBD	O	include	_	0	SENT_52	[p4l604t1228r934b1295],
7	the	DT	O	the	det	8	SENT_52	[p4l970t1228r1088b1295],
8	need	NN	O	need	dobj	6	SENT_52	[p4l1126t1228r1309b1295],
9	for	IN	O	for	_	0	SENT_52	[p4l1346t1228r1454b1295],
10	a	DT	O	a	det	18	SENT_52	[p4l1491t1252r1528b1295],
11	mean	JJ	O	mean	amod	18	SENT_52	[p4l1567t1252r1779b1295],
12	morning	NN	TIME	morning	nn	18	SENT_52	[p4l1817t1232r2152b1318],
13	peak	NN	O	peak	nn	18	SENT_52	[p4l8t1336r185b1425],
14	expiratory	NN	O	expiratory	nn	18	SENT_52	[p4l250t1341r628b1426],
15	flow	NN	O	flow	nn	18	SENT_52	[p4l691t1336r852b1404],
16	(	CD	NUMBER	(	num	18	SENT_52	[p4l921t1341r1122b1426],
17	PEF	NN	O	pef	nn	18	SENT_52	[p4l921t1341r1122b1426],
18	)	NN	O	)	prep_for	8	SENT_52	[p4l921t1341r1122b1426],
19	that	WDT	O	that	nsubj	26	SENT_52	[p4l1191t1336r1338b1404],
20	was	VBD	O	be	cop	26	SENT_52	[p4l1400t1361r1540b1405],
21	between	IN	O	between	quantmod	26	SENT_52	[p4l1606t1336r1922b1405],
22	50	CD	PERCENT	50	number	26	SENT_52	[p4l1991t1341r2151b1407],
23	%	NN	PERCENT	%	dep	26	SENT_52	[p4l1991t1341r2151b1407],
24	and	CC	O	and	_	0	SENT_52	[p4l10t1446r149b1515],
25	85	CD	PERCENT	85	rcmod	18	SENT_52	[p4l202t1451r364b1517],
26	%	NN	PERCENT	%	rcmod	18	SENT_52	[p4l202t1451r364b1517],
27	of	IN	O	of	_	0	SENT_52	[p4l419t1446r503b1514],
28	the	DT	O	the	det	30	SENT_52	[p4l541t1446r659b1515],
29	PEF	NN	O	pef	nn	30	SENT_52	[p4l717t1451r865b1513],
30	value	NN	O	value	prep_of	26	SENT_52	[p4l919t1446r1117b1515],
31	obtained	VBN	O	obtain	partmod	30	SENT_52	[p4l1172t1446r1500b1515],
32	15	CD	DURATION	15	num	33	SENT_52	[p4l1554t1451r1627b1514],
33	min	NN	DURATION	min	dobj	31	SENT_52	[p4l1683t1451r1838b1513],
34	after	IN	O	after	mark	40	SENT_52	[p4l1892t1446r2063b1515],
35	a	DT	O	a	det	37	SENT_52	[p4l2115t1471r2152b1515],
36	standard	JJ	O	standard	amod	37	SENT_52	[p4l11t1557r339b1625],
37	dose	NN	O	dose	nsubj	40	SENT_52	[p4l396t1557r564b1625],
38	of	IN	O	of	_	0	SENT_52	[p4l623t1557r707b1625],
39	albuterol	NN	O	albuterol	prep_of	37	SENT_52	[p4l752t1557r1087b1625],
40	pressurised	VBD	O	pressurise	advcl	31	SENT_52	[p4l1143t1557r1584b1646],
41	metered-dose	JJ	O	metered-dose	amod	42	SENT_52	[p4l1639t1557r2151b1625],
42	inhaler	NN	O	inhaler	dobj	40	SENT_52	[p4l8t1665r279b1733],
43	(	CD	NUMBER	(	num	45	SENT_52	[p4l322t1672r477b1755],
44	2-4	CD	NUMBER	2-4	num	45	SENT_52	[p4l322t1672r477b1755],
45	inhalations	NNS	O	inhalation	nsubj	46	SENT_52	[p4l512t1665r934b1733],
46	[	VBP	O	[	rcmod	42	SENT_52	[p4l980t1671r1085b1754],
47	90	CD	NUMBER	90	num	48	SENT_52	[p4l980t1671r1085b1754],
48	ug	NN	O	ug	dobj	46	SENT_52	[p4l1124t1690r1220b1755],
49	per	IN	O	per	_	0	SENT_52	[p4l1258t1690r1382b1754],
50	inhalation	NN	O	inhalation	nn	52	SENT_52	[p4l1420t1665r1851b1755],
51	]	CD	NUMBER	]	num	52	SENT_52	[p4l1420t1665r1851b1755],
52	)	NN	O	)	prep_per	48	SENT_52	[p4l1420t1665r1851b1755],
53	during	IN	O	during	_	0	SENT_52	[p4l1897t1665r2152b1755],
54	the	DT	DURATION	the	det	57	SENT_52	[p4l7t1774r125b1842],
55	last	JJ	DURATION	last	amod	57	SENT_52	[p4l173t1774r304b1842],
56	7	CD	DURATION	7	num	57	SENT_52	[p4l350t1779r387b1845],
57	days	NNS	NUMBER	day	prep_during	46	SENT_52	[p4l435t1774r597b1864],
58	of	IN	O	of	_	0	SENT_52	[p4l648t1774r732b1842],
59	the	DT	O	the	det	60	SENT_52	[p4l766t1774r884b1842],
60	run-in	NN	O	run-in	prep_of	57	SENT_52	[p4l933t1779r1191b1842],
61	.	.	O	.	_	0	SENT_52	[p4l933t1779r1191b1842],

1	During	IN	O	during	_	0	SENT_53	[p4l1248t1779r1518b1864],
2	run-in	NN	O	run-in	prep_during	6	SENT_53	[p4l1567t1779r1825b1852],
3	,	,	O	,	_	0	SENT_53	[p4l1567t1779r1825b1852],
4	eligible	JJ	O	eligible	amod	5	SENT_53	[p4l1878t1774r2151b1864],
5	individuals	NNS	O	individual	nsubj	6	SENT_53	[p4l9t1885r426b1953],
6	remained	VBD	O	remain	_	0	SENT_53	[p4l467t1885r831b1953],
7	on	IN	O	on	_	0	SENT_53	[p4l870t1909r964b1953],
8	their	PRP$	O	they	poss	11	SENT_53	[p4l1001t1885r1181b1953],
9	present	JJ	DATE	present	amod	11	SENT_53	[p4l1217t1898r1501b1974],
10	asthma	NN	O	asthma	nn	11	SENT_53	[p4l1539t1885r1815b1953],
11	therapy	NN	O	therapy	prep_on	6	SENT_53	[p4l1852t1885r2148b1974],
12	,	,	O	,	_	0	SENT_53	[p4l1852t1885r2148b1974],
13	with	IN	O	with	_	0	SENT_53	[p4l7t1993r174b2061],
14	albuterol	NN	O	albuterol	prep_with	6	SENT_53	[p4l237t1993r573b2061],
15	used	VBN	O	use	partmod	14	SENT_53	[p4l633t1993r812b2061],
16	as	IN	O	as	mark	17	SENT_53	[p4l875t2018r947b2061],
17	needed	VBN	O	need	advcl	15	SENT_53	[p4l1012t1993r1285b2061],
18	for	IN	O	for	_	0	SENT_53	[p4l1346t1993r1454b2061],
19	symptom	NN	O	symptom	nn	20	SENT_53	[p4l1517t2007r1872b2083],
20	relief	NN	O	relief	prep_for	17	SENT_53	[p4l1934t1993r2147b2061],
21	.	.	O	.	_	0	SENT_53	[p4l1934t1993r2147b2061],

1	Individuals	NNS	O	individual	nsubjpass	4	SENT_54	[p4l13t2102r434b2170],
2	were	VBD	O	be	auxpass	4	SENT_54	[p4l459t2127r639b2170],
3	then	RB	O	then	advmod	4	SENT_54	[p4l663t2102r834b2170],
4	randomised	VBN	O	randomise	_	0	SENT_54	[p4l858t2102r1313b2170],
5	to	TO	O	to	xcomp	4	SENT_54	[p4l1335t2116r1424b2170],
6	:	:	O	:	_	0	SENT_54	[p4l1335t2116r1424b2170],
7	(	CD	NUMBER	(	number	8	SENT_54	[p4l1459t2108r1537b2192],
8	1	CD	NUMBER	1	dobj	4	SENT_54	[p4l1459t2108r1537b2192],
9	)	CD	NUMBER	)	num	11	SENT_54	[p4l1459t2108r1537b2192],
10	adjustable-dose	JJ	O	adjustable-dose	amod	11	SENT_54	[p4l1568t2102r2151b2192],
11	budesonide	NN	O	budesonide	nsubj	14	SENT_54	[p4l7t2213r448b2281],
12	plus	CC	O	plus	prep	11	SENT_54	[p4l494t2213r652b2302],
13	formoterol	NN	O	formoterol	dep	12	SENT_54	[p4l701t2213r1107b2281],
14	pressurised	VBD	O	pressurise	rcmod	8	SENT_54	[p4l1154t2213r1594b2302],
15	metered-dose	JJ	O	metered-dose	amod	16	SENT_54	[p4l1639t2213r2151b2281],
16	inhaler	NN	O	inhaler	dobj	14	SENT_54	[p4l8t2321r279b2389],
17	delivered	VBN	O	deliver	partmod	16	SENT_54	[p4l311t2321r655b2389],
18	as	IN	O	as	_	0	SENT_54	[p4l688t2346r761b2389],
19	320	CD	NUMBER	320	num	20	SENT_54	[p4l800t2327r928b2389],
20	ug	NN	O	ug	prep_as	17	SENT_54	[p4l961t2346r1056b2411],
21	and	CC	O	and	_	0	SENT_54	[p4l1090t2321r1229b2389],
22	9	CD	NUMBER	9	num	23	SENT_54	[p4l1262t2328r1301b2390],
23	ug	NN	O	ug	prep_as	17	SENT_54	[p4l1334t2346r1449b2411],
24	,	,	O	,	_	0	SENT_54	[p4l1334t2346r1449b2411],
25	respectively	RB	O	respectively	advmod	17	SENT_54	[p4l1485t2321r1939b2411],
26	,	,	O	,	_	0	SENT_54	[p4l1485t2321r1939b2411],
27	once	RB	DATE	once	advmod	28	SENT_54	[p4l1976t2346r2151b2389],
28	daily	RB	SET	daily	advmod	17	SENT_54	[p4l10t2430r197b2520],
29	,	,	O	,	_	0	SENT_54	[p4l10t2430r197b2520],
30	320	CD	NUMBER	320	num	31	SENT_54	[p4l231t2436r359b2498],
31	pig	NN	O	pig	dobj	14	SENT_54	[p4l384t2455r480b2520],
32	and	CC	O	and	_	0	SENT_54	[p4l506t2430r645b2498],
33	9	CD	NUMBER	9	num	34	SENT_54	[p4l671t2437r710b2499],
34	ug	NN	O	ug	conj_or	16	SENT_54	[p4l736t2455r851b2520],
35	,	,	O	,	_	0	SENT_54	[p4l736t2455r851b2520],
36	respectively	RB	O	respectively	advmod	34	SENT_54	[p4l880t2430r1334b2520],
37	,	,	O	,	_	0	SENT_54	[p4l880t2430r1334b2520],
38	twice	RB	O	twice	advmod	39	SENT_54	[p4l1361t2435r1556b2498],
39	daily	RB	SET	daily	conj_or	16	SENT_54	[p4l1584t2430r1772b2519],
40	,	,	O	,	_	0	SENT_54	[p4l1584t2430r1772b2519],
41	or	CC	O	or	_	0	SENT_54	[p4l1803t2455r1880b2498],
42	640	CD	NUMBER	640	num	43	SENT_54	[p4l1905t2436r2031b2498],
43	ug	NN	O	ug	conj_or	16	SENT_54	[p4l2056t2455r2152b2520],
44	and	CC	O	and	_	0	SENT_54	[p4l10t2540r149b2607],
45	18	CD	NUMBER	18	num	46	SENT_54	[p4l183t2546r257b2607],
46	ug	NN	O	ug	conj_or	16	SENT_54	[p4l290t2564r404b2630],
47	,	,	O	,	_	0	SENT_54	[p4l290t2564r404b2630],
48	respectively	RB	O	respectively	advmod	14	SENT_54	[p4l440t2540r894b2629],
49	,	,	O	,	_	0	SENT_54	[p4l440t2540r894b2629],
50	twice	RB	O	twice	advmod	51	SENT_54	[p4l929t2544r1124b2608],
51	daily	RB	SET	daily	advmod	14	SENT_54	[p4l1158t2540r1346b2629],
52	,	,	O	,	_	0	SENT_54	[p4l1158t2540r1346b2629],
53	stepped	VBD	O	step	dep	14	SENT_54	[p4l1384t2540r1675b2629],
54	up	RP	O	up	advmod	53	SENT_54	[p4l1704t2564r1802b2629],
55	or	CC	O	or	_	0	SENT_54	[p4l1836t2564r1913b2607],
56	down	RP	O	down	conj_or	54	SENT_54	[p4l1945t2540r2152b2608],
57	from	IN	O	from	_	0	SENT_54	[p4l9t2648r195b2716],
58	the	DT	O	the	det	60	SENT_54	[p4l233t2648r351b2716],
59	initial	JJ	O	initial	amod	60	SENT_54	[p4l391t2648r611b2716],
60	dose	NN	O	dose	prep_from	53	SENT_54	[p4l652t2648r821b2716],
61	of	IN	O	of	_	0	SENT_54	[p4l862t2648r946b2716],
62	320	CD	NUMBER	320	num	63	SENT_54	[p4l976t2654r1104b2716],
63	pg	NN	O	pg	prep_of	60	SENT_54	[p4l1143t2673r1239b2738],
64	and	CC	O	and	_	0	SENT_54	[p4l1279t2648r1419b2716],
65	9	CD	NUMBER	9	num	66	SENT_54	[p4l1458t2655r1497b2717],
66	ug	NN	O	ug	conj_and	63	SENT_54	[p4l1537t2673r1651b2738],
67	,	,	O	,	_	0	SENT_54	[p4l1537t2673r1651b2738],
68	respectively	RB	O	respectively	advmod	14	SENT_54	[p4l1694t2648r2148b2738],
69	,	,	O	,	_	0	SENT_54	[p4l1694t2648r2148b2738],
70	twice	RB	O	twice	advmod	71	SENT_54	[p4l7t2762r202b2825],
71	daily	JJ	SET	daily	advmod	72	SENT_54	[p4l243t2757r421b2847],
72	dependent	JJ	O	dependent	dep	14	SENT_54	[p4l459t2757r861b2846],
73	on	IN	O	on	_	0	SENT_54	[p4l900t2782r994b2825],
74	asthma	NN	O	asthma	nn	75	SENT_54	[p4l1034t2757r1310b2825],
75	control	NN	O	control	prep_on	72	SENT_54	[p4l1350t2757r1615b2825],
76	as	IN	O	as	mark	77	SENT_54	[p4l1656t2781r1728b2825],
77	judged	VBN	O	judge	advcl	14	SENT_54	[p4l1769t2757r2029b2847],
78	by	IN	O	by	_	0	SENT_54	[p4l2065t2757r2153b2847],
79	shortacting	VBG	O	shortact	prepc_by	77	SENT_54	[p4l11t2867r436b2957],
80	B,-agonist	JJ	O	b,-agonist	amod	81	SENT_54	[p4l482t2867r850b2957],
81	use	NN	O	use	dobj	79	SENT_54	[p4l889t2891r1017b2935],
82	and	CC	O	and	_	0	SENT_54	[p4l1060t2867r1200b2935],
83	night-time	JJ	O	night-time	amod	84	SENT_54	[p4l1239t2867r1639b2957],
84	awakenings	NNS	O	awakening	conj_and	81	SENT_54	[p4l1682t2867r2147b2957],
85	;	:	O	;	_	0	SENT_54	[p4l1682t2867r2147b2957],

1	www	NN	O	www	_	0	SENT_55	[p4l7t3138r543b3189],
2	.	.	O	.	_	0	SENT_55	[p4l7t3138r543b3189],

1	the	DT	O	the	det	4	SENT_56	[p4l7t3138r543b3189],
2	|	NN	O	|	nn	4	SENT_56	[p4l7t3138r543b3189],
3	ancet.com	NN	O	ancet.com	nn	4	SENT_56	[p4l7t3138r543b3189],
4	Vol	NN	O	vol	_	0	SENT_56	[p4l586t3138r674b3189],
5	370	CD	NUMBER	370	dep	4	SENT_56	[p4l693t3144r797b3196],
6	December	NNP	DATE	December	tmod	5	SENT_56	[p4l847t3138r1126b3189],
7	22/29	CD	DATE	22/29	num	6	SENT_56	[p4l1143t3139r1324b3197],
8	,	,	DATE	,	_	0	SENT_56	[p4l1143t3139r1324b3197],
9	2007	CD	DATE	2007	num	6	SENT_56	[p4l1343t3144r1486b3195],

1	Z	NN	O	z	nn	4	SENT_57	[p5l454t208r530b212],
2	G	NN	O	g	nn	4	SENT_57	[p5l565t186r822b230],
3	|	NNS	O	|	nn	4	SENT_57	[p5l565t186r822b230],
4	y/G	NN	O	y/g	_	0	SENT_57	[p5l565t186r822b230],
5	|	CD	NUMBER	|	num	6	SENT_57	[p5l565t186r822b230],
6	y	NN	O	y	dep	4	SENT_57	[p5l565t186r822b230],
7	(	CD	NUMBER	(	num	8	SENT_57	[p5l565t186r822b230],
8	n	NN	O	n	dep	6	SENT_57	[p5l565t186r822b230],
9	=	JJ	O	=	amod	8	SENT_57	[p5l565t186r822b230],
10	99	CD	NUMBER	99	number	11	SENT_57	[p5l565t186r822b230],
11	)	CD	NUMBER	)	dep	9	SENT_57	[p5l565t186r822b230],
12	:	:	O	:	_	0	SENT_57	[p5l454t257r530b261],
13	Gly/Arg	NN	O	gly/arg	nn	15	SENT_57	[p5l565t241r845b285],
14	(	CD	NUMBER	(	num	15	SENT_57	[p5l565t241r845b285],
15	n	NN	O	n	dep	6	SENT_57	[p5l565t241r845b285],
16	=	JJ	O	=	amod	18	SENT_57	[p5l565t241r845b285],
17	110	CD	NUMBER	110	tmod	16	SENT_57	[p5l565t241r845b285],
18	)	NN	O	)	dep	15	SENT_57	[p5l565t241r845b285],
19	:	:	O	:	_	0	SENT_57	[p5l454t306r530b309],
20	Arg/Arg	NN	O	arg/arg	nn	22	SENT_57	[p5l564t298r831b341],
21	(	CD	NUMBER	(	num	22	SENT_57	[p5l564t298r831b341],
22	n	NN	O	n	dep	6	SENT_57	[p5l564t298r831b341],
23	=	JJ	O	=	amod	22	SENT_57	[p5l564t298r831b341],
24	32	CD	NUMBER	32	tmod	23	SENT_57	[p5l564t298r831b341],
25	)	CD	NUMBER	)	num	26	SENT_57	[p5l564t298r831b341],
26	)	NN	O	)	dep	4	SENT_57	[p5l236t426r277b436],

1	8	CD	NUMBER	8	num	2	SENT_58	[p5l295t405r337b434],
2	Proportion	NN	O	proportion	_	0	SENT_58	[p5l181t622r222b810],
3	of	IN	O	of	_	0	SENT_58	[p5l178t572r212b610],
4	patients	NNS	O	patient	prep_of	2	SENT_58	[p5l181t422r222b564],
5	with	IN	O	with	_	0	SENT_58	[p5l179t334r212b412],
6	exacerbation	NN	O	exacerbation	prep_with	4	SENT_58	[p5l234t495r268b720],
7	(	CD	PERCENT	(	num	8	SENT_58	[p5l236t440r277b481],
8	%	NN	PERCENT	%	dep	2	SENT_58	[p5l236t440r277b481],

1	U1	NN	O	u1	_	0	SENT_59	[p5l319t671r337b705],

1	o	NN	O	o	dep	4	SENT_60	[p5l319t938r339b967],
2	I	CD	NUMBER	i	dep	1	SENT_60	[p5l1112t955r1116b978],
3	I	PRP	O	I	dep	4	SENT_60	[p5l1179t955r1183b978],
4	I	PRP	O	I	dep	6	SENT_60	[p5l1245t955r1249b978],
5	I	PRP	O	I	dep	4	SENT_60	[p5l1312t955r1316b978],
6	I	PRP	O	I	_	0	SENT_60	[p5l1378t955r1382b978],
7	I	PRP	O	I	nsubj	8	SENT_60	[p5l1445t955r1449b978],
8	O	VBP	O	o	rcmod	6	SENT_60	[p5l371t995r392b1024],
9	20	CD	NUMBER	20	dobj	8	SENT_60	[p5l494t995r537b1024],
10	40	CD	NUMBER	40	number	11	SENT_60	[p5l626t995r672b1029],
11	60 80 100 120	CD	NUMBER	60 80 100 120	num	13	SENT_60	[p5l1152t995r1215b1024],[p5l761t990r805b1024],
12	140	CD	NUMBER	140	number	13	SENT_60	[p5l1282t995r1348b1029],
13	160	CD	NUMBER	160	dep	9	SENT_60	[p5l1417t990r1483b1024],

1	Number	NN	O	number	dep	9	SENT_61	[p5l45t1062r196b1096],
2	at	IN	O	at	_	0	SENT_61	[p5l205t1067r243b1096],
3	risk	NN	O	risk	nn	4	SENT_61	[p5l254t1062r318b1096],
4	Gly/Gly	NN	O	gly/gly	prep_at	1	SENT_61	[p5l44t1117r170b1161],
5	833	CD	NUMBER	833	number	6	SENT_61	[p5l376t1117r441b1156],
6	734	CD	NUMBER	734	num	4	SENT_61	[p5l1415t1118r1482b1152],
7	Gly/Arg	NN	O	gly/arg	dep	9	SENT_61	[p5l44t1173r175b1217],
8	1028	CD	DATE	1028	num	7	SENT_61	[p5l352t1173r440b1207],
9	918	CD	NUMBER	918	dep	12	SENT_61	[p5l1416t1172r1482b1211],
10	Arg/Arg	NN	O	arg/arg	dep	9	SENT_61	[p5l43t1229r182b1272],
11	361	CD	NUMBER	361	num	12	SENT_61	[p5l374t1225r440b1264],
12	329	CD	NUMBER	329	_	0	SENT_61	[p5l1415t1229r1481b1263],

1	B	NN	O	b	_	0	SENT_62	[p5l77t1358r105b1398],
2	15	CD	NUMBER	15	num	1	SENT_62	[p5l294t1370r333b1404],

1	Z	NN	O	z	_	0	SENT_63	[p5l454t1432r530b1436],
2	Gly/G	NN	O	gly/g	dep	7	SENT_63	[p5l565t1409r815b1453],
3	|	CD	NUMBER	|	num	4	SENT_63	[p5l565t1409r815b1453],
4	y	NN	O	y	dep	2	SENT_63	[p5l565t1409r815b1453],
5	(	CD	NUMBER	(	num	6	SENT_63	[p5l565t1409r815b1453],
6	n	NN	O	n	dep	7	SENT_63	[p5l565t1409r815b1453],
7	=	JJ	O	=	dep	1	SENT_63	[p5l565t1409r815b1453],
8	15	CD	NUMBER	15	number	9	SENT_63	[p5l565t1409r815b1453],
9	)	CD	NUMBER	)	num	13	SENT_63	[p5l565t1409r815b1453],
10	Z	NN	O	z	nn	13	SENT_63	[p5l454t1480r530b1485],
11	Gly/Arg	NN	O	gly/arg	nn	13	SENT_63	[p5l565t1465r823b1509],
12	(	CD	NUMBER	(	num	13	SENT_63	[p5l565t1465r823b1509],
13	n	NN	O	n	dep	7	SENT_63	[p5l565t1465r823b1509],
14	=	JJ	O	=	amod	13	SENT_63	[p5l565t1465r823b1509],
15	13	CD	NUMBER	13	number	16	SENT_63	[p5l565t1465r823b1509],
16	)	CD	NUMBER	)	dep	14	SENT_63	[p5l565t1465r823b1509],
17	:	:	O	:	_	0	SENT_63	[p5l454t1529r530b1533],
18	Arg/Arg	NN	O	arg/arg	nn	20	SENT_63	[p5l564t1520r812b1565],
19	(	CD	NUMBER	(	num	20	SENT_63	[p5l564t1520r812b1565],
20	n	NN	O	n	dep	1	SENT_63	[p5l564t1520r812b1565],
21	=	JJ	O	=	amod	23	SENT_63	[p5l564t1520r812b1565],
22	6	CD	NUMBER	6	tmod	21	SENT_63	[p5l564t1520r812b1565],
23	)	NN	O	)	dep	20	SENT_63	[p5l564t1520r812b1565],

1	Proportion	NN	O	proportion	_	0	SENT_64	[p5l181t1801r222b1989],
2	of	IN	O	of	_	0	SENT_64	[p5l178t1751r212b1789],
3	patients	NNS	O	patient	prep_of	1	SENT_64	[p5l181t1600r222b1743],
4	with	IN	O	with	_	0	SENT_64	[p5l178t1513r212b1591],
5	exacerbation	NN	O	exacerbation	prep_with	3	SENT_64	[p5l234t1674r268b1898],
6	(	CD	PERCENT	(	num	7	SENT_64	[p5l236t1605r277b1660],
7	%	NN	PERCENT	%	dep	1	SENT_64	[p5l236t1605r277b1660],
8	)	CD	NUMBER	)	dep	7	SENT_64	[p5l236t1605r277b1660],

1	U	NNP	O	U	poss	4	SENT_65	[p5l316t1863r334b1897],
2	'	POS	O	'	_	0	SENT_65	[p5l316t1863r334b1897],
3	|	NN	O	|	nn	4	SENT_65	[p5l316t1863r334b1897],
4	o	NN	O	o	_	0	SENT_65	[p5l372t2168r393b2197],
5	20	CD	NUMBER	20	number	6	SENT_65	[p5l461t2168r504b2197],
6	40	CD	NUMBER	40	amod	4	SENT_65	[p5l549t2168r595b2202],
7	60 80 100 120	CD	NUMBER	60 80 100 120	number	8	SENT_65	[p5l925t2168r989b2197],[p5l645t2163r690b2197],
8	140 160 180 200	CD	NUMBER	140 160 180 200	dep	4	SENT_65	[p5l1307t2168r1374b2197],[p5l1021t2168r1087b2202],
9	220	CD	NUMBER	220	dep	8	SENT_65	[p5l1398t2168r1463b2197],

1	Days	NNS	DURATION	day	_	0	SENT_66	[p5l688t2240r767b2281],
2	since	IN	O	since	_	0	SENT_66	[p5l778t2240r864b2271],
3	randomisation	NN	O	randomisation	prep_since	1	SENT_66	[p5l877t2237r1133b2271],

1	Number	NN	O	number	dep	7	SENT_67	[p5l45t2304r196b2338],
2	at	IN	O	at	_	0	SENT_67	[p5l205t2310r243b2338],
3	risk	NN	O	risk	prep_at	1	SENT_67	[p5l254t2304r318b2338],
4	Gly/Gly	NN	O	gly/gly	dep	7	SENT_67	[p5l44t2359r170b2403],
5	168	CD	NUMBER	168	num	4	SENT_67	[p5l369t2359r436b2393],
6	153	CD	NUMBER	153	num	7	SENT_67	[p5l1398t2364r1459b2398],
7	Gly/Arg	NN	O	gly/arg	dep	12	SENT_67	[p5l44t2415r175b2459],
8	169	CD	NUMBER	169	number	9	SENT_67	[p5l369t2412r436b2451],
9	156	CD	NUMBER	156	dep	7	SENT_67	[p5l1398t2412r1463b2451],
10	Arg/Arg	NN	O	arg/arg	dep	9	SENT_67	[p5l43t2472r182b2515],
11	67	CD	NUMBER	67	num	12	SENT_67	[p5l389t2470r432b2508],
12	61	CD	NUMBER	61	_	0	SENT_67	[p5l1418t2470r1460b2504],

1	Figure	NNP	O	Figure	nsubj	15	SENT_68	[p5l9t2619r125b2665],
2	1	CD	NUMBER	1	num	1	SENT_68	[p5l136t2623r169b2654],
3	:	:	O	:	_	0	SENT_68	[p5l136t2623r169b2654],
4	time	NN	O	time	dep	1	SENT_68	[p5l178t2619r272b2654],
5	to	TO	O	to	aux	6	SENT_68	[p5l281t2624r324b2654],
6	ﬁrst	VB	O	ﬁrst	infmod	4	SENT_68	[p5l335t2617r416b2654],
7	asthma	NN	O	asthma	nn	8	SENT_68	[p5l427t2618r576b2654],
8	exacerbation	NN	O	exacerbation	dobj	6	SENT_68	[p5l588t2618r846b2654],
9	by	IN	O	by	_	0	SENT_68	[p5l859t2618r907b2665],
10	Gly16Arg	NN	O	gly16arg	nn	11	SENT_68	[p5l916t2617r1102b2665],
11	genotype	NN	O	genotype	prep_by	6	SENT_68	[p5l1115t2624r1306b2665],
12	(	CD	NUMBER	(	num	11	SENT_68	[p5l1318t2618r1376b2663],
13	all	DT	O	all	det	14	SENT_68	[p5l1318t2618r1376b2663],
14	participants	NNS	O	participant	nsubj	15	SENT_68	[p5l9t2682r250b2728],
15	genotyped	VBD	O	genotype	_	0	SENT_68	[p5l262t2680r494b2728],
16	)	CD	NUMBER	)	number	17	SENT_68	[p5l262t2680r494b2728],
17	(	CD	NUMBER	(	num	20	SENT_68	[p5l11t2743r65b2787],
18	A	DT	O	a	det	20	SENT_68	[p5l11t2743r65b2787],
19	)	NN	O	)	nn	20	SENT_68	[p5l11t2743r65b2787],
20	Study	NN	O	study	dobj	15	SENT_68	[p5l79t2741r187b2788],
21	1	CD	NUMBER	1	dep	20	SENT_68	[p5l199t2746r228b2784],
22	;	:	O	;	_	0	SENT_68	[p5l199t2746r228b2784],
23	severe	JJ	O	severe	amod	24	SENT_68	[p5l241t2754r359b2778],
24	exacerbations	NNS	O	exacerbation	nsubjpass	26	SENT_68	[p5l371t2741r632b2778],
25	were	VBD	O	be	auxpass	26	SENT_68	[p5l642t2753r733b2778],
26	deﬁned	VBN	O	deﬁned	parataxis	15	SENT_68	[p5l745t2741r885b2778],
27	as	IN	O	as	_	0	SENT_68	[p5l897t2754r935b2778],
28	deterioration	NN	O	deterioration	prep_as	26	SENT_68	[p5l946t2741r1193b2778],
29	in	IN	O	in	_	0	SENT_68	[p5l1209t2744r1240b2777],
30	asthma	NN	O	asthma	prep_in	26	SENT_68	[p5l1253t2741r1393b2778],
31	leading	VBG	O	lead	partmod	30	SENT_68	[p5l11t2803r145b2851],
32	to	TO	O	to	_	0	SENT_68	[p5l156t2810r197b2840],
33	hospitalisation	NN	O	hospitalisation	nn	37	SENT_68	[p5l211t2803r488b2851],
34	and	CC	O	and	_	0	SENT_68	[p5l501t2803r571b2840],
35	emergency	NN	O	emergency	conj_and	33	SENT_68	[p5l583t2816r791b2851],
36	department	NN	O	department	nn	37	SENT_68	[p5l801t2803r1027b2851],
37	treatment	NN	O	treatment	prep_to	31	SENT_68	[p5l1036t2810r1230b2840],
38	as	IN	O	as	_	0	SENT_68	[p5l1242t2816r1279b2840],
39	a	DT	O	a	det	40	SENT_68	[p5l1291t2816r1310b2840],
40	result	NN	O	result	prep_as	31	SENT_68	[p5l1324t2803r1427b2840],
41	of	IN	O	of	_	0	SENT_68	[p5l1438t2803r1478b2840],
42	asthma	NN	O	asthma	nn	46	SENT_68	[p5l9t2865r149b2901],
43	or	CC	O	or	_	0	SENT_68	[p5l161t2877r199b2901],
44	oral	JJ	O	oral	conj_or	42	SENT_68	[p5l209t2865r278b2901],
45	glucocorticosteroid	NN	O	glucocorticosteroid	nn	46	SENT_68	[p5l291t2865r657b2913],
46	treatment	NN	O	treatment	prep_of	40	SENT_68	[p5l666t2872r860b2901],
47	for	IN	O	for	_	0	SENT_68	[p5l871t2865r926b2901],
48	asthma	NN	O	asthma	prep_for	46	SENT_68	[p5l937t2865r1077b2901],
49	of	IN	O	of	_	0	SENT_68	[p5l1088t2865r1128b2901],
50	at	IN	DURATION	at	quantmod	52	SENT_68	[p5l1137t2872r1174b2901],
51	least	JJS	DURATION	least	mwe	50	SENT_68	[p5l1187t2865r1272b2901],
52	3	CD	DURATION	3	num	54	SENT_68	[p5l1283t2870r1303b2907],
53	days	NNS	NUMBER	day	nn	54	SENT_68	[p5l1316t2865r1399b2912],
54	duration	NN	O	duration	prep_of	48	SENT_68	[p5l10t2927r181b2963],
55	.	.	O	.	_	0	SENT_68	[p5l10t2927r181b2963],

1	(	NN	O	(	nn	2	SENT_69	[p5l196t2929r248b2973],
2	B	NN	O	b	nsubjpass	10	SENT_69	[p5l196t2929r248b2973],
3	)	CD	NUMBER	)	num	4	SENT_69	[p5l196t2929r248b2973],
4	Study	NN	O	study	dep	2	SENT_69	[p5l261t2927r370b2974],
5	2	CD	NUMBER	2	dep	2	SENT_69	[p5l381t2932r412b2970],
6	;	:	O	;	_	0	SENT_69	[p5l381t2932r412b2970],
7	asthma	NN	O	asthma	nn	8	SENT_69	[p5l425t2927r565b2963],
8	exacerbations	NNS	O	exacerbation	dep	5	SENT_69	[p5l577t2927r838b2963],
9	were	VBD	O	be	auxpass	10	SENT_69	[p5l848t2939r939b2963],
10	deﬁned	VBN	O	deﬁned	_	0	SENT_69	[p5l951t2927r1092b2963],
11	as	IN	O	as	_	0	SENT_69	[p5l1103t2939r1141b2963],
12	worsening	VBG	O	worsen	amod	13	SENT_69	[p5l1151t2930r1348b2975],
13	asthma	NN	O	asthma	prep_as	10	SENT_69	[p5l1362t2927r1502b2963],
14	that	WDT	O	that	nsubj	15	SENT_69	[p5l8t2989r87b3025],
15	needed	VBD	O	need	ccomp	13	SENT_69	[p5l101t2989r237b3025],
16	treatment	NN	O	treatment	dobj	15	SENT_69	[p5l246t2996r440b3025],
17	with	IN	O	with	_	0	SENT_69	[p5l450t2989r534b3025],
18	oral	JJ	O	oral	amod	19	SENT_69	[p5l547t2989r615b3025],
19	steroids	NNS	O	steroid	prep_with	15	SENT_69	[p5l629t2989r786b3025],
20	.	.	O	.	_	0	SENT_69	[p5l629t2989r786b3025],

1	(	NN	O	(	nsubj	8	SENT_70	[p5l13t3124r75b3183],
2	2	CD	NUMBER	2	number	3	SENT_70	[p5l13t3124r75b3183],
3	)	CD	NUMBER	)	num	5	SENT_70	[p5l13t3124r75b3183],
4	ﬁxed-dose	NN	O	ﬁxed-dose	nn	5	SENT_70	[p5l110t3119r378b3168],
5	budesonide	NN	O	budesonide	dep	1	SENT_70	[p5l409t3119r721b3168],
6	plus	CC	O	plus	prep	1	SENT_70	[p5l753t3119r865b3182],
7	formoterol	NN	O	formoterol	dep	6	SENT_70	[p5l898t3119r1186b3168],
8	pressurised	VBD	O	pressurise	_	0	SENT_70	[p5l1217t3119r1529b3182],
9	metered-dose	JJ	O	metered-dose	amod	10	SENT_70	[p5l9t3197r372b3246],
10	inhaler	NN	O	inhaler	dobj	8	SENT_70	[p5l389t3197r580b3246],
11	320	CD	NUMBER	320	num	12	SENT_70	[p5l598t3201r689b3246],
12	pg	NN	O	pg	dep	10	SENT_70	[p5l705t3214r773b3261],
13	and	CC	O	and	_	0	SENT_70	[p5l790t3197r889b3246],
14	9	CD	NUMBER	9	num	15	SENT_70	[p5l905t3202r933b3246],
15	pg	NN	O	pg	conj_and	10	SENT_70	[p5l950t3214r1031b3261],
16	,	,	O	,	_	0	SENT_70	[p5l950t3214r1031b3261],
17	respectively	RB	O	respectively	advmod	15	SENT_70	[p5l1050t3197r1371b3261],
18	,	,	O	,	_	0	SENT_70	[p5l1050t3197r1371b3261],
19	twice	RB	O	twice	advmod	20	SENT_70	[p5l1389t3200r1528b3246],
20	daily	RB	SET	daily	conj_and	10	SENT_70	[p5l10t3276r147b3339],
21	;	:	O	;	_	0	SENT_70	[p5l10t3276r147b3339],
22	or	CC	O	or	_	0	SENT_70	[p5l181t3293r236b3324],
23	(	CD	NUMBER	(	number	24	SENT_70	[p5l269t3280r331b3340],
24	3	CD	NUMBER	3	num	34	SENT_70	[p5l269t3280r331b3340],
25	)	NN	O	)	nn	34	SENT_70	[p5l269t3280r331b3340],
26	ﬁxed-dose	NN	O	ﬁxed-dose	nn	34	SENT_70	[p5l365t3276r633b3324],
27	ﬂuticasone	NN	O	ﬂuticasone	dep	34	SENT_70	[p5l664t3276r957b3324],
28	plus	CC	O	plus	prep	27	SENT_70	[p5l988t3276r1100b3339],
29	salmeterol	NN	O	salmeterol	dep	28	SENT_70	[p5l1134t3276r1413b3324],
30	dry	JJ	O	dry	amod	34	SENT_70	[p5l1444t3276r1530b3339],
31	powder	NN	O	powder	nn	34	SENT_70	[p5l9t3353r209b3416],
32	inhaler	NN	O	inhaler	nn	34	SENT_70	[p5l241t3353r432b3402],
33	250	CD	NUMBER	250	num	34	SENT_70	[p5l466t3356r558b3402],
34	pg	NN	O	pg	dobj	8	SENT_70	[p5l590t3371r658b3417],
35	and	CC	O	and	_	0	SENT_70	[p5l691t3353r791b3402],
36	50	CD	NUMBER	50	num	37	SENT_70	[p5l825t3356r884b3402],
37	pg	NN	O	pg	conj_and	34	SENT_70	[p5l916t3371r998b3417],
38	,	,	O	,	_	0	SENT_70	[p5l916t3371r998b3417],
39	respectively	RB	O	respectively	advmod	37	SENT_70	[p5l1033t3353r1355b3417],
40	,	,	O	,	_	0	SENT_70	[p5l1033t3353r1355b3417],
41	twice	RB	O	twice	advmod	42	SENT_70	[p5l1389t3356r1528b3402],
42	daily	RB	SET	daily	advmod	8	SENT_70	[p5l10t3431r143b3495],
43	.	.	O	.	_	0	SENT_70	[p5l10t3431r143b3495],

1	Albuterol	NNP	O	Albuterol	nsubjpass	3	SENT_71	[p5l169t3431r422b3480],
2	was	VBD	O	be	auxpass	3	SENT_71	[p5l444t3448r544b3480],
3	used	VBN	O	use	_	0	SENT_71	[p5l568t3431r696b3480],
4	as	IN	O	as	_	0	SENT_71	[p5l719t3448r771b3480],
5	needed	VBN	O	need	amod	12	SENT_71	[p5l797t3431r990b3480],
6	for	IN	O	for	_	0	SENT_71	[p5l1014t3431r1090b3480],
7	symptom	NN	O	symptom	nn	8	SENT_71	[p5l1115t3441r1366b3495],
8	relief	NN	O	relief	prep_for	5	SENT_71	[p5l1390t3431r1537b3480],
9	in	IN	O	in	_	0	SENT_71	[p5l9t3513r63b3558],
10	all	DT	O	all	det	11	SENT_71	[p5l82t3510r143b3558],
11	treatment	NN	O	treatment	prep_in	8	SENT_71	[p5l161t3519r426b3558],
12	arms	NNS	O	arm	prep_as	3	SENT_71	[p5l444t3527r592b3558],
13	.	.	O	.	_	0	SENT_71	[p5l444t3527r592b3558],

1	All	DT	O	all	det	3	SENT_72	[p6l59t21r134b69],
2	study	NN	O	study	nn	3	SENT_72	[p6l161t21r304b85],
3	protocols	NNS	O	protocol	nsubjpass	5	SENT_72	[p6l327t21r569b84],
4	were	VBD	O	be	auxpass	5	SENT_72	[p6l595t39r722b70],
5	approved	VBN	O	approve	_	0	SENT_72	[p6l748t21r993b84],
6	by	IN	O	by	_	0	SENT_72	[p6l1016t21r1078b85],
7	an	DT	O	a	det	10	SENT_72	[p6l1102t39r1166b70],
8	independent	JJ	O	independent	amod	10	SENT_72	[p6l1191t21r1529b84],
9	ethics	NNS	O	ethic	nn	10	SENT_72	[p6l10t99r163b148],
10	committee	NN	O	committee	agent	5	SENT_72	[p6l199t102r484b148],
11	and	CC	O	and	_	0	SENT_72	[p6l520t99r618b148],
12	the	DT	O	the	det	14	SENT_72	[p6l651t99r734b148],
13	principal	JJ	O	principal	amod	14	SENT_72	[p6l768t99r1006b162],
14	investigators	NNS	O	investigator	agent	5	SENT_72	[p6l1041t102r1393b163],
15	,	,	O	,	_	0	SENT_72	[p6l1041t102r1393b163],
16	and	CC	O	and	cc	5	SENT_72	[p6l1431t99r1529b148],
17	thereafter	RB	O	thereafter	advmod	5	SENT_72	[p6l8t177r268b225],
18	independent	JJ	O	independent	amod	19	SENT_72	[p6l298t177r637b240],
19	ethics	NNS	O	ethic	nsubjpass	23	SENT_72	[p6l668t177r821b225],
20	committee	NN	O	committee	nn	21	SENT_72	[p6l854t180r1139b225],
21	approval	NN	O	approval	dep	19	SENT_72	[p6l1172t177r1398b240],
22	was	VBD	O	be	auxpass	23	SENT_72	[p6l1428t194r1527b225],
23	sought	VBN	O	seek	ccomp	5	SENT_72	[p6l11t254r192b318],
24	for	IN	O	for	_	0	SENT_72	[p6l208t254r284b303],
25	any	DT	O	any	det	27	SENT_72	[p6l300t272r394b318],
26	protocol	NN	O	protocol	nn	27	SENT_72	[p6l409t254r627b317],
27	amendments	NNS	O	amendment	prep_for	23	SENT_72	[p6l644t254r1010b303],
28	.	.	O	.	_	0	SENT_72	[p6l644t254r1010b303],

1	Participants	NNS	O	participant	nsubj	2	SENT_73	[p6l1033t257r1346b317],
2	had	VBD	O	have	_	0	SENT_73	[p6l1364t254r1463b303],
3	to	TO	O	to	aux	4	SENT_73	[p6l1478t264r1528b303],
4	sign	VB	O	sign	xcomp	2	SENT_73	[p6l11t335r122b396],
5	a	DT	O	a	det	8	SENT_73	[p6l142t350r168b381],
6	separate	JJ	O	separate	amod	8	SENT_73	[p6l189t342r406b395],
7	informed	JJ	O	informed	amod	8	SENT_73	[p6l426t332r677b381],
8	consent	NN	O	consent	dobj	4	SENT_73	[p6l696t342r904b381],
9	for	IN	O	for	_	0	SENT_73	[p6l922t332r998b381],
10	participation	NN	O	participation	prep_for	4	SENT_73	[p6l1016t335r1354b395],
11	in	IN	O	in	_	0	SENT_73	[p6l1374t335r1427b380],
12	the	DT	O	the	det	14	SENT_73	[p6l1445t332r1528b381],
13	genetic	JJ	O	genetic	amod	14	SENT_73	[p6l10t414r200b475],
14	research	NN	O	research	prep_in	10	SENT_73	[p6l223t411r461b466],
15	,	,	O	,	_	0	SENT_73	[p6l223t411r461b466],
16	in	IN	O	in	_	0	SENT_73	[p6l487t414r540b458],
17	addition	NN	O	addition	_	0	SENT_73	[p6l563t411r783b459],
18	to	TO	O	to	_	0	SENT_73	[p6l805t420r854b459],
19	provision	NN	O	provision	conj_in	10	SENT_73	[p6l877t414r1127b474],
20	of	IN	O	of	_	0	SENT_73	[p6l1150t411r1209b459],
21	consent	NN	O	consent	prep_of	19	SENT_73	[p6l1224t420r1432b459],
22	for	IN	O	for	_	0	SENT_73	[p6l1454t411r1529b459],
23	the	DT	O	the	det	26	SENT_73	[p6l8t488r91b537],
24	main	JJ	O	main	amod	26	SENT_73	[p6l128t491r267b537],
25	clinical	JJ	O	clinical	amod	26	SENT_73	[p6l304t488r493b537],
26	study	NN	O	study	prep_for	21	SENT_73	[p6l531t488r680b552],
27	.	.	O	.	_	0	SENT_73	[p6l531t488r680b552],

1	Patients	NNS	O	patient	nsubj	9	SENT_74	[p6l722t491r942b537],
2	’	CD	NUMBER	’	num	3	SENT_74	[p6l722t491r942b537],
3	participation	NN	O	participation	dep	1	SENT_74	[p6l981t491r1320b551],
4	in	IN	O	in	_	0	SENT_74	[p6l1356t491r1409b536],
5	the	DT	O	the	det	7	SENT_74	[p6l1445t488r1528b537],
6	genetics	NNS	O	genetics	nn	7	SENT_74	[p6l10t569r225b630],
7	studies	NNS	O	study	prep_in	1	SENT_74	[p6l257t566r442b615],
8	was	VBD	O	be	cop	9	SENT_74	[p6l471t583r570b615],
9	voluntary	JJ	O	voluntary	_	0	SENT_74	[p6l599t566r858b630],
10	.	.	O	.	_	0	SENT_74	[p6l599t566r858b630],

1	For	IN	O	for	_	0	SENT_75	[p6l893t569r979b614],
2	those	DT	O	those	det	3	SENT_75	[p6l1006t566r1148b615],
3	patients	NNS	O	patient	prep_for	15	SENT_75	[p6l1177t569r1386b629],
4	who	WP	O	who	nsubj	5	SENT_75	[p6l1416t566r1528b615],
5	consented	VBD	O	consent	rcmod	3	SENT_75	[p6l10t645r281b693],
6	to	TO	O	to	_	0	SENT_75	[p6l303t654r352b693],
7	the	DT	O	the	det	9	SENT_75	[p6l377t645r460b693],
8	genetics	NNS	O	genetics	nn	9	SENT_75	[p6l485t648r700b709],
9	research	NN	O	research	prep_to	5	SENT_75	[p6l726t645r965b700],
10	,	,	O	,	_	0	SENT_75	[p6l726t645r965b700],
11	a	DT	O	a	det	13	SENT_75	[p6l992t662r1018b693],
12	blood	NN	O	blood	nn	13	SENT_75	[p6l1041t645r1191b693],
13	sample	NN	O	sample	nsubjpass	15	SENT_75	[p6l1216t645r1405b708],
14	was	VBD	O	be	auxpass	15	SENT_75	[p6l1428t662r1527b693],
15	obtained	VBN	O	obtain	_	0	SENT_75	[p6l10t722r241b771],
16	at	IN	O	at	_	0	SENT_75	[p6l263t732r310b771],
17	the	DT	O	the	det	19	SENT_75	[p6l330t722r413b771],
18	randomisation	NN	O	randomisation	nn	19	SENT_75	[p6l436t722r829b771],
19	visit	NN	O	visit	prep_at	15	SENT_75	[p6l850t725r972b771],
20	.	.	O	.	_	0	SENT_75	[p6l850t725r972b771],

1	Any	DT	O	any	det	2	SENT_76	[p6l997t726r1105b786],
2	decision	NN	O	decision	nsubj	12	SENT_76	[p6l1127t722r1348b771],
3	not	RB	O	not	neg	5	SENT_76	[p6l1370t732r1458b771],
4	to	TO	O	to	aux	5	SENT_76	[p6l1478t732r1528b771],
5	participate	VB	O	participate	infmod	2	SENT_76	[p6l9t803r289b863],
6	in	IN	O	in	_	0	SENT_76	[p6l329t803r382b848],
7	the	DT	O	the	det	9	SENT_76	[p6l420t800r503b849],
8	genetics	NNS	O	genetics	nn	9	SENT_76	[p6l544t803r760b864],
9	substudy	NN	O	substudy	prep_in	5	SENT_76	[p6l803t800r1042b864],
10	did	VBD	O	do	aux	12	SENT_76	[p6l1080t800r1164b848],
11	not	RB	O	not	neg	12	SENT_76	[p6l1203t810r1290b849],
12	exclude	VB	O	exclude	_	0	SENT_76	[p6l1329t800r1528b849],
13	patients	NNS	O	patient	dobj	12	SENT_76	[p6l9t881r219b941],
14	from	IN	O	from	_	0	SENT_76	[p6l239t878r370b926],
15	the	DT	O	the	det	17	SENT_76	[p6l387t878r470b926],
16	main	JJ	O	main	amod	17	SENT_76	[p6l489t881r628b926],
17	study	NN	O	study	prep_from	12	SENT_76	[p6l648t878r797b941],
18	.	.	O	.	_	0	SENT_76	[p6l648t878r797b941],

1	I	PRP	O	I	_	0	SENT_77	[p6l6t1181r54b1380],
2	Articles	NNPS	O	Articles	dep	1	SENT_77	[p6l101t1344r251b1380],

1	The	DT	O	the	det	4	SENT_78	[p6l78t1639r223b1707],
2	primary	JJ	O	primary	amod	4	SENT_78	[p6l252t1643r557b1728],
3	clinical	JJ	O	clinical	amod	4	SENT_78	[p6l585t1639r855b1707],
4	endpoint	NN	O	endpoint	nsubj	10	SENT_78	[p6l885t1639r1227b1727],
5	in	IN	O	in	_	0	SENT_78	[p6l1254t1643r1329b1705],
6	study	NN	O	study	prep_in	4	SENT_78	[p6l1361t1639r1563b1728],
7	1	CD	NUMBER	1	num	6	SENT_78	[p6l1593t1645r1624b1705],
8	was	VBD	O	be	cop	10	SENT_78	[p6l1650t1663r1790b1707],
9	the	DT	O	the	det	10	SENT_78	[p6l1821t1639r1938b1707],
10	time	NN	O	time	_	0	SENT_78	[p6l1967t1643r2139b1707],
11	to	TO	O	to	_	0	SENT_78	[p6l8t1761r77b1815],
12	first	JJ	ORDINAL	first	amod	15	SENT_78	[p6l110t1747r261b1815],
13	severe	JJ	O	severe	amod	15	SENT_78	[p6l294t1771r527b1815],
14	asthma	NN	O	asthma	nn	15	SENT_78	[p6l561t1747r837b1815],
15	exacerbation	NN	O	exacerbation	prep_to	10	SENT_78	[p6l870t1747r1366b1815],
16	.	.	O	.	_	0	SENT_78	[p6l870t1747r1366b1815],

1	Exacerbations	NNS	O	exacerbation	nsubjpass	3	SENT_79	[p6l1406t1747r1927b1815],
2	were	VBD	O	be	auxpass	3	SENT_79	[p6l1959t1772r2139b1815],
3	deﬁned	VBN	O	deﬁned	_	0	SENT_79	[p6l10t1857r293b1924],
4	as	IN	O	as	_	0	SENT_79	[p6l390t1881r462b1924],
5	deterioration	NN	O	deterioration	prep_as	3	SENT_79	[p6l562t1857r1053b1924],
6	in	IN	O	in	_	0	SENT_79	[p6l1150t1861r1225b1923],
7	asthma	NN	O	asthma	prep_in	3	SENT_79	[p6l1323t1857r1599b1924],
8	leading	VBG	O	lead	amod	7	SENT_79	[p6l1694t1857r1974b1946],
9	to	TO	O	to	_	0	SENT_79	[p6l2069t1870r2139b1924],
10	hospitalisation	NN	O	hospitalisation	prep_to	7	SENT_79	[p6l7t1966r589b2055],
11	,	,	O	,	_	0	SENT_79	[p6l7t1966r589b2055],
12	emergency	NN	O	emergency	nn	14	SENT_79	[p6l647t1991r1064b2056],
13	department	NN	O	department	nn	14	SENT_79	[p6l1118t1966r1561b2055],
14	treatment	NN	O	treatment	prep_to	7	SENT_79	[p6l1613t1980r2005b2044],
15	,	,	O	,	_	0	SENT_79	[p6l1613t1980r2005b2044],
16	or	CC	O	or	_	0	SENT_79	[p6l2064t1991r2141b2034],
17	oral	JJ	O	oral	amod	19	SENT_79	[p6l10t2075r152b2143],
18	glucocorticosteroid	NN	O	glucocorticosteroid	nn	19	SENT_79	[p6l207t2075r932b2165],
19	treatment	NN	O	treatment	prep_to	7	SENT_79	[p6l983t2089r1358b2143],
20	lasting	JJ	O	lasting	amod	19	SENT_79	[p6l1408t2075r1664b2165],
21	3	CD	NUMBER	3	num	24	SENT_79	[p6l1721t2082r1754b2143],
22	or	CC	O	or	_	0	SENT_79	[p6l1813t2100r1890b2143],
23	more	JJR	O	more	num	24	SENT_79	[p6l1941t2100r2139b2143],
24	days	NNS	DURATION	day	tmod	7	SENT_79	[p6l10t2186r193b2275],
25	.	.	O	.	_	0	SENT_79	[p6l10t2186r193b2275],

1	The	DT	O	the	det	4	SENT_80	[p6l249t2186r394b2254],
2	primary	JJ	O	primary	amod	4	SENT_80	[p6l447t2190r752b2275],
3	clinical	JJ	O	clinical	amod	4	SENT_80	[p6l804t2186r1074b2254],
4	endpoint	NN	O	endpoint	nsubj	10	SENT_80	[p6l1128t2186r1470b2275],
5	in	IN	O	in	_	0	SENT_80	[p6l1521t2190r1596b2252],
6	study	NN	O	study	prep_in	4	SENT_80	[p6l1651t2186r1854b2275],
7	2	CD	NUMBER	2	num	6	SENT_80	[p6l1907t2192r1944b2252],
8	was	VBD	O	be	cop	10	SENT_80	[p6l1998t2210r2138b2254],
9	asthma	NN	O	asthma	nn	10	SENT_80	[p6l10t2294r286b2362],
10	control	NN	O	control	_	0	SENT_80	[p6l320t2294r586b2362],
11	as	IN	O	as	_	0	SENT_80	[p6l620t2319r693b2362],
12	assessed	VBN	O	assess	prepc_as	10	SENT_80	[p6l730t2294r1054b2363],
13	by	IN	O	by	_	0	SENT_80	[p6l1084t2294r1172b2384],
14	exacerbations	NNS	O	exacerbation	prep_by	12	SENT_80	[p6l1204t2294r1739b2372],
15	,	,	O	,	_	0	SENT_80	[p6l1204t2294r1739b2372],
16	including	VBG	O	include	prep	10	SENT_80	[p6l1776t2294r2140b2384],
17	the	DT	O	the	det	18	SENT_80	[p6l8t2403r125b2471],
18	number	NN	O	number	npadvmod	34	SENT_80	[p6l187t2403r494b2471],
19	of	IN	O	of	_	0	SENT_80	[p6l555t2403r639b2471],
20	asthma	NN	O	asthma	nn	21	SENT_80	[p6l688t2403r964b2471],
21	exacerbations	NNS	O	exacerbation	prep_of	18	SENT_80	[p6l1027t2403r1562b2481],
22	,	,	O	,	_	0	SENT_80	[p6l1027t2403r1562b2481],
23	time	NN	O	time	conj_and	18	SENT_80	[p6l1625t2408r1797b2471],
24	to	TO	O	to	_	0	SENT_80	[p6l1858t2417r1928b2471],
25	first	JJ	ORDINAL	first	amod	27	SENT_80	[p6l1990t2403r2141b2471],
26	asthma	NN	O	asthma	nn	27	SENT_80	[p6l10t2513r286b2580],
27	exacerbation	NN	O	exacerbation	prep_to	23	SENT_80	[p6l314t2513r810b2591],
28	,	,	O	,	_	0	SENT_80	[p6l314t2513r810b2591],
29	and	CC	O	and	_	0	SENT_80	[p6l842t2513r981b2580],
30	the	DT	O	the	det	31	SENT_80	[p6l1006t2513r1123b2580],
31	percentage	NN	O	percentage	conj_and	18	SENT_80	[p6l1151t2526r1564b2602],
32	of	IN	O	of	_	0	SENT_80	[p6l1593t2513r1676b2580],
33	participants	NNS	O	participant	prep_of	31	SENT_80	[p6l1690t2517r2138b2602],
34	with	IN	O	with	pcomp	16	SENT_80	[p6l7t2621r174b2690],
35	at	IN	O	at	quantmod	37	SENT_80	[p6l233t2635r299b2689],
36	least	JJS	O	least	mwe	35	SENT_80	[p6l354t2621r528b2689],
37	one	CD	NUMBER	one	num	38	SENT_80	[p6l585t2646r720b2689],
38	exacerbation	NN	O	exacerbation	pobj	34	SENT_80	[p6l780t2621r1276b2689],
39	.	.	O	.	_	0	SENT_80	[p6l780t2621r1276b2689],

1	In	IN	O	in	_	0	SENT_81	[p6l1342t2628r1421b2688],
2	study	NN	O	study	prep_in	8	SENT_81	[p6l1482t2621r1684b2711],
3	2	CD	NUMBER	2	num	2	SENT_81	[p6l1742t2628r1801b2699],
4	,	,	O	,	_	0	SENT_81	[p6l1742t2628r1801b2699],
5	asthma	NN	O	asthma	nn	6	SENT_81	[p6l1864t2621r2140b2690],
6	exacerbations	NNS	O	exacerbation	nsubjpass	8	SENT_81	[p6l10t2730r523b2798],
7	were	VBD	O	be	auxpass	8	SENT_81	[p6l566t2755r746b2798],
8	deﬁned	VBN	O	deﬁned	_	0	SENT_81	[p6l791t2730r1073b2798],
9	as	IN	O	as	_	0	SENT_81	[p6l1116t2754r1189b2798],
10	worsening	VBG	O	worsen	amod	11	SENT_81	[p6l1232t2735r1633b2820],
11	asthma	NN	O	asthma	prep_as	8	SENT_81	[p6l1677t2730r1953b2798],
12	that	WDT	O	that	nsubj	13	SENT_81	[p6l1995t2730r2141b2798],
13	needed	VBD	O	need	ccomp	11	SENT_81	[p6l9t2840r282b2907],
14	treatment	NN	O	treatment	dobj	13	SENT_81	[p6l389t2853r764b2907],
15	with	IN	O	with	_	0	SENT_81	[p6l870t2840r1037b2907],
16	oral	JJ	O	oral	amod	17	SENT_81	[p6l1147t2840r1289b2907],
17	steroids	NNS	O	steroid	prep_with	13	SENT_81	[p6l1401t2840r1716b2918],
18	,	,	O	,	_	0	SENT_81	[p6l1401t2840r1716b2918],
19	whereas	IN	O	whereas	mark	26	SENT_81	[p6l1827t2840r2138b2907],
20	hospitalisations	NNS	O	hospitalisation	nsubjpass	26	SENT_81	[p6l7t2949r604b3038],
21	and	CC	O	and	_	0	SENT_81	[p6l640t2949r779b3017],
22	emergency	NN	O	emergency	nn	24	SENT_81	[p6l810t2974r1227b3039],
23	department	NN	O	department	nn	24	SENT_81	[p6l1258t2949r1700b3038],
24	treatments	NNS	O	treatment	conj_and	20	SENT_81	[p6l1728t2963r2138b3017],
25	Were	VBD	O	be	auxpass	26	SENT_81	[p6l7t3084r187b3128],
26	reported	VBN	O	report	advcl	13	SENT_81	[p6l220t3059r542b3148],
27	as	IN	O	as	_	0	SENT_81	[p6l574t3083r647b3127],
28	health-care	JJ	O	health-care	amod	29	SENT_81	[p6l681t3059r1100b3127],
29	use	NN	O	use	prep_as	26	SENT_81	[p6l1132t3083r1281b3127],
30	.	.	O	.	_	0	SENT_81	[p6l1132t3083r1281b3127],

1	In	IN	O	in	_	0	SENT_82	[p6l1322t3066r1401b3126],
2	both	DT	O	both	det	3	SENT_82	[p6l1432t3059r1603b3127],
3	studies	NNS	O	study	prep_in	7	SENT_82	[p6l1638t3059r1924b3137],
4	,	,	O	,	_	0	SENT_82	[p6l1638t3059r1924b3137],
5	FEV1	NN	O	fev1	nsubjpass	7	SENT_82	[p6l1964t3064r2141b3144],
6	was	VBD	O	be	auxpass	7	SENT_82	[p6l7t3193r146b3236],
7	assessed	VBN	O	assess	_	0	SENT_82	[p6l207t3169r531b3236],
8	during	IN	O	during	_	0	SENT_82	[p6l588t3169r843b3258],
9	clinic	NN	O	clinic	nn	10	SENT_82	[p6l901t3169r1104b3236],
10	visits	NNS	O	visit	prep_during	7	SENT_82	[p6l1158t3173r1373b3247],
11	;	:	O	;	_	0	SENT_82	[p6l1158t3173r1373b3247],
12	in	IN	O	in	_	0	SENT_82	[p6l1433t3173r1508b3235],
13	study	NN	O	study	prep_in	19	SENT_82	[p6l1567t3169r1769b3258],
14	1	CD	NUMBER	1	num	13	SENT_82	[p6l1827t3175r1877b3247],
15	,	,	O	,	_	0	SENT_82	[p6l1827t3175r1877b3247],
16	study	NN	O	study	nn	17	SENT_82	[p6l1940t3169r2142b3258],
17	medication	NN	O	medication	nsubjpass	19	SENT_82	[p6l9t3277r435b3346],
18	was	VBD	O	be	auxpass	19	SENT_82	[p6l457t3302r596b3346],
19	taken	VBN	O	take	parataxis	7	SENT_82	[p6l621t3277r829b3345],
20	before	IN	O	before	_	0	SENT_82	[p6l851t3277r1090b3345],
21	the	DT	O	the	det	23	SENT_82	[p6l1113t3277r1231b3345],
22	clinical	JJ	O	clinical	amod	23	SENT_82	[p6l1256t3277r1526b3346],
23	visit	NN	O	visit	prep_before	19	SENT_82	[p6l1547t3282r1723b3355],
24	;	:	O	;	_	0	SENT_82	[p6l1547t3282r1723b3355],
25	in	IN	O	in	_	0	SENT_82	[p6l1751t3282r1825b3344],
26	study	NN	O	study	prep_in	31	SENT_82	[p6l1851t3277r2054b3367],
27	2	CD	NUMBER	2	num	26	SENT_82	[p6l2078t3284r2136b3355],
28	,	,	O	,	_	0	SENT_82	[p6l2078t3284r2136b3355],
29	it	PRP	O	it	nsubjpass	31	SENT_82	[p6l9t3391r60b3453],
30	was	VBD	O	be	auxpass	31	SENT_82	[p6l90t3410r230b3454],
31	withheld	VBN	O	withhold	parataxis	7	SENT_82	[p6l264t3386r599b3454],
32	until	IN	O	until	prep	31	SENT_82	[p6l631t3386r811b3454],
33	after	IN	O	after	pcomp	32	SENT_82	[p6l846t3386r1016b3454],
34	spirometry	NN	O	spirometry	nn	35	SENT_82	[p6l1051t3391r1465b3476],
35	testing	NN	O	testing	pobj	33	SENT_82	[p6l1496t3391r1773b3476],
36	.	.	O	.	_	0	SENT_82	[p6l1496t3391r1773b3476],

1	PEF	NN	O	pef	nsubjpass	3	SENT_83	[p6l1815t3391r1963b3453],
2	was	VBD	O	be	auxpass	3	SENT_83	[p6l1998t3410r2138b3454],
3	measured	VBN	O	measure	_	0	SENT_83	[p6l9t3497r385b3565],
4	daily	RB	SET	daily	advmod	3	SENT_83	[p6l402t3497r580b3586],
5	before	IN	SET	before	mark	7	SENT_83	[p6l594t3497r833b3565],
6	participants	NNS	O	participant	nsubj	7	SENT_83	[p6l850t3501r1297b3586],
7	took	VBD	O	take	advcl	3	SENT_83	[p6l1316t3497r1481b3565],
8	their	PRP$	O	they	poss	9	SENT_83	[p6l1495t3497r1676b3565],
9	medication	NN	O	medication	dobj	7	SENT_83	[p6l1691t3497r2136b3575],
10	;	:	O	;	_	0	SENT_83	[p6l1691t3497r2136b3575],
11	PEF	NN	O	pef	nn	14	SENT_83	[p6l13t3610r183b3683],
12	,	,	O	,	_	0	SENT_83	[p6l13t3610r183b3683],
13	reliever	NN	O	reliever	dep	14	SENT_83	[p6l215t3605r499b3674],
14	use	NN	O	use	nsubjpass	20	SENT_83	[p6l525t3630r674b3684],
15	,	,	O	,	_	0	SENT_83	[p6l525t3630r674b3684],
16	and	CC	O	and	_	0	SENT_83	[p6l706t3605r846b3673],
17	asthma	NN	O	asthma	nn	18	SENT_83	[p6l873t3605r1150b3673],
18	symptoms	NNS	O	symptom	conj_and	14	SENT_83	[p6l1180t3619r1571b3695],
19	were	VBD	O	be	auxpass	20	SENT_83	[p6l1600t3630r1780b3674],
20	recorded	VBN	O	record	parataxis	3	SENT_83	[p6l1808t3605r2141b3674],
21	in	IN	O	in	_	0	SENT_83	[p6l9t3719r84b3781],
22	daily	JJ	SET	daily	amod	23	SENT_83	[p6l116t3714r294b3804],
23	diaries	NNS	O	diary	prep_in	20	SENT_83	[p6l324t3714r573b3782],
24	for	IN	O	for	_	0	SENT_83	[p6l608t3714r715b3782],
25	both	DT	O	both	det	26	SENT_83	[p6l743t3714r914b3782],
26	studies	NNS	O	study	prep_for	23	SENT_83	[p6l947t3714r1233b3782],
27	.	.	O	.	_	0	SENT_83	[p6l947t3714r1233b3782],

1	An	DT	O	a	det	3	SENT_84	[p6l1266t3719r1378b3781],
2	asthma-control	JJ	O	asthma-control	amod	3	SENT_84	[p6l1410t3714r1982b3782],
3	day	NN	DATE	day	_	0	SENT_84	[p6l2014t3714r2142b3804],
4	2119	CD	DATE	2119	dep	3	SENT_84	[p6l2055t1069r2152b1106],

1	was	VBD	O	be	auxpass	2	SENT_85	[p7l7t41r146b85],
2	deﬁned	VBN	O	deﬁned	ccomp	13	SENT_85	[p7l176t17r459b85],
3	as	IN	O	as	_	0	SENT_85	[p7l484t41r557b85],
4	a	DT	O	a	det	6	SENT_85	[p7l586t41r623b85],
5	24-h	JJ	O	24-h	amod	6	SENT_85	[p7l651t17r808b83],
6	period	NN	O	period	prep_as	2	SENT_85	[p7l834t17r1077b106],
7	without	IN	O	without	_	0	SENT_85	[p7l1100t17r1394b85],
8	asthma	NN	O	asthma	nn	9	SENT_85	[p7l1419t17r1695b85],
9	symptoms	NNS	O	symptom	prep_without	2	SENT_85	[p7l1723t30r2136b106],
10	,	,	O	,	_	0	SENT_85	[p7l1723t30r2136b106],
11	night-time	JJ	O	night-time	amod	12	SENT_85	[p7l9t125r409b215],
12	awakenings	NNS	O	awakening	nsubj	13	SENT_85	[p7l463t125r908b215],
13	caused	VBN	O	cause	_	0	SENT_85	[p7l963t125r1221b194],
14	by	IN	O	by	_	0	SENT_85	[p7l1270t125r1358b215],
15	asthma	NN	O	asthma	prep_by	13	SENT_85	[p7l1409t125r1704b203],
16	,	,	O	,	_	0	SENT_85	[p7l1409t125r1704b203],
17	or	CC	O	or	_	0	SENT_85	[p7l1761t150r1838b193],
18	use	NN	O	use	prep_by	13	SENT_85	[p7l1887t150r2016b194],
19	of	IN	O	of	_	0	SENT_85	[p7l2069t125r2153b193],
20	as-needed	JJ	O	as-needed	amod	22	SENT_85	[p7l10t235r388b303],
21	symptom	NN	O	symptom	nn	22	SENT_85	[p7l416t249r771b324],
22	relief	NN	O	relief	prep_of	18	SENT_85	[p7l798t235r1013b303],
23	.	.	O	.	_	0	SENT_85	[p7l798t235r1013b303],

1	Genotyping	VBG	O	genotype	amod	2	SENT_86	[p7l11t456r458b543],
2	Genotyping	NN	O	genotyping	nsubjpass	4	SENT_86	[p7l11t567r437b652],
3	was	VBD	O	be	auxpass	4	SENT_86	[p7l463t586r599b630],
4	done	VBN	O	do	_	0	SENT_86	[p7l630t562r809b630],
5	after	IN	O	after	mark	9	SENT_86	[p7l838t562r1002b630],
6	all	DT	O	all	det	7	SENT_86	[p7l1029t562r1112b630],
7	participants	NNS	O	participant	nsubj	9	SENT_86	[p7l1139t567r1567b651],
8	had	VBD	O	have	aux	9	SENT_86	[p7l1596t562r1732b630],
9	completed	VBN	O	complete	advcl	4	SENT_86	[p7l1760t562r2141b651],
10	the	DT	O	the	det	11	SENT_86	[p7l8t672r122b739],
11	studies	NNS	O	study	dobj	9	SENT_86	[p7l150t672r423b739],
12	.	.	O	.	_	0	SENT_86	[p7l150t672r423b739],

1	All	DT	O	all	det	2	SENT_87	[p7l451t672r555b738],
2	individuals	NNS	O	individual	nsubjpass	12	SENT_87	[p7l580t672r980b739],
3	with	IN	O	with	_	0	SENT_87	[p7l1006t672r1168b739],
4	a	DT	O	a	det	6	SENT_87	[p7l1194t696r1230b739],
5	genetic	JJ	O	genetic	amod	6	SENT_87	[p7l1256t676r1517b761],
6	sample	NN	O	sample	prep_with	2	SENT_87	[p7l1544t672r1804b760],
7	and	CC	O	and	_	0	SENT_87	[p7l1831t672r1966b739],
8	data	NNS	O	datum	prep_with	2	SENT_87	[p7l1991t672r2140b739],
9	after	IN	O	after	_	0	SENT_87	[p7l10t780r173b848],
10	randomisation	NN	O	randomisation	prep_after	8	SENT_87	[p7l195t780r731b848],
11	were	VBD	O	be	auxpass	12	SENT_87	[p7l752t805r927b848],
12	included	VBN	O	include	_	0	SENT_87	[p7l950t780r1269b848],
13	in	IN	O	in	_	0	SENT_87	[p7l1290t785r1363b847],
14	the	DT	O	the	det	16	SENT_87	[p7l1385t780r1499b848],
15	intention-to-treat	JJ	O	intention-to-treat	amod	16	SENT_87	[p7l1523t785r2142b848],
16	population	NN	O	population	prep_in	12	SENT_87	[p7l8t889r403b978],
17	for	IN	O	for	_	0	SENT_87	[p7l447t889r551b957],
18	all	DT	O	all	det	20	SENT_87	[p7l593t889r676b957],
19	efﬁcacy	NN	O	efﬁcacy	nn	20	SENT_87	[p7l720t889r992b979],
20	analyses	NNS	O	analysis	prep_for	16	SENT_87	[p7l1034t889r1355b979],
21	.	.	O	.	_	0	SENT_87	[p7l1034t889r1355b979],

1	The	DT	O	the	det	3	SENT_88	[p7l1400t889r1542b957],
2	safety	NN	O	safety	nn	3	SENT_88	[p7l1588t889r1795b979],
3	analyses	NNS	O	analysis	nsubjpass	5	SENT_88	[p7l1837t889r2138b979],
4	were	VBD	O	be	auxpass	5	SENT_88	[p7l7t1023r182b1066],
5	based	VBN	O	base	_	0	SENT_88	[p7l210t999r420b1066],
6	on	IN	O	on	_	0	SENT_88	[p7l450t1023r542b1066],
7	all	DT	O	all	det	8	SENT_88	[p7l573t999r656b1066],
8	participants	NNS	O	participant	prep_on	5	SENT_88	[p7l685t1003r1113b1088],
9	with	IN	O	with	_	0	SENT_88	[p7l1143t999r1305b1066],
10	a	DT	O	a	det	12	SENT_88	[p7l1335t1023r1373b1066],
11	genetic	JJ	O	genetic	amod	12	SENT_88	[p7l1404t1003r1664b1088],
12	sample	NN	O	sample	prep_with	5	SENT_88	[p7l1696t999r1955b1088],
13	who	WP	O	who	nsubj	14	SENT_88	[p7l1984t999r2139b1066],
14	received	VBD	O	receive	rcmod	12	SENT_88	[p7l9t1107r308b1176],
15	at	IN	O	at	quantmod	17	SENT_88	[p7l332t1121r396b1176],
16	least	JJS	O	least	mwe	15	SENT_88	[p7l416t1107r583b1175],
17	one	CD	NUMBER	one	num	18	SENT_88	[p7l606t1132r737b1175],
18	dose	NN	O	dose	dobj	14	SENT_88	[p7l763t1107r927b1176],
19	of	IN	O	of	_	0	SENT_88	[p7l952t1107r1034b1175],
20	study	NN	O	study	nn	21	SENT_88	[p7l1047t1107r1242b1197],
21	drug	NN	O	drug	prep_of	18	SENT_88	[p7l1265t1107r1453b1197],
22	.	.	O	.	_	0	SENT_88	[p7l1265t1107r1453b1197],

1	Single-nucleotide	JJ	O	single-nucleotide	amod	2	SENT_89	[p7l85t1216r730b1306],
2	polymorphisms	NNS	O	polymorphism	nsubjpass	4	SENT_89	[p7l774t1216r1363b1306],
3	were	VBD	O	be	auxpass	4	SENT_89	[p7l1407t1241r1585b1284],
4	genotyped	VBN	O	genotype	dep	13	SENT_89	[p7l1630t1216r2014b1306],
5	by	IN	O	by	_	0	SENT_89	[p7l2055t1216r2142b1306],
6	use	NN	O	use	agent	4	SENT_89	[p7l8t1350r135b1393],
7	of	IN	O	of	_	0	SENT_89	[p7l246t1326r329b1393],
8	TaqMan	NNP	O	TaqMan	prep_of	6	SENT_89	[p7l423t1330r727b1414],
9	single-nucleotide	JJ	O	single-nucleotide	amod	12	SENT_89	[p7l838t1326r1476b1415],
10	polymorphism	NN	O	polymorphism	nn	12	SENT_89	[p7l1585t1326r2140b1415],
11	genotyping	NN	O	genotyping	nn	12	SENT_89	[p7l10t1439r428b1524],
12	assays	NNS	O	assay	nsubj	13	SENT_89	[p7l460t1459r688b1524],
13	(	VBP	O	(	_	0	SENT_89	[p7l727t1434r1039b1524],
14	Applied	NNP	O	Applied	nn	15	SENT_89	[p7l727t1434r1039b1524],
15	Biosystems	NNP	O	Biosystems	dobj	13	SENT_89	[p7l1073t1439r1510b1524],
16	,	,	O	,	_	0	SENT_89	[p7l1073t1439r1510b1524],
17	Foster	NNP	LOCATION	Foster	nn	22	SENT_89	[p7l1550t1439r1776b1503],
18	City	NNP	LOCATION	City	nn	22	SENT_89	[p7l1808t1439r1966b1524],
19	,	,	O	,	_	0	SENT_89	[p7l1808t1439r1966b1524],
20	CA	NNP	LOCATION	CA	appos	22	SENT_89	[p7l2003t1440r2136b1512],
21	,	,	O	,	_	0	SENT_89	[p7l2003t1440r2136b1512],
22	USA	NNP	LOCATION	USA	appos	15	SENT_89	[p7l13t1548r232b1633],
23	)	CD	NUMBER	)	num	22	SENT_89	[p7l13t1548r232b1633],
24	.	.	O	.	_	0	SENT_89	[p7l13t1548r232b1633],

1	11	CD	NUMBER	11	num	2	SENT_90	[p7l280t1549r347b1610],
2	polymorphisms	NNS	O	polymorphism	nsubjpass	4	SENT_90	[p7l387t1543r977b1633],
3	were	VBD	O	be	auxpass	4	SENT_90	[p7l1019t1568r1197b1611],
4	selected	VBN	O	select	_	0	SENT_90	[p7l1241t1543r1535b1611],
5	for	IN	O	for	_	0	SENT_90	[p7l1575t1543r1682b1611],
6	genotyping	VBG	O	genotype	prepc_for	4	SENT_90	[p7l1722t1548r2140b1633],
7	from	IN	O	from	dep	6	SENT_90	[p7l9t1653r193b1720],
8	within	IN	O	within	_	0	SENT_90	[p7l225t1653r468b1720],
9	the	DT	O	the	det	12	SENT_90	[p7l500t1653r616b1720],
10	ADRB2	NN	O	adrb2	nn	12	SENT_90	[p7l649t1658r938b1719],
11	coding	VBG	O	code	amod	12	SENT_90	[p7l969t1653r1220b1742],
12	region	NN	O	region	prep_within	6	SENT_90	[p7l1254t1657r1494b1742],
13	and	CC	O	and	_	0	SENT_90	[p7l1529t1653r1666b1720],
14	up	RB	O	up	advmod	49	SENT_90	[p7l1698t1677r1794b1741],
15	to	TO	O	to	_	0	SENT_90	[p7l1828t1666r1897b1720],
16	about	IN	O	about	advmod	20	SENT_90	[p7l1933t1653r2141b1720],
17	5	CD	NUMBER	5	num	18	SENT_90	[p7l13t1766r47b1829],
18	kb	NN	O	kb	pobj	16	SENT_90	[p7l91t1761r181b1829],
19	5	CD	NUMBER	5	num	20	SENT_90	[p7l228t1766r284b1829],
20	’	NN	O	’	prep_to	14	SENT_90	[p7l228t1766r284b1829],
21	of	IN	O	of	_	0	SENT_90	[p7l331t1761r414b1829],
22	codon	NN	O	codon	prep_of	20	SENT_90	[p7l444t1761r669b1829],
23	1	CD	NUMBER	1	number	24	SENT_90	[p7l714t1768r744b1828],
24	(	CD	NUMBER	(	num	25	SENT_90	[p7l792t1766r1239b1851],
25	rs11958940	NN	O	rs11958940	dep	20	SENT_90	[p7l792t1766r1239b1851],
26	,	,	O	,	_	0	SENT_90	[p7l792t1766r1239b1851],
27	rs17778257	NN	O	rs17778257	appos	20	SENT_90	[p7l1284t1766r1696b1839],
28	,	,	O	,	_	0	SENT_90	[p7l1284t1766r1696b1839],
29	rs2895795	NN	O	rs2895795	appos	27	SENT_90	[p7l1741t1766r2136b1839],
30	,	,	O	,	_	0	SENT_90	[p7l1741t1766r2136b1839],
31	rs2053044	NN	O	rs2053044	appos	27	SENT_90	[p7l9t1875r401b1948],
32	,	,	O	,	_	0	SENT_90	[p7l9t1875r401b1948],
33	rs12654778	NN	O	rs12654778	appos	27	SENT_90	[p7l440t1875r861b1948],
34	,	,	O	,	_	0	SENT_90	[p7l440t1875r861b1948],
35	1311959427	CD	NUMBER	1311959427	appos	27	SENT_90	[p7l901t1875r1319b1948],
36	,	,	O	,	_	0	SENT_90	[p7l901t1875r1319b1948],
37	rS1042711	NN	O	rs1042711	appos	27	SENT_90	[p7l1358t1875r1723b1948],
38	,	,	O	,	_	0	SENT_90	[p7l1358t1875r1723b1948],
39	1	CD	NUMBER	1	appos	20	SENT_90	[p7l1763t1875r2136b1948],
40	's	POS	O	's	possessive	39	SENT_90	[p7l1763t1875r2136b1948],
41	1042713	CD	NUMBER	1042713	dep	39	SENT_90	[p7l1763t1875r2136b1948],
42	,	,	O	,	_	0	SENT_90	[p7l1763t1875r2136b1948],
43	rs1042714	NN	O	rs1042714	dep	39	SENT_90	[p7l9t1984r377b2058],
44	,	,	O	,	_	0	SENT_90	[p7l9t1984r377b2058],
45	rs1800888	NN	O	rs1800888	dep	39	SENT_90	[p7l445t1986r838b2058],
46	,	,	O	,	_	0	SENT_90	[p7l445t1986r838b2058],
47	and	CC	O	and	_	0	SENT_90	[p7l907t1980r1045b2047],
48	rs1042718	NN	O	rs1042718	dep	39	SENT_90	[p7l1108t1984r1508b2070],
49	)	NN	O	)	prep_within	6	SENT_90	[p7l1108t1984r1508b2070],
50	.	.	O	.	_	0	SENT_90	[p7l1108t1984r1508b2070],

1	Quality-control	JJ	O	quality-control	amod	2	SENT_91	[p7l1579t1980r2140b2069],
2	measures	NNS	O	measure	nsubj	3	SENT_91	[p7l9t2113r366b2157],
3	included	VBD	O	include	_	0	SENT_91	[p7l407t2088r733b2157],
4	a	DT	O	a	det	7	SENT_91	[p7l771t2113r808b2156],
5	genotype	NN	O	genotype	nn	7	SENT_91	[p7l847t2102r1182b2178],
6	call	NN	O	call	nn	7	SENT_91	[p7l1222t2088r1345b2157],
7	rate	NN	O	rate	dobj	3	SENT_91	[p7l1383t2102r1522b2156],
8	of	IN	O	of	_	0	SENT_91	[p7l1562t2088r1645b2157],
9	95	CD	PERCENT	95	num	10	SENT_91	[p7l1671t2093r1831b2159],
10	%	NN	PERCENT	%	prep_of	7	SENT_91	[p7l1671t2093r1831b2159],
11	and	CC	O	and	_	0	SENT_91	[p7l1872t2088r2009b2157],
12	no	DT	O	no	det	59	SENT_91	[p7l2046t2113r2139b2156],
13	signiﬁcant	JJ	O	signiﬁcant	amod	59	SENT_91	[p7l12t2197r404b2287],
14	departures	NNS	O	departure	dep	25	SENT_91	[p7l421t2197r818b2286],
15	from	IN	O	from	_	0	SENT_91	[p7l839t2197r1023b2265],
16	I-Iardy-Weinberg	NN	O	i-iardy-weinberg	nn	17	SENT_91	[p7l1045t2197r1664b2287],
17	Equilibrium	NN	O	equilibrium	prep_from	14	SENT_91	[p7l1686t2197r2140b2286],
18	within	IN	O	within	_	0	SENT_91	[p7l7t2306r249b2374],
19	each	DT	O	each	det	21	SENT_91	[p7l318t2306r486b2374],
20	racial	JJ	O	racial	amod	21	SENT_91	[p7l554t2306r754b2374],
21	group	NN	O	group	prep_within	17	SENT_91	[p7l822t2331r1041b2396],
22	(	CD	NUMBER	(	dep	25	SENT_91	[p7l1115t2313r1323b2396],
23	exact	JJ	O	exact	amod	25	SENT_91	[p7l1115t2313r1323b2396],
24	p	NN	O	p	nn	25	SENT_91	[p7l1388t2331r1433b2395],
25	value	NN	O	value	dep	28	SENT_91	[p7l1499t2306r1694b2374],
26	>	JJR	O	>	dep	25	SENT_91	[p7l1764t2311r2140b2396],
27	0-01	CD	NUMBER	0-01	num	28	SENT_91	[p7l1764t2311r2140b2396],
28	)	NN	O	)	dep	36	SENT_91	[p7l1764t2311r2140b2396],
29	.2	NN	NUMBER	.2	nn	31	SENT_91	[p7l1764t2311r2140b2396],
30	"	''	O	"	punct	31	SENT_91	[p7l1764t2311r2140b2396],
31	‘	NN	O	‘	dep	28	SENT_91	[p7l1764t2311r2140b2396],
32	2	CD	NUMBER	2	number	33	SENT_91	[p7l1764t2311r2140b2396],
33	“	CD	NUMBER	“	num	34	SENT_91	[p7l1764t2311r2140b2396],
34	I-Iaplotypes	NNS	O	i-iaplotype	nsubjpass	36	SENT_91	[p7l13t2417r429b2506],
35	were	VBD	O	be	auxpass	36	SENT_91	[p7l497t2441r675b2485],
36	predicted	VBN	O	predict	ccomp	13	SENT_91	[p7l743t2417r1093b2506],
37	with	IN	O	with	_	0	SENT_91	[p7l1158t2417r1323b2485],
38	publically	RB	O	publically	advmod	39	SENT_91	[p7l1390t2417r1752b2506],
39	available	JJ	O	available	amod	41	SENT_91	[p7l1820t2417r2139b2485],
40	software	NN	O	software	nn	41	SENT_91	[p7l12t2525r322b2594],
41	(	NN	O	(	prep_with	36	SENT_91	[p7l446t2531r961b2615],
42	SNPHNP	NN	O	snphnp	tmod	36	SENT_91	[p7l446t2531r961b2615],
43	—	CD	NUMBER	—	num	42	SENT_91	[p7l446t2531r961b2615],
44	a	DT	O	a	det	45	SENT_91	[p7l446t2531r961b2615],
45	program	NN	O	program	nsubj	55	SENT_91	[p7l1078t2550r1402b2615],
46	for	IN	O	for	_	0	SENT_91	[p7l1520t2525r1626b2593],
47	estimating	VBG	O	estimate	prepc_for	45	SENT_91	[p7l1743t2530r2140b2615],
48	frequencies	NNS	O	frequency	dobj	47	SENT_91	[p7l9t2634r442b2723],
49	of	IN	O	of	_	0	SENT_91	[p7l511t2634r594b2702],
50	large	JJ	O	large	amod	51	SENT_91	[p7l646t2634r828b2724],
51	haplotypes	NNS	O	haplotype	prep_of	48	SENT_91	[p7l894t2634r1293b2724],
52	of	IN	O	of	_	0	SENT_91	[p7l1363t2634r1446b2702],
53	single-nucleotide	JJ	O	single-nucleotide	amod	54	SENT_91	[p7l1501t2634r2139b2724],
54	polymorphisms	NNS	O	polymorphism	prep_of	51	SENT_91	[p7l8t2744r598b2833],
55	[	VBP	O	[	rcmod	42	SENT_91	[p7l630t2749r921b2832],
56	version	NN	O	version	dobj	55	SENT_91	[p7l630t2749r921b2832],
57	1.3	CD	NUMBER	1.3	number	58	SENT_91	[p7l950t2750r1116b2834],
58	]	CD	NUMBER	]	num	59	SENT_91	[p7l950t2750r1116b2834],
59	)	NN	O	)	prep_of	7	SENT_91	[p7l950t2750r1116b2834],
60	.	.	O	.	_	0	SENT_91	[p7l950t2750r1116b2834],

1	Statistical	JJ	O	statistical	amod	2	SENT_92	[p7l10t2962r385b3031],
2	analysis	NN	O	analysis	nsubj	4	SENT_92	[p7l410t2962r708b3052],
3	We	PRP	O	we	nsubj	4	SENT_92	[p7l7t3080r126b3141],
4	tabulated	VBD	O	tabulate	_	0	SENT_92	[p7l160t3073r509b3140],
5	asthma	NN	O	asthma	nn	6	SENT_92	[p7l544t3073r819b3140],
6	exacerbations	NNS	O	exacerbation	dobj	4	SENT_92	[p7l854t3073r1363b3140],
7	by	IN	O	by	_	0	SENT_92	[p7l1399t3073r1487b3162],
8	genotype	NN	O	genotype	nn	9	SENT_92	[p7l1521t3086r1859b3162],
9	group	NN	O	group	prep_by	4	SENT_92	[p7l1896t3097r2136b3162],
10	,	,	O	,	_	0	SENT_92	[p7l1896t3097r2136b3162],
11	and	CC	O	and	_	0	SENT_92	[p7l10t3181r148b3249],
12	by	IN	O	by	_	0	SENT_92	[p7l197t3181r285b3271],
13	treatment	NN	O	treatment	conj_and	9	SENT_92	[p7l334t3195r706b3250],
14	and	CC	O	and	_	0	SENT_92	[p7l757t3181r895b3249],
15	race	NN	O	race	conj_and	13	SENT_92	[p7l946t3206r1118b3250],
16	.	.	O	.	_	0	SENT_92	[p7l946t3206r1118b3250],

1	We	PRP	O	we	nsubj	2	SENT_93	[p7l1173t3188r1290b3250],
2	based	VBD	O	base	_	0	SENT_93	[p7l1342t3181r1558b3250],
3	the	DT	O	the	det	4	SENT_93	[p7l1608t3181r1725b3249],
4	choice	NN	O	choice	dobj	2	SENT_93	[p7l1778t3181r2016b3249],
5	of	IN	O	of	_	0	SENT_93	[p7l2069t3181r2153b3249],
6	statistical	JJ	O	statistical	amod	7	SENT_93	[p7l11t3290r360b3358],
7	models	NNS	O	model	prep_of	4	SENT_93	[p7l385t3290r657b3358],
8	on	IN	O	on	_	0	SENT_93	[p7l686t3315r779b3358],
9	models	NNS	O	model	prep_on	2	SENT_93	[p7l804t3290r1076b3358],
10	used	VBN	O	use	partmod	9	SENT_93	[p7l1102t3290r1281b3358],
11	in	IN	O	in	_	0	SENT_93	[p7l1304t3295r1379b3357],
12	the	DT	O	the	det	15	SENT_93	[p7l1403t3290r1520b3358],
13	primary	JJ	O	primary	amod	15	SENT_93	[p7l1546t3295r1848b3380],
14	clinical	JJ	O	clinical	amod	15	SENT_93	[p7l1873t3290r2140b3358],
15	studies	NNS	O	study	prep_in	10	SENT_93	[p7l11t3400r401b3478],
16	,23	CD	NUMBER	,23	num	17	SENT_93	[p7l11t3400r401b3478],
17	’	NN	O	’	dep	15	SENT_93	[p7l11t3400r401b3478],
18	2	CD	NUMBER	2	num	19	SENT_93	[p7l11t3400r401b3478],
19	“	NN	O	“	dep	17	SENT_93	[p7l11t3400r401b3478],
20	with	IN	O	with	_	0	SENT_93	[p7l432t3400r598b3467],
21	the	DT	O	the	det	22	SENT_93	[p7l632t3400r749b3467],
22	inclusion	NN	O	inclusion	prep_with	10	SENT_93	[p7l786t3400r1137b3467],
23	of	IN	O	of	_	0	SENT_93	[p7l1174t3400r1257b3467],
24	the	DT	O	the	det	25	SENT_93	[p7l1278t3400r1395b3467],
25	effect	NN	O	effect	prep_of	22	SENT_93	[p7l1433t3400r1636b3467],
26	of	IN	O	of	_	0	SENT_93	[p7l1671t3400r1755b3467],
27	genotype	NN	O	genotype	prep_of	25	SENT_93	[p7l1778t3413r2135b3489],
28	.	.	O	.	_	0	SENT_93	[p7l1778t3413r2135b3489],

1	Time	NNP	O	Time	nsubjpass	6	SENT_94	[p7l7t3513r202b3576],
2	to	TO	O	to	aux	3	SENT_94	[p7l223t3522r293b3576],
3	ﬁrst	VB	O	ﬁrst	infmod	1	SENT_94	[p7l316t3508r465b3576],
4	exacerbation	NN	O	exacerbation	dobj	3	SENT_94	[p7l487t3508r959b3577],
5	was	VBD	O	be	auxpass	6	SENT_94	[p7l979t3533r1118b3577],
6	described	VBN	O	describe	_	0	SENT_94	[p7l1143t3508r1503b3577],
7	by	IN	O	by	_	0	SENT_94	[p7l1522t3508r1609b3598],
8	Kaplan-Meier	NNP	O	Kaplan-Meier	nn	9	SENT_94	[p7l1632t3508r2141b3597],
9	plots	NNS	O	plot	agent	6	SENT_94	[p7l8t3617r207b3706],
10	.	.	O	.	_	0	SENT_94	[p7l8t3617r207b3706],

1	For	IN	O	for	_	0	SENT_95	[p7l252t3622r375b3685],
2	study	NN	O	study	nn	4	SENT_95	[p7l413t3617r613b3707],
3	1	CD	NUMBER	1	num	4	SENT_95	[p7l651t3623r681b3684],
4	data	NN	O	datum	prep_for	7	SENT_95	[p7l719t3617r892b3695],
5	,	,	O	,	_	0	SENT_95	[p7l719t3617r892b3695],
6	we	PRP	O	we	nsubj	7	SENT_95	[p7l930t3642r1033b3685],
7	compared	VBD	O	compare	_	0	SENT_95	[p7l1072t3617r1447b3706],
8	genotypes	NNS	O	genotype	dobj	7	SENT_95	[p7l1484t3631r1858b3707],
9	within	IN	O	within	_	0	SENT_95	[p7l1895t3617r2140b3685],
10	treatments	NNS	O	treatment	prep_within	7	SENT_95	[p7l7t3740r413b3795],
11	by	IN	O	by	_	0	SENT_95	[p7l494t3727r582b3816],
12	a	DT	O	a	det	17	SENT_95	[p7l660t3751r697b3795],
13	semiparametric	JJ	O	semiparametric	amod	17	SENT_95	[p7l779t3731r1371b3816],
14	Cox	NN	ORGANIZATION	cox	nn	17	SENT_95	[p7l1453t3732r1592b3795],
15	proportional	JJ	O	proportional	amod	17	SENT_95	[p7l1669t3727r2140b3816],
16	hazards	NNS	O	hazard	nn	17	SENT_95	[p8l7t17r299b85],
17	model	NN	O	model	prep_by	7	SENT_95	[p8l320t17r556b85],
18	including	VBG	O	include	_	0	SENT_95	[p8l574t17r936b107],
19	treatment	NN	O	treatment	prep_including	17	SENT_95	[p8l953t31r1343b96],
20	,	,	O	,	_	0	SENT_95	[p8l953t31r1343b96],
21	genotype	NN	O	genotype	prep_including	17	SENT_95	[p8l1366t31r1724b107],
22	,	,	O	,	_	0	SENT_95	[p8l1366t31r1724b107],
23	treatmentby-genotype	JJ	O	treatmentby-genotype	amod	24	SENT_95	[p8l1745t31r2138b86, p8l7t126r460b216],
24	interaction	NN	O	interaction	prep_including	17	SENT_95	[p8l489t131r918b204],
25	,	,	O	,	_	0	SENT_95	[p8l489t131r918b204],
26	and	CC	O	and	_	0	SENT_95	[p8l951t126r1089b194],
27	country	NN	O	country	prep_including	17	SENT_95	[p8l1117t140r1405b216],
28	as	IN	O	as	_	0	SENT_95	[p8l1432t150r1504b194],
29	factors	NNS	O	factor	prep_as	27	SENT_95	[p8l1535t126r1805b204],
30	;	:	O	;	_	0	SENT_95	[p8l1535t126r1805b204],
31	a	DT	O	a	det	32	SENT_95	[p8l1839t151r1876b194],
32	model	NN	O	model	nsubjpass	38	SENT_95	[p8l1904t126r2140b194],
33	without	IN	O	without	_	0	SENT_95	[p8l7t236r299b303],
34	the	DT	O	the	det	36	SENT_95	[p8l318t236r435b303],
35	interaction	NN	O	interaction	nn	36	SENT_95	[p8l458t240r867b303],
36	term	NN	O	term	prep_without	32	SENT_95	[p8l888t249r1068b303],
37	was	VBD	O	be	auxpass	38	SENT_95	[p8l1088t260r1227b303],
38	used	VBN	O	use	parataxis	7	SENT_95	[p8l1250t236r1428b303],
39	to	TO	O	to	aux	40	SENT_95	[p8l1448t249r1517b303],
40	obtain	VB	O	obtain	xcomp	38	SENT_95	[p8l1541t236r1777b303],
41	the	DT	O	the	det	42	SENT_95	[p8l1797t236r1914b303],
42	effect	NN	O	effect	dobj	40	SENT_95	[p8l1938t236r2141b303],
43	of	IN	O	of	_	0	SENT_95	[p8l10t344r93b412],
44	genotype	NN	O	genotype	prep_of	42	SENT_95	[p8l119t358r476b434],
45	.	.	O	.	_	0	SENT_95	[p8l119t358r476b434],

1	The	DT	O	the	det	2	SENT_96	[p8l517t344r661b412],
2	model	NN	O	model	nsubj	4	SENT_96	[p8l699t344r935b413],
3	seemed	VBD	O	seem	cop	4	SENT_96	[p8l975t344r1261b413],
4	appropriate	JJ	O	appropriate	_	0	SENT_96	[p8l1299t349r1731b433],
5	as	IN	O	as	mark	6	SENT_96	[p8l1770t369r1843b413],
6	judged	VBN	O	judge	advcl	4	SENT_96	[p8l1882t344r2141b434],
7	by	IN	O	by	_	0	SENT_96	[p8l7t453r95b542],
8	the	DT	O	the	det	12	SENT_96	[p8l142t453r260b521],
9	survival	NN	O	survival	nn	12	SENT_96	[p8l314t453r603b521],
10	curve	NN	O	curve	nn	12	SENT_96	[p8l655t478r856b521],
11	(	CD	NUMBER	(	num	12	SENT_96	[p8l913t453r1157b543],
12	ﬁgure	NN	O	ﬁgure	prep_by	6	SENT_96	[p8l913t453r1157b543],
13	1	CD	NUMBER	1	num	14	SENT_96	[p8l1211t460r1289b543],
14	)	NN	O	)	dep	12	SENT_96	[p8l1211t460r1289b543],
15	.	.	O	.	_	0	SENT_96	[p8l1211t460r1289b543],

1	Point	NN	O	point	nn	2	SENT_97	[p8l1347t458r1544b521],
2	estimates	NNS	O	estimate	nsubj	10	SENT_97	[p8l1594t458r1948b521],
3	and	CC	O	and	_	0	SENT_97	[p8l2002t453r2141b521],
4	95	CD	PERCENT	95	number	5	SENT_97	[p8l10t567r171b634],
5	%	NN	PERCENT	%	amod	6	SENT_97	[p8l10t567r171b634],
6	CIs	NNS	O	ci	nsubj	10	SENT_97	[p8l214t568r337b630],
7	of	IN	O	of	_	0	SENT_97	[p8l380t563r463b630],
8	hazard	NN	O	hazard	nn	9	SENT_97	[p8l488t563r746b630],
9	ratios	NNS	O	ratio	prep_of	6	SENT_97	[p8l784t567r990b630],
10	(	VBP	O	(	_	0	SENT_97	[p8l1037t570r1251b653],
11	I-IRs	JJ	O	i-irs	amod	12	SENT_97	[p8l1037t570r1251b653],
12	)	NN	O	)	nsubjpass	18	SENT_97	[p8l1037t570r1251b653],
13	between	IN	O	between	_	0	SENT_97	[p8l1294t563r1609b630],
14	Arg/Arg	NN	O	arg/arg	prep_between	12	SENT_97	[p8l1646t568r1962b652],
15	and	CC	O	and	_	0	SENT_97	[p8l2002t563r2141b630],
16	Gly/Gly	NN	O	gly/gly	prep_between	12	SENT_97	[p8l11t671r307b761],
17	were	VBD	O	be	auxpass	18	SENT_97	[p8l328t696r507b740],
18	calculated	VBN	O	calculate	ccomp	10	SENT_97	[p8l533t671r925b740],
19	.	.	O	.	_	0	SENT_97	[p8l533t671r925b740],

1	In	IN	O	in	_	0	SENT_98	[p8l958t678r1037b738],
2	study	NN	O	study	prep_in	23	SENT_98	[p8l1064t671r1265b761],
3	2	CD	NUMBER	2	num	2	SENT_98	[p8l1290t678r1348b749],
4	,	,	O	,	_	0	SENT_98	[p8l1290t678r1348b749],
5	because	IN	O	because	_	0	SENT_98	[p8l1375t671r1673b739],
6	of	IN	O	of	prepc_because_of	23	SENT_98	[p8l1699t671r1782b739],
7	the	DT	O	the	det	9	SENT_98	[p8l1793t671r1910b739],
8	small	JJ	O	small	amod	9	SENT_98	[p8l1938t671r2140b739],
9	number	NN	O	number	pobj	23	SENT_98	[p8l9t781r314b849],
10	of	IN	O	of	_	0	SENT_98	[p8l347t781r430b849],
11	participants	NNS	O	participant	prep_of	9	SENT_98	[p8l449t786r915b870],
12	,	,	O	,	_	0	SENT_98	[p8l449t786r915b870],
13	the	DT	O	the	det	14	SENT_98	[p8l950t781r1067b849],
14	comparison	NN	O	comparison	nsubjpass	23	SENT_98	[p8l1102t786r1548b870],
15	of	IN	O	of	_	0	SENT_98	[p8l1582t781r1666b849],
16	time	NN	O	time	prep_of	14	SENT_98	[p8l1685t786r1855b849],
17	to	TO	O	to	aux	18	SENT_98	[p8l1888t795r1957b849],
18	ﬁrst	VB	O	ﬁrst	infmod	16	SENT_98	[p8l1991t781r2141b849],
19	exacerbation	NN	O	exacerbation	dobj	18	SENT_98	[p8l10t891r482b958],
20	between	IN	O	between	_	0	SENT_98	[p8l527t891r841b958],
21	genotypes	NNS	O	genotype	prep_between	19	SENT_98	[p8l889t904r1263b980],
22	was	VBD	O	be	auxpass	23	SENT_98	[p8l1310t915r1449b958],
23	obtained	VBN	O	obtain	_	0	SENT_98	[p8l1498t891r1825b958],
24	from	IN	O	from	_	0	SENT_98	[p8l1870t891r2055b958],
25	a	DT	O	a	det	27	SENT_98	[p8l2103t915r2139b958],
26	log-rank	JJ	O	log-rank	amod	27	SENT_98	[p8l7t999r322b1089],
27	test	NN	O	test	prep_from	23	SENT_98	[p8l396t1013r546b1078],
28	,	,	O	,	_	0	SENT_98	[p8l396t1013r546b1078],
29	and	CC	O	and	_	0	SENT_98	[p8l628t999r766b1067],
30	hospitalisations	NNS	O	hospitalisation	nsubjpass	36	SENT_98	[p8l840t999r1432b1088],
31	and	CC	O	and	_	0	SENT_98	[p8l1513t999r1651b1067],
32	emergency	NN	O	emergency	nn	34	SENT_98	[p8l1728t1024r2141b1089],
33	department	NN	O	department	nn	34	SENT_98	[p8l10t1108r449b1197],
34	treatments	NNS	O	treatment	nsubjpass	36	SENT_98	[p8l472t1122r878b1176],
35	were	VBD	O	be	auxpass	36	SENT_98	[p8l905t1133r1084b1176],
36	tabulated	VBN	O	tabulate	conj_and	23	SENT_98	[p8l1110t1108r1477b1176],
37	.	.	O	.	_	0	SENT_98	[p8l1110t1108r1477b1176],

1	Changes	NNS	O	change	nsubjpass	9	SENT_99	[p8l1509t1108r1832b1198],
2	in	IN	O	in	_	0	SENT_99	[p8l1861t1113r1935b1175],
3	FEV	NNP	O	FEV	prep_in	1	SENT_99	[p8l1965t1113r2141b1193],
4	,	,	O	,	_	0	SENT_99	[p8l1965t1113r2141b1193],
5	and	CC	O	and	_	0	SENT_99	[p8l10t1219r148b1287],
6	diary-card	JJ	O	diary-card	amod	7	SENT_99	[p8l183t1219r557b1308],
7	variables	NNS	O	variable	prep_in	1	SENT_99	[p8l588t1219r918b1287],
8	were	VBD	O	be	auxpass	9	SENT_99	[p8l954t1243r1132b1287],
9	compared	VBN	O	compare	_	0	SENT_99	[p8l1169t1219r1544b1308],
10	from	IN	O	from	_	0	SENT_99	[p8l1578t1219r1763b1287],
11	run-in	NN	O	run-in	prep_from	9	SENT_99	[p8l1797t1223r2036b1287],
12	to	TO	O	to	_	0	SENT_99	[p8l2069t1232r2138b1287],
13	the	DT	O	the	det	14	SENT_99	[p8l8t1327r124b1395],
14	average	NN	O	average	prep_to	9	SENT_99	[p8l143t1352r424b1417],
15	during	IN	O	during	_	0	SENT_99	[p8l442t1327r695b1417],
16	the	DT	O	the	det	18	SENT_99	[p8l711t1327r828b1395],
17	treatment	NN	O	treatment	nn	18	SENT_99	[p8l844t1341r1216b1396],
18	period	NN	O	period	prep_during	9	SENT_99	[p8l1230t1327r1490b1416],
19	.	.	O	.	_	0	SENT_99	[p8l1230t1327r1490b1416],

1	This	DT	O	this	det	2	SENT_100	[p8l1509t1327r1673b1395],
2	comparison	NN	O	comparison	nsubjpass	4	SENT_100	[p8l1693t1332r2140b1416],
3	was	VBD	O	be	auxpass	4	SENT_100	[p8l7t1460r146b1504],
4	made	VBN	O	make	_	0	SENT_100	[p8l175t1436r382b1504],
5	by	IN	O	by	_	0	SENT_100	[p8l408t1436r495b1526],
6	use	NN	O	use	agent	4	SENT_100	[p8l519t1460r647b1504],
7	of	IN	O	of	_	0	SENT_100	[p8l676t1436r759b1504],
8	ANOVA	NNP	ORGANIZATION	ANOVA	nn	9	SENT_100	[p8l772t1441r1081b1505],
9	models	NNS	O	model	prep_of	6	SENT_100	[p8l1106t1436r1399b1514],
10	,	,	O	,	_	0	SENT_100	[p8l1106t1436r1399b1514],
11	on	IN	O	on	_	0	SENT_100	[p8l1431t1461r1525b1504],
12	the	DT	O	the	det	13	SENT_100	[p8l1551t1436r1667b1504],
13	assumption	NN	O	assumption	prep_on	4	SENT_100	[p8l1696t1441r2140b1525],
14	that	IN	O	that	complm	19	SENT_100	[p8l7t1547r153b1615],
15	outcomes	NNS	O	outcome	nsubjpass	19	SENT_100	[p8l180t1560r542b1615],
16	were	VBD	O	be	auxpass	19	SENT_100	[p8l570t1571r749b1615],
17	approximately	RB	O	approximately	advmod	18	SENT_100	[p8l779t1547r1314b1636],
18	normally	RB	O	normally	advmod	19	SENT_100	[p8l1339t1547r1679b1636],
19	distributed	VBN	O	distribute	dep	13	SENT_100	[p8l1706t1547r2135b1615],
20	.	.	O	.	_	0	SENT_100	[p8l1706t1547r2135b1615],

1	Change	NNP	O	Change	nsubj	7	SENT_101	[p8l11t1655r297b1745],
2	in	IN	O	in	_	0	SENT_101	[p8l345t1660r420b1722],
3	FEV	NNP	MISC	FEV	prep_in	1	SENT_101	[p8l471t1660r648b1740],
4	,	,	O	,	_	0	SENT_101	[p8l471t1660r648b1740],
5	was	VBD	O	be	cop	7	SENT_101	[p8l692t1680r831b1724],
6	the	DT	O	the	det	7	SENT_101	[p8l879t1655r997b1723],
7	difference	NN	O	difference	_	0	SENT_101	[p8l1046t1655r1422b1723],
8	between	IN	O	between	_	0	SENT_101	[p8l1469t1655r1783b1724],
9	baseline	NN	O	baseline	nn	10	SENT_101	[p8l1829t1655r2139b1724],
10	FEV	NN	MISC	fev	prep_between	7	SENT_101	[p8l13t1769r188b1849],
11	,	,	O	,	_	0	SENT_101	[p8l13t1769r188b1849],
12	and	CC	O	and	_	0	SENT_101	[p8l210t1764r348b1832],
13	the	DT	O	the	det	16	SENT_101	[p8l386t1764r503b1832],
14	average	JJ	O	average	amod	16	SENT_101	[p8l527t1789r808b1854],
15	F	NN	MISC	f	nn	16	SENT_101	[p8l834t1769r875b1831],
16	EV	NN	MISC	ev	prep_between	7	SENT_101	[p8l886t1769r1010b1849],
17	,	,	O	,	_	0	SENT_101	[p8l886t1769r1010b1849],
18	measured	VBN	O	measure	partmod	10	SENT_101	[p8l1031t1764r1405b1832],
19	during	IN	O	during	_	0	SENT_101	[p8l1426t1764r1679b1854],
20	clinic	NN	O	clinic	nn	21	SENT_101	[p8l1703t1764r1904b1832],
21	visits	NNS	O	visit	prep_during	18	SENT_101	[p8l1924t1769r2135b1832],
22	.	.	O	.	_	0	SENT_101	[p8l1924t1769r2135b1832],

1	Models	NNS	O	model	nsubj	2	SENT_102	[p8l12t1874r280b1941],
2	included	VBD	O	include	_	0	SENT_102	[p8l349t1874r678b1941],
3	treatment	NN	O	treatment	dobj	2	SENT_102	[p8l743t1887r1132b1952],
4	,	,	O	,	_	0	SENT_102	[p8l743t1887r1132b1952],
5	genotype	NN	O	genotype	conj_and	3	SENT_102	[p8l1205t1887r1562b1963],
6	,	,	O	,	_	0	SENT_102	[p8l1205t1887r1562b1963],
7	treatmentbygenotype	JJ	O	treatmentbygenotype	amod	8	SENT_102	[p8l1632t1874r2138b1963, p8l10t1996r347b2072],
8	interaction	NN	O	interaction	conj_and	3	SENT_102	[p8l371t1987r798b2060],
9	,	,	O	,	_	0	SENT_102	[p8l371t1987r798b2060],
10	and	CC	O	and	_	0	SENT_102	[p8l825t1982r963b2051],
11	baseline	NN	O	baseline	nn	12	SENT_102	[p8l982t1982r1293b2051],
12	value	NN	O	value	dobj	2	SENT_102	[p8l1314t1982r1510b2051],
13	for	IN	O	for	_	0	SENT_102	[p8l1533t1982r1640b2050],
14	both	DT	O	both	det	15	SENT_102	[p8l1658t1982r1829b2050],
15	studies	NNS	O	study	prep_for	12	SENT_102	[p8l1852t1982r2136b2060],
16	,	,	O	,	_	0	SENT_102	[p8l1852t1982r2136b2060],
17	and	CC	O	and	_	0	SENT_102	[p8l10t2091r148b2159],
18	additionally	RB	O	additionally	advmod	19	SENT_102	[p8l191t2091r632b2181],
19	country	NN	O	country	conj_and	2	SENT_102	[p8l674t2105r962b2181],
20	for	IN	O	for	_	0	SENT_102	[p8l1003t2091r1110b2159],
21	study	NN	O	study	prep_for	19	SENT_102	[p8l1153t2091r1354b2180],
22	1	CD	NUMBER	1	num	21	SENT_102	[p8l1398t2097r1447b2159],
23	.	.	O	.	_	0	SENT_102	[p8l1398t2097r1447b2159],

1	ANOVA	NNP	ORGANIZATION	ANOVA	nn	2	SENT_103	[p8l1492t2096r1801b2160],
2	models	NNS	O	model	nsubjpass	10	SENT_103	[p8l1843t2091r2136b2169],
3	,	,	O	,	_	0	SENT_103	[p8l1843t2091r2136b2169],
4	excluding	VBG	O	exclude	_	0	SENT_103	[p8l10t2201r373b2290],
5	the	DT	O	the	det	7	SENT_103	[p8l405t2201r523b2268],
6	interaction	NN	O	interaction	nn	7	SENT_103	[p8l556t2205r966b2268],
7	term	NN	O	term	prep_excluding	2	SENT_103	[p8l998t2214r1197b2279],
8	,	,	O	,	_	0	SENT_103	[p8l998t2214r1197b2279],
9	were	VBD	O	be	auxpass	10	SENT_103	[p8l1232t2225r1411b2268],
10	used	VBN	O	use	_	0	SENT_103	[p8l1444t2201r1623b2268],
11	to	TO	O	to	aux	12	SENT_103	[p8l1654t2214r1722b2268],
12	assess	VB	O	assess	xcomp	10	SENT_103	[p8l1759t2225r1987b2268],
13	the	DT	O	the	det	14	SENT_103	[p8l2022t2201r2139b2268],
14	effect	NN	O	effect	dobj	12	SENT_103	[p8l10t2310r213b2377],
15	of	IN	O	of	_	0	SENT_103	[p8l244t2309r328b2377],
16	genotype	NN	O	genotype	prep_of	14	SENT_103	[p8l347t2323r685b2399],
17	for	IN	O	for	_	0	SENT_103	[p8l717t2309r824b2377],
18	all	DT	O	all	det	19	SENT_103	[p8l855t2309r940b2377],
19	treatments	NNS	O	treatment	prep_for	12	SENT_103	[p8l970t2323r1376b2378],
20	combined	VBN	O	combine	partmod	19	SENT_103	[p8l1411t2309r1805b2377],
21	.	.	O	.	_	0	SENT_103	[p8l1411t2309r1805b2377],

1	Adverse	JJ	O	adverse	amod	2	SENT_104	[p8l1839t2309r2139b2378],
2	events	NNS	O	event	nsubjpass	4	SENT_104	[p8l10t2432r244b2486],
3	were	VBD	O	be	auxpass	4	SENT_104	[p8l275t2443r454b2486],
4	tabulated	VBN	O	tabulate	_	0	SENT_104	[p8l483t2418r832b2486],
5	according	VBG	O	accord	_	0	SENT_104	[p8l863t2418r1229b2508],
6	to	TO	O	to	prepc_according_to	4	SENT_104	[p8l1259t2432r1327b2486],
7	genotype	NN	O	genotype	pobj	4	SENT_104	[p8l1360t2432r1718b2508],
8	.	.	O	.	_	0	SENT_104	[p8l1360t2432r1718b2508],

1	Haplotype	NN	O	haplotype	nn	2	SENT_105	[p8l1756t2418r2139b2508],
2	analyses	NNS	O	analysis	nsubj	10	SENT_105	[p8l10t2528r320b2617],
3	of	IN	O	of	_	0	SENT_105	[p8l359t2528r442b2595],
4	the	DT	O	the	det	6	SENT_105	[p8l463t2528r579b2595],
5	white	JJ	O	white	amod	6	SENT_105	[p8l613t2528r820b2595],
6	subgroup	NN	O	subgroup	prep_of	2	SENT_105	[p8l858t2528r1214b2617],
7	in	IN	O	in	_	0	SENT_105	[p8l1250t2532r1325b2594],
8	study	NN	O	study	prep_in	6	SENT_105	[p8l1362t2528r1563b2617],
9	1	CD	NUMBER	1	num	8	SENT_105	[p8l1599t2534r1629b2594],
10	used	VBD	O	use	_	0	SENT_105	[p8l1662t2528r1841b2595],
11	similar	JJ	O	similar	amod	12	SENT_105	[p8l1877t2528r2141b2595],
12	models	NNS	O	model	dobj	10	SENT_105	[p8l9t2636r302b2704],
13	.	.	O	.	_	0	SENT_105	[p8l9t2636r302b2704],

1	Study	NNP	O	Study	dep	335	SENT_106	[p8l283t2778r352b2806],
2	1	CD	NUMBER	1	dep	335	SENT_106	[p8l358t2781r371b2799],
3	Study	NNP	O	Study	dep	335	SENT_106	[p8l1060t2778r1129b2806],
4	2	CD	NUMBER	2	dep	335	SENT_106	[p8l1135t2781r1148b2799],
5	Gly/Gly	JJ	O	gly/gly	dep	335	SENT_106	[p8l284t2835r363b2862],
6	Gly/Arg	NN	O	gly/arg	dep	335	SENT_106	[p8l475t2835r557b2863],
7	Arg/Arg	NN	O	arg/arg	dep	335	SENT_106	[p8l665t2836r753b2863],
8	All	DT	O	all	dep	335	SENT_106	[p8l857t2835r884b2856],
9	genotypes	NNS	O	genotype	dep	335	SENT_106	[p8l892t2839r1007b2863],
10	Gly/Gly	JJ	O	gly/gly	dep	335	SENT_106	[p8l1061t2835r1140b2863],
11	Gly/Arg	NN	O	gly/arg	dep	335	SENT_106	[p8l1252t2835r1334b2863],
12	Arg/Arg	NN	O	arg/arg	dep	335	SENT_106	[p8l1442t2836r1530b2863],
13	All	DT	O	all	dep	335	SENT_106	[p8l1633t2835r1661b2856],
14	genotypes	NNS	O	genotype	dep	335	SENT_106	[p8l1669t2839r1784b2863],
15	Participants	NNS	O	participant	dep	335	SENT_106	[p8l44t2893r174b2919],
16	833	CD	NUMBER	833	dep	335	SENT_106	[p8l284t2891r325b2916],
17	(	NN	O	(	dep	335	SENT_106	[p8l334t2892r396b2918],
18	37	CD	PERCENT	37	dep	335	SENT_106	[p8l334t2892r396b2918],
19	%	NN	PERCENT	%	dep	335	SENT_106	[p8l334t2892r396b2918],
20	)	CD	NUMBER	)	dep	335	SENT_106	[p8l334t2892r396b2918],
21	1029	CD	DATE	1029	dep	335	SENT_106	[p8l476t2894r531b2916],
22	(	CD	PERCENT	(	dep	335	SENT_106	[p8l540t2891r606b2918],
23	46	CD	PERCENT	46	dep	335	SENT_106	[p8l540t2891r606b2918],
24	%	NN	PERCENT	%	dep	335	SENT_106	[p8l540t2891r606b2918],
25	)	CD	NUMBER	)	dep	335	SENT_106	[p8l540t2891r606b2918],
26	363	CD	NUMBER	363	dep	335	SENT_106	[p8l665t2891r707b2916],
27	(	NN	O	(	dep	335	SENT_106	[p8l716t2891r780b2918],
28	16	CD	PERCENT	16	dep	335	SENT_106	[p8l716t2891r780b2918],
29	%	NN	PERCENT	%	dep	335	SENT_106	[p8l716t2891r780b2918],
30	)	CD	PERCENT	)	dep	335	SENT_106	[p8l716t2891r780b2918],
31	2225	CD	PERCENT	2225	dep	335	SENT_106	[p8l857t2894r911b2916],
32	(	NN	PERCENT	(	dep	335	SENT_106	[p8l919t2892r998b2918],
33	100	CD	PERCENT	100	dep	335	SENT_106	[p8l919t2892r998b2918],
34	%	NN	PERCENT	%	dep	335	SENT_106	[p8l919t2892r998b2918],
35	)	CD	NUMBER	)	dep	335	SENT_106	[p8l919t2892r998b2918],
36	169	CD	NUMBER	169	dep	335	SENT_106	[p8l1060t2891r1103b2916],
37	(	NN	O	(	dep	335	SENT_106	[p8l1111t2892r1176b2918],
38	42	CD	PERCENT	42	dep	335	SENT_106	[p8l1111t2892r1176b2918],
39	%	NN	PERCENT	%	dep	335	SENT_106	[p8l1111t2892r1176b2918],
40	)	CD	NUMBER	)	dep	335	SENT_106	[p8l1111t2892r1176b2918],
41	169	CD	NUMBER	169	dep	335	SENT_106	[p8l1253t2891r1295b2916],
42	(	NN	O	(	dep	335	SENT_106	[p8l1304t2892r1369b2918],
43	42	CD	PERCENT	42	dep	335	SENT_106	[p8l1304t2892r1369b2918],
44	%	NN	PERCENT	%	dep	335	SENT_106	[p8l1304t2892r1369b2918],
45	)	CD	NUMBER	)	dep	335	SENT_106	[p8l1304t2892r1369b2918],
46	67	CD	NUMBER	67	dep	335	SENT_106	[p8l1444t2891r1471b2915],
47	(	NN	O	(	dep	335	SENT_106	[p8l1479t2891r1543b2918],
48	16	CD	PERCENT	16	dep	335	SENT_106	[p8l1479t2891r1543b2918],
49	%	NN	PERCENT	%	dep	335	SENT_106	[p8l1479t2891r1543b2918],
50	)	CD	NUMBER	)	dep	335	SENT_106	[p8l1479t2891r1543b2918],
51	405	CD	NUMBER	405	dep	335	SENT_106	[p8l1635t2894r1678b2916],
52	(	NN	O	(	dep	335	SENT_106	[p8l1686t2892r1765b2918],
53	100	CD	PERCENT	100	dep	335	SENT_106	[p8l1686t2892r1765b2918],
54	%	NN	PERCENT	%	dep	335	SENT_106	[p8l1686t2892r1765b2918],
55	)	CD	NUMBER	)	dep	335	SENT_106	[p8l1686t2892r1765b2918],
56	Ethnic	JJ	O	ethnic	dep	335	SENT_106	[p8l44t2938r113b2960],
57	origin	NN	O	origin	dep	335	SENT_106	[p8l119t2940r183b2966],
58	White	NNP	O	White	dep	335	SENT_106	[p8l67t2985r133b3007],
59	552	CD	PERCENT	552	dep	335	SENT_106	[p8l284t2985r325b3010],
60	(	CD	PERCENT	(	dep	335	SENT_106	[p8l334t2985r398b3012],
61	73	CD	PERCENT	73	dep	335	SENT_106	[p8l334t2985r398b3012],
62	%	NN	PERCENT	%	dep	335	SENT_106	[p8l334t2985r398b3012],
63	)	CD	NUMBER	)	dep	335	SENT_106	[p8l334t2985r398b3012],
64	733	CD	NUMBER	733	dep	335	SENT_106	[p8l491t2988r531b3010],
65	(	NN	O	(	dep	335	SENT_106	[p8l540t2987r601b3012],
66	71	CD	PERCENT	71	dep	335	SENT_106	[p8l540t2987r601b3012],
67	%	NN	PERCENT	%	dep	335	SENT_106	[p8l540t2987r601b3012],
68	)	CD	NUMBER	)	dep	335	SENT_106	[p8l540t2987r601b3012],
69	229	CD	NUMBER	229	dep	335	SENT_106	[p8l666t2988r707b3010],
70	(	NN	O	(	dep	335	SENT_106	[p8l716t2985r781b3012],
71	53	CD	PERCENT	53	dep	335	SENT_106	[p8l716t2985r781b3012],
72	%	NN	PERCENT	%	dep	335	SENT_106	[p8l716t2985r781b3012],
73	)	CD	NUMBER	)	dep	335	SENT_106	[p8l716t2985r781b3012],
74	1514	CD	DATE	1514	dep	335	SENT_106	[p8l857t2985r913b3010],
75	(	CD	PERCENT	(	dep	335	SENT_106	[p8l921t2987r983b3012],
76	73	CD	PERCENT	73	dep	335	SENT_106	[p8l921t2987r983b3012],
77	%	NN	PERCENT	%	dep	335	SENT_106	[p8l921t2987r983b3012],
78	)	CD	NUMBER	)	dep	335	SENT_106	[p8l921t2987r983b3012],
79	150	CD	NUMBER	150	dep	335	SENT_106	[p8l1060t2988r1101b3010],
80	(	NN	O	(	dep	335	SENT_106	[p8l1109t2985r1176b3012],
81	39	CD	PERCENT	39	dep	335	SENT_106	[p8l1109t2985r1176b3012],
82	%	NN	PERCENT	%	dep	335	SENT_106	[p8l1109t2985r1176b3012],
83	)	CD	NUMBER	)	dep	335	SENT_106	[p8l1109t2985r1176b3012],
84	133	CD	NUMBER	133	dep	335	SENT_106	[p8l1255t2985r1296b3010],
85	(	NN	O	(	dep	335	SENT_106	[p8l1304t2985r1369b3012],
86	82	CD	PERCENT	82	dep	335	SENT_106	[p8l1304t2985r1369b3012],
87	%	NN	PERCENT	%	dep	335	SENT_106	[p8l1304t2985r1369b3012],
88	)	CD	NUMBER	)	dep	335	SENT_106	[p8l1304t2985r1369b3012],
89	45	CD	NUMBER	45	dep	335	SENT_106	[p8l1442t2985r1472b3010],
90	(	NN	O	(	dep	335	SENT_106	[p8l1480t2985r1547b3012],
91	59	CD	PERCENT	59	dep	335	SENT_106	[p8l1480t2985r1547b3012],
92	%	NN	PERCENT	%	dep	335	SENT_106	[p8l1480t2985r1547b3012],
93	)	CD	NUMBER	)	dep	335	SENT_106	[p8l1480t2985r1547b3012],
94	334	CD	NUMBER	334	dep	335	SENT_106	[p8l1636t2988r1679b3010],
95	(	NN	O	(	dep	335	SENT_106	[p8l1686t2985r1751b3012],
96	33	CD	PERCENT	33	dep	335	SENT_106	[p8l1686t2985r1751b3012],
97	%	NN	PERCENT	%	dep	335	SENT_106	[p8l1686t2985r1751b3012],
98	)	CD	NUMBER	)	dep	335	SENT_106	[p8l1686t2985r1751b3012],
99	Black	JJ	O	black	dep	335	SENT_106	[p8l68t3032r124b3054],
100	8	CD	PERCENT	8	dep	335	SENT_106	[p8l311t3032r323b3054],
101	(	NN	PERCENT	(	dep	335	SENT_106	[p8l332t3034r380b3059],
102	1	CD	PERCENT	1	dep	335	SENT_106	[p8l332t3034r380b3059],
103	%	NN	PERCENT	%	dep	335	SENT_106	[p8l332t3034r380b3059],
104	)	CD	NUMBER	)	dep	335	SENT_106	[p8l332t3034r380b3059],
105	8	CD	PERCENT	8	dep	335	SENT_106	[p8l518t3032r531b3054],
106	(	NN	PERCENT	(	dep	335	SENT_106	[p8l540t3034r588b3059],
107	1	CD	PERCENT	1	dep	335	SENT_106	[p8l540t3034r588b3059],
108	%	NN	PERCENT	%	dep	335	SENT_106	[p8l540t3034r588b3059],
109	)	CD	NUMBER	)	dep	335	SENT_106	[p8l540t3034r588b3059],
110	5	CD	NUMBER	5	dep	335	SENT_106	[p8l694t3036r706b3057],
111	(	NN	O	(	dep	335	SENT_106	[p8l714t3034r762b3059],
112	1	CD	PERCENT	1	dep	335	SENT_106	[p8l714t3034r762b3059],
113	%	NN	PERCENT	%	dep	335	SENT_106	[p8l714t3034r762b3059],
114	)	CD	NUMBER	)	dep	335	SENT_106	[p8l714t3034r762b3059],
115	21	CD	NUMBER	21	dep	335	SENT_106	[p8l885t3035r910b3053],
116	(	NN	O	(	dep	335	SENT_106	[p8l918t3034r966b3059],
117	1	CD	PERCENT	1	dep	335	SENT_106	[p8l918t3034r966b3059],
118	%	NN	PERCENT	%	dep	335	SENT_106	[p8l918t3034r966b3059],
119	)	CD	NUMBER	)	dep	335	SENT_106	[p8l918t3034r966b3059],
120	11	CD	NUMBER	11	dep	335	SENT_106	[p8l1076t3035r1101b3053],
121	(	NN	O	(	dep	335	SENT_106	[p8l1109t3034r1157b3059],
122	7	CD	PERCENT	7	dep	335	SENT_106	[p8l1109t3034r1157b3059],
123	%	NN	PERCENT	%	dep	335	SENT_106	[p8l1109t3034r1157b3059],
124	)	CD	PERCENT	)	dep	335	SENT_106	[p8l1109t3034r1157b3059],
125	24	CD	PERCENT	24	dep	335	SENT_106	[p8l1269t3035r1297b3057],
126	(	NN	PERCENT	(	dep	335	SENT_106	[p8l1304t3034r1368b3059],
127	14	CD	PERCENT	14	dep	335	SENT_106	[p8l1304t3034r1368b3059],
128	%	NN	PERCENT	%	dep	335	SENT_106	[p8l1304t3034r1368b3059],
129	)	CD	PERCENT	)	dep	335	SENT_106	[p8l1304t3034r1368b3059],
130	15	CD	PERCENT	15	dep	335	SENT_106	[p8l1445t3035r1470b3057],
131	(	NN	PERCENT	(	dep	335	SENT_106	[p8l1479t3034r1542b3059],
132	22	CD	PERCENT	22	dep	335	SENT_106	[p8l1479t3034r1542b3059],
133	%	NN	PERCENT	%	dep	335	SENT_106	[p8l1479t3034r1542b3059],
134	)	CD	PERCENT	)	dep	335	SENT_106	[p8l1479t3034r1542b3059],
135	50	CD	PERCENT	50	dep	335	SENT_106	[p8l1651t3035r1678b3057],
136	(	CD	PERCENT	(	dep	335	SENT_106	[p8l1686t3034r1749b3059],
137	12	CD	PERCENT	12	dep	335	SENT_106	[p8l1686t3034r1749b3059],
138	%	NN	PERCENT	%	dep	335	SENT_106	[p8l1686t3034r1749b3059],
139	)	CD	NUMBER	)	dep	335	SENT_106	[p8l1686t3034r1749b3059],
140	Asian	JJ	MISC	asian	dep	335	SENT_106	[p8l67t3081r126b3101],
141	31	CD	PERCENT	31	dep	335	SENT_106	[p8l298t3082r324b3104],
142	(	CD	PERCENT	(	dep	335	SENT_106	[p8l332t3081r382b3106],
143	4	CD	PERCENT	4	dep	335	SENT_106	[p8l332t3081r382b3106],
144	%	NN	PERCENT	%	dep	335	SENT_106	[p8l332t3081r382b3106],
145	)	CD	NUMBER	)	dep	335	SENT_106	[p8l332t3081r382b3106],
146	81	CD	NUMBER	81	dep	335	SENT_106	[p8l505t3079r532b3101],
147	(	NN	O	(	dep	335	SENT_106	[p8l540t3079r591b3106],
148	8	CD	PERCENT	8	dep	335	SENT_106	[p8l540t3079r591b3106],
149	%	NN	PERCENT	%	dep	335	SENT_106	[p8l540t3079r591b3106],
150	)	CD	NUMBER	)	dep	335	SENT_106	[p8l540t3079r591b3106],
151	44	CD	NUMBER	44	dep	335	SENT_106	[p8l677t3082r707b3104],
152	(	NN	O	(	dep	335	SENT_106	[p8l714t3081r777b3106],
153	12	CD	PERCENT	12	dep	335	SENT_106	[p8l714t3081r777b3106],
154	%	NN	PERCENT	%	dep	335	SENT_106	[p8l714t3081r777b3106],
155	)	CD	NUMBER	)	dep	335	SENT_106	[p8l714t3081r777b3106],
156	156	CD	NUMBER	156	dep	335	SENT_106	[p8l869t3079r909b3104],
157	(	NN	O	(	dep	335	SENT_106	[p8l918t3081r966b3106],
158	7	CD	PERCENT	7	dep	335	SENT_106	[p8l918t3081r966b3106],
159	%	NN	PERCENT	%	dep	335	SENT_106	[p8l918t3081r966b3106],
160	)	CD	NUMBER	)	dep	335	SENT_106	[p8l918t3081r966b3106],
161	o	NN	O	o	dep	335	SENT_106	[p8l1088t3082r1101b3101],
162	1	CD	NUMBER	1	dep	335	SENT_106	[p8l1285t3082r1296b3100],
163	(	NN	O	(	dep	335	SENT_106	[p8l1304t3081r1352b3106],
164	1	CD	PERCENT	1	dep	335	SENT_106	[p8l1304t3081r1352b3106],
165	%	NN	PERCENT	%	dep	335	SENT_106	[p8l1304t3081r1352b3106],
166	)	CD	NUMBER	)	dep	335	SENT_106	[p8l1304t3081r1352b3106],
167	3	CD	NUMBER	3	dep	335	SENT_106	[p8l1458t3082r1470b3104],
168	(	NN	O	(	dep	335	SENT_106	[p8l1479t3081r1528b3106],
169	5	CD	PERCENT	5	dep	335	SENT_106	[p8l1479t3081r1528b3106],
170	%	NN	PERCENT	%	dep	335	SENT_106	[p8l1479t3081r1528b3106],
171	)	CD	NUMBER	)	dep	335	SENT_106	[p8l1479t3081r1528b3106],
172	4	CD	NUMBER	4	dep	335	SENT_106	[p8l1664t3082r1679b3104],
173	(	NN	O	(	dep	335	SENT_106	[p8l1686t3081r1735b3106],
174	1	CD	PERCENT	1	dep	335	SENT_106	[p8l1686t3081r1735b3106],
175	%	NN	PERCENT	%	dep	335	SENT_106	[p8l1686t3081r1735b3106],
176	)	CD	NUMBER	)	dep	335	SENT_106	[p8l1686t3081r1735b3106],
177	Other	JJ	O	other	dep	335	SENT_106	[p8l67t3126r130b3148],
178	142	CD	NUMBER	142	dep	335	SENT_106	[p8l284t3129r324b3151],
179	(	NN	O	(	dep	335	SENT_106	[p8l332t3128r394b3153],
180	17	CD	PERCENT	17	dep	335	SENT_106	[p8l332t3128r394b3153],
181	%	NN	PERCENT	%	dep	335	SENT_106	[p8l332t3128r394b3153],
182	)	CD	NUMBER	)	dep	335	SENT_106	[p8l332t3128r394b3153],
183	207	CD	NUMBER	207	dep	335	SENT_106	[p8l491t3129r532b3150],
184	(	NN	O	(	dep	335	SENT_106	[p8l540t3128r604b3153],
185	20	CD	PERCENT	20	dep	335	SENT_106	[p8l540t3128r604b3153],
186	%	NN	PERCENT	%	dep	335	SENT_106	[p8l540t3128r604b3153],
187	)	CD	NUMBER	)	dep	335	SENT_106	[p8l540t3128r604b3153],
188	35	CD	NUMBER	35	dep	335	SENT_106	[p8l679t3126r706b3151],
189	(	NN	O	(	dep	335	SENT_106	[p8l714t3128r779b3153],
190	24	CD	PERCENT	24	dep	335	SENT_106	[p8l714t3128r779b3153],
191	%	NN	PERCENT	%	dep	335	SENT_106	[p8l714t3128r779b3153],
192	)	CD	NUMBER	)	dep	335	SENT_106	[p8l714t3128r779b3153],
193	434	CD	NUMBER	434	dep	335	SENT_106	[p8l866t3129r910b3151],
194	(	NN	O	(	dep	335	SENT_106	[p8l918t3128r982b3153],
195	19	CD	PERCENT	19	dep	335	SENT_106	[p8l918t3128r982b3153],
196	%	NN	PERCENT	%	dep	335	SENT_106	[p8l918t3128r982b3153],
197	)	CD	NUMBER	)	dep	335	SENT_106	[p8l918t3128r982b3153],
198	3	CD	NUMBER	3	dep	335	SENT_106	[p8l1088t3126r1100b3148],
199	(	NN	O	(	dep	335	SENT_106	[p8l1109t3128r1158b3153],
200	5	CD	PERCENT	5	dep	335	SENT_106	[p8l1109t3128r1158b3153],
201	%	NN	PERCENT	%	dep	335	SENT_106	[p8l1109t3128r1158b3153],
202	)	CD	NUMBER	)	dep	335	SENT_106	[p8l1109t3128r1158b3153],
203	5	CD	NUMBER	5	dep	335	SENT_106	[p8l1283t3126r1296b3148],
204	(	NN	O	(	dep	335	SENT_106	[p8l1304t3128r1355b3153],
205	4	CD	PERCENT	4	dep	335	SENT_106	[p8l1304t3128r1355b3153],
206	%	NN	PERCENT	%	dep	335	SENT_106	[p8l1304t3128r1355b3153],
207	)	CD	NUMBER	)	dep	335	SENT_106	[p8l1304t3128r1355b3153],
208	3	CD	NUMBER	3	dep	335	SENT_106	[p8l1458t3129r1470b3151],
209	(	NN	O	(	dep	335	SENT_106	[p8l1479t3128r1528b3153],
210	5	CD	PERCENT	5	dep	335	SENT_106	[p8l1479t3128r1528b3153],
211	%	NN	PERCENT	%	dep	335	SENT_106	[p8l1479t3128r1528b3153],
212	)	CD	NUMBER	)	dep	335	SENT_106	[p8l1479t3128r1528b3153],
213	17	CD	NUMBER	17	dep	335	SENT_106	[p8l1654t3129r1679b3150],
214	(	NN	O	(	dep	335	SENT_106	[p8l1686t3128r1737b3153],
215	4	CD	PERCENT	4	dep	335	SENT_106	[p8l1686t3128r1737b3153],
216	%	NN	PERCENT	%	dep	335	SENT_106	[p8l1686t3128r1737b3153],
217	)	CD	NUMBER	)	dep	335	SENT_106	[p8l1686t3128r1737b3153],
218	Men	NN	O	man	dep	335	SENT_106	[p8l44t3175r91b3195],
219	335	CD	PERCENT	335	dep	335	SENT_106	[p8l283t3176r323b3198],
220	(	CD	PERCENT	(	dep	335	SENT_106	[p8l332t3175r398b3200],
221	40	CD	PERCENT	40	dep	335	SENT_106	[p8l332t3175r398b3200],
222	%	NN	PERCENT	%	dep	335	SENT_106	[p8l332t3175r398b3200],
223	)	CD	NUMBER	)	dep	335	SENT_106	[p8l332t3175r398b3200],
224	435	CD	NUMBER	435	dep	335	SENT_106	[p8l488t3173r531b3198],
225	(	NN	O	(	dep	335	SENT_106	[p8l540t3175r604b3200],
226	42	CD	PERCENT	42	dep	335	SENT_106	[p8l540t3175r604b3200],
227	%	NN	PERCENT	%	dep	335	SENT_106	[p8l540t3175r604b3200],
228	)	CD	NUMBER	)	dep	335	SENT_106	[p8l540t3175r604b3200],
229	149	CD	NUMBER	149	dep	335	SENT_106	[p8l666t3176r708b3198],
230	(	NN	O	(	dep	335	SENT_106	[p8l716t3175r780b3200],
231	41	CD	PERCENT	41	dep	335	SENT_106	[p8l716t3175r780b3200],
232	%	NN	PERCENT	%	dep	335	SENT_106	[p8l716t3175r780b3200],
233	)	CD	NUMBER	)	dep	335	SENT_106	[p8l716t3175r780b3200],
234	920	CD	NUMBER	920	dep	335	SENT_106	[p8l867t3176r910b3198],
235	(	NN	O	(	dep	335	SENT_106	[p8l918t3175r982b3200],
236	41	CD	PERCENT	41	dep	335	SENT_106	[p8l918t3175r982b3200],
237	%	NN	PERCENT	%	dep	335	SENT_106	[p8l918t3175r982b3200],
238	)	CD	NUMBER	)	dep	335	SENT_106	[p8l918t3175r982b3200],
239	55	CD	NUMBER	55	dep	335	SENT_106	[p8l1072t3173r1100b3195],
240	(	NN	O	(	dep	335	SENT_106	[p8l1109t3175r1174b3200],
241	39	CD	PERCENT	39	dep	335	SENT_106	[p8l1109t3175r1174b3200],
242	%	NN	PERCENT	%	dep	335	SENT_106	[p8l1109t3175r1174b3200],
243	)	CD	NUMBER	)	dep	335	SENT_106	[p8l1109t3175r1174b3200],
244	75	CD	NUMBER	75	dep	335	SENT_106	[p8l1268t3173r1296b3197],
245	(	NN	O	(	dep	335	SENT_106	[p8l1304t3175r1369b3200],
246	45	CD	PERCENT	45	dep	335	SENT_106	[p8l1304t3175r1369b3200],
247	%	NN	PERCENT	%	dep	335	SENT_106	[p8l1304t3175r1369b3200],
248	)	CD	NUMBER	)	dep	335	SENT_106	[p8l1304t3175r1369b3200],
249	25	CD	NUMBER	25	dep	335	SENT_106	[p8l1444t3176r1470b3198],
250	(	NN	O	(	dep	335	SENT_106	[p8l1479t3175r1541b3200],
251	37	CD	PERCENT	37	dep	335	SENT_106	[p8l1479t3175r1541b3200],
252	%	NN	PERCENT	%	dep	335	SENT_106	[p8l1479t3175r1541b3200],
253	)	CD	NUMBER	)	dep	335	SENT_106	[p8l1479t3175r1541b3200],
254	157	CD	NUMBER	157	dep	335	SENT_106	[p8l1638t3173r1679b3197],
255	(	NN	O	(	dep	335	SENT_106	[p8l1686t3175r1750b3200],
256	41	CD	PERCENT	41	dep	335	SENT_106	[p8l1686t3175r1750b3200],
257	%	NN	PERCENT	%	dep	335	SENT_106	[p8l1686t3175r1750b3200],
258	)	CD	NUMBER	)	dep	335	SENT_106	[p8l1686t3175r1750b3200],
259	A99	NN	O	a99	dep	335	SENT_106	[p8l43t3222r86b3248],
260	(	CD	NUMBER	(	dep	335	SENT_106	[p8l94t3222r166b3248],
261	)	CD	NUMBER	)	dep	335	SENT_106	[p8l94t3222r166b3248],
262	/	:	O	/	dep	335	SENT_106	[p8l94t3222r166b3248],
263	9375	CD	NUMBER	9375	dep	335	SENT_106	[p8l94t3222r166b3248],
264	)	CD	NUMBER	)	dep	335	SENT_106	[p8l94t3222r166b3248],
265	333	CD	NUMBER	333	dep	335	SENT_106	[p8l296t3220r346b3245],
266	(	NN	O	(	dep	335	SENT_106	[p8l354t3220r419b3247],
267	155	CD	NUMBER	155	dep	335	SENT_106	[p8l354t3220r419b3247],
268	)	NN	O	)	dep	335	SENT_106	[p8l354t3220r419b3247],
269	373	CD	NUMBER	373	dep	335	SENT_106	[p8l506t3223r552b3245],
270	(	NN	O	(	dep	335	SENT_106	[p8l560t3220r624b3247],
271	157	CD	NUMBER	157	dep	335	SENT_106	[p8l560t3220r624b3247],
272	)	CD	NUMBER	)	dep	335	SENT_106	[p8l560t3220r624b3247],
273	37-2	CD	NUMBER	37-2	dep	335	SENT_106	[p8l680t3223r726b3245],
274	(	NN	O	(	dep	335	SENT_106	[p8l735t3222r797b3247],
275	173	CD	NUMBER	173	dep	335	SENT_106	[p8l735t3222r797b3247],
276	)	NN	O	)	dep	335	SENT_106	[p8l735t3222r797b3247],
277	373	CD	NUMBER	373	dep	335	SENT_106	[p8l884t3220r931b3245],
278	(	NN	O	(	dep	335	SENT_106	[p8l940t3220r1004b3247],
279	157	CD	NUMBER	157	dep	335	SENT_106	[p8l940t3220r1004b3247],
280	)	NN	O	)	dep	335	SENT_106	[p8l940t3220r1004b3247],
281	393	CD	NUMBER	393	dep	335	SENT_106	[p8l1073t3220r1122b3245],
282	(	NN	O	(	dep	335	SENT_106	[p8l1131t3220r1196b3247],
283	153	CD	NUMBER	153	dep	335	SENT_106	[p8l1131t3220r1196b3247],
284	)	CD	NUMBER	)	dep	335	SENT_106	[p8l1131t3220r1196b3247],
285	39-4	CD	NUMBER	39-4	dep	335	SENT_106	[p8l1268t3223r1319b3245],
286	(	NN	O	(	dep	335	SENT_106	[p8l1326t3222r1388b3247],
287	157	CD	NUMBER	157	dep	335	SENT_106	[p8l1326t3222r1388b3247],
288	)	CD	NUMBER	)	dep	335	SENT_106	[p8l1326t3222r1388b3247],
289	40-9	CD	NUMBER	40-9	dep	335	SENT_106	[p8l1442t3223r1493b3245],
290	(	NN	O	(	dep	335	SENT_106	[p8l1501t3222r1564b3247],
291	13-3	CD	NUMBER	13-3	dep	335	SENT_106	[p8l1501t3222r1564b3247],
292	)	CD	NUMBER	)	dep	335	SENT_106	[p8l1501t3222r1564b3247],
293	39-3	CD	NUMBER	39-3	dep	335	SENT_106	[p8l1650t3220r1700b3245],
294	(	NN	O	(	dep	335	SENT_106	[p8l1709t3222r1771b3247],
295	153	CD	NUMBER	153	dep	335	SENT_106	[p8l1709t3222r1771b3247],
296	)	CD	NUMBER	)	dep	335	SENT_106	[p8l1709t3222r1771b3247],
297	Time	NNP	O	Time	dep	335	SENT_106	[p8l42t3269r99b3289],
298	since	IN	O	since	dep	335	SENT_106	[p8l106t3269r161b3289],
299	asthma	NN	O	asthma	dep	335	SENT_106	[p8l169t3267r251b3289],
300	9	CD	NUMBER	9	dep	335	SENT_106	[p8l338t3270r351b3292],
301	(	NN	O	(	dep	335	SENT_106	[p8l360t3267r429b3294],
302	1-65	CD	NUMBER	1-65	dep	335	SENT_106	[p8l360t3267r429b3294],
303	)	CD	NUMBER	)	dep	335	SENT_106	[p8l360t3267r429b3294],
304	10	CD	NUMBER	10	dep	335	SENT_106	[p8l517t3270r543b3289],
305	(	NN	O	(	dep	335	SENT_106	[p8l551t3269r621b3294],
306	0-70	CD	NUMBER	0-70	dep	335	SENT_106	[p8l551t3269r621b3294],
307	)	CD	NUMBER	)	dep	335	SENT_106	[p8l551t3269r621b3294],
308	9	CD	NUMBER	9	dep	335	SENT_106	[p8l721t3270r733b3292],
309	(	NN	O	(	dep	335	SENT_106	[p8l742t3267r811b3294],
310	1-63	CD	NUMBER	1-63	dep	335	SENT_106	[p8l742t3267r811b3294],
311	)	CD	NUMBER	)	dep	335	SENT_106	[p8l742t3267r811b3294],
312	10	CD	NUMBER	10	dep	335	SENT_106	[p8l899t3270r925b3289],
313	(	NN	O	(	dep	335	SENT_106	[p8l933t3269r1003b3294],
314	0-70	CD	NUMBER	0-70	dep	335	SENT_106	[p8l933t3269r1003b3294],
315	)	CD	NUMBER	)	dep	335	SENT_106	[p8l933t3269r1003b3294],
316	16	CD	NUMBER	16	dep	335	SENT_106	[p8l1102t3267r1128b3289],
317	(	CD	NUMBER	(	dep	335	SENT_106	[p8l1137t3267r1208b3294],
318	1-68	CD	NUMBER	1-68	dep	335	SENT_106	[p8l1137t3267r1208b3294],
319	)	NN	O	)	dep	335	SENT_106	[p8l1137t3267r1208b3294],
320	16	CD	NUMBER	16	dep	335	SENT_106	[p8l1293t3267r1319b3289],
321	(	CD	NUMBER	(	dep	335	SENT_106	[p8l1328t3267r1397b3294],
322	1-63	CD	NUMBER	1-63	dep	335	SENT_106	[p8l1328t3267r1397b3294],
323	)	NN	O	)	dep	335	SENT_106	[p8l1328t3267r1397b3294],
324	22	CD	NUMBER	22	dep	335	SENT_106	[p8l1485t3270r1510b3288],
325	(	CD	NUMBER	(	dep	335	SENT_106	[p8l1519t3267r1589b3294],
326	1-60	CD	NUMBER	1-60	dep	335	SENT_106	[p8l1519t3267r1589b3294],
327	)	NN	O	)	dep	335	SENT_106	[p8l1519t3267r1589b3294],
328	17	CD	NUMBER	17	dep	335	SENT_106	[p8l1677t3270r1702b3291],
329	(	CD	NUMBER	(	dep	335	SENT_106	[p8l1710t3267r1781b3294],
330	1-68	CD	NUMBER	1-68	dep	335	SENT_106	[p8l1710t3267r1781b3294],
331	)	NN	O	)	dep	335	SENT_106	[p8l1710t3267r1781b3294],
332	diagnosis	NN	O	diagnosis	dep	335	SENT_106	[p8l43t3303r148b3331],
333	(	CD	NUMBER	(	dep	335	SENT_106	[p8l156t3304r229b3330],
334	years	NNS	NUMBER	year	dep	335	SENT_106	[p8l156t3304r229b3330],
335	)	IN	O	)	_	0	SENT_106	[p8l156t3304r229b3330],

1	Data	NNS	O	datum	nsubj	3	SENT_107	[p8l32t3374r79b3392],
2	are	VBP	O	be	cop	3	SENT_107	[p8l85t3379r116b3392],
3	number	NN	O	number	_	0	SENT_107	[p8l123t3373r204b3392],
4	(	CD	PERCENT	(	num	5	SENT_107	[p8l210t3374r249b3398],
5	%	NN	PERCENT	%	dep	3	SENT_107	[p8l210t3374r249b3398],
6	)	CD	NUMBER	)	dep	5	SENT_107	[p8l210t3374r249b3398],
7	,	,	O	,	_	0	SENT_107	[p8l210t3374r249b3398],
8	mean	VB	O	mean	ccomp	3	SENT_107	[p8l257t3379r313b3392],
9	(	JJ	O	(	amod	11	SENT_107	[p8l321t3374r369b3398],
10	SD	NN	O	sd	nn	11	SENT_107	[p8l321t3374r369b3398],
11	)	NN	O	)	dobj	8	SENT_107	[p8l321t3374r369b3398],
12	,	,	O	,	_	0	SENT_107	[p8l321t3374r369b3398],
13	or	CC	O	or	dep	17	SENT_107	[p8l376t3379r397b3392],
14	median	JJ	O	median	amod	17	SENT_107	[p8l404t3373r479b3392],
15	(	NN	O	(	nn	17	SENT_107	[p8l487t3374r566b3399],
16	range	NN	O	range	nn	17	SENT_107	[p8l487t3374r566b3399],
17	)	NN	O	)	dep	11	SENT_107	[p8l487t3374r566b3399],
18	,	,	O	,	_	0	SENT_107	[p8l487t3374r566b3399],
19	unless	IN	O	unless	mark	21	SENT_107	[p8l574t3373r636b3392],
20	othen/vise	NN	O	othen/vise	nsubj	21	SENT_107	[p8l642t3373r744b3392],
21	indicated	VBD	O	indicate	dep	11	SENT_107	[p8l751t3373r850b3392],
22	.	.	O	.	_	0	SENT_107	[p8l751t3373r850b3392],

1	Table	NNP	O	Table	_	0	SENT_108	[p8l31t3438r90b3460],
2	1	CD	NUMBER	1	num	1	SENT_108	[p8l97t3441r116b3459],
3	:	:	O	:	_	0	SENT_108	[p8l97t3441r116b3459],
4	Participants	NNS	O	participant	dep	1	SENT_108	[p8l124t3439r270b3466],
5	’	CD	NUMBER	’	num	7	SENT_108	[p8l124t3439r270b3466],
6	demographic	JJ	O	demographic	amod	7	SENT_108	[p8l277t3438r432b3466],
7	details	NNS	O	detail	dep	19	SENT_108	[p8l439t3438r516b3460],
8	at	IN	O	at	_	0	SENT_108	[p8l522t3442r546b3460],
9	study	NN	O	study	nn	10	SENT_108	[p8l552t3438r618b3466],
10	inclusion	NN	O	inclusion	prep_at	7	SENT_108	[p8l625t3438r729b3460],
11	by	IN	O	by	_	0	SENT_108	[p8l737t3438r764b3466],
12	G	NN	O	g	nn	14	SENT_108	[p8l770t3438r879b3466],
13	|	NNS	O	|	nn	14	SENT_108	[p8l770t3438r879b3466],
14	y16Arg	NN	O	y16arg	prep_by	10	SENT_108	[p8l770t3438r879b3466],
15	genotype	NN	O	genotype	dep	19	SENT_108	[p8l886t3442r998b3466],
16	(	CD	NUMBER	(	num	15	SENT_108	[p8l1006t3438r1039b3465],
17	all	DT	O	all	det	19	SENT_108	[p8l1006t3438r1039b3465],
18	randomised	JJ	O	randomised	amod	19	SENT_108	[p8l1048t3438r1187b3460],
19	participants	NNS	O	participant	dep	26	SENT_108	[p8l1193t3439r1335b3466],
20	with	IN	O	with	_	0	SENT_108	[p8l1340t3438r1394b3459],
21	G	NN	O	g	nn	22	SENT_108	[p8l1401t3438r1510b3466],
22	|	NNS	O	|	prep_with	19	SENT_108	[p8l1401t3438r1510b3466],
23	y16Arg	NN	O	y16arg	nn	25	SENT_108	[p8l1401t3438r1510b3466],
24	genotype	NN	O	genotype	nn	25	SENT_108	[p8l1517t3442r1629b3466],
25	data	NNS	O	datum	nsubj	26	SENT_108	[p8l1636t3438r1697b3465],
26	)	VBP	O	)	dep	1	SENT_108	[p8l1636t3438r1697b3465],

1	2120	CD	DATE	2120	num	3	SENT_109	[p8l6t3562r63b3581],
2	www.thelancet.com	NNP	O	www.thelancet.com	nn	3	SENT_109	[p8l1587t3559r1810b3581],
3	Vol	NNP	O	Vol	_	0	SENT_109	[p8l1827t3559r1864b3581],
4	370	CD	NUMBER	370	dep	3	SENT_109	[p8l1872t3562r1915b3584],
5	December	NNP	DATE	December	tmod	4	SENT_109	[p8l1936t3559r2052b3581],
6	22/29	CD	DATE	22/29	num	5	SENT_109	[p8l2059t3560r2134b3584],
7	,	,	DATE	,	_	0	SENT_109	[p8l2059t3560r2134b3584],
8	2007	CD	DATE	2007	num	5	SENT_109	[p8l6t3600r66b3621],

1	Articles	NNPS	O	Articles	_	0	SENT_110	[p9l6t207r156b243],
2	I	PRP	O	I	dep	1	SENT_110	[p9l204t44r251b243],

1	Role	NN	O	role	tmod	8	SENT_111	[p9l13t503r169b572],
2	of	IN	O	of	_	0	SENT_111	[p9l191t502r272b572],
3	the	DT	O	the	det	5	SENT_111	[p9l284t503r410b572],
4	funding	NN	O	funding	nn	5	SENT_111	[p9l431t502r733b593],
5	source	NN	O	source	prep_of	1	SENT_111	[p9l758t526r1000b572],
6	All	DT	O	all	det	7	SENT_111	[p9l7t612r114b679],
7	investigators	NNS	O	investigator	nsubj	8	SENT_111	[p9l162t617r635b702],
8	had	VBD	O	have	_	0	SENT_111	[p9l685t612r824b680],
9	free	JJ	O	free	amod	10	SENT_111	[p9l872t612r1013b680],
10	access	NN	O	access	dobj	8	SENT_111	[p9l1064t636r1292b680],
11	to	TO	O	to	_	0	SENT_111	[p9l1342t626r1411b680],
12	the	DT	O	the	det	15	SENT_111	[p9l1460t612r1576b680],
13	clinical	JJ	O	clinical	amod	15	SENT_111	[p9l1626t612r1891b680],
14	study	NN	O	study	nn	15	SENT_111	[p9l1942t612r2142b702],
15	reports	NNS	O	report	prep_to	10	SENT_111	[p9l9t736r292b812],
16	,	,	O	,	_	0	SENT_111	[p9l9t736r292b812],
17	and	CC	O	and	_	0	SENT_111	[p9l357t723r494b791],
18	they	PRP	O	they	nsubj	19	SENT_111	[p9l553t723r712b812],
19	discussed	VBD	O	discuss	conj_and	8	SENT_111	[p9l772t723r1133b791],
20	the	DT	O	the	det	22	SENT_111	[p9l1192t723r1308b791],
21	study	NN	O	study	nn	22	SENT_111	[p9l1372t723r1571b812],
22	analyses	NNS	O	analysis	dobj	19	SENT_111	[p9l1631t723r1939b812],
23	and	CC	O	and	_	0	SENT_111	[p9l2003t723r2141b791],
24	interpreted	VBD	O	interpret	conj_and	8	SENT_111	[p9l9t831r425b920],
25	the	DT	O	the	det	26	SENT_111	[p9l477t831r593b899],
26	results	NNS	O	result	dobj	24	SENT_111	[p9l648t831r894b900],
27	of	IN	O	of	_	0	SENT_111	[p9l952t831r1035b899],
28	the	DT	O	the	det	30	SENT_111	[p9l1074t831r1191b900],
29	statistical	JJ	O	statistical	amod	30	SENT_111	[p9l1248t831r1593b899],
30	analyses	NNS	O	analysis	prep_of	26	SENT_111	[p9l1648t831r1977b921],
31	.	.	O	.	_	0	SENT_111	[p9l1648t831r1977b921],

1	All	DT	O	all	det	2	SENT_112	[p9l2034t831r2140b898],
2	investigators	NNS	O	investigator	nsubj	10	SENT_112	[p9l9t945r481b1030],
3	reviewed	VBN	O	review	_	0	SENT_112	[p9l532t940r864b1008],
4	drafts	NNS	O	draft	dobj	3	SENT_112	[p9l912t940r1119b1008],
5	of	IN	O	of	_	0	SENT_112	[p9l1171t940r1254b1008],
6	the	DT	O	the	det	7	SENT_112	[p9l1287t940r1404b1008],
7	report	NN	O	report	prep_of	4	SENT_112	[p9l1452t954r1697b1029],
8	,	,	O	,	_	0	SENT_112	[p9l1452t954r1697b1029],
9	and	CC	O	and	_	0	SENT_112	[p9l1749t940r1887b1008],
10	made	VBD	O	make	conj_and	3	SENT_112	[p9l1934t940r2139b1008],
11	editing	NN	O	editing	nn	12	SENT_112	[p9l10t1050r270b1139],
12	suggestions	NNS	O	suggestion	dobj	10	SENT_112	[p9l304t1054r742b1139],
13	and	CC	O	and	_	0	SENT_112	[p9l778t1050r916b1117],
14	ﬁnal	JJ	O	ﬁnal	amod	15	SENT_112	[p9l946t1050r1113b1117],
15	decisions	NNS	O	decision	conj_and	3	SENT_112	[p9l1145t1050r1490b1117],
16	on	IN	O	on	_	0	SENT_112	[p9l1526t1074r1619b1117],
17	all	DT	O	all	det	18	SENT_112	[p9l1652t1050r1737b1117],
18	aspects	NNS	O	aspect	prep_on	15	SENT_112	[p9l1770t1063r2034b1139],
19	of	IN	O	of	_	0	SENT_112	[p9l2070t1050r2153b1117],
20	the	DT	O	the	det	21	SENT_112	[p9l8t1158r123b1226],
21	report	NN	O	report	prep_of	18	SENT_112	[p9l162t1172r407b1247],
22	.	.	O	.	_	0	SENT_112	[p9l162t1172r407b1247],

1	The	DT	O	the	det	2	SENT_113	[p9l447t1158r591b1226],
2	sponsors	NNS	O	sponsor	nsubjpass	7	SENT_113	[p9l632t1183r961b1247],
3	of	IN	O	of	_	0	SENT_113	[p9l1003t1158r1086b1226],
4	the	DT	O	the	det	5	SENT_113	[p9l1109t1158r1226b1227],
5	study	NN	O	study	prep_of	2	SENT_113	[p9l1267t1158r1466b1248],
6	were	VBD	O	be	auxpass	7	SENT_113	[p9l1500t1183r1678b1227],
7	involved	VBN	O	involve	_	0	SENT_113	[p9l1716t1158r2029b1227],
8	in	IN	O	in	_	0	SENT_113	[p9l2066t1163r2140b1225],
9	the	DT	O	the	det	11	SENT_113	[p9l8t1267r123b1335],
10	study	NN	O	study	nn	11	SENT_113	[p9l150t1267r349b1356],
11	designs	NNS	O	design	prep_in	7	SENT_113	[p9l372t1267r674b1357],
12	,	,	O	,	_	0	SENT_113	[p9l372t1267r674b1357],
13	data	NNS	O	datum	nn	14	SENT_113	[p9l701t1267r853b1335],
14	interpretation	NN	O	interpretation	prep_in	7	SENT_113	[p9l876t1272r1412b1356],
15	,	,	O	,	_	0	SENT_113	[p9l876t1272r1412b1356],
16	and	CC	O	and	_	0	SENT_113	[p9l1440t1267r1577b1335],
17	the	DT	O	the	det	18	SENT_113	[p9l1598t1267r1714b1335],
18	decision	NN	O	decision	prep_in	7	SENT_113	[p9l1739t1267r2048b1335],
19	to	TO	O	to	aux	20	SENT_113	[p9l2070t1281r2139b1335],
20	submit	VB	O	submit	xcomp	7	SENT_113	[p9l11t1378r274b1446],
21	the	DT	O	the	det	22	SENT_113	[p9l296t1378r412b1446],
22	report	NN	O	report	dobj	20	SENT_113	[p9l438t1391r665b1467],
23	for	IN	O	for	_	0	SENT_113	[p9l688t1378r795b1446],
24	publication	NN	O	publication	prep_for	22	SENT_113	[p9l817t1378r1240b1467],
25	in	IN	O	in	_	0	SENT_113	[p9l1264t1382r1338b1444],
26	conjunction	NN	O	conjunction	prep_in	20	SENT_113	[p9l1364t1382r1812b1467],
27	with	IN	O	with	_	0	SENT_113	[p9l1834t1378r2000b1446],
28	the	DT	O	the	det	29	SENT_113	[p9l2023t1378r2139b1446],
29	investigators	NNS	O	investigator	prep_with	20	SENT_113	[p9l9t1491r503b1576],
30	.	.	O	.	_	0	SENT_113	[p9l9t1491r503b1576],

1	Employees	NNS	O	employee	nsubj	5	SENT_114	[p9l557t1486r957b1576],
2	of	IN	O	of	_	0	SENT_114	[p9l1008t1486r1090b1555],
3	the	DT	O	the	det	4	SENT_114	[p9l1123t1486r1240b1555],
4	sponsor	NN	O	sponsor	prep_of	1	SENT_114	[p9l1290t1511r1586b1575],
5	obtained	VBN	O	obtain	_	0	SENT_114	[p9l1633t1486r1957b1555],
6	and	CC	O	and	_	0	SENT_114	[p9l2003t1486r2141b1554],
7	managed	VBD	O	manage	conj_and	5	SENT_114	[p9l9t1595r354b1685],
8	the	DT	O	the	det	9	SENT_114	[p9l378t1595r494b1663],
9	data	NNS	O	datum	dobj	7	SENT_114	[p9l522t1595r693b1673],
10	,	,	O	,	_	0	SENT_114	[p9l522t1595r693b1673],
11	and	CC	O	and	_	0	SENT_114	[p9l724t1595r861b1663],
12	did	VBD	O	do	conj_and	5	SENT_114	[p9l887t1595r1004b1663],
13	the	DT	O	the	det	15	SENT_114	[p9l1028t1595r1144b1663],
14	data	NN	O	datum	nn	15	SENT_114	[p9l1171t1595r1324b1663],
15	analysis	NN	O	analysis	dobj	12	SENT_114	[p9l1351t1595r1664b1684],
16	.	.	O	.	_	0	SENT_114	[p9l1351t1595r1664b1684],

1	Results	NNS	O	result	_	0	SENT_115	[p9l14t1803r321b1882],

1	Gly16Arg	NN	O	gly16arg	nn	3	SENT_116	[p9l11t1923r357b2013],
2	genotype	NN	O	genotype	nn	3	SENT_116	[p9l381t1937r717b2013],
3	data	NNS	O	datum	nsubjpass	5	SENT_116	[p9l742t1923r894b1991],
4	were	VBD	O	be	auxpass	5	SENT_116	[p9l915t1948r1093b1991],
5	obtained	VBN	O	obtain	_	0	SENT_116	[p9l1118t1923r1441b1991],
6	from	IN	O	from	_	0	SENT_116	[p9l1463t1923r1647b1991],
7	2225	CD	DATE	2225	prep_from	5	SENT_116	[p9l1673t1928r1843b1991],
8	of	IN	DATE	of	_	0	SENT_116	[p9l1871t1923r1953b1991],
9	2250	CD	DATE	2250	num	11	SENT_116	[p9l1966t1928r2139b1991],
10	randomised	JJ	O	randomised	amod	11	SENT_116	[p9l9t2033r458b2100],
11	individuals	NNS	O	individual	prep_of	7	SENT_116	[p9l497t2033r908b2100],
12	in	IN	O	in	_	0	SENT_116	[p9l951t2037r1026b2099],
13	study	NN	O	study	prep_in	11	SENT_116	[p9l1068t2033r1267b2122],
14	1	CD	NUMBER	1	num	15	SENT_116	[p9l1308t2039r1339b2099],
15	(	NN	O	(	dep	20	SENT_116	[p9l1385t2039r1534b2123],
16	833	CD	NUMBER	833	num	17	SENT_116	[p9l1385t2039r1534b2123],
17	(	NN	O	(	dep	15	SENT_116	[p9l1584t2037r1784b2123],
18	37	CD	PERCENT	37	num	19	SENT_116	[p9l1584t2037r1784b2123],
19	%	NN	PERCENT	%	dep	20	SENT_116	[p9l1584t2037r1784b2123],
20	)	CD	NUMBER	)	dep	28	SENT_116	[p9l1584t2037r1784b2123],
21	Gly/Gly	NNP	O	Gly/Gly	dep	20	SENT_116	[p9l1833t2033r2136b2122],
22	,	,	O	,	_	0	SENT_116	[p9l1833t2033r2136b2122],
23	1029	CD	DATE	1029	number	24	SENT_116	[p9l12t2148r175b2210],
24	(	CD	PERCENT	(	appos	21	SENT_116	[p9l206t2146r408b2231],
25	46	CD	PERCENT	46	num	26	SENT_116	[p9l206t2146r408b2231],
26	%	NN	PERCENT	%	dep	24	SENT_116	[p9l206t2146r408b2231],
27	)	CD	NUMBER	)	num	28	SENT_116	[p9l206t2146r408b2231],
28	Gly/Arg	NN	O	gly/arg	dep	11	SENT_116	[p9l440t2141r760b2231],
29	,	,	O	,	_	0	SENT_116	[p9l440t2141r760b2231],
30	and	CC	O	and	_	0	SENT_116	[p9l789t2141r926b2209],
31	363	CD	PERCENT	363	num	32	SENT_116	[p9l954t2147r1077b2209],
32	(	CD	PERCENT	(	conj_and	11	SENT_116	[p9l1111t2146r1309b2231],
33	16	CD	PERCENT	16	number	34	SENT_116	[p9l1111t2146r1309b2231],
34	%	NN	PERCENT	%	amod	32	SENT_116	[p9l1111t2146r1309b2231],
35	)	CD	NUMBER	)	num	37	SENT_116	[p9l1111t2146r1309b2231],
36	Arg/Arg	NN	O	arg/arg	nn	37	SENT_116	[p9l1338t2147r1652b2231],
37	participants	NNS	O	participant	dep	32	SENT_116	[p9l1675t2146r2136b2230],
38	;	:	O	;	_	0	SENT_116	[p9l1675t2146r2136b2230],
39	further	RB	O	further	advmod	45	SENT_116	[p9l9t2250r274b2318],
40	details	NNS	O	detail	nsubj	45	SENT_116	[p9l331t2250r569b2318],
41	available	JJ	O	available	amod	40	SENT_116	[p9l630t2250r950b2318],
42	from	IN	O	from	_	0	SENT_116	[p9l1009t2250r1193b2318],
43	the	DT	O	the	det	44	SENT_116	[p9l1249t2250r1366b2318],
44	authors	NNS	O	author	prep_from	41	SENT_116	[p9l1425t2250r1755b2340],
45	)	VBP	O	)	parataxis	5	SENT_116	[p9l1425t2250r1755b2340],
46	.	.	O	.	_	0	SENT_116	[p9l1425t2250r1755b2340],

1	In	IN	O	in	_	0	SENT_117	[p9l1821t2257r1899b2317],
2	total	NN	O	total	prep_in	12	SENT_117	[p9l1956t2250r2136b2328],
3	,	,	O	,	_	0	SENT_117	[p9l1956t2250r2136b2328],
4	97	CD	PERCENT	97	num	5	SENT_117	[p9l10t2364r164b2431],
5	%	NN	PERCENT	%	nsubj	12	SENT_117	[p9l10t2364r164b2431],
6	of	IN	O	of	_	0	SENT_117	[p9l205t2360r287b2427],
7	participants	NNS	O	participant	prep_of	5	SENT_117	[p9l313t2364r753b2449],
8	in	IN	O	in	_	0	SENT_117	[p9l794t2364r869b2426],
9	each	DT	O	each	det	11	SENT_117	[p9l908t2360r1076b2427],
10	genotype	NN	O	genotype	nn	11	SENT_117	[p9l1116t2373r1451b2449],
11	group	NN	O	group	prep_in	7	SENT_117	[p9l1492t2384r1710b2449],
12	completed	VBD	O	complete	_	0	SENT_117	[p9l1752t2360r2141b2449],
13	the	DT	O	the	det	14	SENT_117	[p9l8t2468r123b2537],
14	study	NN	O	study	dobj	12	SENT_117	[p9l165t2468r373b2558],
15	.	.	O	.	_	0	SENT_117	[p9l165t2468r373b2558],

1	Five	CD	PERCENT	five	dep	5	SENT_118	[p9l420t2473r566b2536],
2	(	CD	PERCENT	(	dep	1	SENT_118	[p9l611t2473r860b2558],
3	O-6	CD	PERCENT	o-6	num	4	SENT_118	[p9l611t2473r860b2558],
4	%	NN	PERCENT	%	dep	5	SENT_118	[p9l611t2473r860b2558],
5	)	CD	NUMBER	)	dep	14	SENT_118	[p9l611t2473r860b2558],
6	of	IN	O	of	_	0	SENT_118	[p9l905t2468r988b2536],
7	833	CD	NUMBER	833	num	8	SENT_118	[p9l1014t2475r1140b2536],
8	Gly/Gly	NN	O	gly/gly	prep_of	5	SENT_118	[p9l1185t2468r1489b2558],
9	,	,	O	,	_	0	SENT_118	[p9l1185t2468r1489b2558],
10	seven	CD	PERCENT	seven	number	11	SENT_118	[p9l1533t2493r1739b2537],
11	(	CD	PERCENT	(	appos	8	SENT_118	[p9l1783t2473r2025b2558],
12	07	CD	PERCENT	07	num	13	SENT_118	[p9l1783t2473r2025b2558],
13	%	NN	PERCENT	%	dep	11	SENT_118	[p9l1783t2473r2025b2558],
14	)	CD	NUMBER	)	dep	25	SENT_118	[p9l1783t2473r2025b2558],
15	of	IN	O	of	_	0	SENT_118	[p9l2070t2468r2153b2536],
16	1029	CD	DATE	1029	num	17	SENT_118	[p9l12t2583r175b2646],
17	Gly/Arg	NN	O	gly/arg	prep_of	14	SENT_118	[p9l197t2577r517b2667],
18	,	,	O	,	_	0	SENT_118	[p9l197t2577r517b2667],
19	and	CC	O	and	_	0	SENT_118	[p9l540t2577r677b2645],
20	one	CD	NUMBER	one	num	22	SENT_118	[p9l696t2602r830b2645],
21	(	NN	O	(	nn	22	SENT_118	[p9l854t2583r917b2667],
22	o	NN	O	o	prep_of	14	SENT_118	[p9l854t2583r917b2667],
23	-	:	O	-	_	0	SENT_118	[p9l936t2616r947b2628],
24	3	CD	PERCENT	3	num	25	SENT_118	[p9l968t2582r1104b2667],
25	%	NN	PERCENT	%	_	0	SENT_118	[p9l968t2582r1104b2667],
26	)	CD	NUMBER	)	dep	25	SENT_118	[p9l968t2582r1104b2667],
27	of	IN	O	of	_	0	SENT_118	[p9l1129t2577r1212b2645],
28	363	CD	NUMBER	363	num	30	SENT_118	[p9l1222t2583r1345b2645],
29	Arg/Arg	NN	O	arg/arg	nn	30	SENT_118	[p9l1365t2582r1679b2667],
30	participants	NNS	O	participant	prep_of	26	SENT_118	[p9l1698t2582r2137b2666],
31	discontinued	VBN	O	discontinue	partmod	25	SENT_118	[p9l10t2688r498b2756],
32	in	IN	O	in	_	0	SENT_118	[p9l544t2692r618b2754],
33	this	DT	O	this	det	34	SENT_118	[p9l664t2688r800b2756],
34	study	NN	O	study	prep_in	31	SENT_118	[p9l852t2688r1051b2777],
35	because	IN	O	because	_	0	SENT_118	[p9l1095t2688r1390b2756],
36	of	IN	O	of	prepc_because_of	31	SENT_118	[p9l1438t2688r1521b2756],
37	adverse	JJ	O	adverse	amod	38	SENT_118	[p9l1557t2688r1834b2756],
38	events	NNS	O	event	pobj	31	SENT_118	[p9l1882t2701r2136b2756],
39	.	.	O	.	_	0	SENT_118	[p9l1882t2701r2136b2756],

1	Discontinuations	NNS	O	discontinuation	nsubj	17	SENT_119	[p9l13t2802r652b2866],
2	as	IN	O	as	_	0	SENT_119	[p9l720t2822r792b2866],
3	a	DT	O	a	det	4	SENT_119	[p9l859t2822r896b2866],
4	result	NN	O	result	prep_as	1	SENT_119	[p9l960t2797r1173b2866],
5	of	IN	O	of	_	0	SENT_119	[p9l1236t2797r1320b2866],
6	participants	NNS	O	participant	prep_of	4	SENT_119	[p9l1370t2802r1810b2886],
7	lost	VBN	O	lose	partmod	6	SENT_119	[p9l1875t2797r2008b2866],
8	to	TO	O	to	_	0	SENT_119	[p9l2070t2811r2139b2866],
9	follow-up	NN	O	follow-up	prep_to	7	SENT_119	[p9l9t2906r359b2995],
10	or	CC	O	or	_	0	SENT_119	[p9l411t2931r487b2974],
11	non-fulﬁlment	NN	O	non-fulﬁlment	prep_to	7	SENT_119	[p9l535t2906r1088b2974],
12	of	IN	O	of	_	0	SENT_119	[p9l1136t2906r1219b2974],
13	eligibility	NN	O	eligibility	nn	14	SENT_119	[p9l1256t2906r1604b2996],
14	criteria	NNS	O	criterion	prep_of	9	SENT_119	[p9l1652t2911r1914b2974],
15	were	VBD	O	be	cop	17	SENT_119	[p9l1961t2931r2139b2974],
16	similar	JJ	O	similar	amod	17	SENT_119	[p9l11t3016r273b3083],
17	(	NN	O	(	_	0	SENT_119	[p9l328t3020r617b3106],
18	<	JJR	O	<	amod	17	SENT_119	[p9l328t3020r617b3106],
19	1-5	CD	PERCENT	1-5	num	20	SENT_119	[p9l328t3020r617b3106],
20	%	NN	PERCENT	%	dep	18	SENT_119	[p9l328t3020r617b3106],
21	)	CD	NUMBER	)	dep	18	SENT_119	[p9l328t3020r617b3106],
22	in	IN	O	in	dep	21	SENT_119	[p9l672t3020r747b3082],
23	each	DT	O	each	det	25	SENT_119	[p9l798t3016r966b3083],
24	genotype	NN	O	genotype	nn	25	SENT_119	[p9l1016t3029r1351b3105],
25	group	NN	O	group	pobj	22	SENT_119	[p9l1403t3040r1641b3105],
26	.	.	O	.	_	0	SENT_119	[p9l1403t3040r1641b3105],

1	In	IN	O	in	_	0	SENT_120	[p9l1698t3023r1777b3082],
2	study	NN	O	study	prep_in	9	SENT_120	[p9l1829t3016r2029b3105],
3	2	CD	NUMBER	2	num	2	SENT_120	[p9l2079t3022r2136b3094],
4	,	,	O	,	_	0	SENT_120	[p9l2079t3022r2136b3094],
5	Gly16Arg	NN	O	gly16arg	nn	7	SENT_120	[p9l11t3124r357b3214],
6	genotype	NN	O	genotype	nn	7	SENT_120	[p9l392t3138r728b3214],
7	data	NNS	O	datum	nsubjpass	9	SENT_120	[p9l764t3124r916b3192],
8	were	VBD	O	be	auxpass	9	SENT_120	[p9l949t3149r1126b3193],
9	obtained	VBN	O	obtain	_	0	SENT_120	[p9l1162t3124r1486b3193],
10	for	IN	O	for	_	0	SENT_120	[p9l1519t3124r1625b3193],
11	405	CD	NUMBER	405	num	13	SENT_120	[p9l1656t3129r1781b3193],
12	randomised	JJ	O	randomised	amod	13	SENT_120	[p9l1819t3124r2138b3192, p9l9t3233r158b3301],
13	individuals	NNS	O	individual	prep_for	9	SENT_120	[p9l200t3233r633b3311],
14	;	:	O	;	_	0	SENT_120	[p9l200t3233r633b3311],
15	26	CD	PERCENT	26	number	16	SENT_120	[p9l682t3239r764b3301],
16	(	CD	PERCENT	(	dep	13	SENT_120	[p9l814t3238r1012b3323],
17	15	CD	PERCENT	15	num	18	SENT_120	[p9l814t3238r1012b3323],
18	%	NN	PERCENT	%	dep	28	SENT_120	[p9l814t3238r1012b3323],
19	)	CD	NUMBER	)	dep	18	SENT_120	[p9l814t3238r1012b3323],
20	of	IN	O	of	_	0	SENT_120	[p9l1061t3233r1144b3301],
21	169	CD	NUMBER	169	num	22	SENT_120	[p9l1177t3239r1295b3302],
22	Gly/Gly	NN	O	gly/gly	prep_of	19	SENT_120	[p9l1342t3233r1646b3323],
23	,	,	O	,	_	0	SENT_120	[p9l1342t3233r1646b3323],
24	23	CD	PERCENT	23	num	25	SENT_120	[p9l1695t3240r1775b3301],
25	(	CD	PERCENT	(	appos	22	SENT_120	[p9l1827t3238r2020b3323],
26	14	CD	PERCENT	14	num	27	SENT_120	[p9l1827t3238r2020b3323],
27	%	NN	PERCENT	%	dep	28	SENT_120	[p9l1827t3238r2020b3323],
28	)	CD	NUMBER	)	dep	13	SENT_120	[p9l1827t3238r2020b3323],
29	of	IN	O	of	_	0	SENT_120	[p9l2070t3233r2153b3301],
30	169	CD	NUMBER	169	num	31	SENT_120	[p9l12t3349r130b3411],
31	Gly/Arg	NN	O	gly/arg	prep_of	28	SENT_120	[p9l164t3343r485b3432],
32	,	,	O	,	_	0	SENT_120	[p9l164t3343r485b3432],
33	and	CC	O	and	_	0	SENT_120	[p9l519t3343r657b3410],
34	ﬁve	NN	O	ﬁve	nn	35	SENT_120	[p9l685t3343r815b3410],
35	(	NN	O	(	conj_and	13	SENT_120	[p9l852t3347r1007b3433],
36	7	CD	PERCENT	7	number	37	SENT_120	[p9l852t3347r1007b3433],
37	%	NN	PERCENT	%	amod	35	SENT_120	[p9l852t3347r1007b3433],
38	)	CD	NUMBER	)	number	40	SENT_120	[p9l852t3347r1007b3433],
39	of	IN	O	of	quantmod	40	SENT_120	[p9l1044t3343r1126b3410],
40	67	CD	NUMBER	67	tmod	9	SENT_120	[p9l1145t3347r1225b3413],
41	of	IN	O	of	_	0	SENT_120	[p9l1255t3343r1338b3410],
42	Arg/Arg	NN	O	arg/arg	nn	43	SENT_120	[p9l1354t3348r1668b3432],
43	participants	NNS	O	participant	prep_of	40	SENT_120	[p9l1698t3347r2137b3431],
44	discontinued	VBN	O	discontinue	partmod	40	SENT_120	[p9l9t3451r498b3519],
45	mainly	RB	O	mainly	advmod	44	SENT_120	[p9l526t3451r786b3541],
46	because	IN	O	because	mark	49	SENT_120	[p9l812t3451r1108b3520],
47	they	PRP	O	they	nsubj	55	SENT_120	[p9l1138t3451r1296b3541],
48	were	VBD	O	be	auxpass	49	SENT_120	[p9l1322t3476r1500b3520],
49	lost	VBN	O	lose	advcl	44	SENT_120	[p9l1529t3451r1662b3519],
50	to	TO	O	to	_	0	SENT_120	[p9l1688t3465r1757b3519],
51	follow-up	NN	O	follow-up	prep_to	49	SENT_120	[p9l1788t3451r2139b3540],
52	or	CC	O	or	_	0	SENT_120	[p9l10t3585r86b3628],
53	were	VBD	O	be	cop	55	SENT_120	[p9l108t3585r286b3628],
54	not	RB	O	not	neg	55	SENT_120	[p9l313t3574r435b3628],
55	willing	JJ	O	willing	conj_or	49	SENT_120	[p9l457t3560r716b3650],
56	to	TO	O	to	aux	57	SENT_120	[p9l740t3574r809b3628],
57	continue	VB	O	continue	xcomp	55	SENT_120	[p9l837t3565r1165b3628],
58	(	NN	O	(	nn	59	SENT_120	[p9l1197t3560r1373b3650],
59	data	NNS	O	datum	dobj	57	SENT_120	[p9l1197t3560r1373b3650],
60	not	RB	O	not	neg	61	SENT_120	[p9l1398t3574r1521b3628],
61	shown	VBN	O	show	partmod	59	SENT_120	[p9l1547t3560r1837b3650],
62	)	NN	O	)	dep	40	SENT_120	[p9l1547t3560r1837b3650],
63	.	.	O	.	_	0	SENT_120	[p9l1547t3560r1837b3650],

1	Demographic	JJ	O	demographic	amod	2	SENT_121	[p9l83t3670r582b3759],
2	characteristics	NNS	O	characteristic	nsubj	10	SENT_121	[p9l606t3670r1122b3737],
3	of	IN	O	of	_	0	SENT_121	[p9l1150t3670r1231b3737],
4	the	DT	O	the	det	6	SENT_121	[p9l1241t3670r1355b3737],
5	genetic	JJ	O	genetic	amod	6	SENT_121	[p9l1381t3674r1641b3759],
6	subsets	NNS	O	subset	prep_of	2	SENT_121	[p9l1668t3670r1933b3737],
7	from	IN	O	from	_	0	SENT_121	[p9l1959t3670r2140b3737],
8	both	DT	O	both	det	9	SENT_121	[p10l7t16r172b85],
9	studies	NNS	O	study	prep_from	6	SENT_121	[p10l198t16r451b85],
10	(	VBP	O	(	ccomp	44	SENT_121	[p10l483t16r676b106],
11	table	NN	O	table	dobj	10	SENT_121	[p10l483t16r676b106],
12	1	CD	NUMBER	1	num	13	SENT_121	[p10l703t23r754b106],
13	)	NN	O	)	nsubj	15	SENT_121	[p10l703t23r754b106],
14	were	VBD	O	be	cop	15	SENT_121	[p10l781t41r956b85],
15	similar	JJ	O	similar	rcmod	11	SENT_121	[p10l982t16r1239b84],
16	to	TO	O	to	_	0	SENT_121	[p10l1259t30r1326b84],
17	those	DT	O	those	prep_to	15	SENT_121	[p10l1350t16r1545b85],
18	of	IN	O	of	_	0	SENT_121	[p10l1570t16r1652b84],
19	the	DT	O	the	det	22	SENT_121	[p10l1661t16r1775b84],
20	full	JJ	O	full	amod	22	SENT_121	[p10l1800t16r1921b84],
21	study	NN	O	study	nn	22	SENT_121	[p10l1947t16r2142b106],
22	cohorts	NNS	O	cohort	prep_of	17	SENT_121	[p10l9t125r341b203],
23	,	,	O	,	_	0	SENT_121	[p10l9t125r341b203],
24	”	CD	NUMBER	”	number	25	SENT_121	[p10l9t125r341b203],
25	(	CD	NUMBER	(	num	26	SENT_121	[p10l385t125r555b215],
26	data	NNS	O	datum	nsubjpass	44	SENT_121	[p10l385t125r555b215],
27	on	IN	O	on	_	0	SENT_121	[p10l593t150r685b193],
28	ﬁle	NN	O	ﬁle	prep_on	26	SENT_121	[p10l721t125r851b203],
29	,	,	O	,	_	0	SENT_121	[p10l721t125r851b203],
30	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_on	26	SENT_121	[p10l889t130r1367b203],
31	,	,	O	,	_	0	SENT_121	[p10l889t130r1367b203],
32	Lund	NNP	PERSON	Lund	prep_on	26	SENT_121	[p10l1411t125r1614b203],
33	,	,	O	,	_	0	SENT_121	[p10l1411t125r1614b203],
34	Sweden	NNP	LOCATION	Sweden	nn	35	SENT_121	[p10l1660t125r1963b215],
35	)	NNP	O	)	conj_and	28	SENT_121	[p10l1660t125r1963b215],
36	and	CC	O	and	_	0	SENT_121	[p10l2006t125r2141b193],
37	participants	NNS	O	participant	conj_and	28	SENT_121	[p10l8t239r436b324],
38	with	IN	O	with	_	0	SENT_121	[p10l485t235r647b302],
39	Gly16Arg	NN	O	gly16arg	nn	41	SENT_121	[p10l697t235r1036b324],
40	genotype	NN	O	genotype	nn	41	SENT_121	[p10l1085t248r1413b324],
41	data	NNS	O	datum	prep_with	37	SENT_121	[p10l1463t235r1612b302],
42	were	VBD	O	be	auxpass	44	SENT_121	[p10l1658t259r1833b302],
43	equally	RB	O	equally	advmod	44	SENT_121	[p10l1883t235r2142b324],
44	distributed	VBN	O	distribute	_	0	SENT_121	[p10l9t343r407b411],
45	across	IN	O	across	_	0	SENT_121	[p10l469t368r691b412],
46	treatment	NN	O	treatment	nn	47	SENT_121	[p10l754t357r1114b411],
47	groups	NNS	O	group	prep_across	44	SENT_121	[p10l1175t368r1445b433],
48	.	.	O	.	_	0	SENT_121	[p10l1175t368r1445b433],

1	Baseline	NN	O	baseline	nn	2	SENT_122	[p10l1514t343r1818b412],
2	characteristics	NNS	O	characteristic	nsubj	26	SENT_122	[p10l1882t343r2138b411, p10l8t457r308b530],
3	,	,	O	,	_	0	SENT_122	[p10l1882t343r2138b411, p10l8t457r308b530],
4	inhaled	VBN	O	inhale	partmod	2	SENT_122	[p10l337t452r611b520],
5	corticosteroid	NN	O	corticosteroid	nn	6	SENT_122	[p10l636t452r1131b520],
6	use	NN	O	use	dobj	4	SENT_122	[p10l1154t476r1279b520],
7	at	IN	O	at	_	0	SENT_122	[p10l1306t466r1370b520],
8	study	NN	O	study	nn	9	SENT_122	[p10l1396t452r1592b541],
9	entry	NN	O	entry	prep_at	4	SENT_122	[p10l1616t466r1812b542],
10	,	,	O	,	_	0	SENT_122	[p10l1616t466r1812b542],
11	baseline	NN	O	baseline	nn	13	SENT_122	[p10l1839t452r2139b520],
12	lung	NN	O	lung	nn	13	SENT_122	[p10l7t562r175b651],
13	function	NN	O	function	prep_at	4	SENT_122	[p10l206t562r534b640],
14	,	,	O	,	_	0	SENT_122	[p10l206t562r534b640],
15	use	NN	O	use	prep_at	4	SENT_122	[p10l567t586r692b629],
16	of	IN	O	of	_	0	SENT_122	[p10l725t562r807b629],
17	reliever	NN	O	reliever	nn	18	SENT_122	[p10l825t562r1096b629],
18	medication	NN	O	medication	prep_of	15	SENT_122	[p10l1126t562r1554b640],
19	,	,	O	,	_	0	SENT_122	[p10l1126t562r1554b640],
20	and	CC	O	and	_	0	SENT_122	[p10l1589t562r1725b629],
21	night-time	JJ	O	night-time	amod	22	SENT_122	[p10l1754t562r2139b651],
22	awakenings	NNS	O	awakening	conj_and	9	SENT_122	[p10l10t670r438b760],
23	during	IN	O	during	_	0	SENT_122	[p10l505t670r750b760],
24	run-in	NN	O	run-in	prep_during	4	SENT_122	[p10l812t675r1043b739],
25	were	VBD	O	be	cop	26	SENT_122	[p10l1103t695r1278b739],
26	similar	JJ	O	similar	_	0	SENT_122	[p10l1344t670r1599b739],
27	between	IN	O	between	_	0	SENT_122	[p10l1658t670r1964b739],
28	the	DT	O	the	det	31	SENT_122	[p10l2025t670r2139b738],
29	Gly16Arg	NN	O	gly16arg	nn	31	SENT_122	[p10l11t779r350b869],
30	genotype	NN	O	genotype	nn	31	SENT_122	[p10l373t793r701b869],
31	groups	NNS	O	group	prep_between	26	SENT_122	[p10l725t803r974b869],
32	within	IN	O	within	_	0	SENT_122	[p10l998t779r1235b847],
33	each	DT	O	each	det	35	SENT_122	[p10l1259t779r1423b847],
34	independent	JJ	O	independent	amod	35	SENT_122	[p10l1445t779r1909b868],
35	study	NN	O	study	prep_within	26	SENT_122	[p10l1933t779r2136b869],
36	.	.	O	.	_	0	SENT_122	[p10l1933t779r2136b869],

1	Most	JJS	O	most	amod	2	SENT_123	[p10l9t1001r137b1045],
2	participants	NNS	O	participant	nsubj	7	SENT_123	[p10l169t999r472b1059],
3	in	IN	O	in	_	0	SENT_123	[p10l507t999r559b1044],
4	both	DT	O	both	det	5	SENT_123	[p10l592t996r709b1045],
5	studies	NNS	O	study	prep_in	2	SENT_123	[p10l744t996r923b1045],
6	were	VBD	O	be	cop	7	SENT_123	[p10l957t1014r1080b1045],
7	white	JJ	O	white	_	0	SENT_123	[p10l1113t996r1269b1052],
8	,	,	O	,	_	0	SENT_123	[p10l1113t996r1269b1052],
9	and	CC	O	and	_	0	SENT_123	[p10l1306t996r1401b1045],
10	the	DT	O	the	det	11	SENT_123	[p10l1433t996r1514b1045],
11	frequency	NN	O	frequency	nsubj	18	SENT_123	[p10l7t1073r265b1136],
12	of	IN	O	of	_	0	SENT_123	[p10l282t1073r339b1121],
13	each	DT	O	each	det	16	SENT_123	[p10l348t1073r465b1121],
14	genotype	NN	O	genotype	nn	16	SENT_123	[p10l483t1083r715b1136],
15	group	NN	O	group	nn	16	SENT_123	[p10l734t1090r885b1136],
16	di1	NN	O	di1	prep_of	11	SENT_123	[p10l904t1073r1105b1121],
17	°	CD	NUMBER	°	dep	16	SENT_123	[p10l904t1073r1105b1121],
18	fered	VBD	O	fer	conj_and	7	SENT_123	[p10l904t1073r1105b1121],
19	between	IN	O	between	_	0	SENT_123	[p10l1121t1073r1337b1121],
20	ethnic	JJ	O	ethnic	amod	21	SENT_123	[p10l1355t1073r1515b1121],
21	groups	NNS	O	group	prep_between	18	SENT_123	[p10l8t1167r199b1213],
22	,	,	O	,	_	0	SENT_123	[p10l8t1167r199b1213],
23	as	IN	O	as	mark	24	SENT_123	[p10l239t1167r289b1197],
24	expected	VBN	O	expect	advcl	18	SENT_123	[p10l328t1150r562b1212],
25	.	.	O	.	_	0	SENT_123	[p10l328t1150r562b1212],

1	The	DT	O	the	det	4	SENT_124	[p10l600t1150r700b1197],
2	mean	NN	O	mean	nn	4	SENT_124	[p10l737t1167r884b1197],
3	FEV1	NN	O	fev1	nn	4	SENT_124	[p10l923t1153r1044b1209],
4	reversibility	NN	O	reversibility	nsubj	7	SENT_124	[p10l1080t1150r1383b1212],
5	was	VBD	O	be	cop	7	SENT_124	[p10l1416t1167r1513b1197],
6	consistently	RB	O	consistently	advmod	7	SENT_124	[p10l8t1225r314b1288],
7	lower	JJR	O	lower	_	0	SENT_124	[p10l340t1225r484b1273],
8	in	IN	O	in	_	0	SENT_124	[p10l510t1228r562b1272],
9	study	NN	O	study	prep_in	7	SENT_124	[p10l592t1225r729b1288],
10	2	CD	NUMBER	2	npadvmod	11	SENT_124	[p10l758t1230r783b1272],
11	than	IN	O	than	advmod	7	SENT_124	[p10l812t1225r929b1273],
12	in	IN	O	in	_	0	SENT_124	[p10l957t1228r1009b1272],
13	study	NN	O	study	prep_in	7	SENT_124	[p10l1038t1225r1176b1288],
14	1	CD	NUMBER	1	num	13	SENT_124	[p10l1204t1230r1238b1280],
15	,	,	O	,	_	0	SENT_124	[p10l1204t1230r1238b1280],
16	across	IN	O	across	_	0	SENT_124	[p10l1269t1242r1426b1273],
17	all	DT	O	all	det	22	SENT_124	[p10l1456t1225r1515b1273],
18	genotypes	NNS	O	genotype	dep	22	SENT_124	[p10l8t1311r264b1364],
19	(	RB	O	(	dep	18	SENT_124	[p10l287t1301r424b1364],
20	table	NN	O	table	nn	22	SENT_124	[p10l287t1301r424b1364],
21	2	CD	NUMBER	2	num	22	SENT_124	[p10l443t1306r501b1364],
22	)	NN	O	)	prep_across	7	SENT_124	[p10l443t1306r501b1364],
23	.	.	O	.	_	0	SENT_124	[p10l443t1306r501b1364],

1	The	DT	O	the	det	2	SENT_125	[p10l56t1378r157b1426],
2	proportion	NN	O	proportion	nsubjpass	13	SENT_125	[p10l173t1381r455b1441],
3	of	IN	O	of	_	0	SENT_125	[p10l472t1378r530b1426],
4	participants	NNS	O	participant	prep_of	2	SENT_125	[p10l537t1381r845b1441],
5	who	WP	O	who	nsubj	6	SENT_125	[p10l862t1378r972b1426],
6	had	VBD	O	have	rcmod	4	SENT_125	[p10l988t1378r1086b1426],
7	a	DT	O	a	det	10	SENT_125	[p10l1102t1395r1128b1426],
8	severe	JJ	O	severe	amod	10	SENT_125	[p10l1146t1395r1306b1426],
9	asthma	NN	O	asthma	nn	10	SENT_125	[p10l1323t1378r1515b1426],
10	exacerbation	NN	O	exacerbation	dobj	6	SENT_125	[p10l8t1454r337b1502],
11	was	VBD	O	be	auxpass	13	SENT_125	[p10l383t1471r481b1502],
12	not	RB	O	not	neg	13	SENT_125	[p10l531t1464r617b1502],
13	associated	VBN	O	associate	_	0	SENT_125	[p10l665t1454r931b1502],
14	with	IN	O	with	_	0	SENT_125	[p10l977t1454r1093b1502],
15	the	DT	O	the	det	17	SENT_125	[p10l1140t1454r1222b1502],
16	Gly16Arg	NN	O	gly16arg	nn	17	SENT_125	[p10l1272t1454r1515b1517],
17	genotype	NN	O	genotype	prep_with	13	SENT_125	[p10l8t1540r243b1593],
18	(	CD	NUMBER	(	num	19	SENT_125	[p10l271t1530r410b1593],
19	table	NN	O	table	tmod	13	SENT_125	[p10l271t1530r410b1593],
20	3	CD	NUMBER	3	num	21	SENT_125	[p10l436t1535r495b1593],
21	)	NN	O	)	dep	19	SENT_125	[p10l436t1535r495b1593],
22	.	.	O	.	_	0	SENT_125	[p10l436t1535r495b1593],

1	In	IN	O	in	_	0	SENT_126	[p10l523t1535r578b1577],
2	study	NN	O	study	prep_in	15	SENT_126	[p10l603t1530r743b1593],
3	1	CD	NUMBER	1	num	2	SENT_126	[p10l766t1535r788b1577],
4	the	DT	O	the	det	5	SENT_126	[p10l809t1530r891b1578],
5	percentage	NN	O	percentage	nsubj	15	SENT_126	[p10l914t1540r1199b1593],
6	of	IN	O	of	_	0	SENT_126	[p10l1223t1530r1282b1578],
7	Arg/Arg	NN	O	arg/arg	nn	8	SENT_126	[p10l1294t1534r1515b1593],
8	individuals	NNS	O	individual	prep_of	5	SENT_126	[p10l7t1607r296b1654],
9	with	IN	O	with	_	0	SENT_126	[p10l312t1607r429b1654],
10	one	CD	NUMBER	one	num	13	SENT_126	[p10l445t1624r539b1654],
11	or	CC	O	or	_	0	SENT_126	[p10l556t1624r610b1654],
12	more	JJR	O	more	conj_or	10	SENT_126	[p10l625t1624r763b1654],
13	exacerbations	NNS	O	exacerbation	prep_with	8	SENT_126	[p10l780t1607r1134b1654],
14	was	VBD	O	be	cop	15	SENT_126	[p10l1150t1624r1248b1654],
15	similar	JJ	O	similar	_	0	SENT_126	[p10l1267t1607r1451b1654],
16	to	TO	O	to	_	0	SENT_126	[p10l1466t1616r1514b1654],
17	that	DT	O	that	prep_to	15	SENT_126	[p10l6t1682r108b1730],
18	of	IN	O	of	_	0	SENT_126	[p10l168t1682r227b1730],
19	other	JJ	O	other	amod	21	SENT_126	[p10l279t1682r416b1730],
20	genotype	NN	O	genotype	nn	21	SENT_126	[p10l477t1692r712b1745],
21	groups	NNS	O	group	prep_of	17	SENT_126	[p10l774t1699r968b1745],
22	.	.	O	.	_	0	SENT_126	[p10l774t1699r968b1745],

1	The	DT	O	the	det	2	SENT_127	[p10l1030t1682r1131b1730],
2	number	NN	O	number	nsubj	15	SENT_127	[p10l1192t1682r1405b1730],
3	of	IN	O	of	_	0	SENT_127	[p10l1465t1682r1524b1730],
4	exacerbations	NNS	O	exacerbation	prep_of	2	SENT_127	[p10l8t1758r362b1806],
5	that	WDT	O	that	nsubj	6	SENT_127	[p10l425t1758r527b1806],
6	led	VBD	O	lead	rcmod	4	SENT_127	[p10l588t1758r667b1806],
7	to	TO	O	to	_	0	SENT_127	[p10l728t1768r777b1806],
8	hospital	NN	O	hospital	nn	12	SENT_127	[p10l839t1758r1048b1820],
9	or	CC	O	or	_	0	SENT_127	[p10l1111t1775r1165b1806],
10	emergency	NN	O	emergency	nn	12	SENT_127	[p10l1228t1775r1516b1821],
11	department	NN	O	department	nn	12	SENT_127	[p10l8t1835r314b1897],
12	treatment	NN	O	treatment	prep_to	6	SENT_127	[p10l342t1844r601b1882],
13	did	VBD	O	do	aux	15	SENT_127	[p10l631t1835r714b1882],
14	not	RB	O	not	neg	15	SENT_127	[p10l743t1844r829b1882],
15	differ	VB	O	differ	_	0	SENT_127	[p10l859t1835r1001b1882],
16	between	IN	O	between	_	0	SENT_127	[p10l1029t1835r1248b1882],
17	genotype	NN	O	genotype	nn	18	SENT_127	[p10l1279t1844r1514b1898],
18	groups	NNS	O	group	prep_between	15	SENT_127	[p10l8t1927r187b1973],
19	(	RB	O	(	advmod	20	SENT_127	[p10l241t1910r380b1973],
20	table	NN	O	table	rcmod	18	SENT_127	[p10l241t1910r380b1973],
21	3	CD	NUMBER	3	num	22	SENT_127	[p10l431t1915r490b1973],
22	)	NN	O	)	dep	20	SENT_127	[p10l431t1915r490b1973],
23	.	.	O	.	_	0	SENT_127	[p10l431t1915r490b1973],

1	The	DT	O	the	det	2	SENT_128	[p10l539t1910r640b1958],
2	rate	NN	O	rate	_	0	SENT_128	[p10l689t1920r786b1958],
3	of	IN	O	of	_	0	SENT_128	[p10l835t1910r894b1958],
4	severe	JJ	O	severe	amod	5	SENT_128	[p10l934t1927r1095b1958],
5	exacerbations	NNS	O	exacerbation	prep_of	2	SENT_128	[p10l1144t1910r1513b1965],
6	,	,	O	,	_	0	SENT_128	[p10l1144t1910r1513b1965],
7	displayed	VBD	O	display	partmod	5	SENT_128	[p10l8t1987r253b2050],
8	as	IN	O	as	_	0	SENT_128	[p10l275t2004r326b2035],
9	exacerbations	NNS	O	exacerbation	prep_as	7	SENT_128	[p10l350t1987r704b2035],
10	per	IN	O	per	_	0	SENT_128	[p10l727t2005r813b2050],
11	participant	NN	O	participant	prep_per	9	SENT_128	[p10l833t1990r1118b2050],
12	per	IN	O	per	_	0	SENT_128	[p10l1139t2005r1224b2050],
13	6	CD	DURATION	6	num	14	SENT_128	[p10l1246t1991r1274b2035],
14	months	NNS	NUMBER	month	prep_per	11	SENT_128	[p10l1296t1987r1513b2043],
15	,	,	O	,	_	0	SENT_128	[p10l1296t1987r1513b2043],

1	in	IN	O	in	_	0	SENT_129	[p10l7t2088r60b2132],
2	study	NN	O	study	prep_in	6	SENT_129	[p10l80t2085r221b2147],
3	1	CD	NUMBER	1	num	2	SENT_129	[p10l240t2089r262b2131],
4	was	VBD	O	be	cop	6	SENT_129	[p10l280t2102r377b2132],
5	numerically	RB	O	numerically	advmod	6	SENT_129	[p10l398t2085r714b2147],
6	lower	JJR	O	lower	_	0	SENT_129	[p10l731t2085r876b2132],
7	in	IN	O	in	_	0	SENT_129	[p10l895t2088r947b2131],
8	Arg/Arg	NN	O	arg/arg	nn	9	SENT_129	[p10l965t2088r1186b2148],
9	participants	NNS	O	participant	prep_in	6	SENT_129	[p10l1205t2088r1513b2147],
10	than	IN	O	than	prep	6	SENT_129	[p10l6t2160r125b2208],
11	in	IN	O	in	pcomp	10	SENT_129	[p10l156t2163r208b2207],
12	Gly/Gly	NN	O	gly/gly	pobj	11	SENT_129	[p10l241t2160r447b2223],
13	participants	NNS	O	participant	nsubj	6	SENT_129	[p10l476t2163r800b2222],
14	,	,	O	,	_	0	SENT_129	[p10l476t2163r800b2222],
15	a	DT	O	a	det	16	SENT_129	[p10l834t2177r860b2208],
16	trend	NN	O	trend	appos	13	SENT_129	[p10l890t2160r1031b2208],
17	that	WDT	O	that	nsubj	19	SENT_129	[p10l1060t2160r1162b2208],
18	was	VBD	O	be	cop	19	SENT_129	[p10l1190t2177r1287b2208],
19	present	JJ	DATE	present	rcmod	16	SENT_129	[p10l1320t2170r1516b2222],
20	across	IN	O	across	_	0	SENT_129	[p10l8t2253r168b2284],
21	all	DT	O	all	det	22	SENT_129	[p10l211t2236r270b2284],
22	treatment	NN	O	treatment	prep_across	19	SENT_129	[p10l310t2246r569b2284],
23	groups	NNS	O	group	nsubj	24	SENT_129	[p10l609t2253r788b2299],
24	(	VBP	O	(	rcmod	22	SENT_129	[p10l835t2236r958b2299],
25	data	NNS	O	datum	nsubj	26	SENT_129	[p10l835t2236r958b2299],
26	available	JJ	O	available	xcomp	24	SENT_129	[p10l999t2236r1223b2284],
27	from	IN	O	from	_	0	SENT_129	[p10l1264t2236r1393b2284],
28	the	DT	O	the	det	30	SENT_129	[p10l1433t2236r1515b2284],
29	corresponding	JJ	O	corresponding	amod	30	SENT_129	[p10l8t2313r389b2376],
30	author	NN	O	author	poss	33	SENT_129	[p10l426t2313r638b2360],
31	’s	POS	O	’s	_	0	SENT_129	[p10l426t2313r638b2360],
32	website	NN	O	website	nn	33	SENT_129	[p10l674t2313r904b2376],
33	)	NN	O	)	prep_from	26	SENT_129	[p10l674t2313r904b2376],
34	.	.	O	.	_	0	SENT_129	[p10l674t2313r904b2376],

1	A	DT	O	a	det	3	SENT_130	[p10l943t2316r985b2360],
2	similar	JJ	O	similar	amod	3	SENT_130	[p10l1022t2313r1206b2360],
3	trend	NN	O	trend	nsubjpass	5	SENT_130	[p10l1241t2313r1382b2360],
4	was	VBD	O	be	auxpass	5	SENT_130	[p10l1416t2330r1513b2360],
5	seen	VBN	O	see	_	0	SENT_130	[p10l9t2406r126b2437],
6	in	IN	O	in	_	0	SENT_130	[p10l141t2392r194b2436],
7	the	DT	O	the	det	8	SENT_130	[p10l208t2389r290b2437],
8	rate	NN	O	rate	prep_in	5	SENT_130	[p10l306t2398r404b2437],
9	of	IN	O	of	_	0	SENT_130	[p10l421t2389r479b2437],
10	severe	JJ	O	severe	amod	11	SENT_130	[p10l487t2406r648b2437],
11	exacerbations	NNS	O	exacerbation	prep_of	8	SENT_130	[p10l664t2389r1018b2437],
12	that	WDT	O	that	nsubj	13	SENT_130	[p10l1035t2389r1137b2437],
13	led	VBD	O	lead	rcmod	8	SENT_130	[p10l1150t2389r1229b2437],
14	to	TO	O	to	_	0	SENT_130	[p10l1243t2398r1291b2437],
15	hospital	NN	O	hospital	nn	19	SENT_130	[p10l1307t2389r1516b2451],
16	or	CC	O	or	_	0	SENT_130	[p10l8t2484r62b2515],
17	emergency	NN	O	emergency	nn	19	SENT_130	[p10l92t2484r381b2530],
18	department	NN	O	department	nn	19	SENT_130	[p10l411t2466r718b2529],
19	treatment	NN	O	treatment	prep_to	13	SENT_130	[p10l747t2476r1017b2515],
20	.	.	O	.	_	0	SENT_130	[p10l747t2476r1017b2515],

1	Notably	RB	O	notably	advmod	7	SENT_131	[p10l1053t2466r1259b2530],
2	,	,	O	,	_	0	SENT_131	[p10l1053t2466r1259b2530],
3	multiple	JJ	O	multiple	amod	4	SENT_131	[p10l1293t2466r1515b2529],
4	exacerbations	NNS	O	exacerbation	nsubj	7	SENT_131	[p10l8t2544r362b2591],
5	were	VBD	O	be	cop	7	SENT_131	[p10l382t2561r507b2591],
6	not	RB	O	not	neg	7	SENT_131	[p10l527t2553r613b2591],
7	prevalent	JJ	O	prevalent	_	0	SENT_131	[p10l632t2544r875b2606],
8	in	IN	O	in	_	0	SENT_131	[p10l894t2547r946b2591],
9	Arg/Arg	NN	O	arg/arg	nn	10	SENT_131	[p10l965t2547r1186b2607],
10	participants	NNS	O	participant	prep_in	7	SENT_131	[p10l1205t2547r1513b2606],
11	in	IN	O	in	_	0	SENT_131	[p10l7t2622r60b2666],
12	this	DT	O	this	det	13	SENT_131	[p10l97t2619r193b2667],
13	study	NN	O	study	prep_in	10	SENT_131	[p10l236t2619r376b2682],
14	(	CD	NUMBER	(	num	15	SENT_131	[p10l418t2619r541b2682],
15	data	NNS	O	datum	npadvmod	16	SENT_131	[p10l418t2619r541b2682],
16	available	JJ	O	available	amod	13	SENT_131	[p10l581t2619r805b2667],
17	from	IN	O	from	_	0	SENT_131	[p10l844t2619r974b2667],
18	the	DT	O	the	det	20	SENT_131	[p10l1012t2619r1094b2667],
19	corresponding	JJ	O	corresponding	amod	20	SENT_131	[p10l1134t2619r1515b2682],
20	author	NN	O	author	poss	23	SENT_131	[p10l8t2695r219b2743],
21	’s	POS	O	’s	_	0	SENT_131	[p10l8t2695r219b2743],
22	website	NN	O	website	nn	23	SENT_131	[p10l245t2695r475b2758],
23	)	NN	O	)	prep_from	7	SENT_131	[p10l245t2695r475b2758],
24	.	.	O	.	_	0	SENT_131	[p10l245t2695r475b2758],

1	Additionally	RB	O	additionally	advmod	4	SENT_132	[p10l502t2695r830b2758],
2	,	,	O	,	_	0	SENT_132	[p10l502t2695r830b2758],
3	there	EX	O	there	expl	4	SENT_132	[p10l857t2695r991b2743],
4	was	VBD	O	be	_	0	SENT_132	[p10l1016t2712r1113b2743],
5	no	DT	O	no	det	6	SENT_132	[p10l1140t2712r1206b2743],
6	correlation	NN	O	correlation	nsubj	4	SENT_132	[p10l1233t2695r1516b2743],
7	between	IN	O	between	_	0	SENT_132	[p10l6t2772r225b2819],
8	severe	JJ	O	severe	amod	10	SENT_132	[p10l274t2789r435b2819],
9	asthma	NN	O	asthma	nn	10	SENT_132	[p10l484t2772r675b2819],
10	exacerbations	NNS	O	exacerbation	prep_between	6	SENT_132	[p10l724t2772r1077b2819],
11	and	CC	O	and	_	0	SENT_132	[p10l1127t2772r1224b2819],
12	Gly16Arg	NN	O	gly16arg	nn	13	SENT_132	[p10l1272t2772r1515b2835],
13	genotype	NN	O	genotype	conj_and	10	SENT_132	[p10l8t2857r243b2910],
14	after	IN	O	after	mark	26	SENT_132	[p10l266t2847r384b2895],
15	subgroup	NN	O	subgroup	nn	16	SENT_132	[p10l406t2847r655b2910],
16	analyses	NNS	O	analysis	nsubj	26	SENT_132	[p10l678t2847r894b2910],
17	in	IN	O	in	_	0	SENT_132	[p10l917t2850r970b2894],
18	the	DT	O	the	det	25	SENT_132	[p10l990t2847r1072b2895],
19	white	JJ	O	white	amod	25	SENT_132	[p10l1093t2847r1251b2902],
20	,	,	O	,	_	0	SENT_132	[p10l1093t2847r1251b2902],
21	Asian	JJ	MISC	asian	amod	25	SENT_132	[p10l1274t2850r1438b2902],
22	,	,	O	,	_	0	SENT_132	[p10l1274t2850r1438b2902],
23	or	CC	O	or	_	0	SENT_132	[p10l1463t2864r1516b2895],
24	black	JJ	O	black	amod	25	SENT_132	[p10l6t2923r144b2971],
25	populations	NNS	O	population	prep_in	16	SENT_132	[p10l162t2923r471b2985],
26	(	VBP	O	(	advcl	4	SENT_132	[p10l496t2923r619b2986],
27	data	NNS	O	datum	nsubj	28	SENT_132	[p10l496t2923r619b2986],
28	available	JJ	O	available	xcomp	26	SENT_132	[p10l639t2923r863b2971],
29	from	IN	O	from	_	0	SENT_132	[p10l884t2923r1013b2971],
30	the	DT	O	the	det	32	SENT_132	[p10l1032t2923r1114b2971],
31	corresponding	JJ	O	corresponding	amod	32	SENT_132	[p10l1134t2923r1516b2986],
32	author	NN	O	author	poss	35	SENT_132	[p10l8t3000r219b3047],
33	’s	POS	O	’s	_	0	SENT_132	[p10l8t3000r219b3047],
34	website	NN	O	website	nn	35	SENT_132	[p10l237t3000r467b3063],
35	)	NN	O	)	prep_from	28	SENT_132	[p10l237t3000r467b3063],
36	.	.	O	.	_	0	SENT_132	[p10l237t3000r467b3063],

1	In	IN	O	in	_	0	SENT_133	[p10l60t3080r116b3122],
2	study	NN	O	study	prep_in	6	SENT_133	[p10l165t3075r309b3138],
3	1	CD	NUMBER	1	num	2	SENT_133	[p10l356t3080r392b3130],
4	,	,	O	,	_	0	SENT_133	[p10l356t3080r392b3130],
5	there	EX	O	there	expl	6	SENT_133	[p10l441t3075r579b3123],
6	was	VBD	O	be	_	0	SENT_133	[p10l625t3092r725b3123],
7	no	DT	O	no	det	9	SENT_133	[p10l774t3092r840b3123],
8	signiﬁcant	JJ	O	signiﬁcant	amod	9	SENT_133	[p10l890t3075r1174b3138],
9	interaction	NN	O	interaction	nsubj	6	SENT_133	[p10l1220t3078r1515b3123],
10	between	IN	O	between	_	0	SENT_133	[p10l6t3152r231b3200],
11	treatment	NN	O	treatment	prep_between	9	SENT_133	[p10l247t3162r514b3200],
12	and	CC	O	and	_	0	SENT_133	[p10l530t3152r628b3200],
13	genotype	NN	O	genotype	conj_and	11	SENT_133	[p10l645t3162r888b3215],
14	and	CC	O	and	_	0	SENT_133	[p10l905t3152r1004b3200],
15	time	NN	O	time	conj_and	11	SENT_133	[p10l1019t3155r1141b3200],
16	to	TO	O	to	aux	17	SENT_133	[p10l1157t3162r1207b3200],
17	ﬁrst	VB	O	ﬁrst	infmod	9	SENT_133	[p10l1224t3152r1331b3200],
18	severe	JJ	O	severe	amod	21	SENT_133	[p10l1349t3169r1514b3200],
19	exacerbation	NN	O	exacerbation	nn	21	SENT_133	[p10l8t3229r348b3276],
20	(	NN	O	(	nn	21	SENT_133	[p10l369t3233r485b3292],
21	p	NN	O	p	dobj	17	SENT_133	[p10l369t3233r485b3292],
22	=	JJ	O	=	amod	23	SENT_133	[p10l369t3233r485b3292],
23	o	NN	O	o	dep	21	SENT_133	[p10l369t3233r485b3292],
24	-	:	O	-	_	0	SENT_133	[p10l499t3256r506b3264],
25	88	CD	DATE	88	num	26	SENT_133	[p10l520t3233r616b3292],
26	)	NN	O	)	dep	21	SENT_133	[p10l520t3233r616b3292],
27	.	.	O	.	_	0	SENT_133	[p10l520t3233r616b3292],

1	Combination	NN	O	combination	nsubj	14	SENT_134	[p10l637t3229r993b3276],
2	of	IN	O	of	_	0	SENT_134	[p10l1011t3229r1070b3276],
3	all	DT	O	all	det	4	SENT_134	[p10l1079t3229r1140b3276],
4	three	CD	NUMBER	three	prep_of	1	SENT_134	[p10l1156t3229r1295b3276],
5	inhaled	VBN	O	inhale	partmod	1	SENT_134	[p10l1313t3229r1516b3276],
6	corticosteroid	NN	O	corticosteroid	dobj	5	SENT_134	[p10l8t3304r378b3352],
7	plus	CC	O	plus	prep	6	SENT_134	[p10l428t3304r541b3366],
8	longacting	VBG	O	longact	dep	7	SENT_134	[p10l594t3304r880b3367],
9	B,-agonist	JJ	O	b,-agonist	amod	11	SENT_134	[p10l935t3304r1199b3367],
10	treatment	NN	O	treatment	nn	11	SENT_134	[p10l1249t3314r1516b3352],
11	groups	NNS	O	group	dobj	8	SENT_134	[p10l8t3397r192b3443],
12	did	VBD	O	do	aux	14	SENT_134	[p10l221t3380r306b3428],
13	not	RB	O	not	neg	14	SENT_134	[p10l332t3390r420b3428],
14	lead	VB	O	lead	_	0	SENT_134	[p10l444t3380r555b3428],
15	to	TO	O	to	_	0	SENT_134	[p10l580t3390r629b3428],
16	evidence	NN	O	evidence	prep_to	14	SENT_134	[p10l658t3380r891b3428],
17	of	IN	O	of	_	0	SENT_134	[p10l919t3380r978b3428],
18	an	DT	O	a	det	20	SENT_134	[p10l996t3397r1060b3428],
19	overall	JJ	O	overall	amod	20	SENT_134	[p10l1087t3380r1265b3428],
20	effect	NN	O	effect	prep_of	16	SENT_134	[p10l1292t3380r1438b3428],
21	of	IN	O	of	_	0	SENT_134	[p10l1465t3380r1524b3428],
22	genotype	NN	O	genotype	prep_of	20	SENT_134	[p10l8t3466r250b3520],
23	on	IN	O	on	_	0	SENT_134	[p10l298t3474r365b3504],
24	the	DT	O	the	det	25	SENT_134	[p10l411t3457r495b3504],
25	time	NN	O	time	prep_on	14	SENT_134	[p10l541t3460r663b3504],
26	to	TO	O	to	aux	27	SENT_134	[p10l709t3466r759b3504],
27	ﬁrst	VB	O	ﬁrst	infmod	25	SENT_134	[p10l806t3457r914b3504],
28	severe	JJ	O	severe	amod	31	SENT_134	[p10l961t3474r1127b3504],
29	exacerbation	NN	O	exacerbation	nn	31	SENT_134	[p10l1174t3457r1515b3504],
30	(	NN	O	(	nn	31	SENT_134	[p10l11t3532r186b3595],
31	ﬁgure	NN	O	ﬁgure	dobj	27	SENT_134	[p10l11t3532r186b3595],
32	1	CD	NUMBER	1	dep	31	SENT_134	[p10l213t3537r249b3587],
33	;	:	O	;	_	0	SENT_134	[p10l213t3537r249b3587],
34	p	NN	O	p	dep	31	SENT_134	[p10l276t3537r397b3594],
35	=	JJ	O	=	amod	36	SENT_134	[p10l276t3537r397b3594],
36	o	NN	O	o	dep	34	SENT_134	[p10l276t3537r397b3594],
37	-	:	O	-	_	0	SENT_134	[p10l276t3537r397b3594],
38	31	CD	NUMBER	31	num	39	SENT_134	[p10l414t3537r501b3595],
39	)	NN	O	)	dep	31	SENT_134	[p10l414t3537r501b3595],
40	,	,	O	,	_	0	SENT_134	[p10l414t3537r501b3595],
41	or	CC	O	or	_	0	SENT_134	[p10l529t3549r584b3580],
42	evidence	NN	O	evidence	conj_or	39	SENT_134	[p10l608t3532r842b3580],
43	of	IN	O	of	_	0	SENT_134	[p10l868t3532r927b3580],
44	a	DT	O	a	det	45	SENT_134	[p10l944t3549r970b3580],
45	diﬁerence	NN	O	diﬁerence	prep_of	42	SENT_134	[p10l995t3532r1265b3580],
46	between	IN	O	between	_	0	SENT_134	[p10l1289t3532r1515b3580],
47	Gly/Gly	NNP	O	Gly/Gly	prep_between	45	SENT_134	[p10l9t3608r221b3671],
48	and	CC	O	and	_	0	SENT_134	[p10l239t3608r338b3656],
49	Arg/Arg	NN	O	arg/arg	nn	50	SENT_134	[p10l355t3612r582b3671],
50	participants	NNS	O	participant	dobj	27	SENT_134	[p10l601t3611r920b3670],
51	in	IN	O	in	_	0	SENT_134	[p10l940t3611r994b3655],
52	time	NN	O	time	prep_in	50	SENT_134	[p10l1012t3611r1134b3656],
53	to	TO	O	to	aux	54	SENT_134	[p10l1152t3618r1202b3656],
54	ﬁrst	VB	O	ﬁrst	xcomp	27	SENT_134	[p10l1221t3608r1329b3656],
55	severe	JJ	O	severe	amod	56	SENT_134	[p10l1349t3625r1514b3656],
56	exacerbation	NN	O	exacerbation	dobj	54	SENT_134	[p10l8t3685r348b3732],
57	(	CD	NUMBER	(	num	58	SENT_134	[p10l388t3688r630b3748],
58	Arg/Arg	NN	O	arg/arg	dep	56	SENT_134	[p10l388t3688r630b3748],
59	vs	CC	O	vs	_	0	SENT_134	[p10l665t3702r713b3732],
60	Gly/Gly	JJ	O	gly/gly	amod	61	SENT_134	[p10l749t3685r962b3747],
61	HR	NN	DURATION	hr	conj_vs	56	SENT_134	[p10l999t3690r1090b3731],
62	0-87	CD	NUMBER	0-87	dep	61	SENT_134	[p10l1125t3688r1259b3740],
63	;	:	O	;	_	0	SENT_134	[p10l1125t3688r1259b3740],
64	95	CD	PERCENT	95	num	65	SENT_134	[p10l1299t3688r1414b3735],
65	%	NN	PERCENT	%	dep	61	SENT_134	[p10l1299t3688r1414b3735],
66	CI	NN	O	ci	nn	67	SENT_134	[p10l1452t3688r1512b3732],
67	O-67-1-11	NN	O	o-67-1-11	dep	65	SENT_134	[p10l8t3763r285b3815],
68	;	:	O	;	_	0	SENT_134	[p10l8t3763r285b3815],
69	p	NN	O	p	dep	61	SENT_134	[p10l329t3765r559b3823],
70	=	JJ	O	=	amod	72	SENT_134	[p10l329t3765r559b3823],
71	0-28	CD	NUMBER	0-28	tmod	70	SENT_134	[p10l329t3765r559b3823],
72	)	NN	O	)	dep	69	SENT_134	[p10l329t3765r559b3823],
73	.	.	O	.	_	0	SENT_134	[p10l329t3765r559b3823],

1	These	DT	O	these	det	2	SENT_135	[p10l602t3760r763b3808],
2	ﬁndings	NNS	O	ﬁndings	nsubj	4	SENT_135	[p10l805t3760r1026b3823],
3	were	VBD	O	be	cop	4	SENT_135	[p10l1068t3777r1196b3808],
4	consistent	JJ	O	consistent	_	0	SENT_135	[p10l1239t3763r1516b3808],

1	For	IN	O	for	_	0	SENT_136	[p10l1579t2330r1633b2359],
2	corresponding	VBG	O	correspond	prepc_for	6	SENT_136	[p10l1643t2326r1908b2370],
3	author	NN	O	author	poss	5	SENT_136	[p10l1920t2326r2071b2359],
4	’s	POS	O	’s	_	0	SENT_136	[p10l1920t2326r2071b2359],
5	website	NN	O	website	nsubj	6	SENT_136	[p10l1576t2387r1721b2420],
6	see	VBP	O	see	_	0	SENT_136	[p10l1732t2398r1786b2420],
7	www1	NN	O	www1	dobj	6	SENT_136	[p10l1795t2386r2150b2424],
8	.	.	O	.	_	0	SENT_136	[p10l1795t2386r2150b2424],

1	wfubmc.edu	NN	O	wfubmc.edu	_	0	SENT_137	[p10l1795t2386r2150b2424],
2	/	:	O	/	punct	1	SENT_137	[p10l1795t2386r2150b2424],
3	genomics/pub	NN	O	genomics/pub	dep	1	SENT_137	[p10l1577t2448r2153b2492],
4	|	NN	O	|	nn	5	SENT_137	[p10l1577t2448r2153b2492],
5	ications	NNS	O	ication	dep	3	SENT_137	[p10l1577t2448r2153b2492],
6	+	CC	O	+	rcmod	5	SENT_137	[p10l1577t2448r2153b2492],
7	and	CC	O	and	advmod	5	SENT_137	[p10l1577t2448r2153b2492],
8	+	CC	O	+	_	0	SENT_137	[p10l1577t2448r2153b2492],
9	data	NNS	O	datum	dep	3	SENT_137	[p10l1577t2448r2153b2492],
10	across	IN	O	across	_	0	SENT_137	[p11l8t32r173b63],
11	all	DT	O	all	det	13	SENT_137	[p11l195t15r256b63],
12	treatment	NN	O	treatment	nn	13	SENT_137	[p11l275t25r542b63],
13	groups	NNS	O	group	prep_across	5	SENT_137	[p11l562t32r761b78],
14	.	.	O	.	_	0	SENT_137	[p11l562t32r761b78],

1	Study	NNP	O	Study	dep	369	SENT_138	[p11l426t172r493b199],
2	1	CD	NUMBER	1	dep	369	SENT_138	[p11l500t175r512b192],
3	Study	NNP	O	Study	dep	369	SENT_138	[p11l1291t172r1357b199],
4	2	CD	NUMBER	2	dep	369	SENT_138	[p11l1364t174r1375b192],
5	Gly/Gly	JJ	O	gly/gly	dep	369	SENT_138	[p11l427t226r504b254],
6	Gly/Arg	NN	O	gly/arg	dep	369	SENT_138	[p11l640t226r720b254],
7	Arg/Arg	NN	O	arg/arg	dep	369	SENT_138	[p11l852t227r937b254],
8	All	DT	O	all	dep	369	SENT_138	[p11l1065t226r1092b247],
9	genotypes	NNS	O	genotype	dep	369	SENT_138	[p11l1099t230r1212b254],
10	Gly/Gly	JJ	O	gly/gly	dep	369	SENT_138	[p11l1291t226r1368b254],
11	Gly/Arg	NN	O	gly/arg	dep	369	SENT_138	[p11l1504t226r1584b254],
12	Arg/Arg	NN	O	arg/arg	dep	369	SENT_138	[p11l1716t227r1802b254],
13	All	DT	O	all	dep	369	SENT_138	[p11l1929t226r1956b247],
14	genotypes	NNS	O	genotype	dep	369	SENT_138	[p11l1964t230r2076b254],
15	participants	NNS	O	participant	dep	369	SENT_138	[p11l43t283r169b308],
16	833	CD	NUMBER	833	dep	369	SENT_138	[p11l427t277r467b301],
17	(	NN	O	(	dep	369	SENT_138	[p11l475t278r536b303],
18	37	CD	PERCENT	37	dep	369	SENT_138	[p11l475t278r536b303],
19	%	NN	PERCENT	%	dep	369	SENT_138	[p11l475t278r536b303],
20	)	CD	NUMBER	)	dep	369	SENT_138	[p11l475t278r536b303],
21	1029	CD	DATE	1029	dep	369	SENT_138	[p11l640t280r694b301],
22	(	CD	PERCENT	(	dep	369	SENT_138	[p11l702t277r767b303],
23	46	CD	PERCENT	46	dep	369	SENT_138	[p11l702t277r767b303],
24	%	NN	PERCENT	%	dep	369	SENT_138	[p11l702t277r767b303],
25	)	CD	NUMBER	)	dep	369	SENT_138	[p11l702t277r767b303],
26	363	CD	NUMBER	363	dep	369	SENT_138	[p11l852t277r893b301],
27	(	NN	O	(	dep	369	SENT_138	[p11l901t277r964b303],
28	16	CD	PERCENT	16	dep	369	SENT_138	[p11l901t277r964b303],
29	%	NN	PERCENT	%	dep	369	SENT_138	[p11l901t277r964b303],
30	)	CD	PERCENT	)	dep	369	SENT_138	[p11l901t277r964b303],
31	2225	CD	PERCENT	2225	dep	369	SENT_138	[p11l1066t280r1118b301],
32	(	NN	PERCENT	(	dep	369	SENT_138	[p11l1126t278r1203b303],
33	100	CD	PERCENT	100	dep	369	SENT_138	[p11l1126t278r1203b303],
34	%	NN	PERCENT	%	dep	369	SENT_138	[p11l1126t278r1203b303],
35	)	CD	NUMBER	)	dep	369	SENT_138	[p11l1126t278r1203b303],
36	169	CD	NUMBER	169	dep	369	SENT_138	[p11l1291t277r1332b301],
37	(	NN	O	(	dep	369	SENT_138	[p11l1340t278r1403b303],
38	42	CD	PERCENT	42	dep	369	SENT_138	[p11l1340t278r1403b303],
39	%	NN	PERCENT	%	dep	369	SENT_138	[p11l1340t278r1403b303],
40	)	CD	NUMBER	)	dep	369	SENT_138	[p11l1340t278r1403b303],
41	169	CD	NUMBER	169	dep	369	SENT_138	[p11l1504t277r1545b301],
42	(	NN	O	(	dep	369	SENT_138	[p11l1553t278r1616b303],
43	42	CD	PERCENT	42	dep	369	SENT_138	[p11l1553t278r1616b303],
44	%	NN	PERCENT	%	dep	369	SENT_138	[p11l1553t278r1616b303],
45	)	CD	NUMBER	)	dep	369	SENT_138	[p11l1553t278r1616b303],
46	67	CD	NUMBER	67	dep	369	SENT_138	[p11l1717t277r1744b300],
47	(	NN	O	(	dep	369	SENT_138	[p11l1751t277r1813b303],
48	16	CD	PERCENT	16	dep	369	SENT_138	[p11l1751t277r1813b303],
49	%	NN	PERCENT	%	dep	369	SENT_138	[p11l1751t277r1813b303],
50	)	CD	NUMBER	)	dep	369	SENT_138	[p11l1751t277r1813b303],
51	405	CD	NUMBER	405	dep	369	SENT_138	[p11l1929t280r1971b301],
52	(	NN	O	(	dep	369	SENT_138	[p11l1979t278r2055b303],
53	100	CD	PERCENT	100	dep	369	SENT_138	[p11l1979t278r2055b303],
54	%	NN	PERCENT	%	dep	369	SENT_138	[p11l1979t278r2055b303],
55	)	CD	NUMBER	)	dep	369	SENT_138	[p11l1979t278r2055b303],
56	FEV	NN	O	fev	dep	369	SENT_138	[p11l43t329r89b353],
57	,	,	O	,	_	0	SENT_138	[p11l43t329r89b353],
58	(	CD	NUMBER	(	dep	369	SENT_138	[p11l96t328r122b353],
59	L	NN	O	l	dep	369	SENT_138	[p11l96t328r122b353],
60	)	CD	NUMBER	)	dep	369	SENT_138	[p11l96t328r122b353],
61	2-2	CD	NUMBER	2-2	dep	369	SENT_138	[p11l454t330r485b348],
62	(	NN	O	(	dep	369	SENT_138	[p11l494t327r560b353],
63	0-68	CD	NUMBER	0-68	dep	369	SENT_138	[p11l494t327r560b353],
64	)	CD	NUMBER	)	dep	369	SENT_138	[p11l494t327r560b353],
65	2-2	CD	NUMBER	2-2	dep	369	SENT_138	[p11l683t330r714b348],
66	(	NN	O	(	dep	369	SENT_138	[p11l723t327r789b353],
67	0-69	CD	NUMBER	0-69	dep	369	SENT_138	[p11l723t327r789b353],
68	)	CD	NUMBER	)	dep	369	SENT_138	[p11l723t327r789b353],
69	2-2	CD	NUMBER	2-2	dep	369	SENT_138	[p11l880t330r911b348],
70	(	NN	O	(	dep	369	SENT_138	[p11l920t327r986b353],
71	0-66	CD	NUMBER	0-66	dep	369	SENT_138	[p11l920t327r986b353],
72	)	CD	NUMBER	)	dep	369	SENT_138	[p11l920t327r986b353],
73	2-2	CD	NUMBER	2-2	dep	369	SENT_138	[p11l1105t330r1136b348],
74	(	NN	O	(	dep	369	SENT_138	[p11l1145t327r1211b353],
75	0-68	CD	NUMBER	0-68	dep	369	SENT_138	[p11l1145t327r1211b353],
76	)	CD	NUMBER	)	dep	369	SENT_138	[p11l1145t327r1211b353],
77	2-6	CD	NUMBER	2-6	dep	369	SENT_138	[p11l1318t327r1351b348],
78	(	NN	O	(	dep	369	SENT_138	[p11l1359t327r1426b353],
79	0-68	CD	NUMBER	0-68	dep	369	SENT_138	[p11l1359t327r1426b353],
80	)	CD	NUMBER	)	dep	369	SENT_138	[p11l1359t327r1426b353],
81	2-6	CD	NUMBER	2-6	dep	369	SENT_138	[p11l1535t327r1568b348],
82	(	NN	O	(	dep	369	SENT_138	[p11l1576t328r1638b353],
83	0-71	CD	NUMBER	0-71	dep	369	SENT_138	[p11l1576t328r1638b353],
84	)	CD	NUMBER	)	dep	369	SENT_138	[p11l1576t328r1638b353],
85	2-5	CD	NUMBER	2-5	dep	369	SENT_138	[p11l1744t330r1775b351],
86	(	NN	O	(	dep	369	SENT_138	[p11l1784t327r1850b353],
87	0-68	CD	NUMBER	0-68	dep	369	SENT_138	[p11l1784t327r1850b353],
88	)	CD	NUMBER	)	dep	369	SENT_138	[p11l1784t327r1850b353],
89	2-6	CD	NUMBER	2-6	dep	369	SENT_138	[p11l1961t327r1994b348],
90	(	NN	O	(	dep	369	SENT_138	[p11l2002t328r2066b353],
91	0-70	CD	NUMBER	0-70	dep	369	SENT_138	[p11l2002t328r2066b353],
92	)	CD	NUMBER	)	dep	369	SENT_138	[p11l2002t328r2066b353],
93	FEV	NN	O	fev	dep	369	SENT_138	[p11l43t375r89b399],
94	,	,	O	,	_	0	SENT_138	[p11l43t375r89b399],
95	(	CD	PERCENT	(	dep	369	SENT_138	[p11l96t374r121b399],
96	%	NN	PERCENT	%	dep	369	SENT_138	[p11l96t374r121b399],
97	predicted	VBD	O	predict	dep	369	SENT_138	[p11l129t373r238b400],
98	)	CD	PERCENT	)	dep	369	SENT_138	[p11l129t373r238b400],
99	73	CD	PERCENT	73	dep	369	SENT_138	[p11l440t376r485b397],
100	%	NN	PERCENT	%	dep	369	SENT_138	[p11l440t376r485b397],
101	(	CD	NUMBER	(	dep	369	SENT_138	[p11l493t374r556b399],
102	13-4	CD	NUMBER	13-4	dep	369	SENT_138	[p11l493t374r556b399],
103	)	NN	O	)	dep	369	SENT_138	[p11l493t374r556b399],
104	72-3	CD	PERCENT	72-3	dep	369	SENT_138	[p11l669t373r736b396],
105	%	NN	PERCENT	%	dep	369	SENT_138	[p11l669t373r736b396],
106	(	CD	NUMBER	(	dep	369	SENT_138	[p11l744t374r804b399],
107	13-7	CD	NUMBER	13-7	dep	369	SENT_138	[p11l744t374r804b399],
108	)	NN	O	)	dep	369	SENT_138	[p11l744t374r804b399],
109	72	CD	NUMBER	72	dep	369	SENT_138	[p11l866t376r931b397],
110	~	NN	O	~	dep	369	SENT_138	[p11l866t376r931b397],
111	3	CD	PERCENT	3	dep	369	SENT_138	[p11l866t376r931b397],
112	%	NN	PERCENT	%	dep	369	SENT_138	[p11l866t376r931b397],
113	(	CD	NUMBER	(	dep	369	SENT_138	[p11l939t374r1000b399],
114	13-3	CD	NUMBER	13-3	dep	369	SENT_138	[p11l939t374r1000b399],
115	)	NN	O	)	dep	369	SENT_138	[p11l939t374r1000b399],
116	723	CD	PERCENT	723	dep	369	SENT_138	[p11l1091t373r1158b396],
117	%	NN	PERCENT	%	dep	369	SENT_138	[p11l1091t373r1158b396],
118	(	CD	NUMBER	(	dep	369	SENT_138	[p11l1166t374r1227b399],
119	13-5	CD	NUMBER	13-5	dep	369	SENT_138	[p11l1166t374r1227b399],
120	)	NN	O	)	dep	369	SENT_138	[p11l1166t374r1227b399],
121	793	CD	PERCENT	793	dep	369	SENT_138	[p11l1303t376r1369b397],
122	%	NN	PERCENT	%	dep	369	SENT_138	[p11l1303t376r1369b397],
123	(	CD	NUMBER	(	dep	369	SENT_138	[p11l1377t374r1441b399],
124	14-4	CD	NUMBER	14-4	dep	369	SENT_138	[p11l1377t374r1441b399],
125	)	NN	O	)	dep	369	SENT_138	[p11l1377t374r1441b399],
126	774	CD	PERCENT	774	dep	369	SENT_138	[p11l1522t376r1588b396],
127	%	NN	PERCENT	%	dep	369	SENT_138	[p11l1522t376r1588b396],
128	(	CD	NUMBER	(	dep	369	SENT_138	[p11l1596t374r1659b399],
129	14-4	CD	NUMBER	14-4	dep	369	SENT_138	[p11l1596t374r1659b399],
130	)	NN	O	)	dep	369	SENT_138	[p11l1596t374r1659b399],
131	76	CD	NUMBER	76	dep	369	SENT_138	[p11l1729t373r1796b396],
132	~	NN	O	~	dep	369	SENT_138	[p11l1729t373r1796b396],
133	4	CD	PERCENT	4	dep	369	SENT_138	[p11l1729t373r1796b396],
134	%	NN	PERCENT	%	dep	369	SENT_138	[p11l1729t373r1796b396],
135	(	CD	NUMBER	(	dep	369	SENT_138	[p11l1804t374r1867b399],
136	14-3	CD	NUMBER	14-3	dep	369	SENT_138	[p11l1804t374r1867b399],
137	)	NN	O	)	dep	369	SENT_138	[p11l1804t374r1867b399],
138	780	CD	PERCENT	780	dep	369	SENT_138	[p11l1946t373r2013b396],
139	%	NN	PERCENT	%	dep	369	SENT_138	[p11l1946t373r2013b396],
140	(	CD	NUMBER	(	dep	369	SENT_138	[p11l2021t374r2085b399],
141	14-4	CD	NUMBER	14-4	dep	369	SENT_138	[p11l2021t374r2085b399],
142	)	CD	NUMBER	)	dep	369	SENT_138	[p11l2021t374r2085b399],
143	FEV	NN	O	fev	dep	369	SENT_138	[p11l43t420r88b445],
144	,	,	O	,	_	0	SENT_138	[p11l43t420r88b445],
145	reversibility	NN	O	reversibility	dep	369	SENT_138	[p11l96t419r220b446],
146	(	CD	NUMBER	(	dep	369	SENT_138	[p11l227t420r261b445],
147	"	``	O	"	dep	369	SENT_138	[p11l227t420r261b445],
148	/	:	O	/	dep	369	SENT_138	[p11l227t420r261b445],
149	o	NN	O	o	dep	369	SENT_138	[p11l227t420r261b445],
150	)	CD	PERCENT	)	dep	369	SENT_138	[p11l227t420r261b445],
151	245	CD	PERCENT	245	dep	369	SENT_138	[p11l439t421r505b442],
152	%	NN	PERCENT	%	dep	369	SENT_138	[p11l439t421r505b442],
153	(	CD	NUMBER	(	dep	369	SENT_138	[p11l513t420r575b445],
154	13-0	CD	NUMBER	13-0	dep	369	SENT_138	[p11l513t420r575b445],
155	)	NN	O	)	dep	369	SENT_138	[p11l513t420r575b445],
156	24-4	CD	PERCENT	24-4	dep	369	SENT_138	[p11l668t421r736b442],
157	%	NN	PERCENT	%	dep	369	SENT_138	[p11l668t421r736b442],
158	(	CD	NUMBER	(	dep	369	SENT_138	[p11l744t420r805b445],
159	12-5	CD	NUMBER	12-5	dep	369	SENT_138	[p11l744t420r805b445],
160	)	NN	O	)	dep	369	SENT_138	[p11l744t420r805b445],
161	249	CD	PERCENT	249	dep	369	SENT_138	[p11l865t421r933b442],
162	%	NN	PERCENT	%	dep	369	SENT_138	[p11l865t421r933b442],
163	(	CD	NUMBER	(	dep	369	SENT_138	[p11l941t420r1001b445],
164	13-7	CD	NUMBER	13-7	dep	369	SENT_138	[p11l941t420r1001b445],
165	)	NN	O	)	dep	369	SENT_138	[p11l941t420r1001b445],
166	245	CD	PERCENT	245	dep	369	SENT_138	[p11l1090t421r1156b442],
167	%	NN	PERCENT	%	dep	369	SENT_138	[p11l1090t421r1156b442],
168	(	CD	NUMBER	(	dep	369	SENT_138	[p11l1164t420r1227b445],
169	12-9	CD	NUMBER	12-9	dep	369	SENT_138	[p11l1164t420r1227b445],
170	)	NN	O	)	dep	369	SENT_138	[p11l1164t420r1227b445],
171	12-4	CD	PERCENT	12-4	dep	369	SENT_138	[p11l1305t421r1370b442],
172	%	NN	PERCENT	%	dep	369	SENT_138	[p11l1305t421r1370b442],
173	(	CD	PERCENT	(	dep	369	SENT_138	[p11l1379t420r1430b445],
174	9-9	CD	PERCENT	9-9	dep	369	SENT_138	[p11l1379t420r1430b445],
175	)	CD	PERCENT	)	dep	369	SENT_138	[p11l1379t420r1430b445],
176	12-5	CD	PERCENT	12-5	dep	369	SENT_138	[p11l1522t421r1586b442],
177	%	NN	PERCENT	%	dep	369	SENT_138	[p11l1522t421r1586b442],
178	(	CD	NUMBER	(	dep	369	SENT_138	[p11l1594t418r1658b445],
179	10-8	CD	NUMBER	10-8	dep	369	SENT_138	[p11l1594t418r1658b445],
180	)	NN	O	)	dep	369	SENT_138	[p11l1594t418r1658b445],
181	108	CD	PERCENT	108	dep	369	SENT_138	[p11l1730t418r1797b439],
182	%	NN	PERCENT	%	dep	369	SENT_138	[p11l1730t418r1797b439],
183	(	CD	NUMBER	(	dep	369	SENT_138	[p11l1805t420r1867b445],
184	10-5	CD	NUMBER	10-5	dep	369	SENT_138	[p11l1805t420r1867b445],
185	)	NN	O	)	dep	369	SENT_138	[p11l1805t420r1867b445],
186	12-2	RB	PERCENT	12-2	dep	369	SENT_138	[p11l1948t421r2012b439],
187	%	NN	PERCENT	%	dep	369	SENT_138	[p11l1948t421r2012b439],
188	(	CD	NUMBER	(	dep	369	SENT_138	[p11l2020t420r2084b445],
189	10-4	CD	NUMBER	10-4	dep	369	SENT_138	[p11l2020t420r2084b445],
190	)	CD	NUMBER	)	dep	369	SENT_138	[p11l2020t420r2084b445],
191	Inhaled	VBN	O	inhale	dep	369	SENT_138	[p11l43t464r121b485],
192	corticosteroid	NN	O	corticosteroid	dep	369	SENT_138	[p11l128t464r277b485],
193	dose	NN	O	dose	dep	369	SENT_138	[p11l283t464r333b485],
194	at	IN	O	at	dep	369	SENT_138	[p11l340t468r360b485],
195	748	CD	NUMBER	748	dep	369	SENT_138	[p11l426t464r466b488],
196	(	NN	O	(	dep	369	SENT_138	[p11l475t465r533b490],
197	240	CD	NUMBER	240	dep	369	SENT_138	[p11l475t465r533b490],
198	)	NN	O	)	dep	369	SENT_138	[p11l475t465r533b490],
199	730	CD	NUMBER	730	dep	369	SENT_138	[p11l639t467r679b488],
200	(	NN	O	(	dep	369	SENT_138	[p11l687t465r744b490],
201	224	CD	NUMBER	224	dep	369	SENT_138	[p11l687t465r744b490],
202	)	NN	O	)	dep	369	SENT_138	[p11l687t465r744b490],
203	723	CD	NUMBER	723	dep	369	SENT_138	[p11l852t467r891b488],
204	(	NN	O	(	dep	369	SENT_138	[p11l899t465r956b490],
205	230	CD	NUMBER	230	dep	369	SENT_138	[p11l899t465r956b490],
206	)	NN	O	)	dep	369	SENT_138	[p11l899t465r956b490],
207	736	CD	NUMBER	736	dep	369	SENT_138	[p11l1065t464r1105b488],
208	(	NN	O	(	dep	369	SENT_138	[p11l1114t465r1168b490],
209	231	CD	NUMBER	231	dep	369	SENT_138	[p11l1114t465r1168b490],
210	)	NN	O	)	dep	369	SENT_138	[p11l1114t465r1168b490],
211	537	CD	NUMBER	537	dep	369	SENT_138	[p11l1291t467r1330b488],
212	(	NN	O	(	dep	369	SENT_138	[p11l1337t464r1395b490],
213	166	CD	NUMBER	166	dep	369	SENT_138	[p11l1337t464r1395b490],
214	)	NN	O	)	dep	369	SENT_138	[p11l1337t464r1395b490],
215	563	CD	NUMBER	563	dep	369	SENT_138	[p11l1504t464r1544b488],
216	(	NN	O	(	dep	369	SENT_138	[p11l1552t465r1610b490],
217	190	CD	NUMBER	190	dep	369	SENT_138	[p11l1552t465r1610b490],
218	)	NN	O	)	dep	369	SENT_138	[p11l1552t465r1610b490],
219	570	CD	NUMBER	570	dep	369	SENT_138	[p11l1717t467r1756b488],
220	(	NN	O	(	dep	369	SENT_138	[p11l1764t464r1822b490],
221	196	CD	NUMBER	196	dep	369	SENT_138	[p11l1764t464r1822b490],
222	)	NN	O	)	dep	369	SENT_138	[p11l1764t464r1822b490],
223	553	CD	NUMBER	553	dep	369	SENT_138	[p11l1930t467r1968b488],
224	(	NN	O	(	dep	369	SENT_138	[p11l1977t464r2033b490],
225	182	CD	NUMBER	182	dep	369	SENT_138	[p11l1977t464r2033b490],
226	)	NN	O	)	dep	369	SENT_138	[p11l1977t464r2033b490],
227	study	NN	O	study	dep	369	SENT_138	[p11l42t499r102b526],
228	entry	NN	O	entry	dep	369	SENT_138	[p11l108t502r164b526],
229	(	CD	NUMBER	(	dep	369	SENT_138	[p11l171t500r205b526],
230	pg	NN	O	pg	dep	369	SENT_138	[p11l171t500r205b526],
231	per	IN	O	per	dep	369	SENT_138	[p11l212t506r247b526],
232	day	NN	DURATION	day	dep	369	SENT_138	[p11l252t499r298b526],
233	)	CD	NUMBER	)	dep	369	SENT_138	[p11l252t499r298b526],
234	Shortacting	VBG	O	shortact	dep	369	SENT_138	[p11l42t544r164b572],
235	B2	NN	O	b2	dep	369	SENT_138	[p11l172t544r286b572],
236	—	NN	O	—	dep	369	SENT_138	[p11l172t544r286b572],
237	agonist	NN	O	agonist	dep	369	SENT_138	[p11l172t544r286b572],
238	use	NN	O	use	dep	369	SENT_138	[p11l292t551r326b565],
239	durin	NN	O	durin	dep	369	SENT_138	[p11l332t544r386b565],
240	2-4	CD	NUMBER	2-4	dep	369	SENT_138	[p11l454t547r488b568],
241	(	CD	NUMBER	(	dep	369	SENT_138	[p11l495t546r556b570],
242	1-53	CD	NUMBER	1-53	dep	369	SENT_138	[p11l495t546r556b570],
243	)	NN	O	)	dep	369	SENT_138	[p11l495t546r556b570],
244	2-3	CD	NUMBER	2-3	dep	369	SENT_138	[p11l684t547r714b568],
245	(	CD	NUMBER	(	dep	369	SENT_138	[p11l723t546r783b571],
246	1-31	CD	NUMBER	1-31	dep	369	SENT_138	[p11l723t546r783b571],
247	)	NN	O	)	dep	369	SENT_138	[p11l723t546r783b571],
248	2-3	CD	NUMBER	2-3	dep	369	SENT_138	[p11l880t547r911b568],
249	(	CD	NUMBER	(	dep	369	SENT_138	[p11l920t546r983b571],
250	1-40	CD	NUMBER	1-40	dep	369	SENT_138	[p11l920t546r983b571],
251	)	NN	O	)	dep	369	SENT_138	[p11l920t546r983b571],
252	2-3	CD	NUMBER	2-3	dep	369	SENT_138	[p11l1105t547r1136b568],
253	(	CD	NUMBER	(	dep	369	SENT_138	[p11l1145t546r1206b570],
254	1-41	CD	NUMBER	1-41	dep	369	SENT_138	[p11l1145t546r1206b570],
255	)	NN	O	)	dep	369	SENT_138	[p11l1145t546r1206b570],
256	2-7	CD	NUMBER	2-7	dep	369	SENT_138	[p11l1318t547r1350b568],
257	(	CD	NUMBER	(	dep	369	SENT_138	[p11l1357t546r1419b571],
258	2-55	CD	NUMBER	2-55	dep	369	SENT_138	[p11l1357t546r1419b571],
259	)	NN	O	)	dep	369	SENT_138	[p11l1357t546r1419b571],
260	2-7	CD	NUMBER	2-7	dep	369	SENT_138	[p11l1535t547r1567b568],
261	(	CD	NUMBER	(	dep	369	SENT_138	[p11l1574t546r1636b571],
262	2-01	CD	NUMBER	2-01	dep	369	SENT_138	[p11l1574t546r1636b571],
263	)	NN	O	)	dep	369	SENT_138	[p11l1574t546r1636b571],
264	2-3	CD	NUMBER	2-3	dep	369	SENT_138	[p11l1744t547r1775b568],
265	(	CD	NUMBER	(	dep	369	SENT_138	[p11l1784t546r1846b570],
266	1-59	CD	NUMBER	1-59	dep	369	SENT_138	[p11l1784t546r1846b570],
267	)	NN	O	)	dep	369	SENT_138	[p11l1784t546r1846b570],
268	2-7	CD	NUMBER	2-7	dep	369	SENT_138	[p11l1961t547r1993b568],
269	(	CD	NUMBER	(	dep	369	SENT_138	[p11l2000t546r2063b571],
270	2-20	CD	NUMBER	2-20	dep	369	SENT_138	[p11l2000t546r2063b571],
271	)	CD	NUMBER	)	dep	369	SENT_138	[p11l2000t546r2063b571],
272	g	NN	O	g	dep	369	SENT_138	[p11l42t586r54b606],
273	run	NN	O	run	dep	369	SENT_138	[p11l62t581r126b600],
274	—	CD	NUMBER	—	dep	369	SENT_138	[p11l62t581r126b600],
275	in	IN	O	in	dep	369	SENT_138	[p11l62t581r126b600],
276	(	CD	NUMBER	(	dep	369	SENT_138	[p11l135t579r263b605],
277	inhalations	NNS	O	inhalation	dep	369	SENT_138	[p11l135t579r263b605],
278	perday	JJ	O	perday	dep	369	SENT_138	[p11l269t579r354b606],
279	)	CD	NUMBER	)	dep	369	SENT_138	[p11l269t579r354b606],
280	Morning	NN	TIME	morning	dep	369	SENT_138	[p11l43t626r134b652],
281	PEF	NN	O	pef	dep	369	SENT_138	[p11l143t626r180b645],
282	ClUrirIg	NN	O	cluririg	dep	369	SENT_138	[p11l186t625r256b652],
283	FU	NN	O	fu	dep	369	SENT_138	[p11l265t632r284b645],
284	n-in	NN	O	n-in	dep	369	SENT_138	[p11l288t626r335b649],
285	,	,	O	,	_	0	SENT_138	[p11l288t626r335b649],
286	3339	CD	NUMBER	3339	dep	369	SENT_138	[p11l426t627r487b648],
287	(	CD	NUMBER	(	dep	369	SENT_138	[p11l495t624r560b651],
288	96-1	CD	NUMBER	96-1	dep	369	SENT_138	[p11l495t624r560b651],
289	)	NN	O	)	dep	369	SENT_138	[p11l495t624r560b651],
290	336-2	CD	NUMBER	336-2	dep	369	SENT_138	[p11l654t624r714b648],
291	(	CD	NUMBER	(	dep	369	SENT_138	[p11l723t626r787b651],
292	92-5	CD	NUMBER	92-5	dep	369	SENT_138	[p11l723t626r787b651],
293	)	NN	O	)	dep	369	SENT_138	[p11l723t626r787b651],
294	330-7	CD	NUMBER	330-7	dep	369	SENT_138	[p11l852t627r912b648],
295	(	CD	NUMBER	(	dep	369	SENT_138	[p11l920t626r984b651],
296	94-7	CD	NUMBER	94-7	dep	369	SENT_138	[p11l920t626r984b651],
297	)	NN	O	)	dep	369	SENT_138	[p11l920t626r984b651],
298	334-5	CD	NUMBER	334-5	dep	369	SENT_138	[p11l1076t624r1138b648],
299	(	CD	NUMBER	(	dep	369	SENT_138	[p11l1146t626r1213b651],
300	94-4	CD	NUMBER	94-4	dep	369	SENT_138	[p11l1146t626r1213b651],
301	)	NN	O	)	dep	369	SENT_138	[p11l1146t626r1213b651],
302	347-2	CD	NUMBER	347-2	dep	369	SENT_138	[p11l1290t627r1350b648],
303	(	CD	NUMBER	(	dep	369	SENT_138	[p11l1358t624r1424b651],
304	33-3	CD	NUMBER	33-3	dep	369	SENT_138	[p11l1358t624r1424b651],
305	)	NN	O	)	dep	369	SENT_138	[p11l1358t624r1424b651],
306	355-1	CD	NUMBER	355-1	dep	369	SENT_138	[p11l1507t627r1566b648],
307	(	CD	NUMBER	(	dep	369	SENT_138	[p11l1574t626r1640b651],
308	94-0	CD	NUMBER	94-0	dep	369	SENT_138	[p11l1574t626r1640b651],
309	)	NN	O	)	dep	369	SENT_138	[p11l1574t626r1640b651],
310	351-9	CD	NUMBER	351-9	dep	369	SENT_138	[p11l1716t624r1778b648],
311	(	CD	NUMBER	(	dep	369	SENT_138	[p11l1786t626r1849b651],
312	91-5	CD	NUMBER	91-5	dep	369	SENT_138	[p11l1786t626r1849b651],
313	)	CD	NUMBER	)	dep	369	SENT_138	[p11l1786t626r1849b651],
314	3529	CD	NUMBER	3529	dep	369	SENT_138	[p11l1933t627r1994b648],
315	(	NN	O	(	dep	369	SENT_138	[p11l2002t626r2065b651],
316	912	CD	NUMBER	912	dep	369	SENT_138	[p11l2002t626r2065b651],
317	)	NN	O	)	dep	369	SENT_138	[p11l2002t626r2065b651],
318	(	CD	NUMBER	(	dep	369	SENT_138	[p11l43t660r71b685],
319	L	NN	O	l	dep	369	SENT_138	[p11l43t660r71b685],
320	/	:	O	/	dep	369	SENT_138	[p11l43t660r71b685],
321	min	NN	DURATION	min	dep	369	SENT_138	[p11l73t660r122b685],
322	)	CD	NUMBER	)	dep	369	SENT_138	[p11l73t660r122b685],
323	Nights	NNPS	TIME	Nights	dep	369	SENT_138	[p11l43t705r114b732],
324	with	IN	O	with	dep	369	SENT_138	[p11l119t705r167b725],
325	awakenings	NNS	O	awakening	dep	369	SENT_138	[p11l175t705r302b732],
326	during	IN	O	during	dep	369	SENT_138	[p11l308t705r378b732],
327	327	CD	PERCENT	327	dep	369	SENT_138	[p11l440t708r504b729],
328	%	NN	PERCENT	%	dep	369	SENT_138	[p11l440t708r504b729],
329	(	CD	NUMBER	(	dep	369	SENT_138	[p11l513t706r575b731],
330	35-0	CD	NUMBER	35-0	dep	369	SENT_138	[p11l513t706r575b731],
331	)	NN	O	)	dep	369	SENT_138	[p11l513t706r575b731],
332	34-1	CD	PERCENT	34-1	dep	369	SENT_138	[p11l668t708r733b729],
333	%	NN	PERCENT	%	dep	369	SENT_138	[p11l668t708r733b729],
334	(	CD	NUMBER	(	dep	369	SENT_138	[p11l742t706r806b731],
335	34-9	CD	NUMBER	34-9	dep	369	SENT_138	[p11l742t706r806b731],
336	)	NN	O	)	dep	369	SENT_138	[p11l742t706r806b731],
337	35-1	CD	PERCENT	35-1	dep	369	SENT_138	[p11l866t708r930b729],
338	%	NN	PERCENT	%	dep	369	SENT_138	[p11l866t708r930b729],
339	(	CD	NUMBER	(	dep	369	SENT_138	[p11l938t705r1002b731],
340	35-8	CD	NUMBER	35-8	dep	369	SENT_138	[p11l938t705r1002b731],
341	)	NN	O	)	dep	369	SENT_138	[p11l938t705r1002b731],
342	338	CD	PERCENT	338	dep	369	SENT_138	[p11l1091t705r1158b729],
343	%	NN	PERCENT	%	dep	369	SENT_138	[p11l1091t705r1158b729],
344	(	CD	NUMBER	(	dep	369	SENT_138	[p11l1166t706r1227b731],
345	35-1	CD	NUMBER	35-1	dep	369	SENT_138	[p11l1166t706r1227b731],
346	)	NN	O	)	dep	369	SENT_138	[p11l1166t706r1227b731],
347	142	CD	PERCENT	142	dep	369	SENT_138	[p11l1304t708r1369b728],
348	%	NN	PERCENT	%	dep	369	SENT_138	[p11l1304t708r1369b728],
349	(	CD	NUMBER	(	dep	369	SENT_138	[p11l1377t706r1441b731],
350	24-2	CD	NUMBER	24-2	dep	369	SENT_138	[p11l1377t706r1441b731],
351	)	NN	O	)	dep	369	SENT_138	[p11l1377t706r1441b731],
352	16-8	CD	PERCENT	16-8	dep	369	SENT_138	[p11l1521t705r1588b726],
353	%	NN	PERCENT	%	dep	369	SENT_138	[p11l1521t705r1588b726],
354	(	CD	NUMBER	(	dep	369	SENT_138	[p11l1596t706r1661b731],
355	24-9	CD	NUMBER	24-9	dep	369	SENT_138	[p11l1596t706r1661b731],
356	)	NN	O	)	dep	369	SENT_138	[p11l1596t706r1661b731],
357	13-1	CD	PERCENT	13-1	dep	369	SENT_138	[p11l1731t708r1794b729],
358	%	NN	PERCENT	%	dep	369	SENT_138	[p11l1731t708r1794b729],
359	(	CD	NUMBER	(	dep	369	SENT_138	[p11l1802t706r1867b731],
360	20-9	CD	NUMBER	20-9	dep	369	SENT_138	[p11l1802t706r1867b731],
361	)	NN	O	)	dep	369	SENT_138	[p11l1802t706r1867b731],
362	15-1	CD	PERCENT	15-1	dep	369	SENT_138	[p11l1948t708r2011b729],
363	%	NN	PERCENT	%	dep	369	SENT_138	[p11l1948t708r2011b729],
364	(	CD	NUMBER	(	dep	369	SENT_138	[p11l2019t706r2084b731],
365	24-0	CD	NUMBER	24-0	dep	369	SENT_138	[p11l2019t706r2084b731],
366	)	CD	NUMBER	)	dep	369	SENT_138	[p11l2019t706r2084b731],
367	run	NN	O	run	dep	369	SENT_138	[p11l43t741r108b760],
368	—	NN	O	—	dep	369	SENT_138	[p11l43t741r108b760],
369	in	IN	O	in	_	0	SENT_138	[p11l43t741r108b760],

1	Data	NNS	O	datum	nsubj	8	SENT_139	[p11l32t809r76b826],
2	are	VBP	O	be	cop	3	SENT_139	[p11l82t814r112b826],
3	number	NN	O	number	_	0	SENT_139	[p11l119t807r197b826],
4	(	CD	PERCENT	(	num	5	SENT_139	[p11l203t808r234b831],
5	%	NN	PERCENT	%	dep	3	SENT_139	[p11l203t808r234b831],
6	)	CD	NUMBER	)	dep	5	SENT_139	[p11l203t808r234b831],
7	or	CC	O	or	_	0	SENT_139	[p11l241t814r261b826],
8	mean	VB	O	mean	conj_or	3	SENT_139	[p11l268t814r322b826],
9	(	JJ	O	(	amod	11	SENT_139	[p11l329t808r376b831],
10	SD	NN	O	sd	nn	11	SENT_139	[p11l329t808r376b831],
11	)	NN	O	)	dobj	8	SENT_139	[p11l329t808r376b831],
12	,	,	O	,	_	0	SENT_139	[p11l329t808r376b831],
13	unless	IN	O	unless	mark	15	SENT_139	[p11l383t807r443b826],
14	otherwise	RB	O	otherwise	advmod	15	SENT_139	[p11l449t807r547b826],
15	indicated	VBN	O	indicate	dep	11	SENT_139	[p11l553t807r649b826],
16	.	.	O	.	_	0	SENT_139	[p11l553t807r649b826],

1	FEV	NN	O	fev	_	0	SENT_140	[p11l657t807r774b831],
2	,	,	O	,	_	0	SENT_140	[p11l657t807r774b831],
3	=	JJ	O	=	amod	6	SENT_140	[p11l657t807r774b831],
4	forced	JJ	O	forced	amod	6	SENT_140	[p11l657t807r774b831],
5	expiratory	JJ	O	expiratory	amod	6	SENT_140	[p11l781t809r882b832],
6	volume	NN	O	volume	appos	1	SENT_140	[p11l887t807r962b826],
7	in	IN	O	in	_	0	SENT_140	[p11l969t809r985b826],
8	one	CD	DURATION	one	num	9	SENT_140	[p11l991t814r1028b826],
9	second	NN	NUMBER	second	prep_in	6	SENT_140	[p11l1034t807r1109b830],
10	;	:	O	;	_	0	SENT_140	[p11l1034t807r1109b830],
11	PEF	NN	O	pef	dep	1	SENT_140	[p11l1116t807r1211b832],
12	=	JJ	O	=	amod	15	SENT_140	[p11l1116t807r1211b832],
13	peak	NN	O	peak	nn	15	SENT_140	[p11l1116t807r1211b832],
14	expiratony	NN	O	expiratony	nn	15	SENT_140	[p11l1216t809r1318b832],
15	ﬂow	NN	O	ﬂow	dep	11	SENT_140	[p11l1323t807r1370b826],
16	.	.	O	.	_	0	SENT_140	[p11l1323t807r1370b826],

1	Table	NNP	O	Table	_	0	SENT_141	[p11l31t871r88b892],
2	2	CD	NUMBER	2	num	1	SENT_141	[p11l93t874r113b891],
3	:	:	O	:	_	0	SENT_141	[p11l93t874r113b891],
4	Baseline	NN	O	baseline	nn	5	SENT_141	[p11l121t871r213b892],
5	measurements	NNS	O	measurement	dep	1	SENT_141	[p11l220t874r388b892],
6	stratiﬁed	VBN	O	stratiﬁed	partmod	5	SENT_141	[p11l395t871r499b892],
7	by	IN	O	by	_	0	SENT_141	[p11l506t871r533b898],
8	G	NN	O	g	nn	9	SENT_141	[p11l539t871r644b898],
9	|	NNS	O	|	agent	6	SENT_141	[p11l539t871r644b898],
10	y16Arg	NN	O	y16arg	nn	11	SENT_141	[p11l539t871r644b898],
11	genotype	NN	O	genotype	nsubj	15	SENT_141	[p11l652t874r760b898],
12	for	IN	O	for	_	0	SENT_141	[p11l766t871r800b892],
13	each	DT	O	each	det	14	SENT_141	[p11l806t871r856b892],
14	study	NN	O	study	prep_for	11	SENT_141	[p11l863t871r928b898],
15	(	VBD	O	(	rcmod	9	SENT_141	[p11l934t871r967b897],
16	all	DT	O	all	det	18	SENT_141	[p11l934t871r967b897],
17	randomised	JJ	O	randomised	amod	18	SENT_141	[p11l976t871r1110b892],
18	participants	NNS	O	participant	dobj	15	SENT_141	[p11l1116t872r1254b898],
19	with	IN	O	with	_	0	SENT_141	[p11l1260t871r1312b892],
20	G	NN	O	g	nn	21	SENT_141	[p11l1319t871r1425b898],
21	|	NNS	O	|	prep_with	15	SENT_141	[p11l1319t871r1425b898],
22	y16Arg	NN	O	y16arg	nn	24	SENT_141	[p11l1319t871r1425b898],
23	genotype	NN	O	genotype	nn	24	SENT_141	[p11l1432t874r1541b898],
24	data	NNS	O	datum	nsubj	25	SENT_141	[p11l1547t871r1606b897],
25	)	VBP	O	)	rcmod	21	SENT_141	[p11l1547t871r1606b897],

1	www	NN	O	www	_	0	SENT_142	[p11l6t990r229b1012],
2	.	.	O	.	_	0	SENT_142	[p11l6t990r229b1012],

1	the	DT	O	the	det	4	SENT_143	[p11l6t990r229b1012],
2	|	NN	O	|	nn	4	SENT_143	[p11l6t990r229b1012],
3	ancet.com	NN	O	ancet.com	nn	4	SENT_143	[p11l6t990r229b1012],
4	Vol370	NN	O	vol370	_	0	SENT_143	[p11l247t990r335b1015],
5	December	NNP	DATE	December	dep	4	SENT_143	[p11l355t990r471b1012],
6	22/29	CD	DATE	22/29	num	5	SENT_143	[p11l478t991r553b1015],
7	,	,	DATE	,	_	0	SENT_143	[p11l478t991r553b1015],
8	2007	CD	DATE	2007	num	5	SENT_143	[p11l562t993r621b1014],
9	2121	CD	DATE	2121	dep	4	SENT_143	[p11l6t1031r62b1049],

1	I	PRP	O	I	_	0	SENT_144	[p11l6t1124r53b1322],
2	Articles	NNPS	O	Articles	dep	1	SENT_144	[p11l101t1287r251b1323],

1	There	EX	O	there	expl	2	SENT_145	[p11l77t1583r297b1651],
2	were	VBD	O	be	_	0	SENT_145	[p11l324t1607r502b1651],
3	no	DT	O	no	det	4	SENT_145	[p11l530t1607r624b1651],
4	differences	NNS	O	difference	nsubj	2	SENT_145	[p11l653t1583r1065b1651],
5	between	IN	O	between	_	0	SENT_145	[p11l1094t1583r1407b1651],
6	Gly16Arg	NN	O	gly16arg	nn	8	SENT_145	[p11l1437t1583r1785b1672],
7	genotype	NN	O	genotype	nn	8	SENT_145	[p11l1813t1596r2150b1672],
8	groups	NNS	O	group	prep_between	4	SENT_145	[p11l9t1716r265b1782],
9	in	IN	O	in	_	0	SENT_145	[p11l328t1697r403b1759],
10	any	DT	O	any	det	11	SENT_145	[p11l464t1717r595b1782],
11	measure	NN	O	measure	prep_in	8	SENT_145	[p11l653t1716r977b1760],
12	of	IN	O	of	_	0	SENT_145	[p11l1039t1692r1123b1760],
13	asthma	NN	O	asthma	nn	14	SENT_145	[p11l1171t1692r1445b1760],
14	exacerbations	NNS	O	exacerbation	prep_of	11	SENT_145	[p11l1507t1692r2013b1760],
15	in	IN	O	in	_	0	SENT_145	[p11l2076t1697r2151b1759],
16	study	NN	O	study	prep_in	14	SENT_145	[p11l11t1802r211b1891],
17	2	CD	NUMBER	2	num	16	SENT_145	[p11l249t1808r307b1869],
18	.	.	O	.	_	0	SENT_145	[p11l249t1808r307b1869],

1	Across	IN	O	across	_	0	SENT_146	[p11l347t1807r596b1869],
2	all	DT	O	all	det	3	SENT_146	[p11l637t1802r722b1869],
3	races	NNS	O	race	prep_across	16	SENT_146	[p11l759t1826r947b1869],
4	and	CC	O	and	_	0	SENT_146	[p11l988t1802r1127b1869],
5	all	DT	O	all	det	7	SENT_146	[p11l1165t1802r1249b1869],
6	treatment	NN	O	treatment	nn	7	SENT_146	[p11l1286t1815r1656b1869],
7	groups	NNS	O	group	conj_and	3	SENT_146	[p11l1694t1826r1972b1891],
8	,	,	O	,	_	0	SENT_146	[p11l1694t1826r1972b1891],
9	just	RB	O	just	advmod	16	SENT_146	[p11l2012t1806r2152b1891],
10	under	IN	O	under	_	0	SENT_146	[p11l7t1911r234b1980],
11	10	CD	PERCENT	10	num	12	SENT_146	[p11l254t1916r406b1982],
12	%	NN	PERCENT	%	prep_under	9	SENT_146	[p11l254t1916r406b1982],
13	of	IN	O	of	_	0	SENT_146	[p11l427t1911r510b1980],
14	the	DT	O	the	det	15	SENT_146	[p11l516t1911r633b1980],
15	participants	NNS	O	participant	prep_of	12	SENT_146	[p11l652t1916r1095b2000],
16	had	VBD	O	have	_	0	SENT_146	[p11l1116t1911r1255b1980],
17	an	DT	O	a	det	19	SENT_146	[p11l1275t1936r1364b1980],
18	asthma	NN	O	asthma	nn	19	SENT_146	[p11l1385t1911r1659b1980],
19	exacerbation	NN	O	exacerbation	dobj	16	SENT_146	[p11l1679t1911r2151b1980],
20	(	CD	NUMBER	(	num	23	SENT_146	[p11l13t2020r213b2110],
21	table	NN	O	table	nn	23	SENT_146	[p11l13t2020r213b2110],
22	3	CD	NUMBER	3	num	23	SENT_146	[p11l253t2027r337b2110],
23	)	NN	O	)	nsubj	16	SENT_146	[p11l253t2027r337b2110],
24	.	.	O	.	_	0	SENT_146	[p11l253t2027r337b2110],

1	Time	NNP	O	Time	_	0	SENT_147	[p11l375t2025r570b2088],
2	to	TO	O	to	aux	3	SENT_147	[p11l605t2034r674b2088],
3	ﬁrst	VB	O	ﬁrst	infmod	1	SENT_147	[p11l710t2020r860b2088],
4	asthma	NN	O	asthma	nn	5	SENT_147	[p11l895t2020r1169b2088],
5	exacerbation	NN	O	exacerbation	nsubj	7	SENT_147	[p11l1205t2020r1677b2088],
6	was	VBD	O	be	cop	7	SENT_147	[p11l1709t2044r1849b2088],
7	similar	JJ	O	similar	ccomp	3	SENT_147	[p11l1889t2020r2152b2088],
8	between	IN	O	between	_	0	SENT_147	[p11l6t2130r320b2197],
9	genotype	NN	O	genotype	nn	10	SENT_147	[p11l385t2143r722b2219],
10	groups	NNS	O	group	prep_between	7	SENT_147	[p11l788t2154r1045b2219],
11	over	IN	O	over	_	0	SENT_147	[p11l1112t2154r1270b2197],
12	the	DT	O	the	det	13	SENT_147	[p11l1332t2130r1448b2197],
13	duration	NN	O	duration	prep_over	7	SENT_147	[p11l1514t2130r1835b2197],
14	of	IN	O	of	_	0	SENT_147	[p11l1900t2130r1983b2197],
15	the	DT	DURATION	the	det	18	SENT_147	[p11l2033t2130r2150b2197],
16	7	CD	DURATION	7	num	18	SENT_147	[p11l7t2243r45b2309],
17	month	NN	NUMBER	month	nn	18	SENT_147	[p11l65t2238r318b2307],
18	study	NN	O	study	prep_of	13	SENT_147	[p11l343t2238r543b2328],
19	(	CD	NUMBER	(	num	20	SENT_147	[p11l569t2245r730b2328],
20	p	NN	O	p	dep	1	SENT_147	[p11l569t2245r730b2328],
21	=	JJ	O	=	amod	22	SENT_147	[p11l569t2245r730b2328],
22	O	NN	O	o	dep	20	SENT_147	[p11l569t2245r730b2328],
23	-	:	O	-	_	0	SENT_147	[p11l748t2278r759b2289],
24	94	CD	DATE	94	dep	1	SENT_147	[p11l779t2245r878b2316],
25	;	:	O	;	_	0	SENT_147	[p11l779t2245r878b2316],
26	ﬁgure	NN	O	ﬁgure	nn	28	SENT_147	[p11l904t2238r1125b2328],
27	1	CD	NUMBER	1	num	28	SENT_147	[p11l1151t2245r1228b2328],
28	)	NN	O	)	dep	24	SENT_147	[p11l1151t2245r1228b2328],
29	.	.	O	.	_	0	SENT_147	[p11l1151t2245r1228b2328],

1	Asthma-related	JJ	O	asthma-related	amod	3	SENT_148	[p11l1253t2238r1832b2307],
2	hospital	NN	O	hospital	nn	3	SENT_148	[p11l1852t2238r2151b2327],
3	admissions	NNS	O	admission	nsubj	9	SENT_148	[p11l9t2347r434b2415],
4	and	CC	O	and	_	0	SENT_148	[p11l456t2347r595b2415],
5	emergency	NN	O	emergency	nn	6	SENT_148	[p11l614t2372r1027b2437],
6	visits	NNS	O	visit	conj_and	3	SENT_148	[p11l1041t2352r1231b2415],
7	were	VBD	O	be	cop	9	SENT_148	[p11l1251t2372r1430b2415],
8	rare	JJ	O	rare	amod	9	SENT_148	[p11l1449t2372r1596b2415],
9	(	NN	O	(	_	0	SENT_148	[p11l1621t2347r1835b2437],
10	three	CD	NUMBER	three	num	12	SENT_148	[p11l1621t2347r1835b2437],
11	Gly/Gly	NN	O	gly/gly	nn	12	SENT_148	[p11l1857t2347r2153b2437],
12	participants	NNS	O	participant	dep	9	SENT_148	[p11l7t2461r450b2546],
13	and	CC	O	and	_	0	SENT_148	[p11l479t2457r618b2524],
14	one	CD	NUMBER	one	num	16	SENT_148	[p11l644t2481r778b2524],
15	Arg/Arg	NN	O	arg/arg	nn	16	SENT_148	[p11l804t2462r1119b2546],
16	participant	NN	O	participant	conj_and	9	SENT_148	[p11l1144t2461r1570b2546],
17	;	:	O	;	_	0	SENT_148	[p11l1144t2461r1570b2546],
18	table	NN	O	table	nn	20	SENT_148	[p11l1599t2457r1777b2524],
19	3	CD	NUMBER	3	num	20	SENT_148	[p11l1808t2463r1892b2547],
20	)	NN	O	)	dep	16	SENT_148	[p11l1808t2463r1892b2547],
21	.	.	O	.	_	0	SENT_148	[p11l1808t2463r1892b2547],

1	In	IN	O	in	_	0	SENT_149	[p11l83t2572r161b2632],
2	study	NN	O	study	prep_in	9	SENT_149	[p11l204t2565r405b2655],
3	1	CD	NUMBER	1	num	2	SENT_149	[p11l445t2572r495b2644],
4	,	,	O	,	_	0	SENT_149	[p11l445t2572r495b2644],
5	all	DT	O	all	det	8	SENT_149	[p11l540t2565r625b2633],
6	Gly16Arg	NN	O	gly16arg	nn	8	SENT_149	[p11l668t2565r1016b2655],
7	genotype	NN	O	genotype	nn	8	SENT_149	[p11l1057t2579r1394b2655],
8	groups	NNS	O	group	nsubj	9	SENT_149	[p11l1437t2590r1692b2655],
9	showed	VBD	O	show	_	0	SENT_149	[p11l1738t2565r2021b2634],
10	an	DT	O	a	det	11	SENT_149	[p11l2061t2590r2151b2633],
11	improvement	NN	O	improvement	iobj	9	SENT_149	[p11l8t2679r521b2763],
12	in	IN	O	in	_	0	SENT_149	[p11l544t2679r618b2741],
13	morning	NN	TIME	morning	nn	14	SENT_149	[p11l642t2679r974b2764],
14	PEF	NN	O	pef	prep_in	11	SENT_149	[p11l1002t2679r1149b2741],
15	(	CD	NUMBER	(	num	17	SENT_149	[p11l1182t2681r1416b2764],
16	mean	JJ	O	mean	amod	17	SENT_149	[p11l1182t2681r1416b2764],
17	change	NN	O	change	dobj	9	SENT_149	[p11l1440t2674r1707b2764],
18	>	JJR	O	>	amod	17	SENT_149	[p11l1733t2679r1863b2742],
19	25	CD	NUMBER	25	number	20	SENT_149	[p11l1733t2679r1863b2742],
20	L	NN	O	l	dep	18	SENT_149	[p11l1895t2681r1968b2763],
21	/	:	O	/	punct	22	SENT_149	[p11l1895t2681r1968b2763],
22	min	NN	DURATION	min	dep	18	SENT_149	[p11l1974t2679r2147b2752],
23	;	:	O	;	_	0	SENT_149	[p11l1974t2679r2147b2752],
24	figure	NN	O	figure	nn	26	SENT_149	[p11l8t2784r229b2873],
25	2	CD	NUMBER	2	num	26	SENT_149	[p11l283t2790r344b2874],
26	)	NN	O	)	dep	22	SENT_149	[p11l283t2790r344b2874],
27	that	WDT	O	that	nsubjpass	29	SENT_149	[p11l399t2784r545b2851],
28	was	VBD	O	be	auxpass	29	SENT_149	[p11l592t2808r731b2851],
29	sustained	VBN	O	sustain	rcmod	17	SENT_149	[p11l786t2784r1145b2851],
30	over	IN	O	over	_	0	SENT_149	[p11l1195t2808r1353b2851],
31	time	NN	O	time	prep_over	29	SENT_149	[p11l1401t2788r1591b2851],
32	.	.	O	.	_	0	SENT_149	[p11l1401t2788r1591b2851],

1	Further	RB	O	further	advmod	4	SENT_150	[p11l1650t2784r1940b2862],
2	,	,	O	,	_	0	SENT_150	[p11l1650t2784r1940b2862],
3	they	PRP	O	they	nsubj	4	SENT_150	[p11l1993t2784r2153b2873],
4	showed	VBD	O	show	_	0	SENT_150	[p11l11t2893r294b2962],
5	a	DT	O	a	det	7	SENT_150	[p11l326t2918r362b2962],
6	mean	JJ	O	mean	amod	7	SENT_150	[p11l394t2918r606b2962],
7	improvement	NN	O	improvement	dobj	4	SENT_150	[p11l638t2898r1152b2982],
8	in	IN	O	in	_	0	SENT_150	[p11l1182t2898r1257b2961],
9	FEV1	NN	O	fev1	prep_in	4	SENT_150	[p11l1292t2898r1468b2979],
10	of	IN	O	of	_	0	SENT_150	[p11l1500t2893r1584b2962],
11	at	IN	O	at	quantmod	13	SENT_150	[p11l1603t2907r1668b2962],
12	least	JJS	O	least	mwe	11	SENT_150	[p11l1698t2894r1869b2962],
13	0-22	CD	NUMBER	0-22	num	14	SENT_150	[p11l1900t2900r2071b2962],
14	L	NN	O	l	prep_of	9	SENT_150	[p11l2110t2900r2152b2961],
15	during	IN	O	during	_	0	SENT_150	[p11l9t3002r261b3092],
16	the	DT	O	the	det	17	SENT_150	[p11l292t3002r409b3070],
17	study	NN	O	study	prep_during	4	SENT_150	[p11l445t3002r655b3092],
18	.	.	O	.	_	0	SENT_150	[p11l445t3002r655b3092],

1	There	EX	O	there	expl	2	SENT_151	[p11l690t3002r910b3070],
2	was	VBD	O	be	_	0	SENT_151	[p11l941t3026r1080b3070],
3	no	DT	O	no	det	4	SENT_151	[p11l1114t3027r1208b3070],
4	evidence	NN	O	evidence	nsubj	2	SENT_151	[p11l1243t3002r1567b3070],
5	of	IN	O	of	_	0	SENT_151	[p11l1601t3002r1684b3070],
6	a	DT	O	a	det	7	SENT_151	[p11l1704t3027r1742b3070],
7	difference	NN	O	difference	prep_of	4	SENT_151	[p11l1775t3002r2150b3070],
8	in	IN	O	in	_	0	SENT_151	[p12l8t21r82b83],
9	use	NN	O	use	prep_in	7	SENT_151	[p12l138t41r266b85],
10	of	IN	O	of	_	0	SENT_151	[p12l325t17r408b85],
11	as-needed	JJ	O	as-needed	amod	12	SENT_151	[p12l453t17r827b85],
12	medication	NN	O	medication	prep_of	9	SENT_151	[p12l883t17r1305b85],
13	for	IN	O	for	_	0	SENT_151	[p12l1361t17r1468b85],
14	symptom	NN	O	symptom	nn	15	SENT_151	[p12l1526t30r1879b106],
15	relief	NN	O	relief	prep_for	12	SENT_151	[p12l1936t17r2147b95],
16	,	,	O	,	_	0	SENT_151	[p12l1936t17r2147b95],
17	asthma	NN	O	asthma	conj_or	4	SENT_151	[p12l9t125r283b194],
18	total	JJ	O	total	amod	20	SENT_151	[p12l318t125r480b193],
19	symptom	NN	O	symptom	nn	20	SENT_151	[p12l519t139r872b215],
20	score	NN	NUMBER	score	dep	17	SENT_151	[p12l910t150r1122b204],
21	,	,	O	,	_	0	SENT_151	[p12l910t150r1122b204],
22	or	CC	O	or	_	0	SENT_151	[p12l1162t150r1239b194],
23	night-time	JJ	O	night-time	amod	24	SENT_151	[p12l1273t125r1669b215],
24	awakenings	NNS	O	awakening	nsubj	2	SENT_151	[p12l1707t125r2148b215],
25	between	IN	O	between	_	0	SENT_151	[p12l6t234r320b302],
26	Gly16Arg	NN	O	gly16arg	nn	27	SENT_151	[p12l434t234r782b324],
27	genotypes	NNS	O	genotype	prep_between	24	SENT_151	[p12l895t248r1290b324],
28	.	.	O	.	_	0	SENT_151	[p12l895t248r1290b324],

1	Improvements	NNP	O	Improvements	nsubj	6	SENT_152	[p12l1410t241r1962b323],
2	in	IN	O	in	_	0	SENT_152	[p12l2076t239r2151b301],
3	asthma-control	JJ	O	asthma-control	amod	4	SENT_152	[p12l9t344r575b411],
4	days	NNS	DURATION	day	prep_in	1	SENT_152	[p12l644t344r804b433],
5	were	VBD	O	be	cop	6	SENT_152	[p12l872t368r1051b411],
6	independent	JJ	O	independent	conj_and	6	SENT_152	[p12l1119t344r1596b432],
7	of	IN	O	of	_	0	SENT_152	[p12l1663t344r1746b411],
8	Gly16Arg	NN	O	gly16arg	nn	9	SENT_152	[p12l1803t344r2151b433],
9	genotype	NN	O	genotype	prep_of	6	SENT_152	[p12l9t467r346b543],
10	within	IN	O	within	_	0	SENT_152	[p12l367t453r610b521],
11	each	DT	O	each	det	13	SENT_152	[p12l634t453r802b521],
12	treatment	NN	O	treatment	nn	13	SENT_152	[p12l823t467r1194b521],
13	group	NN	O	group	prep_within	6	SENT_152	[p12l1215t478r1435b543],
14	and	CC	O	and	_	0	SENT_152	[p12l1459t453r1597b521],
15	as	IN	O	as	_	0	SENT_152	[p12l1619t478r1691b521],
16	a	DT	O	a	det	17	SENT_152	[p12l1716t478r1754b522],
17	combined	JJ	O	combined	prep_as	6	SENT_152	[p12l1776t453r2152b522],
18	inhaled	VBN	O	inhale	partmod	17	SENT_152	[p12l8t562r289b630],
19	corticosteroid	NN	O	corticosteroid	dobj	18	SENT_152	[p12l326t562r838b630],
20	plus	CC	O	plus	prep	19	SENT_152	[p12l873t562r1029b651],
21	longacting	VBG	O	longact	dep	20	SENT_152	[p12l1067t562r1464b652],
22	B,-agonist	JJ	O	b,-agonist	amod	23	SENT_152	[p12l1506t562r1871b652],
23	group	NN	O	group	dobj	21	SENT_152	[p12l1907t587r2147b652],
24	.	.	O	.	_	0	SENT_152	[p12l1907t587r2147b652],

1	No	DT	O	no	det	3	SENT_153	[p12l11t679r113b739],
2	significant	JJ	O	significant	amod	3	SENT_153	[p12l188t672r583b761],
3	interaction	NN	O	interaction	nsubj	4	SENT_153	[p12l652t676r1060b739],
4	existed	VBD	O	exist	_	0	SENT_153	[p12l1131t672r1389b739],
5	between	IN	O	between	_	0	SENT_153	[p12l1457t672r1772b739],
6	baseline	NN	O	baseline	nn	8	SENT_153	[p12l1841t672r2150b739],
7	bronchodilator	NN	O	bronchodilator	nn	8	SENT_153	[p12l6t780r567b849],
8	reversibility	NN	O	reversibility	prep_between	4	SENT_153	[p12l593t780r1036b870],
9	and	CC	O	and	_	0	SENT_153	[p12l1063t780r1201b848],
10	genotype	NN	O	genotype	prep_between	4	SENT_153	[p12l1230t794r1566b870],
11	with	IN	O	with	_	0	SENT_153	[p12l1593t780r1760b849],
12	respect	NN	O	respect	prep_with	4	SENT_153	[p12l1787t794r2055b869],
13	to	TO	O	to	_	0	SENT_153	[p12l2081t794r2150b849],
14	changes	NNS	O	change	prep_to	4	SENT_153	[p12l8t889r311b979],
15	in	IN	O	in	_	0	SENT_153	[p12l373t894r447b956],
16	lung	NN	O	lung	nn	17	SENT_153	[p12l504t889r676b979],
17	function	NN	O	function	prep_in	14	SENT_153	[p12l735t889r1072b957],
18	.	.	O	.	_	0	SENT_153	[p12l735t889r1072b957],

1	Similarly	RB	O	similarly	advmod	11	SENT_154	[p12l1141t889r1486b979],
2	,	,	O	,	_	0	SENT_154	[p12l1141t889r1486b979],
3	in	IN	O	in	_	0	SENT_154	[p12l1549t894r1623b956],
4	study	NN	O	study	prep_in	11	SENT_154	[p12l1685t889r1885b978],
5	2	CD	NUMBER	2	num	4	SENT_154	[p12l1944t896r2003b967],
6	,	,	O	,	_	0	SENT_154	[p12l1944t896r2003b967],
7	all	DT	O	all	det	10	SENT_154	[p12l2066t889r2151b957],
8	Gly16Arg	NN	O	gly16arg	nn	10	SENT_154	[p12l11t999r358b1088],
9	genotype	NN	O	genotype	nn	10	SENT_154	[p12l398t1012r735b1088],
10	groups	NNS	O	group	nsubj	11	SENT_154	[p12l776t1023r1032b1088],
11	showed	VBD	O	show	_	0	SENT_154	[p12l1076t999r1359b1066],
12	an	DT	O	a	det	13	SENT_154	[p12l1397t1023r1487b1066],
13	improvement	NN	O	improvement	dobj	11	SENT_154	[p12l1525t1003r2039b1088],
14	in	IN	O	in	_	0	SENT_154	[p12l2076t1003r2151b1065],
15	morning	NN	TIME	morning	nn	16	SENT_154	[p12l8t1112r340b1197],
16	PEF	NN	O	pef	prep_in	11	SENT_154	[p12l392t1112r539b1174],
17	and	CC	O	and	_	0	SENT_154	[p12l592t1107r731b1175],
18	there	EX	O	there	expl	19	SENT_154	[p12l777t1107r969b1176],
19	were	VBD	O	be	conj_and	11	SENT_154	[p12l1017t1132r1195b1176],
20	no	DT	O	no	det	22	SENT_154	[p12l1244t1132r1338b1176],
21	clear	JJ	O	clear	amod	22	SENT_154	[p12l1389t1107r1566b1175],
22	differences	NNS	O	difference	nsubj	19	SENT_154	[p12l1614t1107r2025b1176],
23	in	IN	O	in	_	0	SENT_154	[p12l2076t1112r2151b1174],
24	response	NN	O	response	prep_in	22	SENT_154	[p12l8t1240r343b1305],
25	at	IN	O	at	_	0	SENT_154	[p12l399t1230r465b1284],
26	the	DT	O	the	det	43	SENT_154	[p12l517t1216r633b1284],
27	end	NN	O	end	dep	43	SENT_154	[p12l690t1216r828b1284],
28	of	IN	O	of	_	0	SENT_154	[p12l883t1216r966b1284],
29	the	DT	O	the	det	30	SENT_154	[p12l1007t1216r1123b1284],
30	study	NN	O	study	prep_of	27	SENT_154	[p12l1181t1216r1382b1305],
31	between	IN	O	between	_	0	SENT_154	[p12l1432t1216r1746b1284],
32	Gly16Arg	NN	O	gly16arg	nn	34	SENT_154	[p12l1803t1216r2151b1306],
33	genotype	NN	O	genotype	nn	34	SENT_154	[p12l9t1339r346b1415],
34	groups	NNS	O	group	prep_between	30	SENT_154	[p12l381t1350r638b1415],
35	for	IN	O	for	_	0	SENT_154	[p12l674t1326r780b1393],
36	change	NN	O	change	prep_for	34	SENT_154	[p12l813t1326r1080b1415],
37	in	IN	O	in	_	0	SENT_154	[p12l1114t1330r1188b1392],
38	morning	NN	TIME	morning	nn	39	SENT_154	[p12l1221t1330r1554b1415],
39	PEF	NN	O	pef	prep_in	36	SENT_154	[p12l1591t1330r1738b1392],
40	(	CD	NUMBER	(	num	39	SENT_154	[p12l1781t1326r2024b1416],
41	ﬁgure	NN	O	ﬁgure	nn	43	SENT_154	[p12l1781t1326r2024b1416],
42	2	CD	NUMBER	2	num	43	SENT_154	[p12l2061t1332r2147b1416],
43	)	NN	O	)	prep_at	24	SENT_154	[p12l2061t1332r2147b1416],
44	.	.	O	.	_	0	SENT_154	[p12l2061t1332r2147b1416],

1	Additionally	RB	O	additionally	advmod	45	SENT_155	[p12l6t1434r477b1524],
2	,	,	O	,	_	0	SENT_155	[p12l6t1434r477b1524],
3	no	DT	O	no	det	5	SENT_155	[p12l523t1459r617b1503],
4	clear	JJ	O	clear	amod	5	SENT_155	[p12l663t1434r840b1503],
5	differences	NNS	O	difference	nsubjpass	12	SENT_155	[p12l883t1434r1294b1503],
6	in	IN	O	in	_	0	SENT_155	[p12l1340t1439r1415b1501],
7	response	NN	O	response	prep_in	5	SENT_155	[p12l1458t1459r1794b1523],
8	between	IN	O	between	_	0	SENT_155	[p12l1837t1434r2151b1503],
9	Gly16Arg	NN	O	gly16arg	nn	10	SENT_155	[p12l11t1543r358b1633],
10	groups	NNS	O	group	prep_between	7	SENT_155	[p12l427t1567r684b1633],
11	were	VBD	O	be	auxpass	12	SENT_155	[p12l752t1568r930b1611],
12	noted	VBN	O	note	parataxis	45	SENT_155	[p12l1000t1543r1212b1611],
13	with	IN	O	with	_	0	SENT_155	[p12l1277t1543r1443b1611],
14	other	JJ	O	other	amod	17	SENT_155	[p12l1511t1543r1708b1611],
15	secondary	JJ	O	secondary	amod	17	SENT_155	[p12l1777t1543r2153b1633],
16	outcome	NN	O	outcome	nn	17	SENT_155	[p12l10t1666r333b1721],
17	measures	NNS	O	measure	prep_with	12	SENT_155	[p12l365t1677r722b1721],
18	including	VBG	O	include	_	0	SENT_155	[p12l756t1652r1114b1742],
19	change	NN	O	change	prep_including	17	SENT_155	[p12l1146t1652r1411b1742],
20	in	IN	O	in	_	0	SENT_155	[p12l1443t1657r1518b1719],
21	FEV	NNP	O	FEV	prep_in	19	SENT_155	[p12l1552t1657r1745b1737],
22	,	,	O	,	_	0	SENT_155	[p12l1552t1657r1745b1737],
23	,	,	O	,	_	0	SENT_155	[p12l1552t1657r1745b1737],
24	use	NN	O	use	nsubj	45	SENT_155	[p12l1778t1677r1905b1721],
25	of	IN	O	of	_	0	SENT_155	[p12l1939t1652r2022b1721],
26	asneeded	JJ	O	asneeded	amod	27	SENT_155	[p12l2041t1677r2138b1721, p12l9t1761r278b1829],
27	medication	NN	O	medication	prep_of	24	SENT_155	[p12l308t1761r747b1839],
28	,	,	O	,	_	0	SENT_155	[p12l308t1761r747b1839],
29	number	NN	O	number	conj_and	27	SENT_155	[p12l781t1761r1084b1829],
30	of	IN	O	of	_	0	SENT_155	[p12l1114t1761r1198b1829],
31	nights	NNS	TIME	night	prep_of	29	SENT_155	[p12l1216t1761r1448b1851],
32	with	IN	O	with	_	0	SENT_155	[p12l1479t1761r1645b1829],
33	awakenings	NNS	O	awakening	prep_with	31	SENT_155	[p12l1676t1761r2136b1851],
34	,	,	O	,	_	0	SENT_155	[p12l1676t1761r2136b1851],
35	asthma	NN	O	asthma	nn	37	SENT_155	[p12l10t1872r282b1940],
36	symptom	NN	O	symptom	nn	37	SENT_155	[p12l314t1885r664b1961],
37	scores	NNS	O	score	appos	33	SENT_155	[p12l696t1896r944b1950],
38	,	,	O	,	_	0	SENT_155	[p12l696t1896r944b1950],
39	and	CC	O	and	_	0	SENT_155	[p12l978t1872r1115b1940],
40	number	NN	O	number	conj_and	27	SENT_155	[p12l1144t1872r1447b1940],
41	of	IN	O	of	_	0	SENT_155	[p12l1475t1872r1558b1940],
42	asthma	NN	O	asthma	nn	44	SENT_155	[p12l1576t1872r1848b1940],
43	control	NN	O	control	nn	44	SENT_155	[p12l1878t1872r2140b1940],
44	days	NNS	DURATION	day	prep_of	40	SENT_155	[p12l10t1980r169b2070],
45	(	VBP	O	(	_	0	SENT_155	[p12l231t1980r406b2070],
46	data	NNS	O	datum	nsubj	47	SENT_155	[p12l231t1980r406b2070],
47	available	JJ	O	available	xcomp	45	SENT_155	[p12l459t1980r779b2049],
48	from	IN	O	from	_	0	SENT_155	[p12l833t1980r1017b2048],
49	the	DT	O	the	det	51	SENT_155	[p12l1068t1980r1185b2048],
50	corresponding	JJ	O	corresponding	amod	51	SENT_155	[p12l1240t1980r1782b2070],
51	author	NN	O	author	poss	54	SENT_155	[p12l1837t1980r2137b2049],
52	’s	POS	O	’s	_	0	SENT_155	[p12l1837t1980r2137b2049],
53	website	NN	O	website	nn	54	SENT_155	[p12l7t2089r335b2179],
54	)	NN	O	)	prep_from	47	SENT_155	[p12l7t2089r335b2179],
55	.	.	O	.	_	0	SENT_155	[p12l7t2089r335b2179],

1	Importantly	RB	O	importantly	advmod	7	SENT_156	[p12l397t2089r852b2178],
2	,	,	O	,	_	0	SENT_156	[p12l397t2089r852b2178],
3	these	DT	O	these	det	4	SENT_156	[p12l909t2089r1105b2157],
4	results	NNS	O	result	nsubjpass	7	SENT_156	[p12l1160t2089r1407b2157],
5	were	VBD	O	be	auxpass	7	SENT_156	[p12l1462t2114r1640b2157],
6	consistently	RB	O	consistently	advmod	7	SENT_156	[p12l1697t2089r2142b2179],
7	reported	VBN	O	report	_	0	SENT_156	[p12l9t2199r325b2288],
8	with	IN	O	with	_	0	SENT_156	[p12l384t2199r549b2266],
9	two	CD	NUMBER	two	prep_with	7	SENT_156	[p12l610t2212r742b2266],
10	different	JJ	O	different	amod	9	SENT_156	[p12l807t2199r1129b2266],
11	longacting	VBG	O	longact	xcomp	7	SENT_156	[p12l1189t2199r1583b2288],
12	B,-agonists	NNS	O	b,-agonist	nsubj	14	SENT_156	[p12l1651t2199r2142b2288],
13	—	CD	NUMBER	—	num	14	SENT_156	[p12l1651t2199r2142b2288],
14	formoterol	NN	O	formoterol	xcomp	11	SENT_156	[p12l9t2308r409b2377],
15	and	CC	O	and	_	0	SENT_156	[p12l455t2308r593b2377],
16	salmeterol	NN	O	salmeterol	xcomp	11	SENT_156	[p12l639t2308r1046b2377],
17	.	.	O	.	_	0	SENT_156	[p12l639t2308r1046b2377],

1	56	CD	PERCENT	56	num	2	SENT_157	[p12l1099t2313r1257b2379],
2	%	NN	PERCENT	%	nsubj	11	SENT_157	[p12l1099t2313r1257b2379],
3	of	IN	O	of	_	0	SENT_157	[p12l1304t2308r1387b2377],
4	the	DT	O	the	det	5	SENT_157	[p12l1417t2308r1533b2377],
5	participants	NNS	O	participant	prep_of	2	SENT_157	[p12l1578t2313r2018b2397],
6	in	IN	O	in	_	0	SENT_157	[p12l2066t2313r2140b2376],
7	study	NN	O	study	prep_in	5	SENT_157	[p12l11t2418r211b2507],
8	2	CD	NUMBER	2	num	7	SENT_157	[p12l275t2425r311b2485],
9	did	VBD	O	do	aux	11	SENT_157	[p12l378t2418r495b2486],
10	not	RB	O	not	neg	11	SENT_157	[p12l557t2432r680b2486],
11	have	VB	O	have	_	0	SENT_157	[p12l740t2418r911b2487],
12	baseline	NN	O	baseline	nn	13	SENT_157	[p12l973t2418r1281b2486],
13	FEV	NN	O	fev	dobj	11	SENT_157	[p12l1349t2423r1524b2503],
14	,	,	O	,	_	0	SENT_157	[p12l1349t2423r1524b2503],
15	bronchodilator	NN	O	bronchodilator	nn	16	SENT_157	[p12l1584t2418r2141b2486],
16	reversibility	NN	O	reversibility	appos	13	SENT_157	[p12l9t2528r449b2617],
17	of	IN	O	of	_	0	SENT_157	[p12l473t2528r555b2595],
18	at	IN	O	at	quantmod	20	SENT_157	[p12l569t2541r634b2595],
19	least	JJS	O	least	mwe	18	SENT_157	[p12l656t2528r827b2595],
20	12	CD	PERCENT	12	num	21	SENT_157	[p12l853t2532r1022b2599],
21	%	NN	PERCENT	%	prep_of	16	SENT_157	[p12l853t2532r1022b2599],
22	.	.	O	.	_	0	SENT_157	[p12l853t2532r1022b2599],

1	No	DT	O	no	det	3	SENT_158	[p12l1054t2535r1156b2595],
2	signiﬁcant	NN	O	signiﬁcant	nn	3	SENT_158	[p12l1185t2528r1578b2617],
3	difference	NN	O	difference	nsubjpass	5	SENT_158	[p12l1602t2528r1975b2595],
4	was	VBD	O	be	auxpass	5	SENT_158	[p12l1999t2552r2137b2595],
5	noted	VBN	O	note	_	0	SENT_158	[p12l9t2636r220b2705],
6	in	IN	O	in	_	0	SENT_158	[p12l269t2641r343b2703],
7	response	NN	O	response	prep_in	5	SENT_158	[p12l393t2661r727b2725],
8	by	IN	O	by	_	0	SENT_158	[p12l776t2636r864b2726],
9	genotype	NN	O	genotype	agent	5	SENT_158	[p12l913t2650r1248b2726],
10	in	IN	O	in	_	0	SENT_158	[p12l1299t2641r1374b2703],
11	the	DT	O	the	det	15	SENT_158	[p12l1423t2636r1539b2704],
12	reversible	JJ	O	reversible	amod	15	SENT_158	[p12l1590t2636r1951b2705],
13	and	CC	O	and	_	0	SENT_158	[p12l2003t2636r2141b2704],
14	non-reversible	JJ	O	non-reversible	amod	15	SENT_158	[p12l9t2745r545b2813],
15	participants	NNS	O	participant	prep_in	9	SENT_158	[p12l604t2750r1044b2834],
16	(	VBP	O	(	rcmod	15	SENT_158	[p12l1111t2745r1287b2835],
17	data	NNS	O	datum	nsubj	18	SENT_158	[p12l1111t2745r1287b2835],
18	available	JJ	O	available	xcomp	16	SENT_158	[p12l1402t2745r1721b2813],
19	from	IN	O	from	_	0	SENT_158	[p12l1781t2745r1965b2813],
20	the	DT	O	the	det	22	SENT_158	[p12l2023t2745r2139b2813],
21	corresponding	JJ	O	corresponding	amod	22	SENT_158	[p12l9t2855r553b2944],
22	author	NN	O	author	poss	25	SENT_158	[p12l579t2855r880b2922],
23	’s	POS	O	’s	_	0	SENT_158	[p12l579t2855r880b2922],
24	website	NN	O	website	nn	25	SENT_158	[p12l907t2855r1235b2945],
25	)	NN	O	)	prep_from	18	SENT_158	[p12l907t2855r1235b2945],
26	.	.	O	.	_	0	SENT_158	[p12l907t2855r1235b2945],

1	All	DT	O	all	nsubjpass	12	SENT_159	[p12l78t2963r184b3030],
2	inhaled	VBN	O	inhale	partmod	1	SENT_159	[p12l234t2963r515b3031],
3	corticosteroid	NN	O	corticosteroid	dobj	2	SENT_159	[p12l565t2963r1073b3031],
4	plus	CC	O	plus	prep	3	SENT_159	[p12l1121t2963r1277b3052],
5	longacting	VBG	O	longact	dep	4	SENT_159	[p12l1328t2963r1723b3053],
6	[	CD	NUMBER	[	num	9	SENT_159	[p12l1778t2963r2141b3053],
7	32-agonist	JJ	O	32-agonist	amod	9	SENT_159	[p12l1778t2963r2141b3053],
8	treatment	NN	O	treatment	nn	9	SENT_159	[p12l8t3086r377b3140],
9	regimens	NNS	O	regimen	dobj	5	SENT_159	[p12l418t3077r768b3162],
10	were	VBD	O	be	auxpass	12	SENT_159	[p12l812t3097r991b3140],
11	well	RB	O	well	advmod	12	SENT_159	[p12l1033t3072r1184b3140],
12	tolerated	VBN	O	tolerate	_	0	SENT_159	[p12l1226t3072r1553b3140],
13	irrespective	RB	O	irrespective	_	0	SENT_159	[p12l1595t3077r2025b3161],
14	of	IN	O	of	_	0	SENT_159	[p12l2070t3072r2153b3140],
15	ADRB2	NN	O	adrb2	nn	17	SENT_159	[p12l7t3187r297b3248],
16	Gly16Arg	NN	O	gly16arg	nn	17	SENT_159	[p12l366t3182r712b3271],
17	genotype	NN	O	genotype	prep_irrespective_of	12	SENT_159	[p12l785t3195r1139b3271],
18	.	.	O	.	_	0	SENT_159	[p12l785t3195r1139b3271],

1	In	IN	O	in	_	0	SENT_160	[p12l1219t3189r1297b3248],
2	study	NN	O	study	prep_in	21	SENT_160	[p12l1371t3182r1570b3271],
3	1	CD	NUMBER	1	nsubj	21	SENT_160	[p12l1643t3188r1691b3260],
4	,	,	O	,	_	0	SENT_160	[p12l1643t3188r1691b3260],
5	the	DT	O	the	det	11	SENT_160	[p12l1765t3182r1882b3249],
6	most	RBS	O	most	advmod	7	SENT_160	[p12l1954t3195r2141b3249],
7	frequently	RB	O	frequently	advmod	8	SENT_160	[p12l9t3291r394b3381],
8	reported	VBN	O	report	amod	11	SENT_160	[p12l446t3291r762b3380],
9	serious	JJ	O	serious	amod	10	SENT_160	[p12l817t3296r1082b3360],
10	adverse	JJ	O	adverse	amod	11	SENT_160	[p12l1139t3291r1417b3360],
11	event	NN	O	event	appos	3	SENT_160	[p12l1473t3305r1689b3369],
12	,	,	O	,	_	0	SENT_160	[p12l1473t3305r1689b3369],
13	worsening	VBG	O	worsen	amod	16	SENT_160	[p12l1745t3296r2140b3381],
14	asthma	NN	O	asthma	nn	16	SENT_160	[p12l10t3400r282b3468],
15	(	NN	O	(	nn	16	SENT_160	[p12l333t3405r574b3490],
16	n	NN	O	n	appos	3	SENT_160	[p12l333t3405r574b3490],
17	=	JJ	O	=	amod	16	SENT_160	[p12l333t3405r574b3490],
18	17	CD	NUMBER	17	num	19	SENT_160	[p12l333t3405r574b3490],
19	)	NN	O	)	dep	17	SENT_160	[p12l333t3405r574b3490],
20	,	,	O	,	_	0	SENT_160	[p12l333t3405r574b3490],
21	arose	VBD	O	arise	_	0	SENT_160	[p12l624t3424r818b3468],
22	at	IN	O	at	_	0	SENT_160	[p12l865t3414r930b3468],
23	a	DT	O	a	det	25	SENT_160	[p12l974t3425r1010b3468],
24	similar	JJ	O	similar	amod	25	SENT_160	[p12l1058t3400r1320b3468],
25	frequency	NN	O	frequency	prep_at	21	SENT_160	[p12l1363t3400r1736b3490],
26	across	IN	O	across	_	0	SENT_160	[p12l1780t3424r2007b3468],
27	all	DT	O	all	det	29	SENT_160	[p12l2056t3400r2140b3468],
28	genotype	NN	O	genotype	nn	29	SENT_160	[p12l10t3523r345b3599],
29	groups	NNS	O	group	prep_across	21	SENT_160	[p12l410t3534r686b3599],
30	.	.	O	.	_	0	SENT_160	[p12l410t3534r686b3599],

1	Five	CD	NUMBER	five	num	2	SENT_161	[p12l757t3514r904b3577],
2	participants	NNS	O	participant	_	0	SENT_161	[p12l968t3514r1407b3598],
3	discontinued	VBN	O	discontinue	partmod	2	SENT_161	[p12l1474t3510r1962b3577],
4	the	DT	O	the	det	5	SENT_161	[p12l2023t3510r2139b3577],
5	study	NN	O	study	dobj	3	SENT_161	[p12l11t3618r211b3708],
6	because	IN	O	because	_	0	SENT_161	[p12l232t3618r528b3687],
7	of	IN	O	of	prepc_because_of	3	SENT_161	[p12l555t3618r638b3686],
8	asthma	NN	O	asthma	pobj	3	SENT_161	[p12l652t3618r943b3697],
9	;	:	O	;	_	0	SENT_161	[p12l652t3618r943b3697],
10	four	CD	NUMBER	four	dep	2	SENT_161	[p12l972t3618r1130b3687],
11	with	IN	O	with	_	0	SENT_161	[p12l1151t3618r1317b3687],
12	the	DT	O	the	det	14	SENT_161	[p12l1340t3618r1457b3686],
13	Gly/Gly	NNP	O	Gly/Gly	nn	14	SENT_161	[p12l1485t3618r1780b3708],
14	genotype	NN	O	genotype	prep_with	10	SENT_161	[p12l1804t3632r2139b3708],
15	and	CC	O	and	_	0	SENT_161	[p12l10t3727r147b3795],
16	one	CD	NUMBER	one	conj_and	10	SENT_161	[p12l171t3752r305b3795],
17	with	IN	O	with	_	0	SENT_161	[p12l328t3727r493b3795],
18	the	DT	O	the	det	20	SENT_161	[p12l515t3727r632b3795],
19	Gly/Arg	NN	O	gly/arg	nn	20	SENT_161	[p12l659t3727r960b3817],
20	genotype	NN	O	genotype	prep_with	16	SENT_161	[p12l985t3741r1339b3817],
21	.	.	O	.	_	0	SENT_161	[p12l985t3741r1339b3817],

1	Two	CD	NUMBER	two	num	2	SENT_162	[p12l1366t3732r1518b3795],
2	individuals	NNS	O	individual	nsubj	3	SENT_162	[p12l1544t3727r1955b3795],
3	died	VBD	O	die	_	0	SENT_162	[p12l1982t3727r2141b3795],
4	during	IN	O	during	_	0	SENT_162	[p13l10t18r261b107],
5	the	DT	O	the	det	6	SENT_162	[p13l285t18r401b85],
6	study	NN	O	study	prep_during	3	SENT_162	[p13l430t18r639b107],
7	,	,	O	,	_	0	SENT_162	[p13l430t18r639b107],
8	one	CD	NUMBER	one	prep_during	3	SENT_162	[p13l669t42r803b85],
9	with	IN	O	with	_	0	SENT_162	[p13l827t18r992b85],
10	the	DT	O	the	det	12	SENT_162	[p13l1017t18r1132b85],
11	Gly/Gly	NNP	O	Gly/Gly	nn	12	SENT_162	[p13l1162t18r1455b107],
12	genotype	NN	O	genotype	prep_with	8	SENT_162	[p13l1480t31r1816b107],
13	and	CC	O	and	_	0	SENT_162	[p13l1843t18r1980b85],
14	one	CD	NUMBER	one	conj_and	6	SENT_162	[p13l2006t42r2139b85],
15	with	IN	O	with	_	0	SENT_162	[p13l7t126r172b195],
16	the	DT	O	the	det	18	SENT_162	[p13l204t126r321b194],
17	Gly/Arg	NN	O	gly/arg	nn	18	SENT_162	[p13l358t126r659b216],
18	genotype	NN	O	genotype	prep_with	3	SENT_162	[p13l694t140r1048b216],
19	.	.	O	.	_	0	SENT_162	[p13l694t140r1048b216],

1	Neither	DT	O	neither	det	2	SENT_163	[p13l1089t126r1368b194],
2	death	NN	O	death	nsubjpass	4	SENT_163	[p13l1401t126r1605b195],
3	was	VBD	O	be	auxpass	4	SENT_163	[p13l1636t151r1775b195],
4	regarded	VBN	O	regard	_	0	SENT_163	[p13l1811t126r2141b216],
5	by	IN	O	by	_	0	SENT_163	[p13l7t235r94b325],
6	the	DT	O	the	det	7	SENT_163	[p13l119t235r235b303],
7	investigator	NN	O	investigator	agent	4	SENT_163	[p13l264t240r704b325],
8	as	IN	O	as	_	0	SENT_163	[p13l731t259r803b303],
9	causally	RB	O	causally	advmod	10	SENT_163	[p13l834t235r1129b325],
10	related	VBN	O	relate	amod	14	SENT_163	[p13l1156t235r1409b303],
11	to	TO	O	to	_	0	SENT_163	[p13l1435t249r1503b303],
12	the	DT	O	the	det	13	SENT_163	[p13l1532t235r1648b303],
13	study	NN	O	study	prep_to	10	SENT_163	[p13l1679t235r1879b325],
14	drugs	NNS	O	drug	prep_as	7	SENT_163	[p13l1906t235r2135b325],
15	.	.	O	.	_	0	SENT_163	[p13l1906t235r2135b325],

1	One	CD	NUMBER	one	nsubjpass	16	SENT_164	[p13l11t351r165b412],
2	of	IN	O	of	_	0	SENT_164	[p13l188t345r270b412],
3	the	DT	O	the	det	7	SENT_164	[p13l277t345r393b412],
4	six	CD	NUMBER	six	num	7	SENT_164	[p13l417t349r516b412],
5	serious	JJ	O	serious	amod	7	SENT_164	[p13l537t349r801b412],
6	adverse	JJ	O	adverse	amod	7	SENT_164	[p13l825t345r1103b412],
7	events	NNS	O	event	prep_of	1	SENT_164	[p13l1126t358r1358b412],
8	in	IN	O	in	_	0	SENT_164	[p13l1381t349r1455b411],
9	the	DT	O	the	det	11	SENT_164	[p13l1475t345r1591b412],
10	genetic	JJ	O	genetic	amod	11	SENT_164	[p13l1614t349r1881b434],
11	subset	NN	O	subset	prep_in	7	SENT_164	[p13l1904t345r2141b412],
12	in	IN	O	in	_	0	SENT_164	[p13l9t458r83b520],
13	study	NN	O	study	prep_in	11	SENT_164	[p13l152t453r351b543],
14	2	CD	NUMBER	2	num	13	SENT_164	[p13l419t460r455b520],
15	was	VBD	O	be	auxpass	16	SENT_164	[p13l523t478r661b522],
16	caused	VBN	O	cause	_	0	SENT_164	[p13l731t453r985b522],
17	by	IN	O	by	_	0	SENT_164	[p13l1049t453r1136b543],
18	worsening	VBG	O	worsen	amod	19	SENT_164	[p13l1199t458r1595b543],
19	asthma	NN	O	asthma	agent	16	SENT_164	[p13l1662t453r1953b531],
20	;	:	O	;	_	0	SENT_164	[p13l1662t453r1953b531],
21	the	DT	O	the	det	22	SENT_164	[p13l2023t453r2139b522],
22	individual	NN	O	individual	nsubj	23	SENT_164	[p13l9t562r385b630],
23	had	VBD	O	have	parataxis	16	SENT_164	[p13l409t562r548b630],
24	an	DT	O	a	det	26	SENT_164	[p13l574t587r663b630],
25	Arg/Arg	NN	O	arg/arg	nn	26	SENT_164	[p13l687t567r1002b652],
26	genotype	NN	O	genotype	dobj	23	SENT_164	[p13l1028t576r1382b652],
27	.	.	O	.	_	0	SENT_164	[p13l1028t576r1382b652],

1	Six	CD	NUMBER	six	num	2	SENT_165	[p13l85t677r189b741],
2	haplotypes	NNS	O	haplotype	nsubjpass	12	SENT_165	[p13l217t673r610b762],
3	with	IN	O	with	_	0	SENT_165	[p13l642t673r805b741],
4	a	DT	O	a	det	5	SENT_165	[p13l837t697r874b741],
5	frequency	NN	O	frequency	prep_with	2	SENT_165	[p13l905t673r1272b762],
6	of	IN	O	of	_	0	SENT_165	[p13l1303t673r1385b741],
7	more	JJR	O	more	mwe	8	SENT_165	[p13l1403t697r1597b741],
8	than	IN	O	than	quantmod	9	SENT_165	[p13l1627t673r1794b741],
9	1	CD	PERCENT	1	num	10	SENT_165	[p13l1828t677r1933b744],
10	%	NN	PERCENT	%	prep_of	5	SENT_165	[p13l1828t677r1933b744],
11	were	VBD	O	be	auxpass	12	SENT_165	[p13l1964t697r2139b741],
12	predicted	VBN	O	predict	_	0	SENT_165	[p13l8t781r352b870],
13	in	IN	O	in	_	0	SENT_165	[p13l383t786r456b848],
14	the	DT	O	the	det	18	SENT_165	[p13l487t781r602b849],
15	study	NN	O	study	nn	18	SENT_165	[p13l638t781r834b871],
16	1	CD	NUMBER	1	num	18	SENT_165	[p13l867t788r898b848],
17	white	JJ	O	white	amod	18	SENT_165	[p13l927t781r1131b850],
18	population	NN	O	population	prep_in	12	SENT_165	[p13l1163t781r1562b870],
19	from	IN	O	from	_	0	SENT_165	[p13l1594t781r1776b849],
20	genotype	NN	O	genotype	nn	21	SENT_165	[p13l1809t795r2139b871],
21	data	NNS	O	datum	prep_from	18	SENT_165	[p13l10t890r160b958],
22	for	IN	O	for	_	0	SENT_165	[p13l218t890r323b958],
23	11	CD	NUMBER	11	num	26	SENT_165	[p13l383t896r449b957],
24	ADRB2	NN	O	adrb2	nn	26	SENT_165	[p13l506t896r792b957],
25	single-nucleotide	JJ	O	single-nucleotide	amod	26	SENT_165	[p13l849t890r1476b980],
26	polymorphisms	NNS	O	polymorphism	prep_for	21	SENT_165	[p13l1534t890r2136b979],
27	.	.	O	.	_	0	SENT_165	[p13l1534t890r2136b979],

1	Study	NNP	O	Study	_	0	SENT_166	[p13l452t1053r518b1080],
2	1	CD	NUMBER	1	num	1	SENT_166	[p13l525t1055r537b1073],
3	Study	NNP	O	Study	dep	1	SENT_166	[p13l1819t1053r1886b1080],
4	2	CD	NUMBER	2	num	3	SENT_166	[p13l1892t1055r1904b1073],
5	All	DT	O	all	det	6	SENT_166	[p13l451t1107r480b1128],
6	treatments	NNS	O	treatment	dep	1	SENT_166	[p13l486t1111r615b1128],
7	Budesonide/formoterol	NNP	O	Budesonide/formoterol	nn	11	SENT_166	[p13l793t1107r1060b1131],
8	Budesonide/formoterol	NNP	O	Budesonide/formoterol	nn	11	SENT_166	[p13l1130t1107r1397b1131],
9	Fluticasone/salmeterol	NNP	O	Fluticasone/salmeterol	nn	11	SENT_166	[p13l1483t1107r1741b1131],
10	All	NNP	O	All	dep	11	SENT_166	[p13l1819t1107r1848b1128],
11	treatments	NNS	O	treatment	dep	6	SENT_166	[p13l1853t1109r1994b1132],
12	§	IN	O	§	prep	11	SENT_166	[p13l1853t1109r1994b1132],

1	maintenance	NN	O	maintenance	_	0	SENT_167	[p13l792t1143r940b1163],
2	and	CC	O	and	_	0	SENT_167	[p13l947t1142r989b1163],
3	re	VB	O	re	conj_and	1	SENT_167	[p13l997t1142r1090b1163],
4	|	JJ	O	|	amod	6	SENT_167	[p13l997t1142r1090b1163],
5	iever	NN	O	iever	nn	6	SENT_167	[p13l997t1142r1090b1163],
6	*	NN	O	*	nsubj	7	SENT_167	[p13l997t1142r1090b1163],
7	ﬁxed	VBD	O	ﬁxed	ccomp	3	SENT_167	[p13l1129t1142r1185b1163],
8	dosei	JJ	O	dosei	amod	9	SENT_167	[p13l1192t1142r1257b1164],
9	‘	NN	O	‘	nsubj	10	SENT_167	[p13l1192t1142r1257b1164],
10	ﬁxed	VBD	O	ﬁxed	ccomp	7	SENT_167	[p13l1481t1142r1538b1163],
11	doseili	NNS	O	doseilus	dobj	10	SENT_167	[p13l1544t1142r1609b1164],

1	Gly/Gly	RB	O	gly/gly	dep	243	SENT_168	[p13l452t1197r529b1224],
2	Gly/Arg	NN	O	gly/arg	dep	243	SENT_168	[p13l556t1197r636b1224],
3	Arg/Arg	NN	O	arg/arg	dep	243	SENT_168	[p13l667t1198r752b1224],
4	Gly/Gly	NN	O	gly/gly	dep	243	SENT_168	[p13l792t1197r869b1224],
5	Gly/Arg	NN	O	gly/arg	dep	243	SENT_168	[p13l895t1197r975b1224],
6	Arg/Arg	NN	O	arg/arg	dep	243	SENT_168	[p13l1005t1198r1090b1224],
7	Gly/Gly	NN	O	gly/gly	dep	243	SENT_168	[p13l1130t1197r1207b1224],
8	Gly/Arg	NN	O	gly/arg	dep	243	SENT_168	[p13l1244t1197r1324b1224],
9	Arg/Arg	NN	O	arg/arg	dep	243	SENT_168	[p13l1354t1198r1439b1224],
10	Gly/Gly	NN	O	gly/gly	dep	243	SENT_168	[p13l1483t1197r1560b1224],
11	Gly/Arg	NN	O	gly/arg	dep	243	SENT_168	[p13l1588t1197r1668b1224],
12	Arg/Arg	NN	O	arg/arg	dep	243	SENT_168	[p13l1696t1198r1781b1224],
13	Gly/Gly	NN	O	gly/gly	dep	243	SENT_168	[p13l1820t1197r1897b1224],
14	Gly/Arg	NN	O	gly/arg	dep	243	SENT_168	[p13l1922t1197r2002b1224],
15	Arg/Arg	NN	O	arg/arg	dep	243	SENT_168	[p13l2028t1198r2113b1224],
16	Participants	NNS	O	participant	dep	243	SENT_168	[p13l43t1254r169b1279],
17	333 1028 361 290	CD	NUMBER	333 1028 361 290	dep	243	SENT_168	[p13l793t1255r835b1276],[p13l459t1252r499b1276],
18	334 114 284 330	CD	NUMBER	334 114 284 330	dep	243	SENT_168	[p13l1251t1255r1291b1276],[p13l897t1255r939b1276],
19	133 259 364 114	CD	NUMBER	133 259 364 114	dep	243	SENT_168	[p13l1709t1255r1748b1275],[p13l1363t1255r1401b1276],
20	163	CD	NUMBER	163	dep	243	SENT_168	[p13l1821t1252r1862b1273],
21	169	CD	NUMBER	169	dep	243	SENT_168	[p13l1923t1252r1964b1276],
22	67	CD	NUMBER	67	dep	243	SENT_168	[p13l2050t1252r2076b1275],
23	All	DT	O	all	dep	243	SENT_168	[p13l42t1302r69b1323],
24	severe	JJ	O	severe	dep	243	SENT_168	[p13l76t1309r143b1323],
25	exacerbations	NNS	O	exacerbation	dep	243	SENT_168	[p13l150t1302r299b1323],
26	Participants	NNS	O	participant	dep	243	SENT_168	[p13l67t1354r192b1379],
27	with	IN	O	with	dep	243	SENT_168	[p13l198t1352r246b1373],
28	21	CD	NUMBER	21	dep	243	SENT_168	[p13l254t1355r279b1373],
29	99	CD	NUMBER	99	dep	243	SENT_168	[p13l471t1355r499b1376],
30	110	CD	NUMBER	110	dep	243	SENT_168	[p13l573t1355r611b1373],
31	32	CD	NUMBER	32	dep	243	SENT_168	[p13l688t1355r714b1376],
32	27	CD	NUMBER	27	dep	243	SENT_168	[p13l810t1355r836b1376],
33	28	CD	NUMBER	28	dep	243	SENT_168	[p13l911t1352r938b1373],
34	6	CD	DATE	6	dep	243	SENT_168	[p13l1043t1352r1056b1373],
35	38	CD	DATE	38	dep	243	SENT_168	[p13l1150t1352r1176b1376],
36	34	CD	DATE	34	dep	243	SENT_168	[p13l1264t1355r1292b1376],
37	15	CD	DATE	15	dep	243	SENT_168	[p13l1377t1355r1401b1376],
38	34	CD	DATE	34	dep	243	SENT_168	[p13l1503t1351r1530b1372],
39	48	CD	DATE	48	dep	243	SENT_168	[p13l1602t1348r1631b1371],
40	11	CD	DATE	11	dep	243	SENT_168	[p13l1724t1351r1748b1368],
41	15	CD	DATE	15	dep	243	SENT_168	[p13l1838t1351r1862b1372],
42	13	CD	DATE	13	dep	243	SENT_168	[p13l1940t1351r1964b1372],
43	6	CD	NUMBER	6	dep	243	SENT_168	[p13l2063t1348r2076b1369],
44	(	NN	O	(	dep	243	SENT_168	[p13l452t1388r513b1413],
45	12	CD	PERCENT	12	dep	243	SENT_168	[p13l452t1388r513b1413],
46	%	NN	PERCENT	%	dep	243	SENT_168	[p13l452t1388r513b1413],
47	)	CD	PERCENT	)	dep	243	SENT_168	[p13l452t1388r513b1413],
48	(	CD	PERCENT	(	dep	243	SENT_168	[p13l556t1388r616b1413],
49	11	CD	PERCENT	11	dep	243	SENT_168	[p13l556t1388r616b1413],
50	%	NN	PERCENT	%	dep	243	SENT_168	[p13l556t1388r616b1413],
51	)	CD	PERCENT	)	dep	243	SENT_168	[p13l556t1388r616b1413],
52	(	CD	PERCENT	(	dep	243	SENT_168	[p13l667t1388r717b1413],
53	9	CD	PERCENT	9	dep	243	SENT_168	[p13l667t1388r717b1413],
54	%	NN	PERCENT	%	dep	243	SENT_168	[p13l667t1388r717b1413],
55	)	CD	PERCENT	)	dep	243	SENT_168	[p13l667t1388r717b1413],
56	(	CD	PERCENT	(	dep	243	SENT_168	[p13l792t1388r842b1413],
57	9	CD	PERCENT	9	dep	243	SENT_168	[p13l792t1388r842b1413],
58	%	NN	PERCENT	%	dep	243	SENT_168	[p13l792t1388r842b1413],
59	)	CD	NUMBER	)	dep	243	SENT_168	[p13l792t1388r842b1413],
60	(	NN	O	(	dep	243	SENT_168	[p13l896t1387r945b1413],
61	8	CD	PERCENT	8	dep	243	SENT_168	[p13l896t1387r945b1413],
62	%	NN	PERCENT	%	dep	243	SENT_168	[p13l896t1387r945b1413],
63	)	CD	NUMBER	)	dep	243	SENT_168	[p13l896t1387r945b1413],
64	(	NN	O	(	dep	243	SENT_168	[p13l1008t1388r1056b1413],
65	5	CD	PERCENT	5	dep	243	SENT_168	[p13l1008t1388r1056b1413],
66	%	NN	PERCENT	%	dep	243	SENT_168	[p13l1008t1388r1056b1413],
67	)	CD	PERCENT	)	dep	243	SENT_168	[p13l1008t1388r1056b1413],
68	(	CD	PERCENT	(	dep	243	SENT_168	[p13l1130t1388r1191b1413],
69	13	CD	PERCENT	13	dep	243	SENT_168	[p13l1130t1388r1191b1413],
70	%	NN	PERCENT	%	dep	243	SENT_168	[p13l1130t1388r1191b1413],
71	)	CD	PERCENT	)	dep	243	SENT_168	[p13l1130t1388r1191b1413],
72	(	CD	PERCENT	(	dep	243	SENT_168	[p13l1244t1388r1306b1413],
73	10	CD	PERCENT	10	dep	243	SENT_168	[p13l1244t1388r1306b1413],
74	%	NN	PERCENT	%	dep	243	SENT_168	[p13l1244t1388r1306b1413],
75	)	CD	PERCENT	)	dep	243	SENT_168	[p13l1244t1388r1306b1413],
76	(	CD	PERCENT	(	dep	243	SENT_168	[p13l1355t1388r1414b1413],
77	11	CD	PERCENT	11	dep	243	SENT_168	[p13l1355t1388r1414b1413],
78	%	NN	PERCENT	%	dep	243	SENT_168	[p13l1355t1388r1414b1413],
79	)	CD	PERCENT	)	dep	243	SENT_168	[p13l1355t1388r1414b1413],
80	(	CD	PERCENT	(	dep	243	SENT_168	[p13l1483t1383r1544b1408],
81	13	CD	PERCENT	13	dep	243	SENT_168	[p13l1483t1383r1544b1408],
82	%	NN	PERCENT	%	dep	243	SENT_168	[p13l1483t1383r1544b1408],
83	)	CD	PERCENT	)	dep	243	SENT_168	[p13l1483t1383r1544b1408],
84	(	CD	PERCENT	(	dep	243	SENT_168	[p13l1588t1384r1649b1408],
85	13	CD	PERCENT	13	dep	243	SENT_168	[p13l1588t1384r1649b1408],
86	%	NN	PERCENT	%	dep	243	SENT_168	[p13l1588t1384r1649b1408],
87	)	CD	PERCENT	)	dep	243	SENT_168	[p13l1588t1384r1649b1408],
88	(	CD	PERCENT	(	dep	243	SENT_168	[p13l1697t1384r1758b1408],
89	10	CD	PERCENT	10	dep	243	SENT_168	[p13l1697t1384r1758b1408],
90	%	NN	PERCENT	%	dep	243	SENT_168	[p13l1697t1384r1758b1408],
91	)	CD	PERCENT	)	dep	243	SENT_168	[p13l1697t1384r1758b1408],
92	(	CD	PERCENT	(	dep	243	SENT_168	[p13l1820t1384r1869b1408],
93	9	CD	PERCENT	9	dep	243	SENT_168	[p13l1820t1384r1869b1408],
94	%	NN	PERCENT	%	dep	243	SENT_168	[p13l1820t1384r1869b1408],
95	)	CD	NUMBER	)	dep	243	SENT_168	[p13l1820t1384r1869b1408],
96	(	NN	O	(	dep	243	SENT_168	[p13l1922t1382r1972b1408],
97	8	CD	PERCENT	8	dep	243	SENT_168	[p13l1922t1382r1972b1408],
98	%	NN	PERCENT	%	dep	243	SENT_168	[p13l1922t1382r1972b1408],
99	)	CD	PERCENT	)	dep	243	SENT_168	[p13l1922t1382r1972b1408],
100	(	CD	PERCENT	(	dep	243	SENT_168	[p13l2029t1383r2079b1408],
101	9	CD	PERCENT	9	dep	243	SENT_168	[p13l2029t1383r2079b1408],
102	%	NN	PERCENT	%	dep	243	SENT_168	[p13l2029t1383r2079b1408],
103	)	CD	NUMBER	)	dep	243	SENT_168	[p13l2029t1383r2079b1408],
104	Participants	NNS	O	participant	dep	243	SENT_168	[p13l67t1439r192b1464],
105	with	IN	O	with	dep	243	SENT_168	[p13l198t1437r246b1458],
106	22	CD	NUMBER	22	dep	243	SENT_168	[p13l254t1440r279b1458],
107	28	CD	NUMBER	28	dep	243	SENT_168	[p13l472t1437r499b1458],
108	23	CD	NUMBER	23	dep	243	SENT_168	[p13l586t1440r611b1461],
109	6	CD	NUMBER	6	dep	243	SENT_168	[p13l701t1437r714b1458],
110	6	CD	NUMBER	6	dep	243	SENT_168	[p13l822t1437r835b1458],
111	5	CD	NUMBER	5	dep	243	SENT_168	[p13l927t1440r938b1461],
112	2	CD	DATE	2	dep	243	SENT_168	[p13l1045t1440r1056b1458],
113	10	CD	DATE	10	dep	243	SENT_168	[p13l1152t1440r1177b1458],
114	3	CD	DATE	3	dep	243	SENT_168	[p13l1279t1440r1291b1461],
115	2	CD	DATE	2	dep	243	SENT_168	[p13l1390t1440r1401b1458],
116	12	CD	DATE	12	dep	243	SENT_168	[p13l1505t1436r1529b1453],
117	15	CD	DATE	15	dep	243	SENT_168	[p13l1607t1436r1631b1456],
118	2	CD	DATE	2	dep	243	SENT_168	[p13l1736t1436r1747b1453],
119	o	NN	O	o	dep	243	SENT_168	[p13l1850t1436r1863b1453],
120	4	CD	NUMBER	4	dep	243	SENT_168	[p13l1951t1435r1966b1456],
121	3	CD	NUMBER	3	dep	243	SENT_168	[p13l2064t1436r2075b1456],
122	(	NN	O	(	dep	243	SENT_168	[p13l452t1473r500b1498],
123	3	CD	PERCENT	3	dep	243	SENT_168	[p13l452t1473r500b1498],
124	%	NN	PERCENT	%	dep	243	SENT_168	[p13l452t1473r500b1498],
125	)	CD	NUMBER	)	dep	243	SENT_168	[p13l452t1473r500b1498],
126	(	NN	O	(	dep	243	SENT_168	[p13l563t1473r610b1498],
127	2	CD	PERCENT	2	dep	243	SENT_168	[p13l563t1473r610b1498],
128	%	NN	PERCENT	%	dep	243	SENT_168	[p13l563t1473r610b1498],
129	)	CD	NUMBER	)	dep	243	SENT_168	[p13l563t1473r610b1498],
130	(	NN	O	(	dep	243	SENT_168	[p13l667t1473r715b1498],
131	2	CD	PERCENT	2	dep	243	SENT_168	[p13l667t1473r715b1498],
132	%	NN	PERCENT	%	dep	243	SENT_168	[p13l667t1473r715b1498],
133	)	CD	NUMBER	)	dep	243	SENT_168	[p13l667t1473r715b1498],
134	(	NN	O	(	dep	243	SENT_168	[p13l792t1473r840b1498],
135	2	CD	PERCENT	2	dep	243	SENT_168	[p13l792t1473r840b1498],
136	%	NN	PERCENT	%	dep	243	SENT_168	[p13l792t1473r840b1498],
137	)	CD	NUMBER	)	dep	243	SENT_168	[p13l792t1473r840b1498],
138	(	NN	O	(	dep	243	SENT_168	[p13l896t1473r942b1498],
139	1	CD	PERCENT	1	dep	243	SENT_168	[p13l896t1473r942b1498],
140	%	NN	PERCENT	%	dep	243	SENT_168	[p13l896t1473r942b1498],
141	)	CD	NUMBER	)	dep	243	SENT_168	[p13l896t1473r942b1498],
142	(	NN	O	(	dep	243	SENT_168	[p13l1008t1473r1056b1498],
143	2	CD	PERCENT	2	dep	243	SENT_168	[p13l1008t1473r1056b1498],
144	%	NN	PERCENT	%	dep	243	SENT_168	[p13l1008t1473r1056b1498],
145	)	CD	NUMBER	)	dep	243	SENT_168	[p13l1008t1473r1056b1498],
146	(	NN	O	(	dep	243	SENT_168	[p13l1130t1473r1179b1498],
147	4	CD	PERCENT	4	dep	243	SENT_168	[p13l1130t1473r1179b1498],
148	%	NN	PERCENT	%	dep	243	SENT_168	[p13l1130t1473r1179b1498],
149	)	CD	NUMBER	)	dep	243	SENT_168	[p13l1130t1473r1179b1498],
150	(	NN	O	(	dep	243	SENT_168	[p13l1244t1473r1291b1498],
151	1	CD	PERCENT	1	dep	243	SENT_168	[p13l1244t1473r1291b1498],
152	%	NN	PERCENT	%	dep	243	SENT_168	[p13l1244t1473r1291b1498],
153	)	CD	NUMBER	)	dep	243	SENT_168	[p13l1244t1473r1291b1498],
154	(	NN	O	(	dep	243	SENT_168	[p13l1355t1473r1402b1498],
155	2	CD	PERCENT	2	dep	243	SENT_168	[p13l1355t1473r1402b1498],
156	%	NN	PERCENT	%	dep	243	SENT_168	[p13l1355t1473r1402b1498],
157	)	CD	NUMBER	)	dep	243	SENT_168	[p13l1355t1473r1402b1498],
158	(	NN	O	(	dep	243	SENT_168	[p13l1483t1468r1531b1493],
159	5	CD	PERCENT	5	dep	243	SENT_168	[p13l1483t1468r1531b1493],
160	%	NN	PERCENT	%	dep	243	SENT_168	[p13l1483t1468r1531b1493],
161	)	CD	NUMBER	)	dep	243	SENT_168	[p13l1483t1468r1531b1493],
162	(	NN	O	(	dep	243	SENT_168	[p13l1589t1468r1638b1493],
163	4	CD	PERCENT	4	dep	243	SENT_168	[p13l1589t1468r1638b1493],
164	%	NN	PERCENT	%	dep	243	SENT_168	[p13l1589t1468r1638b1493],
165	)	CD	NUMBER	)	dep	243	SENT_168	[p13l1589t1468r1638b1493],
166	(	NN	O	(	dep	243	SENT_168	[p13l1699t1468r1747b1493],
167	2	CD	PERCENT	2	dep	243	SENT_168	[p13l1699t1468r1747b1493],
168	%	NN	PERCENT	%	dep	243	SENT_168	[p13l1699t1468r1747b1493],
169	)	CD	NUMBER	)	dep	243	SENT_168	[p13l1699t1468r1747b1493],
170	(	NN	O	(	dep	243	SENT_168	[p13l1922t1468r1970b1493],
171	2	CD	PERCENT	2	dep	243	SENT_168	[p13l1922t1468r1970b1493],
172	%	NN	PERCENT	%	dep	243	SENT_168	[p13l1922t1468r1970b1493],
173	)	CD	NUMBER	)	dep	243	SENT_168	[p13l1922t1468r1970b1493],
174	(	NN	O	(	dep	243	SENT_168	[p13l2029t1468r2078b1493],
175	4	CD	PERCENT	4	dep	243	SENT_168	[p13l2029t1468r2078b1493],
176	%	NN	PERCENT	%	dep	243	SENT_168	[p13l2029t1468r2078b1493],
177	)	CD	NUMBER	)	dep	243	SENT_168	[p13l2029t1468r2078b1493],
178	Total	JJ	O	total	dep	243	SENT_168	[p13l64t1522r118b1543],
179	severe	JJ	O	severe	dep	243	SENT_168	[p13l126t1529r193b1543],
180	exacerbations	NNS	O	exacerbation	dep	243	SENT_168	[p13l200t1522r349b1543],
181	153	CD	NUMBER	153	dep	243	SENT_168	[p13l461t1525r499b1546],
182	152	CD	NUMBER	152	dep	243	SENT_168	[p13l573t1525r610b1546],
183	38	CD	NUMBER	38	dep	243	SENT_168	[p13l687t1522r714b1546],
184	33	CD	NUMBER	33	dep	243	SENT_168	[p13l809t1525r835b1546],
185	35	CD	NUMBER	35	dep	243	SENT_168	[p13l912t1525r938b1546],
186	3	CD	NUMBER	3	dep	243	SENT_168	[p13l1044t1522r1056b1543],
187	59	CD	NUMBER	59	dep	243	SENT_168	[p13l1150t1525r1176b1546],
188	37	CD	NUMBER	37	dep	243	SENT_168	[p13l1266t1525r1291b1546],
189	17	CD	NUMBER	17	dep	243	SENT_168	[p13l1377t1525r1402b1545],
190	51	CD	NUMBER	51	dep	243	SENT_168	[p13l1504t1517r1530b1538],
191	30	CD	NUMBER	30	dep	243	SENT_168	[p13l1604t1517r1631b1538],
192	13	CD	NUMBER	13	dep	243	SENT_168	[p13l1723t1520r1747b1541],
193	15	CD	NUMBER	15	dep	243	SENT_168	[p13l1838t1520r1862b1541],
194	13	CD	NUMBER	13	dep	243	SENT_168	[p13l1939t1517r1964b1538],
195	10	CD	NUMBER	10	dep	243	SENT_168	[p13l2051t1520r2076b1538],
196	Exacerbations	NNS	O	exacerbation	dep	243	SENT_168	[p13l67t1572r215b1593],
197	per	IN	O	per	dep	243	SENT_168	[p13l222t1579r256b1599],
198	participant	NN	O	participant	dep	243	SENT_168	[p13l262t1574r380b1599],
199	per	IN	O	per	dep	243	SENT_168	[p13l386t1579r420b1599],
200	0-20	CD	NUMBER	0-20	dep	243	SENT_168	[p13l452t1575r499b1593],
201	0-16	CD	NUMBER	0-16	dep	243	SENT_168	[p13l564t1572r611b1593],
202	0-12	CD	NUMBER	0-12	dep	243	SENT_168	[p13l669t1575r714b1593],
203	0-13	CD	NUMBER	0-13	dep	243	SENT_168	[p13l792t1575r837b1596],
204	0-12	CD	NUMBER	0-12	dep	243	SENT_168	[p13l895t1575r940b1593],
205	0-08	CD	NUMBER	0-08	dep	243	SENT_168	[p13l1007t1572r1056b1593],
206	0-23	CD	NUMBER	0-23	dep	243	SENT_168	[p13l1131t1575r1176b1596],
207	0-12	CD	NUMBER	0-12	dep	243	SENT_168	[p13l1246t1575r1290b1593],
208	0-14	CD	NUMBER	0-14	dep	243	SENT_168	[p13l1355t1575r1402b1596],
209	0-26	CD	NUMBER	0-26	dep	243	SENT_168	[p13l1482t1568r1530b1588],
210	0-24	CD	NUMBER	0-24	dep	243	SENT_168	[p13l1588t1571r1636b1591],
211	0-13	CD	NUMBER	0-13	dep	243	SENT_168	[p13l1702t1571r1747b1592],
212	0	CD	NUMBER	0	dep	243	SENT_168	[p13l1820t1571r1868b1592],
213	'09	CD	NUMBER	'09	dep	243	SENT_168	[p13l1820t1571r1868b1592],
214	0-10	CD	NUMBER	0-10	dep	243	SENT_168	[p13l1922t1571r1968b1589],
215	0-14	CD	NUMBER	0-14	dep	243	SENT_168	[p13l2029t1571r2077b1591],
216	6	CD	DURATION	6	dep	243	SENT_168	[p13l66t1607r79b1628],
217	months	NNS	NUMBER	month	dep	243	SENT_168	[p13l87t1607r170b1628],
218	Hospital	NN	O	hospital	dep	243	SENT_168	[p13l43t1652r130b1680],
219	or	CC	O	or	dep	243	SENT_168	[p13l138t1660r160b1673],
220	emergency	NN	O	emergency	dep	243	SENT_168	[p13l166t1659r285b1680],
221	department	NN	O	department	dep	243	SENT_168	[p13l290t1652r419b1680],
222	treatments	NNS	O	treatment	dep	243	SENT_168	[p13l424t1656r545b1673],
223	because	IN	O	because	dep	243	SENT_168	[p13l552t1652r636b1673],
224	of	IN	O	of	dep	243	SENT_168	[p13l643t1652r666b1673],
225	asthma	NN	O	asthma	dep	243	SENT_168	[p13l671t1652r751b1673],
226	Participants	NNS	O	participant	dep	243	SENT_168	[p13l66t1700r192b1725],
227	with	IN	O	with	dep	243	SENT_168	[p13l198t1698r246b1719],
228	21	CD	NUMBER	21	dep	243	SENT_168	[p13l254t1701r279b1719],
229	42	CD	NUMBER	42	dep	243	SENT_168	[p13l472t1701r499b1722],
230	52	CD	NUMBER	52	dep	243	SENT_168	[p13l585t1701r610b1722],
231	16	CD	NUMBER	16	dep	243	SENT_168	[p13l688t1698r714b1719],
232	10	CD	NUMBER	10	dep	243	SENT_168	[p13l810t1701r835b1719],
233	17	CD	NUMBER	17	dep	243	SENT_168	[p13l914t1701r939b1722],
234	3	CD	NUMBER	3	dep	243	SENT_168	[p13l1044t1701r1056b1722],
235	14	CD	NUMBER	14	dep	243	SENT_168	[p13l1151t1701r1178b1722],
236	10	CD	NUMBER	10	dep	243	SENT_168	[p13l1278t1701r1303b1719],
237	7	CD	NUMBER	7	dep	243	SENT_168	[p13l1389t1701r1402b1722],
238	18	CD	NUMBER	18	dep	243	SENT_168	[p13l1516t1698r1541b1719],
239	25	CD	NUMBER	25	dep	243	SENT_168	[p13l1618t1701r1643b1722],
240	6	CD	NUMBER	6	dep	243	SENT_168	[p13l1735t1698r1747b1719],
241	n/a	NN	O	n/a	dep	243	SENT_168	[p13l1830t1699r1863b1722],
242	n/a	NN	O	n/a	dep	243	SENT_168	[p13l1932t1699r1965b1722],
243	n/a	NN	O	n/a	_	0	SENT_168	[p13l2043t1699r2076b1722],

1	Participants	NNS	O	participant	dep	8	SENT_169	[p13l66t1780r192b1806],
2	with	IN	O	with	_	0	SENT_169	[p13l198t1778r246b1799],
3	22	CD	NUMBER	22	num	4	SENT_169	[p13l254t1781r279b1799],
4	13	CD	NUMBER	13	prep_with	1	SENT_169	[p13l475t1781r499b1802],
5	9	CD	NUMBER	9	num	6	SENT_169	[p13l598t1781r610b1802],
6	o	NN	O	o	dep	8	SENT_169	[p13l702t1781r714b1799],
7	3	CD	NUMBER	3	num	8	SENT_169	[p13l823t1781r835b1802],
8	3	CD	NUMBER	3	dep	18	SENT_169	[p13l926t1781r938b1802],
9	o	NN	O	o	nn	12	SENT_169	[p13l1044t1781r1056b1799],
10	3	CD	NUMBER	3	num	12	SENT_169	[p13l1165t1781r1177b1802],
11	o	NN	O	o	nn	12	SENT_169	[p13l1290t1781r1303b1799],
12	o	NN	O	o	dep	8	SENT_169	[p13l1389t1781r1401b1799],
13	7	CD	NUMBER	7	number	14	SENT_169	[p13l1530t1782r1542b1802],
14	6	CD	NUMBER	6	dep	12	SENT_169	[p13l1630t1778r1643b1799],
15	o	NN	O	o	nn	18	SENT_169	[p13l1735t1781r1748b1799],
16	n/a	NN	O	n/a	nn	18	SENT_169	[p13l1830t1779r1863b1802],
17	n/a	NN	O	n/a	nn	18	SENT_169	[p13l1932t1779r1965b1802],
18	n/a	NN	O	n/a	_	0	SENT_169	[p13l2043t1779r2076b1802],

1	Total	JJ	O	total	amod	3	SENT_170	[p13l64t1859r118b1879],
2	severe	JJ	O	severe	amod	3	SENT_170	[p13l126t1866r193b1879],
3	exacerbations	NNS	O	exacerbation	dep	12	SENT_170	[p13l200t1859r349b1879],
4	70	CD	NUMBER	70	number	5	SENT_170	[p13l473t1861r499b1882],
5	74	CD	NUMBER	74	dep	3	SENT_170	[p13l585t1861r612b1882],
6	16	CD	NUMBER	16	num	7	SENT_170	[p13l688t1858r714b1879],
7	13	CD	NUMBER	13	dep	5	SENT_170	[p13l811t1861r835b1882],
8	22	CD	NUMBER	22	dep	12	SENT_170	[p13l913t1861r938b1879],
9	3	CD	NUMBER	3	number	10	SENT_170	[p13l1044t1861r1056b1882],
10	24	CD	NUMBER	24	num	12	SENT_170	[p13l1150t1861r1178b1882],
11	10	CD	NUMBER	10	number	12	SENT_170	[p13l1278t1861r1303b1879],
12	7	CD	NUMBER	7	dep	25	SENT_170	[p13l1390t1862r1402b1882],
13	33	CD	NUMBER	33	number	14	SENT_170	[p13l1516t1861r1542b1882],
14	42	CD	NUMBER	42	num	19	SENT_170	[p13l1616t1861r1643b1882],
15	6	CD	NUMBER	6	num	19	SENT_170	[p13l1735t1858r1747b1879],
16	n/a	NN	O	n/a	nn	19	SENT_170	[p13l1830t1859r1863b1882],
17	n/a	NN	O	n/a	nn	19	SENT_170	[p13l1932t1859r1965b1882],
18	n/a	NN	O	n/a	nn	19	SENT_170	[p13l2043t1859r2076b1882],
19	Exacerbations	NNS	O	exacerbation	npadvmod	12	SENT_170	[p13l66t1904r215b1925],
20	per	IN	O	per	_	0	SENT_170	[p13l222t1911r256b1931],
21	participant	NN	O	participant	prep_per	12	SENT_170	[p13l262t1906r380b1931],
22	per	IN	O	per	_	0	SENT_170	[p13l386t1911r420b1931],
23	0-09	CD	NUMBER	0-09	num	24	SENT_170	[p13l452t1907r500b1928],
24	0-08	CD	NUMBER	0-08	prep_per	21	SENT_170	[p13l562t1904r610b1925],
25	0-05	CD	NUMBER	0-05	dep	27	SENT_170	[p13l667t1907r714b1928],
26	0-05	CD	NUMBER	0-05	num	27	SENT_170	[p13l792t1907r839b1928],
27	0-07	CD	NUMBER	0-07	dep	31	SENT_170	[p13l895t1907r942b1928],
28	0-03	CD	NUMBER	0-03	num	29	SENT_170	[p13l1009t1907r1056b1928],
29	0-09	CD	NUMBER	0-09	dep	27	SENT_170	[p13l1130t1907r1178b1928],
30	0-03	CD	NUMBER	0-03	num	31	SENT_170	[p13l1256t1907r1303b1928],
31	0-06	CD	NUMBER	0-06	dep	37	SENT_170	[p13l1354t1904r1403b1925],
32	0-14	CD	NUMBER	0-14	num	33	SENT_170	[p13l1495t1907r1543b1928],
33	0-13	CD	NUMBER	0-13	dep	31	SENT_170	[p13l1600t1907r1645b1928],
34	0-06	CD	NUMBER	0-06	num	37	SENT_170	[p13l1699t1904r1747b1925],
35	n/a	NN	O	n/a	nn	37	SENT_170	[p13l1830t1905r1863b1928],
36	n/a	NN	O	n/a	nn	37	SENT_170	[p13l1932t1905r1965b1928],
37	n/a	NN	O	n/a	_	0	SENT_170	[p13l2043t1905r2076b1928],
38	6	CD	DURATION	6	num	39	SENT_170	[p13l66t1939r79b1960],
39	months	NNS	NUMBER	month	dep	37	SENT_170	[p13l87t1939r170b1960],

1	Data	NNS	O	datum	nsubj	6	SENT_171	[p13l32t2009r77b2026],
2	are	VBP	O	be	cop	6	SENT_171	[p13l83t2013r113b2026],
3	number	NN	O	number	nn	6	SENT_171	[p13l120t2007r198b2026],
4	or	CC	O	or	_	0	SENT_171	[p13l204t2013r224b2026],
5	numbe	NN	O	numbe	nn	6	SENT_171	[p13l231t2007r300b2026],
6	u	NN	O	u	_	0	SENT_171	[p13l333t2018r339b2026],
7	.	.	O	.	_	0	SENT_171	[p13l350t2023r353b2026],

1	n/a	NN	O	n/a	nsubj	4	SENT_172	[p13l361t2007r441b2029],
2	=	JJ	O	=	advmod	3	SENT_172	[p13l361t2007r441b2029],
3	not	RB	O	not	neg	4	SENT_172	[p13l361t2007r441b2029],
4	assessed	VBN	O	assess	_	0	SENT_172	[p13l447t2007r536b2026],
5	.	.	O	.	_	0	SENT_172	[p13l447t2007r536b2026],

1	*	NN	O	*	nn	2	SENT_173	[p13l541t2007r669b2026],
2	Budesonide	NN	O	budesonide	_	0	SENT_173	[p13l541t2007r669b2026],
3	plus	CC	O	plus	prep	2	SENT_173	[p13l675t2007r715b2032],
4	formoterol	NN	O	formoterol	nn	6	SENT_173	[p13l721t2007r830b2026],
5	160	CD	NUMBER	160	num	6	SENT_173	[p13l837t2007r875b2026],
6	pg	NN	O	pg	dep	3	SENT_173	[p13l883t2013r906b2032],
7	and	CC	O	and	_	0	SENT_173	[p13l913t2007r950b2026],
8	45	CD	NUMBER	45	num	9	SENT_173	[p13l956t2009r987b2029],
9	pg	NN	O	pg	conj_and	2	SENT_173	[p13l994t2013r1023b2032],
10	,	,	O	,	_	0	SENT_173	[p13l994t2013r1023b2032],
11	ectively	RB	O	ectively	advmod	9	SENT_173	[p13l1073t2007r1152b2032],
12	,	,	O	,	_	0	SENT_173	[p13l1073t2007r1152b2032],
13	twice	RB	O	twice	advmod	14	SENT_173	[p13l1157t2008r1211b2026],
14	daily	RB	SET	daily	appos	2	SENT_173	[p13l1217t2007r1264b2032],
15	plus	CC	O	plus	prep	14	SENT_173	[p13l1269t2007r1309b2032],
16	as	RB	O	as	advmod	17	SENT_173	[p13l1316t2007r1418b2026],
17	—	JJ	O	—	dep	15	SENT_173	[p13l1316t2007r1418b2026],
18	needed	VBN	O	need	partmod	17	SENT_173	[p13l1316t2007r1418b2026],
19	for	IN	O	for	_	0	SENT_173	[p13l1424t2007r1453b2026],
20	symptom	NN	O	symptom	nn	21	SENT_173	[p13l1459t2010r1554b2032],
21	relief	NN	O	relief	prep_for	18	SENT_173	[p13l1562t2007r1616b2026],
22	.	.	O	.	_	0	SENT_173	[p13l1562t2007r1616b2026],

1	’	NN	O	’	nn	2	SENT_174	[p13l1623t2007r1752b2027],
2	rBudesonide	NN	O	rbudesonide	_	0	SENT_174	[p13l1623t2007r1752b2027],
3	plus	CC	O	plus	prep	2	SENT_174	[p13l1758t2007r1798b2032],
4	formoterol	NN	O	formoterol	nn	6	SENT_174	[p13l1804t2007r1913b2026],
5	320	CD	NUMBER	320	num	6	SENT_174	[p13l1920t2009r1957b2029],
6	pg	NN	O	pg	dep	3	SENT_174	[p13l1965t2013r1988b2032],
7	and	CC	O	and	_	0	SENT_174	[p13l1995t2007r2032b2026],
8	9	CD	NUMBER	9	num	9	SENT_174	[p13l2039t2009r2050b2029],
9	pg	NN	O	pg	dep	3	SENT_174	[p13l2058t2013r2087b2032],
10	,	,	O	,	_	0	SENT_174	[p13l2058t2013r2087b2032],
11	respectively	RB	O	respectively	advmod	6	SENT_174	[p13l32t2041r152b2066],
12	,	,	O	,	_	0	SENT_174	[p13l32t2041r152b2066],
13	twice	RB	O	twice	advmod	6	SENT_174	[p13l158t2043r211b2061],
14	daily	JJ	SET	daily	amod	16	SENT_174	[p13l217t2041r264b2066],
15	wit	NN	O	wit	nn	16	SENT_174	[p13l269t2043r301b2060],
16	butaline	NN	O	butaline	dep	6	SENT_174	[p13l348t2041r430b2061],
17	as-needed	JJ	O	as-needed	amod	16	SENT_174	[p13l436t2041r538b2061],
18	for	IN	O	for	_	0	SENT_174	[p13l544t2041r573b2061],
19	symptom	NN	O	symptom	nn	20	SENT_174	[p13l579t2045r674b2066],
20	relief	NN	O	relief	prep_for	17	SENT_174	[p13l683t2041r736b2061],
21	.	.	O	.	_	0	SENT_174	[p13l683t2041r736b2061],

1	1	CD	NUMBER	1	_	0	SENT_175	[p13l743t2041r868b2062],
2	:	:	O	:	_	0	SENT_175	[p13l743t2041r868b2062],
3	Fluticasone	NN	PERSON	fluticasone	dep	1	SENT_175	[p13l743t2041r868b2062],
4	plus	CC	O	plus	prep	3	SENT_175	[p13l874t2041r914b2066],
5	salmetero	NN	O	salmetero	nn	6	SENT_175	[p13l920t2041r1019b2061],
6	pg	NN	O	pg	dep	4	SENT_175	[p13l1076t2048r1099b2067],
7	and	CC	O	and	_	0	SENT_175	[p13l1106t2041r1143b2060],
8	50	CD	NUMBER	50	num	9	SENT_175	[p13l1150t2044r1174b2063],
9	pg	NN	O	pg	dep	4	SENT_175	[p13l1182t2048r1211b2067],
10	,	,	O	,	_	0	SENT_175	[p13l1182t2048r1211b2067],
11	respectively	RB	O	respectively	amod	3	SENT_175	[p13l1219t2041r1339b2066],
12	,	,	O	,	_	0	SENT_175	[p13l1219t2041r1339b2066],
13	twice	RB	O	twice	advmod	14	SENT_175	[p13l1345t2043r1398b2061],
14	daily	RB	SET	daily	advmod	18	SENT_175	[p13l1404t2041r1451b2066],
15	with	IN	O	with	_	0	SENT_175	[p13l1456t2041r1500b2060],
16	terbutaline	NN	O	terbutaline	prep_with	14	SENT_175	[p13l1506t2041r1617b2061],
17	as	IN	O	as	amod	16	SENT_175	[p13l1623t2048r1643b2061],
18	needed	VBN	O	need	partmod	3	SENT_175	[p13l1650t2041r1722b2061],
19	for	IN	O	for	_	0	SENT_175	[p13l1727t2041r1756b2061],
20	symptom	NN	O	symptom	nn	21	SENT_175	[p13l1762t2045r1858b2066],
21	relief	NN	O	relief	prep_for	18	SENT_175	[p13l1866t2041r1919b2061],
22	.	.	O	.	_	0	SENT_175	[p13l1866t2041r1919b2061],

1	§	NN	O	§	nn	3	SENT_176	[p13l1927t2041r2099b2066],
2	Adjustable-dose	NN	O	adjustable-dose	nn	3	SENT_176	[p13l1927t2041r2099b2066],
3	budesonide	NN	O	budesonide	_	0	SENT_176	[p13l31t2076r147b2095],
4	plus	CC	O	plus	_	0	SENT_176	[p13l153t2076r193b2101],
5	formoterol	NN	O	formoterol	nn	7	SENT_176	[p13l199t2075r308b2095],
6	320	CD	NUMBER	320	num	7	SENT_176	[p13l315t2078r353b2098],
7	pg	NN	O	pg	dep	3	SENT_176	[p13l360t2082r383b2101],
8	and	CC	O	and	_	0	SENT_176	[p13l390t2076r427b2095],
9	9	CD	NUMBER	9	num	10	SENT_176	[p13l434t2078r445b2098],
10	pg	NN	O	pg	conj_and	7	SENT_176	[p13l453t2082r482b2101],
11	,	,	O	,	_	0	SENT_176	[p13l453t2082r482b2101],
12	ctivel	NN	O	ctivel	conj_and	10	SENT_176	[p13l543t2076r594b2095],
13	,	,	O	,	_	0	SENT_176	[p13l607t2092r611b2098],
14	nce	NN	O	nce	conj_and	10	SENT_176	[p13l632t2082r664b2095],
15	daily	RB	SET	daily	advmod	14	SENT_176	[p13l670t2076r721b2101],
16	,	,	O	,	_	0	SENT_176	[p13l670t2076r721b2101],
17	320	CD	NUMBER	320	num	18	SENT_176	[p13l727t2078r765b2098],
18	pg	NN	O	pg	conj_and	10	SENT_176	[p13l772t2082r796b2101],
19	and	CC	O	and	_	0	SENT_176	[p13l803t2076r840b2095],
20	9	CD	NUMBER	9	num	21	SENT_176	[p13l846t2078r858b2098],
21	pg	NN	O	pg	conj_and	10	SENT_176	[p13l866t2082r895b2101],
22	,	,	O	,	_	0	SENT_176	[p13l866t2082r895b2101],
23	respectively	RB	O	respectively	advmod	10	SENT_176	[p13l903t2076r1023b2101],
24	,	,	O	,	_	0	SENT_176	[p13l903t2076r1023b2101],
25	twice	RB	O	twice	advmod	26	SENT_176	[p13l1029t2077r1082b2095],
26	daily	RB	SET	daily	appos	10	SENT_176	[p13l1088t2076r1139b2101],
27	,	,	O	,	_	0	SENT_176	[p13l1088t2076r1139b2101],
28	and	CC	O	and	_	0	SENT_176	[p13l1146t2076r1183b2095],
29	640	CD	NUMBER	640	num	30	SENT_176	[p13l1190t2075r1229b2098],
30	pg	NN	O	pg	dep	3	SENT_176	[p13l1236t2082r1260b2101],
31	and	CC	O	and	_	0	SENT_176	[p13l1267t2076r1304b2095],
32	18	CD	NUMBER	18	num	33	SENT_176	[p13l1310t2075r1334b2095],
33	pg	NN	O	pg	conj_and	30	SENT_176	[p13l1342t2082r1371b2101],
34	,	,	O	,	_	0	SENT_176	[p13l1342t2082r1371b2101],
35	respectively	RB	O	respectively	advmod	33	SENT_176	[p13l1379t2076r1499b2101],
36	,	,	O	,	_	0	SENT_176	[p13l1379t2076r1499b2101],
37	twice	RB	O	twice	advmod	38	SENT_176	[p13l1505t2077r1558b2095],
38	daily	RB	SET	daily	dep	3	SENT_176	[p13l1564t2076r1611b2101],
39	plus	CC	O	plus	dep	41	SENT_176	[p13l1617t2076r1657b2101],
40	albuterol	RB	O	albuterol	advmod	41	SENT_176	[p13l1663t2076r1751b2095],
41	as	IN	O	as	dep	38	SENT_176	[p13l1758t2082r1778b2095],
42	rescue	NN	O	rescue	nn	43	SENT_176	[p13l1785t2082r1847b2095],
43	medicine	NN	O	medicine	pobj	41	SENT_176	[p13l1854t2076r1949b2098],
44	;	:	O	;	_	0	SENT_176	[p13l1854t2076r1949b2098],
45	budesonide	NN	O	budesonide	dep	43	SENT_176	[p13l1957t2076r2072b2095],
46	plus	CC	O	plus	prep	45	SENT_176	[p13l2079t2076r2119b2101],
47	formoterol	NN	O	formoterol	nn	49	SENT_176	[p13l30t2110r139b2129],
48	320	CD	NUMBER	320	num	49	SENT_176	[p13l146t2113r184b2132],
49	pg	NN	O	pg	dep	46	SENT_176	[p13l191t2116r214b2135],
50	and	CC	O	and	_	0	SENT_176	[p13l221t2110r258b2129],
51	9	CD	NUMBER	9	num	52	SENT_176	[p13l265t2113r277b2132],
52	pg	NN	O	pg	conj_and	43	SENT_176	[p13l284t2117r314b2135],
53	,	,	O	,	_	0	SENT_176	[p13l284t2117r314b2135],
54	respectively	RB	O	respectively	advmod	52	SENT_176	[p13l322t2110r442b2135],
55	,	,	O	,	_	0	SENT_176	[p13l322t2110r442b2135],
56	twic	JJ	O	twic	amod	60	SENT_176	[p13l448t2112r490b2129],
57	’	NN	O	’	nn	60	SENT_176	[p13l532t2112r535b2115],
58	y	NN	O	y	nn	60	SENT_176	[p13l543t2117r554b2135],
59	plu	NN	O	plu	nn	60	SENT_176	[p13l559t2110r589b2135],
60	uterol	NN	O	uterol	conj_and	43	SENT_176	[p13l637t2110r694b2129],
61	as	IN	O	as	_	0	SENT_176	[p13l701t2117r721b2129],
62	rescue	NN	O	rescue	nn	63	SENT_176	[p13l728t2117r789b2129],
63	medicine	NN	O	medicine	prep_as	60	SENT_176	[p13l797t2110r892b2133],
64	;	:	O	;	_	0	SENT_176	[p13l797t2110r892b2133],
65	or	CC	O	or	_	0	SENT_176	[p13l898t2117r919b2129],
66	ﬂuticasone	NN	O	ﬂuticasone	pobj	41	SENT_176	[p13l924t2110r1034b2129],
67	plus	CC	O	plus	prep	66	SENT_176	[p13l1040t2110r1080b2135],
68	salmeterol	NN	O	salmeterol	dep	67	SENT_176	[p13l1087t2110r1191b2129],
69	250	CD	NUMBER	250	num	68	SENT_176	[p13l1198t2113r1235b2132],
70	and	CC	O	and	_	0	SENT_176	[p13l1242t2110r1279b2129],
71	50	CD	NUMBER	50	num	72	SENT_176	[p13l1285t2113r1310b2132],
72	pg	NN	O	pg	conj_and	38	SENT_176	[p13l1317t2116r1346b2135],
73	,	,	O	,	_	0	SENT_176	[p13l1317t2116r1346b2135],
74	respectively	RB	O	respectively	advmod	72	SENT_176	[p13l1354t2110r1474b2135],
75	,	,	O	,	_	0	SENT_176	[p13l1354t2110r1474b2135],
76	twice	RB	O	twice	advmod	77	SENT_176	[p13l1480t2112r1534b2129],
77	daily	RB	SET	daily	appos	3	SENT_176	[p13l1540t2110r1586b2135],
78	plus	CC	O	plus	dep	80	SENT_176	[p13l1592t2110r1632b2135],
79	albuterol	RB	O	albuterol	advmod	80	SENT_176	[p13l1638t2110r1726b2129],
80	as	IN	O	as	dep	77	SENT_176	[p13l1734t2117r1754b2129],
81	rescue	NN	O	rescue	nn	82	SENT_176	[p13l1761t2117r1822b2129],
82	medicine	NN	O	medicine	pobj	80	SENT_176	[p13l1829t2110r1924b2129],
83	.	.	O	.	_	0	SENT_176	[p13l1829t2110r1924b2129],

1	Table	NNP	O	Table	_	0	SENT_177	[p13l31t2174r88b2195],
2	3	CD	NUMBER	3	num	1	SENT_177	[p13l92t2177r113b2198],
3	:	:	O	:	_	0	SENT_177	[p13l92t2177r113b2198],
4	Asthma	NN	O	asthma	nn	5	SENT_177	[p13l119t2174r208b2195],
5	exacerbations	NNS	O	exacerbation	dep	1	SENT_177	[p13l215t2174r373b2195],
6	by	IN	O	by	_	0	SENT_177	[p13l380t2174r407b2201],
7	G	NN	O	g	nn	10	SENT_177	[p13l413t2174r519b2201],
8	|	NNS	O	|	nn	10	SENT_177	[p13l413t2174r519b2201],
9	y16Arg	NN	O	y16arg	nn	10	SENT_177	[p13l413t2174r519b2201],
10	genotype	NN	O	genotype	prep_by	5	SENT_177	[p13l526t2177r635b2201],
11	for	IN	O	for	_	0	SENT_177	[p13l640t2174r674b2195],
12	each	DT	O	each	det	13	SENT_177	[p13l680t2174r730b2195],
13	study	NN	O	study	prep_for	10	SENT_177	[p13l737t2174r802b2201],

1	2122	CD	DATE	2122	num	3	SENT_178	[p13l6t2296r61b2314],
2	www.thelancet.com	NNP	O	www.thelancet.com	nn	3	SENT_178	[p13l1587t2293r1810b2315],
3	Vol	NNP	O	Vol	_	0	SENT_178	[p13l1827t2293r1864b2315],
4	370	CD	NUMBER	370	dep	3	SENT_178	[p13l1872t2296r1915b2318],
5	December	NNP	DATE	December	tmod	4	SENT_178	[p13l1936t2293r2052b2315],
6	22/29	CD	DATE	22/29	num	5	SENT_178	[p13l2059t2294r2134b2318],
7	,	,	DATE	,	_	0	SENT_178	[p13l2059t2294r2134b2318],
8	2007	CD	DATE	2007	num	5	SENT_178	[p13l6t2334r66b2355],

1	Articles	NNPS	O	Articles	_	0	SENT_179	[p13l6t2593r156b2629],

1	:	:	O	:	_	0	SENT_180	[p14l1259t947r1366b952],
2	Gly/Gly	NN	O	gly/gly	nn	4	SENT_180	[p14l1414t914r1802b977],
3	(	CD	NUMBER	(	num	4	SENT_180	[p14l1414t914r1802b977],
4	n	NN	O	n	_	0	SENT_180	[p14l1414t914r1802b977],
5	=	JJ	O	=	quantmod	7	SENT_180	[p14l1414t914r1802b977],
6	833	CD	NUMBER	833	number	7	SENT_180	[p14l1414t914r1802b977],
7	)	CD	NUMBER	)	num	11	SENT_180	[p14l1414t914r1802b977],
8	Z	NN	O	z	nn	11	SENT_180	[p14l1259t1015r1366b1020],
9	Gly/Arg	NN	O	gly/arg	nn	11	SENT_180	[p14l1414t992r1844b1055],
10	(	CD	NUMBER	(	num	11	SENT_180	[p14l1414t992r1844b1055],
11	n	NN	O	n	dep	4	SENT_180	[p14l1414t992r1844b1055],
12	=	JJ	O	=	amod	11	SENT_180	[p14l1414t992r1844b1055],
13	1028	CD	DATE	1028	number	14	SENT_180	[p14l1414t992r1844b1055],
14	)	CD	NUMBER	)	dep	12	SENT_180	[p14l1414t992r1844b1055],
15	:	:	O	:	_	0	SENT_180	[p14l1259t1083r1366b1088],
16	Arg/Arg	NN	O	arg/arg	nn	18	SENT_180	[p14l1413t1070r1821b1132],
17	(	CD	NUMBER	(	num	18	SENT_180	[p14l1413t1070r1821b1132],
18	n	NN	O	n	dep	11	SENT_180	[p14l1413t1070r1821b1132],
19	=	JJ	O	=	amod	21	SENT_180	[p14l1413t1070r1821b1132],
20	361	CD	NUMBER	361	tmod	19	SENT_180	[p14l1413t1070r1821b1132],
21	)	NN	O	)	dep	18	SENT_180	[p14l1413t1070r1821b1132],

1	Change	NNP	O	Change	_	0	SENT_181	[p14l311t925r374b1108],
2	in	IN	O	in	_	0	SENT_181	[p14l315t867r358b907],
3	morning	NN	TIME	morning	nn	4	SENT_181	[p14l315t638r374b847],
4	PEF	NN	O	pef	prep_in	1	SENT_181	[p14l316t533r358b617],
5	(	CD	NUMBER	(	num	7	SENT_181	[p14l313t336r371b517],
6	L/min	NN	O	l/min	nn	7	SENT_181	[p14l313t336r371b517],
7	)	NN	O	)	dep	1	SENT_181	[p14l313t336r371b517],

1	Z	NN	O	z	nn	2	SENT_182	[p14l1259t2338r1366b2343],
2	Gly/Gly	NN	O	gly/gly	_	0	SENT_182	[p14l1414t2305r1804b2368],
3	(	CD	NUMBER	(	num	4	SENT_182	[p14l1414t2305r1804b2368],
4	n	NN	O	n	dep	2	SENT_182	[p14l1414t2305r1804b2368],
5	=	JJ	O	=	amod	7	SENT_182	[p14l1414t2305r1804b2368],
6	168	CD	NUMBER	168	tmod	5	SENT_182	[p14l1414t2305r1804b2368],
7	)	NN	O	)	dep	4	SENT_182	[p14l1414t2305r1804b2368],
8	:	:	O	:	_	0	SENT_182	[p14l1259t2406r1366b2411],
9	Gly/Arg	NN	O	gly/arg	nn	11	SENT_182	[p14l1414t2383r1815b2446],
10	(	CD	NUMBER	(	num	11	SENT_182	[p14l1414t2383r1815b2446],
11	n	NN	O	n	dep	4	SENT_182	[p14l1414t2383r1815b2446],
12	=	JJ	O	=	quantmod	13	SENT_182	[p14l1414t2383r1815b2446],
13	169	CD	NUMBER	169	num	14	SENT_182	[p14l1414t2383r1815b2446],
14	)	NN	O	)	dep	11	SENT_182	[p14l1414t2383r1815b2446],
15	:	:	O	:	_	0	SENT_182	[p14l1259t2474r1366b2479],
16	Arg/Arg	NN	O	arg/arg	nn	18	SENT_182	[p14l1413t2461r1790b2523],
17	(	CD	NUMBER	(	num	18	SENT_182	[p14l1413t2461r1790b2523],
18	n	NN	O	n	dep	4	SENT_182	[p14l1413t2461r1790b2523],
19	=	JJ	O	=	amod	21	SENT_182	[p14l1413t2461r1790b2523],
20	67	CD	NUMBER	67	tmod	19	SENT_182	[p14l1413t2461r1790b2523],
21	)	NN	O	)	dep	18	SENT_182	[p14l1413t2461r1790b2523],

1	/	:	O	/	punct	2	SENT_183	[p14l314t1710r371b1725],
2	\	CD	NUMBER	\	_	0	SENT_183	[p14l314t1710r371b1725],
3	E	NN	O	e	dep	2	SENT_183	[p14l315t1731r358b1771],

1	E	NN	O	e	nn	2	SENT_184	[p14l313t1827r365b1869],
2	xx	NN	O	xx	_	0	SENT_184	[p14l314t1876r371b1891],
3	LI	NNP	O	LI	dep	2	SENT_184	[p14l316t1907r358b1930],
4	.	.	O	.	_	0	SENT_184	[p14l316t1907r358b1930],

1	LI	NNP	O	LI	_	0	SENT_185	[p14l316t1937r358b1960],
2	.	.	O	.	_	0	SENT_185	[p14l316t1937r358b1960],

1	l	NN	O	l	_	0	SENT_186	[p14l316t1937r358b1960],
2	D.	NNP	O	D.	nn	5	SENT_186	[p14l316t1966r358b1991],
3	U3	NN	O	u3	nn	5	SENT_186	[p14l327t2012r374b2038],
4	E	NN	O	e	nn	5	SENT_186	[p14l315t2044r358b2085],
5	C	NN	O	c	dep	1	SENT_186	[p14l327t2092r358b2117],
6	3	CD	NUMBER	3	dep	5	SENT_186	[p14l327t2122r358b2137],
7	.	.	O	.	_	0	SENT_186	[p14l327t2122r358b2137],

1	E	NN	O	e	nn	7	SENT_187	[p14l327t2143r359b2221],
2	E	NN	O	e	nn	7	SENT_187	[p14l315t2241r358b2282],
3	G	NN	O	g	nn	7	SENT_187	[p14l327t2299r359b2324],
4	)	CD	NUMBER	)	num	7	SENT_187	[p14l327t2299r359b2324],
5	C	NN	O	c	nn	7	SENT_187	[p14l327t2329r374b2356],
6	‘	NN	O	‘	nn	7	SENT_187	[p14l327t2329r374b2356],
7	C	NN	O	c	_	0	SENT_187	[p14l327t2361r358b2386],
8	(	CD	MONEY	(	number	9	SENT_187	[p14l327t2392r359b2418],
9	5	CD	MONEY	5	num	11	SENT_187	[p14l327t2392r359b2418],
10	£	NN	MONEY	£	nn	11	SENT_187	[p14l312t2423r358b2448],
11	K	NN	O	k	dep	7	SENT_187	[p14l315t2453r359b2482],
12	)	CD	NUMBER	)	dep	11	SENT_187	[p14l315t2453r359b2482],

1	Days	NNS	DURATION	day	_	0	SENT_188	[p14l966t2797r1078b2854],
2	since	IN	O	since	_	0	SENT_188	[p14l1093t2796r1214b2840],
3	randomisation	NN	O	randomisation	prep_since	1	SENT_188	[p14l1232t2793r1589b2840],

1	Figure	NN	O	figure	_	0	SENT_189	[p14l12t2967r173b3032],
2	2	CD	NUMBER	2	num	1	SENT_189	[p14l186t2972r234b3016],
3	:	:	O	:	_	0	SENT_189	[p14l186t2972r234b3016],
4	mean	VB	O	mean	dep	1	SENT_189	[p14l254t2983r405b3017],
5	daily	JJ	SET	daily	amod	6	SENT_189	[p14l423t2965r557b3032],
6	change	NN	O	change	dobj	4	SENT_189	[p14l572t2966r772b3032],
7	from	IN	O	from	_	0	SENT_189	[p14l786t2965r923b3017],
8	baseline	NN	O	baseline	prep_from	4	SENT_189	[p14l942t2966r1167b3017],
9	in	IN	O	in	_	0	SENT_189	[p14l1185t2967r1233b3015],
10	morning	NN	TIME	morning	nn	11	SENT_189	[p14l1254t2967r1492b3032],
11	peak	NN	O	peak	nn	25	SENT_189	[p14l1510t2965r1643b3032],
12	expiratory	JJ	O	expiratory	amod	25	SENT_189	[p14l1658t2967r1950b3032],
13	ﬂow	NN	O	ﬂow	nn	16	SENT_189	[p14l1963t2965r2090b3017],
14	(	CD	NUMBER	(	num	16	SENT_189	[p14l13t3055r153b3117],
15	PEF	NN	O	pef	nn	16	SENT_189	[p14l13t3055r153b3117],
16	)	NN	O	)	dep	12	SENT_189	[p14l13t3055r153b3117],
17	during	IN	O	during	_	0	SENT_189	[p14l170t3052r353b3119],
18	the	DT	O	the	det	20	SENT_189	[p14l368t3052r460b3104],
19	treatment	NN	O	treatment	nn	20	SENT_189	[p14l473t3061r765b3104],
20	period	NN	O	period	prep_during	16	SENT_189	[p14l779t3052r960b3119],
21	by	IN	O	by	_	0	SENT_189	[p14l977t3052r1043b3119],
22	G	NN	O	g	nn	23	SENT_189	[p14l1057t3052r1317b3119],
23	|	NNS	O	|	prep_by	20	SENT_189	[p14l1057t3052r1317b3119],
24	y16Arg	NN	O	y16arg	nn	25	SENT_189	[p14l1057t3052r1317b3119],
25	genotype	NN	O	genotype	prep_in	8	SENT_189	[p14l1334t3061r1601b3119],
26	(	CD	NUMBER	(	tmod	4	SENT_189	[p14l1619t3052r1700b3117],
27	all	DT	O	all	det	28	SENT_189	[p14l1619t3052r1700b3117],
28	participants	NNS	O	participant	nsubj	29	SENT_189	[p14l1717t3054r2056b3119],
29	genotyped	VBD	O	genotype	rcmod	26	SENT_189	[p14l11t3138r336b3205],
30	)	CD	NUMBER	)	number	31	SENT_189	[p14l11t3138r336b3205],
31	(	CD	NUMBER	(	num	34	SENT_189	[p14l13t3227r90b3289],
32	A	DT	O	a	det	34	SENT_189	[p14l13t3227r90b3289],
33	)	NN	O	)	nn	34	SENT_189	[p14l13t3227r90b3289],
34	Study	NN	O	study	dobj	29	SENT_189	[p14l109t3224r261b3291],
35	1	CD	NUMBER	1	dep	34	SENT_189	[p14l277t3231r318b3284],
36	;	:	O	;	_	0	SENT_189	[p14l277t3231r318b3284],
37	(	CD	NUMBER	(	num	40	SENT_189	[p14l338t3227r410b3289],
38	B	NN	O	b	nn	40	SENT_189	[p14l338t3227r410b3289],
39	)	NN	O	)	nn	40	SENT_189	[p14l338t3227r410b3289],
40	study	NN	O	study	dep	34	SENT_189	[p14l429t3224r575b3291],
41	2	CD	NUMBER	2	dep	40	SENT_189	[p14l591t3231r633b3275],
42	.	.	O	.	_	0	SENT_189	[p14l591t3231r633b3275],

1	All	DT	O	all	det	2	SENT_190	[p14l650t3224r715b3274],
2	participants	NNS	O	participant	nsubjpass	9	SENT_190	[p14l734t3229r1061b3290],
3	,	,	O	,	_	0	SENT_190	[p14l734t3229r1061b3290],
4	with	IN	O	with	_	0	SENT_190	[p14l1077t3224r1194b3275],
5	available	JJ	O	available	amod	6	SENT_190	[p14l1214t3224r1442b3275],
6	data	NNS	O	datum	prep_with	2	SENT_190	[p14l1458t3224r1587b3284],
7	,	,	O	,	_	0	SENT_190	[p14l1458t3224r1587b3284],
8	are	VBP	O	be	auxpass	9	SENT_190	[p14l1605t3242r1684b3275],
9	included	VBN	O	include	_	0	SENT_190	[p14l1703t3224r1924b3275],
10	at	IN	O	at	_	0	SENT_190	[p14l1941t3233r1992b3275],
11	all	DT	O	all	det	13	SENT_190	[p14l2008t3224r2062b3275],
12	time	NN	O	time	nn	13	SENT_190	[p14l9t3315r132b3361],
13	points	NNS	O	point	prep_at	9	SENT_190	[p14l149t3315r329b3376],
14	.	.	O	.	_	0	SENT_190	[p14l149t3315r329b3376],

1	Haplotypes	NNS	O	haplotype	nn	2	SENT_191	[p15l15t96r424b185],
2	4a	NN	O	4a	nsubj	15	SENT_191	[p15l471t102r550b163],
3	and	CC	O	and	_	0	SENT_191	[p15l596t96r732b163],
4	4b	NN	O	4b	conj_and	2	SENT_191	[p15l775t96r878b174],
5	,	,	O	,	_	0	SENT_191	[p15l775t96r878b174],
6	which	WDT	O	which	nsubj	7	SENT_191	[p15l926t96r1151b164],
7	encode	VBP	O	encode	rcmod	2	SENT_191	[p15l1197t96r1454b163],
8	the	DT	O	the	det	10	SENT_191	[p15l1499t96r1614b163],
9	Arg	NN	O	arg	nn	10	SENT_191	[p15l1660t101r1796b186],
10	allele	NN	O	allele	dobj	7	SENT_191	[p15l1842t96r2029b163],
11	at	IN	O	at	_	0	SENT_191	[p15l2076t109r2140b163],
12	aminoacid	JJ	O	aminoacid	amod	13	SENT_191	[p15l12t204r398b272],
13	16	CD	NUMBER	16	prep_at	7	SENT_191	[p15l464t210r557b283],
14	,	,	O	,	_	0	SENT_191	[p15l464t210r557b283],
15	arose	VBD	O	arise	_	0	SENT_191	[p15l626t229r816b272],
16	with	IN	O	with	_	0	SENT_191	[p15l879t204r1042b272],
17	a	DT	O	a	det	19	SENT_191	[p15l1107t229r1144b272],
18	combined	JJ	O	combined	amod	19	SENT_191	[p15l1209t204r1577b272],
19	frequency	NN	O	frequency	prep_with	15	SENT_191	[p15l1640t204r2007b294],
20	of	IN	O	of	prep	19	SENT_191	[p15l2070t204r2152b272],
21	about	IN	O	about	pcomp	20	SENT_191	[p15l12t313r218b381],
22	37	CD	PERCENT	37	num	23	SENT_191	[p15l246t318r415b384],
23	%	NN	PERCENT	%	pobj	21	SENT_191	[p15l246t318r415b384],
24	.	.	O	.	_	0	SENT_191	[p15l246t318r415b384],

1	No	DT	O	no	det	3	SENT_192	[p15l448t320r549b381],
2	signiﬁcant	NN	O	signiﬁcant	nn	3	SENT_192	[p15l579t313r964b403],
3	relation	NN	O	relation	nsubjpass	5	SENT_192	[p15l989t313r1270b381],
4	was	VBD	O	be	auxpass	5	SENT_192	[p15l1294t337r1431b381],
5	noted	VBN	O	note	dep	11	SENT_192	[p15l1460t313r1668b381],
6	between	IN	O	between	_	0	SENT_192	[p15l1692t313r1999b381],
7	the	DT	O	the	det	10	SENT_192	[p15l2024t313r2138b381],
8	common	JJ	O	common	amod	10	SENT_192	[p15l12t447r344b490],
9	haplotype	NN	O	haplotype	nn	10	SENT_192	[p15l370t423r727b512],
10	pairs	NNS	O	pair	prep_between	5	SENT_192	[p15l755t427r933b512],
11	(	VBP	O	(	_	0	SENT_192	[p15l969t427r1201b513],
12	>	JJR	O	>	dobj	11	SENT_192	[p15l969t427r1201b513],
13	5	CD	PERCENT	5	number	14	SENT_192	[p15l969t427r1201b513],
14	%	NN	PERCENT	%	amod	12	SENT_192	[p15l969t427r1201b513],
15	)	CD	NUMBER	)	nsubj	11	SENT_192	[p15l969t427r1201b513],
16	,	,	O	,	_	0	SENT_192	[p15l969t427r1201b513],
17	representing	VBG	O	represent	partmod	11	SENT_192	[p15l1233t427r1701b513],
18	all	DT	O	all	det	20	SENT_192	[p15l1730t423r1813b490],
19	possible	JJ	O	possible	amod	20	SENT_192	[p15l1840t423r2138b512],
20	combinations	NNS	O	combination	dobj	17	SENT_192	[p15l12t531r513b599],
21	of	IN	O	of	_	0	SENT_192	[p15l543t531r626b599],
22	haplotypes	NNS	O	haplotype	prep_of	20	SENT_192	[p15l638t531r1030b621],
23	2a	RB	O	2a	advmod	22	SENT_192	[p15l1062t538r1160b609],
24	,	,	O	,	_	0	SENT_192	[p15l1062t538r1160b609],
25	4a	NN	O	4a	conj_and	20	SENT_192	[p15l1189t538r1286b610],
26	,	,	O	,	_	0	SENT_192	[p15l1189t538r1286b610],
27	and	CC	O	and	_	0	SENT_192	[p15l1317t531r1453b599],
28	6a	NN	O	6a	conj_and	20	SENT_192	[p15l1481t537r1579b610],
29	,	,	O	,	_	0	SENT_192	[p15l1481t537r1579b610],
30	and	CC	O	and	_	0	SENT_192	[p15l1611t531r1747b599],
31	any	DT	O	any	conj_and	20	SENT_192	[p15l1774t556r1902b621],
32	of	IN	O	of	_	0	SENT_192	[p15l1928t531r2011b599],
33	the	DT	O	the	det	37	SENT_192	[p15l2024t531r2138b599],
34	demographic	JJ	O	demographic	amod	37	SENT_192	[p15l12t640r497b730],
35	or	CC	O	or	_	0	SENT_192	[p15l541t665r617b708],
36	baseline	NN	O	baseline	amod	37	SENT_192	[p15l657t640r959b708],
37	variables	NNS	O	variable	prep_of	31	SENT_192	[p15l1001t640r1323b708],
38	previously	RB	DATE	previously	advmod	39	SENT_192	[p15l1368t640r1746b730],
39	described	VBN	O	describe	partmod	31	SENT_192	[p15l1789t640r2140b708],
40	for	IN	O	for	_	0	SENT_192	[p15l11t750r116b817],
41	the	DT	O	the	det	47	SENT_192	[p15l171t750r285b817],
42	genotype	NN	O	genotype	nn	43	SENT_192	[p15l344t763r674b840],
43	analyses	NNS	O	analysis	dep	47	SENT_192	[p15l733t750r1036b839],
44	(	RB	O	(	dep	43	SENT_192	[p15l1101t750r1295b840],
45	table	NN	O	table	nn	47	SENT_192	[p15l1101t750r1295b840],
46	2	CD	NUMBER	2	num	47	SENT_192	[p15l1356t756r1440b840],
47	)	NN	O	)	prep_for	39	SENT_192	[p15l1356t756r1440b840],
48	.	.	O	.	_	0	SENT_192	[p15l1356t756r1440b840],

1	No	DT	O	no	det	2	SENT_193	[p15l1503t756r1605b817],
2	relation	NN	O	relation	nsubjpass	4	SENT_193	[p15l1663t750r1945b817],
3	was	VBD	O	be	auxpass	4	SENT_193	[p15l2000t774r2137b817],
4	established	VBN	O	establish	_	0	SENT_193	[p15l12t858r423b926],
5	between	IN	O	between	_	0	SENT_193	[p15l448t858r755b926],
6	haplotype	NN	O	haplotype	nn	7	SENT_193	[p15l781t858r1138b948],
7	pair	NN	O	pair	prep_between	4	SENT_193	[p15l1166t863r1310b947],
8	and	CC	O	and	_	0	SENT_193	[p15l1337t858r1473b926],
9	the	DT	O	the	det	10	SENT_193	[p15l1498t858r1613b926],
10	percentage	NN	O	percentage	prep_between	4	SENT_193	[p15l1641t872r2041b948],
11	of	IN	O	of	_	0	SENT_193	[p15l2070t858r2152b926],
12	participants	NNS	O	participant	prep_of	10	SENT_193	[p15l11t972r442b1056],
13	with	IN	O	with	_	0	SENT_193	[p15l465t967r627b1035],
14	asthma	NN	O	asthma	nn	15	SENT_193	[p15l651t967r920b1035],
15	exacerbations	NNS	O	exacerbation	prep_with	12	SENT_193	[p15l943t967r1437b1035],
16	(	RB	O	(	advmod	12	SENT_193	[p15l1468t967r1662b1057],
17	table	NN	O	table	nn	19	SENT_193	[p15l1468t967r1662b1057],
18	4	CD	NUMBER	4	num	19	SENT_193	[p15l1683t974r1766b1057],
19	)	NN	O	)	dep	12	SENT_193	[p15l1683t974r1766b1057],
20	.	.	O	.	_	0	SENT_193	[p15l1683t974r1766b1057],

1	Although	IN	O	although	mark	3	SENT_194	[p15l1791t967r2139b1057],
2	there	EX	O	there	expl	3	SENT_194	[p15l10t1077r198b1144],
3	was	VBD	O	be	advcl	31	SENT_194	[p15l260t1101r397b1144],
4	a	DT	O	a	det	5	SENT_194	[p15l462t1101r499b1144],
5	trend	NN	O	trend	nsubj	3	SENT_194	[p15l560t1077r758b1144],
6	toward	IN	O	toward	_	0	SENT_194	[p15l818t1077r1072b1145],
7	a	DT	O	a	det	9	SENT_194	[p15l1134t1101r1171b1144],
8	higher	JJR	O	higher	amod	9	SENT_194	[p15l1232t1077r1476b1167],
9	rate	NN	O	rate	prep_toward	5	SENT_194	[p15l1537t1090r1673b1144],
10	of	IN	O	of	_	0	SENT_194	[p15l1737t1077r1820b1144],
11	asthma	NN	O	asthma	nn	12	SENT_194	[p15l1871t1077r2139b1144],
12	exacerbations	NNS	O	exacerbation	prep_of	9	SENT_194	[p15l12t1185r507b1253],
13	in	IN	O	in	_	0	SENT_194	[p15l534t1190r608b1252],
14	individuals	NNS	O	individual	prep_in	12	SENT_194	[p15l632t1185r1036b1254],
15	with	IN	O	with	_	0	SENT_194	[p15l1062t1185r1225b1253],
16	the	DT	O	the	det	19	SENT_194	[p15l1248t1185r1363b1253],
17	2a/2a	JJ	O	2a/2a	amod	19	SENT_194	[p15l1391t1192r1590b1274],
18	haplotype	NN	O	haplotype	nn	19	SENT_194	[p15l1614t1185r1971b1275],
19	pair	NN	O	pair	prep_with	14	SENT_194	[p15l1996t1190r2140b1274],
20	versus	CC	O	versus	prep	19	SENT_194	[p15l9t1318r243b1362],
21	other	JJ	O	other	amod	23	SENT_194	[p15l303t1294r496b1362],
22	haplotype	NN	O	haplotype	nn	23	SENT_194	[p15l549t1294r906b1384],
23	pairs	NNS	O	pair	dep	20	SENT_194	[p15l963t1299r1161b1383],
24	,	,	O	,	_	0	SENT_194	[p15l963t1299r1161b1383],
25	no	DT	O	no	det	26	SENT_194	[p15l1221t1319r1313b1362],
26	differences	NNS	O	difference	nsubjpass	31	SENT_194	[p15l1372t1294r1774b1362],
27	between	IN	O	between	_	0	SENT_194	[p15l1832t1294r2139b1362],
28	haplotype	NN	O	haplotype	nn	29	SENT_194	[p15l10t1404r367b1492],
29	pairs	NNS	O	pair	prep_between	26	SENT_194	[p15l418t1408r596b1492],
30	were	VBD	O	be	auxpass	31	SENT_194	[p15l647t1428r823b1471],
31	recorded	VBN	O	record	_	0	SENT_194	[p15l874t1404r1197b1471],
32	in	IN	O	in	_	0	SENT_194	[p15l1247t1408r1320b1470],
33	pulmonary	JJ	O	pulmonary	amod	35	SENT_194	[p15l1371t1404r1778b1492],
34	function	NN	O	function	nn	35	SENT_194	[p15l1827t1404r2139b1471],
35	measurements	NNS	O	measurement	prep_in	31	SENT_194	[p15l11t1500r580b1554],
36	.	.	O	.	_	0	SENT_194	[p15l11t1500r580b1554],

1	Discussion	NN	O	discussion	nsubj	34	SENT_195	[p15l17t1697r468b1772],
2	The	DT	O	the	det	3	SENT_195	[p15l10t1814r152b1882],
3	results	NNS	O	result	nsubj	9	SENT_195	[p15l187t1814r429b1882],
4	of	IN	O	of	_	0	SENT_195	[p15l467t1813r549b1882],
5	study	NN	O	study	prep_of	3	SENT_195	[p15l572t1814r769b1903],
6	1	CD	NUMBER	1	num	5	SENT_195	[p15l804t1820r834b1880],
7	did	VBD	O	do	aux	9	SENT_195	[p15l870t1814r986b1882],
8	not	RB	O	not	neg	9	SENT_195	[p15l1019t1827r1140b1882],
9	show	VB	O	show	rcmod	1	SENT_195	[p15l1175t1814r1366b1882],
10	an	DT	O	a	det	11	SENT_195	[p15l1399t1838r1488b1882],
11	effect	NN	O	effect	dobj	9	SENT_195	[p15l1522t1814r1721b1882],
12	of	IN	O	of	_	0	SENT_195	[p15l1755t1813r1837b1882],
13	ADRB2	NN	O	adrb2	nn	14	SENT_195	[p15l1857t1819r2143b1880],
14	polymorphism	NN	O	polymorphism	prep_of	11	SENT_195	[p15l11t1922r557b2011],
15	on	IN	O	on	_	0	SENT_195	[p15l582t1947r674b1990],
16	the	DT	O	the	det	17	SENT_195	[p15l696t1922r811b1990],
17	effectiveness	NN	O	effectiveness	prep_on	9	SENT_195	[p15l836t1923r1301b1990],
18	or	CC	O	or	_	0	SENT_195	[p15l1329t1947r1404b1990],
19	safety	NN	O	safety	conj_or	17	SENT_195	[p15l1429t1922r1637b2011],
20	of	IN	O	of	_	0	SENT_195	[p15l1660t1922r1742b1990],
21	longacting	VBG	O	longact	prepc_of	17	SENT_195	[p15l1752t1922r2139b2012],
22	B,-agonist	JJ	O	b,-agonist	amod	23	SENT_195	[p15l16t2032r373b2122],
23	therapy	NN	O	therapy	dobj	21	SENT_195	[p15l414t2032r692b2121],
24	with	IN	O	with	_	0	SENT_195	[p15l732t2032r895b2100],
25	either	CC	O	either	preconj	26	SENT_195	[p15l941t2032r1154b2100],
26	formoterol	NN	O	formoterol	prep_with	21	SENT_195	[p15l1197t2032r1591b2100],
27	or	CC	O	or	_	0	SENT_195	[p15l1636t2056r1712b2099],
28	salmeterol	NN	O	salmeterol	conj_or	26	SENT_195	[p15l1757t2032r2139b2100],
29	when	WRB	O	when	advmod	30	SENT_195	[p15l9t2140r214b2209],
30	given	VBN	O	give	advcl	21	SENT_195	[p15l251t2145r447b2230],
31	in	IN	O	in	_	0	SENT_195	[p15l483t2145r557b2207],
32	combination	NN	O	combination	prep_in	30	SENT_195	[p15l594t2140r1060b2208],
33	with	IN	O	with	prep	30	SENT_195	[p15l1094t2140r1257b2208],
34	inhaled	VBN	O	inhale	_	0	SENT_195	[p15l1293t2140r1569b2208],
35	corticosteroids	NNS	O	corticosteroid	dobj	34	SENT_195	[p15l1605t2140r2137b2208],
36	in	IN	O	in	_	0	SENT_195	[p15l11t2254r85b2316],
37	individuals	NNS	O	individual	prep_in	34	SENT_195	[p15l114t2249r518b2317],
38	with	IN	O	with	_	0	SENT_195	[p15l549t2249r712b2317],
39	asthma	NN	O	asthma	prep_with	34	SENT_195	[p15l743t2249r1029b2317],
40	.	.	O	.	_	0	SENT_195	[p15l743t2249r1029b2317],

1	There	EX	O	there	expl	2	SENT_196	[p15l1062t2249r1277b2317],
2	was	VBD	O	be	_	0	SENT_196	[p15l1307t2273r1443b2317],
3	no	DT	O	no	det	4	SENT_196	[p15l1476t2274r1568b2317],
4	indication	NN	O	indication	nsubj	2	SENT_196	[p15l1600t2249r1969b2317],
5	that	IN	O	that	complm	10	SENT_196	[p15l1998t2249r2141b2317],
6	the	DT	O	the	det	8	SENT_196	[p15l10t2359r124b2426],
7	Arg/Arg	NN	O	arg/arg	nn	8	SENT_196	[p15l161t2364r471b2449],
8	genotype	NN	O	genotype	nsubj	10	SENT_196	[p15l508t2372r838b2449],
9	was	VBD	O	be	cop	10	SENT_196	[p15l874t2383r1011b2426],
10	responsible	JJ	O	responsible	ccomp	2	SENT_196	[p15l1050t2359r1472b2448],
11	for	IN	O	for	_	0	SENT_196	[p15l1510t2359r1614b2426],
12	a	DT	O	a	det	14	SENT_196	[p15l1651t2383r1688b2426],
13	therapeutic	JJ	O	therapeutic	amod	14	SENT_196	[p15l1723t2359r2139b2448],
14	outcome	NN	O	outcome	prep_for	10	SENT_196	[p15l12t2481r330b2535],
15	different	JJ	O	different	amod	14	SENT_196	[p15l352t2467r669b2535],
16	from	IN	O	from	_	0	SENT_196	[p15l688t2467r870b2535],
17	that	DT	O	that	prep_from	15	SENT_196	[p15l889t2467r1031b2535],
18	of	IN	O	of	_	0	SENT_196	[p15l1051t2467r1134b2535],
19	any	DT	O	any	det	21	SENT_196	[p15l1142t2492r1270b2557],
20	other	JJ	O	other	amod	21	SENT_196	[p15l1290t2467r1483b2535],
21	genotype	NN	O	genotype	prep_of	17	SENT_196	[p15l1503t2481r1851b2557],
22	,	,	O	,	_	0	SENT_196	[p15l1503t2481r1851b2557],
23	neither	CC	O	neither	dep	15	SENT_196	[p15l1875t2467r2140b2535],
24	for	IN	O	for	conj	15	SENT_196	[p15l11t2576r116b2644],
25	asthma	NN	O	asthma	nn	26	SENT_196	[p15l134t2576r403b2644],
26	exacerbations	NNS	O	exacerbation	pobj	24	SENT_196	[p15l423t2576r917b2644],
27	nor	CC	O	nor	_	0	SENT_196	[p15l939t2601r1067b2644],
28	for	IN	O	for	conj_nor	10	SENT_196	[p15l1084t2576r1189b2644],
29	day-to-day	JJ	O	day-to-day	amod	32	SENT_196	[p15l1207t2576r1576b2666],
30	asthma	NN	O	asthma	nn	32	SENT_196	[p15l1594t2576r1863b2644],
31	control	NN	O	control	nn	32	SENT_196	[p15l1882t2576r2139b2644],
32	measures	NNS	O	measure	pobj	28	SENT_196	[p15l11t2710r363b2753],
33	such	JJ	O	such	_	0	SENT_196	[p15l420t2686r590b2753],
34	as	IN	O	as	_	0	SENT_196	[p15l644t2710r715b2753],
35	lung	NN	O	lung	nn	36	SENT_196	[p15l768t2686r936b2776],
36	function	NN	O	function	prep_such_as	32	SENT_196	[p15l988t2686r1318b2764],
37	,	,	O	,	_	0	SENT_196	[p15l988t2686r1318b2764],
38	as-needed	JJ	O	as-needed	amod	40	SENT_196	[p15l1374t2686r1740b2753],
39	symptom	NN	O	symptom	nn	40	SENT_196	[p15l1793t2699r2139b2775],
40	wvvw	NN	O	wvvw	appos	36	SENT_196	[p15l7t2955r539b3006],
41	.	.	O	.	_	0	SENT_196	[p15l7t2955r539b3006],

1	the	DT	O	the	det	4	SENT_197	[p15l7t2955r539b3006],
2	|	NN	O	|	nn	4	SENT_197	[p15l7t2955r539b3006],
3	ancet.com	NN	O	ancet.com	nn	4	SENT_197	[p15l7t2955r539b3006],
4	Vol	NN	O	vol	_	0	SENT_197	[p15l582t2955r669b3006],
5	370	CD	NUMBER	370	dep	4	SENT_197	[p15l689t2961r792b3013],
6	December	NNP	DATE	December	tmod	5	SENT_197	[p15l841t2955r1118b3006],
7	22/29	CD	DATE	22/29	num	6	SENT_197	[p15l1135t2956r1314b3014],
8	,	,	DATE	,	_	0	SENT_197	[p15l1135t2956r1314b3014],
9	2007	CD	DATE	2007	num	6	SENT_197	[p15l1334t2961r1476b3012],

1	relief	NN	O	relief	_	0	SENT_198	[p16l7t71r154b127],
2	,	,	O	,	_	0	SENT_198	[p16l7t71r154b127],
3	or	CC	O	or	_	0	SENT_198	[p16l175t89r229b120],
4	asthma	NN	O	asthma	nn	5	SENT_198	[p16l245t71r438b120],
5	symptoms	NNS	O	symptom	conj_or	1	SENT_198	[p16l456t81r743b135],
6	.	.	O	.	_	0	SENT_198	[p16l456t81r743b135],

1	Because	IN	O	because	_	0	SENT_199	[p16l766t76r977b120],
2	of	IN	O	of	prepc_because_of	10	SENT_199	[p16l996t71r1054b120],
3	the	DT	O	the	det	4	SENT_199	[p16l1061t71r1143b120],
4	importance	NN	O	importance	pobj	10	SENT_199	[p16l1161t74r1462b134],
5	of	IN	O	of	_	0	SENT_199	[p16l1480t71r1539b120],
6	these	DT	O	these	det	7	SENT_199	[p16l6t149r144b198],
7	results	NNS	O	result	prep_of	4	SENT_199	[p16l160t149r349b205],
8	,	,	O	,	_	0	SENT_199	[p16l160t149r349b205],
9	we	PRP	O	we	nsubj	10	SENT_199	[p16l366t167r438b198],
10	chose	VBD	O	choose	_	0	SENT_199	[p16l456t149r603b198],
11	to	TO	O	to	aux	12	SENT_199	[p16l619t159r667b197],
12	investigate	VB	O	investigate	xcomp	10	SENT_199	[p16l684t152r964b213],
13	the	DT	O	the	det	14	SENT_199	[p16l980t149r1062b198],
14	effects	NNS	O	effect	dobj	12	SENT_199	[p16l1079t149r1245b198],
15	of	IN	O	of	_	0	SENT_199	[p16l1264t149r1322b197],
16	ADRB2	NN	O	adrb2	nn	17	SENT_199	[p16l1328t153r1532b197],
17	variation	NN	O	variation	prep_of	14	SENT_199	[p16l6t230r237b275],
18	in	IN	O	in	_	0	SENT_199	[p16l262t230r314b274],
19	a	DT	DURATION	a	det	26	SENT_199	[p16l340t244r366b275],
20	second	JJ	DURATION	second	amod	26	SENT_199	[p16l393t227r575b275],
21	separate	JJ	O	separate	amod	26	SENT_199	[p16l600t236r828b290],
22	,	,	O	,	_	0	SENT_199	[p16l600t236r828b290],
23	but	CC	O	but	_	0	SENT_199	[p16l854t227r943b275],
24	comparable	JJ	O	comparable	conj_but	21	SENT_199	[p16l967t227r1286b290],
25	,	,	O	,	_	0	SENT_199	[p16l967t227r1286b290],
26	study	NN	O	study	prep_in	12	SENT_199	[p16l1316t227r1456b290],
27	of	IN	O	of	_	0	SENT_199	[p16l1480t227r1539b275],
28	7	CD	DURATION	7	num	29	SENT_199	[p16l7t307r33b354],
29	months	NNS	NUMBER	month	prep_of	26	SENT_199	[p16l62t304r275b353],
30	’	CD	NUMBER	’	num	33	SENT_199	[p16l62t304r275b353],
31	duration	NN	O	duration	nn	33	SENT_199	[p16l309t304r534b353],
32	(	NN	O	(	nn	33	SENT_199	[p16l568t304r725b368],
33	study	NN	O	study	nsubj	39	SENT_199	[p16l568t304r725b368],
34	2	CD	NUMBER	2	num	35	SENT_199	[p16l756t309r799b368],
35	)	NN	O	)	dep	33	SENT_199	[p16l756t309r799b368],
36	in	IN	O	in	_	0	SENT_199	[p16l833t307r886b352],
37	which	WDT	O	which	prep_in	33	SENT_199	[p16l915t304r1076b353],
38	both	CC	O	both	advmod	39	SENT_199	[p16l1105t304r1223b353],
39	longacting	VBG	O	longact	rcmod	29	SENT_199	[p16l1253t304r1530b368],
40	B2-agonist	JJ	O	b2-agonist	amod	41	SENT_199	[p16l11t382r266b446],
41	combinations	NNS	O	combination	nsubjpass	43	SENT_199	[p16l330t382r688b431],
42	were	VBD	O	be	auxpass	43	SENT_199	[p16l752t400r878b431],
43	used	VBN	O	use	ccomp	39	SENT_199	[p16l942t382r1079b438],
44	,	,	O	,	_	0	SENT_199	[p16l942t382r1079b438],
45	and	CC	O	and	_	0	SENT_199	[p16l1146t382r1244b431],
46	multiple	JJ	O	multiple	amod	47	SENT_199	[p16l1307t382r1529b445],
47	outcomes	NNS	O	outcome	nsubj	48	SENT_199	[p16l8t461r580b525],
48	—	VBP	O	—	conj_and	10	SENT_199	[p16l8t461r580b525],
49	including	VBG	O	include	_	0	SENT_199	[p16l8t461r580b525],
50	exacerbations	NNS	O	exacerbation	prep_including	62	SENT_199	[p16l597t461r966b516],
51	,	,	O	,	_	0	SENT_199	[p16l597t461r966b516],
52	pulmonary	JJ	O	pulmonary	amod	53	SENT_199	[p16l985t461r1276b524],
53	function	NN	O	function	prep_including	62	SENT_199	[p16l1291t461r1527b516],
54	,	,	O	,	_	0	SENT_199	[p16l1291t461r1527b516],
55	and	CC	O	and	_	0	SENT_199	[p16l8t538r105b587],
56	asthma	NN	O	asthma	nn	58	SENT_199	[p16l120t538r313b587],
57	control	NN	O	control	nn	58	SENT_199	[p16l328t538r512b587],
58	measures	NNS	O	measure	prep_including	62	SENT_199	[p16l527t556r971b587],
59	—	CD	NUMBER	—	nsubjpass	62	SENT_199	[p16l527t556r971b587],
60	were	VBD	O	be	auxpass	62	SENT_199	[p16l527t556r971b587],
61	also	RB	O	also	advmod	62	SENT_199	[p16l987t538r1087b587],
62	assessed	VBN	O	assess	ccomp	48	SENT_199	[p16l1104t538r1340b587],
63	.	.	O	.	_	0	SENT_199	[p16l1104t538r1340b587],

1	Again	RB	O	again	advmod	8	SENT_200	[p16l1358t541r1527b602],
2	,	,	O	,	_	0	SENT_200	[p16l1358t541r1527b602],
3	no	DT	O	no	det	4	SENT_200	[p16l7t634r73b664],
4	ADRB2	NN	O	adrb2	nsubjpass	8	SENT_200	[p16l91t620r296b664],
5	genotypic	JJ	O	genotypic	amod	6	SENT_200	[p16l313t619r565b680],
6	effects	NNS	O	effect	dep	4	SENT_200	[p16l584t616r750b665],
7	were	VBD	O	be	auxpass	8	SENT_200	[p16l768t634r894b665],
8	noted	VBN	O	note	_	0	SENT_200	[p16l913t616r1062b665],
9	in	IN	O	in	_	0	SENT_200	[p16l1079t619r1132b664],
10	study	NN	O	study	prep_in	8	SENT_200	[p16l1152t616r1293b680],
11	2	CD	NUMBER	2	num	10	SENT_200	[p16l1311t621r1352b664],
12	.	.	O	.	_	0	SENT_200	[p16l1311t621r1352b664],

1	These	DT	O	these	det	2	SENT_201	[p16l1372t616r1529b665],
2	data	NNS	O	datum	nsubj	3	SENT_201	[p16l8t695r115b743],
3	suggested	VBD	O	suggest	_	0	SENT_201	[p16l139t695r400b759],
4	that	IN	O	that	complm	14	SENT_201	[p16l421t695r523b743],
5	variation	NN	O	variation	nsubj	14	SENT_201	[p16l543t698r774b743],
6	of	IN	O	of	_	0	SENT_201	[p16l797t695r856b743],
7	the	DT	O	the	det	9	SENT_201	[p16l868t695r950b743],
8	longacting	VBG	O	longact	amod	9	SENT_201	[p16l972t695r1250b759],
9	[	NN	O	[	prep_of	5	SENT_201	[p16l1276t694r1531b759],
10	32-agonist	JJ	O	32-agonist	amod	11	SENT_201	[p16l1276t694r1531b759],
11	dose	NN	O	dose	dep	9	SENT_201	[p16l8t772r126b821],
12	does	VBZ	O	do	aux	14	SENT_201	[p16l162t772r278b821],
13	not	RB	O	not	neg	14	SENT_201	[p16l314t782r401b821],
14	lead	VB	O	lead	ccomp	3	SENT_201	[p16l434t772r541b821],
15	to	TO	O	to	_	0	SENT_201	[p16l574t782r623b821],
16	an	DT	O	a	det	17	SENT_201	[p16l659t790r722b821],
17	interaction	NN	O	interaction	prep_to	14	SENT_201	[p16l757t775r1042b821],
18	between	IN	O	between	_	0	SENT_201	[p16l1075t772r1295b821],
19	ADRB2	NN	O	adrb2	prep_between	17	SENT_201	[p16l1328t776r1533b820],

1	genotype	NN	O	genotype	nn	4	SENT_202	[p16l8t860r244b914],
2	and	CC	O	and	_	0	SENT_202	[p16l294t850r391b899],
3	clinical	JJ	O	clinical	conj_and	1	SENT_202	[p16l440t850r625b899],
4	outcomes	NNS	O	outcome	nsubj	9	SENT_202	[p16l675t860r942b906],
5	,	,	O	,	_	0	SENT_202	[p16l675t860r942b906],
6	since	IN	O	since	_	0	SENT_202	[p16l995t853r1128b899],
7	both	DT	O	both	det	8	SENT_202	[p16l1176t850r1295b899],
8	studies	NNS	O	study	prep_since	4	SENT_202	[p16l1346t850r1528b899],
9	included	VBD	O	include	_	0	SENT_202	[p16l7t929r236b977],
10	an	DT	O	a	det	13	SENT_202	[p16l256t946r319b977],
11	adjustable-dose	JJ	O	adjustable-dose	amod	13	SENT_202	[p16l338t929r742b992],
12	treatment	NN	O	treatment	nn	13	SENT_202	[p16l761t938r1020b977],
13	group	NN	O	group	dobj	9	SENT_202	[p16l1039t946r1193b993],
14	in	IN	O	in	_	0	SENT_202	[p16l1213t932r1266b976],
15	which	WDT	O	which	rel	20	SENT_202	[p16l1283t929r1444b977],
16	no	DT	O	no	det	18	SENT_202	[p16l1463t946r1529b977],
17	genotype	NN	O	genotype	nn	18	SENT_202	[p16l8t1016r244b1070],
18	effect	NN	O	effect	nsubjpass	20	SENT_202	[p16l263t1007r405b1055],
19	was	VBD	O	be	auxpass	20	SENT_202	[p16l420t1024r518b1055],
20	recorded	VBN	O	record	rcmod	13	SENT_202	[p16l537t1006r779b1055],
21	.	.	O	.	_	0	SENT_202	[p16l537t1006r779b1055],

1	Studies	NNS	O	study	nsubj	21	SENT_203	[p16l62t1084r254b1133],
2	investigating	VBG	O	investigate	partmod	1	SENT_203	[p16l273t1087r617b1148],
3	the	DT	O	the	det	4	SENT_203	[p16l634t1084r717b1133],
4	effects	NNS	O	effect	dobj	2	SENT_203	[p16l735t1084r904b1133],
5	of	IN	O	of	_	0	SENT_203	[p16l924t1084r983b1132],
6	ADRB2	NN	O	adrb2	nn	7	SENT_203	[p16l990t1088r1197b1132],
7	variation	NN	O	variation	prep_of	4	SENT_203	[p16l1210t1087r1445b1133],
8	on	IN	O	on	_	0	SENT_203	[p16l1463t1102r1530b1133],
9	clinical	JJ	O	clinical	amod	10	SENT_203	[p16l8t1163r197b1211],
10	outcome	NN	O	outcome	prep_on	7	SENT_203	[p16l223t1172r454b1211],
11	in	IN	O	in	_	0	SENT_203	[p16l480t1166r533b1210],
12	small	JJ	O	small	amod	13	SENT_203	[p16l561t1163r704b1211],
13	numbers	NNS	O	number	prep_in	10	SENT_203	[p16l729t1163r970b1211],
14	of	IN	O	of	_	0	SENT_203	[p16l998t1163r1057b1211],
15	asthmatics	NNS	O	asthmatic	prep_of	13	SENT_203	[p16l1074t1163r1359b1211],
16	given	VBN	O	give	prep	2	SENT_203	[p16l1387t1166r1530b1227],
17	shortacting	VBG	O	shortact	amod	18	SENT_203	[p16l9t1240r308b1304],
18	B,-agonists	NNS	O	b,-agonist	dep	16	SENT_203	[p16l370t1240r653b1304],
19	have	VBP	O	have	aux	21	SENT_203	[p16l713t1240r834b1289],
20	generally	RB	O	generally	advmod	21	SENT_203	[p16l894t1240r1137b1304],
21	shown	VBN	O	show	_	0	SENT_203	[p16l1196t1240r1370b1289],
22	that	IN	O	that	complm	28	SENT_203	[p16l1427t1240r1531b1289],
23	individuals	NNS	O	individual	nsubj	28	SENT_203	[p16l7t1318r301b1367],
24	with	IN	O	with	_	0	SENT_203	[p16l321t1318r439b1367],
25	the	DT	O	the	det	27	SENT_203	[p16l457t1318r540b1367],
26	Arg/Arg	NN	O	arg/arg	nn	27	SENT_203	[p16l559t1321r783b1382],
27	genotype	NN	O	genotype	prep_with	23	SENT_203	[p16l803t1328r1043b1382],
28	had	VBD	O	have	ccomp	21	SENT_203	[p16l1061t1318r1160b1367],
29	worsening	VBG	O	worsen	dobj	28	SENT_203	[p16l1177t1321r1460b1382],
30	of	IN	O	of	_	0	SENT_203	[p16l1480t1318r1539b1367],
31	lung	NN	O	lung	nn	32	SENT_203	[p16l6t1397r128b1461],
32	function	NN	O	function	prep_of	29	SENT_203	[p16l163t1397r478b1445],
33	.	.	O	.	_	0	SENT_203	[p16l163t1397r478b1445],

1	“	NN	O	“	npadvmod	12	SENT_204	[p16l163t1397r478b1445],
2	'17	CD	NUMBER	'17	num	1	SENT_204	[p16l163t1397r478b1445],
3	In	IN	O	in	_	0	SENT_204	[p16l514t1402r570b1444],
4	two	CD	NUMBER	two	num	6	SENT_204	[p16l604t1406r698b1445],
5	small	JJ	O	small	amod	6	SENT_204	[p16l735t1397r878b1445],
6	studies	NNS	O	study	prep_in	12	SENT_204	[p16l914t1397r1115b1453],
7	,	,	O	,	_	0	SENT_204	[p16l914t1397r1115b1453],
8	Wechsler	NNP	PERSON	Wechsler	nsubj	12	SENT_204	[p16l1151t1397r1398b1446],
9	and	CC	O	and	_	0	SENT_204	[p16l1432t1397r1531b1445],
10	colleagues	NNS	O	colleague	conj_and	8	SENT_204	[p16l8t1474r313b1538],
11	“	RB	O	“	advmod	12	SENT_204	[p16l8t1474r313b1538],
12	showed	VBD	O	show	_	0	SENT_204	[p16l335t1474r536b1523],
13	reduced	VBN	O	reduce	amod	14	SENT_204	[p16l556t1474r770b1523],
14	responses	NNS	O	response	dobj	12	SENT_204	[p16l789t1492r1054b1537],
15	to	TO	O	to	_	0	SENT_204	[p16l1075t1484r1125b1523],
16	the	DT	O	the	det	19	SENT_204	[p16l1145t1474r1228b1523],
17	longacting	VBG	O	longact	amod	19	SENT_204	[p16l1248t1474r1530b1538],
18	B,-agonist	NN	O	b,-agonist	nn	19	SENT_204	[p16l11t1552r270b1616],
19	salmeterol	NN	O	salmeterol	prep_to	12	SENT_204	[p16l300t1552r578b1601],
20	in	IN	O	in	_	0	SENT_204	[p16l606t1555r659b1600],
21	Arg/Arg	NN	O	arg/arg	nn	22	SENT_204	[p16l687t1556r911b1616],
22	individuals	NNS	O	individual	prep_in	19	SENT_204	[p16l940t1552r1233b1601],
23	compared	VBN	O	compare	_	0	SENT_204	[p16l1265t1552r1531b1615],
24	with	IN	O	with	prepc_compared_with	12	SENT_204	[p16l6t1630r124b1678],
25	Gly/Gly	JJ	O	gly/gly	amod	26	SENT_204	[p16l167t1630r377b1693],
26	individuals	NNS	O	individual	pobj	12	SENT_204	[p16l418t1630r726b1678],
27	.	.	O	.	_	0	SENT_204	[p16l418t1630r726b1678],

1	The	DT	O	the	det	2	SENT_205	[p16l770t1630r872b1678],
2	studies	NNS	O	study	nsubj	5	SENT_205	[p16l917t1630r1102b1678],
3	reported	VBN	O	report	partmod	2	SENT_205	[p16l1145t1630r1372b1693],
4	here	RB	O	here	advmod	3	SENT_205	[p16l1411t1630r1529b1678],
5	included	VBD	O	include	_	0	SENT_205	[p16l7t1707r240b1756],
6	a	DT	O	a	det	9	SENT_205	[p16l263t1725r290b1756],
7	longer	RBR	O	longer	amod	9	SENT_205	[p16l313t1707r485b1771],
8	treatment	NN	O	treatment	nn	9	SENT_205	[p16l507t1717r771b1756],
9	period	NN	O	period	nsubj	22	SENT_205	[p16l793t1707r964b1770],
10	and	CC	O	and	_	0	SENT_205	[p16l988t1707r1086b1756],
11	larger	JJR	O	larger	amod	12	SENT_205	[p16l1108t1707r1265b1771],
12	numbers	NNS	O	number	nsubj	22	SENT_205	[p16l1287t1707r1528b1756],
13	of	IN	O	of	_	0	SENT_205	[p16l8t1785r67b1834],
14	Arg/Arg	NN	O	arg/arg	nn	15	SENT_205	[p16l99t1788r324b1849],
15	homozygotes	NNS	O	homozygote	prep_of	12	SENT_205	[p16l365t1785r719b1849],
16	than	IN	O	than	advmod	22	SENT_205	[p16l762t1785r883b1834],
17	in	IN	O	in	_	0	SENT_205	[p16l925t1788r978b1833],
18	the	DT	O	the	det	19	SENT_205	[p16l1020t1785r1103b1834],
19	Salmeterol	NNP	ORGANIZATION	Salmeterol	prep_in	16	SENT_205	[p16l1150t1785r1433b1834],
20	or	CC	O	or	_	0	SENT_205	[p16l1476t1803r1531b1834],
21	Corticosteroids	NNS	O	corticosteroid	conj_or	19	SENT_205	[p16l9t1864r410b1912],
22	(	VBP	O	(	dep	5	SENT_205	[p16l443t1867r634b1928],
23	SOCS	NN	MISC	soc	nn	25	SENT_205	[p16l443t1867r634b1928],
24	)	CD	NUMBER	)	num	25	SENT_205	[p16l443t1867r634b1928],
25	trial	NN	O	trial	dobj	22	SENT_205	[p16l665t1864r771b1912],
26	and	CC	O	and	_	0	SENT_205	[p16l799t1864r898b1912],
27	the	DT	O	the	det	29	SENT_205	[p16l923t1864r1006b1912],
28	Salmeterol	NNP	ORGANIZATION	Salmeterol	nn	29	SENT_205	[p16l1038t1864r1321b1912],
29	and/or	NN	O	and/or	nsubj	30	SENT_205	[p16l1349t1864r1531b1927],
30	Inhaled	VBN	MISC	inhale	conj_and	22	SENT_205	[p16l10t1941r213b1990],
31	Corticosteroid	NN	MISC	corticosteroid	nsubj	35	SENT_205	[p16l234t1941r610b1990],
32	(	CD	NUMBER	(	num	35	SENT_205	[p16l634t1945r799b2005],
33	SLIC	NNP	ORGANIZATION	SLIC	nn	35	SENT_205	[p16l634t1945r799b2005],
34	)	CD	NUMBER	)	num	35	SENT_205	[p16l634t1945r799b2005],
35	trial	NN	O	trial	xcomp	30	SENT_205	[p16l823t1941r974b1990],
36	.	.	O	.	_	0	SENT_205	[p16l823t1941r974b1990],

1	”	NN	O	”	nsubj	11	SENT_206	[p16l823t1941r974b1990],
2	Furthermore	RB	O	furthermore	advmod	1	SENT_206	[p16l997t1941r1351b1997],
3	,	,	O	,	_	0	SENT_206	[p16l997t1941r1351b1997],
4	in	IN	O	in	_	0	SENT_206	[p16l1374t1944r1427b1989],
5	the	DT	O	the	det	7	SENT_206	[p16l1446t1941r1529b1990],
6	present	JJ	DATE	present	amod	7	SENT_206	[p16l7t2029r207b2082],
7	studies	NNS	O	study	prep_in	11	SENT_206	[p16l223t2019r423b2075],
8	,	,	O	,	_	0	SENT_206	[p16l223t2019r423b2075],
9	all	DT	O	all	det	10	SENT_206	[p16l441t2019r502b2068],
10	patients	NNS	O	patient	nsubj	11	SENT_206	[p16l516t2022r726b2082],
11	received	VBD	O	receive	_	0	SENT_206	[p16l743t2019r962b2068],
12	combination	NN	O	combination	nn	13	SENT_206	[p16l977t2019r1316b2068],
13	therapy	NN	O	therapy	dobj	11	SENT_206	[p16l1330t2019r1531b2083],
14	(	CD	NUMBER	(	nsubj	15	SENT_206	[p16l11t2098r228b2162],
15	inhaled	VBD	O	inhale	rcmod	13	SENT_206	[p16l11t2098r228b2162],
16	corticosteroids	NNS	O	corticosteroid	dobj	15	SENT_206	[p16l254t2098r642b2146],
17	plus	CC	O	plus	prep	16	SENT_206	[p16l671t2098r782b2161],
18	longacting	VBG	O	longact	dep	17	SENT_206	[p16l810t2098r1092b2162],
19	B,-agonists	NNS	O	b,-agonist	dobj	18	SENT_206	[p16l1123t2097r1424b2162],
20	)	CD	NUMBER	)	num	19	SENT_206	[p16l1123t2097r1424b2162],
21	for	IN	O	for	_	0	SENT_206	[p16l1455t2098r1531b2146],
22	the	DT	O	the	det	23	SENT_206	[p16l6t2175r89b2224],
23	duration	NN	O	duration	prep_for	19	SENT_206	[p16l108t2175r336b2224],
24	of	IN	O	of	_	0	SENT_206	[p16l355t2175r414b2224],
25	the	DT	O	the	det	26	SENT_206	[p16l421t2175r504b2224],
26	study	NN	O	study	prep_of	23	SENT_206	[p16l525t2175r674b2239],
27	,	,	O	,	_	0	SENT_206	[p16l525t2175r674b2239],
28	unlike	IN	O	unlike	_	0	SENT_206	[p16l693t2175r862b2224],
29	the	DT	O	the	det	31	SENT_206	[p16l880t2175r963b2224],
30	SOCS	NN	MISC	soc	nn	31	SENT_206	[p16l985t2179r1138b2224],
31	trial	NN	O	trial	prep_unlike	15	SENT_206	[p16l1158t2175r1278b2231],
32	,	,	O	,	_	0	SENT_206	[p16l1158t2175r1278b2231],
33	in	IN	O	in	_	0	SENT_206	[p16l1298t2178r1351b2223],
34	which	WDT	O	which	rel	38	SENT_206	[p16l1367t2175r1530b2224],
35	participants	NNS	O	participant	nsubj	38	SENT_206	[p16l7t2255r321b2315],
36	did	VBD	O	do	aux	38	SENT_206	[p16l387t2252r471b2300],
37	not	RB	O	not	neg	38	SENT_206	[p16l534t2262r622b2300],
38	receive	VB	O	receive	rcmod	31	SENT_206	[p16l684t2255r868b2301],
39	concomitant	JJ	O	concomitant	dobj	38	SENT_206	[p16l933t2255r1268b2300],
40	inhaled	VBN	O	inhale	partmod	39	SENT_206	[p16l1330t2252r1531b2300],
41	corticosteroids	NNS	O	corticosteroid	dobj	40	SENT_206	[p16l8t2331r411b2379],
42	.	.	O	.	_	0	SENT_206	[p16l8t2331r411b2379],

1	Individuals	NNS	O	individual	nsubj	2	SENT_207	[p16l451t2331r748b2379],
2	included	VBD	O	include	_	0	SENT_207	[p16l784t2331r1017b2379],
3	in	IN	O	in	mark	10	SENT_207	[p16l1051t2334r1104b2379],
4	the	DT	O	the	det	6	SENT_207	[p16l1137t2331r1220b2379],
5	SLIC	NNP	ORGANIZATION	SLIC	nn	6	SENT_207	[p16l1259t2334r1388b2379],
6	trial	NN	O	trial	nsubjpass	10	SENT_207	[p16l1423t2331r1530b2379],
7	were	VBD	O	be	auxpass	10	SENT_207	[p16l6t2425r133b2456],
8	not	RB	O	not	neg	10	SENT_207	[p16l170t2417r258b2456],
9	well	RB	O	well	advmod	10	SENT_207	[p16l292t2407r400b2456],
10	controlled	VBN	O	control	advcl	2	SENT_207	[p16l437t2407r706b2456],
11	before	IN	O	before	_	0	SENT_207	[p16l741t2407r909b2456],
12	enrolment	NN	O	enrolment	prep_before	10	SENT_207	[p16l947t2407r1228b2456],
13	compared	VBN	O	compare	_	0	SENT_207	[p16l1265t2407r1531b2470],
14	with	IN	O	with	prepc_compared_with	10	SENT_207	[p16l6t2485r124b2534],
15	those	DT	O	those	pobj	10	SENT_207	[p16l151t2485r294b2534],
16	in	IN	O	in	_	0	SENT_207	[p16l323t2488r376b2533],
17	studies	NNS	O	study	prep_in	15	SENT_207	[p16l406t2485r591b2534],
18	1	CD	NUMBER	1	num	17	SENT_207	[p16l623t2490r646b2533],
19	and	CC	O	and	_	0	SENT_207	[p16l674t2485r773b2534],
20	2	CD	NUMBER	2	prep_in	15	SENT_207	[p16l802t2490r843b2534],
21	.	.	O	.	_	0	SENT_207	[p16l802t2490r843b2534],

1	A	DT	O	a	det	2	SENT_208	[p16l873t2489r916b2533],
2	combination	NN	O	combination	nsubj	7	SENT_208	[p16l944t2485r1283b2534],
3	of	IN	O	of	_	0	SENT_208	[p16l1312t2485r1371b2534],
4	these	DT	O	these	det	5	SENT_208	[p16l1389t2485r1529b2534],
5	factors	NNS	O	factor	prep_of	2	SENT_208	[p16l7t2564r183b2612],
6	might	MD	O	might	aux	7	SENT_208	[p16l208t2564r370b2628],
7	help	VB	O	help	_	0	SENT_208	[p16l391t2564r506b2627],
8	to	TO	O	to	aux	9	SENT_208	[p16l529t2573r578b2612],
9	explain	VB	O	explain	xcomp	7	SENT_208	[p16l603t2564r794b2627],
10	why	WRB	O	why	advmod	16	SENT_208	[p16l816t2564r926b2627],
11	results	NNS	O	result	nsubj	16	SENT_208	[p16l948t2564r1124b2612],
12	in	IN	O	in	_	0	SENT_208	[p16l1149t2567r1202b2611],
13	the	DT	O	the	det	15	SENT_208	[p16l1224t2564r1307b2612],
14	present	JJ	DATE	present	amod	15	SENT_208	[p16l1331t2573r1531b2627],
15	studies	NNS	O	study	prep_in	11	SENT_208	[p16l9t2641r194b2690],
16	differ	VBP	O	differ	advcl	9	SENT_208	[p16l215t2641r360b2690],
17	from	IN	O	from	_	0	SENT_208	[p16l377t2641r509b2690],
18	those	DT	O	those	prep_from	16	SENT_208	[p16l526t2641r669b2690],
19	of	IN	O	of	_	0	SENT_208	[p16l688t2641r748b2690],
20	Wechsler	NNP	PERSON	Wechsler	prep_of	18	SENT_208	[p16l756t2641r1003b2690],
21	and	CC	O	and	_	0	SENT_208	[p16l1022t2641r1120b2690],
22	colleagues	NNS	O	colleague	prep_of	18	SENT_208	[p16l1138t2641r1427b2705],
23	.	.	O	.	_	0	SENT_208	[p16l1138t2641r1427b2705],

1	Our	PRP$	O	we	poss	2	SENT_209	[p16l60t2723r165b2768],
2	ﬁndings	NNS	O	ﬁndings	nsubj	4	SENT_209	[p16l188t2719r407b2783],
3	are	VBP	O	be	cop	4	SENT_209	[p16l434t2737r513b2768],
4	consistent	JJ	O	consistent	_	0	SENT_209	[p16l539t2722r812b2768],
5	with	IN	O	with	_	0	SENT_209	[p16l833t2719r951b2768],
6	a	DT	O	a	det	8	SENT_209	[p16l976t2737r1002b2768],
7	12-week	JJ	DURATION	12-week	amod	8	SENT_209	[p16l1028t2719r1238b2768],
8	study	NN	O	study	prep_with	4	SENT_209	[p16l1263t2719r1405b2783],
9	that	WDT	O	that	nsubj	10	SENT_209	[p16l1427t2719r1531b2768],
10	assessed	VBD	O	assess	rcmod	8	SENT_209	[p16l8t2798r236b2846],
11	inhaled	VBN	O	inhale	dep	10	SENT_209	[p16l250t2798r451b2846],
12	corticosteroid	NN	O	corticosteroid	dobj	11	SENT_209	[p16l466t2798r830b2846],
13	plus	CC	O	plus	_	0	SENT_209	[p16l844t2798r955b2861],
14	longacting	VBG	O	longact	amod	16	SENT_209	[p16l971t2798r1253b2862],
15	B2-agonist	JJ	O	b2-agonist	amod	16	SENT_209	[p16l1271t2797r1531b2862],
16	combination	NN	O	combination	conj_plus	12	SENT_209	[p16l8t2874r347b2923],
17	of	IN	O	of	_	0	SENT_209	[p16l396t2874r455b2923],
18	ﬂuticasone	NN	O	ﬂuticasone	prep_of	16	SENT_209	[p16l494t2874r785b2923],
19	plus	CC	O	plus	prep	16	SENT_209	[p16l834t2874r945b2937],
20	salmeterol	NN	O	salmeterol	dep	19	SENT_209	[p16l997t2874r1320b2930],
21	,	,	O	,	_	0	SENT_209	[p16l997t2874r1320b2930],
22	”	NN	O	”	conj_plus	12	SENT_209	[p16l997t2874r1320b2930],
23	which	WDT	O	which	nsubj	24	SENT_209	[p16l1367t2874r1530b2923],
24	showed	VBD	O	show	rcmod	22	SENT_209	[p16l9t2951r210b2999],
25	a	DT	O	a	det	27	SENT_209	[p16l230t2968r256b2999],
26	sustained	JJ	O	sustained	amod	27	SENT_209	[p16l277t2951r532b2999],
27	improvement	NN	O	improvement	dobj	24	SENT_209	[p16l550t2954r915b3014],
28	in	IN	O	in	_	0	SENT_209	[p16l934t2954r987b2999],
29	asthma	NN	O	asthma	nn	30	SENT_209	[p16l1007t2951r1202b2999],
30	control	NN	O	control	prep_in	24	SENT_209	[p16l1222t2951r1409b2999],
31	that	WDT	O	that	nsubj	33	SENT_209	[p16l1427t2951r1531b2999],
32	was	VBD	O	be	cop	33	SENT_209	[p16l6t3047r104b3078],
33	independent	JJ	O	independent	rcmod	12	SENT_209	[p16l124t3030r463b3093],
34	of	IN	O	of	_	0	SENT_209	[p16l481t3030r540b3078],
35	genotype	NN	O	genotype	prep_of	33	SENT_209	[p16l550t3039r803b3094],
36	.	.	O	.	_	0	SENT_209	[p16l550t3039r803b3094],

1	Another	DT	O	another	det	2	SENT_210	[p16l823t3030r1044b3078],
2	study	NN	O	study	nsubj	14	SENT_210	[p16l1063t3030r1206b3093],
3	of	IN	O	of	_	0	SENT_210	[p16l1223t3030r1282b3078],
4	response	NN	O	response	prep_of	2	SENT_210	[p16l1291t3047r1529b3093],
5	to	TO	O	to	_	0	SENT_210	[p16l6t3117r56b3156],
6	treatment	NN	O	treatment	prep_to	4	SENT_210	[p16l74t3117r338b3156],
7	with	IN	O	with	_	0	SENT_210	[p16l354t3107r472b3156],
8	a	DT	O	a	det	9	SENT_210	[p16l491t3125r518b3156],
9	[	NN	O	[	prep_with	6	SENT_210	[p16l540t3107r799b3171],
10	32-agonist	JJ	O	32-agonist	amod	9	SENT_210	[p16l540t3107r799b3171],
11	plus	CC	O	plus	advmod	12	SENT_210	[p16l816t3107r928b3171],
12	inhaled	VBN	O	inhale	partmod	9	SENT_210	[p16l948t3107r1149b3156],
13	corticosteroid	NN	O	corticosteroid	dobj	12	SENT_210	[p16l1167t3107r1531b3156],
14	showed	VBD	O	show	_	0	SENT_210	[p16l9t3185r210b3234],
15	no	DT	O	no	det	16	SENT_210	[p16l239t3203r305b3233],
16	effect	NN	O	effect	dobj	14	SENT_210	[p16l336t3185r481b3234],
17	of	IN	O	of	_	0	SENT_210	[p16l509t3185r568b3234],
18	ADRB2	NN	O	adrb2	nn	19	SENT_210	[p16l587t3189r794b3233],
19	haplotype	NN	O	haplotype	prep_of	16	SENT_210	[p16l820t3185r1079b3249],
20	or	CC	O	or	_	0	SENT_210	[p16l1110t3203r1164b3234],
21	genotype	NN	O	genotype	conj_or	19	SENT_210	[p16l1193t3195r1433b3249],
22	on	IN	O	on	_	0	SENT_210	[p16l1463t3203r1530b3233],
23	bronchodilator	NN	O	bronchodilator	nn	24	SENT_210	[p16l6t3263r404b3311],
24	response	NN	O	response	prep_on	14	SENT_210	[p16l421t3266r709b3326],
25	.	.	O	.	_	0	SENT_210	[p16l421t3266r709b3326],

1	”	NN	O	”	_	0	SENT_211	[p16l421t3266r709b3326],

1	The	DT	O	the	det	4	SENT_212	[p16l57t3339r159b3388],
2	important	JJ	O	important	amod	4	SENT_212	[p16l172t3343r441b3402],
3	clinical	JJ	O	clinical	amod	4	SENT_212	[p16l452t3339r642b3388],
4	outcome	NN	O	outcome	nsubj	11	SENT_212	[p16l654t3349r885b3388],
5	of	IN	O	of	_	0	SENT_212	[p16l898t3339r957b3388],
6	asthma	NN	O	asthma	nn	7	SENT_212	[p16l960t3339r1155b3388],
7	exacerbations	NNS	O	exacerbation	prep_of	4	SENT_212	[p16l1168t3339r1528b3388],
8	was	VBD	O	be	cop	11	SENT_212	[p16l6t3433r105b3465],
9	the	DT	O	the	det	11	SENT_212	[p16l145t3416r228b3464],
10	main	JJ	O	main	amod	11	SENT_212	[p16l268t3419r407b3464],
11	endpoint	NN	O	endpoint	_	0	SENT_212	[p16l446t3416r687b3479],
12	in	IN	O	in	prep	11	SENT_212	[p16l725t3419r778b3464],
13	both	CC	O	both	dep	11	SENT_212	[p16l816t3416r937b3464],
14	studies	NNS	O	study	conj	11	SENT_212	[p16l978t3416r1163b3464],
15	selected	VBN	O	select	partmod	14	SENT_212	[p16l1206t3416r1416b3464],
16	for	IN	O	for	_	0	SENT_212	[p16l1455t3416r1531b3464],
17	pharmacogenetic	JJ	O	pharmacogenetic	amod	18	SENT_212	[p16l7t3495r469b3559],
18	investigation	NN	O	investigation	prep_for	15	SENT_212	[p16l490t3498r847b3559],
19	.	.	O	.	_	0	SENT_212	[p16l490t3498r847b3559],

1	In	IN	O	in	_	0	SENT_213	[p16l874t3500r930b3542],
2	study	NN	O	study	prep_in	9	SENT_213	[p16l953t3495r1096b3558],
3	1	CD	NUMBER	1	num	2	SENT_213	[p16l1118t3499r1153b3550],
4	,	,	O	,	_	0	SENT_213	[p16l1118t3499r1153b3550],
5	the	DT	O	the	det	7	SENT_213	[p16l1176t3495r1259b3543],
6	Gly16Arg	NN	O	gly16arg	nn	7	SENT_213	[p16l1283t3495r1530b3559],
7	genotype	NN	O	genotype	nsubjpass	9	SENT_213	[p16l8t3582r248b3636],
8	was	VBD	O	be	auxpass	9	SENT_213	[p16l263t3590r362b3621],
9	assessed	VBN	O	assess	_	0	SENT_213	[p16l381t3572r609b3621],
10	in	IN	O	in	_	0	SENT_213	[p16l624t3575r678b3620],
11	2225	CD	DATE	2225	num	12	SENT_213	[p16l696t3575r817b3621],
12	participants	NNS	O	participant	prep_in	9	SENT_213	[p16l836t3575r1165b3635],
13	,	,	O	,	_	0	SENT_213	[p16l836t3575r1165b3635],
14	363	CD	NUMBER	363	nsubj	17	SENT_213	[p16l1187t3577r1275b3621],
15	of	IN	O	of	_	0	SENT_213	[p16l1295t3572r1354b3621],
16	whom	WP	O	whom	prep_of	14	SENT_213	[p16l1360t3572r1530b3621],
17	had	VBD	O	have	rcmod	12	SENT_213	[p16l6t3650r105b3699],
18	the	DT	O	the	det	20	SENT_213	[p16l127t3650r210b3699],
19	Arg/Arg	NN	O	arg/arg	nn	20	SENT_213	[p16l232t3654r457b3714],
20	genotype	NN	O	genotype	dobj	17	SENT_213	[p16l481t3660r734b3714],
21	.	.	O	.	_	0	SENT_213	[p16l481t3660r734b3714],

1	In	IN	O	in	_	0	SENT_214	[p16l763t3655r819b3698],
2	study	NN	O	study	prep_in	9	SENT_214	[p16l844t3650r986b3714],
3	2	CD	NUMBER	2	num	2	SENT_214	[p16l1009t3655r1051b3706],
4	,	,	O	,	_	0	SENT_214	[p16l1009t3655r1051b3706],
5	67	CD	NUMBER	67	nsubj	9	SENT_214	[p16l1077t3653r1134b3700],
6	of	IN	O	of	_	0	SENT_214	[p16l1157t3650r1216b3699],
7	405	CD	NUMBER	405	num	8	SENT_214	[p16l1229t3653r1318b3699],
8	participants	NNS	O	participant	prep_of	5	SENT_214	[p16l1343t3653r1528b3713, p16l7t3738r150b3792],
9	had	VBD	O	have	_	0	SENT_214	[p16l177t3729r277b3777],
10	the	DT	O	the	det	12	SENT_214	[p16l301t3729r384b3777],
11	Arg/Arg	NN	O	arg/arg	nn	12	SENT_214	[p16l410t3732r635b3793],
12	genotype	NN	O	genotype	dobj	9	SENT_214	[p16l662t3738r915b3793],
13	.	.	O	.	_	0	SENT_214	[p16l662t3738r915b3793],

1	The	DT	O	the	det	2	SENT_215	[p16l943t3729r1046b3777],
2	size	NN	O	size	nsubj	7	SENT_215	[p16l1074t3732r1174b3777],
3	of	IN	O	of	_	0	SENT_215	[p16l1202t3729r1261b3777],
4	the	DT	O	the	det	6	SENT_215	[p16l1277t3729r1360b3777],
5	study	NN	O	study	nn	6	SENT_215	[p16l1389t3729r1531b3792],
6	population	NN	O	population	prep_of	2	SENT_215	[p17l7t13r296b76],
7	was	VBD	O	be	_	0	SENT_215	[p17l346t31r445b62],
8	of	IN	O	of	_	0	SENT_215	[p17l498t13r557b62],
9	importance	NN	O	importance	prep_of	7	SENT_215	[p17l599t16r919b76],
10	,	,	O	,	_	0	SENT_215	[p17l599t16r919b76],
11	especially	RB	O	especially	advmod	7	SENT_215	[p17l973t13r1230b77],
12	with	IN	O	with	_	0	SENT_215	[p17l1278t13r1396b62],
13	the	DT	O	the	det	14	SENT_215	[p17l1446t13r1529b62],
14	variability	NN	O	variability	prep_with	7	SENT_215	[p17l6t91r270b155],
15	of	IN	O	of	_	0	SENT_215	[p17l301t91r360b139],
16	individual	JJ	O	individual	amod	17	SENT_215	[p17l382t91r651b140],
17	responses	NNS	O	response	prep_of	14	SENT_215	[p17l682t108r946b154],
18	to	TO	O	to	_	0	SENT_215	[p17l979t101r1028b140],
19	pharmacotherapy	NN	O	pharmacotherapy	prep_to	17	SENT_215	[p17l1060t91r1531b155],
20	both	CC	O	both	dep	17	SENT_215	[p17l6t169r127b217],
21	between	IN	O	between	conj	17	SENT_215	[p17l161t169r385b217],
22	and	CC	O	and	_	0	SENT_215	[p17l421t169r520b217],
23	within	IN	O	within	conj_and	21	SENT_215	[p17l554t169r727b217],
24	individuals	NNS	O	individual	pobj	23	SENT_215	[p17l763t169r1057b217],
25	on	IN	O	on	_	0	SENT_215	[p17l1096t186r1162b217],
26	a	DT	O	a	det	29	SENT_215	[p17l1199t186r1226b217],
27	day-to-day	JJ	O	day-to-day	amod	29	SENT_215	[p17l1262t169r1531b232],
28	basis	NN	O	basis	nn	29	SENT_215	[p17l6t246r226b295],
29	.3	NN	NUMBER	.3	prep_on	24	SENT_215	[p17l6t246r226b295],
30	°	CD	NUMBER	°	num	31	SENT_215	[p17l6t246r226b295],
31	’31	CD	NUMBER	’31	dep	17	SENT_215	[p17l6t246r226b295],
32	These	DT	O	these	det	34	SENT_215	[p17l234t246r393b295],
33	large	JJ	O	large	amod	34	SENT_215	[p17l403t246r534b310],
34	populations	NNS	O	population	nsubj	35	SENT_215	[p17l544t246r859b310],
35	allowed	VBD	O	allow	rcmod	14	SENT_215	[p17l872t246r1074b295],
36	a	DT	O	a	det	38	SENT_215	[p17l1085t264r1111b295],
37	comprehensive	JJ	O	comprehensive	amod	38	SENT_215	[p17l1122t246r1529b310],
38	investigation	NN	O	investigation	dobj	35	SENT_215	[p17l7t327r351b388],
39	of	IN	O	of	_	0	SENT_215	[p17l435t324r494b373],
40	the	DT	O	the	det	41	SENT_215	[p17l567t324r650b373],
41	relation	NN	O	relation	prep_of	38	SENT_215	[p17l734t324r939b373],
42	between	IN	O	between	_	0	SENT_215	[p17l1021t324r1244b373],
43	ADRB2	NN	O	adrb2	nn	44	SENT_215	[p17l1326t328r1533b372],
44	polymorphisms	NNS	O	polymorphism	prep_between	41	SENT_215	[p17l7t403r428b466],
45	and	CC	O	and	_	0	SENT_215	[p17l477t403r575b451],
46	clinical	JJ	O	clinical	amod	47	SENT_215	[p17l621t403r810b451],
47	outcomes	NNS	O	outcome	conj_and	41	SENT_215	[p17l856t412r1113b451],
48	for	IN	O	for	_	0	SENT_215	[p17l1160t403r1236b451],
49	Gly16Arg	NN	O	gly16arg	nn	50	SENT_215	[p17l1283t403r1530b467],
50	genotypes	NNS	O	genotype	prep_for	47	SENT_215	[p17l8t490r273b544],
51	and	CC	O	and	_	0	SENT_215	[p17l294t480r393b529],
52	ADRB2	NN	O	adrb2	nn	53	SENT_215	[p17l409t484r616b528],
53	haplotypes	NNS	O	haplotype	conj_and	50	SENT_215	[p17l631t480r931b544],
54	.	.	O	.	_	0	SENT_215	[p17l631t480r931b544],

1	In	IN	O	in	_	0	SENT_216	[p17l61t563r116b606],
2	addition	NN	O	addition	_	0	SENT_216	[p17l132t558r348b607],
3	to	TO	O	to	_	0	SENT_216	[p17l362t568r411b606],
4	the	DT	O	the	det	6	SENT_216	[p17l426t558r508b607],
5	large	JJ	O	large	amod	6	SENT_216	[p17l523t558r652b622],
6	number	NN	O	number	prep_in_addition_to	20	SENT_216	[p17l668t558r882b607],
7	of	IN	O	of	_	0	SENT_216	[p17l897t558r955b606],
8	participants	NNS	O	participant	prep_of	6	SENT_216	[p17l961t561r1284b621],
9	,	,	O	,	_	0	SENT_216	[p17l961t561r1284b621],
10	a	DT	O	a	det	12	SENT_216	[p17l1303t576r1329b607],
11	further	JJ	O	further	amod	12	SENT_216	[p17l1345t558r1531b607],
12	strength	NN	O	strength	nsubj	20	SENT_216	[p17l9t637r227b701],
13	of	IN	O	of	_	0	SENT_216	[p17l274t637r333b685],
14	the	DT	O	the	det	16	SENT_216	[p17l370t637r452b685],
15	two	CD	NUMBER	two	num	16	SENT_216	[p17l498t646r592b685],
16	studies	NNS	O	study	prep_of	12	SENT_216	[p17l641t637r824b685],
17	presented	VBN	O	present	partmod	16	SENT_216	[p17l872t637r1132b700],
18	here	RB	O	here	advmod	17	SENT_216	[p17l1177t637r1293b685],
19	is	VBZ	O	be	cop	20	SENT_216	[p17l1341t640r1381b685],
20	that	IN	O	that	_	0	SENT_216	[p17l1429t637r1531b685],

1	Articles	NNPS	O	Articles	_	0	SENT_217	[p17l101t1104r251b1140],

1	2a/23	NN	O	2a/23	_	0	SENT_218	[p17l731t1351r805b1373],
2	*	SYM	O	*	dep	5	SENT_218	[p17l731t1351r805b1373],
3	2a/43	FW	O	2a/43	nn	5	SENT_218	[p17l966t1351r1042b1373],
4	*	FW	O	*	nn	5	SENT_218	[p17l966t1351r1042b1373],
5	2a/6a	FW	O	2a/6a	rcmod	1	SENT_218	[p17l1201t1350r1277b1373],
6	*	FW	O	*	nn	12	SENT_218	[p17l1201t1350r1277b1373],
7	4a/4a	FW	O	4a/4a	nn	12	SENT_218	[p17l1436t1351r1514b1373],
8	*	FW	O	*	nn	12	SENT_218	[p17l1436t1351r1514b1373],
9	4a/6a	FW	O	4a/6a	nn	12	SENT_218	[p17l1671t1350r1749b1373],
10	*	FW	O	*	nn	12	SENT_218	[p17l1671t1350r1749b1373],
11	6al6a	FW	O	6al6a	nn	12	SENT_218	[p17l1907t1350r1984b1373],
12	*	FW	O	*	dep	1	SENT_218	[p17l1907t1350r1984b1373],

1	Participants	NNS	O	participant	_	0	SENT_219	[p17l411t1406r537b1432],
2	254 434 235 217	CD	NUMBER	254 434 235 217	number	3	SENT_219	[p17l1446t1408r1484b1428],[p17l738t1408r779b1429],
3	215	CD	NUMBER	215	dep	1	SENT_219	[p17l1681t1408r1719b1429],
4	50	CD	NUMBER	50	num	7	SENT_219	[p17l1928t1408r1954b1429],
5	Severe	JJ	O	severe	amod	7	SENT_219	[p17l410t1452r480b1471],
6	asthma	NN	O	asthma	nn	7	SENT_219	[p17l486t1450r566b1471],
7	exacerbations	NNS	O	exacerbation	dep	3	SENT_219	[p17l573t1450r722b1471],

1	21	CD	NUMBER	21	dep	119	SENT_220	[p17l433t1499r458b1517],
2	event	NN	O	event	dep	119	SENT_220	[p17l465t1500r525b1517],
3	36	CD	PERCENT	36	dep	119	SENT_220	[p17l751t1496r778b1520],
4	(	CD	PERCENT	(	dep	119	SENT_220	[p17l786t1497r848b1522],
5	14	CD	PERCENT	14	dep	119	SENT_220	[p17l786t1497r848b1522],
6	%	NN	PERCENT	%	dep	119	SENT_220	[p17l786t1497r848b1522],
7	)	CD	NUMBER	)	dep	119	SENT_220	[p17l786t1497r848b1522],
8	47	CD	NUMBER	47	dep	119	SENT_220	[p17l987t1499r1014b1520],
9	(	NN	O	(	dep	119	SENT_220	[p17l1021t1497r1081b1522],
10	11	CD	PERCENT	11	dep	119	SENT_220	[p17l1021t1497r1081b1522],
11	%	NN	PERCENT	%	dep	119	SENT_220	[p17l1021t1497r1081b1522],
12	)	CD	NUMBER	)	dep	119	SENT_220	[p17l1021t1497r1081b1522],
13	23	CD	NUMBER	23	dep	119	SENT_220	[p17l1224t1499r1248b1520],
14	(	NN	O	(	dep	119	SENT_220	[p17l1257t1497r1318b1522],
15	10	CD	PERCENT	10	dep	119	SENT_220	[p17l1257t1497r1318b1522],
16	%	NN	PERCENT	%	dep	119	SENT_220	[p17l1257t1497r1318b1522],
17	)	CD	NUMBER	)	dep	119	SENT_220	[p17l1257t1497r1318b1522],
18	18	CD	NUMBER	18	dep	119	SENT_220	[p17l1458t1496r1483b1517],
19	(	NN	O	(	dep	119	SENT_220	[p17l1492t1496r1541b1522],
20	8	CD	PERCENT	8	dep	119	SENT_220	[p17l1492t1496r1541b1522],
21	%	NN	PERCENT	%	dep	119	SENT_220	[p17l1492t1496r1541b1522],
22	)	CD	NUMBER	)	dep	119	SENT_220	[p17l1492t1496r1541b1522],
23	30	CD	NUMBER	30	dep	119	SENT_220	[p17l1692t1499r1719b1520],
24	(	NN	O	(	dep	119	SENT_220	[p17l1727t1497r1789b1522],
25	14	CD	PERCENT	14	dep	119	SENT_220	[p17l1727t1497r1789b1522],
26	%	NN	PERCENT	%	dep	119	SENT_220	[p17l1727t1497r1789b1522],
27	)	CD	NUMBER	)	dep	119	SENT_220	[p17l1727t1497r1789b1522],
28	3	CD	NUMBER	3	dep	119	SENT_220	[p17l1942t1499r1954b1520],
29	(	NN	O	(	dep	119	SENT_220	[p17l1962t1496r2012b1522],
30	6	CD	PERCENT	6	dep	119	SENT_220	[p17l1962t1496r2012b1522],
31	%	NN	PERCENT	%	dep	119	SENT_220	[p17l1962t1496r2012b1522],
32	)	CD	NUMBER	)	dep	119	SENT_220	[p17l1962t1496r2012b1522],
33	Total	JJ	O	total	dep	119	SENT_220	[p17l432t1542r486b1563],
34	events	NNS	O	event	dep	119	SENT_220	[p17l493t1546r564b1563],
35	66	CD	NUMBER	66	dep	119	SENT_220	[p17l750t1542r778b1563],
36	76	CD	NUMBER	76	dep	119	SENT_220	[p17l986t1542r1013b1565],
37	36	CD	NUMBER	36	dep	119	SENT_220	[p17l1221t1542r1248b1566],
38	26	CD	NUMBER	26	dep	119	SENT_220	[p17l1457t1542r1484b1563],
39	35	CD	NUMBER	35	dep	119	SENT_220	[p17l1693t1545r1719b1566],
40	3	CD	NUMBER	3	dep	119	SENT_220	[p17l1942t1545r1954b1566],
41	Exacerbations	NNS	O	exacerbation	dep	119	SENT_220	[p17l434t1588r578b1608],
42	per	IN	O	per	dep	119	SENT_220	[p17l584t1595r618b1615],
43	0-29	CD	NUMBER	0-29	dep	119	SENT_220	[p17l766t1590r813b1611],
44	0-19	CD	NUMBER	0-19	dep	119	SENT_220	[p17l1001t1590r1047b1611],
45	0-17	CD	NUMBER	0-17	dep	119	SENT_220	[p17l1236t1590r1281b1611],
46	0-13	CD	NUMBER	0-13	dep	119	SENT_220	[p17l1471t1590r1516b1611],
47	0-18	CD	NUMBER	0-18	dep	119	SENT_220	[p17l1707t1587r1753b1608],
48	0-07	CD	NUMBER	0-07	dep	119	SENT_220	[p17l1942t1590r1989b1611],
49	participant	NN	O	participant	dep	119	SENT_220	[p17l433t1624r547b1649],
50	per	IN	O	per	dep	119	SENT_220	[p17l553t1629r586b1649],
51	6	CD	DURATION	6	dep	119	SENT_220	[p17l593t1622r605b1643],
52	months	NNS	NUMBER	month	dep	119	SENT_220	[p17l613t1622r694b1643],
53	Change	NNP	O	Change	dep	119	SENT_220	[p17l410t1668r489b1695],
54	in	IN	O	in	dep	119	SENT_220	[p17l496t1669r513b1688],
55	morning	NN	TIME	morning	dep	119	SENT_220	[p17l521t1669r611b1695],
56	PEF	NN	O	pef	dep	119	SENT_220	[p17l619t1670r655b1688],
57	25-7	CD	NUMBER	25-7	dep	119	SENT_220	[p17l753t1670r798b1691],
58	(	CD	NUMBER	(	dep	119	SENT_220	[p17l806t1667r929b1694],
59	19-6-313	CD	NUMBER	19-6-313	dep	119	SENT_220	[p17l806t1667r929b1694],
60	)	NN	O	)	dep	119	SENT_220	[p17l806t1667r929b1694],
61	26-1	CD	NUMBER	26-1	dep	119	SENT_220	[p17l986t1667r1033b1688],
62	(	CD	NUMBER	(	dep	119	SENT_220	[p17l1041t1669r1161b1694],
63	21-1-30-9	CD	NUMBER	21-1-30-9	dep	119	SENT_220	[p17l1041t1669r1161b1694],
64	)	NN	O	)	dep	119	SENT_220	[p17l1041t1669r1161b1694],
65	27-2	CD	NUMBER	27-2	dep	119	SENT_220	[p17l1224t1670r1268b1691],
66	(	CD	NUMBER	(	dep	119	SENT_220	[p17l1277t1667r1399b1694],
67	20-8-335	CD	NUMBER	20-8-335	dep	119	SENT_220	[p17l1277t1667r1399b1694],
68	)	NN	O	)	dep	119	SENT_220	[p17l1277t1667r1399b1694],
69	25-3	CD	NUMBER	25-3	dep	119	SENT_220	[p17l1459t1670r1503b1691],
70	(	CD	NUMBER	(	dep	119	SENT_220	[p17l1512t1667r1633b1694],
71	18-5-32-0	CD	NUMBER	18-5-32-0	dep	119	SENT_220	[p17l1512t1667r1633b1694],
72	)	NN	O	)	dep	119	SENT_220	[p17l1512t1667r1633b1694],
73	24-2	CD	NUMBER	24-2	dep	119	SENT_220	[p17l1692t1670r1739b1691],
74	(	CD	NUMBER	(	dep	119	SENT_220	[p17l1747t1669r1869b1694],
75	17-4-30-9	CD	NUMBER	17-4-30-9	dep	119	SENT_220	[p17l1747t1669r1869b1694],
76	)	NN	O	)	dep	119	SENT_220	[p17l1747t1669r1869b1694],
77	29-9	CD	NUMBER	29-9	dep	119	SENT_220	[p17l1927t1670r1975b1691],
78	(	CD	NUMBER	(	dep	119	SENT_220	[p17l1984t1667r2106b1694],
79	16-3-43-5	CD	NUMBER	16-3-43-5	dep	119	SENT_220	[p17l1984t1667r2106b1694],
80	)	NN	O	)	dep	119	SENT_220	[p17l1984t1667r2106b1694],
81	(	CD	NUMBER	(	dep	119	SENT_220	[p17l411t1703r500b1728],
82	L/min	NN	O	l/min	dep	119	SENT_220	[p17l411t1703r500b1728],
83	)	CD	NUMBER	)	dep	119	SENT_220	[p17l411t1703r500b1728],
84	’	NN	O	’	dep	119	SENT_220	[p17l411t1703r500b1728],
85	r	NN	O	r	dep	119	SENT_220	[p17l411t1703r500b1728],
86	Change	NNP	O	Change	dep	119	SENT_220	[p17l410t1748r490b1775],
87	in	IN	O	in	dep	119	SENT_220	[p17l498t1750r516b1768],
88	FEV	NNP	O	FEV	dep	119	SENT_220	[p17l525t1750r570b1774],
89	,	,	O	,	_	0	SENT_220	[p17l525t1750r570b1774],
90	(	CD	NUMBER	(	dep	119	SENT_220	[p17l577t1749r617b1774],
91	L	NN	O	l	dep	119	SENT_220	[p17l577t1749r617b1774],
92	)	NN	O	)	dep	119	SENT_220	[p17l577t1749r617b1774],
93	'	''	O	'	_	0	SENT_220	[p17l577t1749r617b1774],
94	|	NN	O	|	dep	119	SENT_220	[p17l577t1749r617b1774],
95	'	''	O	'	_	0	SENT_220	[p17l577t1749r617b1774],
96	0-19	CD	NUMBER	0-19	dep	119	SENT_220	[p17l766t1751r812b1772],
97	(	CD	NUMBER	(	dep	119	SENT_220	[p17l819t1749r938b1774],
98	0-15-0-24	CD	NUMBER	0-15-0-24	dep	119	SENT_220	[p17l819t1749r938b1774],
99	)	NN	O	)	dep	119	SENT_220	[p17l819t1749r938b1774],
100	0-19	CD	NUMBER	0-19	dep	119	SENT_220	[p17l1001t1751r1047b1772],
101	(	CD	NUMBER	(	dep	119	SENT_220	[p17l1055t1748r1174b1774],
102	016-023	CD	NUMBER	016-023	dep	119	SENT_220	[p17l1055t1748r1174b1774],
103	)	NN	O	)	dep	119	SENT_220	[p17l1055t1748r1174b1774],
104	013	CD	NUMBER	013	dep	119	SENT_220	[p17l1237t1748r1282b1769],
105	(	NN	O	(	dep	119	SENT_220	[p17l1290t1749r1407b1774],
106	O-13-0-23	NN	O	o-13-0-23	dep	119	SENT_220	[p17l1290t1749r1407b1774],
107	)	CD	NUMBER	)	dep	119	SENT_220	[p17l1290t1749r1407b1774],
108	O-23	NN	O	o-23	dep	119	SENT_220	[p17l1472t1751r1516b1772],
109	(	CD	NUMBER	(	dep	119	SENT_220	[p17l1524t1748r1645b1774],
110	0-18-0-29	CD	NUMBER	0-18-0-29	dep	119	SENT_220	[p17l1524t1748r1645b1774],
111	)	NN	O	)	dep	119	SENT_220	[p17l1524t1748r1645b1774],
112	0-19	CD	NUMBER	0-19	dep	119	SENT_220	[p17l1707t1751r1752b1772],
113	(	CD	NUMBER	(	dep	119	SENT_220	[p17l1760t1749r1880b1774],
114	0-14-0-24	CD	NUMBER	0-14-0-24	dep	119	SENT_220	[p17l1760t1749r1880b1774],
115	)	NN	O	)	dep	119	SENT_220	[p17l1760t1749r1880b1774],
116	0-24	CD	NUMBER	0-24	dep	119	SENT_220	[p17l1942t1751r1989b1771],
117	(	CD	NUMBER	(	dep	119	SENT_220	[p17l1996t1749r2116b1774],
118	0-14-0-34	CD	NUMBER	0-14-0-34	dep	119	SENT_220	[p17l1996t1749r2116b1774],
119	)	NN	O	)	_	0	SENT_220	[p17l1996t1749r2116b1774],

1	Data	NNS	O	datum	nsubj	11	SENT_221	[p17l399t1817r444b1835],
2	are	VBP	O	be	cop	3	SENT_221	[p17l451t1822r480b1835],
3	number	NN	O	number	_	0	SENT_221	[p17l488t1816r569b1838],
4	,	,	O	,	_	0	SENT_221	[p17l488t1816r569b1838],
5	number	NN	O	number	appos	3	SENT_221	[p17l577t1816r655b1835],
6	(	CD	PERCENT	(	num	7	SENT_221	[p17l662t1817r699b1840],
7	%	NN	PERCENT	%	dep	5	SENT_221	[p17l662t1817r699b1840],
8	)	CD	NUMBER	)	dep	5	SENT_221	[p17l662t1817r699b1840],
9	,	,	O	,	_	0	SENT_221	[p17l662t1817r699b1840],
10	or	CC	O	or	_	0	SENT_221	[p17l706t1822r726b1835],
11	mean	VB	O	mean	conj_or	3	SENT_221	[p17l733t1822r787b1835],
12	(	RB	O	(	advmod	11	SENT_221	[p17l795t1817r846b1840],
13	95	CD	PERCENT	95	number	14	SENT_221	[p17l795t1817r846b1840],
14	%	NN	PERCENT	%	amod	16	SENT_221	[p17l795t1817r846b1840],
15	Cl	NN	O	cl	nn	16	SENT_221	[p17l852t1817r883b1840],
16	)	NN	O	)	dobj	11	SENT_221	[p17l852t1817r883b1840],
17	,	,	O	,	_	0	SENT_221	[p17l852t1817r883b1840],
18	unless	IN	O	unless	mark	20	SENT_221	[p17l891t1816r951b1835],
19	otherwise	RB	O	otherwise	advmod	20	SENT_221	[p17l957t1816r1056b1835],
20	indicated	VBN	O	indicate	advcl	3	SENT_221	[p17l1063t1816r1159b1835],
21	.	.	O	.	_	0	SENT_221	[p17l1063t1816r1159b1835],

1	PEF	NN	O	pef	_	0	SENT_222	[p17l1167t1816r1263b1841],
2	=	JJ	O	=	amod	5	SENT_222	[p17l1167t1816r1263b1841],
3	peak	NN	O	peak	nn	5	SENT_222	[p17l1167t1816r1263b1841],
4	expiratory	NN	O	expiratory	nn	5	SENT_222	[p17l1269t1817r1371b1841],
5	ﬂow	NN	O	ﬂow	dep	1	SENT_222	[p17l1376t1816r1425b1838],
6	;	:	O	;	_	0	SENT_222	[p17l1376t1816r1425b1838],
7	FEV	NNP	O	FEV	dep	1	SENT_222	[p17l1433t1816r1552b1840],
8	,	,	O	,	_	0	SENT_222	[p17l1433t1816r1552b1840],
9	=	JJ	O	=	amod	12	SENT_222	[p17l1433t1816r1552b1840],
10	forced	JJ	O	forced	amod	12	SENT_222	[p17l1433t1816r1552b1840],
11	expiratory	JJ	O	expiratory	amod	12	SENT_222	[p17l1558t1817r1660b1841],
12	volume	NN	O	volume	appos	7	SENT_222	[p17l1665t1816r1740b1835],
13	in	IN	O	in	_	0	SENT_222	[p17l1748t1817r1764b1835],
14	1	CD	NUMBER	1	num	15	SENT_222	[p17l1772t1818r1782b1835],
15	s.	NN	O	s.	prep_in	12	SENT_222	[p17l1788t1816r1917b1841],
16	*	CD	NUMBER	*	num	18	SENT_222	[p17l1788t1816r1917b1841],
17	Haplotype	NN	O	haplotype	nn	18	SENT_222	[p17l1788t1816r1917b1841],
18	nomenclature	NN	O	nomenclature	nsubjpass	20	SENT_222	[p17l1925t1816r2064b1835],
19	was	VBD	O	be	auxpass	20	SENT_222	[p17l2069t1822r2107b1835],
20	based	VBN	O	base	rcmod	15	SENT_222	[p17l399t1850r455b1869],
21	on	IN	O	on	_	0	SENT_222	[p17l461t1857r486b1869],
22	ADRB2	NN	O	adrb2	nn	23	SENT_222	[p17l492t1852r559b1869],
23	haplotypes	NNS	O	haplotype	prep_on	20	SENT_222	[p17l567t1850r676b1875],
24	described	VBN	O	describe	partmod	23	SENT_222	[p17l682t1850r776b1869],
25	previously	RB	DATE	previously	advmod	24	SENT_222	[p17l782t1850r902b1875],
26	.	.	O	.	_	0	SENT_222	[p17l782t1850r902b1875],

1	”	NN	O	”	nn	3	SENT_223	[p17l782t1850r902b1875],
2	‘	CD	NUMBER	‘	num	3	SENT_223	[p17l908t1852r1055b1875],
3	rLeast-squares	NNS	O	rleast-square	nsubj	4	SENT_223	[p17l908t1852r1055b1875],
4	means	VBZ	O	mean	_	0	SENT_223	[p17l1062t1857r1127b1869],
5	and	CC	O	and	_	0	SENT_223	[p17l1133t1850r1170b1869],
6	95	CD	PERCENT	95	num	7	SENT_223	[p17l1177t1853r1219b1872],
7	%	NN	PERCENT	%	conj_and	4	SENT_223	[p17l1177t1853r1219b1872],
8	Cls	NNS	O	cl	nsubjpass	10	SENT_223	[p17l1226t1852r1253b1869],
9	were	VBD	O	be	auxpass	10	SENT_223	[p17l1258t1857r1307b1869],
10	measured	VBN	O	measure	rcmod	7	SENT_223	[p17l1314t1850r1411b1869],
11	from	IN	O	from	_	0	SENT_223	[p17l1416t1850r1465b1869],
12	ANOVA	NNP	ORGANIZATION	ANOVA	nn	13	SENT_223	[p17l1471t1852r1548b1869],
13	models	NNS	O	model	prep_from	10	SENT_223	[p17l1555t1850r1626b1869],
14	oftreatment-average	JJ	O	oftreatment-average	amod	15	SENT_223	[p17l1632t1850r1846b1875],
15	change	NN	O	change	dep	13	SENT_223	[p17l1853t1850r1924b1875],
16	from	IN	O	from	_	0	SENT_223	[p17l1930t1850r1978b1869],
17	baseline	NN	O	baseline	prep_from	7	SENT_223	[p17l1986t1850r2066b1869],
18	in	IN	O	in	_	0	SENT_223	[p17l2074t1852r2090b1869],
19	PEF	NN	O	pef	prep_in	7	SENT_223	[p17l399t1886r434b1904],
20	and	CC	O	and	_	0	SENT_223	[p17l440t1885r477b1904],
21	FEV	NN	O	fev	prep_in	7	SENT_223	[p17l484t1886r531b1909],
22	,	,	O	,	_	0	SENT_223	[p17l484t1886r531b1909],

1	Table	NNP	O	Table	_	0	SENT_224	[p17l398t1948r455b1969],
2	4	CD	NUMBER	4	num	1	SENT_224	[p17l460t1951r480b1972],
3	:	:	O	:	_	0	SENT_224	[p17l460t1951r480b1972],
4	Clinical	JJ	O	clinical	amod	5	SENT_224	[p17l487t1948r566b1969],
5	outcomes	NNS	O	outcome	dep	1	SENT_224	[p17l573t1952r686b1969],
6	in	IN	O	in	_	0	SENT_224	[p17l693t1949r712b1969],
7	white	JJ	O	white	amod	8	SENT_224	[p17l719t1948r785b1969],
8	participants	NNS	O	participant	prep_in	5	SENT_224	[p17l791t1949r929b1975],
9	by	IN	O	by	_	0	SENT_224	[p17l936t1948r963b1975],
10	haplotype	NN	O	haplotype	nn	11	SENT_224	[p17l969t1948r1084b1975],
11	pair	NN	O	pair	prep_by	8	SENT_224	[p17l1091t1949r1135b1975],
12	in	IN	O	in	_	0	SENT_224	[p17l1141t1949r1161b1969],
13	study	NN	O	study	prep_in	11	SENT_224	[p17l1168t1948r1232b1975],
14	1	CD	NUMBER	1	num	13	SENT_224	[p17l1239t1951r1251b1969],

1	pharrnacogenetic	JJ	O	pharrnacogenetic	amod	2	SENT_225	[p17l374t2035r633b2071],
2	data	NNS	O	datum	nsubj	4	SENT_225	[p17l655t2035r716b2062],
3	were	VBD	O	be	cop	4	SENT_225	[p17l736t2044r808b2062],
4	available	JJ	O	available	_	0	SENT_225	[p17l830t2035r958b2062],
5	from	IN	O	from	_	0	SENT_225	[p17l979t2034r1053b2062],
6	individuals	NNS	O	individual	prep_from	4	SENT_225	[p17l1075t2034r1239b2062],
7	treated	VBN	O	treat	partmod	6	SENT_225	[p17l641t2085r820b2132],
8	during	IN	O	during	_	0	SENT_225	[p17l859t2085r1034b2148],
9	a	DT	O	a	det	13	SENT_225	[p17l1073t2102r1099b2132],
10	much	RB	O	much	advmod	11	SENT_225	[p17l1138t2085r1290b2132],
11	longer	JJR	O	longer	amod	13	SENT_225	[p17l1328t2085r1495b2148],
12	(	CD	NUMBER	(	num	13	SENT_225	[p17l1537t2085r1775b2148],
13	6-month	NN	DURATION	6-month	prep_during	7	SENT_225	[p17l1537t2085r1775b2148],
14	or	CC	O	or	_	0	SENT_225	[p17l1815t2102r1868b2132],
15	7-month	JJ	DURATION	7-month	amod	18	SENT_225	[p17l1906t2085r2140b2148],
16	)	NN	O	)	nn	18	SENT_225	[p17l1906t2085r2140b2148],
17	treatment	NN	O	treatment	nn	18	SENT_225	[p17l641t2170r897b2208],
18	period	NN	O	period	prep_during	7	SENT_225	[p17l914t2160r1081b2222],
19	than	IN	O	than	mark	21	SENT_225	[p17l1098t2160r1215b2208],
20	previously	RB	DATE	previously	advmod	21	SENT_225	[p17l1233t2160r1500b2223],
21	described	VBN	O	describe	advcl	4	SENT_225	[p17l1518t2160r1777b2208],
22	.	.	O	.	_	0	SENT_225	[p17l1518t2160r1777b2208],

1	All	DT	O	all	det	3	SENT_226	[p17l1798t2160r1872b2207],
2	treatment	NN	O	treatment	nn	3	SENT_226	[p17l1889t2170r2145b2208],
3	regimens	NNS	O	regimen	nsubj	8	SENT_226	[p17l642t2239r886b2299],
4	provided	VBN	O	provide	partmod	3	SENT_226	[p17l927t2236r1154b2298],
5	combination	NN	O	combination	nn	6	SENT_226	[p17l1194t2236r1523b2284],
6	therapy	NN	O	therapy	dobj	4	SENT_226	[p17l1563t2236r1758b2299],
7	with	IN	O	with	prep	4	SENT_226	[p17l1795t2236r1910b2284],
8	inhaled	VBN	O	inhale	_	0	SENT_226	[p17l1950t2236r2145b2284],
9	corticosteroids	NNS	O	corticosteroid	dobj	8	SENT_226	[p17l643t2313r1018b2360],
10	and	CC	O	and	_	0	SENT_226	[p17l1037t2313r1134b2360],
11	longacting	VBG	O	longact	amod	12	SENT_226	[p17l1148t2313r1421b2376],
12	B2-agonists	NNS	O	b2-agonist	conj_and	9	SENT_226	[p17l1442t2313r1731b2376],
13	,	,	O	,	_	0	SENT_226	[p17l1442t2313r1731b2376],
14	consistent	JJ	O	consistent	amod	9	SENT_226	[p17l1751t2316r2015b2360],
15	with	IN	O	with	_	0	SENT_226	[p17l2029t2313r2144b2360],
16	national	JJ	O	national	amod	20	SENT_226	[p17l642t2388r853b2436],
17	and	CC	O	and	_	0	SENT_226	[p17l889t2388r985b2436],
18	international	JJ	O	international	conj_and	16	SENT_226	[p17l1020t2388r1355b2436],
19	guideline	NN	O	guideline	nn	20	SENT_226	[p17l1391t2388r1633b2451],
20	recommendations	NNS	O	recommendation	prep_with	14	SENT_226	[p17l1669t2388r2142b2436],
21	for	IN	O	for	_	0	SENT_226	[p17l642t2464r716b2512],
22	the	DT	O	the	det	23	SENT_226	[p17l738t2464r818b2512],
23	care	NN	O	care	prep_for	20	SENT_226	[p17l843t2481r947b2512],
24	of	IN	O	of	_	0	SENT_226	[p17l971t2464r1029b2512],
25	moderate	JJ	O	moderate	amod	29	SENT_226	[p17l1044t2464r1289b2512],
26	and	CC	O	and	_	0	SENT_226	[p17l1313t2464r1409b2512],
27	severe	JJ	O	severe	conj_and	25	SENT_226	[p17l1433t2481r1592b2512],
28	persistent	JJ	O	persistent	amod	29	SENT_226	[p17l1616t2467r1872b2526],
29	asthma	NN	O	asthma	prep_of	23	SENT_226	[p17l1895t2464r2145b2512],
30	.	.	O	.	_	0	SENT_226	[p17l1895t2464r2145b2512],

1	”	NN	O	”	nsubj	4	SENT_227	[p17l1895t2464r2145b2512],
2	The	DT	O	the	det	3	SENT_227	[p17l641t2541r741b2588],
3	possibility	NN	O	possibility	dep	1	SENT_227	[p17l776t2541r1040b2603],
4	exists	VBZ	O	exist	_	0	SENT_227	[p17l1074t2544r1214b2588],
5	that	IN	O	that	complm	16	SENT_227	[p17l1249t2541r1350b2588],
6	use	NN	O	use	nsubj	16	SENT_227	[p17l1383t2558r1471b2588],
7	of	IN	O	of	_	0	SENT_227	[p17l1507t2541r1565b2588],
8	concomitant	JJ	O	concomitant	prep_of	6	SENT_227	[p17l1591t2544r1917b2588],
9	inhaled	VBN	O	inhale	partmod	8	SENT_227	[p17l1950t2541r2145b2588],
10	corticosteroids	NNS	O	corticosteroid	dobj	9	SENT_227	[p17l643t2616r1018b2664],
11	in	IN	O	in	_	0	SENT_227	[p17l1045t2619r1097b2663],
12	our	PRP$	O	we	poss	13	SENT_227	[p17l1122t2633r1211b2664],
13	investigations	NNS	O	investigation	prep_in	10	SENT_227	[p17l1235t2619r1592b2679],
14	might	MD	O	might	aux	16	SENT_227	[p17l1618t2616r1776b2679],
15	have	VB	O	have	aux	16	SENT_227	[p17l1799t2616r1917b2664],
16	masked	VBN	O	mask	ccomp	4	SENT_227	[p17l1942t2616r2145b2664],
17	an	DT	O	a	det	18	SENT_227	[p17l643t2709r705b2740],
18	interaction	NN	O	interaction	dobj	16	SENT_227	[p17l724t2695r1005b2740],
19	between	IN	O	between	_	0	SENT_227	[p17l1023t2692r1240b2740],
20	ADRB2	NN	O	adrb2	nn	21	SENT_227	[p17l1258t2696r1460b2739],
21	genotype	NN	O	genotype	prep_between	18	SENT_227	[p17l1477t2702r1710b2755],
22	and	CC	O	and	_	0	SENT_227	[p17l1730t2692r1826b2740],
23	response	NN	O	response	prep_between	18	SENT_227	[p17l1844t2709r2076b2754],
24	to	TO	O	to	_	0	SENT_227	[p17l2095t2702r2143b2740],
25	longacting	VBG	O	longact	prepc_to	16	SENT_227	[p17l641t2769r915b2832],
26	B2-agonist	JJ	O	b2-agonist	amod	27	SENT_227	[p17l936t2769r1188b2832],
27	therapy	NN	O	therapy	dobj	25	SENT_227	[p17l1203t2769r1405b2831],
28	.	.	O	.	_	0	SENT_227	[p17l1203t2769r1405b2831],

1	However	RB	O	however	advmod	26	SENT_228	[p17l1428t2774r1666b2824],
2	,	,	O	,	_	0	SENT_228	[p17l1428t2774r1666b2824],
3	as	IN	O	as	mark	7	SENT_228	[p17l1687t2786r1737b2816],
4	neither	DT	O	neither	det	6	SENT_228	[p17l1756t2769r1944b2816],
5	clinical	JJ	O	clinical	amod	6	SENT_228	[p17l1961t2769r2144b2816],
6	study	NN	O	study	nsubj	7	SENT_228	[p17l644t2844r782b2907],
7	contained	VBD	O	contain	advcl	26	SENT_228	[p17l826t2844r1081b2892],
8	a	DT	O	a	dep	9	SENT_228	[p17l1126t2861r1151b2892],
9	formoterol-only	JJ	O	formoterol-only	dobj	7	SENT_228	[p17l1196t2844r1603b2907],
10	or	CC	O	or	_	0	SENT_228	[p17l1647t2861r1701b2892],
11	salmeterol-only	JJ	O	salmeterol-only	amod	13	SENT_228	[p17l1746t2844r2145b2907],
12	treatment	NN	O	treatment	nn	13	SENT_228	[p17l641t2930r897b2968],
13	group	NN	O	group	dobj	7	SENT_228	[p17l917t2937r1082b2983],
14	,	,	O	,	_	0	SENT_228	[p17l917t2937r1082b2983],
15	the	DT	O	the	det	18	SENT_228	[p17l1103t2920r1184b2968],
16	potential	JJ	O	potential	amod	18	SENT_228	[p17l1204t2920r1431b2982],
17	protective	JJ	O	protective	amod	18	SENT_228	[p17l1450t2923r1702b2982],
18	effect	NN	O	effect	nsubjpass	26	SENT_228	[p17l1723t2920r1863b2968],
19	of	IN	O	of	_	0	SENT_228	[p17l1882t2920r1940b2968],
20	inhaled	VBN	O	inhale	prepc_of	18	SENT_228	[p17l1950t2920r2145b2968],
21	corticosteroid	NN	O	corticosteroid	nn	22	SENT_228	[p17l643t2997r995b3044],
22	therapy	NN	O	therapy	dobj	20	SENT_228	[p17l1010t2997r1206b3059],
23	can	MD	O	can	aux	26	SENT_228	[p17l1223t3006r1398b3044],
24	not	RB	O	not	neg	26	SENT_228	[p17l1223t3006r1398b3044],
25	be	VB	O	be	auxpass	26	SENT_228	[p17l1413t2997r1474b3044],
26	assessed	VBN	O	assess	_	0	SENT_228	[p17l1492t2997r1714b3044],
27	here	RB	O	here	advmod	26	SENT_228	[p17l1729t2997r1856b3044],
28	.	.	O	.	_	0	SENT_228	[p17l1729t2997r1856b3044],

1	In	IN	O	in	_	0	SENT_229	[p17l695t3077r750b3119],
2	both	DT	O	both	det	3	SENT_229	[p17l765t3072r882b3120],
3	studies	NNS	O	study	prep_in	6	SENT_229	[p17l901t3072r1095b3127],
4	,	,	O	,	_	0	SENT_229	[p17l901t3072r1095b3127],
5	individuals	NNS	O	individual	nsubj	6	SENT_229	[p17l1114t3072r1399b3120],
6	used	VBD	O	use	_	0	SENT_229	[p17l1416t3072r1540b3120],
7	shortacting	VBG	O	shortact	xcomp	6	SENT_229	[p17l1557t3072r1847b3135],
8	[	CD	NUMBER	[	num	9	SENT_229	[p17l1867t3072r2142b3135],
9	32-agonists	NNS	O	32-agonist	dobj	7	SENT_229	[p17l1867t3072r2142b3135],
10	for	IN	O	for	_	0	SENT_229	[p17l642t3148r716b3196],
11	symptom	NN	O	symptom	nn	12	SENT_229	[p17l751t3158r996b3211],
12	relief	NN	O	relief	prep_for	7	SENT_229	[p17l1030t3148r1172b3196],
13	in	IN	O	in	_	0	SENT_229	[p17l1197t3151r1249b3195],
14	the	DT	O	the	det	16	SENT_229	[p17l1283t3148r1364b3196],
15	run-in	NN	O	run-in	nn	16	SENT_229	[p17l1399t3151r1563b3196],
16	periods	NNS	O	period	prep_in	12	SENT_229	[p17l1597t3148r1802b3210],
17	.	.	O	.	_	0	SENT_229	[p17l1597t3148r1802b3210],

1	In	IN	O	in	_	0	SENT_230	[p17l1842t3153r1897b3195],
2	study	NN	O	study	prep_in	9	SENT_230	[p17l1933t3148r2072b3211],
3	1	CD	NUMBER	1	num	2	SENT_230	[p17l2107t3152r2141b3203],
4	,	,	O	,	_	0	SENT_230	[p17l2107t3152r2141b3203],
5	two-thirds	NNS	O	two-third	nsubj	9	SENT_230	[p17l641t3225r903b3272],
6	of	IN	O	of	_	0	SENT_230	[p17l923t3225r981b3272],
7	randomised	JJ	O	randomised	amod	8	SENT_230	[p17l990t3225r1302b3272],
8	participants	NNS	O	participant	prep_of	5	SENT_230	[p17l1319t3228r1623b3287],
9	took	VBD	O	take	_	0	SENT_230	[p17l1642t3225r1755b3272],
10	terbutaline	NN	O	terbutaline	dobj	9	SENT_230	[p17l1770t3225r2053b3272],
11	for	IN	O	for	_	0	SENT_230	[p17l2071t3225r2145b3272],
12	as-needed	JJ	O	as-needed	amod	14	SENT_230	[p17l643t3300r901b3348],
13	symptom	NN	O	symptom	nn	14	SENT_230	[p17l915t3310r1159b3363],
14	relief	NN	O	relief	prep_for	9	SENT_230	[p17l1171t3300r1317b3355],
15	,	,	O	,	_	0	SENT_230	[p17l1171t3300r1317b3355],
16	and	CC	O	and	_	0	SENT_230	[p17l1332t3300r1428b3348],
17	a	DT	O	a	det	18	SENT_230	[p17l1441t3317r1467b3348],
18	third	JJ	ORDINAL	third	nsubj	19	SENT_230	[p17l1478t3300r1606b3348],
19	took	VBD	O	take	conj_and	9	SENT_230	[p17l1617t3300r1730b3348],
20	the	DT	O	the	det	22	SENT_230	[p17l1740t3300r1821b3348],
21	rapid-acting	JJ	O	rapid-acting	amod	22	SENT_230	[p17l1835t3300r2144b3363],
22	budesonide	NN	O	budesonide	dobj	19	SENT_230	[p17l641t3376r943b3424],
23	plus	CC	O	plus	prep	22	SENT_230	[p17l973t3376r1082b3438],
24	formoterol	NN	O	formoterol	nn	25	SENT_230	[p17l1114t3376r1392b3424],
25	combination	NN	O	combination	dep	23	SENT_230	[p17l1423t3376r1752b3424],
26	for	IN	O	for	_	0	SENT_230	[p17l1783t3376r1856b3424],
27	as-needed	JJ	O	as-needed	amod	29	SENT_230	[p17l1886t3376r2145b3424],
28	symptom	NN	O	symptom	nn	29	SENT_230	[p17l644t3462r888b3515],
29	relief	NN	O	relief	prep_for	19	SENT_230	[p17l911t3453r1089b3500],
30	.	.	O	.	_	0	SENT_230	[p17l911t3453r1089b3500],

1	”	NN	O	”	npadvmod	9	SENT_231	[p17l911t3453r1089b3500],
2	In	IN	O	in	_	0	SENT_231	[p17l1115t3458r1170b3499],
3	study	NN	O	study	prep_in	9	SENT_231	[p17l1195t3453r1333b3515],
4	2	CD	NUMBER	2	num	3	SENT_231	[p17l1356t3457r1397b3508],
5	,	,	O	,	_	0	SENT_231	[p17l1356t3457r1397b3508],
6	all	DT	O	all	det	8	SENT_231	[p17l1423t3453r1481b3500],
7	randomised	JJ	O	randomised	amod	8	SENT_231	[p17l1504t3453r1816b3500],
8	participants	NNS	O	participant	nsubj	9	SENT_231	[p17l1838t3456r2142b3515],
9	received	VBD	O	receive	_	0	SENT_231	[p17l642t3528r855b3576],
10	albuterol	NN	O	albuterol	dobj	9	SENT_231	[p17l886t3528r1115b3576],
11	for	IN	O	for	_	0	SENT_231	[p17l1145t3528r1220b3576],
12	as-needed	JJ	O	as-needed	amod	14	SENT_231	[p17l1250t3528r1508b3576],
13	symptom	NN	O	symptom	nn	14	SENT_231	[p17l1540t3538r1784b3591],
14	relief	NN	O	relief	prep_for	9	SENT_231	[p17l1815t3528r1960b3576],
15	.	.	O	.	_	0	SENT_231	[p17l1815t3528r1960b3576],

1	Other	JJ	O	other	amod	2	SENT_232	[p17l1995t3528r2145b3576],
2	studies	NNS	O	study	nsubj	9	SENT_232	[p17l644t3604r824b3652],
3	that	WDT	O	that	nsubj	4	SENT_232	[p17l862t3604r962b3652],
4	detected	VBD	O	detect	rcmod	2	SENT_232	[p17l998t3604r1212b3652],
5	apparent	JJ	O	apparent	amod	7	SENT_232	[p17l1249t3614r1478b3666],
6	genotype-related	JJ	O	genotype-related	amod	7	SENT_232	[p17l1514t3604r1942b3667],
7	effects	NNS	O	effect	dobj	4	SENT_232	[p17l1978t3604r2142b3652],
8	also	RB	O	also	advmod	4	SENT_232	[p17l643t3681r742b3728],
9	used	VBD	O	use	ccomp	26	SENT_232	[p17l787t3681r911b3728],
10	shortacting	VBG	O	shortact	xcomp	9	SENT_232	[p17l957t3681r1247b3744],
11	B,-agonists	NNS	O	b,-agonist	nsubj	17	SENT_232	[p17l1296t3681r1571b3744],
12	during	IN	O	during	_	0	SENT_232	[p17l1619t3681r1793b3744],
13	run-in	NN	O	run-in	prep_during	11	SENT_232	[p17l1839t3684r2002b3728],
14	and	CC	O	and	_	0	SENT_232	[p17l2049t3681r2145b3728],
15	treatment	NN	O	treatment	prep_during	11	SENT_232	[p17l641t3759r1009b3804],
16	.15	CD	NUMBER	.15	num	17	SENT_232	[p17l641t3759r1009b3804],
17	’	NN	O	’	xcomp	10	SENT_232	[p17l641t3759r1009b3804],
18	1	CD	NUMBER	1	num	19	SENT_232	[p17l641t3759r1009b3804],
19	“	NN	O	“	tmod	10	SENT_232	[p17l641t3759r1009b3804],
20	8	CD	NUMBER	8	npadvmod	21	SENT_232	[p17l641t3759r1009b3804],
21	Thus	RB	O	thus	advmod	19	SENT_232	[p17l1042t3757r1188b3811],
22	,	,	O	,	_	0	SENT_232	[p17l1042t3757r1188b3811],
23	we	PRP	O	we	nsubj	26	SENT_232	[p17l1224t3774r1296b3804],
24	do	VBP	O	do	aux	26	SENT_232	[p17l1331t3757r1392b3804],
25	not	RB	O	not	neg	26	SENT_232	[p17l1427t3766r1512b3804],
26	believe	VB	O	believe	_	0	SENT_232	[p17l1544t3757r1723b3804],
27	that	IN	O	that	complm	39	SENT_232	[p17l1756t3757r1857b3804],
28	the	DT	O	the	det	31	SENT_232	[p17l1889t3757r1970b3804],
29	study	NN	O	study	nn	31	SENT_232	[p17l2007t3757r2145b3819],
30	Bronchodilator	NN	O	bronchodilator	nn	31	SENT_232	[p17l1318t2035r1540b2062],
31	reversibility	NN	O	reversibility	nsubj	39	SENT_232	[p17l1552t2035r1730b2071],
32	,	,	O	,	_	0	SENT_232	[p17l1552t2035r1730b2071],
33	an	DT	O	a	det	35	SENT_232	[p17l1745t2044r1780b2062],
34	established	JJ	O	established	amod	35	SENT_232	[p17l1794t2034r1959b2062],
35	criterion	NN	O	criterion	appos	31	SENT_232	[p17l1972t2036r2098b2062],
36	for	IN	O	for	_	0	SENT_232	[p17l2111t2034r2154b2062],
37	designs	NNS	O	design	prep_for	35	SENT_232	[p18l643t13r838b76],
38	we	PRP	O	we	dep	35	SENT_232	[p18l855t30r927b61],
39	used	VBD	O	use	ccomp	26	SENT_232	[p18l943t13r1066b61],
40	confound	NN	O	confound	dobj	39	SENT_232	[p18l1083t13r1332b61],
41	or	CC	O	or	_	0	SENT_232	[p18l1348t30r1402b61],
42	restrict	VB	O	restrict	conj_or	26	SENT_232	[p18l1417t16r1599b61],
43	interpretation	NN	O	interpretation	dobj	42	SENT_232	[p18l1615t16r1973b75],
44	of	IN	O	of	_	0	SENT_232	[p18l1990t13r2048b61],
45	our	PRP$	O	we	poss	46	SENT_232	[p18l2056t30r2145b61],
46	data	NNS	O	datum	prep_of	43	SENT_232	[p18l643t90r749b137],
47	or	CC	O	or	_	0	SENT_232	[p18l769t107r823b137],
48	the	DT	O	the	det	49	SENT_232	[p18l841t90r922b137],
49	ability	NN	O	ability	conj_or	46	SENT_232	[p18l943t90r1100b152],
50	to	TO	O	to	aux	51	SENT_232	[p18l1117t99r1166b137],
51	address	VB	O	address	xcomp	42	SENT_232	[p18l1187t90r1382b137],
52	the	DT	O	the	det	54	SENT_232	[p18l1402t90r1484b137],
53	principal	JJ	O	principal	amod	54	SENT_232	[p18l1504t90r1735b152],
54	question	NN	O	question	dobj	51	SENT_232	[p18l1756t93r1979b152],
55	about	IN	O	about	_	0	SENT_232	[p18l2000t90r2145b137],
56	the	DT	O	the	det	57	SENT_232	[p18l641t165r722b213],
57	relation	NN	O	relation	prep_about	51	SENT_232	[p18l751t165r950b213],
58	between	IN	O	between	_	0	SENT_232	[p18l977t165r1194b213],
59	Gly16Arg	NN	O	gly16arg	nn	60	SENT_232	[p18l1224t165r1464b228],
60	genotype	NN	O	genotype	prep_between	57	SENT_232	[p18l1493t175r1726b228],
61	and	CC	O	and	_	0	SENT_232	[p18l1756t165r1851b213],
62	functional	JJ	O	functional	amod	64	SENT_232	[p18l1879t165r2144b213],
63	asthma	NN	O	asthma	nn	64	SENT_232	[p18l643t241r833b289],
64	outcomes	NNS	O	outcome	conj_and	60	SENT_232	[p18l869t251r1132b289],
65	.	.	O	.	_	0	SENT_232	[p18l869t251r1132b289],

1	Importantly	RB	O	importantly	advmod	8	SENT_233	[p18l1173t241r1488b304],
2	,	,	O	,	_	0	SENT_233	[p18l1173t241r1488b304],
3	individuals	NNS	O	individual	nsubj	8	SENT_233	[p18l1526t241r1811b289],
4	in	IN	O	in	_	0	SENT_233	[p18l1848t244r1900b288],
5	the	DT	O	the	det	7	SENT_233	[p18l1935t241r2016b289],
6	two	CD	NUMBER	two	num	7	SENT_233	[p18l2051t251r2143b289],
7	studies	NNS	O	study	prep_in	3	SENT_233	[p18l644t318r824b365],
8	showed	VBD	O	show	_	0	SENT_233	[p18l869t318r1065b365],
9	strong	JJ	O	strong	amod	10	SENT_233	[p18l1108t327r1271b381],
10	improvement	NN	O	improvement	dobj	8	SENT_233	[p18l1313t321r1668b380],
11	on	IN	O	on	_	0	SENT_233	[p18l1709t335r1775b365],
12	initiation	NN	O	initiation	prep_on	8	SENT_233	[p18l1816t321r2053b365],
13	of	IN	O	of	_	0	SENT_233	[p18l2095t318r2153b365],
14	inhaled	VBN	O	inhale	prepc_of	12	SENT_233	[p18l642t393r837b441],
15	corticosteroid	NN	O	corticosteroid	dobj	14	SENT_233	[p18l917t393r1269b441],
16	plus	CC	O	plus	prep	15	SENT_233	[p18l1347t393r1456b455],
17	longacting	VBG	O	longact	dep	16	SENT_233	[p18l1536t393r1810b456],
18	B2-agonist	JJ	O	b2-agonist	amod	20	SENT_233	[p18l1893t393r2145b456],
19	maintenance	NN	O	maintenance	nn	20	SENT_233	[p18l642t472r980b517],
20	treatment	NN	O	treatment	dobj	17	SENT_233	[p18l1001t479r1268b517],
21	.	.	O	.	_	0	SENT_233	[p18l1001t479r1268b517],

1	This	DT	O	this	det	2	SENT_234	[p18l1291t469r1405b517],
2	ﬁnding	NN	O	ﬁnding	nsubj	3	SENT_234	[p18l1428t469r1617b532],
3	illustrates	VBZ	O	illustrate	_	0	SENT_234	[p18l1638t469r1889b517],
4	response	NN	O	response	dobj	3	SENT_234	[p18l1912t486r2143b531],
5	to	TO	O	to	_	0	SENT_234	[p18l641t555r689b593],
6	the	DT	O	the	det	9	SENT_234	[p18l709t546r790b593],
7	longacting	VBG	O	longact	amod	9	SENT_234	[p18l809t546r1082b609],
8	B2-agonist	NN	O	b2-agonist	nn	9	SENT_234	[p18l1105t546r1357b609],
9	component	NN	O	component	prep_to	3	SENT_234	[p18l1376t555r1672b608],
10	despite	IN	O	despite	_	0	SENT_234	[p18l1692t546r1874b608],
11	any	DT	O	any	det	12	SENT_234	[p18l1895t563r1986b608],
12	effect	NN	O	effect	prep_despite	3	SENT_234	[p18l2005t546r2145b593],
13	caused	VBN	O	cause	partmod	12	SENT_234	[p18l643t621r820b669],
14	by	IN	O	by	_	0	SENT_234	[p18l827t621r888b684],
15	periodic	JJ	O	periodic	agent	13	SENT_234	[p18l896t621r1107b683],
16	shortacting	VBG	O	shortact	partmod	15	SENT_234	[p18l1118t621r1408b684],
17	B2-agonist	JJ	O	b2-agonist	amod	18	SENT_234	[p18l1421t621r1672b684],
18	use	NN	O	use	dobj	16	SENT_234	[p18l1680t638r1782b669],
19	.	.	O	.	_	0	SENT_234	[p18l1680t638r1782b669],

1	Furthermore	RB	O	furthermore	advmod	6	SENT_235	[p18l1797t622r2141b676],
2	,	,	O	,	_	0	SENT_235	[p18l1797t622r2141b676],
3	improvement	NN	O	improvement	nsubj	22	SENT_235	[p18l642t700r997b759],
4	with	IN	O	with	_	0	SENT_235	[p18l1034t697r1149b745],
5	combination	NN	O	combination	prep_with	3	SENT_235	[p18l1190t697r1519b745],
6	inhaled	VBD	O	inhale	_	0	SENT_235	[p18l1558t697r1753b745],
7	corticosteroid	NN	O	corticosteroid	nsubjpass	13	SENT_235	[p18l1793t697r2145b745],
8	plus	CC	O	plus	prep	7	SENT_235	[p18l642t774r750b836],
9	longacting	VBG	O	longact	dep	8	SENT_235	[p18l769t774r1042b837],
10	B2-agonist	JJ	O	b2-agonist	amod	11	SENT_235	[p18l1064t774r1315b837],
11	therapy	NN	O	therapy	dobj	9	SENT_235	[p18l1331t774r1527b836],
12	was	VBD	O	be	auxpass	13	SENT_235	[p18l1541t791r1638b821],
13	maintained	VBN	O	maintain	ccomp	6	SENT_235	[p18l1657t774r1956b821],
14	for	IN	O	for	_	0	SENT_235	[p18l1973t774r2047b821],
15	the	DT	O	the	det	16	SENT_235	[p18l2063t774r2143b821],
16	duration	NN	O	duration	prep_for	13	SENT_235	[p18l643t849r864b897],
17	of	IN	O	of	_	0	SENT_235	[p18l883t849r941b897],
18	the	DT	O	the	det	19	SENT_235	[p18l949t849r1030b897],
19	studies	NNS	O	study	prep_of	16	SENT_235	[p18l1051t849r1231b897],
20	and	CC	O	and	_	0	SENT_235	[p18l1251t849r1348b897],
21	was	VBD	O	be	cop	22	SENT_235	[p18l1363t866r1460b897],
22	independent	JJ	O	independent	conj_and	6	SENT_235	[p18l1480t849r1809b911],
23	of	IN	O	of	_	0	SENT_235	[p18l1827t849r1885b897],
24	genotype	NN	O	genotype	prep_of	22	SENT_235	[p18l1895t859r2141b912],
25	.	.	O	.	_	0	SENT_235	[p18l1895t859r2141b912],

1	We	PRP	O	we	nsubj	2	SENT_236	[p18l641t930r724b973],
2	believe	VBP	O	believe	_	0	SENT_236	[p18l750t925r928b973],
3	that	IN	O	that	complm	15	SENT_236	[p18l954t925r1055b973],
4	the	DT	O	the	det	5	SENT_236	[p18l1079t925r1160b973],
5	absence	NN	O	absence	nsubj	15	SENT_236	[p18l1188t925r1392b973],
6	of	IN	O	of	_	0	SENT_236	[p18l1420t925r1478b973],
7	a	DT	O	a	det	9	SENT_236	[p18l1495t942r1522b973],
8	placebo	NN	O	placebo	nn	9	SENT_236	[p18l1547t925r1743b987],
9	group	NN	O	group	prep_of	5	SENT_236	[p18l1771t942r1923b988],
10	in	IN	O	in	prep	5	SENT_236	[p18l1950t928r2001b972],
11	both	CC	O	both	dep	10	SENT_236	[p18l2027t925r2144b973],
12	studies	NNS	O	study	conj	10	SENT_236	[p18l644t1002r824b1049],
13	does	VBZ	O	do	aux	15	SENT_236	[p18l851t1002r966b1049],
14	not	RB	O	not	neg	15	SENT_236	[p18l992t1011r1077b1049],
15	restrict	VB	O	restrict	ccomp	2	SENT_236	[p18l1100t1005r1282b1049],
16	the	DT	O	the	det	17	SENT_236	[p18l1304t1002r1385b1049],
17	interpretation	NN	O	interpretation	dobj	15	SENT_236	[p18l1410t1005r1768b1064],
18	of	IN	O	of	_	0	SENT_236	[p18l1793t1002r1851b1049],
19	the	DT	O	the	det	20	SENT_236	[p18l1865t1002r1946b1049],
20	results	NNS	O	result	prep_of	17	SENT_236	[p18l1971t1002r2142b1049],
21	presented	VBN	O	present	partmod	20	SENT_236	[p18l642t1078r898b1140],
22	here	RB	O	here	advmod	21	SENT_236	[p18l911t1078r1026b1126],
23	because	IN	O	because	mark	28	SENT_236	[p18l1040t1078r1246b1126],
24	our	PRP$	O	we	poss	26	SENT_236	[p18l1262t1095r1350b1126],
25	pharmacogenetic	JJ	O	pharmacogenetic	amod	26	SENT_236	[p18l1364t1078r1813b1141],
26	analysis	NN	O	analysis	nsubjpass	28	SENT_236	[p18l1828t1078r2030b1141],
27	was	VBD	O	be	auxpass	28	SENT_236	[p18l2046t1095r2142b1126],
28	designed	VBN	O	design	advcl	21	SENT_236	[p18l643t1154r876b1217],
29	to	TO	O	to	aux	30	SENT_236	[p18l892t1164r940b1202],
30	assess	VB	O	assess	xcomp	28	SENT_236	[p18l959t1171r1116b1202],
31	genotype	NN	O	genotype	nn	32	SENT_236	[p18l1136t1164r1369b1217],
32	effects	NNS	O	effect	dobj	30	SENT_236	[p18l1388t1154r1551b1202],
33	within	IN	O	within	_	0	SENT_236	[p18l1569t1154r1738b1202],
34	each	DT	O	each	det	36	SENT_236	[p18l1756t1154r1872b1202],
35	treatment	NN	O	treatment	nn	36	SENT_236	[p18l1889t1164r2145b1202],
36	group	NN	O	group	prep_within	30	SENT_236	[p18l643t1248r795b1294],
37	or	CC	O	or	_	0	SENT_236	[p18l814t1248r867b1278],
38	class	NN	O	class	prep_within	30	SENT_236	[p18l884t1231r1003b1278],
39	rather	RB	O	rather	_	0	SENT_236	[p18l1022t1231r1179b1278],
40	than	IN	O	than	_	0	SENT_236	[p18l1194t1231r1312b1278],
41	between	IN	O	between	_	0	SENT_236	[p18l1327t1231r1544b1278],
42	groups	NNS	O	group	prep_between	30	SENT_236	[p18l1562t1248r1754b1294],
43	.	.	O	.	_	0	SENT_236	[p18l1562t1248r1754b1294],

1	diagnosing	VBG	O	diagnose	partmod	6	SENT_237	[p18l10t1636r414b1725],
2	asthma	NN	O	asthma	dobj	1	SENT_237	[p18l444t1636r806b1714],
3	,	,	O	,	_	0	SENT_237	[p18l444t1636r806b1714],
4	“	NN	O	“	nsubjpass	6	SENT_237	[p18l444t1636r806b1714],
5	was	VBD	O	be	auxpass	6	SENT_237	[p18l834t1660r970b1703],
6	used	VBN	O	use	_	0	SENT_237	[p18l1001t1636r1175b1703],
7	to	TO	O	to	aux	8	SENT_237	[p18l1202t1649r1270b1703],
8	diagnose	VB	O	diagnose	xcomp	6	SENT_237	[p18l1302t1636r1625b1725],
9	asthma	NN	O	asthma	dobj	8	SENT_237	[p18l1657t1636r1925b1703],
10	in	IN	O	in	_	0	SENT_237	[p18l1954t1640r2027b1702],
11	all	DT	O	all	det	12	SENT_237	[p18l2057t1636r2140b1703],
12	participants	NNS	O	participant	prep_in	8	SENT_237	[p18l8t1749r436b1833],
13	in	IN	O	in	_	0	SENT_237	[p18l487t1749r560b1811],
14	study	NN	O	study	prep_in	12	SENT_237	[p18l610t1744r805b1834],
15	1	CD	NUMBER	1	num	14	SENT_237	[p18l853t1751r901b1812],
16	.	.	O	.	_	0	SENT_237	[p18l853t1751r901b1812],

1	This	DT	O	this	det	3	SENT_238	[p18l952t1744r1112b1813],
2	diagnostic	JJ	O	diagnostic	amod	3	SENT_238	[p18l1163t1744r1535b1834],
3	criterion	NN	O	criterion	nsubj	6	SENT_238	[p18l1583t1749r1893b1813],
4	could	MD	O	could	aux	6	SENT_238	[p18l1942t1744r2141b1813],
5	potentially	RB	O	potentially	advmod	6	SENT_238	[p18l8t1853r391b1942],
6	lead	VB	O	lead	_	0	SENT_238	[p18l440t1853r590b1921],
7	to	TO	O	to	_	0	SENT_238	[p18l640t1867r708b1921],
8	the	DT	O	the	det	9	SENT_238	[p18l761t1853r875b1921],
9	selection	NN	O	selection	prep_to	6	SENT_238	[p18l930t1853r1248b1921],
10	of	IN	O	of	_	0	SENT_238	[p18l1302t1853r1384b1921],
11	a	DT	O	a	det	14	SENT_238	[p18l1424t1878r1460b1921],
12	more	RBR	O	more	advmod	14	SENT_238	[p18l1513t1878r1705b1921],
13	B2agonistresponsive	JJ	O	b2agonistresponsive	amod	14	SENT_238	[p18l1764t1853r2138b1943, p18l9t1967r398b2052],
14	group	NN	O	group	prep_of	9	SENT_238	[p18l426t1987r639b2052],
15	of	IN	O	of	_	0	SENT_238	[p18l667t1963r749b2030],
16	individuals	NNS	O	individual	prep_of	14	SENT_238	[p18l762t1963r1162b2030],
17	with	IN	O	with	_	0	SENT_238	[p18l1188t1963r1350b2030],
18	asthma	NN	O	asthma	prep_with	6	SENT_238	[p18l1377t1963r1644b2030],
19	in	IN	O	in	_	0	SENT_238	[p18l1669t1967r1743b2029],
20	whom	WP	O	whom	rel	28	SENT_238	[p18l1766t1963r2001b2030],
21	the	DT	O	the	det	22	SENT_238	[p18l2025t1963r2139b2030],
22	relation	NN	O	relation	nsubj	28	SENT_238	[p18l9t2071r287b2140],
23	between	IN	O	between	_	0	SENT_238	[p18l319t2071r624b2140],
24	response	NN	O	response	prep_between	22	SENT_238	[p18l657t2096r983b2160],
25	and	CC	O	and	_	0	SENT_238	[p18l1017t2071r1153b2140],
26	genotype	NN	O	genotype	prep_between	22	SENT_238	[p18l1186t2085r1514b2161],
27	could	MD	O	could	aux	28	SENT_238	[p18l1548t2071r1747b2140],
28	vary	VB	O	vary	rcmod	18	SENT_238	[p18l1777t2096r1928b2161],
29	from	IN	O	from	_	0	SENT_238	[p18l1959t2071r2140b2139],
30	that	DT	O	that	prep_from	28	SENT_238	[p18l8t2181r149b2249],
31	of	IN	O	of	_	0	SENT_238	[p18l167t2181r249b2249],
32	the	DT	O	the	det	35	SENT_238	[p18l253t2181r367b2249],
33	overall	JJ	O	overall	amod	35	SENT_238	[p18l387t2181r626b2250],
34	asthmatic	JJ	O	asthmatic	amod	35	SENT_238	[p18l645t2181r999b2249],
35	population	NN	O	population	prep_of	30	SENT_238	[p18l1017t2181r1429b2270],
36	.	.	O	.	_	0	SENT_238	[p18l1017t2181r1429b2270],

1	However	RB	O	however	advmod	8	SENT_239	[p18l1456t2188r1791b2259],
2	,	,	O	,	_	0	SENT_239	[p18l1456t2188r1791b2259],
3	bronchodilator	NN	O	bronchodilator	nn	4	SENT_239	[p18l1811t2181r2138b2249, p18l10t2291r244b2358],
4	reversibility	NN	O	reversibility	nsubj	8	SENT_239	[p18l272t2291r700b2380],
5	was	VBD	O	be	cop	8	SENT_239	[p18l725t2315r861b2358],
6	not	RB	O	not	neg	8	SENT_239	[p18l893t2304r1013b2358],
7	a	DT	O	a	det	8	SENT_239	[p18l1042t2315r1078b2358],
8	diagnostic	JJ	O	diagnostic	_	0	SENT_239	[p18l1109t2291r1481b2380],
9	or	CC	O	or	_	0	SENT_239	[p18l1510t2315r1586b2358],
10	entry	NN	O	entry	nn	11	SENT_239	[p18l1615t2304r1802b2380],
11	criterion	NN	O	criterion	conj_or	8	SENT_239	[p18l1831t2295r2140b2358],
12	in	IN	O	in	_	0	SENT_239	[p18l9t2404r82b2466],
13	study	NN	O	study	prep_in	11	SENT_239	[p18l117t2399r312b2489],
14	2	CD	NUMBER	2	num	13	SENT_239	[p18l346t2406r382b2466],
15	and	CC	O	and	_	0	SENT_239	[p18l419t2399r571b2478],
16	,	,	O	,	_	0	SENT_239	[p18l419t2399r571b2478],
17	although	IN	O	although	mark	19	SENT_239	[p18l608t2399r932b2489],
18	there	EX	O	there	expl	19	SENT_239	[p18l963t2399r1151b2467],
19	were	VBD	O	be	csubj	29	SENT_239	[p18l1182t2424r1357b2468],
20	differences	NNS	O	difference	nsubj	19	SENT_239	[p18l1392t2399r1792b2468],
21	in	IN	O	in	_	0	SENT_239	[p18l1827t2404r1900b2466],
22	mean	JJ	O	mean	amod	24	SENT_239	[p18l1933t2424r2140b2467],
23	baseline	NN	O	baseline	nn	24	SENT_239	[p18l7t2508r308b2576],
24	reversibility	NN	O	reversibility	prep_in	20	SENT_239	[p18l428t2508r856b2598],
25	between	IN	O	between	_	0	SENT_239	[p18l972t2508r1278b2576],
26	the	DT	O	the	det	28	SENT_239	[p18l1396t2508r1510b2576],
27	two	CD	NUMBER	two	num	28	SENT_239	[p18l1631t2522r1760b2576],
28	studies	NNS	O	study	prep_between	24	SENT_239	[p18l1885t2508r2138b2576],
29	(	VBP	O	(	ccomp	8	SENT_239	[p18l14t2622r275b2708],
30	24-5	CD	PERCENT	24-5	num	31	SENT_239	[p18l14t2622r275b2708],
31	%	NN	PERCENT	%	dobj	29	SENT_239	[p18l14t2622r275b2708],
32	[	CD	NUMBER	[	num	33	SENT_239	[p18l312t2623r439b2706],
33	SD	NN	O	sd	dep	31	SENT_239	[p18l312t2623r439b2706],
34	12-9	CD	NUMBER	12-9	num	35	SENT_239	[p18l475t2624r652b2707],
35	]	NN	O	]	dep	33	SENT_239	[p18l475t2624r652b2707],
36	in	IN	O	in	_	0	SENT_239	[p18l687t2622r760b2684],
37	study	NN	O	study	prep_in	35	SENT_239	[p18l793t2618r989b2707],
38	1	CD	NUMBER	1	num	37	SENT_239	[p18l1021t2624r1068b2696],
39	;	:	O	;	_	0	SENT_239	[p18l1021t2624r1068b2696],
40	12-2	RB	PERCENT	12-2	num	41	SENT_239	[p18l1106t2622r1339b2689],
41	%	NN	PERCENT	%	dep	35	SENT_239	[p18l1106t2622r1339b2689],
42	[	CD	NUMBER	[	num	43	SENT_239	[p18l1376t2623r1503b2706],
43	SD	NN	O	sd	dep	41	SENT_239	[p18l1376t2623r1503b2706],
44	10-4	CD	NUMBER	10-4	num	45	SENT_239	[p18l1539t2624r1711b2707],
45	]	NN	O	]	dep	41	SENT_239	[p18l1539t2624r1711b2707],
46	in	IN	O	in	_	0	SENT_239	[p18l1746t2622r1819b2684],
47	study	NN	O	study	prep_in	45	SENT_239	[p18l1853t2618r2048b2707],
48	2	CD	NUMBER	2	num	47	SENT_239	[p18l2080t2624r2136b2696],
49	;	:	O	;	_	0	SENT_239	[p18l2080t2624r2136b2696],
50	table	NN	O	table	dep	35	SENT_239	[p18l8t2726r181b2795],
51	3	CD	NUMBER	3	num	52	SENT_239	[p18l218t2733r300b2816],
52	)	NN	O	)	dep	50	SENT_239	[p18l218t2733r300b2816],
53	,	,	O	,	_	0	SENT_239	[p18l218t2733r300b2816],
54	neither	CC	O	neither	dep	29	SENT_239	[p18l336t2726r600b2795],
55	showed	VBD	O	show	conj	29	SENT_239	[p18l633t2726r910b2795],
56	an	DT	O	a	det	57	SENT_239	[p18l942t2751r1029b2794],
57	effect	NN	O	effect	dobj	55	SENT_239	[p18l1063t2727r1260b2794],
58	of	IN	O	of	_	0	SENT_239	[p18l1293t2726r1375b2794],
59	genotype	NN	O	genotype	prep_of	57	SENT_239	[p18l1395t2740r1723b2816],
60	on	IN	O	on	_	0	SENT_239	[p18l1758t2751r1849b2795],
61	clinical	JJ	O	clinical	amod	62	SENT_239	[p18l1883t2726r2140b2795],
62	outcomes	NNS	O	outcome	prep_on	55	SENT_239	[p18l10t2849r381b2903],
63	.	.	O	.	_	0	SENT_239	[p18l10t2849r381b2903],

1	There	EX	O	there	expl	2	SENT_240	[p18l432t2835r646b2903],
2	was	VBD	O	be	_	0	SENT_240	[p18l693t2859r829b2903],
3	no	DT	O	no	det	5	SENT_240	[p18l879t2860r972b2903],
4	differential	JJ	O	differential	amod	5	SENT_240	[p18l1022t2835r1422b2903],
5	effect	NN	O	effect	nsubj	2	SENT_240	[p18l1472t2836r1669b2903],
6	of	IN	O	of	_	0	SENT_240	[p18l1717t2835r1799b2903],
7	Arg/Arg	NN	O	arg/arg	nn	8	SENT_240	[p18l1832t2840r2140b2925],
8	genotype	NN	O	genotype	prep_of	5	SENT_240	[p18l10t2958r338b3034],
9	on	IN	O	on	_	0	SENT_240	[p18l379t2969r472b3012],
10	therapeutic	JJ	O	therapeutic	amod	11	SENT_240	[p18l511t2945r924b3033],
11	responses	NNS	O	response	prep_on	2	SENT_240	[p18l963t2969r1325b3033],
12	in	IN	O	in	_	0	SENT_240	[p18l1368t2949r1441b3011],
13	study	NN	O	study	prep_in	11	SENT_240	[p18l1483t2945r1678b3034],
14	2	CD	NUMBER	2	num	13	SENT_240	[p18l1719t2951r1756b3011],
15	when	WRB	O	when	advmod	17	SENT_240	[p18l1796t2945r2000b3012],
16	we	PRP	O	we	nsubj	17	SENT_240	[p18l2038t2969r2139b3012],
17	compared	VBD	O	compare	advcl	2	SENT_240	[p18l9t3054r375b3143],
18	the	DT	O	the	det	20	SENT_240	[p18l416t3054r530b3123],
19	56	CD	PERCENT	56	num	20	SENT_240	[p18l580t3059r735b3125],
20	%	NN	PERCENT	%	dobj	17	SENT_240	[p18l580t3059r735b3125],
21	of	IN	O	of	_	0	SENT_240	[p18l782t3054r864b3123],
22	individuals	NNS	O	individual	prep_of	20	SENT_240	[p18l895t3054r1296b3123],
23	with	IN	O	with	_	0	SENT_240	[p18l1341t3054r1503b3123],
24	asthma	NN	O	asthma	prep_with	22	SENT_240	[p18l1548t3054r1816b3123],
25	without	IN	O	without	_	0	SENT_240	[p18l1858t3054r2141b3123],
26	baseline	NN	O	baseline	nn	28	SENT_240	[p18l7t3163r307b3231],
27	bronchodilator	NN	O	bronchodilator	nn	28	SENT_240	[p18l377t3163r920b3231],
28	reversibility	NN	O	reversibility	prep_without	17	SENT_240	[p18l989t3163r1416b3253],
29	with	IN	O	with	_	0	SENT_240	[p18l1483t3163r1645b3231],
30	those	DT	O	those	prep_with	28	SENT_240	[p18l1714t3163r1909b3231],
31	with	IN	O	with	_	0	SENT_240	[p18l1978t3163r2140b3231],
32	reversibility	NN	O	reversibility	prep_with	30	SENT_240	[p18l9t3273r444b3362],
33	.	.	O	.	_	0	SENT_240	[p18l9t3273r444b3362],

1	These	DT	O	these	det	2	SENT_241	[p18l560t3273r778b3340],
2	ﬁndings	NNS	O	ﬁndings	nsubj	3	SENT_241	[p18l891t3273r1192b3362],
3	suggest	VBP	O	suggest	_	0	SENT_241	[p18l1310t3286r1585b3362],
4	that	IN	O	that	complm	8	SENT_241	[p18l1696t3273r1837b3340],
5	acute	JJ	O	acute	amod	7	SENT_241	[p18l1949t3286r2139b3340],
6	bronchodilator	NN	O	bronchodilator	nn	7	SENT_241	[p18l7t3381r551b3450],
7	reversibility	NN	O	reversibility	nsubj	8	SENT_241	[p18l569t3381r996b3471],
8	had	VBD	O	have	ccomp	3	SENT_241	[p18l1013t3381r1150b3449],
9	no	DT	O	no	det	10	SENT_241	[p18l1168t3406r1260b3450],
10	effect	NN	O	effect	dobj	8	SENT_241	[p18l1283t3382r1480b3450],
11	on	IN	O	on	_	0	SENT_241	[p18l1499t3406r1592b3449],
12	the	DT	O	the	det	13	SENT_241	[p18l1611t3381r1725b3449],
13	interaction	NN	O	interaction	prep_on	10	SENT_241	[p18l1746t3386r2140b3449],
14	between	IN	O	between	_	0	SENT_241	[p18l7t3491r313b3559],
15	genotype	NN	O	genotype	prep_between	8	SENT_241	[p18l347t3505r675b3581],
16	and	CC	O	and	_	0	SENT_241	[p18l710t3491r845b3559],
17	responsiveness	NN	O	responsiveness	prep_between	8	SENT_241	[p18l877t3496r1430b3580],
18	to	TO	O	to	aux	19	SENT_241	[p18l1464t3505r1532b3559],
19	inhaled	VBN	O	inhale	xcomp	8	SENT_241	[p18l1566t3491r1840b3559],
20	corticosteroid	NN	O	corticosteroid	dobj	19	SENT_241	[p18l1873t3496r2138b3559, p18l11t3601r258b3668],
21	plus	CC	O	plus	prep	20	SENT_241	[p18l281t3601r433b3689],
22	longacting	VBG	O	longact	dep	21	SENT_241	[p18l458t3601r843b3690],
23	B2-agonist	JJ	O	b2-agonist	amod	25	SENT_241	[p18l871t3601r1225b3690],
24	combination	NN	O	combination	nn	25	SENT_241	[p18l1248t3601r1712b3668],
25	therapy	NN	O	therapy	dobj	22	SENT_241	[p18l1734t3601r2018b3690],
26	.	.	O	.	_	0	SENT_241	[p18l1734t3601r2018b3690],

1	Previous	JJ	O	previous	amod	2	SENT_242	[p18l83t3714r402b3777],
2	studies	NNS	O	study	nsubj	4	SENT_242	[p18l490t3709r749b3777],
3	have	VBP	O	have	aux	4	SENT_242	[p18l834t3709r1004b3777],
4	shown	VBN	O	show	_	0	SENT_242	[p18l1090t3709r1334b3777],
5	that	IN	O	that	_	0	SENT_242	[p18l1416t3709r1561b3777],
6	few	JJ	O	few	amod	7	SENT_242	[p18l1643t3709r1775b3777],
7	ADRB2	NN	O	adrb2	prep_that	4	SENT_242	[p18l1855t3715r2144b3776],

1	haplotypes	NNS	O	haplotype	nsubj	2	SENT_243	[p19l7t27r406b116],
2	account	VBP	O	account	_	0	SENT_243	[p19l434t41r725b95],
3	for	IN	O	for	_	0	SENT_243	[p19l748t27r854b95],
4	most	JJS	O	most	prep_for	2	SENT_243	[p19l877t41r1064b95],
5	of	IN	O	of	_	0	SENT_243	[p19l1088t27r1170b95],
6	the	DT	O	the	det	8	SENT_243	[p19l1180t27r1296b95],
7	haplotypic	JJ	O	haplotypic	amod	8	SENT_243	[p19l1320t27r1707b117],
8	diversity	NN	O	diversity	prep_of	4	SENT_243	[p19l1732t27r2047b116],
9	of	IN	O	of	dep	2	SENT_243	[p19l2070t27r2153b95],
10	the	DT	O	the	det	12	SENT_243	[p19l8t137r123b204],
11	ADRB2	NN	O	adrb2	nn	12	SENT_243	[p19l168t142r457b203],
12	gene	NN	O	gene	pobj	9	SENT_243	[p19l499t161r694b226],
13	,	,	O	,	_	0	SENT_243	[p19l499t161r694b226],
14	and	CC	O	and	_	0	SENT_243	[p19l743t137r881b204],
15	that	IN	O	that	complm	21	SENT_243	[p19l924t137r1068b204],
16	the	DT	O	the	det	17	SENT_243	[p19l1110t137r1227b204],
17	frequency	NN	O	frequency	nsubj	21	SENT_243	[p19l1272t137r1645b226],
18	of	IN	O	of	_	0	SENT_243	[p19l1689t137r1771b204],
19	common	JJ	O	common	amod	20	SENT_243	[p19l1804t161r2140b204],
20	haplotypes	NNS	O	haplotype	prep_of	17	SENT_243	[p19l7t245r406b335],
21	differs	VBZ	O	differ	dep	2	SENT_243	[p19l468t245r704b313],
22	between	IN	O	between	_	0	SENT_243	[p19l763t245r1075b313],
23	population	NN	O	population	nn	24	SENT_243	[p19l1132t245r1537b334],
24	groups	NNS	O	group	prep_between	21	SENT_243	[p19l1596t251r1971b335],
25	?	.	O	?	_	0	SENT_243	[p19l1596t251r1971b335],

1	”	NN	O	”	nsubj	37	SENT_244	[p19l1596t251r1971b335],
2	An	DT	O	a	det	3	SENT_244	[p19l2029t251r2140b312],
3	effect	NN	O	effect	nsubjpass	15	SENT_244	[p19l10t355r212b422],
4	of	IN	O	of	_	0	SENT_244	[p19l273t354r355b422],
5	ADRB2	NN	O	adrb2	nn	6	SENT_244	[p19l403t359r692b421],
6	haplotype	NN	O	haplotype	prep_of	3	SENT_244	[p19l748t354r1111b444],
7	on	IN	O	on	_	0	SENT_244	[p19l1174t379r1268b422],
8	acute	JJ	O	acute	amod	10	SENT_244	[p19l1329t368r1524b422],
9	bronchodilator	NN	O	bronchodilator	nn	10	SENT_244	[p19l1584t354r2141b422],
10	responses	NNS	O	response	prep_on	6	SENT_244	[p19l9t489r378b554],
11	to	TO	O	to	_	0	SENT_244	[p19l405t478r474b533],
12	albuterol	NN	O	albuterol	prep_to	10	SENT_244	[p19l501t465r832b533],
13	has	VBZ	O	have	aux	15	SENT_244	[p19l855t465r980b533],
14	been	VBN	O	be	auxpass	15	SENT_244	[p19l1006t465r1187b533],
15	shown	VBN	O	show	rcmod	1	SENT_244	[p19l1214t465r1458b533],
16	in	IN	O	in	_	0	SENT_244	[p19l1483t469r1557b531],
17	some	DT	O	some	det	18	SENT_244	[p19l1585t489r1782b533],
18	studies	NNS	O	study	prep_in	15	SENT_244	[p19l1810t465r2139b543],
19	,	,	O	,	_	0	SENT_244	[p19l1810t465r2139b543],
20	”	NN	O	”	appos	18	SENT_244	[p19l1810t465r2139b543],
21	but	CC	O	but	_	0	SENT_244	[p19l7t574r132b643],
22	not	RB	O	not	_	0	SENT_244	[p19l161t588r284b643],
23	in	IN	O	in	_	0	SENT_244	[p19l313t579r387b642],
24	others	NNS	O	other	prep_in	26	SENT_244	[p19l419t574r770b643],
25	.1	CD	NUMBER	.1	number	26	SENT_244	[p19l419t574r770b643],
26	“	CD	NUMBER	“	prep_in	15	SENT_244	[p19l419t574r770b643],
27	"	``	O	"	punct	26	SENT_244	[p19l419t574r770b643],
28	The	DT	O	the	det	29	SENT_244	[p19l799t575r942b643],
29	size	NN	O	size	dep	26	SENT_244	[p19l976t579r1116b643],
30	of	IN	O	of	_	0	SENT_244	[p19l1149t574r1232b643],
31	the	DT	O	the	det	33	SENT_244	[p19l1248t575r1364b643],
32	white	JJ	O	white	amod	33	SENT_244	[p19l1394t575r1599b643],
33	population	NN	O	population	prep_of	29	SENT_244	[p19l1631t575r2036b663],
34	in	IN	O	in	_	0	SENT_244	[p19l2066t579r2140b642],
35	study	NN	O	study	prep_in	33	SENT_244	[p19l11t683r211b772],
36	1	CD	NUMBER	1	num	35	SENT_244	[p19l265t690r295b750],
37	enabled	VBD	O	enable	_	0	SENT_244	[p19l349t683r641b751],
38	the	DT	O	the	det	41	SENT_244	[p19l692t683r808b751],
39	most	RBS	O	most	advmod	40	SENT_244	[p19l862t697r1050b751],
40	robust	JJ	O	robust	amod	41	SENT_244	[p19l1101t683r1342b751],
41	analysis	NN	O	analysis	dobj	37	SENT_244	[p19l1394t683r1686b773],
42	of	IN	O	of	_	0	SENT_244	[p19l1743t683r1826b751],
43	asthma	NN	O	asthma	nn	44	SENT_244	[p19l1868t683r2140b751],
44	outcomes	NNS	O	outcome	prep_of	41	SENT_244	[p19l10t807r369b862],
45	by	IN	O	by	_	0	SENT_244	[p19l419t794r506b883],
46	ADRB2	NN	O	adrb2	nn	47	SENT_244	[p19l551t799r840b860],
47	haplotype	NN	O	haplotype	prep_by	37	SENT_244	[p19l884t794r1247b883],
48	so	RB	O	so	advmod	49	SENT_244	[p19l1300t818r1376b862],
49	far	RB	O	far	advmod	37	SENT_244	[p19l1426t794r1538b862],
50	.	.	O	.	_	0	SENT_244	[p19l1426t794r1538b862],

1	There	EX	O	there	expl	2	SENT_245	[p19l1589t794r1808b862],
2	was	VBD	O	be	dep	20	SENT_245	[p19l1856t818r1994b862],
3	no	DT	O	no	det	4	SENT_245	[p19l2046t818r2139b862],
4	evidence	NN	O	evidence	nsubj	2	SENT_245	[p19l10t902r332b971],
5	that	IN	O	that	complm	9	SENT_245	[p19l353t902r498b970],
6	clinical	JJ	O	clinical	amod	7	SENT_245	[p19l519t902r784b971],
7	outcomes	NNS	O	outcome	nsubjpass	9	SENT_245	[p19l806t916r1165b971],
8	were	VBD	O	be	auxpass	9	SENT_245	[p19l1187t927r1364b970],
9	affected	VBN	O	affect	ccomp	2	SENT_245	[p19l1388t902r1678b971],
10	by	IN	O	by	_	0	SENT_245	[p19l1697t902r1784b992],
11	common	JJ	O	common	amod	13	SENT_245	[p19l1804t927r2140b971],
12	ADRB2	NN	O	adrb2	nn	13	SENT_245	[p19l7t1016r297b1078],
13	haplotypes	NNS	O	haplotype	agent	9	SENT_245	[p19l343t1011r764b1101],
14	,	,	O	,	_	0	SENT_245	[p19l343t1011r764b1101],
15	consisting	VBG	O	consist	xcomp	9	SENT_245	[p19l820t1016r1203b1101],
16	of	IN	O	of	_	0	SENT_245	[p19l1255t1011r1338b1079],
17	11	CD	NUMBER	11	num	19	SENT_245	[p19l1380t1017r1447b1078],
18	single-nucleotide	JJ	O	single-nucleotide	amod	19	SENT_245	[p19l1501t1011r2139b1101],
19	polymorphisms	NNS	O	polymorphism	prep_of	15	SENT_245	[p19l8t1121r598b1210],
20	(	VBP	O	(	_	0	SENT_245	[p19l689t1121r1070b1211],
21	including	VBG	O	include	_	0	SENT_245	[p19l689t1121r1070b1211],
22	the	DT	O	the	det	25	SENT_245	[p19l1151t1121r1267b1188],
23	B-upstream	JJ	MISC	b-upstream	amod	25	SENT_245	[p19l1357t1121r1781b1209],
24	peptide	NN	O	peptide	nn	25	SENT_245	[p19l1863t1121r2139b1209],
25	Cys	NN	O	cy	prep_including	20	SENT_245	[p19l11t1235r425b1319],
26	—	CD	NUMBER	—	num	27	SENT_245	[p19l11t1235r425b1319],
27	19Arg	NN	O	19arg	nsubj	20	SENT_245	[p19l11t1235r425b1319],
28	,	,	O	,	_	0	SENT_245	[p19l11t1235r425b1319],
29	Gln27Glu	NN	O	gln27glu	nsubj	20	SENT_245	[p19l546t1229r928b1307],
30	,	,	O	,	_	0	SENT_245	[p19l546t1229r928b1307],
31	Gly16Arg	NN	O	gly16arg	conj_and	27	SENT_245	[p19l1048t1229r1413b1319],
32	,	,	O	,	_	0	SENT_245	[p19l1048t1229r1413b1319],
33	and	CC	O	and	_	0	SENT_245	[p19l1533t1229r1671b1297],
34	Thr164Ile	NN	O	thr164ile	nn	35	SENT_245	[p19l1783t1229r2139b1298],
35	polymorphisms	NNS	O	polymorphism	conj_and	27	SENT_245	[p19l8t1338r646b1428],
36	)	CD	NUMBER	)	dep	35	SENT_245	[p19l8t1338r646b1428],
37	.	.	O	.	_	0	SENT_245	[p19l8t1338r646b1428],

1	Our	PRP$	O	we	poss	2	SENT_246	[p19l682t1344r829b1406],
2	results	NNS	O	result	nsubj	3	SENT_246	[p19l856t1338r1103b1406],
3	show	VBP	O	show	_	0	SENT_246	[p19l1137t1338r1330b1406],
4	that	IN	O	that	complm	11	SENT_246	[p19l1356t1338r1501b1406],
5	combinations	NNS	O	combination	nsubj	11	SENT_246	[p19l1528t1338r2038b1406],
6	of	IN	O	of	_	0	SENT_246	[p19l2070t1338r2153b1406],
7	ADRB2	NN	O	adrb2	nn	8	SENT_246	[p19l7t1454r297b1515],
8	polymorphisms	NNS	O	polymorphism	prep_of	5	SENT_246	[p19l359t1449r949b1538],
9	do	VBP	O	do	aux	11	SENT_246	[p19l1019t1449r1107b1517],
10	not	RB	O	not	neg	11	SENT_246	[p19l1175t1462r1298b1517],
11	affect	VB	O	affect	ccomp	3	SENT_246	[p19l1364t1449r1566b1517],
12	responses	NNS	O	response	nsubj	14	SENT_246	[p19l1632t1473r2001b1538],
13	to	TO	O	to	aux	14	SENT_246	[p19l2070t1462r2139b1517],
14	inhaled	VBN	O	inhale	xcomp	11	SENT_246	[p19l9t1557r289b1625],
15	corticosteroid	NN	O	corticosteroid	dobj	14	SENT_246	[p19l315t1557r824b1625],
16	plus	CC	O	plus	prep	15	SENT_246	[p19l848t1557r1004b1646],
17	longacting	VBG	O	longact	dep	16	SENT_246	[p19l1032t1557r1427b1647],
18	B,-agonist	JJ	O	b,-agonist	amod	19	SENT_246	[p19l1458t1557r1821b1647],
19	therapy	NN	O	therapy	dobj	17	SENT_246	[p19l1845t1558r2136b1647],
20	.	.	O	.	_	0	SENT_246	[p19l1845t1558r2136b1647],

1	Additionally	RB	O	additionally	advmod	20	SENT_247	[p19l7t1666r475b1756],
2	,	,	O	,	_	0	SENT_247	[p19l7t1666r475b1756],
3	since	IN	O	since	mark	9	SENT_247	[p19l551t1671r740b1734],
4	these	DT	O	these	det	6	SENT_247	[p19l809t1666r1004b1734],
5	same	JJ	O	same	amod	6	SENT_247	[p19l1078t1690r1271b1734],
6	haplotypes	NNS	O	haplotype	nsubj	9	SENT_247	[p19l1340t1666r1739b1755],
7	are	VBP	O	be	cop	9	SENT_247	[p19l1813t1691r1924b1734],
8	also	RB	O	also	advmod	9	SENT_247	[p19l1996t1666r2139b1734],
9	common	JJ	O	common	advcl	20	SENT_247	[p19l9t1800r346b1843],
10	in	IN	O	in	_	0	SENT_247	[p19l368t1780r443b1842],
11	individuals	NNS	O	individual	prep_in	9	SENT_247	[p19l465t1776r877b1843],
12	from	IN	O	from	_	0	SENT_247	[p19l903t1776r1087b1843],
13	other	JJ	O	other	amod	15	SENT_247	[p19l1111t1776r1306b1843],
14	racial	JJ	O	racial	amod	15	SENT_247	[p19l1328t1776r1529b1843],
15	groups	NNS	O	group	prep_from	11	SENT_247	[p19l1553t1800r1829b1865],
16	,	,	O	,	_	0	SENT_247	[p19l1553t1800r1829b1865],
17	ADRB2	NN	O	adrb2	nn	18	SENT_247	[p19l1855t1781r2144b1842],
18	haplotypes	NNS	O	haplotype	nsubj	20	SENT_247	[p19l7t1884r406b1974],
19	are	VBP	O	be	cop	20	SENT_247	[p19l475t1909r586b1952],
20	unlikely	JJ	O	unlikely	_	0	SENT_247	[p19l651t1884r954b1974],
21	to	TO	O	to	aux	22	SENT_247	[p19l1016t1898r1085b1952],
22	contribute	VB	O	contribute	xcomp	20	SENT_247	[p19l1152t1884r1536b1953],
23	to	TO	O	to	_	0	SENT_247	[p19l1600t1898r1670b1952],
24	population	NN	O	population	nn	25	SENT_247	[p19l1735t1884r2140b1973],
25	differences	NNS	O	difference	prep_to	22	SENT_247	[p19l10t1994r419b2062],
26	in	IN	O	in	_	0	SENT_247	[p19l471t1999r545b2061],
27	response	NN	O	response	prep_in	25	SENT_247	[p19l594t2018r928b2083],
28	to	TO	O	to	aux	29	SENT_247	[p19l976t2008r1045b2062],
29	inhaled	VBN	O	inhale	xcomp	22	SENT_247	[p19l1096t1994r1376b2062],
30	corticosteroid	NN	O	corticosteroid	dobj	29	SENT_247	[p19l1425t1994r1934b2062],
31	plus	CC	O	plus	prep	30	SENT_247	[p19l1982t1994r2137b2083],
32	longacting	VBG	O	longact	dep	31	SENT_247	[p19l7t2104r402b2193],
33	B,-agonist	JJ	O	b,-agonist	amod	35	SENT_247	[p19l433t2104r796b2193],
34	combination	NN	O	combination	nn	35	SENT_247	[p19l822t2104r1296b2171],
35	therapies	NNS	O	therapy	dobj	32	SENT_247	[p19l1320t2104r1683b2192],
36	.	.	O	.	_	0	SENT_247	[p19l1320t2104r1683b2192],

1	Articles	NNPS	O	Articles	_	0	SENT_248	[p19l6t2671r156b2707],
2	I	PRP	O	I	dep	1	SENT_248	[p19l204t2508r252b2706],

1	The	DT	O	the	det	2	SENT_249	[p19l72t2953r205b3015],
2	data	NNS	O	datum	nsubj	3	SENT_249	[p19l237t2953r378b3015],
3	show	VBP	O	show	_	0	SENT_249	[p19l410t2953r589b3015],
4	that	IN	O	that	complm	9	SENT_249	[p19l616t2953r751b3015],
5	ADRB2	NN	O	adrb2	nn	6	SENT_249	[p19l778t2957r1046b3014],
6	genotype	NN	O	genotype	nsubj	9	SENT_249	[p19l1074t2965r1385b3035],
7	does	VBZ	O	do	aux	9	SENT_249	[p19l1417t2953r1570b3015],
8	not	RB	O	not	neg	9	SENT_249	[p19l1602t2965r1716b3015],
9	predict	VB	O	predict	ccomp	3	SENT_249	[p19l1744t2953r1986b3034],
10	11	CD	NUMBER	11	dobj	9	SENT_249	[p19l2094t2971r2142b3015],

1	effectiveness	NN	O	effectiveness	nsubj	5	SENT_250	[p19l8t3055r448b3117],
2	or	CC	O	or	_	0	SENT_250	[p19l505t3077r576b3117],
3	safety	NN	O	safety	nsubj	5	SENT_250	[p19l631t3054r827b3137],
4	of	IN	O	of	prep	1	SENT_250	[p19l880t3054r957b3117],
5	inhaled	VBN	O	inhale	_	0	SENT_250	[p19l999t3054r1259b3117],
6	corticosteroid	NN	O	corticosteroid	dobj	5	SENT_250	[p19l1313t3054r1785b3117],
7	plus	CC	O	plus	prep	6	SENT_250	[p19l1838t3054r1982b3136],
8	longacting	VBG	O	longact	amod	10	SENT_250	[p19l6t3145r372b3228],
9	B,-agonist	JJ	O	b,-agonist	amod	10	SENT_250	[p19l406t3145r742b3228],
10	therapies	NNS	O	therapy	dep	7	SENT_250	[p19l768t3145r1106b3227],
11	,	,	O	,	_	0	SENT_250	[p19l768t3145r1106b3227],
12	and	CC	O	and	_	0	SENT_250	[p19l1138t3145r1266b3207],
13	individuals	NNS	O	individual	conj_and	6	SENT_250	[p19l1294t3145r1675b3207],
14	who	WP	O	who	nsubj	16	SENT_250	[p19l1704t3145r1850b3207],
15	are	VBP	O	be	cop	16	SENT_250	[p19l1881t3167r1983b3207],
16	www	NN	O	www	rcmod	13	SENT_250	[p19l641t2374r1174b2425],
17	.	.	O	.	_	0	SENT_250	[p19l641t2374r1174b2425],

1	the	DT	O	the	det	4	SENT_251	[p19l641t2374r1174b2425],
2	|	NN	O	|	nn	4	SENT_251	[p19l641t2374r1174b2425],
3	ancet.com	NN	O	ancet.com	nn	4	SENT_251	[p19l641t2374r1174b2425],
4	Vol	NN	O	vol	_	0	SENT_251	[p19l1217t2374r1304b2425],
5	370	CD	NUMBER	370	dep	4	SENT_251	[p19l1324t2381r1427b2432],
6	December	NNP	DATE	December	tmod	5	SENT_251	[p19l1476t2374r1754b2425],
7	22/29	CD	DATE	22/29	num	6	SENT_251	[p19l1771t2376r1950b2433],
8	,	,	DATE	,	_	0	SENT_251	[p19l1771t2376r1950b2433],
9	2007	CD	DATE	2007	num	6	SENT_251	[p19l1970t2381r2112b2431],

1	symptomatic	JJ	O	symptomatic	amod	4	SENT_252	[p19l10t3242r458b3321],
2	on	IN	O	on	_	0	SENT_252	[p19l485t3261r571b3301],
3	inhaled	VBN	O	inhale	prepc_on	1	SENT_252	[p19l598t3238r858b3301],
4	corticosteroids	NNS	O	corticosteroid	nsubj	6	SENT_252	[p19l884t3238r1388b3301],
5	should	MD	O	should	aux	6	SENT_252	[p19l1419t3238r1653b3301],
6	continue	VB	O	continue	_	0	SENT_252	[p19l1680t3242r1983b3301],
7	12	CD	NUMBER	12	dobj	6	SENT_252	[p19l2094t3195r2146b3238],
8	to	TO	O	to	aux	10	SENT_252	[p19l6t3341r70b3391],
9	be	VB	O	be	auxpass	10	SENT_252	[p19l108t3328r188b3391],
10	prescribed	VBN	O	prescribe	xcomp	6	SENT_252	[p19l226t3328r591b3410],
11	inhaled	VBN	O	inhale	dep	10	SENT_252	[p19l628t3328r888b3391],
12	corticosteroid	NN	O	corticosteroid	dobj	11	SENT_252	[p19l926t3328r1398b3391],
13	plus	CC	O	plus	prep	12	SENT_252	[p19l1435t3328r1579b3410],
14	longacting	VBG	O	longact	amod	16	SENT_252	[p19l1619t3328r1984b3411],
15	B,-agonist	JJ	O	b,-agonist	amod	16	SENT_252	[p19l13t3430r349b3513],
16	combinations	NNS	O	combination	dep	13	SENT_252	[p19l399t3430r891b3502],
17	,	,	O	,	_	0	SENT_252	[p19l399t3430r891b3502],
18	irrespective	RB	O	irrespective	_	0	SENT_252	[p19l944t3434r1343b3512],
19	of	IN	O	of	_	0	SENT_252	[p19l1394t3430r1471b3492],
20	their	PRP$	O	they	poss	23	SENT_252	[p19l1508t3430r1672b3492],
21	ADRB2	NN	O	adrb2	nn	23	SENT_252	[p19l1720t3434r1988b3491],
22	13	CD	NUMBER	13	num	23	SENT_252	[p19l2094t3410r2145b3454],
23	genotype	NN	O	genotype	prep_irrespective_of	11	SENT_252	[p19l9t3532r337b3602],
24	.	.	O	.	_	0	SENT_252	[p19l9t3532r337b3602],

1	Contributors	NNS	O	contributor	_	0	SENT_253	[p19l8t3645r341b3692],

1	ERB	NNP	O	ERB	nn	3	SENT_254	[p19l10t3727r139b3780],
2	,	,	O	,	_	0	SENT_254	[p19l10t3727r139b3780],
3	DSP	NNP	ORGANIZATION	DSP	nsubj	7	SENT_254	[p19l163t3727r295b3780],
4	,	,	O	,	_	0	SENT_254	[p19l163t3727r295b3780],
5	and	CC	O	and	_	0	SENT_254	[p19l317t3724r417b3773],
6	DAM	NN	O	dam	conj_and	3	SENT_254	[p19l437t3727r579b3772],
7	generated	VBD	O	generate	_	0	SENT_254	[p19l601t3724r866b3788],
8	an	DT	O	a	det	10	SENT_254	[p19l885t3742r949b3773],
9	initial	JJ	O	initial	amod	10	SENT_254	[p19l967t3724r1124b3773],
10	draft	NN	O	draft	dobj	7	SENT_254	[p19l1143t3724r1269b3773],
11	of	IN	O	of	_	0	SENT_254	[p19l1287t3724r1347b3773],
12	the	DT	O	the	det	13	SENT_254	[p19l1355t3724r1439b3773],
13	report	NN	O	report	prep_of	10	SENT_254	[p19l1458t3734r1635b3788],
14	,	,	O	,	_	0	SENT_254	[p19l1458t3734r1635b3788],
15	participated	VBD	O	participate	dep	7	SENT_254	[p19l1656t3724r1975b3788],
16	in	IN	O	in	_	0	SENT_254	[p20l7t21r61b66],
17	discussions	NNS	O	discussion	prep_in	15	SENT_254	[p20l80t18r390b67],
18	on	IN	O	on	_	0	SENT_254	[p20l411t35r479b67],
19	study	NN	O	study	nn	20	SENT_254	[p20l499t18r643b82],
20	analyses	NNS	O	analysis	prep_on	15	SENT_254	[p20l661t18r898b82],
21	,	,	O	,	_	0	SENT_254	[p20l661t18r898b82],
22	in	IN	O	in	_	0	SENT_254	[p20l919t21r973b66],
23	interpretation	NN	O	interpretation	prep_in	7	SENT_254	[p20l992t21r1365b81],
24	of	IN	O	of	_	0	SENT_254	[p20l1384t18r1444b67],
25	the	DT	O	the	det	26	SENT_254	[p20l1452t18r1536b67],
26	data	NNS	O	datum	prep_of	23	SENT_254	[p20l1556t18r1679b74],
27	,	,	O	,	_	0	SENT_254	[p20l1556t18r1679b74],
28	in	IN	O	in	_	0	SENT_254	[p20l1700t21r1754b66],
29	writing	VBG	O	write	prepc_in	23	SENT_254	[p20l1771t21r1967b82],
30	the	DT	O	the	det	31	SENT_254	[p20l6t104r90b153],
31	report	NN	O	report	dobj	29	SENT_254	[p20l109t114r286b168],
32	,	,	O	,	_	0	SENT_254	[p20l109t114r286b168],
33	and	CC	O	and	_	0	SENT_254	[p20l308t104r408b153],
34	in	IN	O	in	_	0	SENT_254	[p20l425t107r479b152],
35	the	DT	O	the	det	36	SENT_254	[p20l496t104r580b153],
36	decision	NN	O	decision	conj_and	23	SENT_254	[p20l600t104r823b153],
37	to	TO	O	to	aux	38	SENT_254	[p20l841t114r891b153],
38	submit	VB	O	submit	infmod	36	SENT_254	[p20l912t104r1102b153],
39	the	DT	O	the	det	40	SENT_254	[p20l1118t104r1203b153],
40	report	NN	O	report	dobj	38	SENT_254	[p20l1221t114r1398b168],
41	.	.	O	.	_	0	SENT_254	[p20l1221t114r1398b168],

1	RL	NN	O	rl	nsubj	2	SENT_255	[p20l1422t108r1495b152],
2	completed	VBD	O	complete	_	0	SENT_255	[p20l1513t104r1794b168],
3	the	DT	O	the	det	5	SENT_255	[p20l1811t104r1895b153],
4	statistical	JJ	O	statistical	amod	5	SENT_255	[p20l9t191r258b240],
5	analysis	NN	O	analysis	dobj	2	SENT_255	[p20l278t191r488b255],
6	of	IN	O	of	_	0	SENT_255	[p20l509t191r569b240],
7	the	DT	O	the	det	8	SENT_255	[p20l578t191r661b240],
8	studies	NNS	O	study	prep_of	5	SENT_255	[p20l682t191r885b247],
9	,	,	O	,	_	0	SENT_255	[p20l682t191r885b247],
10	including	VBG	O	include	_	0	SENT_255	[p20l906t191r1165b255],
11	the	DT	O	the	det	12	SENT_255	[p20l1183t191r1267b240],
12	production	NN	O	production	prep_including	2	SENT_255	[p20l1286t191r1583b254],
13	of	IN	O	of	_	0	SENT_255	[p20l1602t191r1661b240],
14	tables	NNS	O	table	prep_of	12	SENT_255	[p20l1670t191r1824b240],
15	and	CC	O	and	_	0	SENT_255	[p20l1845t191r1944b240],
16	ﬁgures	NNS	O	ﬁgures	prep_of	12	SENT_255	[p20l7t277r207b341],
17	.	.	O	.	_	0	SENT_255	[p20l7t277r207b341],

1	HA	NNP	O	HA	nsubj	4	SENT_256	[p20l231t280r325b325],
2	and	CC	O	and	_	0	SENT_256	[p20l343t277r443b325],
3	MG	NN	O	mg	conj_and	1	SENT_256	[p20l462t280r563b326],
4	participated	VBD	O	participate	_	0	SENT_256	[p20l583t277r902b340],
5	in	IN	O	in	_	0	SENT_256	[p20l920t280r974b325],
6	the	DT	O	the	det	7	SENT_256	[p20l991t277r1075b326],
7	decision	NN	O	decision	prep_in	4	SENT_256	[p20l1095t277r1318b326],
8	to	TO	O	to	aux	9	SENT_256	[p20l1336t287r1386b325],
9	obtain	VB	O	obtain	xcomp	4	SENT_256	[p20l1406t277r1574b325],
10	genetic	JJ	O	genetic	amod	11	SENT_256	[p20l1594t280r1786b341],
11	samples	NNS	O	sample	dobj	9	SENT_256	[p20l9t363r226b427],
12	in	IN	O	in	_	0	SENT_256	[p20l247t366r300b411],
13	the	DT	O	the	det	15	SENT_256	[p20l318t363r402b412],
14	two	CD	NUMBER	two	num	15	SENT_256	[p20l420t373r516b412],
15	studies	NNS	O	study	prep_in	9	SENT_256	[p20l537t363r724b412],
16	and	CC	O	and	_	0	SENT_256	[p20l745t363r844b412],
17	in	IN	O	in	_	0	SENT_256	[p20l862t366r916b411],
18	the	DT	O	the	det	19	SENT_256	[p20l933t363r1017b412],
19	design	NN	O	design	prep_in	9	SENT_256	[p20l1037t363r1215b427],
20	of	IN	O	of	_	0	SENT_256	[p20l1234t363r1293b412],
21	the	DT	O	the	det	23	SENT_256	[p20l1302t363r1386b412],
22	pharmacogenetic	JJ	O	pharmacogenetic	amod	23	SENT_256	[p20l1405t363r1871b427],
23	studies	NNS	O	study	prep_of	19	SENT_256	[p20l9t449r211b498],
24	.	.	O	.	_	0	SENT_256	[p20l9t449r211b498],

1	All	DT	O	all	det	2	SENT_257	[p20l232t449r309b497],
2	authors	NNS	O	author	nsubj	36	SENT_257	[p20l328t449r530b498],
3	had	VBD	O	have	_	0	SENT_257	[p20l550t449r650b498],
4	full	JJ	O	full	amod	5	SENT_257	[p20l667t449r758b498],
5	access	NN	O	access	dobj	3	SENT_257	[p20l777t467r941b498],
6	to	TO	O	to	_	0	SENT_257	[p20l961t459r1011b498],
7	the	DT	O	the	det	9	SENT_257	[p20l1029t449r1113b498],
8	original	JJ	O	original	amod	9	SENT_257	[p20l1133t449r1341b514],
9	data	NNS	O	datum	prep_to	5	SENT_257	[p20l1360t449r1484b505],
10	,	,	O	,	_	0	SENT_257	[p20l1360t449r1484b505],
11	reviewed	VBN	O	review	partmod	9	SENT_257	[p20l1505t449r1744b498],
12	the	DT	O	the	det	14	SENT_257	[p20l1761t449r1845b498],
13	data	NN	O	datum	nn	14	SENT_257	[p20l1865t449r1975b498],
14	analyses	NNS	O	analysis	dobj	11	SENT_257	[p20l8t535r246b599],
15	,	,	O	,	_	0	SENT_257	[p20l8t535r246b599],
16	contributed	VBD	O	contribute	conj_and	3	SENT_257	[p20l268t535r580b584],
17	to	TO	O	to	_	0	SENT_257	[p20l597t545r647b584],
18	the	DT	O	the	det	19	SENT_257	[p20l665t535r749b584],
19	writing	NN	O	writing	prep_to	16	SENT_257	[p20l767t539r963b600],
20	of	IN	O	of	_	0	SENT_257	[p20l982t535r1041b584],
21	the	DT	O	the	det	22	SENT_257	[p20l1049t535r1134b584],
22	report	NN	O	report	prep_of	19	SENT_257	[p20l1153t545r1330b599],
23	,	,	O	,	_	0	SENT_257	[p20l1153t545r1330b599],
24	and	CC	O	and	_	0	SENT_257	[p20l1351t535r1451b584],
25	made	VBD	O	make	conj_and	3	SENT_257	[p20l1469t535r1617b584],
26	ﬁnal	JJ	O	ﬁnal	amod	27	SENT_257	[p20l1636t535r1756b584],
27	decisions	NNS	O	decision	dobj	25	SENT_257	[p20l8t621r257b671],
28	on	IN	O	on	_	0	SENT_257	[p20l278t639r345b671],
29	all	DT	O	all	det	30	SENT_257	[p20l364t621r426b671],
30	aspects	NNS	O	aspect	prep_on	25	SENT_257	[p20l444t631r636b686],
31	of	IN	O	of	_	0	SENT_257	[p20l656t621r716b671],
32	the	DT	O	the	det	33	SENT_257	[p20l725t621r809b671],
33	report	NN	O	report	prep_of	30	SENT_257	[p20l828t631r1005b686],
34	,	,	O	,	_	0	SENT_257	[p20l828t631r1005b686],
35	and	CC	O	and	_	0	SENT_257	[p20l1026t621r1126b671],
36	approved	VBD	O	approve	conj_and	3	SENT_257	[p20l1145t621r1392b686],
37	the	DT	O	the	det	39	SENT_257	[p20l1408t621r1492b671],
38	ﬁnal	JJ	O	ﬁnal	amod	39	SENT_257	[p20l1511t621r1631b671],
39	version	NN	O	version	dobj	36	SENT_257	[p20l1649t625r1847b671],
40	of	IN	O	of	_	0	SENT_257	[p20l1865t621r1925b671],
41	the	DT	O	the	det	43	SENT_257	[p20l6t708r90b757],
42	submitted	VBN	O	submit	amod	43	SENT_257	[p20l111t708r385b757],
43	report	NN	O	report	prep_of	39	SENT_257	[p20l402t718r579b772],
44	.	.	O	.	_	0	SENT_257	[p20l402t718r579b772],

1	Conﬂict	NN	O	conﬂict	nsubj	35	SENT_258	[p20l8t829r209b877],
2	of	IN	O	of	_	0	SENT_258	[p20l223t829r279b877],
3	interest	NN	O	interest	nn	5	SENT_258	[p20l292t831r493b877],
4	statement	NN	O	statement	nn	5	SENT_258	[p20l508t837r780b877],
5	ERB	NNP	O	ERB	prep_of	1	SENT_258	[p20l10t912r123b957],
6	has	VBZ	O	have	aux	7	SENT_258	[p20l143t909r234b958],
7	received	VBN	O	receive	_	0	SENT_258	[p20l254t909r476b958],
8	grant	NN	O	grant	nn	9	SENT_258	[p20l494t919r636b974],
9	support	NN	O	support	dobj	7	SENT_258	[p20l655t919r863b973],
10	to	TO	O	to	aux	11	SENT_258	[p20l879t919r929b958],
11	perform	VB	O	perform	xcomp	7	SENT_258	[p20l948t909r1171b973],
12	clinical	JJ	O	clinical	amod	13	SENT_258	[p20l1189t909r1381b958],
13	trials	NNS	O	trial	dobj	11	SENT_258	[p20l1398t909r1531b958],
14	from	IN	O	from	_	0	SENT_258	[p20l1551t909r1684b958],
15	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_from	11	SENT_258	[p20l6t992r346b1039],
16	and	CC	O	and	_	0	SENT_258	[p20l365t989r464b1039],
17	GlaxoSmithI	NNP	O	GlaxoSmithI	prep_from	11	SENT_258	[p20l483t989r963b1046],
18	<	JJR	O	<	amod	19	SENT_258	[p20l483t989r963b1046],
19	line	NN	O	line	dep	15	SENT_258	[p20l483t989r963b1046],
20	,	,	O	,	_	0	SENT_258	[p20l483t989r963b1046],
21	has	VBZ	O	have	aux	22	SENT_258	[p20l983t989r1073b1039],
22	served	VBN	O	serve	dep	7	SENT_258	[p20l1095t989r1267b1039],
23	as	IN	O	as	_	0	SENT_258	[p20l1285t1007r1337b1039],
24	a	DT	O	a	det	25	SENT_258	[p20l1358t1007r1385b1039],
25	consultant	NN	O	consultant	prep_as	22	SENT_258	[p20l1404t989r1687b1039],
26	with	IN	O	with	_	0	SENT_258	[p20l1703t989r1822b1039],
27	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_with	25	SENT_258	[p20l6t1072r346b1119],
28	and	CC	O	and	_	0	SENT_258	[p20l365t1069r464b1118],
29	GlaxoSmithI	NNP	O	GlaxoSmithI	prep_with	25	SENT_258	[p20l484t1069r963b1126],
30	<	JJR	O	<	amod	31	SENT_258	[p20l484t1069r963b1126],
31	line	NN	O	line	dobj	7	SENT_258	[p20l484t1069r963b1126],
32	,	,	O	,	_	0	SENT_258	[p20l484t1069r963b1126],
33	and	CC	O	and	_	0	SENT_258	[p20l984t1069r1084b1118],
34	has	VBZ	O	have	aux	35	SENT_258	[p20l1101t1069r1191b1118],
35	presented	VBN	O	present	conj_and	7	SENT_258	[p20l1211t1069r1477b1134],
36	CME	NNP	ORGANIZATION	CME	nsubj	39	SENT_258	[p20l1497t1072r1629b1118],
37	and	CC	O	and	_	0	SENT_258	[p20l1651t1069r1750b1118],
38	other	JJ	O	other	conj_and	36	SENT_258	[p20l1769t1069r1910b1118],
39	lectures	VBZ	O	lecture	ccomp	35	SENT_258	[p20l6t1150r216b1200],
40	sponsored	VBN	O	sponsor	dep	39	SENT_258	[p20l238t1150r516b1215],
41	by	IN	O	by	_	0	SENT_258	[p20l532t1150r596b1215],
42	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_by	40	SENT_258	[p20l611t1154r951b1200],
43	and	CC	O	and	_	0	SENT_258	[p20l970t1150r1070b1200],
44	GlaxoSmithKline	NNP	ORGANIZATION	GlaxoSmithKline	prep_by	40	SENT_258	[p20l1089t1150r1567b1200],
45	.	.	O	.	_	0	SENT_258	[p20l1089t1150r1567b1200],

1	DAM	NN	O	dam	nsubj	3	SENT_259	[p20l1599t1154r1740b1199],
2	has	VBZ	O	have	aux	3	SENT_259	[p20l1761t1150r1851b1200],
3	received	VBN	O	receive	_	0	SENT_259	[p20l7t1230r229b1279],
4	grant	NN	O	grant	nn	5	SENT_259	[p20l248t1240r389b1294],
5	funding	NN	O	funding	dobj	3	SENT_259	[p20l407t1230r623b1294],
6	from	IN	O	from	_	0	SENT_259	[p20l641t1230r774b1279],
7	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_from	3	SENT_259	[p20l792t1233r1131b1279],
8	for	IN	O	for	_	0	SENT_259	[p20l1149t1230r1226b1279],
9	directing	VBG	O	direct	prepc_for	3	SENT_259	[p20l1245t1230r1485b1294],
10	a	DT	O	a	det	13	SENT_259	[p20l1503t1248r1530b1279],
11	2-day	JJ	DURATION	2-day	amod	13	SENT_259	[p20l1550t1230r1691b1294],
12	postgraduate	NN	O	postgraduate	nn	13	SENT_259	[p20l7t1310r356b1374],
13	course	NN	O	course	dobj	9	SENT_259	[p20l375t1327r550b1359],
14	on	IN	O	on	_	0	SENT_259	[p20l571t1328r638b1359],
15	human	JJ	O	human	amod	16	SENT_259	[p20l655t1310r852b1359],
16	genetics	NNS	O	genetics	prep_on	9	SENT_259	[p20l872t1313r1089b1374],
17	and	CC	O	and	_	0	SENT_259	[p20l1110t1310r1210b1359],
18	pharmacogenetics	NNS	O	pharmacogenetic	prep_on	9	SENT_259	[p20l1227t1310r1719b1374],
19	in	IN	O	in	_	0	SENT_259	[p20l1739t1313r1793b1358],
20	2006	CD	DATE	2006	prep_in	16	SENT_259	[p20l1813t1314r1938b1359],
21	and	CC	DATE	and	_	0	SENT_259	[p20l8t1391r107b1440],
22	2007	CD	DATE	2007	prep_in	16	SENT_259	[p20l127t1394r250b1442],
23	.	.	O	.	_	0	SENT_259	[p20l127t1394r250b1442],

1	DSP	NNP	ORGANIZATION	DSP	nsubj	3	SENT_260	[p20l274t1394r390b1440],
2	has	VBZ	O	have	aux	3	SENT_260	[p20l409t1391r500b1440],
3	received	VBN	O	receive	_	0	SENT_260	[p20l520t1391r742b1440],
4	research	NN	O	research	nn	5	SENT_260	[p20l759t1391r987b1440],
5	funding	NN	O	funding	dobj	3	SENT_260	[p20l1005t1391r1222b1455],
6	from	IN	O	from	_	0	SENT_260	[p20l1240t1391r1373b1440],
7	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_from	3	SENT_260	[p20l1390t1394r1743b1440],
8	.	.	O	.	_	0	SENT_260	[p20l1390t1394r1743b1440],

1	RL	NN	O	rl	nsubj	8	SENT_261	[p20l1767t1396r1852b1447],
2	,	,	O	,	_	0	SENT_261	[p20l1767t1396r1852b1447],
3	HA	NNP	LOCATION	HA	conj_and	1	SENT_261	[p20l1876t1394r1982b1447],
4	,	,	O	,	_	0	SENT_261	[p20l1876t1394r1982b1447],
5	and	CC	O	and	_	0	SENT_261	[p20l8t1471r107b1520],
6	MG	NN	O	mg	conj_and	1	SENT_261	[p20l127t1474r228b1520],
7	are	VBP	O	be	cop	8	SENT_261	[p20l249t1488r329b1520],
8	employees	NNS	O	employee	_	0	SENT_261	[p20l349t1471r631b1535],
9	of	IN	O	of	_	0	SENT_261	[p20l652t1471r712b1520],
10	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_of	8	SENT_261	[p20l721t1474r1060b1520],
11	and	CC	O	and	_	0	SENT_261	[p20l1079t1471r1178b1520],
12	hold	VB	O	hold	dep	13	SENT_261	[p20l1195t1471r1316b1520],
13	stock	NN	O	stock	conj_and	8	SENT_261	[p20l1336t1471r1473b1520],
14	in	IN	O	in	_	0	SENT_261	[p20l1490t1474r1544b1519],
15	the	DT	O	the	det	16	SENT_261	[p20l1561t1471r1645b1520],
16	company	NN	O	company	prep_in	13	SENT_261	[p20l1665t1488r1918b1535],
17	.	.	O	.	_	0	SENT_261	[p20l1665t1488r1918b1535],

1	All	PDT	O	all	predet	4	SENT_262	[p20l6t1551r83b1599],
2	the	DT	O	the	det	4	SENT_262	[p20l101t1551r185b1600],
3	pharmaceutical	JJ	O	pharmaceutical	amod	4	SENT_262	[p20l203t1551r621b1614],
4	industry	NN	O	industry	_	0	SENT_262	[p20l639t1551r865b1615],
5	grant	NN	O	grant	nn	6	SENT_262	[p20l883t1561r1025b1615],
6	support	NN	O	support	nsubjpass	8	SENT_262	[p20l1044t1561r1252b1614],
7	was	VBD	O	be	auxpass	8	SENT_262	[p20l1267t1568r1367b1600],
8	administered	VBN	O	administer	rcmod	4	SENT_262	[p20l1388t1551r1747b1600],
9	through	IN	O	through	_	0	SENT_262	[p20l1763t1551r1982b1615],
10	their	PRP$	O	they	poss	12	SENT_262	[p20l6t1632r135b1681],
11	respective	JJ	O	respective	amod	12	SENT_262	[p20l152t1635r419b1696],
12	University	NNP	O	University	prep_through	8	SENT_262	[p20l441t1635r743b1696],
13	/	:	O	/	punct	4	SENT_262	[p20l441t1635r743b1696],
14	Medical	NNP	O	Medical	nn	15	SENT_262	[p20l750t1632r960b1681],
15	Centers	NNPS	O	Centers	nsubjpass	25	SENT_262	[p20l980t1635r1184b1681],
16	for	IN	O	for	_	0	SENT_262	[p20l1204t1632r1281b1681],
17	the	DT	O	the	det	19	SENT_262	[p20l1298t1632r1382b1681],
18	above	JJ	O	above	amod	19	SENT_262	[p20l1401t1632r1553b1681],
19	authors	NNS	O	author	prep_for	15	SENT_262	[p20l1572t1632r1774b1681],
20	and	CC	O	and	_	0	SENT_262	[p20l1795t1632r1895b1681],
21	no	DT	O	no	det	23	SENT_262	[p20l1913t1650r1980b1681],
22	ﬁnancial	JJ	O	ﬁnancial	amod	23	SENT_262	[p20l7t1712r240b1761],
23	support	NN	O	support	conj_and	19	SENT_262	[p20l261t1722r468b1775],
24	was	VBD	O	be	auxpass	25	SENT_262	[p20l484t1729r584b1761],
25	received	VBN	O	receive	dep	4	SENT_262	[p20l604t1712r826b1761],
26	by	IN	O	by	_	0	SENT_262	[p20l843t1712r905b1776],
27	any	DT	O	any	agent	25	SENT_262	[p20l923t1729r1017b1776],
28	of	IN	O	of	_	0	SENT_262	[p20l1035t1712r1095b1760],
29	the	DT	O	the	det	30	SENT_262	[p20l1104t1712r1187b1761],
30	authors	NNS	O	author	prep_of	27	SENT_262	[p20l1207t1712r1409b1761],
31	for	IN	O	for	_	0	SENT_262	[p20l1430t1712r1507b1760],
32	the	DT	O	the	det	33	SENT_262	[p20l1523t1712r1607b1761],
33	studies	NNS	O	study	prep_for	25	SENT_262	[p20l1628t1712r1815b1761],
34	presented	VBN	O	present	partmod	33	SENT_262	[p20l7t1792r273b1855],
35	in	IN	O	in	_	0	SENT_262	[p20l291t1795r345b1840],
36	this	DT	O	this	det	37	SENT_262	[p20l362t1792r460b1841],
37	report	NN	O	report	prep_in	34	SENT_262	[p20l481t1801r657b1855],
38	.	.	O	.	_	0	SENT_262	[p20l481t1801r657b1855],

1	Acknowledgments	NNS	O	acknowledgment	nsubjpass	8	SENT_263	[p20l7t1913r498b1974],
2	The	DT	O	the	det	4	SENT_263	[p20l6t2009r110b2058],
3	clinical	JJ	O	clinical	amod	4	SENT_263	[p20l129t2009r320b2058],
4	studies	NNS	O	study	dep	1	SENT_263	[p20l341t2009r528b2058],
5	presented	VBN	O	present	partmod	1	SENT_263	[p20l549t2009r814b2072],
6	here	RB	O	here	advmod	5	SENT_263	[p20l831t2009r950b2058],
7	were	VBD	O	be	auxpass	8	SENT_263	[p20l968t2026r1096b2058],
8	sponsored	VBN	O	sponsor	_	0	SENT_263	[p20l1117t2009r1395b2072],
9	by	IN	O	by	_	0	SENT_263	[p20l1411t2009r1475b2073],
10	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	agent	8	SENT_263	[p20l1490t2012r1843b2058],
11	.	.	O	.	_	0	SENT_263	[p20l1490t2012r1843b2058],

1	We	PRP	O	we	nsubj	2	SENT_264	[p20l1864t2013r1949b2058],
2	thank	VBP	O	thank	_	0	SENT_264	[p20l6t2090r163b2139],
3	Ieni	NNP	PERSON	Ieni	nn	4	SENT_264	[p20l181t2093r285b2152],
4	Fagan	NNP	PERSON	Fagan	dobj	2	SENT_264	[p20l306t2093r463b2154],
5	(	CD	NUMBER	(	num	8	SENT_264	[p20l485t2090r765b2154],
6	MediTech	NNP	ORGANIZATION	MediTech	nn	8	SENT_264	[p20l485t2090r765b2154],
7	Media	NNP	ORGANIZATION	Media	nn	8	SENT_264	[p20l786t2090r951b2139],
8	Ltd	NNP	ORGANIZATION	Ltd	dep	4	SENT_264	[p20l972t2090r1066b2146],
9	,	,	O	,	_	0	SENT_264	[p20l972t2090r1066b2146],
10	UK	NNP	LOCATION	UK	nn	11	SENT_264	[p20l1090t2094r1194b2154],
11	)	NNP	O	)	appos	4	SENT_264	[p20l1090t2094r1194b2154],
12	who	WP	O	who	nsubj	13	SENT_264	[p20l1215t2090r1328b2139],
13	provided	VBD	O	provide	rcmod	11	SENT_264	[p20l1348t2090r1584b2153],
14	editorial	NN	O	editorial	nn	15	SENT_264	[p20l1602t2090r1824b2139],
15	support	NN	O	support	dobj	13	SENT_264	[p20l9t2180r216b2234],
16	on	IN	O	on	_	0	SENT_264	[p20l234t2188r302b2220],
17	behalf	NN	O	behalf	_	0	SENT_264	[p20l319t2170r496b2220],
18	of	IN	O	of	_	0	SENT_264	[p20l506t2170r566b2220],
19	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_on_behalf_of	13	SENT_264	[p20l574t2173r926b2220],
20	.	.	O	.	_	0	SENT_264	[p20l574t2173r926b2220],

1	References	NNS	O	reference	_	0	SENT_265	[p20l10t2291r285b2339],
2	1	CD	NUMBER	1	num	4	SENT_265	[p20l9t2368r31b2412],
3	O’Byrne	NN	O	o’byrne	nn	4	SENT_265	[p20l140t2368r358b2428],
4	PM	NN	O	pm	dep	1	SENT_265	[p20l381t2368r486b2420],
5	,	,	O	,	_	0	SENT_265	[p20l381t2368r486b2420],
6	Bisgaard	NNP	ORGANIZATION	Bisgaard	nn	7	SENT_265	[p20l510t2364r742b2428],
7	H	NNP	ORGANIZATION	H	appos	4	SENT_265	[p20l762t2368r825b2419],
8	,	,	O	,	_	0	SENT_265	[p20l762t2368r825b2419],
9	Godard	NNP	PERSON	Godard	nn	10	SENT_265	[p20l848t2364r1047b2413],
10	PP	NNP	O	PP	appos	4	SENT_265	[p20l1067t2368r1154b2420],
11	,	,	O	,	_	0	SENT_265	[p20l1067t2368r1154b2420],
12	et	FW	O	et	nn	13	SENT_265	[p20l1176t2374r1223b2412],
13	al.	FW	O	al.	appos	4	SENT_265	[p20l1241t2364r1298b2412],
14	.	.	O	.	_	0	SENT_265	[p20l1241t2364r1298b2412],

1	Budesonide/formoterol	NNP	O	Budesonide/formoterol	nn	3	SENT_266	[p20l1322t2364r1956b2427],
2	combination	NN	O	combination	nn	3	SENT_266	[p20l139t2436r481b2485],
3	therapy	NN	O	therapy	_	0	SENT_266	[p20l499t2436r702b2500],
4	as	IN	O	as	_	0	SENT_266	[p20l720t2454r772b2485],
5	both	DT	O	both	preconj	9	SENT_266	[p20l792t2436r913b2485],
6	maintenance	NN	O	maintenance	nn	9	SENT_266	[p20l931t2440r1283b2485],
7	and	CC	O	and	_	0	SENT_266	[p20l1303t2436r1402b2485],
8	reliever	NN	O	reliever	nn	9	SENT_266	[p20l1420t2436r1621b2485],
9	medication	NN	O	medication	prep_as	3	SENT_266	[p20l1639t2436r1942b2485],
10	in	IN	O	in	_	0	SENT_266	[p20l138t2513r192b2558],
11	asthma	NN	O	asthma	prep_in	3	SENT_266	[p20l211t2510r421b2559],
12	.	.	O	.	_	0	SENT_266	[p20l211t2510r421b2559],

1	Am	VBP	O	be	cop	2	SENT_267	[p20l441t2513r579b2574],
2	]	CD	NUMBER	]	dep	6	SENT_267	[p20l441t2513r579b2574],
3	Respir	NNP	O	Respir	nn	5	SENT_267	[p20l599t2512r758b2574],
4	Crit	NNP	O	Crit	nn	5	SENT_267	[p20l776t2512r871b2559],
5	Care	NNP	O	Care	nsubj	6	SENT_267	[p20l893t2513r1008b2559],
6	Med	VBD	O	med	_	0	SENT_267	[p20l1027t2510r1137b2559],
7	2005	CD	DATE	2005	dobj	6	SENT_267	[p20l1156t2513r1295b2566],
8	;	:	O	;	_	0	SENT_267	[p20l1156t2513r1295b2566],
9	171	CD	NUMBER	171	num	11	SENT_267	[p20l1318t2513r1416b2560],
10	:	:	O	:	_	0	SENT_267	[p20l1318t2513r1416b2560],
11	129-36	CD	NUMBER	129-36	dep	7	SENT_267	[p20l1438t2514r1636b2559],
12	.	.	O	.	_	0	SENT_267	[p20l1438t2514r1636b2559],

1	2	CD	NUMBER	2	_	0	SENT_268	[p20l9t2597r35b2641],
2	Lemanske	NNP	O	Lemanske	nn	4	SENT_268	[p20l141t2593r414b2641],
3	RF	NNP	O	RF	nn	4	SENT_268	[p20l436t2596r508b2641],
4	Ir	NNP	O	Ir	dep	1	SENT_268	[p20l530t2597r582b2655],
5	,	,	O	,	_	0	SENT_268	[p20l530t2597r582b2655],
6	Sorkness	NNP	ORGANIZATION	Sorkness	nn	7	SENT_268	[p20l608t2593r846b2641],
7	CA	NNP	ORGANIZATION	CA	appos	4	SENT_268	[p20l869t2596r965b2648],
8	,	,	O	,	_	0	SENT_268	[p20l869t2596r965b2648],
9	Mauger	NNP	PERSON	Mauger	nn	10	SENT_268	[p20l988t2597r1195b2657],
10	EA	NN	PERSON	ea	appos	4	SENT_268	[p20l1216t2596r1305b2649],
11	,	,	O	,	_	0	SENT_268	[p20l1216t2596r1305b2649],
12	et	FW	O	et	nn	13	SENT_268	[p20l1327t2603r1374b2641],
13	al.	FW	O	al.	appos	4	SENT_268	[p20l1392t2593r1449b2641],
14	.	.	O	.	_	0	SENT_268	[p20l1392t2593r1449b2641],

1	Inhaled	VBN	O	inhale	dep	14	SENT_269	[p20l1473t2593r1679b2641],
2	corticosteroid	NN	O	corticosteroid	nn	3	SENT_269	[p20l139t2665r506b2714],
3	reduction	NN	O	reduction	dobj	1	SENT_269	[p20l524t2665r783b2714],
4	and	CC	O	and	_	0	SENT_269	[p20l802t2665r902b2714],
5	elimination	NN	O	elimination	dobj	1	SENT_269	[p20l920t2665r1233b2714],
6	in	IN	O	in	_	0	SENT_269	[p20l1251t2668r1305b2713],
7	patients	NNS	O	patient	prep_in	3	SENT_269	[p20l1323t2668r1536b2729],
8	with	IN	O	with	_	0	SENT_269	[p20l1554t2665r1674b2714],
9	persistent	JJ	O	persistent	amod	10	SENT_269	[p20l1692t2668r1959b2729],
10	asthma	NN	O	asthma	prep_with	1	SENT_269	[p20l139t2739r336b2788],
11	receiving	VBG	O	receive	partmod	10	SENT_269	[p20l354t2742r600b2803],
12	salmeterol	NN	O	salmeterol	dobj	11	SENT_269	[p20l620t2739r914b2788],
13	:	:	O	:	_	0	SENT_269	[p20l620t2739r914b2788],
14	a	DT	O	a	_	0	SENT_269	[p20l936t2756r963b2788],
15	randomized	VBN	O	randomize	partmod	14	SENT_269	[p20l981t2739r1308b2788],
16	controlled	JJ	O	controlled	amod	17	SENT_269	[p20l1327t2739r1598b2788],
17	trial	NN	O	trial	dobj	15	SENT_269	[p20l1615t2739r1736b2788],
18	.	.	O	.	_	0	SENT_269	[p20l1615t2739r1736b2788],

1	JAMA	NNP	O	JAMA	_	0	SENT_270	[p20l1750t2742r1926b2803],
2	2001	CD	DATE	2001	num	1	SENT_270	[p20l140t2815r273b2867],
3	;	:	O	;	_	0	SENT_270	[p20l140t2815r273b2867],
4	285	CD	NUMBER	285	num	6	SENT_270	[p20l296t2814r403b2860],
5	:	:	O	:	_	0	SENT_270	[p20l296t2814r403b2860],
6	2594-603	CD	NUMBER	2594-603	dep	1	SENT_270	[p20l425t2814r690b2860],
7	.	.	O	.	_	0	SENT_270	[p20l425t2814r690b2860],

1	3	CD	NUMBER	3	num	3	SENT_271	[p20l10t2900r34b2944],
2	Pauwels	NNP	ORGANIZATION	Pauwels	nn	3	SENT_271	[p20l141t2895r358b2944],
3	RA	NN	ORGANIZATION	ra	_	0	SENT_271	[p20l381t2898r475b2952],
4	,	,	O	,	_	0	SENT_271	[p20l381t2898r475b2952],
5	Lofdahl	NNP	PERSON	Lofdahl	nn	6	SENT_271	[p20l499t2895r700b2944],
6	CG	NNP	O	CG	appos	3	SENT_271	[p20l721t2898r821b2952],
7	,	,	O	,	_	0	SENT_271	[p20l721t2898r821b2952],
8	Postma	NNP	PERSON	Postma	nn	9	SENT_271	[p20l845t2900r1043b2944],
9	DS	NN	O	d	appos	3	SENT_271	[p20l1064t2898r1157b2952],
10	,	,	O	,	_	0	SENT_271	[p20l1064t2898r1157b2952],
11	et	FW	O	et	nn	12	SENT_271	[p20l1179t2905r1226b2944],
12	al.	FW	O	al.	appos	3	SENT_271	[p20l1245t2895r1301b2944],
13	.	.	O	.	_	0	SENT_271	[p20l1245t2895r1301b2944],

1	Effect	NN	O	effect	nsubj	3	SENT_272	[p20l1326t2895r1477b2944],
2	of	IN	O	of	prep	1	SENT_272	[p20l1495t2895r1555b2944],
3	inhaled	VBN	O	inhale	_	0	SENT_272	[p20l1564t2895r1767b2944],
4	formoterol	NN	O	formoterol	dobj	3	SENT_272	[p20l138t2968r428b3017],
5	and	CC	O	and	_	0	SENT_272	[p20l447t2968r546b3017],
6	budesonide	NN	O	budesonide	dobj	3	SENT_272	[p20l563t2968r876b3017],
7	on	IN	O	on	_	0	SENT_272	[p20l896t2985r964b3017],
8	exacerbations	NNS	O	exacerbation	prep_on	3	SENT_272	[p20l983t2968r1347b3017],
9	of	IN	O	of	_	0	SENT_272	[p20l1368t2968r1427b3017],
10	asthma	NN	O	asthma	prep_of	8	SENT_272	[p20l1438t2968r1647b3017],
11	.	.	O	.	_	0	SENT_272	[p20l1438t2968r1647b3017],

1	Formoterol	NNP	O	Formoterol	_	0	SENT_273	[p20l1672t2968r1972b3017],
2	and	CC	O	and	_	0	SENT_273	[p20l139t3041r238b3090],
3	Corticosteroids	NNS	O	corticosteroid	conj_and	1	SENT_273	[p20l258t3041r662b3090],
4	Establishing	VBG	O	establish	partmod	1	SENT_273	[p20l685t3041r1017b3106],
5	Therapy	NN	O	therapy	dobj	4	SENT_273	[p20l1034t3041r1257b3105],
6	(	CD	NUMBER	(	num	5	SENT_273	[p20l1278t3044r1508b3106],
7	FACET	NNP	O	FACET	nn	11	SENT_273	[p20l1278t3044r1508b3106],
8	)	NNP	O	)	nn	11	SENT_273	[p20l1278t3044r1508b3106],
9	International	NNP	O	International	nn	11	SENT_273	[p20l1533t3041r1886b3090],
10	Study	NNP	O	Study	nn	11	SENT_273	[p20l142t3115r293b3179],
11	Group	NNP	O	Group	dep	5	SENT_273	[p20l312t3118r497b3179],
12	.	.	O	.	_	0	SENT_273	[p20l312t3118r497b3179],

1	N	NN	O	n	nn	3	SENT_274	[p20l521t3120r568b3164],
2	Engl	NNP	O	Engl	nn	3	SENT_274	[p20l586t3115r696b3179],
3	]	NNP	O	]	nsubj	4	SENT_274	[p20l706t3120r739b3179],
4	Med	VBD	O	med	_	0	SENT_274	[p20l756t3115r866b3164],
5	1997	CD	DATE	1997	dobj	4	SENT_274	[p20l885t3118r1013b3171],
6	;	:	O	;	_	0	SENT_274	[p20l885t3118r1013b3171],
7	337	CD	NUMBER	337	num	9	SENT_274	[p20l1036t3118r1143b3165],
8	:	:	O	:	_	0	SENT_274	[p20l1036t3118r1143b3165],
9	1405-11	CD	DATE	1405-11	dep	5	SENT_274	[p20l1166t3118r1380b3164],
10	.	.	O	.	_	0	SENT_274	[p20l1166t3118r1380b3164],

1	4	CD	NUMBER	4	_	0	SENT_275	[p20l6t3202r37b3246],
2	British	JJ	O	british	amod	4	SENT_275	[p20l141t3197r321b3247],
3	Thoracic	NNP	ORGANIZATION	Thoracic	nn	4	SENT_275	[p20l339t3197r574b3247],
4	Society	NNP	ORGANIZATION	Society	dep	1	SENT_275	[p20l596t3201r783b3262],
5	and	CC	O	and	_	0	SENT_275	[p20l801t3197r901b3247],
6	Scottish	NNP	O	Scottish	nn	7	SENT_275	[p20l922t3197r1134b3247],
7	Intercollegiate	NNP	O	Intercollegiate	conj_and	4	SENT_275	[p20l1155t3197r1539b3263],
8	Guidelines	NNS	O	guideline	dep	1	SENT_275	[p20l1560t3197r1851b3247],

1	Network	NNP	O	Network	_	0	SENT_276	[p20l140t3271r380b3320],
2	.	.	O	.	_	0	SENT_276	[p20l140t3271r380b3320],

1	British	JJ	O	british	amod	2	SENT_277	[p20l405t3271r585b3320],
2	Guideline	NN	O	guideline	_	0	SENT_277	[p20l605t3271r869b3320],
3	on	IN	O	on	_	0	SENT_277	[p20l889t3289r956b3320],
4	the	DT	O	the	det	5	SENT_277	[p20l974t3271r1058b3320],
5	Management	NN	O	management	prep_on	2	SENT_277	[p20l1079t3276r1436b3335],
6	of	IN	O	of	_	0	SENT_277	[p20l1454t3271r1515b3320],
7	Asthma	NNP	O	Asthma	prep_of	2	SENT_277	[p20l1522t3271r1749b3327],
8	,	,	O	,	_	0	SENT_277	[p20l1522t3271r1749b3327],
9	a	DT	O	a	det	12	SENT_277	[p20l1770t3289r1797b3320],
10	national	JJ	O	national	amod	12	SENT_277	[p20l138t3345r358b3394],
11	clinical	JJ	O	clinical	amod	12	SENT_277	[p20l377t3345r568b3394],
12	guideline	NN	O	guideline	appos	7	SENT_277	[p20l588t3345r853b3409],
13	.	.	O	.	_	0	SENT_277	[p20l588t3345r853b3409],

1	http	NN	O	http	_	0	SENT_278	[p20l873t3345r995b3408],
2	:	:	O	:	_	0	SENT_278	[p20l873t3345r995b3408],
3	/	:	O	/	punct	1	SENT_278	[p20l1003t3345r1747b3409],
4	/	:	O	/	punct	1	SENT_278	[p20l1003t3345r1747b3409],
5	wvvw.brit-thoracic	JJ	O	wvvw.brit-thoracic	dep	1	SENT_278	[p20l1003t3345r1747b3409],
6	.	.	O	.	_	0	SENT_278	[p20l1003t3345r1747b3409],

1	org	NN	O	org	_	0	SENT_279	[p20l1003t3345r1747b3409],
2	.	.	O	.	_	0	SENT_279	[p20l1003t3345r1747b3409],

1	uk	NN	O	uk	_	0	SENT_280	[p20l1003t3345r1747b3409],
2	/	:	O	/	punct	1	SENT_280	[p20l1003t3345r1747b3409],
3	(	CD	NUMBER	(	nsubj	4	SENT_280	[p20l142t3418r390b3484],
4	accessed	VBN	O	access	dep	1	SENT_280	[p20l142t3418r390b3484],
5	Aug	NNP	DATE	Aug	tmod	4	SENT_280	[p20l408t3422r517b3484],
6	16	CD	DATE	16	num	5	SENT_280	[p20l537t3423r605b3475],
7	,	,	DATE	,	_	0	SENT_280	[p20l537t3423r605b3475],
8	2007	CD	DATE	2007	num	5	SENT_280	[p20l628t3421r782b3484],
9	)	NN	O	)	dep	5	SENT_280	[p20l628t3421r782b3484],
10	.	.	O	.	_	0	SENT_280	[p20l628t3421r782b3484],

1	5	CD	NUMBER	5	_	0	SENT_281	[p20l10t3506r35b3552],
2	National	NNP	ORGANIZATION	National	nn	4	SENT_281	[p20l140t3503r367b3552],
3	Asthma	NNP	ORGANIZATION	Asthma	nn	4	SENT_281	[p20l384t3503r597b3552],
4	Education	NNP	ORGANIZATION	Education	dep	1	SENT_281	[p20l618t3503r887b3552],
5	and	CC	O	and	_	0	SENT_281	[p20l906t3503r1006b3552],
6	Prevention	NNP	O	Prevention	nn	7	SENT_281	[p20l1026t3506r1318b3552],
7	Program	NNP	O	Program	conj_and	4	SENT_281	[p20l1340t3508r1588b3567],
8	.	.	O	.	_	0	SENT_281	[p20l1340t3508r1588b3567],

1	Expert	NN	O	expert	nn	2	SENT_282	[p20l1612t3506r1782b3567],
2	Panel	NN	O	panel	_	0	SENT_282	[p20l1803t3503r1949b3552],

1	Report	NNP	O	Report	nsubj	15	SENT_283	[p20l141t3580r331b3640],
2	:	:	O	:	_	0	SENT_283	[p20l141t3580r331b3640],
3	guidelines	NNS	O	guideline	dep	1	SENT_283	[p20l353t3576r631b3641],
4	for	IN	O	for	mark	11	SENT_283	[p20l651t3576r728b3625],
5	the	DT	O	the	det	6	SENT_283	[p20l745t3576r829b3625],
6	diagnosis	NN	O	diagnosis	nsubj	11	SENT_283	[p20l849t3576r1102b3641],
7	and	CC	O	and	_	0	SENT_283	[p20l1123t3576r1223b3625],
8	management	NN	O	management	nsubj	11	SENT_283	[p20l1240t3586r1599b3641],
9	of	IN	O	of	_	0	SENT_283	[p20l1618t3576r1678b3625],
10	asthma	NN	O	asthma	prep_of	6	SENT_283	[p20l1688t3576r1884b3625],
11	update	VBP	O	update	dep	3	SENT_283	[p20l137t3650r320b3714],
12	on	IN	O	on	_	0	SENT_283	[p20l340t3667r408b3699],
13	selected	VBN	O	select	amod	14	SENT_283	[p20l428t3650r640b3699],
14	topics	NNS	O	topic	prep_on	11	SENT_283	[p20l657t3653r1023b3714],
15	—	VBP	O	—	_	0	SENT_283	[p20l657t3653r1023b3714],
16	2002	CD	DATE	2002	dobj	15	SENT_283	[p20l657t3653r1023b3714],
17	.	.	O	.	_	0	SENT_283	[p20l657t3653r1023b3714],
18	]	SYM	O	]	dep	15	SENT_283	[p20l1038t3655r1071b3714],

1	Allergy	NN	O	allergy	nn	2	SENT_284	[p20l1085t3650r1262b3714],
2	Clin	NN	O	clin	_	0	SENT_284	[p20l1284t3650r1390b3699],
3	Immunol	NNP	O	Immunol	dep	2	SENT_284	[p20l1411t3650r1649b3699],
4	2002	CD	DATE	2002	num	3	SENT_284	[p20l1668t3654r1807b3706],
5	;	:	O	;	_	0	SENT_284	[p20l1668t3654r1807b3706],
6	110	CD	NUMBER	110	dep	2	SENT_284	[p20l139t3728r237b3773],
7	:	:	O	:	_	0	SENT_284	[p20l139t3728r237b3773],
8	S141	NN	O	s141	nn	9	SENT_284	[p20l262t3727r511b3773],
9	—	NN	O	—	dep	6	SENT_284	[p20l262t3727r511b3773],
10	219	CD	NUMBER	219	dep	9	SENT_284	[p20l262t3727r511b3773],
11	.	.	O	.	_	0	SENT_284	[p20l262t3727r511b3773],

1	’	NN	O	’	_	0	SENT_285	[p20l2094t1972r2151b1984],
2	\	CD	NUMBER	\	num	1	SENT_285	[p20l2094t1972r2151b1984],
3	¢	NN	O	¢	dep	1	SENT_285	[p20l2094t1972r2151b1984],
4	'	''	O	'	_	0	SENT_285	[p20l2094t1972r2151b1984],
5	\	CD	NUMBER	\	num	6	SENT_285	[p20l2094t1972r2151b1984],
6	AA	NN	O	aa	dep	1	SENT_285	[p20l2094t2001r2153b2032],

1	6	CD	NUMBER	6	_	0	SENT_286	[p21l8t28r36b72],
2	Global	JJ	O	global	amod	3	SENT_286	[p21l140t23r311b73],
3	Initiative	NNP	O	Initiative	dep	1	SENT_286	[p21l331t27r561b73],
4	for	IN	O	for	_	0	SENT_286	[p21l579t23r655b72],
5	Asthma	NNP	O	Asthma	prep_for	3	SENT_286	[p21l670t23r890b73],
6	.	.	O	.	_	0	SENT_286	[p21l670t23r890b73],

1	Global	JJ	O	global	amod	2	SENT_287	[p21l912t23r1083b73],
2	strategy	NN	O	strategy	_	0	SENT_287	[p21l1102t33r1305b88],
3	for	IN	O	for	_	0	SENT_287	[p21l1320t23r1396b73],
4	asthma	NN	O	asthma	nn	5	SENT_287	[p21l1412t23r1605b73],
5	management	NN	O	management	prep_for	2	SENT_287	[p21l1622t33r1974b88],
6	and	CC	O	and	_	0	SENT_287	[p21l139t98r237b148],
7	prevention	NN	O	prevention	conj_and	5	SENT_287	[p21l253t102r537b163],
8	2006	CD	DATE	2006	num	7	SENT_287	[p21l555t103r691b148],
9	.	.	O	.	_	0	SENT_287	[p21l555t103r691b148],

1	www.ginasthma.com	NNP	O	www.ginasthma.com	nsubj	3	SENT_288	[p21l710t98r1267b163],
2	(	CD	NUMBER	(	num	1	SENT_288	[p21l1288t98r1530b163],
3	accessed	VBD	O	access	_	0	SENT_288	[p21l1288t98r1530b163],
4	Aug	NNP	DATE	Aug	dobj	3	SENT_288	[p21l1545t102r1666b163],
5	,	,	O	,	_	0	SENT_288	[p21l1545t102r1666b163],
6	16	CD	NUMBER	16	appos	4	SENT_288	[p21l1687t103r1753b155],
7	,	,	O	,	_	0	SENT_288	[p21l1687t103r1753b155],
8	2007	CD	DATE	2007	num	9	SENT_288	[p21l1775t102r1925b163],
9	)	NN	O	)	appos	6	SENT_288	[p21l1775t102r1925b163],
10	.	.	O	.	_	0	SENT_288	[p21l1775t102r1925b163],

1	7	CD	NUMBER	7	num	3	SENT_289	[p21l7t185r34b232],
2	Becker	NNP	O	Becker	nn	3	SENT_289	[p21l141t182r323b230],
3	A	NNP	O	A	_	0	SENT_289	[p21l339t185r395b238],
4	,	,	O	,	_	0	SENT_289	[p21l339t185r395b238],
5	Lemiere	NNP	O	Lemiere	nn	6	SENT_289	[p21l419t185r637b230],
6	C	NNP	O	C	appos	3	SENT_289	[p21l658t185r711b238],
7	,	,	O	,	_	0	SENT_289	[p21l658t185r711b238],
8	Berube	NNP	PERSON	Berube	nn	9	SENT_289	[p21l735t182r925b231],
9	D	NNP	O	D	appos	3	SENT_289	[p21l947t186r1004b237],
10	,	,	O	,	_	0	SENT_289	[p21l947t186r1004b237],
11	et	FW	O	et	nn	12	SENT_289	[p21l1025t191r1073b230],
12	al.	FW	O	al.	appos	3	SENT_289	[p21l1091t182r1148b230],
13	.	.	O	.	_	0	SENT_289	[p21l1091t182r1148b230],

1	Summary	NN	O	summary	_	0	SENT_290	[p21l1173t185r1437b246],
2	of	IN	O	of	_	0	SENT_290	[p21l1455t182r1514b230],
3	recommendations	NNS	O	recommendation	prep_of	1	SENT_290	[p21l138t253r630b302],
4	from	IN	O	from	_	0	SENT_290	[p21l650t253r783b302],
5	the	DT	O	the	det	9	SENT_290	[p21l801t253r885b302],
6	Canadian	JJ	MISC	canadian	amod	9	SENT_290	[p21l906t253r1160b302],
7	Asthma	NN	MISC	asthma	nn	9	SENT_290	[p21l1177t253r1389b302],
8	Consensus	NN	MISC	consensus	nn	9	SENT_290	[p21l1410t257r1702b302],
9	guidelines	NNS	O	guideline	prep_from	1	SENT_290	[p21l139t328r432b393],
10	,	,	O	,	_	0	SENT_290	[p21l139t328r432b393],
11	2003	CD	DATE	2003	appos	9	SENT_290	[p21l455t333r593b378],
12	.	.	O	.	_	0	SENT_290	[p21l455t333r593b378],

1	CMA	NNP	ORGANIZATION	CMA	_	0	SENT_291	[p21l620t332r785b393],
2	]	CD	NUMBER	]	num	1	SENT_291	[p21l620t332r785b393],
3	2005	CD	DATE	2005	num	5	SENT_291	[p21l803t331r942b385],
4	;	:	O	;	_	0	SENT_291	[p21l803t331r942b385],
5	173	CD	NUMBER	173	dep	1	SENT_291	[p21l964t331r1067b378],
6	:	:	O	:	_	0	SENT_291	[p21l964t331r1067b378],
7	S3-11	NN	O	s3-11	dep	1	SENT_291	[p21l1092t332r1252b378],
8	.	.	O	.	_	0	SENT_291	[p21l1092t332r1252b378],

1	8	CD	NUMBER	8	num	3	SENT_292	[p21l8t416r36b460],
2	Salpeter	NNP	O	Salpeter	nn	3	SENT_292	[p21l142t411r357b476],
3	SR	NN	O	sr	_	0	SENT_292	[p21l379t415r465b468],
4	,	,	O	,	_	0	SENT_292	[p21l379t415r465b468],
5	Buckley	NNP	ORGANIZATION	Buckley	nn	6	SENT_292	[p21l489t411r698b476],
6	NS	NNP	ORGANIZATION	NS	appos	3	SENT_292	[p21l717t415r810b468],
7	,	,	O	,	_	0	SENT_292	[p21l717t415r810b468],
8	Ormiston	NNP	PERSON	Ormiston	nn	9	SENT_292	[p21l833t415r1094b460],
9	TM	NNP	O	TM	appos	3	SENT_292	[p21l1112t414r1221b468],
10	,	,	O	,	_	0	SENT_292	[p21l1112t414r1221b468],
11	Salpeter	NNP	PERSON	Salpeter	nn	12	SENT_292	[p21l1246t411r1461b476],
12	EE	NNP	O	EE	appos	3	SENT_292	[p21l1481t414r1565b460],
13	.	.	O	.	_	0	SENT_292	[p21l1481t414r1565b460],

1	Meta-analysis	NN	O	meta-analysis	_	0	SENT_293	[p21l1588t411r1966b476],
2	:	:	O	:	_	0	SENT_293	[p21l1588t411r1966b476],
3	effect	NN	O	effect	dep	1	SENT_293	[p21l139t486r285b535],
4	of	IN	O	of	_	0	SENT_293	[p21l303t485r363b535],
5	long-acting	JJ	O	long-acting	amod	6	SENT_293	[p21l371t485r674b550],
6	beta-agonists	NNS	O	beta-agonist	prep_of	3	SENT_293	[p21l691t485r1043b550],
7	on	IN	O	on	_	0	SENT_293	[p21l1065t503r1132b535],
8	severe	JJ	O	severe	amod	10	SENT_293	[p21l1152t503r1317b535],
9	asthma	NN	O	asthma	nn	10	SENT_293	[p21l1337t485r1534b535],
10	exacerbations	NNS	O	exacerbation	prep_on	6	SENT_293	[p21l1553t485r1917b535],
11	and	CC	O	and	_	0	SENT_293	[p21l139t559r238b608],
12	asthma-related	JJ	O	asthma-related	amod	13	SENT_293	[p21l257t559r657b608],
13	deaths	NNS	O	death	prep_on	6	SENT_293	[p21l675t559r863b608],
14	.	.	O	.	_	0	SENT_293	[p21l675t559r863b608],

1	Ann	NNP	PERSON	Ann	nn	3	SENT_294	[p21l883t562r996b607],
2	Intern	NNP	O	Intern	nn	3	SENT_294	[p21l1018t564r1174b608],
3	Med	NNP	O	Med	_	0	SENT_294	[p21l1194t559r1304b608],
4	2006	CD	DATE	2006	num	3	SENT_294	[p21l1322t563r1461b616],
5	;	:	O	;	_	0	SENT_294	[p21l1322t563r1461b616],
6	144	CD	NUMBER	144	num	8	SENT_294	[p21l1484t563r1587b608],
7	:	:	O	:	_	0	SENT_294	[p21l1484t563r1587b608],
8	904-12	CD	NUMBER	904-12	dep	3	SENT_294	[p21l1609t563r1803b608],
9	.	.	O	.	_	0	SENT_294	[p21l1609t563r1803b608],

1	9	CD	NUMBER	9	num	3	SENT_295	[p21l8t647r36b691],
2	Sin	NNP	O	Sin	nn	3	SENT_295	[p21l142t645r227b691],
3	DD	NNP	O	DD	_	0	SENT_295	[p21l248t647r352b699],
4	,	,	O	,	_	0	SENT_295	[p21l248t647r352b699],
5	Man	NNP	O	Man	nn	9	SENT_295	[p21l375t647r495b691],
6	I	PRP	O	I	dep	9	SENT_295	[p21l515t647r549b705],
7	,	,	O	,	_	0	SENT_295	[p21l515t647r549b705],
8	Sharpe	NNP	PERSON	Sharpe	dep	9	SENT_295	[p21l574t642r759b707],
9	H	NNP	PERSON	H	appos	3	SENT_295	[p21l781t647r843b699],
10	,	,	O	,	_	0	SENT_295	[p21l781t647r843b699],
11	Gan	NNP	O	Gan	nn	12	SENT_295	[p21l866t646r976b691],
12	WQ	NNP	O	WQ	appos	3	SENT_295	[p21l994t646r1116b705],
13	,	,	O	,	_	0	SENT_295	[p21l994t646r1116b705],
14	Man	NNP	O	Man	nn	15	SENT_295	[p21l1139t647r1259b691],
15	SF	NNP	O	SF	appos	3	SENT_295	[p21l1281t645r1362b691],
16	.	.	O	.	_	0	SENT_295	[p21l1281t645r1362b691],

1	Pharmacological	JJ	O	pharmacological	amod	2	SENT_296	[p21l1386t642r1833b707],
2	management	NN	O	management	_	0	SENT_296	[p21l138t726r498b781],
3	to	TO	O	to	aux	4	SENT_296	[p21l514t726r564b766],
4	reduce	VB	O	reduce	infmod	2	SENT_296	[p21l583t716r764b766],
5	exacerbations	NNS	O	exacerbation	dobj	4	SENT_296	[p21l784t716r1147b766],
6	in	IN	O	in	_	0	SENT_296	[p21l1168t720r1222b765],
7	adults	NNS	O	adult	prep_in	4	SENT_296	[p21l1240t716r1400b766],
8	with	IN	O	with	_	0	SENT_296	[p21l1419t716r1539b766],
9	asthma	NN	O	asthma	prep_with	7	SENT_296	[p21l1558t716r1768b766],
10	:	:	O	:	_	0	SENT_296	[p21l1558t716r1768b766],
11	a	DT	O	a	det	13	SENT_296	[p21l1790t734r1817b766],
12	systematic	JJ	O	systematic	amod	13	SENT_296	[p21l140t793r421b854],
13	review	NN	O	review	dep	2	SENT_296	[p21l439t793r615b839],
14	and	CC	O	and	_	0	SENT_296	[p21l633t790r732b838],
15	meta-analysis	NN	O	meta-analysis	conj_and	13	SENT_296	[p21l750t790r1130b854],
16	.	.	O	.	_	0	SENT_296	[p21l750t790r1130b854],

1	JAMA	NNP	O	JAMA	_	0	SENT_297	[p21l1145t793r1321b854],
2	2004	CD	DATE	2004	num	1	SENT_297	[p21l1339t794r1475b846],
3	;	:	O	;	_	0	SENT_297	[p21l1339t794r1475b846],
4	292	CD	NUMBER	292	num	6	SENT_297	[p21l1498t794r1605b838],
5	:	:	O	:	_	0	SENT_297	[p21l1498t794r1605b838],
6	367-76	CD	NUMBER	367-76	dep	1	SENT_297	[p21l1629t793r1821b840],
7	.	.	O	.	_	0	SENT_297	[p21l1629t793r1821b840],

1	10	CD	NUMBER	10	_	0	SENT_298	[p21l9t877r63b922],
2	Donohue	NNP	ORGANIZATION	Donohue	dep	1	SENT_298	[p21l141t873r390b922],
3	IF	IN	ORGANIZATION	if	amod	2	SENT_298	[p21l410t876r480b935],
4	.	.	O	.	_	0	SENT_298	[p21l410t876r480b935],

1	Therapeutic	JJ	O	therapeutic	amod	2	SENT_299	[p21l501t873r826b937],
2	responses	NNS	O	response	_	0	SENT_299	[p21l844t890r1112b937],
3	in	IN	O	in	_	0	SENT_299	[p21l1132t876r1186b921],
4	asthma	NN	O	asthma	prep_in	2	SENT_299	[p21l1205t873r1402b922],
5	and	CC	O	and	_	0	SENT_299	[p21l1420t873r1520b922],
6	COPD	NN	O	copd	prep_in	2	SENT_299	[p21l1540t876r1727b922],
7	.	.	O	.	_	0	SENT_299	[p21l1540t876r1727b922],

1	Bronchodilators	NNS	O	bronchodilator	_	0	SENT_300	[p21l141t946r586b995],
2	.	.	O	.	_	0	SENT_300	[p21l141t946r586b995],

1	Chest	NN	O	chest	_	0	SENT_301	[p21l612t946r748b995],
2	2004	CD	DATE	2004	num	1	SENT_301	[p21l767t950r902b1002],
3	;	:	O	;	_	0	SENT_301	[p21l767t950r902b1002],
4	126	CD	NUMBER	126	dep	1	SENT_301	[p21l925t950r1027b995],
5	:	:	O	:	_	0	SENT_301	[p21l925t950r1027b995],
6	125S	CD	NUMBER	125s	number	7	SENT_301	[p21l1050t949r1315b997],
7	—	CD	NUMBER	—	num	8	SENT_301	[p21l1050t949r1315b997],
8	37S	NN	O	37	dep	4	SENT_301	[p21l1050t949r1315b997],
9	.	.	O	.	_	0	SENT_301	[p21l1050t949r1315b997],

1	www	NN	O	www	_	0	SENT_302	[p21l6t1169r500b1216],
2	.	.	O	.	_	0	SENT_302	[p21l6t1169r500b1216],

1	the	DT	O	the	det	4	SENT_303	[p21l6t1169r500b1216],
2	|	NN	O	|	nn	4	SENT_303	[p21l6t1169r500b1216],
3	ancet.com	NN	O	ancet.com	nn	4	SENT_303	[p21l6t1169r500b1216],
4	Vol	NN	O	vol	_	0	SENT_303	[p21l540t1169r621b1216],
5	370	CD	NUMBER	370	dep	4	SENT_303	[p21l639t1175r735b1223],
6	December	NNP	DATE	December	tmod	5	SENT_303	[p21l781t1169r1038b1216],
7	22/29	CD	DATE	22/29	num	6	SENT_303	[p21l1054t1170r1220b1224],
8	,	,	DATE	,	_	0	SENT_303	[p21l1054t1170r1220b1224],
9	2007	CD	DATE	2007	num	6	SENT_303	[p21l1239t1175r1370b1222],

1	Reihsaus	NNP	MISC	Reihsaus	nn	2	SENT_304	[p21l14t1359r207b1399],
2	E	NNP	O	E	_	0	SENT_304	[p21l226t1362r263b1405],
3	,	,	O	,	_	0	SENT_304	[p21l226t1362r263b1405],
4	Innis	NNP	PERSON	Innis	nn	5	SENT_304	[p21l282t1362r393b1399],
5	M	NNP	O	M	appos	2	SENT_304	[p21l411t1363r466b1405],
6	,	,	O	,	_	0	SENT_304	[p21l411t1363r466b1405],
7	Maclntyre	NNP	ORGANIZATION	Maclntyre	nn	8	SENT_304	[p21l485t1363r705b1411],
8	N	NNP	ORGANIZATION	N	appos	2	SENT_304	[p21l722t1363r768b1405],
9	,	,	O	,	_	0	SENT_304	[p21l722t1363r768b1405],
10	Liggett	NNP	ORGANIZATION	Liggett	nn	11	SENT_304	[p21l787t1362r935b1412],
11	SB	NN	O	sb	appos	2	SENT_304	[p21l952t1362r1020b1399],
12	.	.	O	.	_	0	SENT_304	[p21l952t1362r1020b1399],

1	Mutations	NNS	O	mutation	_	0	SENT_305	[p21l1039t1362r1258b1399],
2	in	IN	O	in	_	0	SENT_305	[p21l1274t1362r1317b1398],
3	the	DT	O	the	det	4	SENT_305	[p21l1331t1359r1399b1399],
4	gene	NN	O	gene	prep_in	1	SENT_305	[p21l12t1433r114b1471],
5	encoding	VBG	O	encode	partmod	1	SENT_305	[p21l130t1419r330b1471],
6	for	IN	O	for	_	0	SENT_305	[p21l345t1419r407b1459],
7	the	DT	O	the	det	10	SENT_305	[p21l420t1419r488b1458],
8	beta	NN	O	beta	nn	10	SENT_305	[p21l502t1419r592b1459],
9	2-adrenergic	JJ	O	2-adrenergic	amod	10	SENT_305	[p21l609t1419r880b1471],
10	receptor	NN	O	receptor	prep_for	5	SENT_305	[p21l894t1427r1073b1470],
11	in	IN	O	in	_	0	SENT_305	[p21l1087t1422r1130b1458],
12	normal	JJ	O	normal	amod	15	SENT_305	[p21l1145t1419r1304b1459],
13	and	CC	O	and	_	0	SENT_305	[p21l1319t1419r1399b1459],
14	asthmatic	JJ	O	asthmatic	conj_and	12	SENT_305	[p21l12t1478r224b1517],
15	subjects	NNS	O	subject	prep_in	10	SENT_305	[p21l240t1478r425b1530],
16	.	.	O	.	_	0	SENT_305	[p21l240t1478r425b1530],

1	Am	VBP	O	be	dep	2	SENT_306	[p21l441t1481r552b1530],
2	]	CD	NUMBER	]	_	0	SENT_306	[p21l441t1481r552b1530],
3	Respir	NNP	O	Respir	nn	6	SENT_306	[p21l568t1479r696b1529],
4	Cell	NN	O	cell	nn	6	SENT_306	[p21l711t1478r785b1517],
5	Mol	NNP	O	Mol	nn	6	SENT_306	[p21l801t1478r881b1517],
6	Biol	NNP	O	Biol	dep	2	SENT_306	[p21l898t1478r978b1517],
7	1993	CD	DATE	1993	dep	6	SENT_306	[p21l994t1481r1101b1523],
8	;	:	O	;	_	0	SENT_306	[p21l994t1481r1101b1523],
9	8	CD	NUMBER	8	dep	7	SENT_306	[p21l1119t1481r1153b1517],
10	:	:	O	:	_	0	SENT_306	[p21l1119t1481r1153b1517],
11	334-39	CD	NUMBER	334-39	dep	9	SENT_306	[p21l1172t1481r1333b1518],
12	.	.	O	.	_	0	SENT_306	[p21l1172t1481r1333b1518],

1	Hawkins	NNP	ORGANIZATION	Hawkins	nn	2	SENT_307	[p21l14t1545r205b1585],
2	GA	NNP	ORGANIZATION	GA	_	0	SENT_307	[p21l223t1548r304b1590],
3	,	,	O	,	_	0	SENT_307	[p21l223t1548r304b1590],
4	Tantisira	NNP	PERSON	Tantisira	nn	5	SENT_307	[p21l321t1547r510b1585],
5	K	NNP	PERSON	K	appos	2	SENT_307	[p21l528t1549r569b1590],
6	,	,	O	,	_	0	SENT_307	[p21l528t1549r569b1590],
7	Meyers	NNP	ORGANIZATION	Meyers	nn	8	SENT_307	[p21l587t1549r741b1597],
8	DA	NNP	ORGANIZATION	DA	appos	2	SENT_307	[p21l759t1548r840b1591],
9	,	,	O	,	_	0	SENT_307	[p21l759t1548r840b1591],
10	et	FW	O	et	nn	11	SENT_307	[p21l858t1553r896b1585],
11	al.	FW	O	al.	appos	2	SENT_307	[p21l910t1545r957b1585],
12	.	.	O	.	_	0	SENT_307	[p21l910t1545r957b1585],

1	Sequence	NN	O	sequence	nn	6	SENT_308	[p21l977t1548r1193b1597],
2	,	,	O	,	_	0	SENT_308	[p21l977t1548r1193b1597],
3	haplotype	NN	O	haplotype	nn	6	SENT_308	[p21l1209t1545r1420b1597],
4	and	CC	O	and	_	0	SENT_308	[p21l12t1604r92b1643],
5	association	NN	O	association	nn	6	SENT_308	[p21l107t1606r347b1643],
6	analysis	NN	O	analysis	_	0	SENT_308	[p21l362t1604r532b1656],
7	of	IN	O	of	_	0	SENT_308	[p21l549t1603r598b1643],
8	ADR	NN	O	adr	nn	10	SENT_308	[p21l604t1603r869b1656],
9	{	NN	O	{	nn	10	SENT_308	[p21l604t1603r869b1656],
10	beta	NN	O	beta	prep_of	6	SENT_308	[p21l604t1603r869b1656],
11	}	CD	NUMBER	}	number	12	SENT_308	[p21l604t1603r869b1656],
12	2	CD	NUMBER	2	dep	6	SENT_308	[p21l604t1603r869b1656],
13	in	IN	O	in	_	0	SENT_308	[p21l886t1606r929b1643],
14	multi-ethnic	JJ	O	multi-ethnic	amod	17	SENT_308	[p21l944t1604r1213b1643],
15	asthma	NN	O	asthma	nn	17	SENT_308	[p21l1229t1604r1387b1643],
16	case/control	NN	O	case/control	nn	17	SENT_308	[p21l12t1662r278b1714],
17	subjects	NNS	O	subject	prep_in	12	SENT_308	[p21l294t1662r479b1714],
18	.	.	O	.	_	0	SENT_308	[p21l294t1662r479b1714],

1	Am	VBP	O	be	cop	2	SENT_309	[p21l496t1665r607b1714],
2	]	CD	NUMBER	]	dep	6	SENT_309	[p21l496t1665r607b1714],
3	Respir	NNP	O	Respir	nn	5	SENT_309	[p21l622t1664r750b1714],
4	Crit	NNP	O	Crit	nn	5	SENT_309	[p21l766t1664r842b1702],
5	Care	NNP	O	Care	nsubj	6	SENT_309	[p21l860t1665r953b1702],
6	Med	VBD	O	med	_	0	SENT_309	[p21l968t1662r1057b1702],
7	2006	CD	DATE	2006	dobj	6	SENT_309	[p21l1072t1666r1184b1708],
8	;	:	O	;	_	0	SENT_309	[p21l1072t1666r1184b1708],
9	174	CD	NUMBER	174	num	11	SENT_309	[p21l1202t1665r1285b1703],
10	:	:	O	:	_	0	SENT_309	[p21l1202t1665r1285b1703],
11	1101-09	CD	DATE	1101-09	dep	7	SENT_309	[p21l1304t1666r1479b1702],
12	.	.	O	.	_	0	SENT_309	[p21l1304t1666r1479b1702],

1	Contopoulos-Ioannidis	NNP	O	Contopoulos-Ioannidis	_	0	SENT_310	[p21l13t1730r509b1781],
2	DG	NNS	O	dg	dep	1	SENT_310	[p21l528t1733r612b1775],
3	,	,	O	,	_	0	SENT_310	[p21l528t1733r612b1775],
4	Manoli	NNP	LOCATION	Manoli	nn	5	SENT_310	[p21l631t1730r783b1770],
5	EN	NNP	LOCATION	EN	appos	2	SENT_310	[p21l800t1732r875b1775],
6	,	,	O	,	_	0	SENT_310	[p21l800t1732r875b1775],
7	Ioannidis	NNP	PERSON	Ioannidis	nn	9	SENT_310	[p21l895t1730r1097b1770],
8	]	NNP	O	]	nn	9	SENT_310	[p21l1115t1734r1173b1780],
9	P.	NNP	O	P.	appos	2	SENT_310	[p21l1115t1734r1173b1780],
10	Meta-analysis	NN	O	meta-analysis	dep	9	SENT_310	[p21l1192t1730r1484b1782],
11	of	IN	O	of	prep	10	SENT_310	[p21l12t1788r60b1828],
12	the	DT	O	the	det	13	SENT_310	[p21l67t1788r135b1828],
13	association	NN	O	association	dep	17	SENT_310	[p21l151t1791r391b1828],
14	of	IN	O	of	_	0	SENT_310	[p21l406t1788r454b1828],
15	beta2-adrenergic	JJ	O	beta2-adrenergic	amod	16	SENT_310	[p21l461t1788r825b1841],
16	receptor	NN	O	receptor	prep_of	13	SENT_310	[p21l839t1796r1018b1840],
17	polymorphisms	NNS	O	polymorphism	dep	11	SENT_310	[p21l1032t1788r1375b1840],
18	with	IN	O	with	_	0	SENT_310	[p21l1390t1788r1487b1828],
19	asthma	NN	O	asthma	nn	20	SENT_310	[p21l12t1847r171b1887],
20	phenotypes	NNS	O	phenotype	prep_with	17	SENT_310	[p21l185t1847r446b1899],
21	.	.	O	.	_	0	SENT_310	[p21l185t1847r446b1899],
22	]	SYM	O	]	dep	10	SENT_310	[p21l457t1851r484b1899],

1	Allergy	NN	O	allergy	nn	2	SENT_311	[p21l495t1847r638b1900],
2	Clin	NN	O	clin	_	0	SENT_311	[p21l656t1847r741b1887],
3	Immunol	NNP	O	Immunol	dep	2	SENT_311	[p21l759t1847r950b1887],
4	2005	CD	DATE	2005	num	3	SENT_311	[p21l966t1850r1078b1893],
5	;	:	O	;	_	0	SENT_311	[p21l966t1850r1078b1893],
6	115	CD	NUMBER	115	num	8	SENT_311	[p21l1096t1849r1175b1887],
7	:	:	O	:	_	0	SENT_311	[p21l1096t1849r1175b1887],
8	963-72	CD	NUMBER	963-72	dep	2	SENT_311	[p21l1193t1850r1353b1888],
9	.	.	O	.	_	0	SENT_311	[p21l1193t1850r1353b1888],

1	Green	NNP	ORGANIZATION	Green	nn	2	SENT_312	[p21l13t1918r145b1954],
2	SA	NNP	ORGANIZATION	SA	_	0	SENT_312	[p21l163t1918r234b1960],
3	,	,	O	,	_	0	SENT_312	[p21l163t1918r234b1960],
4	Turki	NNP	PERSON	Turki	nn	5	SENT_312	[p21l250t1915r365b1954],
5	I	NNP	PERSON	I	appos	2	SENT_312	[p21l382t1918r408b1965],
6	,	,	O	,	_	0	SENT_312	[p21l382t1918r408b1965],
7	Innis	NNP	PERSON	Innis	nn	8	SENT_312	[p21l428t1917r539b1954],
8	M	NNP	O	M	appos	2	SENT_312	[p21l557t1919r611b1960],
9	,	,	O	,	_	0	SENT_312	[p21l557t1919r611b1960],
10	Liggett	NNP	ORGANIZATION	Liggett	nn	11	SENT_312	[p21l631t1917r778b1967],
11	SB	NN	O	sb	appos	2	SENT_312	[p21l795t1918r864b1954],
12	.	.	O	.	_	0	SENT_312	[p21l795t1918r864b1954],

1	Amino-terminal	JJ	O	amino-terminal	amod	2	SENT_313	[p21l880t1915r1234b1954],
2	polymorphisms	NNS	O	polymorphism	nsubj	13	SENT_313	[p21l11t1973r354b2025],
3	of	IN	O	of	_	0	SENT_313	[p21l371t1973r420b2013],
4	the	DT	O	the	det	6	SENT_313	[p21l426t1973r494b2013],
5	human	JJ	O	human	amod	6	SENT_313	[p21l509t1973r667b2013],
6	beta	NN	O	beta	prep_of	2	SENT_313	[p21l681t1973r771b2013],
7	2-adrenergic	JJ	O	2-adrenergic	amod	8	SENT_313	[p21l787t1973r1058b2026],
8	receptor	NN	O	receptor	nsubj	9	SENT_313	[p21l1073t1981r1252b2025],
9	impart	VB	O	impart	rcmod	6	SENT_313	[p21l1266t1976r1413b2025],
10	distinct	JJ	O	distinct	amod	12	SENT_313	[p21l12t2033r174b2073],
11	agonist	NN	O	agonist	nn	12	SENT_313	[p21l188t2033r574b2085],
12	—	NN	O	—	dobj	9	SENT_313	[p21l188t2033r574b2085],
13	promoted	VBD	O	promote	_	0	SENT_313	[p21l188t2033r574b2085],
14	regulatory	JJ	O	regulatory	amod	15	SENT_313	[p21l588t2033r810b2085],
15	properties	NNS	O	property	dobj	13	SENT_313	[p21l824t2036r1055b2085],
16	.	.	O	.	_	0	SENT_313	[p21l824t2036r1055b2085],

1	Biochemistry	NNP	O	Biochemistry	_	0	SENT_314	[p21l1076t2033r1339b2085],
2	1994	CD	DATE	1994	num	1	SENT_314	[p21l1354t2037r1459b2079],
3	;	:	O	;	_	0	SENT_314	[p21l1354t2037r1459b2079],
4	33	CD	NUMBER	33	num	6	SENT_314	[p21l12t2096r73b2132],
5	:	:	O	:	_	0	SENT_314	[p21l12t2096r73b2132],
6	9414-19	CD	NUMBER	9414-19	dep	1	SENT_314	[p21l91t2096r266b2132],
7	.	.	O	.	_	0	SENT_314	[p21l91t2096r266b2132],

1	Israel	NNP	LOCATION	Israel	nn	2	SENT_315	[p21l14t2158r132b2198],
2	E	NNP	O	E	_	0	SENT_315	[p21l150t2161r187b2204],
3	,	,	O	,	_	0	SENT_315	[p21l150t2161r187b2204],
4	Drazen	NNP	PERSON	Drazen	nn	5	SENT_315	[p21l206t2162r363b2198],
5	IM	NNP	PERSON	IM	appos	2	SENT_315	[p21l379t2162r453b2209],
6	,	,	O	,	_	0	SENT_315	[p21l379t2162r453b2209],
7	Liggett	NNP	ORGANIZATION	Liggett	nn	8	SENT_315	[p21l472t2161r620b2211],
8	SB	NN	O	sb	appos	2	SENT_315	[p21l637t2161r706b2204],
9	,	,	O	,	_	0	SENT_315	[p21l637t2161r706b2204],
10	et	FW	O	et	nn	11	SENT_315	[p21l723t2166r761b2198],
11	al.	FW	O	al.	appos	2	SENT_315	[p21l776t2158r822b2198],
12	.	.	O	.	_	0	SENT_315	[p21l776t2158r822b2198],

1	The	DT	O	the	det	2	SENT_316	[p21l838t2158r922b2198],
2	effect	NN	O	effect	_	0	SENT_316	[p21l938t2158r1055b2198],
3	of	IN	O	of	_	0	SENT_316	[p21l1070t2158r1118b2198],
4	polymorphisms	NNS	O	polymorphism	prep_of	2	SENT_316	[p21l1125t2158r1469b2210],
5	of	IN	O	of	_	0	SENT_316	[p21l12t2218r60b2258],
6	the	DT	O	the	det	8	SENT_316	[p21l67t2218r135b2258],
7	beta	NN	O	beta	nn	8	SENT_316	[p21l149t2218r546b2270],
8	(	NN	O	(	prep_of	4	SENT_316	[p21l149t2218r546b2270],
9	2	CD	NUMBER	2	dep	8	SENT_316	[p21l149t2218r546b2270],
10	)	SYM	O	)	dep	2	SENT_316	[p21l149t2218r546b2270],
11	-	:	O	-	_	0	SENT_316	[p21l149t2218r546b2270],
12	adrenergic	JJ	O	adrenergic	amod	13	SENT_316	[p21l149t2218r546b2270],
13	receptor	NN	O	receptor	dep	2	SENT_316	[p21l560t2226r739b2269],
14	on	IN	O	on	_	0	SENT_316	[p21l754t2232r808b2257],
15	the	DT	O	the	det	16	SENT_316	[p21l822t2218r890b2258],
16	response	NN	O	response	prep_on	13	SENT_316	[p21l905t2232r1100b2269],
17	to	TO	O	to	_	0	SENT_316	[p21l1114t2226r1154b2258],
18	regular	JJ	O	regular	amod	19	SENT_316	[p21l1170t2218r1326b2270],
19	use	NN	O	use	prep_to	16	SENT_316	[p21l1340t2232r1414b2258],
20	of	IN	O	of	_	0	SENT_316	[p21l1430t2218r1478b2257],
21	albuterol	NN	O	albuterol	prep_of	19	SENT_316	[p21l12t2276r204b2316],
22	in	IN	O	in	_	0	SENT_316	[p21l219t2279r262b2315],
23	asthma	NN	O	asthma	prep_in	21	SENT_316	[p21l278t2276r447b2316],
24	.	.	O	.	_	0	SENT_316	[p21l278t2276r447b2316],

1	Am	VBP	O	be	cop	2	SENT_317	[p21l464t2279r540b2316],
2	]	CD	NUMBER	]	dep	6	SENT_317	[p21l548t2280r575b2328],
3	Respir	NNP	O	Respir	nn	5	SENT_317	[p21l590t2278r718b2328],
4	Crit	NNP	O	Crit	nn	5	SENT_317	[p21l734t2278r810b2316],
5	Care	NNP	O	Care	nsubj	6	SENT_317	[p21l828t2279r921b2316],
6	Med	VBD	O	med	_	0	SENT_317	[p21l936t2276r1025b2316],
7	2000	CD	DATE	2000	dobj	6	SENT_317	[p21l1040t2280r1152b2322],
8	;	:	O	;	_	0	SENT_317	[p21l1040t2280r1152b2322],
9	162	CD	NUMBER	162	num	11	SENT_317	[p21l1170t2280r1253b2316],
10	:	:	O	:	_	0	SENT_317	[p21l1170t2280r1253b2316],
11	75-80	CD	NUMBER	75-80	dep	7	SENT_317	[p21l1269t2279r1405b2317],
12	.	.	O	.	_	0	SENT_317	[p21l1269t2279r1405b2317],

1	Israel	NNP	LOCATION	Israel	nn	2	SENT_318	[p21l14t2344r133b2384],
2	E	NNP	O	E	_	0	SENT_318	[p21l150t2347r187b2389],
3	,	,	O	,	_	0	SENT_318	[p21l150t2347r187b2389],
4	Chinchilli	NNP	PERSON	Chinchilli	nn	5	SENT_318	[p21l205t2344r421b2384],
5	VM	NNP	O	VM	appos	2	SENT_318	[p21l435t2348r527b2389],
6	,	,	O	,	_	0	SENT_318	[p21l435t2348r527b2389],
7	Ford	NNP	ORGANIZATION	Ford	nn	9	SENT_318	[p21l546t2344r644b2384],
8	]	CD	NUMBER	]	num	9	SENT_318	[p21l659t2347r725b2395],
9	G	NN	O	g	appos	2	SENT_318	[p21l659t2347r725b2395],
10	,	,	O	,	_	0	SENT_318	[p21l659t2347r725b2395],
11	et	FW	O	et	nn	12	SENT_318	[p21l743t2352r781b2384],
12	al.	FW	O	al.	appos	2	SENT_318	[p21l795t2344r841b2384],
13	.	.	O	.	_	0	SENT_318	[p21l795t2344r841b2384],

1	Use	NN	O	use	nsubj	4	SENT_319	[p21l861t2348r943b2384],
2	of	IN	O	of	prep	1	SENT_319	[p21l959t2344r1008b2384],
3	regularly	RB	O	regularly	pcomp	2	SENT_319	[p21l1015t2344r1209b2396],
4	scheduled	VBN	O	schedule	_	0	SENT_319	[p21l1224t2344r1443b2384],
5	albuterol	NN	O	albuterol	nn	6	SENT_319	[p21l12t2403r204b2442],
6	treatment	NN	O	treatment	tmod	4	SENT_319	[p21l219t2411r433b2442],
7	in	IN	O	in	_	0	SENT_319	[p21l447t2405r490b2442],
8	asthma	NN	O	asthma	prep_in	6	SENT_319	[p21l506t2403r675b2442],
9	:	:	O	:	_	0	SENT_319	[p21l506t2403r675b2442],
10	genotype-Stratiﬁed	JJ	O	genotype-stratiﬁed	amod	16	SENT_319	[p21l693t2402r1108b2455],
11	,	,	O	,	_	0	SENT_319	[p21l693t2402r1108b2455],
12	randomised	JJ	O	randomised	amod	16	SENT_319	[p21l1125t2403r1396b2448],
13	,	,	O	,	_	0	SENT_319	[p21l1125t2403r1396b2448],
14	placebo-controlled	JJ	O	placebo-controlled	amod	16	SENT_319	[p21l11t2461r412b2513],
15	cross-over	JJ	O	cross-over	amod	16	SENT_319	[p21l426t2475r645b2501],
16	trial	NN	O	trial	dep	6	SENT_319	[p21l658t2461r755b2501],
17	.	.	O	.	_	0	SENT_319	[p21l658t2461r755b2501],

1	Lancet	NNP	O	Lancet	_	0	SENT_320	[p21l775t2465r909b2501],
2	2004	CD	DATE	2004	num	1	SENT_320	[p21l924t2465r1033b2507],
3	;	:	O	;	_	0	SENT_320	[p21l924t2465r1033b2507],
4	364	CD	NUMBER	364	num	6	SENT_320	[p21l1051t2465r1138b2501],
5	:	:	O	:	_	0	SENT_320	[p21l1051t2465r1138b2501],
6	1505-12	CD	DATE	1505-12	dep	1	SENT_320	[p21l1156t2464r1336b2501],
7	.	.	O	.	_	0	SENT_320	[p21l1156t2464r1336b2501],

1	Taylor	NNP	PERSON	Taylor	nn	2	SENT_321	[p21l11t2529r144b2581],
2	DR	NN	O	dr	_	0	SENT_321	[p21l160t2533r240b2574],
3	,	,	O	,	_	0	SENT_321	[p21l160t2533r240b2574],
4	Drazen	NNP	PERSON	Drazen	nn	5	SENT_321	[p21l259t2533r416b2568],
5	IM	NNP	PERSON	IM	appos	2	SENT_321	[p21l432t2532r506b2579],
6	,	,	O	,	_	0	SENT_321	[p21l432t2532r506b2579],
7	Herbison	NNP	PERSON	Herbison	nn	8	SENT_321	[p21l525t2529r728b2568],
8	GP	NNP	O	GP	appos	2	SENT_321	[p21l744t2532r822b2574],
9	,	,	O	,	_	0	SENT_321	[p21l744t2532r822b2574],
10	et	FW	O	et	nn	11	SENT_321	[p21l840t2537r878b2568],
11	al.	FW	O	al.	appos	2	SENT_321	[p21l893t2529r939b2568],
12	.	.	O	.	_	0	SENT_321	[p21l893t2529r939b2568],

1	Asthma	NN	O	asthma	nn	2	SENT_322	[p21l955t2529r1127b2568],
2	exacerbations	NNS	O	exacerbation	_	0	SENT_322	[p21l1142t2529r1435b2568],
3	during	IN	O	during	_	0	SENT_322	[p21l12t2587r158b2640],
4	long	JJ	O	long	amod	8	SENT_322	[p21l172t2587r269b2640],
5	term	NN	O	term	nn	8	SENT_322	[p21l283t2595r387b2627],
6	beta	NN	O	beta	nn	8	SENT_322	[p21l401t2587r491b2627],
7	agonist	NN	O	agonist	nn	8	SENT_322	[p21l507t2590r664b2640],
8	use	NN	O	use	prep_during	2	SENT_322	[p21l678t2601r763b2627],
9	:	:	O	:	_	0	SENT_322	[p21l678t2601r763b2627],
10	influence	NN	O	influence	dep	2	SENT_322	[p21l780t2587r984b2627],
11	of	IN	O	of	_	0	SENT_322	[p21l1000t2587r1048b2627],
12	beta	NN	O	beta	prep_of	10	SENT_322	[p21l1055t2587r1200b2640],
13	(	CD	NUMBER	(	num	12	SENT_322	[p21l1055t2587r1200b2640],
14	2	CD	NUMBER	2	num	17	SENT_322	[p21l1055t2587r1200b2640],
15	)	NN	O	)	nn	17	SENT_322	[p21l1055t2587r1200b2640],
16	adrenoceptor	NN	O	adrenoceptor	nn	17	SENT_322	[p21l12t2647r299b2699],
17	polymorphism	NN	O	polymorphism	dep	10	SENT_322	[p21l313t2647r646b2699],
18	.	.	O	.	_	0	SENT_322	[p21l313t2647r646b2699],

1	Thorax	NNP	O	Thorax	_	0	SENT_323	[p21l667t2647r817b2687],
2	2000	CD	DATE	2000	num	1	SENT_323	[p21l831t2650r943b2692],
3	;	:	O	;	_	0	SENT_323	[p21l831t2650r943b2692],
4	55	CD	NUMBER	55	num	6	SENT_323	[p21l962t2649r1021b2687],
5	:	:	O	:	_	0	SENT_323	[p21l962t2649r1021b2687],
6	762-67	CD	NUMBER	762-67	dep	1	SENT_323	[p21l1038t2649r1187b2688],
7	.	.	O	.	_	0	SENT_323	[p21l1038t2649r1187b2688],

1	Wechsler	NNP	PERSON	Wechsler	nn	2	SENT_324	[p21l11t2713r212b2753],
2	ME	NNP	O	ME	_	0	SENT_324	[p21l228t2716r313b2759],
3	,	,	O	,	_	0	SENT_324	[p21l228t2716r313b2759],
4	Lehman	NNP	ORGANIZATION	Lehman	nn	5	SENT_324	[p21l332t2713r510b2753],
5	E	NNP	ORGANIZATION	E	appos	2	SENT_324	[p21l527t2716r564b2759],
6	,	,	O	,	_	0	SENT_324	[p21l527t2716r564b2759],
7	Lazarus	NNP	PERSON	Lazarus	nn	8	SENT_324	[p21l583t2717r749b2753],
8	SC	NNP	O	SC	appos	2	SENT_324	[p21l769t2716r839b2759],
9	,	,	O	,	_	0	SENT_324	[p21l769t2716r839b2759],
10	et	FW	O	et	nn	11	SENT_324	[p21l856t2721r895b2753],
11	al.	FW	O	al.	appos	2	SENT_324	[p21l909t2713r955b2753],
12	.	.	O	.	_	0	SENT_324	[p21l909t2713r955b2753],

1	Beta	NN	O	beta	_	0	SENT_325	[p21l975t2713r1315b2766],
2	—	CD	NUMBER	—	num	5	SENT_325	[p21l975t2713r1315b2766],
3	adrenergic	JJ	O	adrenergic	amod	5	SENT_325	[p21l975t2713r1315b2766],
4	receptor	NN	O	receptor	nn	5	SENT_325	[p21l11t2780r191b2824],
5	polymorphisms	NNS	O	polymorphism	dep	1	SENT_325	[p21l204t2772r547b2824],
6	and	CC	O	and	_	0	SENT_325	[p21l564t2772r645b2812],
7	response	NN	O	response	nn	9	SENT_325	[p21l659t2786r853b2824],
8	to	TO	O	to	dep	9	SENT_325	[p21l868t2780r908b2812],
9	salmeterol	NN	O	salmeterol	conj_and	5	SENT_325	[p21l925t2772r1162b2812],
10	.	.	O	.	_	0	SENT_325	[p21l925t2772r1162b2812],

1	Am	VBP	O	be	cop	2	SENT_326	[p21l10t2835r122b2884],
2	]	CD	NUMBER	]	dep	6	SENT_326	[p21l10t2835r122b2884],
3	Respir	NNP	O	Respir	nn	5	SENT_326	[p21l137t2833r265b2883],
4	Crit	NNP	O	Crit	nn	5	SENT_326	[p21l281t2833r357b2872],
5	Care	NNP	O	Care	nsubj	6	SENT_326	[p21l375t2835r467b2872],
6	Med	VBD	O	med	_	0	SENT_326	[p21l483t2832r572b2871],
7	2006	CD	DATE	2006	dobj	6	SENT_326	[p21l587t2835r699b2877],
8	;	:	O	;	_	0	SENT_326	[p21l587t2835r699b2877],
9	173	CD	NUMBER	173	num	11	SENT_326	[p21l717t2834r800b2872],
10	:	:	O	:	_	0	SENT_326	[p21l717t2834r800b2872],
11	519-26	CD	NUMBER	519-26	dep	7	SENT_326	[p21l819t2834r977b2872],
12	.	.	O	.	_	0	SENT_326	[p21l819t2834r977b2872],

1	Bleecker	NNP	O	Bleecker	nn	2	SENT_327	[p21l14t2898r197b2938],
2	ER	NN	O	er	_	0	SENT_327	[p21l213t2901r285b2944],
3	,	,	O	,	_	0	SENT_327	[p21l213t2901r285b2944],
4	Yancey	NNP	PERSON	Yancey	nn	5	SENT_327	[p21l301t2902r452b2950],
5	SW	NNP	PERSON	SW	appos	2	SENT_327	[p21l469t2901r547b2944],
6	,	,	O	,	_	0	SENT_327	[p21l469t2901r547b2944],
7	Baitinger	NNP	ORGANIZATION	Baitinger	nn	8	SENT_327	[p21l567t2901r766b2951],
8	LA	NNP	ORGANIZATION	LA	appos	2	SENT_327	[p21l782t2901r852b2944],
9	,	,	O	,	_	0	SENT_327	[p21l782t2901r852b2944],
10	et	FW	O	et	nn	11	SENT_327	[p21l870t2906r908b2938],
11	al.	FW	O	al.	appos	2	SENT_327	[p21l922t2898r968b2938],
12	.	.	O	.	_	0	SENT_327	[p21l922t2898r968b2938],

1	Salmeterol	NNP	ORGANIZATION	Salmeterol	nn	2	SENT_328	[p21l989t2898r1220b2938],
2	response	NN	O	response	nsubjpass	5	SENT_328	[p21l1234t2912r1429b2950],
3	is	VBZ	O	be	auxpass	5	SENT_328	[p21l1444t2901r1477b2938],
4	not	RB	O	not	neg	5	SENT_328	[p21l11t2966r83b2998],
5	aﬁected	VBN	O	aﬁected	_	0	SENT_328	[p21l97t2958r267b2998],
6	by	IN	O	by	_	0	SENT_328	[p21l280t2958r330b3010],
7	beta	NN	O	beta	agent	5	SENT_328	[p21l343t2958r739b3010],
8	(	CD	NUMBER	(	dobj	5	SENT_328	[p21l343t2958r739b3010],
9	2	CD	NUMBER	2	rcmod	8	SENT_328	[p21l343t2958r739b3010],
10	)	SYM	O	)	dep	9	SENT_328	[p21l343t2958r739b3010],
11	-	:	O	-	_	0	SENT_328	[p21l343t2958r739b3010],
12	adrenergic	JJ	O	adrenergic	amod	14	SENT_328	[p21l343t2958r739b3010],
13	receptor	NN	O	receptor	nn	14	SENT_328	[p21l754t2966r933b3010],
14	genotype	NN	O	genotype	npadvmod	9	SENT_328	[p21l948t2966r1143b3010],
15	in	IN	O	in	_	0	SENT_328	[p21l1158t2961r1202b2997],
16	subjects	NNS	O	subject	prep_in	9	SENT_328	[p21l1218t2958r1391b3010],
17	with	IN	O	with	_	0	SENT_328	[p21l10t3017r107b3056],
18	persistent	JJ	O	persistent	amod	19	SENT_328	[p21l121t3019r336b3068],
19	asthma	NN	O	asthma	prep_with	16	SENT_328	[p21l351t3017r520b3056],
20	.	.	O	.	_	0	SENT_328	[p21l351t3017r520b3056],
21	]	SYM	O	]	dep	8	SENT_328	[p21l532t3021r558b3069],

1	Allergy	NNP	O	Allergy	nn	3	SENT_329	[p21l570t3017r713b3069],
2	Clin	NNP	O	Clin	nn	3	SENT_329	[p21l731t3017r816b3056],
3	Immnnol	NNP	O	Immnnol	_	0	SENT_329	[p21l833t3017r1025b3056],
4	2006	CD	DATE	2006	num	3	SENT_329	[p21l1040t3020r1152b3062],
5	;	:	O	;	_	0	SENT_329	[p21l1040t3020r1152b3062],
6	118	CD	NUMBER	118	num	8	SENT_329	[p21l1171t3020r1249b3056],
7	:	:	O	:	_	0	SENT_329	[p21l1171t3020r1249b3056],
8	809-16	CD	NUMBER	809-16	dep	3	SENT_329	[p21l1267t3020r1427b3056],
9	.	.	O	.	_	0	SENT_329	[p21l1267t3020r1427b3056],

1	Nelson	NNP	PERSON	Nelson	nn	2	SENT_330	[p21l13t3083r164b3123],
2	HS	NN	O	h	_	0	SENT_330	[p21l181t3086r261b3129],
3	,	,	O	,	_	0	SENT_330	[p21l181t3086r261b3129],
4	Weiss	NNP	ORGANIZATION	Weiss	appos	2	SENT_330	[p21l277t3086r403b3123],
5	ST	JJ	ORGANIZATION	st	amod	8	SENT_330	[p21l423t3086r484b3129],
6	,	,	O	,	_	0	SENT_330	[p21l423t3086r484b3129],
7	Bleecker	NNP	O	Bleecker	dep	8	SENT_330	[p21l503t3083r686b3123],
8	ER	NN	O	er	dep	4	SENT_330	[p21l703t3086r774b3129],
9	,	,	O	,	_	0	SENT_330	[p21l703t3086r774b3129],
10	Yancey	NNP	PERSON	Yancey	nn	11	SENT_330	[p21l790t3087r941b3135],
11	SW	NNP	PERSON	SW	appos	2	SENT_330	[p21l958t3086r1036b3129],
12	,	,	O	,	_	0	SENT_330	[p21l958t3086r1036b3129],
13	Dorinsky	NNP	O	Dorinsky	nn	14	SENT_330	[p21l1056t3083r1254b3135],
14	PM	NNP	O	PM	appos	2	SENT_330	[p21l1270t3087r1355b3123],
15	.	.	O	.	_	0	SENT_330	[p21l1270t3087r1355b3123],

1	The	DT	O	the	det	6	SENT_331	[p21l1372t3083r1455b3123],
2	Salmeterol	NNP	O	Salmeterol	nn	6	SENT_331	[p21l15t3143r246b3182],
3	Multicenter	NNP	O	Multicenter	nn	6	SENT_331	[p21l262t3143r515b3182],
4	Asthma	NNP	O	Asthma	nn	6	SENT_331	[p21l528t3143r700b3182],
5	Research	NNP	O	Research	nn	6	SENT_331	[p21l717t3143r912b3182],
6	Trial	NNP	O	Trial	_	0	SENT_331	[p21l925t3143r1033b3182],
7	:	:	O	:	_	0	SENT_331	[p21l925t3143r1033b3182],
8	a	DT	O	a	det	9	SENT_331	[p21l1051t3157r1073b3182],
9	comparison	NN	O	comparison	dep	6	SENT_331	[p21l1088t3145r1346b3194],
10	of	IN	O	of	_	0	SENT_331	[p21l1361t3143r1409b3182],
11	usual	JJ	O	usual	amod	12	SENT_331	[p21l11t3201r129b3241],
12	pharmacotherapy	NN	O	pharmacotherapy	prep_of	9	SENT_331	[p21l144t3201r527b3253],
13	for	IN	O	for	_	0	SENT_331	[p21l541t3201r603b3241],
14	asthma	NN	O	asthma	prep_for	12	SENT_331	[p21l617t3201r776b3241],
15	or	CC	O	or	_	0	SENT_331	[p21l792t3216r836b3241],
16	usual	JJ	O	usual	amod	17	SENT_331	[p21l849t3201r967b3241],
17	pharmacotherapy	NN	O	pharmacotherapy	conj_or	12	SENT_331	[p21l982t3201r1366b3253],
18	plus	CC	O	plus	prep	17	SENT_331	[p21l1379t3201r1470b3253],
19	salmeterol	NN	O	salmeterol	dep	18	SENT_331	[p21l13t3260r250b3300],
20	.	.	O	.	_	0	SENT_331	[p21l13t3260r250b3300],

1	Chest	NN	O	chest	_	0	SENT_332	[p21l271t3260r381b3300],
2	2006	CD	DATE	2006	num	1	SENT_332	[p21l396t3264r508b3306],
3	;	:	O	;	_	0	SENT_332	[p21l396t3264r508b3306],
4	129	CD	NUMBER	129	num	6	SENT_332	[p21l526t3264r609b3300],
5	:	:	O	:	_	0	SENT_332	[p21l526t3264r609b3300],
6	15-26	CD	DATE	15-26	dep	1	SENT_332	[p21l627t3263r760b3300],
7	.	.	O	.	_	0	SENT_332	[p21l627t3263r760b3300],

1	we	PRP	O	we	_	0	SENT_333	[p21l2095t57r2119b103],
2	<	JJR	O	<	nsubj	8	SENT_333	[p21l2125t57r2154b103],
3	3	CD	NUMBER	3	num	4	SENT_333	[p21l2125t57r2154b103],
4	LA	NNP	O	LA	dep	2	SENT_333	[p21l2095t287r2119b332],
5	’	CD	NUMBER	’	num	4	SENT_333	[p21l2095t287r2119b332],
6	|	SYM	O	|	dep	8	SENT_333	[p21l2126t287r2148b332],
7	-	:	O	-	_	0	SENT_333	[p21l2126t287r2148b332],
8	&	CC	O	&	rcmod	1	SENT_333	[p21l2126t287r2148b332],

1	Pulmonary-Allergy	NNP	ORGANIZATION	Pulmonary-Allergy	nn	4	SENT_334	[p22l14t18r425b70],
2	Drugs	NNPS	ORGANIZATION	Drugs	nn	4	SENT_334	[p22l441t21r572b70],
3	Advisory	NNP	ORGANIZATION	Advisory	nn	4	SENT_334	[p22l587t18r778b69],
4	Committee	NNP	ORGANIZATION	Committee	_	0	SENT_334	[p22l793t20r1036b57],
5	Meeting	VBG	O	meet	partmod	4	SENT_334	[p22l1053t20r1231b70],
6	Minutes	NNPS	DURATION	Minutes	dobj	5	SENT_334	[p22l1247t20r1437b57],
7	.	.	O	.	_	0	SENT_334	[p22l1247t20r1437b57],

1	FDA	NNP	ORGANIZATION	FDA	nn	5	SENT_335	[p22l14t79r114b115],
2	Pulmonary-Allergy	NNP	ORGANIZATION	Pulmonary-Allergy	nn	5	SENT_335	[p22l130t76r541b129],
3	Drugs	NNPS	ORGANIZATION	Drugs	nn	5	SENT_335	[p22l557t80r688b129],
4	Advisory	NNP	ORGANIZATION	Advisory	nn	5	SENT_335	[p22l704t76r895b128],
5	Committee	NNP	ORGANIZATION	Committee	_	0	SENT_335	[p22l910t79r1164b122],
6	,	,	O	,	_	0	SENT_335	[p22l910t79r1164b122],
7	2006	CD	DATE	2006	appos	5	SENT_335	[p22l1182t80r1294b116],
8	.	.	O	.	_	0	SENT_335	[p22l1182t80r1294b116],

1	(	NN	O	(	_	0	SENT_336	[p22l1314t76r1410b129],
2	The	DT	O	the	nn	3	SENT_336	[p22l1314t76r1410b129],
3	committee	NN	O	committee	dobj	4	SENT_336	[p22l12t139r244b176],
4	discussed	VBD	O	discuss	dep	1	SENT_336	[p22l260t136r471b176],
5	the	DT	O	the	det	6	SENT_336	[p22l485t136r552b176],
6	implications	NNS	O	implication	npadvmod	7	SENT_336	[p22l567t136r837b188],
7	of	IN	O	of	advmod	11	SENT_336	[p22l854t136r902b176],
8	recently	RB	DATE	recently	advmod	7	SENT_336	[p22l910t136r1083b188],
9	available	JJ	O	available	amod	10	SENT_336	[p22l1097t136r1283b176],
10	data	NNS	O	datum	pobj	7	SENT_336	[p22l1298t136r1387b176],
11	related	VBN	O	relate	dep	4	SENT_336	[p22l11t195r159b234],
12	to	TO	O	to	_	0	SENT_336	[p22l173t203r213b234],
13	the	DT	O	the	det	14	SENT_336	[p22l228t195r296b234],
14	safety	NN	O	safety	prep_to	11	SENT_336	[p22l312t194r436b247],
15	of	IN	O	of	dep	4	SENT_336	[p22l450t194r498b234],
16	long	JJ	O	long	advmod	17	SENT_336	[p22l505t195r601b247],
17	acting	VBG	O	act	pcomp	15	SENT_336	[p22l616t197r748b247],
18	beta-agonist	JJ	O	beta-agonist	amod	19	SENT_336	[p22l762t195r1026b247],
19	bronchodilators	NNS	O	bronchodilator	dobj	17	SENT_336	[p22l1039t195r1425b247],
20	.	.	O	.	_	0	SENT_336	[p22l1039t195r1425b247],
21	)	SYM	O	)	dep	1	SENT_336	[p22l1039t195r1425b247],

1	.	.	O	.	_	0	SENT_337	[p22l1039t195r1425b247],

1	Martinez	NNP	PERSON	Martinez	nn	2	SENT_338	[p22l13t265r207b302],
2	FD	NNP	O	FD	_	0	SENT_338	[p22l225t264r300b302],
3	.	.	O	.	_	0	SENT_338	[p22l225t264r300b302],

1	Safety	NN	O	safety	nsubj	7	SENT_339	[p22l321t262r449b314],
2	of	IN	O	of	_	0	SENT_339	[p22l463t262r511b302],
3	long	JJ	O	long	amod	6	SENT_339	[p22l518t262r762b314],
4	—	NN	O	—	nn	6	SENT_339	[p22l518t262r762b314],
5	acting	VBG	O	act	amod	6	SENT_339	[p22l518t262r762b314],
6	beta-agonists	NNS	O	beta-agonist	prep_of	1	SENT_339	[p22l776t262r1168b314],
7	—	VBP	O	—	_	0	SENT_339	[p22l776t262r1168b314],
8	an	DT	O	a	det	10	SENT_339	[p22l776t262r1168b314],
9	urgent	JJ	O	urgent	amod	10	SENT_339	[p22l1182t270r1328b314],
10	need	NN	O	need	dobj	7	SENT_339	[p22l1342t262r1447b302],
11	to	TO	O	to	aux	12	SENT_339	[p22l11t329r51b361],
12	clear	VB	O	clear	infmod	10	SENT_339	[p22l67t321r169b361],
13	the	DT	O	the	det	14	SENT_339	[p22l183t321r251b361],
14	air	NN	O	air	dobj	12	SENT_339	[p22l266t323r329b361],
15	.	.	O	.	_	0	SENT_339	[p22l266t323r329b361],

1	N	NN	O	n	nn	3	SENT_340	[p22l349t325r387b360],
2	Engl	NNP	O	Engl	nn	3	SENT_340	[p22l401t321r524b373],
3	]	NNP	O	]	nsubj	4	SENT_340	[p22l401t321r524b373],
4	Med	VBD	O	med	_	0	SENT_340	[p22l539t321r627b360],
5	2005	CD	DATE	2005	dobj	4	SENT_340	[p22l642t323r754b366],
6	;	:	O	;	_	0	SENT_340	[p22l642t323r754b366],
7	353	CD	NUMBER	353	num	9	SENT_340	[p22l772t323r859b361],
8	:	:	O	:	_	0	SENT_340	[p22l772t323r859b361],
9	2637-39	CD	NUMBER	2637-39	dep	5	SENT_340	[p22l877t323r1064b362],
10	.	.	O	.	_	0	SENT_340	[p22l877t323r1064b362],

1	Kuna	NNP	O	Kuna	nn	2	SENT_341	[p22l14t391r127b427],
2	P	NN	O	p	_	0	SENT_341	[p22l144t391r182b433],
3	,	,	O	,	_	0	SENT_341	[p22l144t391r182b433],
4	Peters	NNP	PERSON	Peters	nn	6	SENT_341	[p22l201t391r331b427],
5	M	NN	O	m	nn	6	SENT_341	[p22l349t391r422b438],
6	]	NN	O	]	appos	2	SENT_341	[p22l349t391r422b438],
7	,	,	O	,	_	0	SENT_341	[p22l349t391r422b438],
8	Manjra	NNP	PERSON	Manjra	nn	9	SENT_341	[p22l441t390r595b439],
9	AI	NNP	O	AI	appos	2	SENT_341	[p22l609t390r674b433],
10	,	,	O	,	_	0	SENT_341	[p22l609t390r674b433],
11	et	FW	O	et	nn	12	SENT_341	[p22l691t395r729b427],
12	al.	FW	O	al.	appos	2	SENT_341	[p22l744t387r790b427],
13	.	.	O	.	_	0	SENT_341	[p22l744t387r790b427],

1	Effect	NN	O	effect	_	0	SENT_342	[p22l809t387r932b427],
2	of	IN	O	of	_	0	SENT_342	[p22l946t387r995b427],
3	budesonide/formoterol	NN	O	budesonide/formoterol	nn	4	SENT_342	[p22l10t447r520b499],
4	maintenance	NN	O	maintenance	prep_of	1	SENT_342	[p22l535t450r819b487],
5	and	CC	O	and	_	0	SENT_342	[p22l835t447r915b487],
6	reliever	NN	O	reliever	nn	7	SENT_342	[p22l929t447r1092b487],
7	therapy	NN	O	therapy	prep_of	1	SENT_342	[p22l1105t447r1269b499],
8	on	IN	O	on	_	0	SENT_342	[p22l1283t461r1337b487],
9	asthma	NN	O	asthma	nn	10	SENT_342	[p22l12t506r171b545],
10	exacerbations	NNS	O	exacerbation	prep_on	4	SENT_342	[p22l186t506r492b545],
11	.	.	O	.	_	0	SENT_342	[p22l186t506r492b545],

1	Int	NN	O	int	nn	4	SENT_343	[p22l512t509r606b558],
2	]	CD	NUMBER	]	num	4	SENT_343	[p22l512t509r606b558],
3	Clin	NNP	O	Clin	nn	4	SENT_343	[p22l623t506r708b545],
4	Pract	NNP	O	Pract	_	0	SENT_343	[p22l725t510r832b545],
5	2007	CD	DATE	2007	dep	4	SENT_343	[p22l847t508r956b551],
6	;	:	O	;	_	0	SENT_343	[p22l847t508r956b551],
7	61	CD	NUMBER	61	num	9	SENT_343	[p22l974t509r1030b545],
8	:	:	O	:	_	0	SENT_343	[p22l974t509r1030b545],
9	725-36	CD	NUMBER	725-36	dep	4	SENT_343	[p22l1047t508r1209b547],
10	.	.	O	.	_	0	SENT_343	[p22l1047t508r1209b547],

1	Busse	NNP	PERSON	Busse	nn	2	SENT_344	[p22l14t577r139b613],
2	WW	NNP	O	WW	_	0	SENT_344	[p22l153t577r256b618],
3	,	,	O	,	_	0	SENT_344	[p22l153t577r256b618],
4	Shah	NNP	PERSON	Shah	nn	5	SENT_344	[p22l276t573r384b613],
5	SR	NN	O	sr	appos	2	SENT_344	[p22l402t576r471b619],
6	,	,	O	,	_	0	SENT_344	[p22l402t576r471b619],
7	Martin	NNP	PERSON	Martin	nn	8	SENT_344	[p22l490t576r636b613],
8	P	NN	PERSON	p	appos	2	SENT_344	[p22l653t577r692b619],
9	,	,	O	,	_	0	SENT_344	[p22l653t577r692b619],
10	et	FW	O	et	nn	11	SENT_344	[p22l709t581r747b613],
11	al.	FW	O	al.	appos	2	SENT_344	[p22l762t573r808b613],
12	.	.	O	.	_	0	SENT_344	[p22l762t573r808b613],

1	Comparison	NN	O	comparison	nsubj	11	SENT_345	[p22l827t576r1095b625],
2	of	IN	O	of	_	0	SENT_345	[p22l1110t573r1158b613],
3	asthma	NN	O	asthma	nn	4	SENT_345	[p22l1166t573r1325b613],
4	exacerbations	NNS	O	exacerbation	prep_of	1	SENT_345	[p22l12t632r305b672],
5	and	CC	O	and	_	0	SENT_345	[p22l322t632r403b672],
6	lung	NN	O	lung	nn	7	SENT_345	[p22l416t632r515b684],
7	function	NN	O	function	conj_and	1	SENT_345	[p22l530t632r715b672],
8	with	IN	O	with	_	0	SENT_345	[p22l729t632r825b672],
9	adjustable-dose	JJ	O	adjustable-dose	amod	10	SENT_345	[p22l840t632r1175b684],
10	budesonide/formoterol	NN	O	budesonide/formoterol	prep_with	7	SENT_345	[p22l10t690r520b742],
11	pressurized	VBD	O	pressurize	_	0	SENT_345	[p22l535t690r790b742],
12	metered-dose	JJ	O	metered-dose	amod	16	SENT_345	[p22l804t690r1098b730],
13	inhaler	NN	O	inhaler	nn	16	SENT_345	[p22l1113t690r1269b730],
14	(	NN	O	(	nn	16	SENT_345	[p22l15t752r231b802],
15	BUD/FM	NN	O	bud/fm	nn	16	SENT_345	[p22l15t752r231b802],
16	pMDI	NN	O	pmdus	dobj	11	SENT_345	[p22l248t754r406b802],
17	)	CD	NUMBER	)	dep	16	SENT_345	[p22l248t754r406b802],
18	,	,	O	,	_	0	SENT_345	[p22l248t754r406b802],
19	ﬁxed-dose	JJ	O	ﬁxed-dose	amod	21	SENT_345	[p22l423t750r641b790],
20	BUD/PM	NN	O	bud/pm	nn	21	SENT_345	[p22l658t754r861b802],
21	pMDI	NN	O	pmdus	appos	17	SENT_345	[p22l878t754r1020b802],
22	,	,	O	,	_	0	SENT_345	[p22l878t754r1020b802],
23	and	CC	O	and	_	0	SENT_345	[p22l1038t750r1118b790],
24	ﬁxed-dose	JJ	O	ﬁxed-dose	amod	25	SENT_345	[p22l1132t750r1350b790],
25	ﬂuticasone	NN	O	ﬂuticasone	dobj	11	SENT_345	[p22l11t809r500b860],
26	/	:	O	/	punct	27	SENT_345	[p22l11t809r500b860],
27	salmeterol	NN	O	salmeterol	dep	25	SENT_345	[p22l11t809r500b860],
28	dry	JJ	O	dry	amod	30	SENT_345	[p22l515t809r585b861],
29	powder	NN	O	powder	nn	30	SENT_345	[p22l598t809r760b860],
30	inhaler	NN	O	inhaler	dep	27	SENT_345	[p22l775t809r930b849],
31	(	CD	NUMBER	(	num	32	SENT_345	[p22l947t811r1034b861],
32	FP	NN	O	fp	dep	30	SENT_345	[p22l947t811r1034b861],
33	/	:	O	/	punct	27	SENT_345	[p22l947t811r1034b861],
34	SM	NNP	O	SM	nn	36	SENT_345	[p22l1040t812r1109b849],
35	DPI	NNP	O	DPI	nn	36	SENT_345	[p22l1129t813r1241b861],
36	)	NN	O	)	dep	25	SENT_345	[p22l1129t813r1241b861],
37	.	.	O	.	_	0	SENT_345	[p22l1129t813r1241b861],

1	San	NNP	LOCATION	San	nn	2	SENT_346	[p22l1261t812r1339b849],
2	Francisco	NNP	LOCATION	Francisco	_	0	SENT_346	[p22l14t870r229b907],
3	:	:	O	:	_	0	SENT_346	[p22l14t870r229b907],
4	American	NNP	O	American	nn	6	SENT_346	[p22l246t870r461b907],
5	Thoracic	NNP	ORGANIZATION	Thoracic	nn	6	SENT_346	[p22l475t867r664b907],
6	Society	NNP	ORGANIZATION	Society	dep	2	SENT_346	[p22l682t870r838b919],
7	.	.	O	.	_	0	SENT_346	[p22l682t870r838b919],

1	2007	CD	DATE	2007	_	0	SENT_347	[p22l857t870r956b908],
2	American	JJ	MISC	american	amod	4	SENT_347	[p22l10t937r226b975],
3	Thoracic	NNP	MISC	Thoracic	nn	4	SENT_347	[p22l240t935r430b975],
4	Society	NNP	MISC	Society	dep	1	SENT_347	[p22l448t938r603b987],
5	.	.	O	.	_	0	SENT_347	[p22l448t938r603b987],

1	Standards	NNP	O	Standards	_	0	SENT_348	[p22l624t935r838b975],
2	for	IN	O	for	_	0	SENT_348	[p22l854t935r916b975],
3	the	DT	O	the	det	4	SENT_348	[p22l929t935r997b975],
4	diagnosis	NN	O	diagnosis	prep_for	1	SENT_348	[p22l1013t935r1217b987],
5	and	CC	O	and	_	0	SENT_348	[p22l1234t935r1315b974],
6	care	NN	O	care	prep_for	1	SENT_348	[p22l1329t949r1417b975],
7	of	IN	O	of	_	0	SENT_348	[p22l1432t935r1481b975],
8	patients	NNS	O	patient	prep_of	4	SENT_348	[p22l11t996r182b1045],
9	with	IN	O	with	_	0	SENT_348	[p22l198t994r294b1033],
10	chronic	JJ	O	chronic	amod	16	SENT_348	[p22l309t994r473b1033],
11	obstructive	JJ	O	obstructive	amod	16	SENT_348	[p22l488t994r726b1033],
12	pulmonary	JJ	O	pulmonary	amod	16	SENT_348	[p22l741t994r982b1046],
13	disease	NN	O	disease	nn	16	SENT_348	[p22l996t994r1152b1033],
14	(	CD	NUMBER	(	num	16	SENT_348	[p22l1170t997r1338b1046],
15	COPD	NN	O	copd	nn	16	SENT_348	[p22l1170t997r1338b1046],
16	)	NN	O	)	prep_with	1	SENT_348	[p22l1170t997r1338b1046],
17	and	CC	O	and	_	0	SENT_348	[p22l1356t994r1437b1033],
18	asthma	NN	O	asthma	prep_with	1	SENT_348	[p22l12t1052r181b1092],
19	.	.	O	.	_	0	SENT_348	[p22l12t1052r181b1092],

1	Am	VBP	O	be	dep	4	SENT_349	[p22l198t1055r275b1091],
2	Rev	NN	O	rev	nn	4	SENT_349	[p22l291t1056r364b1092],
3	Respir	NNP	O	Respir	nn	4	SENT_349	[p22l381t1054r508b1104],
4	Dis	NNP	O	Dis	_	0	SENT_349	[p22l523t1054r590b1091],
5	1987	CD	DATE	1987	num	4	SENT_349	[p22l605t1055r708b1098],
6	;	:	O	;	_	0	SENT_349	[p22l605t1055r708b1098],
7	136	CD	NUMBER	136	dep	4	SENT_349	[p22l726t1056r809b1092],
8	:	:	O	:	_	0	SENT_349	[p22l726t1056r809b1092],
9	225-44	CD	NUMBER	225-44	dep	7	SENT_349	[p22l827t1055r986b1092],
10	.	.	O	.	_	0	SENT_349	[p22l827t1055r986b1092],

1	Crow	NN	O	crow	_	0	SENT_350	[p22l13t1123r126b1159],
2	IF	IN	O	if	amod	1	SENT_350	[p22l141t1122r198b1170],
3	.	.	O	.	_	0	SENT_350	[p22l141t1122r198b1170],

1	Eighty	CD	DATE	eighty	num	2	SENT_351	[p22l217t1120r354b1172],
2	years	NNS	DATE	year	_	0	SENT_351	[p22l367t1134r477b1172],
3	ago	RB	DATE	ago	advmod	2	SENT_351	[p22l494t1134r579b1172],
4	:	:	O	:	_	0	SENT_351	[p22l494t1134r579b1172],
5	the	DT	O	the	det	6	SENT_351	[p22l596t1120r664b1159],
6	beginnings	NNS	O	beginning	dep	2	SENT_351	[p22l678t1120r923b1172],
7	of	IN	O	of	_	0	SENT_351	[p22l939t1120r988b1159],
8	population	NN	O	population	nn	9	SENT_351	[p22l995t1120r1231b1171],
9	genetics	NNS	O	genetics	prep_of	6	SENT_351	[p22l1246t1122r1434b1172],
10	.	.	O	.	_	0	SENT_351	[p22l1246t1122r1434b1172],

1	Genetics	NNP	O	Genetics	_	0	SENT_352	[p22l15t1180r183b1218],
2	1988	CD	DATE	1988	num	1	SENT_352	[p22l198t1182r305b1224],
3	;	:	O	;	_	0	SENT_352	[p22l198t1182r305b1224],
4	119	CD	NUMBER	119	num	6	SENT_352	[p22l323t1182r402b1218],
5	:	:	O	:	_	0	SENT_352	[p22l323t1182r402b1218],
6	473-76	CD	NUMBER	473-76	dep	1	SENT_352	[p22l418t1181r574b1220],
7	.	.	O	.	_	0	SENT_352	[p22l418t1181r574b1220],

1	Hosking	VBG	PERSON	hosk	_	0	SENT_353	[p22l14t1246r199b1298],
2	L	NN	PERSON	l	dobj	1	SENT_353	[p22l216t1250r250b1292],
3	,	,	O	,	_	0	SENT_353	[p22l216t1250r250b1292],
4	Lumsden	NNP	PERSON	Lumsden	nn	5	SENT_353	[p22l270t1246r472b1286],
5	S	NNP	O	S	appos	2	SENT_353	[p22l490t1249r525b1291],
6	,	,	O	,	_	0	SENT_353	[p22l490t1249r525b1291],
7	Lewis	NNP	PERSON	Lewis	nn	8	SENT_353	[p22l545t1248r664b1286],
8	K	NNP	PERSON	K	appos	2	SENT_353	[p22l683t1250r724b1291],
9	,	,	O	,	_	0	SENT_353	[p22l683t1250r724b1291],
10	et	FW	O	et	nn	11	SENT_353	[p22l741t1254r780b1285],
11	al.	FW	O	al.	appos	2	SENT_353	[p22l794t1246r840b1286],
12	.	.	O	.	_	0	SENT_353	[p22l794t1246r840b1286],

1	Detection	NN	O	detection	_	0	SENT_354	[p22l860t1249r1068b1286],
2	of	IN	O	of	_	0	SENT_354	[p22l1083t1246r1131b1286],
3	genotyping	VBG	O	genotype	prepc_of	1	SENT_354	[p22l1140t1248r1383b1298],
4	errors	NNS	O	error	dobj	3	SENT_354	[p22l12t1318r140b1344],
5	by	IN	O	by	_	0	SENT_354	[p22l155t1304r206b1356],
6	Hardy-Weinberg	JJ	O	hardy-weinberg	amod	8	SENT_354	[p22l222t1304r582b1357],
7	equilibrium	NN	O	equilibrium	nn	8	SENT_354	[p22l597t1304r857b1356],
8	testing	NN	O	testing	prep_by	3	SENT_354	[p22l871t1307r1030b1357],
9	.	.	O	.	_	0	SENT_354	[p22l871t1307r1030b1357],

1	Eur	NNP	O	Eur	nn	4	SENT_355	[p22l1050t1307r1158b1356],
2	]	CD	NUMBER	]	num	4	SENT_355	[p22l1050t1307r1158b1356],
3	Hum	NNP	O	Hum	nn	4	SENT_355	[p22l1173t1308r1281b1344],
4	Genet	NNP	O	Genet	_	0	SENT_355	[p22l1299t1307r1415b1344],
5	2004	CD	DATE	2004	dep	4	SENT_355	[p22l13t1367r122b1409],
6	;	:	O	;	_	0	SENT_355	[p22l13t1367r122b1409],
7	12	CD	NUMBER	12	num	9	SENT_355	[p22l140t1367r197b1403],
8	:	:	O	:	_	0	SENT_355	[p22l140t1367r197b1403],
9	395-99	CD	NUMBER	395-99	dep	4	SENT_355	[p22l216t1366r379b1403],
10	.	.	O	.	_	0	SENT_355	[p22l216t1366r379b1403],

1	Wigginton	NNP	PERSON	Wigginton	nn	2	SENT_356	[p22l11t1433r242b1483],
2	IE	NN	O	ie	_	0	SENT_356	[p22l258t1433r315b1481],
3	,	,	O	,	_	0	SENT_356	[p22l258t1433r315b1481],
4	Cutler	NNP	PERSON	Cutler	nn	6	SENT_356	[p22l333t1431r469b1470],
5	D	NNP	O	D	nn	6	SENT_356	[p22l485t1434r550b1481],
6	]	NNP	O	]	appos	2	SENT_356	[p22l485t1434r550b1481],
7	,	,	O	,	_	0	SENT_356	[p22l485t1434r550b1481],
8	Abecasis	NNP	O	Abecasis	nn	9	SENT_356	[p22l566t1431r753b1470],
9	GR	NN	O	gr	appos	6	SENT_356	[p22l771t1433r851b1470],
10	.	.	O	.	_	0	SENT_356	[p22l771t1433r851b1470],

1	A	DT	O	a	det	2	SENT_357	[p22l868t1433r902b1470],
2	note	NN	O	note	_	0	SENT_357	[p22l916t1439r1010b1470],
3	on	IN	O	on	_	0	SENT_357	[p22l1026t1445r1081b1470],
4	exact	JJ	O	exact	amod	5	SENT_357	[p22l1096t1439r1203b1470],
5	tests	NNS	O	test	prep_on	2	SENT_357	[p22l1217t1439r1313b1470],
6	of	IN	O	of	_	0	SENT_357	[p22l1330t1430r1378b1470],
7	Hardy-Weinberg	JJ	LOCATION	hardy-weinberg	amod	8	SENT_357	[p22l14t1489r374b1542],
8	equilibrium	NN	O	equilibrium	prep_of	2	SENT_357	[p22l389t1489r660b1541],
9	.	.	O	.	_	0	SENT_357	[p22l389t1489r660b1541],

1	Am	VBP	O	be	dep	4	SENT_358	[p22l676t1492r787b1542],
2	]	CD	NUMBER	]	num	4	SENT_358	[p22l676t1492r787b1542],
3	Hum	NNP	O	Hum	nn	4	SENT_358	[p22l803t1493r911b1529],
4	Genet	NNP	O	Genet	_	0	SENT_358	[p22l929t1492r1045b1529],
5	2005	CD	DATE	2005	num	4	SENT_358	[p22l1060t1492r1172b1535],
6	;	:	O	;	_	0	SENT_358	[p22l1060t1492r1172b1535],
7	76	CD	NUMBER	76	dep	4	SENT_358	[p22l1190t1492r1250b1530],
8	:	:	O	:	_	0	SENT_358	[p22l1190t1492r1250b1530],
9	887-93	CD	NUMBER	887-93	dep	7	SENT_358	[p22l1268t1492r1429b1530],
10	.	.	O	.	_	0	SENT_358	[p22l1268t1492r1429b1530],

1	Taylor	NNP	PERSON	Taylor	nn	2	SENT_359	[p22l11t1557r144b1609],
2	DR	NN	O	dr	_	0	SENT_359	[p22l160t1561r240b1602],
3	,	,	O	,	_	0	SENT_359	[p22l160t1561r240b1602],
4	Epton	NNP	PERSON	Epton	nn	6	SENT_359	[p22l259t1559r386b1608],
5	M	NNP	O	M	nn	6	SENT_359	[p22l402t1561r475b1608],
6	]	NN	O	]	appos	2	SENT_359	[p22l402t1561r475b1608],
7	,	,	O	,	_	0	SENT_359	[p22l402t1561r475b1608],
8	Kennedy	NNP	PERSON	Kennedy	nn	9	SENT_359	[p22l495t1557r684b1609],
9	MA	NNP	PERSON	MA	appos	2	SENT_359	[p22l700t1560r789b1602],
10	,	,	O	,	_	0	SENT_359	[p22l700t1560r789b1602],
11	et	FW	O	et	nn	14	SENT_359	[p22l807t1565r845b1597],
12	al	FW	O	al	nn	14	SENT_359	[p22l860t1557r895b1597],
13	Bronchodilator	NN	O	bronchodilator	nn	14	SENT_359	[p22l912t1557r1239b1597],
14	response	NN	O	response	appos	2	SENT_359	[p22l1253t1571r1447b1608],
15	in	IN	O	in	_	0	SENT_359	[p22l11t1618r55b1654],
16	relation	NN	O	relation	prep_in	14	SENT_359	[p22l69t1615r236b1655],
17	to	TO	O	to	_	0	SENT_359	[p22l250t1623r291b1655],
18	beta2	NN	O	beta2	nn	19	SENT_359	[p22l305t1615r725b1667],
19	—	NN	O	—	prep_to	16	SENT_359	[p22l305t1615r725b1667],
20	adrenoceptor	NN	O	adrenoceptor	nn	21	SENT_359	[p22l305t1615r725b1667],
21	haplotype	NN	O	haplotype	dep	2	SENT_359	[p22l738t1615r950b1667],
22	in	IN	O	in	_	0	SENT_359	[p22l965t1618r1008b1654],
23	patients	NNS	O	patient	prep_in	21	SENT_359	[p22l1023t1618r1194b1667],
24	with	IN	O	with	_	0	SENT_359	[p22l1209t1615r1306b1655],
25	asthma	NN	O	asthma	prep_with	23	SENT_359	[p22l1321t1615r1490b1655],
26	.	.	O	.	_	0	SENT_359	[p22l1321t1615r1490b1655],

1	Am	VBP	O	be	cop	2	SENT_360	[p22l11t1677r122b1726],
2	]	CD	NUMBER	]	dep	6	SENT_360	[p22l11t1677r122b1726],
3	Respir	NNP	O	Respir	nn	5	SENT_360	[p22l137t1676r265b1726],
4	Crit	NNP	O	Crit	nn	5	SENT_360	[p22l281t1676r357b1714],
5	Care	NNP	O	Care	nsubj	6	SENT_360	[p22l375t1677r467b1714],
6	Med	VBD	O	med	_	0	SENT_360	[p22l483t1674r572b1714],
7	2005	CD	DATE	2005	dobj	6	SENT_360	[p22l587t1677r699b1720],
8	;	:	O	;	_	0	SENT_360	[p22l587t1677r699b1720],
9	172	CD	NUMBER	172	num	11	SENT_360	[p22l717t1677r800b1714],
10	:	:	O	:	_	0	SENT_360	[p22l717t1677r800b1714],
11	700-03	CD	NUMBER	700-03	dep	7	SENT_360	[p22l816t1677r978b1715],
12	.	.	O	.	_	0	SENT_360	[p22l816t1677r978b1715],

1	Calhoun	NNP	PERSON	Calhoun	nn	3	SENT_361	[p22l13t1742r197b1781],
2	W	NNP	O	W	nn	3	SENT_361	[p22l211t1745r289b1792],
3	]	NN	O	]	_	0	SENT_361	[p22l211t1745r289b1792],
4	,	,	O	,	_	0	SENT_361	[p22l211t1745r289b1792],
5	Sutton	NNP	PERSON	Sutton	nn	6	SENT_361	[p22l309t1744r449b1781],
6	LB	NNP	O	LB	appos	3	SENT_361	[p22l467t1745r534b1787],
7	,	,	O	,	_	0	SENT_361	[p22l467t1745r534b1787],
8	Emmett	NNP	PERSON	Emmett	nn	9	SENT_361	[p22l554t1744r728b1781],
9	A	NNP	O	A	appos	3	SENT_361	[p22l742t1745r787b1787],
10	,	,	O	,	_	0	SENT_361	[p22l742t1745r787b1787],
11	Dorinsky	NNP	O	Dorinsky	nn	12	SENT_361	[p22l806t1742r1004b1793],
12	PM	NNP	O	PM	appos	3	SENT_361	[p22l1020t1746r1105b1781],
13	.	.	O	.	_	0	SENT_361	[p22l1020t1746r1105b1781],

1	Asthma	NN	O	asthma	nn	2	SENT_362	[p22l1122t1742r1293b1781],
2	variability	NN	O	variability	_	0	SENT_362	[p22l10t1800r226b1852],
3	in	IN	O	in	advmod	6	SENT_362	[p22l239t1803r283b1839],
4	patients	NNS	O	patient	pobj	3	SENT_362	[p22l297t1803r468b1852],
5	previously	RB	DATE	previously	advmod	4	SENT_362	[p22l484t1800r709b1852],
6	treated	VBN	O	treat	partmod	2	SENT_362	[p22l722t1800r872b1840],
7	with	IN	O	with	prep	6	SENT_362	[p22l885t1800r981b1840],
8	beta2-agonists	NNS	O	beta2-agonist	dep	7	SENT_362	[p22l996t1800r1306b1853],
9	alone	RB	O	alone	dep	8	SENT_362	[p22l1323t1800r1449b1840],
10	.	.	O	.	_	0	SENT_362	[p22l1323t1800r1449b1840],
11	]	SYM	O	]	dep	2	SENT_362	[p22l6t1864r32b1912],

1	Allergy	NN	O	allergy	nn	2	SENT_363	[p22l44t1860r187b1912],
2	Clin	NN	O	clin	_	0	SENT_363	[p22l204t1860r290b1900],
3	Immunol	NNP	O	Immunol	dep	2	SENT_363	[p22l307t1860r499b1900],
4	2003	CD	DATE	2003	num	3	SENT_363	[p22l514t1863r626b1906],
5	;	:	O	;	_	0	SENT_363	[p22l514t1863r626b1906],
6	112	CD	NUMBER	112	num	8	SENT_363	[p22l644t1863r723b1900],
7	:	:	O	:	_	0	SENT_363	[p22l644t1863r723b1900],
8	1088-94	CD	NUMBER	1088-94	dep	2	SENT_363	[p22l742t1863r924b1900],
9	.	.	O	.	_	0	SENT_363	[p22l742t1863r924b1900],

1	Drazen	NNP	PERSON	Drazen	nn	2	SENT_364	[p22l14t1930r171b1966],
2	IM	NNP	PERSON	IM	_	0	SENT_364	[p22l187t1930r261b1977],
3	,	,	O	,	_	0	SENT_364	[p22l187t1930r261b1977],
4	Silverman	NNP	PERSON	Silverman	nn	5	SENT_364	[p22l281t1926r500b1966],
5	EK	NNP	PERSON	EK	appos	2	SENT_364	[p22l517t1929r588b1972],
6	,	,	O	,	_	0	SENT_364	[p22l517t1929r588b1972],
7	Lee	NNP	PERSON	Lee	nn	8	SENT_364	[p22l607t1930r679b1966],
8	TH	NN	O	th	appos	5	SENT_364	[p22l693t1929r778b1966],
9	.	.	O	.	_	0	SENT_364	[p22l693t1929r778b1966],

1	Heterogeneity	NN	O	heterogeneity	_	0	SENT_365	[p22l798t1929r1105b1979],
2	of	IN	O	of	_	0	SENT_365	[p22l1120t1926r1168b1966],
3	therapeutic	JJ	O	therapeutic	amod	4	SENT_365	[p22l1175t1926r1421b1978],
4	responses	NNS	O	response	prep_of	1	SENT_365	[p22l11t2000r226b2038],
5	in	IN	O	in	_	0	SENT_365	[p22l243t1989r286b2025],
6	asthma	NN	O	asthma	prep_in	1	SENT_365	[p22l302t1986r471b2026],
7	.	.	O	.	_	0	SENT_365	[p22l302t1986r471b2026],

1	Br	NNP	O	Br	nn	3	SENT_366	[p22l492t1990r542b2025],
2	Med	NNP	O	Med	nn	3	SENT_366	[p22l555t1986r643b2026],
3	Bull	NNP	O	Bull	_	0	SENT_366	[p22l660t1986r742b2026],
4	2000	CD	DATE	2000	num	3	SENT_366	[p22l758t1990r869b2031],
5	;	:	O	;	_	0	SENT_366	[p22l758t1990r869b2031],
6	56	CD	NUMBER	56	num	8	SENT_366	[p22l889t1988r948b2026],
7	:	:	O	:	_	0	SENT_366	[p22l889t1988r948b2026],
8	1054-70	CD	NUMBER	1054-70	dep	3	SENT_366	[p22l966t1988r1145b2027],
9	.	.	O	.	_	0	SENT_366	[p22l966t1988r1145b2027],

1	National	NNP	O	National	nn	2	SENT_367	[p22l13t2054r196b2093],
2	Institutes	NNPS	O	Institutes	_	0	SENT_367	[p22l213t2056r416b2093],
3	of	IN	O	of	_	0	SENT_367	[p22l433t2053r481b2093],
4	Health	NNP	O	Health	prep_of	2	SENT_367	[p22l491t2054r647b2093],
5	:	:	O	:	_	0	SENT_367	[p22l491t2054r647b2093],
6	National	NNP	O	National	nn	8	SENT_367	[p22l666t2054r849b2093],
7	Heart	NNP	O	Heart	nn	8	SENT_367	[p22l866t2057r989b2093],
8	LaBl	NNP	O	LaBl	dep	2	SENT_367	[p22l1005t2057r1116b2093],
9	.	.	O	.	_	0	SENT_367	[p22l1005t2057r1116b2093],

1	Guidelines	NNS	O	guideline	_	0	SENT_368	[p22l1134t2054r1368b2093],
2	for	IN	O	for	_	0	SENT_368	[p22l1384t2053r1446b2093],
3	the	DT	O	the	det	4	SENT_368	[p22l11t2111r79b2151],
4	diagnosis	NN	O	diagnosis	prep_for	1	SENT_368	[p22l94t2111r299b2164],
5	and	CC	O	and	_	0	SENT_368	[p22l316t2111r396b2151],
6	management	NN	O	management	prep_for	1	SENT_368	[p22l410t2119r700b2164],
7	of	IN	O	of	_	0	SENT_368	[p22l715t2111r763b2151],
8	asthma	NN	O	asthma	prep_of	4	SENT_368	[p22l771t2111r940b2151],
9	.	.	O	.	_	0	SENT_368	[p22l771t2111r940b2151],

1	NIH	NNP	ORGANIZATION	NIH	nn	2	SENT_369	[p22l960t2115r1060b2151],
2	Publication	NNP	O	Publication	_	0	SENT_369	[p22l1076t2111r1309b2151],
3	1997	CD	DATE	1997	num	2	SENT_369	[p22l13t2174r116b2217],
4	;	:	O	;	_	0	SENT_369	[p22l13t2174r116b2217],
5	97	CD	NUMBER	97	dep	2	SENT_369	[p22l134t2174r195b2212],
6	.	.	O	.	_	0	SENT_369	[p22l134t2174r195b2212],

1	Drysdale	NNP	PERSON	Drysdale	nn	2	SENT_370	[p22l14t2237r196b2289],
2	CM	NN	O	cm	_	0	SENT_370	[p22l212t2240r300b2283],
3	,	,	O	,	_	0	SENT_370	[p22l212t2240r300b2283],
4	McGraw	NNP	PERSON	McGraw	nn	5	SENT_370	[p22l316t2240r497b2277],
5	DW	NNP	O	DW	appos	2	SENT_370	[p22l511t2241r599b2283],
6	,	,	O	,	_	0	SENT_370	[p22l511t2241r599b2283],
7	Stack	NNP	O	Stack	nn	8	SENT_370	[p22l617t2237r728b2277],
8	CB	NNP	O	CB	appos	2	SENT_370	[p22l741t2240r815b2283],
9	,	,	O	,	_	0	SENT_370	[p22l741t2240r815b2283],
10	et	FW	O	et	nn	11	SENT_370	[p22l831t2245r868b2277],
11	al.	FW	O	al.	appos	2	SENT_370	[p22l881t2237r926b2277],
12	.	.	O	.	_	0	SENT_370	[p22l881t2237r926b2277],

1	Complex	NN	O	complex	nn	2	SENT_371	[p22l943t2237r1130b2289],
2	promoter	NN	O	promoter	nsubj	10	SENT_371	[p22l1142t2245r1342b2289],
3	and	CC	O	and	_	0	SENT_371	[p22l1355t2237r1433b2277],
4	coding	VBG	O	code	amod	6	SENT_371	[p22l12t2313r154b2365],
5	region	NN	O	region	nn	6	SENT_371	[p22l167t2316r303b2365],
6	beta	NN	O	beta	nsubj	10	SENT_371	[p22l315t2313r402b2353],
7	2-adrenergic	JJ	O	2-adrenergic	amod	9	SENT_371	[p22l417t2313r678b2365],
8	receptor	NN	O	receptor	nn	9	SENT_371	[p22l691t2321r864b2365],
9	haplotypes	NNS	O	haplotype	dep	2	SENT_371	[p22l876t2313r1101b2365],
10	alter	VBP	O	alter	_	0	SENT_371	[p22l1116t2313r1208b2353],
11	receptor	NN	O	receptor	nn	12	SENT_371	[p22l1221t2321r1394b2365],
12	expression	NN	O	expression	dobj	10	SENT_371	[p22l12t2375r236b2423],
13	and	CC	O	and	_	0	SENT_371	[p22l250t2372r328b2411],
14	predict	VB	O	predict	conj_and	10	SENT_371	[p22l341t2372r488b2423],
15	in	FW	O	in	nn	16	SENT_371	[p22l500t2375r542b2411],
16	vivo	FW	O	vivo	advmod	14	SENT_371	[p22l554t2375r638b2412],
17	responsiveness	NN	O	responsiveness	dobj	14	SENT_371	[p22l651t2374r982b2423],
18	.	.	O	.	_	0	SENT_371	[p22l651t2374r982b2423],

1	Proc	NNP	ORGANIZATION	Proc	nn	5	SENT_372	[p22l1000t2376r1087b2411],
2	Natl	NNP	ORGANIZATION	Natl	nn	5	SENT_372	[p22l1101t2372r1188b2411],
3	Acad	NNP	ORGANIZATION	Acad	nn	5	SENT_372	[p22l1199t2372r1302b2411],
4	Sci	NNP	ORGANIZATION	Sci	nn	5	SENT_372	[p22l1318t2373r1375b2411],
5	USA	NNP	ORGANIZATION	USA	_	0	SENT_372	[p22l1396t2375r1490b2411],
6	2000	CD	DATE	2000	num	5	SENT_372	[p22l13t2434r122b2476],
7	;	:	O	;	_	0	SENT_372	[p22l13t2434r122b2476],
8	97	CD	NUMBER	97	num	10	SENT_372	[p22l138t2433r197b2471],
9	:	:	O	:	_	0	SENT_372	[p22l138t2433r197b2471],
10	10483-88	CD	NUMBER	10483-88	dep	5	SENT_372	[p22l214t2434r421b2470],
11	.	.	O	.	_	0	SENT_372	[p22l214t2434r421b2470],

